PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alperin, M; Hoehler, T				Alperin, Marc; Hoehler, Tori			BIOGEOCHEMISTRY The Ongoing Mystery of Sea-Floor Methane	SCIENCE			English	Editorial Material							ANAEROBIC OXIDATION; BACTERIA; CONSTRAINTS; SEDIMENTS; CONSORTIUM; ARCHAEA		[Alperin, Marc] Univ N Carolina, Chapel Hill, NC 27599 USA; [Hoehler, Tori] NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA	University of North Carolina; University of North Carolina Chapel Hill; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Alperin, M (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	alperin@email.unc.edu; tori.m.hoehler@nasa.gov						Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Alperin MJ, 2009, AM J SCI, V309, P958, DOI 10.2475/10.2009.02; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; House CH, 2009, ENVIRON MICROBIOL, V11, P2207, DOI 10.1111/j.1462-2920.2009.01934.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Londry KL, 2008, ORG GEOCHEM, V39, P608, DOI 10.1016/j.orggeochem.2008.03.002; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; REEBURGH WS, 1976, EARTH PLANET SC LETT, V28, P337, DOI 10.1016/0012-821X(76)90195-3; Sommer S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002389; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	16	29	33	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					288	289		10.1126/science.1189966	http://dx.doi.org/10.1126/science.1189966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647456				2022-12-24	WOS:000279925900028
J	Clayton, J				Clayton, Julie			Chagas disease: pushing through the pipeline	NATURE			English	Editorial Material							TRYPANOSOMA-CRUZI; ERGOSTEROL BIOSYNTHESIS; POSACONAZOLE; AMIODARONE; INFECTION											Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; *CLINICALTRIALS GO, 2005, BENEFIT TRIAL EV US; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; *GEORG I INT HLTH, 2007, G FINDER GLOB FUND I; *INT FED PHARM MAN, 2009, HLTH PARTN DEV WORLD; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Munoz J, 2009, CLIN INFECT DIS, V48, P1736, DOI 10.1086/599223; Paniz-Mondolfi AE, 2009, CHEMOTHERAPY, V55, P228, DOI 10.1159/000219436; Pinazo MJ, 2010, AM J TROP MED HYG, V82, P583, DOI 10.4269/ajtmh.2010.09-0620; Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022; Silva DT, 2006, INT J ANTIMICROB AG, V27, P530, DOI 10.1016/j.ijantimicag.2005.12.012; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Yun O, 2009, PLOS NEGLECT TROP D, V3, P1	13	111	112	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S12	S15		10.1038/nature09224	http://dx.doi.org/10.1038/nature09224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571548	Bronze			2022-12-24	WOS:000279056900028
J	Chen, SK; Tvrdik, P; Peden, E; Cho, S; Wu, S; Spangrude, G; Capecchi, MR				Chen, Shau-Kwaun; Tvrdik, Petr; Peden, Erik; Cho, Scott; Wu, Sen; Spangrude, Gerald; Capecchi, Mario R.			Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice	CELL			English	Article							OBSESSIVE-COMPULSIVE DISORDER; HOX-2.4 HOMEOBOX GENE; COMMON VARIANTS; SERIAL ORDER; MICROGLIA; SCHIZOPHRENIA; EXPRESSION; MOUSE; DIFFERENTIATION; PROGENITORS	Mouse Hoxb8 mutants show unexpected behavior manifested by compulsive grooming and hair removal, similar to behavior in humans with the obsessive-compulsive disorder spectrum disorder trichotillomania. As Hox gene disruption often has pleiotropic effects, the root cause of this behavioral deficit was unclear. Here we report that, in the brain, Hoxb8 cell lineage exclusively labels bone marrow-derived microglia. Furthermore, transplantation of wild-type bone marrow into Hoxb8 mutant mice rescues their pathological phenotype. It has been suggested that the grooming dysfunction results from a nociceptive defect, also exhibited by Hoxb8 mutant mice. However, bone marrow transplant experiments and cell type-specific disruption of Hoxb8 reveal that these two phenotypes are separable, with the grooming phenotype derived from the hematopoietic lineage and the sensory defect derived from the spinal cord cells. Immunological dysfunctions have been associated with neuropsychiatric disorders, but the causative relationships are unclear. In this mouse, a distinct compulsive behavioral disorder is associated with mutant microglia.	[Chen, Shau-Kwaun; Tvrdik, Petr; Peden, Erik; Wu, Sen; Capecchi, Mario R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA; [Cho, Scott; Spangrude, Gerald] Univ Utah, Dept Pathol & Med, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu	Tvrdik, Petr/AAK-4398-2021	Tvrdik, Petr/0000-0002-8750-9672; CHEN, SHAU-KWAUN/0000-0002-0701-6799; Peden, Erik/0000-0002-8436-3217; Cho, Scott/0000-0002-7909-4702	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R37 HD030701] Funding Source: Medline; NIGMS NIH HHS [R01 GM021168, R01 GM021168-36] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD030701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE JW, 1993, PSYCHOL SCI, V4, P391, DOI 10.1111/j.1467-9280.1993.tb00587.x; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; Brash HM, 2005, J NEUROSCI METH, V142, P107, DOI 10.1016/j.jneumeth.2004.08.001; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; da Rocha FF, 2008, PROG NEURO-PSYCHOPH, V32, P1139, DOI 10.1016/j.pnpbp.2007.12.026; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Holstege JC, 2008, P NATL ACAD SCI USA, V105, P6338, DOI 10.1073/pnas.0802176105; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; Hounie AG, 2008, NEUROSCI LETT, V442, P86, DOI 10.1016/j.neulet.2008.07.022; Huey ED, 2008, J NEUROPSYCH CLIN N, V20, P390, DOI 10.1176/appi.neuropsych.20.4.390; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kaur C, 2001, MICROSC RES TECHNIQ, V54, P2, DOI 10.1002/jemt.1114; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; Krishnaraju K, 1997, BLOOD, V90, P1840, DOI 10.1182/blood.V90.5.1840; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; PERKINS AC, 1993, EMBO J, V12, P3835, DOI 10.1002/j.1460-2075.1993.tb06062.x; PETRINI M, 1992, BLOOD, V80, P185; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spangrude GJ, 2006, STEM CELLS, V24, P2045, DOI 10.1634/stemcells.2006-0013; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Strous RD, 2006, J AUTOIMMUN, V27, P71, DOI 10.1016/j.jaut.2006.07.006; Taylor JL, 2010, BRAIN RES, V1322, P92, DOI 10.1016/j.brainres.2010.01.052; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang HF, 2006, EXP HEMATOL, V34, P1730, DOI 10.1016/j.exphem.2006.08.001; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	36	285	294	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					775	785		10.1016/j.cell.2010.03.055	http://dx.doi.org/10.1016/j.cell.2010.03.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510925	Green Accepted, Bronze			2022-12-24	WOS:000278132900013
J	Geraghty, LN				Geraghty, Laurel Naversen			The Denver II	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												laurel.geraghty@med.nyu.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2012	2012		10.1001/jama.2010.623	http://dx.doi.org/10.1001/jama.2010.623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501916				2022-12-24	WOS:000278018200001
J	Gregg, C; Zhang, JW; Butler, JE; Haig, D; Dulac, C				Gregg, Christopher; Zhang, Jiangwen; Butler, James E.; Haig, David; Dulac, Catherine			Sex-Specific Parent-of-Origin Allelic Expression in the Mouse Brain	SCIENCE			English	Article							X-CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; INTERLEUKIN-18; EVOLUTION; GENES	Genomic imprinting results in preferential gene expression from paternally versus maternally inherited chromosomes. We used a genome-wide approach to uncover sex-specific parent-of-origin allelic effects in the adult mouse brain. Our study identified preferential selection of the maternally inherited X chromosome in glutamatergic neurons of the female cortex. Moreover, analysis of the cortex and hypothalamus identified 347 autosomal genes with sex-specific imprinting features. In the hypothalamus, sex-specific imprinted genes were mostly found in females, which suggests parental influence over the hypothalamic function of daughters. We show that interleukin-18, a gene linked to diseases with sex-specific prevalence, is subject to complex, regional, and sex-specific parental effects in the brain. Parent-of-origin effects thus provide new avenues for investigation of sexual dimorphism in brain function and disease.	[Gregg, Christopher; Butler, James E.; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gregg, Christopher; Butler, James E.; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Dulac, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; Dulac, Catherine/0000-0001-5024-5418	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank L. Luo, T. Maniatis, R. Losick, S. Hippenmeyer, and members of the Maniatis and Dulac labs for critical comments on the manuscript. We thank R. Hellmiss for help with figures and R. Jaenisch for X<SUP>egfp</SUP> mice. This work was supported by the Klarman Foundation for Eating Disorders and the Howard Hughes Medical Institute (HHMI). C. G. is supported by a Human Frontiers long-term fellowship and Alberta Heritage Foundation for Medical Research Incentive Award. C. D. is an HHMI investigator. All data can be found in GEO: GSE22131.	Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; [Anonymous], 2008, SEX DIFFERENCES BRAI; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Baysal BE, 2004, AM J MED GENET C, V129C, P85, DOI 10.1002/ajmg.c.30018; Chadwick LH, 2005, MAMM GENOME, V16, P691, DOI 10.1007/s00335-005-0059-2; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; FALCONER DS, 1982, GENET RES, V39, P237, DOI 10.1017/S0016672300020930; FOWLIS DJ, 1991, GENET RES, V58, P63, DOI 10.1017/S001667230002961X; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Haig D, 2006, CYTOGENET GENOME RES, V113, P68, DOI 10.1159/000090816; Haig D, 2006, EVOLUTION, V60, P440; HALL JG, 1990, AM J HUM GENET, V46, P857; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Herrera BM, 2008, NEUROLOGY, V71, P799, DOI 10.1212/01.wnl.0000312377.50395.00; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	27	246	251	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					682	685		10.1126/science.1190831	http://dx.doi.org/10.1126/science.1190831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616234	Green Accepted			2022-12-24	WOS:000280602700039
J	Hyppa, RW; Smith, GR				Hyppa, Randy W.; Smith, Gerald R.			Crossover Invariance Determined by Partner Choice for Meiotic DNA Break Repair	CELL			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; STRAND EXCHANGE; RECOMBINATION REPAIR; JOINT MOLECULES; PROTEIN COMPLEX; RAD52 HOMOLOGS; DMC1; MEIOSIS	Crossovers between meiotic homologs are crucial for their proper segregation, and crossover number and position are carefully controlled. Crossover homeostasis in budding yeast maintains crossovers at the expense of noncrossovers when double-strand DNA break (DSB) frequency is reduced. The mechanism of maintaining constant crossover levels in other species has been unknown. Here we investigate in fission yeast a different aspect of crossover control-the near invariance of crossover frequency per kb of DNA despite large variations in DSB intensity across the genome. Crossover invariance involves the choice of sister chromatid versus homolog for DSB repair. At strong DSB hotspots, intersister repair outnumbers interhomolog repair similar to 3:1, but our genetic and physical data indicate the converse in DSB-cold regions. This unanticipated mechanism of crossover control may operate in many species and explain, for example, the large excess of DSBs over crossovers and the repair of DSBs on unpaired chromosomes in diverse species.	[Hyppa, Randy W.; Smith, Gerald R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	gsmith@fhcrc.org		Smith, Gerald/0000-0002-8747-1352	National Institutes of Health [GM031693]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Hiroshi Iwasaki for strains; Chad Ellermeier, Joseph Farah, and Emily Higuchi for unpublished recombination data; Michael Lichten and Hiroshi Iwasaki for unpublished information; Gareth Cromie for critical discussions and unpublished DSB data from the mbs1-19 mutant; and Sue Amundsen, Michael Lichten, and Naina Phadnis for helpful comments on the manuscript. This work was supported by research grant GM031693 from the National Institutes of Health to G.R.S.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cromie GA, 2005, GENETICS, V169, P595, DOI 10.1534/genetics.104.037176; Cromie Gareth, 2008, V3, P195, DOI 10.1007/7050_2007_025; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; DEVEAUX LC, 1992, GENETICS, V130, P251; Egel R, 2008, RECOMBINATION MEIOSI; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Farah JA, 2009, P NATL ACAD SCI USA, V106, P9356, DOI 10.1073/pnas.0902793106; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Fukushima K, 2000, NUCLEIC ACIDS RES, V28, P2709, DOI 10.1093/nar/28.14.2709; Grishchuk AL, 2003, GENETICS, V165, P1031; GUTZ H, 1971, GENETICS, V69, P331; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hyppa RW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000267; Jaramillo-Lambert A, 2010, GENETICS, V184, P613, DOI 10.1534/genetics.109.110338; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; KADYK LC, 1992, GENETICS, V132, P387; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Khasanov FK, 1999, GENETICS, V152, P1557; Khasanov FK, 2008, CURR GENET, V54, P197, DOI 10.1007/s00294-008-0212-z; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mercier R, 2005, CURR BIOL, V15, P692, DOI 10.1016/j.cub.2005.02.056; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; MOENS PB, 1987, MEIOSIS; MUNZ P, 1994, GENETICS, V137, P701; Muris DFR, 1997, CURR GENET, V31, P248, DOI 10.1007/s002940050202; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Octobre G, 2008, GENETICS, V178, P2399, DOI 10.1534/genetics.107.085696; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; SCHMIDT H, 1987, CURR GENET, V11, P303, DOI 10.1007/BF00355404; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; TEASE C, 1979, CHROMOSOMA, V73, P75, DOI 10.1007/BF00294847; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsutsui Y, 2001, GENETICS, V159, P91; Tsutsui Y, 2000, GENETICS, V154, P1451; van den Bosch M, 2001, MUTAT RES-DNA REPAIR, V461, P311, DOI 10.1016/S0921-8777(00)00060-4; Webber HA, 2004, J CELL BIOL, V164, P819, DOI 10.1083/jcb.200310077; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Young JA, 2002, MOL CELL, V9, P253, DOI 10.1016/S1097-2765(02)00452-5	65	59	60	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					243	255		10.1016/j.cell.2010.05.041	http://dx.doi.org/10.1016/j.cell.2010.05.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655467	Bronze, Green Accepted			2022-12-24	WOS:000280204300016
J	Qi, HH; Sarkissian, M; Hu, GQ; Wang, ZB; Bhattacharjee, A; Gordon, DB; Gonzales, M; Lan, F; Ongusaha, PP; Huarte, M; Yaghi, NK; Lim, H; Garcia, BA; Brizuela, L; Zhao, KJ; Roberts, TM; Shi, Y				Qi, Hank H.; Sarkissian, Madathia; Hu, Gang-Qing; Wang, Zhibin; Bhattacharjee, Arindam; Gordon, D. Benjamin; Gonzales, Michelle; Lan, Fei; Ongusaha, Pat P.; Huarte, Maite; Yaghi, Nasser K.; Lim, Huijun; Garcia, Benjamin A.; Brizuela, Leonardo; Zhao, Keji; Roberts, Thomas M.; Shi, Yang			Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development	NATURE			English	Article							STRUCTURAL INSIGHTS; MENTAL-RETARDATION; GENES; TRANSCRIPTION; METHYLATION; FAMILY; IDENTIFICATION; LYSINE-20; GENOME; MUTATIONS	X-linked mental retardation (XLMR) is a complex human disease that causes intellectual disability(1). Causal mutations have been found in approximately 90 X-linked genes(2); however, molecular and biological functions of many of these genetically defined XLMR genes remain unknown. PHF8 (PHD (plant homeo domain) finger protein 8) is a JmjC domain-containing protein and its mutations have been found in patients with XLMR and craniofacial deformities. Here we provide multiple lines of evidence establishing PHF8 as the first mono-methyl histone H4 lysine 20 (H4K20me1) demethylase, with additional activities towards histone H3K9me1 and me2. PHF8 is located around the transcription start sites (TSS) of similar to 7,000 RefSeq genes and in gene bodies and intergenic regions (non-TSS). PHF8 depletion resulted in upregulation of H4K20me1 and H3K9me1 at the TSS and H3K9me2 in the non-TSS sites, respectively, demonstrating differential substrate specificities at different target locations. PHF8 positively regulates gene expression, which is dependent on its H3K4me3-binding PHD and catalytic domains. Importantly, patient mutations significantly compromised PHF8 catalytic function. PHF8 regulates cell survival in the zebrafish brain and jaw development, thus providing a potentially relevant biological context for understanding the clinical symptoms associated with PHF8 patients. Lastly, genetic and molecular evidence supports a model whereby PHF8 regulates zebrafish neuronal cell survival and jaw development in part by directly regulating the expression of the homeodomain transcription factor MSX1/MSXB, which functions downstream of multiple signalling and developmental pathways(3). Our findings indicate that an imbalance of histone methylation dynamics has a critical role in XLMR.	[Qi, Hank H.; Lan, Fei; Huarte, Maite; Yaghi, Nasser K.; Lim, Huijun; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Qi, Hank H.; Lim, Huijun; Shi, Yang] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Sarkissian, Madathia; Roberts, Thomas M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hu, Gang-Qing; Wang, Zhibin; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Bhattacharjee, Arindam; Gordon, D. Benjamin; Brizuela, Leonardo] Agilent Technol, Santa Clara, CA 95051 USA; [Gonzales, Michelle; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ongusaha, Pat P.] Brigham & Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA; [Ongusaha, Pat P.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Agilent Technologies; Princeton University; Harvard University; Brigham & Women's Hospital; Harvard University	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	Thomas_Roberts@dfci.harvard.edu; yshi@hms.harvard.edu	Huarte, Maite/J-6903-2014; HU, GANGQING/K-5849-2012; Hu, Gangqing/ABA-3507-2020; Yaghi, Nasser/AAL-7001-2021	Huarte, Maite/0000-0003-3753-6493; HU, GANGQING/0000-0001-5453-6888; Qi, Hank/0000-0002-3401-4940; Yaghi, Nasser/0000-0003-0810-8502	Ruth L. Kirschstein-National Service [T32 NS007473, T32 CA09031-32]; Harvard SHURP; Agency for Science, Technology and Research (A*STAR); National Science Foundation [CBET-0941143]; NIH [GM 071004, NCI118487, CA50661]; Ellison Foundation; NATIONAL CANCER INSTITUTE [P01CA050661, T32CA009031] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007473] Funding Source: NIH RePORTER	Ruth L. Kirschstein-National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard SHURP; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shi laboratory members for helpful discussions and N. Mosammaparast and S. Chen for providing the nucleosomes. We thank G. Rosenfeld for sharing unpublished PHF8 results, and G. Rosenfeld, A. Schier and P. Hinds for discussions. H.H.Q. is a recipient of Ruth L. Kirschstein-National Service Research Award (T32 NS007473 and T32 CA09031-32). N.K.Y. was supported by Harvard SHURP (Summer Honors Undergraduate Research Program). H.L. is a recipient of the Agency for Science, Technology and Research (A*STAR) National Science Scholarship. This work was supported by grants from the National Science Foundation (CBET-0941143) to B.A.G.; NIH (GM 071004 and NCI118487) to Y. S.; a Senior Scholar Grant from the Ellison Foundation, and an NIH PO1 grant (CA50661) to T.M.R.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; DARZYNKIEWICZ Z, 1999, CURR PROTOC CELL BIO, V1; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Postlethwait JH, 2006, GENOME DYN, V2, P183, DOI 10.1159/000095104; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Tetel MJ, 2009, J NEUROENDOCRINOL, V21, P229, DOI 10.1111/j.1365-2826.2009.01827.x; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	39	212	222	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					503	U11		10.1038/nature09261	http://dx.doi.org/10.1038/nature09261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20622853	Green Accepted			2022-12-24	WOS:000280141200039
J	Hurley, R				Hurley, Richard			HIV/AIDS How Ukraine is tackling Europe's worst HIV epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England			rhurley@bmj.com						[Anonymous], 2008, EP FACT SHEET HIV AI; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; *MIN HLTH WHO UKR, 2009, INT HIV AIDS ALL UKR; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; *UNAIDS, 2008, E EUR CENTR AS FACTS	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3538	10.1136/bmj.c3538	http://dx.doi.org/10.1136/bmj.c3538			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627980				2022-12-24	WOS:000280156600007
J	Elliott, P; Toledano, MB; Bennett, J; Beale, L; de Hoogh, K; Best, N; Briggs, DJ				Elliott, Paul; Toledano, Mireille B.; Bennett, J.; Beale, L.; de Hoogh, K.; Best, N.; Briggs, D. J.			Mobile phone base stations and early childhood cancers: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CENTRAL-NERVOUS-SYSTEM; TELEVISION TRANSMITTERS; GREAT-BRITAIN; ELECTROMAGNETIC-FIELDS; EXPOSURE METRICS; RADIO; LEUKEMIA; HEALTH; BRAIN; EPIDEMIOLOGY	Objective To investigate the risk of early childhood cancers associated with the mother's exposure to radiofrequency from and proximity to macrocell mobile phone base stations (masts) during pregnancy. Design Case-control study. Setting Cancer registry and national birth register data in Great Britain. Participants 1397 cases of cancer in children aged 0-4 from national cancer registry 1999-2001 and 5588 birth controls from national birth register, individually matched by sex and date of birth (four controls per case). Main outcome measures Incidence of cancers of the brain and central nervous system, leukaemia, and non-Hodgkin's lymphomas, and all cancers combined, adjusted for small area measures of education level, socioeconomic deprivation, population density, and population mixing. Results Mean distance of registered address at birth from a macrocell base station, based on a national database of 76890 base station antennas in 1996-2001, was similar for cases and controls (1107 (SD 1131) m v 1073 (SD 1130) m, P=0.31), as was total power output of base stations within 700 m of the address (2.89 (SD 5.9) kW v 3.00 (SD 6.0) kW, P=0.54) and modelled power density (-30.3 (SD 21.7) dBm v-29.7 (SD 21.5) dBm, P=0.41). For modelled power density at the address at birth, compared with the lowest exposure category the adjusted odds ratios were 1.01 (95% confidence interval 0.87 to 1.18) in the intermediate and 1.02 (0.88 to 1.20) in the highest exposure category for all cancers (P=0.79 for trend), 0.97 (0.69 to 1.37) and 0.76 (0.51 to 1.12), respectively, for brain and central nervous system cancers (P=0.33 for trend), and 1.16 (0.90 to 1.48) and 1.03 (0.79 to 1.34) for leukaemia and non-Hodgkin's lymphoma (P=0.51 for trend). Conclusions There is no association between risk of early childhood cancers and estimates of the mother's exposure to mobile phone base stations during pregnancy.	[Elliott, Paul; Toledano, Mireille B.; Bennett, J.; Beale, L.; de Hoogh, K.; Best, N.; Briggs, D. J.] Univ London Imperial Coll Sci Technol & Med, Small Area Hlth Stat Unit, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, London W2 1PG, England	Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Small Area Hlth Stat Unit, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, St Marys Campus, London W2 1PG, England.	p.elliott@imperial.ac.uk		Elliott, Paul/0000-0002-7511-5684; Bennett, James Elston/0000-0002-9616-6878	UK Mobile Telecommunications Health Research (MTHR); UK Department of Health; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056, G0801056B] Funding Source: researchfish	UK Mobile Telecommunications Health Research (MTHR); UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: The study was funded through the UK Mobile Telecommunications Health Research (MTHR) Programme (www.mthr.org.uk), an independent body set up to provide funding for research into the possible health effects of mobile telecommunications. The MTHR is jointly funded by the UK Department of Health and the mobile telecommunications industry. Members of the independent MTHR programme management committee approved the study design and commented on a draft manuscript. Data collection and analysis, interpretation of data, and the decision to submit the paper for publication were the sole responsibility of the authors.	Adair RK, 2003, RADIAT RES, V159, P128, DOI 10.1667/0033-7587(2003)159[0128:EOTTPP]2.0.CO;2; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Cooper D, 2001, AM J EPIDEMIOL, V153, P202, DOI 10.1093/aje/153.2.202; Dolk H, 1997, AM J EPIDEMIOL, V145, P10, DOI 10.1093/oxfordjournals.aje.a009026; Dolk H, 1997, AM J EPIDEMIOL, V145, P1, DOI 10.1093/oxfordjournals.aje.a009025; Eaton N, 1997, BRIT J CANCER, V75, P1080, DOI 10.1038/bjc.1997.184; Eger H, 2004, UMWELT MED GESELLSCH, V17, P325; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Ha M, 2008, AM J EPIDEMIOL, V167, P884, DOI 10.1093/aje/kwn013; Ha M, 2007, AM J EPIDEMIOL, V166, P270, DOI 10.1093/aje/kwm083; Hocking B, 1996, MED J AUSTRALIA, V165, P601, DOI 10.5694/j.1326-5377.1996.tb138661.x; Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P287, DOI 10.1080/15287390600974973; Kundi Michael, 2009, Pathophysiology, V16, P123, DOI 10.1016/j.pathophys.2009.01.008; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, P316, DOI 10.1289/ehp.11902; MANN SM, 2000, R321 NRPB; Maskarinec Gertraud, 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P33; McKenzie DR, 1998, AUST NZ J PUBL HEAL, V22, P360, DOI 10.1111/j.1467-842X.1998.tb01392.x; Merzenich H, 2008, AM J EPIDEMIOL, V168, P1169, DOI 10.1093/aje/kwn230; Michelozzi P, 2002, AM J EPIDEMIOL, V155, P1096, DOI 10.1093/aje/155.12.1096; *NAT COUNC RAD PRO, 2003, BIOL EFF MOD RAD FIE; Nelson PD, 2006, NEUROLOGY, V66, P284, DOI 10.1212/01.wnl.0000194218.79519.ea; Neubauer G, 2007, BIOELECTROMAGNETICS, V28, P224, DOI 10.1002/bem.20298; OBERFELD G, 2008, UMWELTEPIDEMIOLOGISC; *ORDN SURV, 2010, ADDR POINT; Otitoloju AA, 2010, B ENVIRON CONTAM TOX, V84, P51, DOI 10.1007/s00128-009-9894-2; Park SK, 2004, INT ARCH OCC ENV HEA, V77, P387, DOI 10.1007/s00420-004-0512-7; *R FDN STAT COMP, 2010, R PROJ STAT CMP; Regel SJ, 2006, ENVIRON HEALTH PERSP, V114, P1270, DOI 10.1289/ehp.8934; Rodrigues L, 1991, STUDIES MED POPULATI, P47; Schmiedel S, 2009, BIOELECTROMAGNETICS, V30, P81, DOI 10.1002/bem.20460; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2000, J EXPO ANAL ENV EPID, V10, P600, DOI 10.1038/sj.jea.7500115; Schuz J, 2009, BIOELECTROMAGNETICS, V30, P511, DOI 10.1002/bem.20510; Siegrist M, 2005, RISK ANAL, V25, P1253, DOI 10.1111/j.1539-6924.2005.00672.x; Stewart W., 2000, REPORT INDEPENDENT E, P1; Wolf R, 2004, INT J CANC PREVENTIO, V1, P1; [No title captured]	44	30	31	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3077	10.1136/bmj.c3077	http://dx.doi.org/10.1136/bmj.c3077			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IO	20570865	hybrid, Green Published			2022-12-24	WOS:000279346300005
J	Spence, D				Spence, Des			From The Frontline Bad medicine: chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2000, LANCET, V355, P253; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Ku E, 2009, ARCH INTERN MED, V169, P1015, DOI 10.1001/archinternmed.2009.128; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE	4	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c3188	10.1136/bmj.c3188	http://dx.doi.org/10.1136/bmj.c3188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554677				2022-12-24	WOS:000279051900022
J	Cooper, CJ; Metch, B; Dragavon, J; Coombs, RW; Baden, LR				Cooper, Cristine J.; Metch, Barbara; Dragavon, Joan; Coombs, Robert W.; Baden, Lindsey R.		NIAID HVTN VISP Task Force	Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT GLYCOPROTEIN-120 VACCINE; PHASE-I TRIAL; CANDIDATE VACCINE; EFFICACY TRIAL; DOUBLE-BLIND; SAFETY; IMMUNOGENICITY; INFECTION; HEALTHY	Context Induction of protective anti-human immunodeficiency virus (HIV) immune responses is the goal of an HIV vaccine. However, this may cause a reactive result in routine HIV testing in the absence of HIV infection. Objective To evaluate the frequency of vaccine-induced seropositivity/reactivity (VISP) in HIV vaccine trial participants. Design, Setting, and Participants Three common US Food and Drug Administration-approved enzyme immunoassay (EIA) HIV antibody kits were used to determine VISP, and a routine diagnostic HIV algorithm was used to evaluate VISP frequency in healthy, HIV-seronegative adults who completed phase 1 (n=25) and phase 2a (n=2) vaccine trials conducted from 2000-2010 in the United States, South America, Thailand, and Africa. Main Outcome Measure Vaccine-induced seropositivity/reactivity, defined as reactive on 1 or more EIA tests and either Western blot-negative or Western blot-indeterminate/atypical positive (profile consistent with vaccine product) and HIV-1-negative by nucleic acid testing. Results Among 2176 participants free of HIV infection who received a vaccine product, 908 (41.7%; 95% confidence interval [CI], 39.6%-43.8%) had VISP, but the occurrence of VISP varied substantially across different HIV vaccine product types: 399 of 460 (86.7%; 95% CI, 83.3%-89.7%) adenovirus 5 product recipients, 295 of 552 (53.4%; 95% CI, 49.2%-57.7%) recipients of poxvirus alone or as a boost, and 35 of 555 (6.3%; 95% CI, 4.4%-8.7%) of DNA-alone product recipients developed VISP. Overall, the highest proportion of VISP (891/2176 tested [40.9%]) occurred with the HIV 1/2 (rDNA) EIA kit compared with the rLAV EIA (150/700 tested [21.4%]), HIV-1 Plus O Microelisa System (193/1309 tested [14.7%]), and HIV 1/2 Peptide and HIV 1/2 Plus O (189/2150 tested [8.8%]) kits. Only 17 of the 908 participants (1.9%) with VISP tested nonreactive using the HIV 1/2 (rDNA) kit. All recipients of a glycoprotein 140 vaccine (n=70) had VISP, with 94.3% testing reactive with all 3 EIA kits tested. Among 901 participants with VISP and a Western blot result, 92 (10.2%) had a positive Western blot result (displaying an atypical pattern consistent with vaccine product), and 592 (65.7%) had an indeterminate result. Only 8 participants with VISP received a vaccine not containing an envelope insert. Conclusions The induction of VISP in HIV vaccine recipients is common, especially with vaccines containing both the HIV-1 envelope and group-specific core antigen gene proteins. Development and detection of VISP appear to be associated with the immunogenicity of the vaccine and the EIA assay used. JAMA. 2010;304(3):275-283 www.jama.com	[Baden, Lindsey R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Cooper, Cristine J.; Metch, Barbara] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Dragavon, Joan; Coombs, Robert W.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Baden, LR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, PBB-A4,75 Francis St, Boston, MA 02115 USA.	lbaden@partners.org		Allen, Mary/0000-0001-8163-0714	NIAID [U01 AI046747, AI068614, AI46725, AI068618, AI046703, AI068635, AI069412]; University of Washington Center for AIDS Research [AI27757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI068614, UM1AI068618, U01AI046703, UM1AI068635, UM1AI068614, U01AI068635, UM1AI069412, U01AI069412, U01AI046747, U01AI046725, U01AI068618] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIAID grants U01 AI046747, AI068614, AI46725, AI068618, AI046703, AI068635, and AI069412 and by the University of Washington Center for AIDS Research grant AI27757.	Ackers ML, 2003, J INFECT DIS, V187, P879, DOI 10.1086/368169; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cleghorn F, 2007, JAIDS-J ACQ IMM DEF, V46, P222, DOI 10.1097/QAI.0b013e318149297d; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Goepfert PA, 2005, J INFECT DIS, V192, P1249, DOI 10.1086/432915; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Gorse GJ, 2008, VACCINE, V26, P215, DOI 10.1016/j.vaccine.2007.10.061; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gust DA, 2009, JAIDS-J ACQ IMM DEF, V52, P294, DOI 10.1097/QAI.0b013e3181ab6e93; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678; Pialoux G, 2008, VACCINE, V26, P2657, DOI 10.1016/j.vaccine.2007.11.002; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Quirk EK, 2008, CLIN INFECT DIS, V47, P1593, DOI 10.1086/593313; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; SCHWARTZ DH, 1995, CLIN DIAGN LAB IMMUN, V2, P268, DOI 10.1128/CDLI.2.3.268-271.1995; Silbermann B, 2008, AIDS RES HUM RETROV, V24, P1445, DOI 10.1089/aid.2008.0107; SIMONSEN L, 1995, AM J EPIDEMIOL, V141, P1089, DOI 10.1093/oxfordjournals.aje.a117374; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; *WHO, 2008, GLOB SUMM AIDS EP	30	32	33	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					275	283		10.1001/jama.2010.926	http://dx.doi.org/10.1001/jama.2010.926			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639561	Green Accepted, Bronze			2022-12-24	WOS:000280107500017
J	Savile, CK; Janey, JM; Mundorff, EC; Moore, JC; Tam, S; Jarvis, WR; Colbeck, JC; Krebber, A; Fleitz, FJ; Brands, J; Devine, PN; Huisman, GW; Hughes, GJ				Savile, Christopher K.; Janey, Jacob M.; Mundorff, Emily C.; Moore, Jeffrey C.; Tam, Sarena; Jarvis, William R.; Colbeck, Jeffrey C.; Krebber, Anke; Fleitz, Fred J.; Brands, Jos; Devine, Paul N.; Huisman, Gjalt W.; Hughes, Gregory J.			Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture	SCIENCE			English	Article							SUBSTRATE-SPECIFICITY; AMINOTRANSFERASE; TRANSAMINASE; CHEMISTRY; EVOLUTION	Pharmaceutical synthesis can benefit greatly from the selectivity gains associated with enzymatic catalysis. Here, we report an efficient biocatalytic process to replace a recently implemented rhodium-catalyzed asymmetric enamine hydrogenation for the large-scale manufacture of the antidiabetic compound sitagliptin. Starting from an enzyme that had the catalytic machinery to perform the desired chemistry but lacked any activity toward the prositagliptin ketone, we applied a substrate walking, modeling, and mutation approach to create a transaminase with marginal activity for the synthesis of the chiral amine; this variant was then further engineered via directed evolution for practical application in a manufacturing setting. The resultant biocatalysts showed broad applicability toward the synthesis of chiral amines that previously were accessible only via resolution. This work underscores the maturation of biocatalysis to enable efficient, economical, and environmentally benign processes for the manufacture of pharmaceuticals.	[Savile, Christopher K.; Mundorff, Emily C.; Tam, Sarena; Jarvis, William R.; Colbeck, Jeffrey C.; Krebber, Anke; Huisman, Gjalt W.] Codexis Inc, Redwood City, CA 94063 USA; [Janey, Jacob M.; Moore, Jeffrey C.; Fleitz, Fred J.; Brands, Jos; Devine, Paul N.; Hughes, Gregory J.] Merck & Co Inc, Merck Res Labs, Dept Proc Res, Rahway, NJ 07065 USA	Merck & Company	Savile, CK (corresponding author), Codexis Inc, 200 Penobscot Dr, Redwood City, CA 94063 USA.	christopher.savile@codexis.com; jacob_janey@merck.com		Janey, Jacob/0000-0001-7697-1709; Huisman, Gjalt/0000-0003-1955-1120				Chen ZL, 2005, J MOL BIOL, V348, P1273, DOI 10.1016/j.jmb.2005.02.070; Cho BK, 2008, BIOTECHNOL BIOENG, V99, P275, DOI 10.1002/bit.21591; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Crump S. P., 1992, BIOCATALYTIC PRODUCT, P43; Davies IW, 2009, SCIENCE, V325, P701, DOI 10.1126/science.1174501; De Wildeman SMA, 2007, ACCOUNTS CHEM RES, V40, P1260, DOI 10.1021/ar7001073; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Hansen KB, 2009, J AM CHEM SOC, V131, P8798, DOI 10.1021/ja902462q; Hohne M, 2008, CHEMBIOCHEM, V9, P363, DOI 10.1002/cbic.200700601; Huisman G.W., 2006, BIOCATALYSIS PHARM B, P717; Huisman GW, 2010, CURR OPIN CHEM BIOL, V14, P122, DOI 10.1016/j.cbpa.2009.12.003; Iwasaki A, 2006, APPL MICROBIOL BIOT, V69, P499, DOI 10.1007/s00253-005-0002-1; Johnson NB, 2007, ACCOUNTS CHEM RES, V40, P1291, DOI 10.1021/ar700114k; Kendall DM, 2009, EUR J INTERN MED, V20, pS329, DOI 10.1016/j.ejim.2009.05.009; Koszeleivski D, 2008, ANGEW CHEM INT EDIT, V47, P9337, DOI 10.1002/anie.200803763; Koszelewski D, 2009, EUR J ORG CHEM, V2009, P2289, DOI 10.1002/ejoc.200801265; Koszelewski D, 2008, ADV SYNTH CATAL, V350, P2761, DOI 10.1002/adsc.200800496; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Moore JC, 2007, ACCOUNTS CHEM RES, V40, P1412, DOI 10.1021/ar700167a; Shin JS, 2002, J ORG CHEM, V67, P2848, DOI 10.1021/jo016115i; Stutzman-Engwall K, 2005, METAB ENG, V7, P27, DOI 10.1016/j.ymben.2004.07.003; Truppo MD, 2009, CHEM COMMUN, P2127, DOI 10.1039/b902995h; Truppo MD, 2009, ORG BIOMOL CHEM, V7, P395, DOI 10.1039/b817730a; Williams-Herman Debora, 2008, BMC Endocr Disord, V8, P14, DOI 10.1186/1472-6823-8-14; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504	26	1063	1122	31	792	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					305	309		10.1126/science.1188934	http://dx.doi.org/10.1126/science.1188934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	625VW	20558668				2022-12-24	WOS:000279925900036
J	Schmid, MC; Mrowka, SW; Turchi, J; Saunders, RC; Wilke, M; Peters, AJ; Ye, FQ; Leopold, DA				Schmid, Michael C.; Mrowka, Sylwia W.; Turchi, Janita; Saunders, Richard C.; Wilke, Melanie; Peters, Andrew J.; Ye, Frank Q.; Leopold, David A.			Blindsight depends on the lateral geniculate nucleus	NATURE			English	Article							VISUAL RESPONSE PROPERTIES; SUPERIOR COLLICULUS; AREA MT; STRIATE CORTEX; MACAQUE MONKEY; GANGLION-CELLS; AFFERENT BASIS; PROJECTION; NEURONS; ACTIVATION	Injury to the primary visual cortex (V1) leads to the loss of visual experience. Nonetheless, careful testing shows that certain visually guided behaviours can persist even in the absence of visual awareness(1-4). The neural circuits supporting this phenomenon, which is often termed blindsight, remain uncertain(4). Here we demonstrate that the thalamic lateral geniculate nucleus (LGN) has a causal role in V1-independent processing of visual information. By comparing functional magnetic resonance imaging (fMRI) and behavioural measures with and without temporary LGN inactivation, we assessed the contribution of the LGN to visual functions of macaque monkeys (Macaca mulatta) with chronic V1 lesions. Before LGN inactivation, high-contrast stimuli presented to the lesion-affected visual field (scotoma) produced significant V1-independent fMRI activation in the extrastriate cortical areas V2, V3, V4, V5/middle temporal (MT), fundus of the superior temporal sulcus (FST) and lateral intraparietal area (LIP) and the animals correctly located the stimuli in a detection task. However, following reversible inactivation of the LGN in the V1-lesioned hemisphere, fMRI responses and behavioural detection were abolished. These results demonstrate that direct LGN projections to the extrastriate cortex have a critical functional contribution to blindsight. They suggest a viable pathway to mediate fast detection during normal vision.	[Schmid, Michael C.; Mrowka, Sylwia W.; Turchi, Janita; Saunders, Richard C.; Wilke, Melanie; Peters, Andrew J.; Leopold, David A.] NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; [Ye, Frank Q.; Leopold, David A.] NEI, Neurophysiol Imaging Facil, NIMH, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); NIH National Institute of Mental Health (NIMH); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schmid, MC (corresponding author), NIMH, Neuropsychol Lab, 49 Convent Dr, Bethesda, MD 20892 USA.	schmidmicha@gmail.com	Schmid, Michael C./G-1867-2010; Schmid, Michael Christoph/AAH-4835-2020	Schmid, Michael C./0000-0003-1424-130X; Schmid, Michael Christoph/0000-0003-1424-130X; Leopold, David/0000-0002-1345-6360; Peters, Andrew/0000-0001-9351-1456	NIMH; NINDS; NEI; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002899, ZIAMH002896, ZIAMH002838] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Maier and D. McMahon for comments on the manuscript; S. Smirnakis, R. Berman, R. Wurtz, B. Richmond, S. Guderian and M. Fukushima for discussions; C. Zhu and H. Merkle for magnetic resonance coil construction; K. Smith, N. Phipps, J. Yu, G. Dold, D. Ide and T. Talbot for technical assistance; D. Sheinberg for developing visual stimulation software; and members of the Brian Wandell laboratory for developing and sharing mrVista software. This work was supported by the Intramural Research Programme of the NIMH, the NINDS, and the NEI.	Baseler HA, 1999, J NEUROSCI, V19, P2619; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Brewer AA, 2002, J NEUROSCI, V22, P10416; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; BULLIER J, 1983, EXP BRAIN RES, V53, P168; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; Collins CE, 2003, J NEUROSCI, V23, P2251; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; COWEY A, 1989, EXP BRAIN RES, V75, P631, DOI 10.1007/bf00249914; COWEY A, 1989, NEUROSCIENCE, V29, P65, DOI 10.1016/0306-4522(89)90333-3; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; Cowey A, 1997, NEUROPSYCHOLOGIA, V35, P929, DOI 10.1016/S0028-3932(97)00021-3; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; HARTING JK, 1991, J COMP NEUROL, V304, P275, DOI 10.1002/cne.903040210; KEATING EG, 1980, BRAIN RES, V187, P271, DOI 10.1016/0006-8993(80)90203-6; Lyon DC, 2010, NEURON, V65, P270, DOI 10.1016/j.neuron.2010.01.003; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; McAnany JJ, 2007, VISION RES, V47, P2327, DOI 10.1016/j.visres.2007.05.013; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Schmid MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005527; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709	30	224	227	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					373	377		10.1038/nature09179	http://dx.doi.org/10.1038/nature09179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20574422	Green Accepted			2022-12-24	WOS:000279867100050
J	Trivedi, B				Trivedi, Bijal			The primate connection	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S5	S5		10.1038/nature09236	http://dx.doi.org/10.1038/nature09236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631704	Bronze			2022-12-24	WOS:000279867100025
J	Willyard, C				Willyard, Cassandra			Tiny steps towards an HIV vaccine	NATURE			English	Editorial Material							MONKEYS; INFECTION; RESPONSES											Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	5	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S8	S8		10.1038/nature09238	http://dx.doi.org/10.1038/nature09238			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631706				2022-12-24	WOS:000279867100027
J	Patenaude, G				Patenaude, Genevieve			Climate class for business schools	NATURE			English	Editorial Material									Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	University of Edinburgh	Patenaude, G (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland.	genevieve.patenaude@ed.ac.uk	Patenaude, Genevieve/F-3115-2010	Patenaude, Genevieve/0000-0001-7552-7470				*ASP I, GREY PINSTR 2009 201, P23114; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; *EC COM, WHICH MBA 2009 FULL, P23114; Felicelli M., 2008, 2008 ROUTE TOP; Goodall AH, 2008, J MANAGE INQUIRY, V17, P408, DOI 10.1177/1056492607311930; *PRICEWATERHOUSECO, 2009, GLOB 500 REP, P23114; Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed; *UNFCCC, GREENH GAS INV DAT 2, P23114	8	11	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					30	30		10.1038/466030a	http://dx.doi.org/10.1038/466030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618HW	20595996				2022-12-24	WOS:000279343800020
J	Petherick, A				Petherick, Anna			Campaigning for Chagas disease	NATURE			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S21	S22		10.1038/nature09227	http://dx.doi.org/10.1038/nature09227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571551	Bronze			2022-12-24	WOS:000279056900031
J	Mayr, FB; Yende, S; Linde-Zwirble, WT; Peck-Palmer, OM; Barnato, AE; Weissfeld, LA; Angus, DC				Mayr, Florian B.; Yende, Sachin; Linde-Zwirble, Walter T.; Peck-Palmer, Octavia M.; Barnato, Amber E.; Weissfeld, Lisa A.; Angus, Derek C.			Infection Rate and Acute Organ Dysfunction Risk as Explanations for Racial Differences in Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EPIDEMIOLOGY; DISEASES; OUTCOMES; ADULTS; CARE	Context Severe sepsis, defined as infection complicated by acute organ dysfunction, occurs more frequently and leads to more deaths in black than in white individuals. The optimal approach to minimize these disparities is unclear. Objective To determine the extent to which higher severe sepsis rates in black than in white patients are due to higher infection rates or to a higher risk of acute organ dysfunction. Design, Setting, and Participants Analysis of infection-related hospitalizations from the 2005 hospital discharge data of 7 US states and infection-related emergency department visits from the 2003-2007 National Hospital Ambulatory Care Survey. Main Outcome Measure Age-and sex-standardized severe sepsis and infection hospitalization rates and the risk of acute organ dysfunction. Results Of 8 661 227 non-childbirth-related discharges, 2 261 857 were associated with an infection, and of these, 381 787 (16.8%) had severe sepsis. Black patients had a 67% higher age-and sex-standardized severe sepsis rate than did white patients (9.4; 95% confidence interval [CI], 9.3-9.5 vs 5.6; 95% CI, 5.6-5.6 per 1000 population; P<.001) and 80% higher standardized mortality (1.8, 95% CI, 1.8-1.9 vs 1.0, 95% CI, 1.0-1.1 per 1000 population; P<.001). The higher severe sepsis rate was explained by both a higher infection rate in black patients (47.3; 95% CI, 47.1-47.4 vs 34.0; 95% CI, 33.9-34.0 per 1000 population; incidence rate ratio, 1.39; P<.001) and a higher risk of developing acute organ dysfunction (age-and sex-adjusted odds ratio [OR], 1.29; 95% CI, 1.27-1.30; P<.001). Differences in infection presented broadly across different sites and etiology of infection and for community-and hospital-acquired infections and occurred despite a lower likelihood of being admitted for infection from the emergency department (adjusted OR, 0.70; 95% CI, 0.64-0.76; P<.001). The higher risk of organ dysfunction persisted but was attenuated after adjusting for age, sex, comorbid conditions, poverty, and hospital effect (OR, 1.14; 95% CI, 1.13-1.16; P<.001). Racial disparities in infection and severe sepsis incidence and mortality rates were largest among younger adults (eg, the proportion of invasive pneumococcal disease occurring in adults <65 years was 73.9% among black patients vs 44.5% among white patients, P<.001). Conclusion Racial differences in severe sepsis are explained by both a higher infection rate and a higher risk of acute organ dysfunction in black than in white individuals. JAMA. 2010; 303(24): 2495-2503	[Yende, Sachin] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA 15261 USA; [Mayr, Florian B.; Yende, Sachin; Linde-Zwirble, Walter T.; Peck-Palmer, Octavia M.; Barnato, Amber E.; Angus, Derek C.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Lab, Pittsburgh, PA 15261 USA; [Peck-Palmer, Octavia M.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Barnato, Amber E.] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Linde-Zwirble, Walter T.] ZD Associates, Perkasie, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yende, S (corresponding author), Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, 642A Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012		National Institutes of Health [T32 HL007820-10, K23GM083215]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM083215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Mayr was supported by grant T32 HL007820-10, and Dr Yende was supported by grant K23GM083215 both from the National Institutes of Health.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; [Anonymous], NATL HOSP AMBULATORY; BAMATO AE, 2008, AM J RESP CRIT CARE, V177, P279; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V268, P3079, DOI 10.1001/jama.268.21.3079; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; CARRIERE KC, 1994, AM J EPIDEMIOL, V140, P472, DOI 10.1093/oxfordjournals.aje.a117269; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu JH, 2003, ARCH SURG-CHICAGO, V138, P1106, DOI 10.1001/archsurg.138.10.1106; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Morse DL, 2009, ANN INTERN MED, V150, P40, DOI 10.7326/0003-4819-150-1-200901060-00008; Mrus JM, 2005, CRIT CARE, V9, pR623, DOI 10.1186/cc3811; OBRIEN TR, 1989, JAMA-J AM MED ASSOC, V262, P1485, DOI 10.1001/jama.262.11.1485; READE MC, 2009, SEPSIS NONINFECTIOUS; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yang HL, 2008, SINGAP MED J, V49, P441; Zajacova A, 2009, J GERONTOL A-BIOL, V64, P272, DOI 10.1093/gerona/gln012	27	164	176	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2495	2503		10.1001/jama.2010.851	http://dx.doi.org/10.1001/jama.2010.851			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571016	Green Accepted, Bronze			2022-12-24	WOS:000279010900027
J	Yakubovskaya, E; Mejia, E; Byrnes, J; Hambardjieva, E; Garcia-Diaz, M				Yakubovskaya, Elena; Mejia, Edison; Byrnes, James; Hambardjieva, Elena; Garcia-Diaz, Miguel			Helix Unwinding and Base Flipping Enable Human MTERF1 to Terminate Mitochondrial Transcription	CELL			English	Article							MAMMALIAN MITOCHONDRIA; MTDNA TRANSCRIPTION; CRYSTAL-STRUCTURE; POINT MUTATION; NUCLEIC-ACIDS; RIBOSOMAL-RNA; DNA; PROTEIN; BIOGENESIS; FAMILY	Defects in mitochondrial gene expression are associated with aging and disease. Mterf proteins have been implicated in modulating transcription, replication and protein synthesis. We have solved the structure of a member of this family, the human mitochondrial transcriptional terminator MTERF1, bound to dsDNA containing the termination sequence. The structure indicates that upon sequence recognition MTERF1 unwinds the DNA molecule, promoting eversion of three nucleotides. Base flipping is critical for stable binding and transcriptional termination. Additional structural and biochemical results provide insight into the DNA binding mechanism and explain how MTERF1 recognizes its target sequence. Finally, we have demonstrated that the mitochondrial pathogenic G3249A and G3244A mutations interfere with key interactions for sequence recognition, eliminating termination. Our results provide insight into the role of mterf proteins and suggest a link between mitochondrial disease and the regulation of mitochondrial transcription.	[Yakubovskaya, Elena; Mejia, Edison; Byrnes, James; Hambardjieva, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, BST 7-169, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Garcia-Diaz, M (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, BST 7-169, Stony Brook, NY 11794 USA.	mgd@pharm.stonybrook.edu			Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health;  [R00 ES015421]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Drs. Bebenek, Bogenhagen, De los Santos, Demple, Garcia-Segura, and Kunkel for critical reading of the manuscript; and the NSLS Protein Crystallography group. NSLS beamlines 325 and 329 are mainly supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and the National Center for Research Resources of the National Institutes of Health. This work was supported by R00 ES015421 to M.G.-D.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FORTELLE EDL, 1997, METHODS ENZYMOLOGY, V276; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HENDRICKSON WA, 1997, METHODS ENZYMOLOGY, V276; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Lu G, 2009, CURR OPIN STRUC BIOL, V19, P110, DOI 10.1016/j.sbi.2008.12.009; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005; Nam SC, 2005, J BIOCHEM MOL BIOL, V38, P690; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010	40	75	79	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					982	993		10.1016/j.cell.2010.05.018	http://dx.doi.org/10.1016/j.cell.2010.05.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550934	Bronze, Green Accepted			2022-12-24	WOS:000278618800013
J	Abdool Karim, Q; AbouZahr, C; Dehne, K; Mangiaterra, V; Moodley, J; Rollins, N; Say, L; Schaffer, N; Rosen, JE; de Zoysa, I				Abdool Karim, Quarraisha; AbouZahr, Carla; Dehne, Karl; Mangiaterra, Viviana; Moodley, Jack; Rollins, Nigel; Say, Lale; Schaffer, Nathan; Rosen, James E.; de Zoysa, Isabelle			HIV and maternal mortality: turning the tide	LANCET			English	Editorial Material							SOUTH-AFRICA; MORBIDITY; MALAWI; WOMEN		[AbouZahr, Carla; Mangiaterra, Viviana; Rollins, Nigel; Say, Lale; Schaffer, Nathan; de Zoysa, Isabelle] WHO, CH-1211 Geneva 27, Switzerland; [Abdool Karim, Quarraisha] Ctr AIDS Programme Res S Africa, Durban, Kwazulu Natal, South Africa; [Dehne, Karl] UNAIDS, Geneva, Switzerland; [Moodley, Jack] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa; [Rosen, James E.] Univ KwaZulu Natal, Washington, DC USA	World Health Organization; UNAIDS; University of Kwazulu Natal	de Zoysa, I (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Abdool Karim, Quarraisha/GVS-1160-2022; , lalesay/AAG-1912-2021	Abdool Karim, Quarraisha/0000-0002-0985-477X; MANGIATERRA, VIVIANA/0000-0002-8815-0841				Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Louis J, 2007, OBSTET GYNECOL, V110, P385, DOI 10.1097/01.AOG.0000275263.81272.fc; Mbizvo M T, 2005, Cent Afr J Med, V51, P91; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; National Committee for Confidential Enquiry into Maternal Deaths, 2008, 4 NAT COMM CONF ENQ; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; 2010, LANCET, V375, P865	16	42	44	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1948	1949		10.1016/S0140-6736(10)60747-7	http://dx.doi.org/10.1016/S0140-6736(10)60747-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569827	Green Submitted			2022-12-24	WOS:000278689600008
J	Caplan, AL; Moreno, JD				Caplan, Arthur L.; Moreno, Jonathan D.			The Havasu 'Baaja tribe and informed consent	LANCET			English	Editorial Material									[Caplan, Arthur L.; Moreno, Jonathan D.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Caplan, AL (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						Caplan Arthur, 2009, TRAFFICKING ORGANS T; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Eriksson S, 2005, EUR J HUM GENET, V13, P1071, DOI 10.1038/sj.ejhg.5201458; Harmon A, 2010, NY TIMES        0422, P17; MARKOW T, 1993, AM J HUM GENET, V53, P943; MARKOW TA, 1993, ANN HUM BIOL, V20, P389, DOI 10.1080/03014469300002792; Skloot R, 2011, IMMORTAL LIFE HENRIE; Solbakk JH, 2009, ETHICS OF RESEARCH BIOBANKING, P1, DOI 10.1007/978-0-387-93872-1; Wadman M, 2009, NATURE, V462, P837, DOI 10.1038/462837a	9	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					621	622		10.1016/S0140-6736(10)60818-5	http://dx.doi.org/10.1016/S0140-6736(10)60818-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	20630579				2022-12-24	WOS:000287776600009
J	Burkle, FM; Hsu, EB				Burkle, Frederick M., Jr.; Hsu, Edbert B.			Ram Janki Temple: understanding human stampedes	LANCET			English	Editorial Material									[Burkle, Frederick M., Jr.] Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Hsu, Edbert B.] Johns Hopkins Univ, Inst Med, Dept Emergency Med, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University	Burkle, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hsph.harvard.edu	Burkle, Frederick/AAE-5423-2020					Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Burkle FM, 2010, PREHOSPITAL DISASTER, V25, P34, DOI [10.1017/S1049023X00007639, 10.1017/S1049023X00007998]; EM-DAT, 2010, INT DIS DAT; Evans A, 2009, MANAGING SCARCITY I; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Hsieh YH, 2009, DISASTER MED PUBLIC, V3, P217, DOI 10.1097/DMP.0b013e3181c5b4ba; Ngai KM, 2009, DISASTER MED PUBLIC, V3, P191, DOI 10.1097/DMP.0b013e3181c5b494; Singh HS, 2010, CNN             0305	8	38	38	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					106	107		10.1016/S0140-6736(10)60442-4	http://dx.doi.org/10.1016/S0140-6736(10)60442-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	20655584				2022-12-24	WOS:000286292800008
J	Moreno, JGB; Licea, JAI; Ajenjo, CR				Bustamante Moreno, Jose Guadalupe; Izazola Licea, Jose Antonio; Ajenjo, Carlos Rodriguez			Tackling HIV and drug addiction in Mexico	LANCET			English	Editorial Material							TIJUANA		[Bustamante Moreno, Jose Guadalupe] Ctr Civ, Mexicali 21000, Baja California, Mexico; [Izazola Licea, Jose Antonio] Ctr Nacl Prevenc & Control VIH SIDA, Mexico City, DF, Mexico; [Ajenjo, Carlos Rodriguez] Consejo Nacl Contras Adicc, Mexico City, DF, Mexico		Moreno, JGB (corresponding author), Ctr Civ, Mexicali 21000, Baja California, Mexico.	jbustamante@baja.gob.mx			NIDA NIH HHS [R21 DA024381-01, R21 DA024381, R01 DA019829-01A1, R01 DA019829] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024381, R01DA019829] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; *CENSIDA, 2009, ACT REDD US DROG INF; Iniguez-Stevens E, 2009, GAC MED MEX, V145, P189; MORENO JGB, 2008, INT C AIDS MEX CIT M; *NAT I PSYCH RAM F, 2009, 2008 NAT HOUS SURV A; Patterson TL, 2009, AIDS, V23, P1763, DOI 10.1097/QAD.0b013e32832f08a1; Philbin MM, 2009, INT J DRUG POLICY, V20, P329, DOI 10.1016/j.drugpo.2008.09.002; *SECR SAL, 2009, CAS SIDA MEX; Strathdee SA, 2008, JAMA-J AM MED ASSOC, V300, P571, DOI 10.1001/jama.300.5.571; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690	10	28	28	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					493	495		10.1016/S0140-6736(10)60883-5	http://dx.doi.org/10.1016/S0140-6736(10)60883-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20650521	Green Accepted			2022-12-24	WOS:000281266800007
J	Gregg, C; Zhang, JW; Weissbourd, B; Luo, SJ; Schroth, GP; Haig, D; Dulac, C				Gregg, Christopher; Zhang, Jiangwen; Weissbourd, Brandon; Luo, Shujun; Schroth, Gary P.; Haig, David; Dulac, Catherine			High-Resolution Analysis of Parent-of-Origin Allelic Expression in the Mouse Brain	SCIENCE			English	Article							IMPRINTED GENE; H19; IGF2; POLYADENYLATION; IDENTIFICATION; MECHANISMS; MUTATION; CELLS	Genomic imprinting results in preferential expression of the paternal or maternal allele of certain genes. We have performed a genome-wide characterization of imprinting in the mouse embryonic and adult brain. This approach uncovered parent-of-origin allelic effects of more than 1300 loci. We identified parental bias in the expression of individual genes and of specific transcript isoforms, with differences between brain regions. Many imprinted genes are expressed in neural systems associated with feeding and motivated behaviors, and parental biases preferentially target genetic pathways governing metabolism and cell adhesion. We observed a preferential maternal contribution to gene expression in the developing brain and a major paternal contribution in the adult brain. Thus, parental expression bias emerges as a major mode of epigenetic regulation in the brain.	[Gregg, Christopher; Weissbourd, Brandon; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gregg, Christopher; Weissbourd, Brandon; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Illumina	Gregg, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	cgregg@mcb.harvard.edu; dulac@fas.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; Dulac, Catherine/0000-0001-5024-5418	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank L. Luo, T. Maniatis, R. Losick, S. Hippenmeyer, and members of the Maniatis and Dulac labs for critical comments on the manuscript. We thank R. Hellmiss for help with figures and R. Jaenisch for X<SUP>egfp</SUP> mice. This work was supported by the Klarman Foundation for Eating Disorders and the Howard Hughes Medical Institute (HHMI). C. G. is supported by a Human Frontiers long-term fellowship and Alberta Heritage Foundation for Medical Research Incentive Award. C. D. is an HHMI investigator. All data can be found in GEO: GSE22131.	ALLEN ND, 1995, P NATL ACAD SCI USA, V92, P10782, DOI 10.1073/pnas.92.23.10782; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Caqueret A, 2005, HORM RES, V64, P222, DOI 10.1159/000088977; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; HALL JG, 1990, AM J HUM GENET, V46, P857; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Keverne EB, 2001, HORM BEHAV, V40, P146, DOI 10.1006/hbeh.2001.1685; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MCEWEN KR, 2009, GENOMIC IMPRINTING M, P235; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wood AJ, 2008, GENE DEV, V22, P1141, DOI 10.1101/gad.473408; Wood AJ, 2007, NUCLEIC ACIDS RES, V35, P7031, DOI 10.1093/nar/gkm742; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	46	394	401	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					643	648		10.1126/science.1190830	http://dx.doi.org/10.1126/science.1190830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616232	Green Accepted			2022-12-24	WOS:000280602700029
J	Gudasz, C; Bastviken, D; Steger, K; Premke, K; Sobek, S; Tranvik, LJ				Gudasz, Cristian; Bastviken, David; Steger, Kristin; Premke, Katrin; Sobek, Sebastian; Tranvik, Lars J.			Temperature-controlled organic carbon mineralization in lake sediments	NATURE			English	Article							TERRESTRIAL CARBON; CLIMATE-CHANGE; BOREAL FOREST; SOIL CARBON; BURIAL; CYCLE; ACCUMULATION; RESPIRATION; RESERVOIRS; DYNAMICS	Peatlands, soils and the ocean floor are well-recognized as sites of organic carbonaccumulation andrepresentimportant global carbon sinks(1,2). Although the annual burial of organic carbon in lakes and reservoirs exceeds that of ocean sediments(3), these inland waters are components of the global carbon cycle that receive only limited attention(4-6). Of the organic carbon that is being deposited onto the sediments, a certain proportion will be mineralized and the remainder will be buried over geological timescales. Here we assess the relationship between sediment organic carbon mineralization and temperature in a cross-system survey of boreal lakes in Sweden, and with input froma compilation of published data from awide range of lakes that differ with respect to climate, productivity and organic carbon source. We find that the mineralization of organic carbon in lake sediments exhibits a strongly positive relationship with temperature, which suggests that warmer water temperatures lead to more mineralization and less organic carbon burial. Assuming that future organic carbon delivery to the lake sediments will be similar to that under present-day conditions, we estimate that temperature increases following the latest scenarios presented by the Intergovernmental Panel on Climate Change(7) could result in a 4-27 per cent (0.9-6.4 Tg Cyr(-1)) decrease in annual organic carbon burial in boreal lakes.	[Gudasz, Cristian; Steger, Kristin; Premke, Katrin; Sobek, Sebastian; Tranvik, Lars J.] Uppsala Univ, Dept Ecol & Evolut, SE-75236 Uppsala, Sweden; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58662 Linkoping, Sweden	Uppsala University; Linkoping University	Gudasz, C (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	cristian.gudasz@ebc.uu.se	Steger, Kristin/F-3000-2014; Tranvik, Lars J/H-2222-2011; Steger, Kristin/F-4187-2014	Steger, Kristin/0000-0001-6446-8022; Steger, Kristin/0000-0002-7737-0697; Tranvik, Lars J./0000-0003-3509-8266; Premke, Katrin/0000-0001-6216-5386; Bastviken, David/0000-0003-0038-2152	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning); VR (the Swedish Research Council)	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); VR (the Swedish Research Council)(Swedish Research Council)	The study was part of the research environment LEREC (Lake Ecosystem Response to Environmental Change), financially supported by FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning). Additional funding from VR (the Swedish Research Council) to L.J.T. and to D.B., and from FORMAS to S.S., is acknowledged.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; den Heyer C, 1998, LIMNOL OCEANOGR, V43, P695, DOI 10.4319/lo.1998.43.4.0695; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Einsele G, 2001, GLOBAL PLANET CHANGE, V30, P167, DOI 10.1016/S0921-8181(01)00105-9; Emerson S, 1988, PALEOCEANOGRAPHY, V3, P621, DOI 10.1029/PA003i005p00621; Fang X, 1999, CLIMATIC CHANGE, V42, P377, DOI 10.1023/A:1005431523281; Girard R. E., 2007, HIST CHEM PHYS BIOL; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; GRANELI W, 1979, Holarctic Ecology, V2, P51; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Jankowski T, 2006, LIMNOL OCEANOGR, V51, P815, DOI 10.4319/lo.2006.51.2.0815; Kortelainen P, 2006, GLOBAL CHANGE BIOL, V12, P1554, DOI 10.1111/j.1365-2486.2006.01167.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Molot LA, 1996, GLOBAL BIOGEOCHEM CY, V10, P483, DOI 10.1029/96GB01666; MULHOLLAND PJ, 1982, TELLUS, V34, P490, DOI 10.1111/j.2153-3490.1982.tb01837.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; PACE ML, 2004, RESP AQUATIC SYSTEMS, P103; PERSSON G, 2009, 4552 NAT SWED EPA; Rapalee G, 1998, GLOBAL BIOGEOCHEM CY, V12, P687, DOI 10.1029/98GB02336; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Sobek S, 2009, LIMNOL OCEANOGR, V54, P2243, DOI 10.4319/lo.2009.54.6.2243; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Wetzel R. G, 1990, VERH INT VEREIN LIMN, V24, P6, DOI DOI 10.1080/03680770.1989.11898687; ZAR JH, 1984, BIOSTAT ANAL, P292	35	353	378	23	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					478	U3		10.1038/nature09186	http://dx.doi.org/10.1038/nature09186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651689	Green Submitted			2022-12-24	WOS:000280141200033
J	Pujades-Rodriguez, M; Balkan, S; Arnould, L; Brinkhof, MAW; Calmy, A				Pujades-Rodriguez, Mar; Balkan, Suna; Arnould, Line; Brinkhof, Martin A. W.; Calmy, Alexandra		AIDS Working Grp MSF	Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIRETROVIRAL THERAPY; MULTIPLE IMPUTATION; MISSING VALUES; POOR SETTINGS; VIRAL LOAD; REGIMEN; ADHERENCE; SURVIVAL; RESISTANCE; PROGRAM	Context Long-term antiretroviral therapy (ART) use in resource-limited countries leads to increasing numbers of patients with HIV taking second-line therapy. Limited access to further therapeutic options makes essential the evaluation of second-line regimen efficacy in these settings. Objectives To investigate failure rates in patients receiving second-line therapy and factors associated with failure and death. Design, Setting, and Participants Multicohort study of 632 patients >14 years old receiving second-line therapy for more than 6 months in 27 ART programs in Africa and Asia between January 2001 and October 2008. Main Outcome Measures Clinical, immunological, virological, and immunovirological failure (first diagnosed episode of immunological or virological failure) rates, and mortality after 6 months of second-line therapy use. Sensitivity analyses were performed using alternative CD4 cell count thresholds for immunological and immunovirological definitions of failure and for cohort attrition instead of death. Results The 632 patients provided 740.7 person-years of follow-up; 119 (18.8%) met World Health Organization failure criteria after a median 11.9 months following the start of second-line therapy (interquartile range [IQR], 8.7-17.0 months), and 34 (5.4%) died after a median 15.1 months (IQR, 11.9-25.7 months). Failure rates were lower in those who changed 2 nucleoside reverse transcriptase inhibitors (NRTIs) instead of 1 (179.2 vs 251.6 per 1000 person-years; incidence rate ratio [IRR], 0.64; 95% confidence interval [CI], 0.42-0.96), and higher in those with lowest adherence index (383.5 vs 176.0 per 1000 person-years; IRR, 3.14; 95% CI, 1.67-5.90 for <80% vs >= 95% [percentage adherent, as represented by percentage of appointments attended with no delay]). Failure rates increased with lower CD4 cell counts when second-line therapy was started, from 156.3 vs 96.2 per 1000 person-years; IRR, 1.59 (95% CI, 0.78-3.25) for 100 to 199/mu L to 336.8 per 1000 person-years; IRR, 3.32 (95% CI, 1.81-6.08) for less than 50/mu L vs 200/mu L or higher; and decreased with time using second-line therapy, from 250.0 vs 123.2 per 1000 person-years; IRR, 1.90 (95% CI, 1.19-3.02) for 6 to 11 months to 212.0 per 1000 person-years; 1.71 (95% CI, 1.01-2.88) for 12 to 17 months vs 18 or more months. Mortality for those taking second-line therapy was lower in women (32.4 vs 68.3 per 1000 person-years; hazard ratio [HR], 0.45; 95% CI, 0.23-0.91); and higher in patients with treatment failure of any type (91.9 vs 28.1 per 1000 person-years; HR, 2.83; 95% CI, 1.38-5.80). Sensitivity analyses showed similar results. Conclusions Among patients in Africa and Asia receiving second-line therapy for HIV, treatment failure was associated with low CD4 cell counts at second-line therapy start, use of suboptimal second-line regimens, and poor adherence. Mortality was associated with diagnosed treatment failure. JAMA. 2010;304(3):303-312 www.jama.com	[Pujades-Rodriguez, Mar] Med Sans Frontieres, Epictr, F-75011 Paris, France; [Arnould, Line] Med Sans Frontieres, Brussels, Belgium; [Brinkhof, Martin A. W.] Inst Social & Prevent Med, Bern, Switzerland; [Calmy, Alexandra] Med Sans Frontieres Campaign Access Essential Med, Geneva, Switzerland	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Pujades-Rodriguez, M (corresponding author), Med Sans Frontieres, Epictr, 42 Bis,Bd,8 Rue St Sabin, F-75011 Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/T-1129-2018; Pujades-Rodriguez, Mar/G-4388-2014	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Pujades-Rodriguez, Mar/0000-0002-7778-3520; Brinkhof, Martin/0000-0002-9319-665X	Swiss National Science Foundation [32473B-122116]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partly supported by grant 32473B-122116 from the Swiss National Science Foundation, from which external funds for this particular project were provided. Salaries of Drs Pujades-Rodriguez, Balkan, and Arnould are ensured by MSF (Drs Balkan and Arnould are employed by the Medical Department of MSF; Dr Pujades-Rodriguez is employed by Epicentre, a satellite nongovernmental organization closely linked to and funded by MSF). Role of the Sponsor: The sponsor did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Online-Only Material: eTables 1 through 4 are available at http://www.jama.com.	Ananworanich J, 2007, FUTURE HIV THERAPY, V1, P81; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Calmy A, 2004, AIDS, V18, P2353; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Crowley S, 2010, LANCET, V375, P874, DOI 10.1016/S0140-6736(09)62064-X; FEIVESON A, CALCULATING POWER SI; Feiveson AH, 2002, STATA J, V2, P107, DOI 10.1177/1536867X0200200201; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; *HIV AIDS DEP WHO, UN ACC SCAL PRIOR HI; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Keiding N, 1997, STAT MED, V16, P215; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; LEWDEN C, 2009, SURVIVAL LOSS TO FOL; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; PUJADESRODRIGUE.M, 2010, 18 INT AIDS C JUL 18; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Willig JH, 2008, AIDS, V22, P1951, DOI 10.1097/QAD.0b013e32830efd79; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; YAZDANPANAH Y, 2008, 17 INT AIDS C AUG 3; Zhou J, 2010, HIV MED, V11, P31, DOI 10.1111/j.1468-1293.2009.00738.x	39	75	79	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					303	312		10.1001/jama.2010.980	http://dx.doi.org/10.1001/jama.2010.980			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639564	Bronze			2022-12-24	WOS:000280107500020
J	DeWeerdt, S				DeWeerdt, Sarah			Dancing with an escape artist	NATURE			English	Editorial Material							HIV-1											Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107	3	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S6	S7		10.1038/nature09237	http://dx.doi.org/10.1038/nature09237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631705	Bronze			2022-12-24	WOS:000279867100026
J	Borthwick, E; Ferguson, A				Borthwick, Emma; Ferguson, Andrew			Perioperative acute kidney injury: risk factors, recognition, management, and outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; PREDICT; MORTALITY		[Ferguson, Andrew] Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland; [Borthwick, Emma] Belfast City Hosp, Belfast BT12 7BA, Antrim, North Ireland	Belfast City Hospital	Ferguson, A (corresponding author), Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland.	fergua@yahoo.ca	Ferguson, Andrew J/B-8878-2012	Ferguson, Andrew J/0000-0002-4081-1567	Northern Ireland Kidney Research Fund; Northern Ireland Research and Development Office	Northern Ireland Kidney Research Fund; Northern Ireland Research and Development Office	All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) EB and AF have had no support from any company for the submitted work; (2) AF has no relationships with any company that might have an interest in the submitted work in the previous 3 years. EB received travel and accommodation expenses for conference attendance in 2009 from Biosite (Inverness Medical), who manufacture a point of care testing device for NGAL. EB's salary was funded by the Northern Ireland Kidney Research Fund from August 2008 to August 2009. EB received a bursary for part time MPhil fees from the Northern Ireland Research and Development Office; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) EB and AF have no non-financial interests that may be relevant to the submitted work.	Abelha FJ, 2009, NEFROLOGIA, V29, P404, DOI 10.3265/Nefrologia.2009.29.5.5456.en.full; Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Awad AS, 2007, AM J PHYSIOL-RENAL, V293, pF28, DOI 10.1152/ajprenal.00159.2007; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; De Santo LS, 2010, J HEART VALVE DIS, V19, P139; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Englberger L, 2011, J THORAC CARDIOV SUR, V141, P552, DOI 10.1016/j.jtcvs.2010.02.045; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Haase M, 2009, ANN THORAC SURG, V88, P124, DOI 10.1016/j.athoracsur.2009.04.023; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Kagan A, 2010, CLIN CARDIOL, V33, P62, DOI 10.1002/clc.20687; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kolhe Nitin V, 2008, Crit Care, V12 Suppl 1, pS2, DOI 10.1186/cc7003; Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Macedo E, 2008, RENAL FAILURE, V30, P287, DOI 10.1080/08860220701857522; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Stewart J, 2009, ADDING INSULT INJURY; Sward K, 2004, CRIT CARE MED, V32, P1310; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089	29	84	88	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2010	341								c3365	10.1136/bmj.c3365	http://dx.doi.org/10.1136/bmj.c3365			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DJ	20603317				2022-12-24	WOS:000279874000002
J	Chudler, EH				Chudler, Eric H.			Resources for Anyone Interested in the Brain	SCIENCE			English	Editorial Material									Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chudler, EH (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	chudler@u.washington.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR012312] Funding Source: NIH RePORTER; NCRR NIH HHS [R25RR12312] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; CHUDLER EH, 2002, NEUR ABSTR; CHUDLER EH, 2007, NEUR ABSTR; *DANA, DANA ALL BRAIN IN; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Moore RW, 1997, J RES SCI TEACH, V34, P327, DOI 10.1002/(SICI)1098-2736(199704)34:4<327::AID-TEA3>3.3.CO;2-V; *NIH, 1997, R25RR12312 NIH NAT C; Society for Neuroscience, 2008, BRAIN FACTS PRIM BRA	9	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1648	1649		10.1126/science.1186935	http://dx.doi.org/10.1126/science.1186935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576881				2022-12-24	WOS:000279107400031
J	Sund, J; Ander, M; Aqvist, J				Sund, Johan; Ander, Martin; Aqvist, Johan			Principles of stop-codon reading on the ribosome	NATURE			English	Article							POLYPEPTIDE RELEASE FACTORS; DIFFERENT GROWTH-RATES; TRANSFER-RNA; ESCHERICHIA-COLI; TRANSLATION TERMINATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FACTOR RF2; GGQ MOTIF; COMPLEX	In termination of protein synthesis, the bacterial release factors RF1 and RF2 bind to the ribosome through specific recognition of messenger RNA stop codons and trigger hydrolysis of the bond between the nascent polypeptide and the transfer RNA at the peptidyl-tRNA site, thereby releasing the newly synthesized protein. The release factors are highly specific for a U in the first stop-codon position 1 and recognize different combinations of purines in the second and third positions, with RF1 reading UAA and UAG and RF2 reading UAA and UGA. With recently determined crystal structures of termination complexes(2-4), it has become possible to decipher the energetics of stop-codon reading by computational analysis and to clarify the origin of the high release-factor binding accuracy. Here we report molecular dynamics free-energy calculations on different cognate and non-cognate termination complexes. The simulations quantitatively explain the basic principles of decoding in all three codon positions and reveal the key elements responsible for specificity of the release factors. The overall reading mechanism involves hitherto unidentified interactions and recognition switches that cannot be described in terms of a tripeptide anticodon model. Further simulations of complexes with tRNA(Trp), the tRNA recognizing the triplet codon for Trp, explain the observation of a 'leaky' stop codon 5 and highlight the fundamentally different third position reading by RF2, which leads to a high stop-codon specificity with strong discrimination against the Trp codon. The simulations clearly illustrate the versatility of codon reading by protein, which goes far beyond tRNA mimicry.	[Sund, Johan; Ander, Martin; Aqvist, Johan] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Uppsala University	Aqvist, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	aqvist@xray.bmc.uu.se	Aqvist, Johan/A-4360-2012		Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Support from the Swedish Research Council is gratefully acknowledged. We thank M. Ehrenberg for discussions and M. Laurberg, H. Noller, A. Weixlbaumer and V. Ramakrishnan for sending us their atomic coordinates before release and for providing electron density maps.	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; Almlof M, 2007, BIOCHEMISTRY-US, V46, P200, DOI 10.1021/bi061713i; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; HIRSH D, 1971, J MOL BIOL, V58, P459, DOI 10.1016/0022-2836(71)90363-9; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; KING G, 1989, J CHEM PHYS, V91, P3647, DOI 10.1063/1.456845; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Kristensen O, 2002, CURR PROTEIN PEPT SC, V3, P133, DOI 10.2174/1389203023380837; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; Trobro S, 2005, P NATL ACAD SCI USA, V102, P12395, DOI 10.1073/pnas.0504043102; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Trobro S, 2009, BIOCHEMISTRY-US, V48, P11296, DOI 10.1021/bi9017297; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	33	44	45	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					947	U12		10.1038/nature09082	http://dx.doi.org/10.1038/nature09082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20512119				2022-12-24	WOS:000278804500042
J	Zhang, Y; Zhu, XL; Torelli, AT; Lee, M; Dzikovski, B; Koralewski, RM; Wang, E; Freed, J; Krebs, C; Ealick, SE; Lin, HN				Zhang, Yang; Zhu, Xuling; Torelli, Andrew T.; Lee, Michael; Dzikovski, Boris; Koralewski, Rachel M.; Wang, Eileen; Freed, Jack; Krebs, Carsten; Ealick, Steven E.; Lin, Hening			Diphthamide biosynthesis requires an organic radical generated by an iron-sulphur enzyme	NATURE			English	Article							TOXIN-RESISTANT MUTANTS; S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; DIPHTHERIA-TOXIN; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SAM; PROTEINS; SYNTHASE; LOCALIZATION	Archaeal and eukaryotic translation elongation factor 2 contain a unique post-translationally modified histidine residue called diphthamide, which is the target of diphtheria toxin. The biosynthesis of diphthamide was proposed to involve three steps, with the first being the formation of a C-C bond between the histidine residue and the 3-amino-3-carboxypropyl group of S-adenosyl-L-methionine (SAM). However, further details of the biosynthesis remain unknown. Here we present structural and biochemical evidence showing that the first step of diphthamide biosynthesis in the archaeon Pyrococcus horikoshii uses a novel iron-sulphur-cluster enzyme, Dph2. Dph2 is a homodimer and each of its monomers can bind a [4Fe-4S] cluster. Biochemical data suggest that unlike the enzymes in the radical SAM superfamily, Dph2 does not form the canonical 59-deoxyadenosyl radical. Instead, it breaks the Cc, Met-S bond of SAM and generates a 3-amino-3-carboxypropyl radical. Our results suggest that P. horikoshii Dph2 represents a previously unknown, SAM-dependent, [4Fe-4S]-containing enzyme that catalyses unprecedented chemistry.	[Zhang, Yang; Zhu, Xuling; Torelli, Andrew T.; Dzikovski, Boris; Koralewski, Rachel M.; Wang, Eileen; Freed, Jack; Ealick, Steven E.; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Lee, Michael; Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	see3@cornell.edu; hl379@cornell.edu	Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	Dreyfus Foundation; NIH/NIGMS [R01GM088276]; NIH/NCRR [P41-RR016292]; US National Center for Research Resources at the US National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR016292, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088276] Funding Source: NIH RePORTER	Dreyfus Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Center for Research Resources at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kinsland for assistance with manuscript preparation, the Dreyfus Foundation for a New Faculty Award to H. L., NIH/NIGMS R01GM088276 to H. L. and S. E. E., and NIH/NCRR P41-RR016292 for the ACERT Center Grant to J.F. This work is based upon research conducted at the Advanced Photon Source (APS), Argonne National Laboratory, on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the US National Center for Research Resources at the US National Institutes of Health. Use of the APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CDCP, 2005, DIPHTH DIS LIST DIPH; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; Cicchillo RM, 2005, J AM CHEM SOC, V127, P7310, DOI 10.1021/ja051369x; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; MAKINEN GB, 1987, ENDOR EPR ELECT SPIN, P129; Marinoni I, 2008, FEBS J, V275, P5090, DOI 10.1111/j.1742-4658.2008.06641.x; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MATTHEAKIS LC, 1993, GENE, V132, P149, DOI 10.1016/0378-1119(93)90528-B; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips NJ, 1996, CANCER LETT, V102, P85, DOI 10.1016/0304-3835(96)04169-9; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Rekittke I, 2008, J AM CHEM SOC, V130, P17206, DOI 10.1021/ja806668q; Sakuraba H, 2005, J BIOL CHEM, V280, P26645, DOI 10.1074/jbc.C500192200; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Schultz DC, 1998, GENOMICS, V52, P186, DOI 10.1006/geno.1998.5420; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; WALSH CT, 2006, POSTTRANSLATIONAL MO, P321	47	142	146	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					891	U4		10.1038/nature09138	http://dx.doi.org/10.1038/nature09138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559380	Green Accepted			2022-12-24	WOS:000278804500030
J	Bongaarts, J; Over, M				Bongaarts, John; Over, Mead			Global HIV/AIDS Policy in Transition	SCIENCE			English	Editorial Material							HEALTH; AID		[Bongaarts, John] Populat Council, New York, NY 10017 USA; [Over, Mead] Ctr Global Dev, Washington, DC 20036 USA	Population Council	Bongaarts, J (corresponding author), Populat Council, New York, NY 10017 USA.	jbongaarts@popcouncil.org						[Anonymous], AIDS EP UPD DEC 2007; Bongaarts J, 2010, LANCET, V375, P103, DOI 10.1016/S0140-6736(09)61756-6; Clinton Hillary, 2010, COMMUNICATION   0106; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; *I MED, 2007, PEPFAR IMPL PROGR PR; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; *OFF US GLOB AIDS, 2008, US PRES EM PLAN AIDS; Over M, 2004, MACROECONOMICS OF HIV/AIDS, P311; Over M., 2010, USING INCENTIVES PRE; OVER M, 2009, REV EC DEV, V23, P107; Over M., 2010, GLOBAL AIDS TRANSITI; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; UNAIDS, 2009, AIDS EP UPD NOV 2009; WHO, 2009, UN ACC; World Bank, 2009, IMPROVING EFFECTIVENESS AND OUTCOMES FOR THE POOR IN HEALTH, NUTRITION, AND POPULATION: AN EVALUATION OF WORLD BANK GROUP SUPPORT SINCE 1997, P1, DOI 10.1596/978-0-8213-7542-6; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2009, RAP ADV ANT THER HIV	20	33	33	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1359	1360		10.1126/science.1191804	http://dx.doi.org/10.1126/science.1191804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538936				2022-12-24	WOS:000278598400023
J	Oreskes, N; Conway, EM				Oreskes, Naomi; Conway, Erik M.			Defeating the merchants of doubt	NATURE			English	Editorial Material									[Oreskes, Naomi] Univ Calif San Diego, La Jolla, CA 92093 USA; [Conway, Erik M.] CALTECH, Pasadena, CA 91109 USA	University of California System; University of California San Diego; California Institute of Technology	Oreskes, N (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	naoreskes@ucsd.edu						Gleick PH, 2010, SCIENCE, V328, P689, DOI 10.1126/science.328.5979.689; GWYNNE P, 1975, NEWSWEEK        0428, V64; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; Leiserowitz A., 2003, THESIS; Michaels D, 2008, DOUBT IS THEIR PRODU, V1st; *NAT AC SCI ARCH, 1979, EV EV CO2 IND CLIM C; Nisbet MC, 2007, PUBLIC OPIN QUART, V71, P444, DOI 10.1093/poq/nfm031; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; Oreskes Naomi, 2010, MERCHANTS DOUBT; Peterson TC, 2008, B AM METEOROL SOC, V89, P1325, DOI 10.1175/2008BAMS2370.1	10	92	93	6	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					686	687		10.1038/465686a	http://dx.doi.org/10.1038/465686a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535183				2022-12-24	WOS:000278551800017
J	Terauchi, A; Johnson-Venkatesh, EM; Toth, AB; Javed, D; Sutton, MA; Umemori, H				Terauchi, Akiko; Johnson-Venkatesh, Erin M.; Toth, Anna B.; Javed, Danish; Sutton, Michael A.; Umemori, Hisashi			Distinct FGFs promote differentiation of excitatory and inhibitory synapses	NATURE			English	Article							PRESYNAPTIC ORGANIZING MOLECULES; SYNAPTIC-TRANSMISSION; GROWTH-FACTOR; BRAIN; INTERNEURONS; LOCALIZATION; EPILEPSY; FAMILY	The differential formation of excitatory (glutamate-mediated) and inhibitory(GABA-mediated) synapses is a critical step for the proper functioning of the brain. An imbalance in these synapses may lead to various neurological disorders such as autism, schizophrenia, Tourette's syndrome and epilepsy(1-4). Synapses are formed through communication between the appropriate synaptic partners(5-8). However, the molecular mechanisms that mediate the formation of specific synaptic types are not known. Here we show that two members of the fibroblast growth factor (FGF) family, FGF22 and FGF7, promote the organization of excitatory and inhibitory presynaptic terminals, respectively, as target-derived presynaptic organizers. FGF22 and FGF7 are expressed by CA3 pyramidal neurons in the hippocampus. The differentiation of excitatory or inhibitory nerve terminals on dendrites of CA3 pyramidal neurons is specifically impaired in mutants lacking FGF22 or FGF7. These presynaptic defects are rescued by postsynaptic expression of the appropriate FGF. FGF22-deficientmice are resistant to epileptic seizures, and FGF7-deficient mice are prone to them, as expected from the alterations in excitatory/inhibitory balance. Differential effects of FGF22 and FGF7 involve both their distinct synaptic localizations and their use of different signalling pathways. These results demonstrate that specific FGFs act as target-derived presynaptic organizers and help to organize specific presynaptic terminals in the mammalian brain.	[Terauchi, Akiko; Johnson-Venkatesh, Erin M.; Toth, Anna B.; Javed, Danish; Sutton, Michael A.; Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Sutton, Michael A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	umemoh@umich.edu	Sutton, Michael/C-6264-2011	Sutton, Michael/0000-0002-0692-6459; Umemori, Hisashi/0000-0001-7198-2062	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr Foundation; March of Dimes Foundation; Whitehall Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070005] Funding Source: NIH RePORTER	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr Foundation; March of Dimes Foundation(March of Dimes); Whitehall Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Sanes and M. Hortsch for critical comments on the manuscript; M. Webb and P. Woodhams for the antibody Py; D. Sorenson for help with electron microscopy; A. Murayama for plasmid construction; M. De Freitas for help with histology; and M. Zhang for technical assistance. This work was supported by the Ester A. & Joseph Klingenstein Fund, the Edward Mallinckrodt Jr Foundation, the March of Dimes Foundation and the Whitehall Foundation (H. U.).	Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Goslin K., 1998, CULTURING NERVE CELL, P339; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	25	139	144	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					783	U8		10.1038/nature09041	http://dx.doi.org/10.1038/nature09041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20505669	Green Accepted			2022-12-24	WOS:000278551800046
J	Gustafson, JL; Lim, D; Miller, SJ				Gustafson, Jeffrey L.; Lim, Daniel; Miller, Scott J.			Dynamic Kinetic Resolution of Biaryl Atropisomers via Peptide-Catalyzed Asymmetric Bromination	SCIENCE			English	Article							ORGANIC-SYNTHESIS; N-BROMOSUCCINIMIDE; METAL-COMPLEXES; DIMETHYLFORMAMIDE; STEREOCHEMISTRY; RACEMIZATION; DERIVATIVES; CONVERSION; DIPHENYLS; MILD	Despite the widespread use of axially chiral, or atropisomeric, biaryl ligands in modern synthesis and the occurrence of numerous natural products exhibiting axial chirality, few catalytic methods have emerged for the direct asymmetric preparation of this compound class. Here, we present a tripeptide-derived small-molecule catalyst for the dynamic kinetic resolution of racemic biaryl substrates. The reaction proceeds via an atropisomer-selective electrophilic aromatic substitution reaction using simple bromination reagents. The result is an enantioselective synthesis that delivers chiral nonracemic biaryl compounds with excellent optical purity and good isolated chemical yields (in most cases a >95:5 enantiomer ratio and isolated yields of 65 to 87%). A mechanistic model is advanced that accounts for the basis of selectivity observed.	[Gustafson, Jeffrey L.; Lim, Daniel; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Miller, SJ (corresponding author), Yale Univ, Dept Chem, 225 Prospect St,POB 208107, New Haven, CT 06520 USA.	scott.miller@yale.edu	Miller, Scott/N-7761-2017	Miller, Scott/0000-0001-7817-1318	National Institute of General Medical Sciences of the NIH [GM068649]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068649, R37GM068649] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the National Institute of General Medical Sciences of the NIH for support (GM068649). Metrical parameters for the solid state structure of compound 3d are available free of charge from the Cambridge Crystallographic Data Centre under CCDC-773872.	Adams R, 1933, CHEM REV, V12, P261, DOI 10.1021/cr60042a003; Ahmad SM, 2007, TETRAHEDRON LETT, V48, P915, DOI 10.1016/j.tetlet.2006.12.042; BOTT G, 1980, J AM CHEM SOC, V102, P5618, DOI 10.1021/ja00537a036; Bringmann G, 2001, ACCOUNTS CHEM RES, V34, P615, DOI 10.1021/ar000106z; Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661; Clayden J, 2009, ANGEW CHEM INT EDIT, V48, P6398, DOI 10.1002/anie.200901719; Clayden J, 2009, J AM CHEM SOC, V131, P5331, DOI 10.1021/ja900722q; Davie EAC, 2007, CHEM REV, V107, P5759, DOI 10.1021/cr068377w; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Eliel E. N., 1994, STEREOCHEMISTRY ORGA; France S, 2005, EUR J ORG CHEM, V2005, P475, DOI 10.1002/ejoc.200400517; Haque TS, 1996, J AM CHEM SOC, V118, P6975, DOI 10.1021/ja960429j; HAYASHI T, 1988, J AM CHEM SOC, V110, P8153, DOI 10.1021/ja00232a030; JOHNSON F, 1968, CHEM REV, V68, P375, DOI 10.1021/cr60254a001; Kakiuchi F, 2000, TETRAHEDRON-ASYMMETR, V11, P2647, DOI 10.1016/S0957-4166(00)00244-5; KENDE AS, 1976, J AM CHEM SOC, V98, P267, DOI 10.1021/ja00417a060; Kenner J, 1921, J CHEM SOC, V119, P593, DOI 10.1039/ct9211900593; Lewis CA, 2008, J AM CHEM SOC, V130, P16358, DOI 10.1021/ja807120z; Li XL, 2003, J ORG CHEM, V68, P5500, DOI 10.1021/jo0340206; Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; MEYERS AI, 1985, J AM CHEM SOC, V107, P682, DOI 10.1021/ja00289a023; Miller SJ, 2004, ACCOUNTS CHEM RES, V37, P601, DOI 10.1021/ar030061c; MITCHELL RH, 1979, J ORG CHEM, V44, P4733, DOI 10.1021/jo00393a066; NOYORI R, 1995, B CHEM SOC JPN, V68, P36, DOI 10.1246/bcsj.68.36; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Sakakura A, 2007, NATURE, V445, P900, DOI 10.1038/nature05553; Seebach D, 1997, TETRAHEDRON, V53, P7539, DOI 10.1016/S0040-4020(97)00456-0; SHINDO M, 1992, J AM CHEM SOC, V114, P8732, DOI 10.1021/ja00048a074; Steinreiber J, 2008, CHEM-EUR J, V14, P8060, DOI 10.1002/chem.200701643; Stoughton RW, 1932, J AM CHEM SOC, V54, P4426, DOI 10.1021/ja01350a046; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yin JJ, 2000, J AM CHEM SOC, V122, P12051, DOI 10.1021/ja005622z; Zhang W, 2009, J AM CHEM SOC, V131, P3832, DOI 10.1021/ja8099008	34	314	314	6	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1251	1255		10.1126/science.1188403	http://dx.doi.org/10.1126/science.1188403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	605AC	20522769	Green Accepted			2022-12-24	WOS:000278318600027
J	Kahn, R; Gale, EAM				Kahn, Richard; Gale, Edwin A. M.			Gridlocked guidelines for diabetes	LANCET			English	Editorial Material									[Kahn, Richard] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Gale, Edwin A. M.] Univ Bristol, Fac Med, Bristol BS8 1TH, Avon, England	University of North Carolina; University of North Carolina Chapel Hill; University of Bristol	Kahn, R (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.	rak6200@gmail.com						*AACE DIAB MELL CL, 2007, ENDOCR PRACT S1, V13, P1; [Anonymous], 1989, DIABETES CARE, V12, P365; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020	10	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2203	2204		10.1016/S0140-6736(10)60714-3	http://dx.doi.org/10.1016/S0140-6736(10)60714-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609960				2022-12-24	WOS:000279652900009
J	Marti, K; Kerridge, J				Marti, Kurt; Kerridge, John			Nitrogen in the Solar System	SCIENCE			English	Editorial Material							RATIO		[Marti, Kurt; Kerridge, John] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Marti, K (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	jkerridg@ucsd.edu						Abbas MM, 2004, ASTROPHYS J, V602, P1063, DOI 10.1086/381084; Bizzocchi L, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913835; Briani G, 2009, P NATL ACAD SCI USA, V106, P10522, DOI 10.1073/pnas.0901546106; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Gerin M, 2009, ASTRON ASTROPHYS, V498, pL9, DOI 10.1051/0004-6361/200911759; KALLIO APA, 2010, 41 LUN PLAN SCI C WO; KERRIDGE JF, 1993, REV GEOPHYS, V31, P423, DOI 10.1029/93RG01953; KIM JS, 1995, NATURE, V375, P383, DOI 10.1038/375383a0; Marty B, 2010, GEOCHIM COSMOCHIM AC, V74, P340, DOI 10.1016/j.gca.2009.09.007; Mathew KJ, 1998, GEOPHYS RES LETT, V25, P4293, DOI 10.1029/1998GL900181; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; Wieler R, 1999, EARTH PLANET SC LETT, V167, P47, DOI 10.1016/S0012-821X(99)00012-6	12	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1112	1113		10.1126/science.1189836	http://dx.doi.org/10.1126/science.1189836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508118				2022-12-24	WOS:000278104700028
J	Argos, M; Kalra, T; Rathouz, PJ; Chen, Y; Pierce, B; Parvez, F; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Slavkovich, V; van Geen, A; Graziano, J; Ahsan, H				Argos, Maria; Kalra, Tara; Rathouz, Paul J.; Chen, Yu; Pierce, Brandon; Parvez, Faruque; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Slavkovich, Vesna; van Geen, Alexander; Graziano, Joseph; Ahsan, Habibul			Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study	LANCET			English	Article							BLADDER-CANCER MORTALITY; PERIPHERAL VASCULAR-DISEASE; ENDEMIC AREA; SUPPLY-SYSTEM; SOUTHWESTERN TAIWAN; SKIN-LESIONS; LUNG; REDUCTION; RISK; INSTALLATION	Background Millions of people worldwide are chronically exposed to arsenic through drinking water, including 35-77 million people in Bangladesh. The association between arsenic exposure and mortality rate has not been prospectively investigated by use of individual-level data. We therefore prospectively assessed whether chronic and recent changes in arsenic exposure are associated with all-cause and chronic-disease mortalities in a Bangladeshi population. Methods In the prospective cohort Health Effects of Arsenic Longitudinal Study (HEALS), trained physicians unaware of arsenic exposure interviewed in person and clinically assessed 11 746 population-based participants (aged 18-75 years) from Araihazar, Bangladesh. Participants were recruited from October, 2000, to May, 2002, and followed-up biennially. Data for mortality rates were available throughout February, 2009. We used Cox proportional hazards model to estimate hazard ratios (HRs) of mortality, with adjustment for potential confounders, at different doses of arsenic exposure. Findings 407 deaths were ascertained between October, 2000, and February, 2009. Multivariate adjusted HRs for all-cause mortality in a comparison of arsenic at concentrations of 10.1-50.0 mu g/L, 501-1500 mu g/L, and 150.1-864.0 mu g/L with at least 10.0 mu g/L in well water were 1.34 (95% CI 0.99-1.82), 1.09 (0.81-1.47), and 1.68 (1.26-2.23), respectively. Results were similar with daily arsenic dose and total arsenic concentration in urine. Recent change in exposure, measurement of total arsenic concentrations in urine repeated biennially, did not have much effect on the mortality rate. Interpretation Chronic arsenic exposure through drinking water was associated with an increase in the mortality rate. Follow-up data from this cohort will be used to assess the long-term effects of arsenic exposure and how they might be affected by changes in exposure. However, solutions and resources are urgently needed to mitigate the resulting health effects of arsenic exposure.	[Argos, Maria; Kalra, Tara; Rathouz, Paul J.; Pierce, Brandon; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Argos, Maria; Ahsan, Habibul] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Parvez, Faruque; Slavkovich, Vesna; Graziano, Joseph] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Chen, Yu] NYU, Dept Environm Med, New York, NY 10016 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Columbia Univ, Dhaka, Bangladesh; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Univ Chicago, Res Off Bangladesh, Dhaka, Bangladesh; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Columbia University; Columbia University; New York University; Columbia University	Ahsan, H (corresponding author), Univ Chicago, Ctr Canc Epidemiol & Prevent, 5841 S Maryland Ave,Suite N102, Chicago, IL 60637 USA.	habib@uchicago.edu	Hug, Balthasar L./G-1568-2010	Pierce, Brandon/0000-0002-7829-952X; Chen, Yu/0000-0002-1519-4894	National Institute of Health, Bethesda, MD, USA [P42ES010349, R01CA102484, R01CA107431, P30ES009089, P30CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599, R01CA107431, R01CA102484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institute of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research is supported by National Institute of Health, Bethesda, MD, USA (grants P42ES010349, R01CA102484, R01CA107431, P30ES009089, and P30CA014599).	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chang CC, 2004, J TOXICOL ENV HEAL A, V67, P1353, DOI 10.1080/15287390490471451; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Harbut MR, 2000, ARCH ENVIRON HEALTH, V55, P285; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Morales KH, 2000, ENVIRON HEALTH PERSP, V108, P655, DOI 10.2307/3434887; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NIXON DE, 1991, CLIN CHEM, V37, P1575; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Taeger D, 2004, J OCCUP ENVIRON MED, V46, P1007, DOI 10.1097/01.jom.0000141655.00168.0d; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Tseng CS, 2002, ANGIOLOGY, V53, P529, DOI 10.1177/000331970205300505; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; World Health Organization; Water Sanitation and Health Team, 2004, WATER SANITATION HYG; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P533, DOI 10.1080/15287390801907509; Yang CY, 2004, ARCH ENVIRON HEALTH, V59, P484, DOI 10.1080/00039890409603430; Yang CY, 2005, ENVIRON RES, V98, P127, DOI 10.1016/j.envres.2004.07.013; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	30	467	480	7	167	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					252	258		10.1016/S0140-6736(10)60481-3	http://dx.doi.org/10.1016/S0140-6736(10)60481-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20646756	Green Accepted			2022-12-24	WOS:000280457200034
J	Grabbe, KL; Bunnell, R				Grabbe, Kristina L.; Bunnell, Rebecca			Reframing HIV Prevention in Sub-Saharan Africa Using Couple-Centered Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSMISSION		[Grabbe, Kristina L.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Bunnell, Rebecca] US Ctr Dis Control & Prevent, Div Adult & Community Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Grabbe, KL (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, 1600 Clifton Rd NE,MS E04, Atlanta, GA 30333 USA.	kgrabbe@cdc.gov						Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; *MEAS DHS MACRO IN, DEM HLTH SURV; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; UNAIDS, UN ACC SCAL PRIOR HI; UNAIDS, AIDS EP UPD DEC 2009; WASHERNA NU, 2010, REG M ARUSH TANZ MAY	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					346	347		10.1001/jama.2010.1011	http://dx.doi.org/10.1001/jama.2010.1011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639571				2022-12-24	WOS:000280107500027
J	Horton, R				Horton, Richard			Science will never be the same again	LANCET			English	Editorial Material							CLIMATE-CHANGE; HEALTH		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; PEARCE R, 2010, CLIMATE FILES; [No title captured]	5	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 17	2010	376	9736					143	144		10.1016/S0140-6736(10)61091-4	http://dx.doi.org/10.1016/S0140-6736(10)61091-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638553				2022-12-24	WOS:000280313100004
J	Viner, RM; Roche, E; Maguire, SA; Nicholls, DE				Viner, Russell M.; Roche, Edna; Maguire, Sabine A.; Nicholls, Dasha E.			Childhood protection and obesity: framework for practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEXUAL-ABUSE; BIRTH COHORT; ADULTHOOD; NEGLECT; CARE; MALTREATMENT; OUTCOMES; CHILDREN; ISSUE; RISK		[Viner, Russell M.] UCL Inst Child Hlth, London WC1N 3EH, England; [Roche, Edna] Univ Dublin Trinity Coll, Dublin 2, Ireland; [Maguire, Sabine A.] Cardiff Univ, Sch Med, Cardiff, Wales; [Nicholls, Dasha E.] Great Ormond St Hosp Sick Children, London, England	University of London; University College London; Trinity College Dublin; Cardiff University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Viner, RM (corresponding author), UCL Inst Child Hlth, London WC1N 3EH, England.	rviner@ich.ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247				Alexander SM, 2009, MED J AUSTRALIA, V190, P136, DOI 10.5694/j.1326-5377.2009.tb02313.x; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Cole A, 2007, BRIT MED J, V334, P1343, DOI 10.1136/bmj.39259.668565.DB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Edwards C, 2006, EUR J CLIN NUTR, V60, P587, DOI 10.1038/sj.ejcn.1602353; FISHER BA, 2006, DEPAUL L REV, V55, P711; Fitzpatrick M, 2008, BRIT J GEN PRACT, V58, P742, DOI 10.3399/bjgp08X342589; FREEMAN S, 2009, DAILY MAIL      1207; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Greenfield EA, 2009, SOC SCI MED, V68, P791, DOI 10.1016/j.socscimed.2008.12.004; Grilo CM, 2006, OBES SURG, V16, P454, DOI 10.1381/096089206776327288; Hadfield SC, 2008, CHILD CARE HLTH DEV, V34, P710, DOI 10.1111/j.1365-2214.2008.00874.x; HENDERSON M, 2009, TIMES           1207; JEFFREYS B, 2007, BBC NEWS        0614; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lobstein T, 2007, TACKLING OBESITIES F; Mamun AA, 2007, OBESITY, V15, P2103, DOI 10.1038/oby.2007.250; Pinhas-Hamiel O, 2009, ACTA PAEDIATR, V98, P144, DOI 10.1111/j.1651-2227.2008.01044.x; ROBERTS B, 2008, MIRROR          1008; SHERMAN J, 2008, TIMES           0816; Varness T, 2009, PEDIATRICS, V123, P399, DOI 10.1542/peds.2008-0712; Viner R, 2005, ARCH DIS CHILD, V90, P385, DOI 10.1136/adc.2004.062224; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008	27	21	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2010	341								c3074	10.1136/bmj.c3074	http://dx.doi.org/10.1136/bmj.c3074			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XD	20634344	Green Accepted			2022-12-24	WOS:000280156800001
J	MacKay, C; Declais, AC; Lundin, C; Agostinho, A; Deans, AJ; MacArtney, TJ; Hofmann, K; Gartner, A; West, SC; Helleday, T; Lilley, DMJ; Rouse, J				MacKay, Craig; Declais, Anne-Cecile; Lundin, Cecilia; Agostinho, Ana; Deans, Andrew J.; MacArtney, Thomas J.; Hofmann, Kay; Gartner, Anton; West, Stephen C.; Helleday, Thomas; Lilley, David M. J.; Rouse, John			Identification of KIAA1018/FAN1, a DNA Repair Nuclease Recruited to DNA Damage by Monoubiquitinated FANCD2	CELL			English	Article							HOLLIDAY JUNCTION RESOLVASE; FANCONI-ANEMIA; CROSS-LINKS; REPLICATION; PROTEIN; ACTIVATION; KINETICS; DOMAINS; FAAP24; BRCA1	DNA interstrand crosslinks (ICLs) are highly toxic because they block the progression of replisomes. The Fanconi Anemia (FA) proteins, encoded by genes that are mutated in FA, are important for repair of ICLs. The FA core complex catalyzes the monoubiquitination of FANCD2, and this event is essential for several steps of ICL repair. However, how monoubiquitination of FANCD2 promotes ICL repair at the molecular level is unknown. Here, we describe a highly conserved protein, KIAA1018/MTMR15/FAN1, that interacts with, and is recruited to sites of DNA damage by, the monoubiquitinated form of FANCD2. FAN1 exhibits endonuclease activity toward 50 flaps and has 5' exonuclease activity, and these activities are mediated by an ancient VRR_nuc domain. Depletion of FAN1 from human cells causes hypersensitivity to ICLs, defects in ICL repair, and genome instability. These data at least partly explain how ubiquitination of FANCD2 promotes DNA repair.	[MacKay, Craig; MacArtney, Thomas J.; Rouse, John] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [MacKay, Craig; Lilley, David M. J.] Univ Dundee, Coll Life Sci, CRUK Nucle Acids Struct Res Grp, Dundee DD1 5EH, Scotland; [Agostinho, Ana; Gartner, Anton] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Lundin, Cecilia; Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany; [Deans, Andrew J.; West, Stephen C.] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	University of Dundee; University of Dundee; University of Dundee; University of Oxford; Miltenyi Biotec; Cancer Research UK; Stockholm University	Rouse, J (corresponding author), Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.	j.rouse@dundee.ac.uk	Deans, Andrew/U-3515-2019; Deans, Andrew J/E-5817-2011; Helleday, Thomas/D-5224-2013; Hofmann, Kay/D-6714-2011	Deans, Andrew/0000-0002-5271-4422; Deans, Andrew J/0000-0002-5271-4422; Hofmann, Kay/0000-0002-2289-9083; Declais, Anne-Cecile/0000-0002-1904-6469; Gartner, Anton/0000-0003-4639-9902; Helleday, Thomas/0000-0002-7384-092X; Agostinho, Ana/0000-0001-6270-7384; West, Stephen/0000-0001-8848-9418	UK Medical Research Council; Cancer Research UK; Fanconi Anemia Research Fund; Biotechnology and Biological Sciences Research Council [BB/E001777/1] Funding Source: researchfish; Cancer Research UK [11582] Funding Source: researchfish; Medical Research Council [MC_U127070192, G0700730] Funding Source: researchfish; BBSRC [BB/E001777/1] Funding Source: UKRI; MRC [MC_U127070192, G0700730] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Fanconi Anemia Research Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Katja Kratz and Joe Jiricny for experimental advice, for helping us with the purification of FAN1, and for communicating results prior to publication. We thank K.J. Patel, Johan de Winter, and Maureen Hoatlin for kind gifts of antibodies. pDEST40-V5-FANCD2 wild-type and pDEST40-V5-FANCD2 K561R plasmids were kind gifts from Niall Howlett and Thomas Glover. We thank Alan d'Andrea for the kind gifts of FANCD2<SUP>-/-</SUP> fibroblasts (PD20 cells) corrected with vector, FANCD2 wild-type, or FANCD2 K561R. We are grateful to James Hastie, Hilary MacLauchlan, and the Antibody Production Team at Division of Signal Transduction Therapy, University of Dundee, to Bob Gourlay, Sanjay Kothiya, and Nick Morrice for help with mass spectrometry, and to the DNA Sequencing Service at the College of Life Sciences (CLS), University of Dundee. We are grateful to the microscopy facility, CLS, University of Dundee for assistance with microscopy. We thank Jim Haber and the J.R. lab for critical reading of the manuscript. This work was funded by the UK Medical Research Council (C.M., T.J.H., and J.R.), Cancer Research UK (A.C.D, A.G., and D.M.J.L.), and the Fanconi Anemia Research Fund (A.J.D. and S.C.W.).	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRENNER S, 1974, GENETICS, V77, P71; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Leskovac A, 2010, TOHOKU J EXP MED, V221, P69, DOI 10.1620/tjem.221.69; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Mccabe KM, 2009, J CELL PHYSIOL, V220, P569, DOI 10.1002/jcp.21811; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	32	230	238	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					65	76		10.1016/j.cell.2010.06.021	http://dx.doi.org/10.1016/j.cell.2010.06.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603015	Bronze, Green Accepted			2022-12-24	WOS:000279637300013
J	Hotchkiss, RS; Opal, S				Hotchkiss, Richard S.; Opal, Steven			Immunotherapy for Sepsis - A New Approach against an Ancient Foe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA; [Opal, Steven] Mem Hosp Rhode Isl, Div Infect Dis, Providence, RI USA; [Opal, Steven] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brown University	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA.				NIGMS NIH HHS [R01 GM044118] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Opal SM, 2009, JAMA-J AM MED ASSOC, V302, P2367, DOI 10.1001/jama.2009.1774; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106	5	268	303	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					87	89		10.1056/NEJMcibr1004371	http://dx.doi.org/10.1056/NEJMcibr1004371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592301	Green Published, Green Accepted			2022-12-24	WOS:000279343000016
J	Biertumpfel, C; Zhao, Y; Kondo, Y; Ramon-Maiques, S; Gregory, M; Lee, JY; Masutani, C; Lehmann, AR; Hanaoka, F; Yang, W				Biertuempfel, Christian; Zhao, Ye; Kondo, Yuji; Ramon-Maiques, Santiago; Gregory, Mark; Lee, Jae Young; Masutani, Chikahide; Lehmann, Alan R.; Hanaoka, Fumio; Yang, Wei			Structure and mechanism of human DNA polymerase eta	NATURE			English	Article							SYN THYMINE DIMER; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; MOLECULAR ANALYSIS; BYPASS; LESION; RECOGNITION; REPLICATION; MUTATIONS; CISPLATIN	The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA polymerase eta (Pol eta), a DNA polymerase that enables replication through ultraviolet-induced pyrimidine dimers. Here we report high-resolution crystal structures of human Pol eta at four consecutive steps during DNA synthesis through cis-syn cyclobutane thymine dimers. Pol eta acts like a 'molecular splint' to stabilize damaged DNA in a normal B-form conformation. An enlarged active site accommodates the thymine dimer with excellent stereochemistry for two-metal ion catalysis. Two residues conserved among Pol eta orthologues form specific hydrogen bonds with the lesion and the incoming nucleotide to assist translesion synthesis. On the basis of the structures, eight Pol eta missense mutations causing XPV can be rationalized as undermining the molecular splint or perturbing the active-site alignment. The structures also provide an insight into the role of Pol eta in replicating through D loop and DNA fragile sites.	[Biertuempfel, Christian; Zhao, Ye; Ramon-Maiques, Santiago; Gregory, Mark; Lee, Jae Young; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhao, Ye] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Kondo, Yuji; Masutani, Chikahide; Hanaoka, Fumio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Zhejiang University; Osaka University; University of Sussex; Gakushuin University	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, 9000 Rockville Pike,Bldg 5,Room B103, Bethesda, MD 20892 USA.	fumio.hanaoka@gakushuin.ac.jp; wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Zhao, Ye/I-2936-2014; Masutani, Chikahide/I-6160-2014; Ramon-Maiques, Santiago/R-2533-2019	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Zhao, Ye/0000-0002-5455-2586; Biertumpfel, Christian/0000-0002-7528-6547; Ramon-Maiques, Santiago/0000-0001-9674-8088; Masutani, Chikahide/0000-0002-8600-8227	NIDDK, NIH; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Chinese Ministry of Education; NIH-Zhejiang University; Human Frontiers Science Program; MRC [G0501450] Funding Source: UKRI; Medical Research Council [G0501450, G0801130B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036146, ZIADK036119] Funding Source: NIH RePORTER	NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chinese Ministry of Education(Ministry of Education, China); NIH-Zhejiang University; Human Frontiers Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Leahy, M. Gellert and R. Craigie for critical reading of the manuscript. The research was funded by the intramural research program of NIDDK, NIH, and grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Y.Z. is the recipient of a Chinese Ministry of Education scholarship and joint PhD student in NIH-Zhejiang University Graduate Partnership Program. S.R.-M. received a fellowship from the Human Frontiers Science Program.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassett E, 2003, BIOCHEMISTRY-US, V42, P14197, DOI 10.1021/bi035359p; Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Brash DE, 1997, TRENDS GENET, V13, P410, DOI 10.1016/S0168-9525(97)01246-8; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Lucca J, 2009, EUR J CANCER, V45, P3228, DOI 10.1016/j.ejca.2009.04.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glick E, 2001, EMBO J, V20, P7303, DOI 10.1093/emboj/20.24.7303; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x; Kusumoto R, 2002, BIOCHEMISTRY-US, V41, P6090, DOI 10.1021/bi025549k; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; Saribasak H, 2009, PHILOS T R SOC B, V364, P605, DOI 10.1098/rstb.2008.0188; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2008, ADV EXP MED BIOL, V637, P47; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; Wang LH, 2009, J MOL BIOL, V389, P787, DOI 10.1016/j.jmb.2009.04.029; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Yao JQ, 2001, ENVIRON MOL MUTAGEN, V38, P19, DOI 10.1002/em.1046	58	248	249	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1044	U102		10.1038/nature09196	http://dx.doi.org/10.1038/nature09196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577208	Green Accepted			2022-12-24	WOS:000279056900045
J	Kautz, T; Bendavid, E; Bhattacharya, J; Miller, G				Kautz, Tim; Bendavid, Eran; Bhattacharya, Jay; Miller, Grant			AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPACT; HIV/AIDS	Objectives To determine the relation between the HIV/AIDS epidemic and support for dependent elderly people in Africa. Design Retrospective analysis using data from Demographic and Health Surveys. Setting 22 African countries between 1991 and 2006. Participants 123 176 individuals over the age of 60. Main outcome measures We investigated how three measures of the living arrangements of older people have been affected by the HIV/AIDS epidemic: the number of older individuals living alone (that is, the number of unattended elderly people); the number of older individuals living with only dependent children under the age of 10 (that is, in missing generation households); and the number of adults age 18-59 (that is, prime age adults) per household where an older person lives. Results An increase in annual AIDS mortality of one death per 1000 people was associated with a 1.5% increase in the proportion of older individuals living alone (95% CI 1.2% to 1.9%) and a 0.4% increase in the number of older individuals living in missing generation households (95% CI 0.3% to 0.6%). Increases in AIDS mortality were also associated with fewer prime age adults in households with at least one older person and at least one prime age adult (P<0.001). These findings suggest that in our study countries, which encompass 70% of the sub-Saharan population, the HIV/AIDS epidemic could be responsible for 582 200-917 000 older individuals living alone without prime age adults and 141 000-323 100 older individuals being the sole caregivers for young children. Conclusions Africa's HIV/AIDS epidemic might be responsible for a large number of older people losing their support and having to care for young children. This population has previously been under-recognised. Efforts to reduce HIV/AIDS deaths could have large "spillover" benefits for elderly people in Africa.	[Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, CHP, Stanford, CA 94305 USA; [Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, Ctr Primary Care & Outcomes Res PCOR, Stanford, CA 94305 USA; [Kautz, Tim] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	Stanford University; Stanford University; University of Chicago	Miller, G (corresponding author), Stanford Univ, CHP, Stanford, CA 94305 USA.	ngmiller@stanford.edu			National Institute on Aging [K02-AG024237]; National Institute of Child Health and Human Development [K01-HD053504]; Agency for Healthcare Research and Quality [T32-HS000028]; National Institute of Allergy and Infectious Diseases [K01-AI084582]; Stanford Center for Demography and Economics of Aging [P30-AG017253]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD053504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024237, P30AG017253] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Center for Demography and Economics of Aging; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging (K02-AG024237), the National Institute of Child Health and Human Development (K01-HD053504), the Agency for Healthcare Research and Quality (T32-HS000028), the National Institute of Allergy and Infectious Diseases (K01-AI084582), and the Stanford Center for Demography and Economics of Aging (P30-AG017253). The supporting agencies had no part in formulating, analysing, or writing this work.	Aboderin I, 2004, J GERONTOL B-PSYCHOL, V59, pS128, DOI 10.1093/geronb/59.3.S128; Agesa R.U, 2004, REV ECON HOUSEHOLD, V2, P161, DOI DOI 10.1023/B:REHO.0000031612.77882.29; [Anonymous], WORLD URB PROSP 2005; Barrientos A, 2003, WORLD DEV, V31, P555, DOI 10.1016/S0305-750X(02)00211-5; CATTELL M G, 1990, Journal of Cross-Cultural Gerontology, V5, P375, DOI 10.1007/BF00057646; DAYTON J, 2002, POLICY RES DIVISION, V160; GHYS PD, 2004, SEX TRANSM INFECT S1, V80, P5; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; Knodel J, 2001, SOC SCI MED, V52, P1313, DOI 10.1016/S0277-9536(00)00233-1; KNODEL J, 2002, AIDS S3, V16, P77; Merli M. G, 2006, AGING SUBSAHARAN AFR, P117; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Ntozi James P. M., 1999, CONTINUING AFRICAN H, P193; Nyambedha EO, 2003, SOC SCI MED, V57, P301, DOI 10.1016/S0277-9536(02)00359-3; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; SMITH J, 2007, AIDS S6, V21, P81; Ssengonzi R, 2007, J CROSS-CULT GERONTO, V22, P339, DOI 10.1007/s10823-007-9043-5; UNAIDS, 2008, REP GLOB AIDS EP; Unanka GO, 2002, J SOC ISSUES, V58, P681, DOI 10.1111/1540-4560.00040; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; *US BUR CENS, 2008, INT DAT; Wachter KW, 2003, J ECONOMETRICS, V112, P193, DOI 10.1016/S0304-4076(02)00160-4; Wachter KW, 2002, DEMOGRAPHY, V39, P25, DOI 10.1353/dem.2002.0012; WILLIAMS A, 1996, ASIAN STUDIES REV, V20, P98; ZIMMER Z, 2000, POPUL STUD CAMB, V59, P295	26	46	46	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2010	340								c2841	10.1136/bmj.c2841	http://dx.doi.org/10.1136/bmj.c2841			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554660	Green Published, hybrid			2022-12-24	WOS:000279051900002
J	Davies, AA; Neiss, A; Ulrich, HD				Davies, Adelina A.; Neiss, Andrea; Ulrich, Helle D.			Ubiquitylation of the 9-1-1 Checkpoint Clamp Is Independent of Rad6-Rad18 and DNA Damage	CELL			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; RAD6 PATHWAY; SOS RESPONSE; UBIQUITIN; REPAIR; PCNA; POLYMERASE; CELLS; SUMO	A recent report proposed a function of the ubiquitin conjugation factors Rad6 and Rad18 comparable to the bacterial SOS response, controlling damage-induced transcriptional activation and contributing to checkpoint signaling. The relevant ubiquitylation target was identified as budding yeast Rad17, a subunit of the PCNA-like 9-1-1 checkpoint clamp. We report here that in fact all three subunits of the 9-1-1 complex are ubiquitylated. However, in contrast to previous results, we found modification of Rad17 to be independent of DNA damage, the Rad6-Rad18 complex, the putative acceptor site (lysine 197), and loading of the complex onto DNA. Consistently, we were unable to observe enhanced damage sensitivity or defects in checkpoint signaling in a rad17(K197R) mutant. Instead, our findings suggest that ubiquitylation of the 9-1-1 complex may be a background reaction that in some cases can mediate proteasomal degradation.	[Davies, Adelina A.; Ulrich, Helle D.] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England; [Neiss, Andrea] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Cancer Research UK; Max Planck Society	Ulrich, HD (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, Blanche Lane, S Mimms EN6 3LD, Herts, England.	helle.ulrich@cancer.org.uk		Ulrich, Helle D./0000-0003-0431-2223	Cancer Research UK; Deutsche Forschungsgemeinschaft	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Susan Gasser and Wolfram Siede for yeast strains. This work was supported by Cancer Research UK and a grant from the Deutsche Forschungsgemeinschaft.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Frei C, 2000, GENE DEV, V14, P81; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Zhang H, 2001, J BIOL CHEM, V276, P26715, DOI 10.1074/jbc.M103682200; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	32	10	10	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1080	1087		10.1016/j.cell.2010.04.039	http://dx.doi.org/10.1016/j.cell.2010.04.039			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550940	Bronze			2022-12-24	WOS:000278618800021
J	Singh, R; Cresswell, P				Singh, Reshma; Cresswell, Peter			Defective Cross-Presentation of Viral Antigens in GILT-Free Mice	SCIENCE			English	Article							MHC CLASS-I; HERPES-SIMPLEX-VIRUS; THIOL REDUCTASE GILT; DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; DISULFIDE BONDS; INFLUENZA-VIRUS; GLYCOPROTEIN-B; CROSSPRESENTATION; LYSOSOMES	Gamma-interferon-inducible lysosomal thiolreductase (GILT) promotes major histocompatibility complex (MHC) class II-restricted presentation of exogenous antigens containing disulfide bonds. Here, we show that GILT also facilitates MHC class I-restricted recognition of such antigens by CD8(+) T cells, or cross-presentation. GILT is essential for cross-presentation of a CD8(+) T cell epitope of glycoprotein B (gB) from herpes simplex virus 1 (HSV-1) but not for its presentation by infected cells. Initiation of the gB-specific CD8(+) T cell response during HSV-1 infection, or cross-priming, is highly GILT-dependent, as is initiation of the response to the envelope glycoproteins of influenza A virus. Efficient cross-presentation of disulfide-rich antigens requires a complex pathway involving GILT-mediated reduction, unfolding, and partial proteolysis, followed by translocation into the cytosol for proteasomal processing.	[Singh, Reshma; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06250 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, 300 Cedar St,POB 208011, New Haven, CT 06250 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute; NIH [R37AI23081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute and NIH grant R37AI23081 (P.C.).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MCCOY KL, 1989, J IMMUNOL, V143, P29; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	29	108	113	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1394	1398		10.1126/science.1189176	http://dx.doi.org/10.1126/science.1189176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538950	Green Accepted			2022-12-24	WOS:000278598400038
J	Yao, NY; O'Donnell, M				Yao, Nina Y.; O'Donnell, Mike			SnapShot: The Replisome	CELL			English	Editorial Material							REPLICATION FORK		[Yao, Nina Y.] Rockefeller Univ, New York, NY 10065 USA; HHMI, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Yao, NY (corresponding author), Rockefeller Univ, New York, NY 10065 USA.			O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [R01 GM038839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; SINHA NK, 1980, J BIOL CHEM, V255, P4290; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; Yao NY, 2009, CURR OPIN CELL BIOL, V21, P336, DOI 10.1016/j.ceb.2009.02.008	6	39	40	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					1088	U181	1088.e1	10.1016/j.cell.2010.05.042	http://dx.doi.org/10.1016/j.cell.2010.05.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550941	Bronze, Green Accepted			2022-12-24	WOS:000278618800022
J	Rodriguez-Munoz, R; Bretman, A; Slate, J; Walling, CA; Tregenza, T				Rodriguez-Munoz, R.; Bretman, A.; Slate, J.; Walling, C. A.; Tregenza, T.			Natural and Sexual Selection in a Wild Insect Population	SCIENCE			English	Article							FEMALES; DOMINANCE	The understanding of natural and sexual selection requires both field and laboratory studies to exploit the advantages and avoid the disadvantages of each approach. However, studies have tended to be polarized among the types of organisms studied, with vertebrates studied in the field and invertebrates in the lab. We used video monitoring combined with DNA profiling of all of the members of a wild population of field crickets across two generations to capture the factors predicting the reproductive success of males and females. The factors that predict a male's success in gaining mates differ from those that predict how many offspring he has. We confirm the fundamental prediction that males vary more in their reproductive success than females, and we find that females as well as males leave more offspring when they mate with more partners.	[Rodriguez-Munoz, R.; Bretman, A.; Tregenza, T.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 EZ, England; [Bretman, A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Slate, J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Walling, C. A.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Exeter; University of East Anglia; University of Sheffield; University of Edinburgh	Tregenza, T (corresponding author), Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Cornwall Campus, Penryn TR10 EZ, England.	t.tregenza@exeter.ac.uk	Slate, Jon/D-2925-2012; Walling, Craig/HGT-8539-2022; Tregenza, Tom/B-1078-2014	Slate, Jon/0000-0003-3356-5123; Tregenza, Tom/0000-0003-4182-2222; Bretman, Amanda/0000-0002-4421-3337	Natural Environment Research Council (NERC) [NE/E005403/1]; NERC Sheffield Biomolecular Analysis Facility; Leverhulme Trust; Royal Society; NERC [NBAF010001, NE/H02364X/1] Funding Source: UKRI; Natural Environment Research Council [NBAF010001, NE/E005403/1, NE/H02364X/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC Sheffield Biomolecular Analysis Facility; Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC) (grant NE/E005403/1), the NERC Sheffield Biomolecular Analysis Facility, the Leverhulme Trust, and a Royal Society Fellowship to T. T. We thank L. Rodriguez and M. C. Munoz for providing access and facilities at the study site; J. M. Lopez, C. Lopez, E. Gonzalez, C. R. del Valle, and F. Gonzalez for assistance with the field work; and D. J. Hodgson and A. Wetherelt for assistance with data analysis and surveying.	Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2006, BIOL LETT-UK, V2, P409, DOI 10.1098/rsbl.2006.0493; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clutton-Brock T. H., 1988, REPROD SUCCESS; Darwin G., 1871, P423; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; FINCKE OM, 1986, EVOLUTION, V40, P791, DOI 10.1111/j.1558-5646.1986.tb00539.x; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 1999, AM NAT, V154, P358, DOI 10.1086/303235; Kortet R, 2005, BEHAV ECOL SOCIOBIOL, V59, P77, DOI 10.1007/s00265-005-0011-1; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Schwarzenbach GA, 2005, J EVOLUTION BIOL, V18, P455, DOI 10.1111/j.1420-9101.2004.00820.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Snyder BF, 2007, EVOLUTION, V61, P2457, DOI 10.1111/j.1558-5646.2007.00212.x; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; ZUK M, 1993, BEHAV ECOL SOCIOBIOL, V33, P339; Zuk Marlene, 1997, P89, DOI 10.1017/CBO9780511721946.006	25	158	157	0	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1269	1272		10.1126/science.1188102	http://dx.doi.org/10.1126/science.1188102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522773				2022-12-24	WOS:000278318600032
J	Manfredi, AA; Rovere-Querini, P				Manfredi, Angelo A.; Rovere-Querini, Patrizia			The Mitochondrion - A Trojan Horse That Kicks Off Inflammation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DAMPS		[Manfredi, Angelo A.] Ist Sci San Raffaele, Milan, Italy; Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Manfredi, AA (corresponding author), Ist Sci San Raffaele, Milan, Italy.		Manfredi, Angelo A./C-7018-2014; Rovere-Querini, Patrizia/J-2340-2012	Manfredi, Angelo A./0000-0001-8370-6970; 				Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Davidov Y, 2009, BIOESSAYS, V31, P748, DOI 10.1002/bies.200900018; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	5	58	59	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2132	2134		10.1056/NEJMcibr1003521	http://dx.doi.org/10.1056/NEJMcibr1003521			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20519686				2022-12-24	WOS:000278242200016
J	Unwin, N; Whiting, D; Roglic, G				Unwin, Nigel; Whiting, David; Roglic, Gojka			Social determinants of diabetes and challenges of prevention	LANCET			English	Editorial Material							HEALTH; CHINA		[Unwin, Nigel] Newcastle Univ, Inst Hlth & Soc, WHO Collaborating Ctr Res & Training Diabet, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Whiting, David] Int Diabet Federat, Brussels, Belgium; [Roglic, Gojka] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland	Newcastle University - UK; World Health Organization	Unwin, N (corresponding author), Newcastle Univ, Inst Hlth & Soc, WHO Collaborating Ctr Res & Training Diabet, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	n.c.unwin@ncl.ac.uk		Unwin, Nigel/0000-0002-1368-1648; Roglic, Gojka/0000-0003-0872-0689; Whiting, David/0000-0001-9827-2896				Goldstein J, 2005, PREV MED, V41, P800, DOI 10.1016/j.ypmed.2005.06.001; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; *INT DIAB FED, 2010, DIAB ATL; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Normile D, 2010, SCIENCE, V328, P422, DOI 10.1126/science.328.5977.422; Shobhana R, 2000, DIABETES RES CLIN PR, V48, P37, DOI 10.1016/S0168-8227(99)00130-8; Simmons RK, 2010, DIABETES RES CLIN PR, V87, P143, DOI 10.1016/j.diabres.2009.10.003; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	12	18	19	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2204	2205		10.1016/S0140-6736(10)60840-9	http://dx.doi.org/10.1016/S0140-6736(10)60840-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609961				2022-12-24	WOS:000279652900010
J	Cvetkovic, A; Menon, AL; Thorgersen, MP; Scott, JW; Poole, FL; Jenney, FE; Lancaster, WA; Praissman, JL; Shanmukh, S; Vaccaro, BJ; Trauger, SA; Kalisiak, E; Apon, JV; Siuzdak, G; Yannone, SM; Tainer, JA; Adams, MWW				Cvetkovic, Aleksandar; Menon, Angeli Lal; Thorgersen, Michael P.; Scott, Joseph W.; Poole, Farris L., II; Jenney, Francis E., Jr.; Lancaster, W. Andrew; Praissman, Jeremy L.; Shanmukh, Saratchandra; Vaccaro, Brian J.; Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary; Yannone, Steven M.; Tainer, John A.; Adams, Michael W. W.			Microbial metalloproteomes are largely uncharacterized	NATURE			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEON; MASS-SPECTROMETRY; TRACE-ELEMENTS; KEY ROLE; PROTEINS; METABOLISM; RUBREDOXIN; INSIGHTS; DATABASE	Metal ion cofactors afford proteins virtually unlimited catalytic potential, enable electron transfer reactions and have a great impact on protein stability(1,2). Consequently, metalloproteins have key roles in most biological processes, including respiration (iron and copper), photosynthesis (manganese) and drug metabolism (iron). Yet, predicting from genome sequence the numbers and types of metal an organism assimilates from its environment or uses in its metalloproteome is currently impossible because metal coordination sites are diverse and poorly recognized(2-4). We present here a robust, metal-based approach to determine all metals an organism assimilates and identify its metalloproteins on a genome-wide scale. This shifts the focus from classical protein-based purification to metal-based identification and purification by liquid chromatography, high-throughput tandem mass spectrometry (HT-MS/MS) and inductively coupled plasma mass spectrometry (ICP-MS) to characterize cytoplasmic metalloproteins from an exemplary microorganism (Pyrococcus furiosus). Of 343 metal peaks in chromatography fractions, 158 did not match any predicted metalloprotein. Unassigned peaks included metals known to be used (cobalt, iron, nickel, tungsten and zinc; 83 peaks) plus metals the organism was not thought to assimilate (lead, manganese, molybdenum, uranium and vanadium; 75 peaks). Purification of eight of 158 unexpected metal peaks yielded four novel nickel- and molybdenum-containing proteins, whereas four purified proteins contained sub-stoichiometric amounts of misincorporated lead and uranium. Analyses of two additional microorganisms (Escherichia coli and Sulfolobus solfataricus) revealed species-specific assimilation of yet more unexpected metals. Metalloproteomes are therefore much more extensive and diverse than previously recognized, and promise to provide key insights for cell biology, microbial growth and toxicity mechanisms.	[Cvetkovic, Aleksandar; Menon, Angeli Lal; Thorgersen, Michael P.; Scott, Joseph W.; Poole, Farris L., II; Jenney, Francis E., Jr.; Lancaster, W. Andrew; Praissman, Jeremy L.; Shanmukh, Saratchandra; Vaccaro, Brian J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Scripps Ctr Mass Spectrometry, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Yannone, Steven M.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University System of Georgia; University of Georgia; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	Tainer, John/GWQ-4878-2022; Vaccaro, Brian/F-8526-2017; Yannone, Steven/ABA-3524-2021; Yannone, Steven/G-1927-2011	Tainer, John/0000-0003-1659-2429; Jenney, Francis/0000-0002-1667-6924; Thorgersen, Michael/0000-0001-9552-762X; Siuzdak, Gary/0000-0002-4749-0014; Adams, Michael/0000-0002-9796-5014; Trauger, Sunia/0000-0002-1678-8715	Department of Energy [DE-FG0207ER64326]	Department of Energy(United States Department of Energy (DOE))	This research is part of the MAGGIE (Molecular Assemblies, Genes and Genomes Integrated Efficiently) project supported by Department of Energy grant (DE-FG0207ER64326). We thank S. Hammond, L. Wells, R. Hopkins and D. Phillips for help with in-gel MS analyses.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Aiuppa A, 2000, J VOLCANOL GEOTH RES, V98, P189, DOI 10.1016/S0377-0273(99)00156-0; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Atanassova Anelia, 2008, V426, P319, DOI 10.1007/978-1-60327-058-8_20; BLAKE PR, 1991, BIOCHEMISTRY-US, V30, P10885, DOI 10.1021/bi00109a012; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Cai Y, 2000, SPECTROCHIM ACTA B, V55, P1411, DOI 10.1016/S0584-8547(00)00247-0; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chai SC, 2008, J BIOL CHEM, V283, P26879, DOI 10.1074/jbc.M804345200; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Gray H.B., 2006, BIOL INORGANIC CHEM; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jenney FE, 2001, METHOD ENZYMOL, V334, P45; Karthikeyan S, 2006, ANAL CHIM ACTA, V576, P23, DOI 10.1016/j.aca.2006.05.051; Kasampalidis IN, 2007, PROTEINS, V68, P123, DOI 10.1002/prot.21384; Kosnett MJ, 2007, BASIC CLIN PHARMACOL, V10th, P945; Lobinski R, 2006, MASS SPECTROM REV, V25, P255, DOI 10.1002/mas.20069; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; Menon AL, 2009, MOL CELL PROTEOMICS, V8, P735, DOI 10.1074/mcp.M800246-MCP200; Messerschmidt A., 2005, HDB METALLOPROTEINS, V1-3; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Poole FL, 2005, J BACTERIOL, V187, P7325, DOI 10.1128/JB.187.21.7325-7332.2005; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; Sambrook J., 1989, MOL CLONING LAB MANU, P3; Sanz-Medel A, 2008, ANAL BIOANAL CHEM, V390, P3, DOI 10.1007/s00216-007-1615-2; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shi WX, 2005, STRUCTURE, V13, P1473, DOI 10.1016/j.str.2005.07.014; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886	37	276	280	5	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					779	U18		10.1038/nature09265	http://dx.doi.org/10.1038/nature09265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20639861	Green Submitted			2022-12-24	WOS:000280562500044
J	Clark, RH; McTaggart, JS; Webster, R; Mannikko, R; Iberl, M; Sim, XL; Rorsman, P; Glitsch, M; Beeson, D; Ashcroft, FM				Clark, Rebecca H.; McTaggart, James S.; Webster, Richard; Mannikko, Roope; Iberl, Michaela; Sim, Xiu Li; Rorsman, Patrik; Glitsch, Maike; Beeson, David; Ashcroft, Frances M.			Muscle Dysfunction Caused by a K-ATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin	SCIENCE			English	Article							SULFONYLUREA RECEPTOR; KIR6.2; INSULIN; KCNJ11; THERAPY; SUBUNIT; MYOCARDIUM; PATIENT; GENE	Gain-of-function mutations in Kir6.2 (KCNJ11), the pore-forming subunit of the adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channel, cause neonatal diabetes. Many patients also suffer from hypotonia (weak and flaccid muscles) and balance problems. The diabetes arises from suppressed insulin secretion by overactive K-ATP channels in pancreatic beta-cells, but the source of the motor phenotype is unknown. By using mice carrying a human Kir6.2 mutation (Val(59)-> Met(59)) targeted to either muscle or nerve, we show that analogous motor impairments originate in the central nervous system rather than in muscle or peripheral nerves. We also identify locomotor hyperactivity as a feature of K-ATP channel overactivity. These findings suggest that drugs targeted against neuronal, rather than muscle, K-ATP channels are needed to treat the motor deficits and that such drugs require high blood-brain barrier permeability.	[Clark, Rebecca H.; McTaggart, James S.; Mannikko, Roope; Iberl, Michaela; Sim, Xiu Li; Glitsch, Maike; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Webster, Richard; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Rorsman, Patrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	frances.ashcroft@dpag.ox.ac.uk	Mannikko, Roope/Q-3567-2016; Rorsman, Patrik/A-4331-2016	Mannikko, Roope/0000-0002-8727-9184; Rorsman, Patrik/0000-0001-7578-0767; Glitsch, Maike/0000-0003-0723-3117; Webster, Richard/0000-0001-7893-1348	Wellcome Trust; Medical Research Council; Royal Society; European Union [LHSB-CT-2004-005137, HEALTH-F4-2007-201924]; Muscular Dystrophy Campaign; Myasthenia Gravis Association; MRC [G0701521] Funding Source: UKRI; Medical Research Council [G0701521] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); European Union(European Commission); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Myasthenia Gravis Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Girard for generating the ROSA mouse and help with early experiments; J. Bruning for the Mck-Cre mice; R. Deacon for help with the mouse behavioral tests and for the use of the OXION mouse behavior facility; and the Wellcome Trust, the Medical Research Council, the Royal Society, the European Union (LHSB-CT-2004-005137 and HEALTH-F4-2007-201924), the Muscular Dystrophy Campaign, and Myasthenia Gravis Association for support. R. H. C. holds an OXION Wellcome Trust prize studentship and J. S. M. holds a Medical Research Council studentship. F. M. A. is a Royal Society University Research Professor.	Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Ghosh S, 2001, J AM COLL CARDIOL, V37, P711, DOI 10.1016/S0735-1097(00)01161-X; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2008, J CLIN ENDOCR METAB, V93, P1054, DOI 10.1210/jc.2007-1826; Mlynarski WC, 2007, NAT CLIN PRACT NEURO, V3, P640, DOI 10.1038/ncpneuro0640; MOURRE C, 1990, BRAIN RES, V519, P29, DOI 10.1016/0006-8993(90)90057-I; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Slingerland AS, 2008, DIABETIC MED, V25, P277, DOI 10.1111/j.1464-5491.2007.02373.x; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	19	70	72	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					458	461		10.1126/science.1186146	http://dx.doi.org/10.1126/science.1186146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595581	Green Accepted			2022-12-24	WOS:000280196500042
J	Moseley, JB; Nurse, P				Moseley, James B.; Nurse, Paul			Cell Division Intersects with Cell Geometry	CELL			English	Article							BACILLUS-SUBTILIS; SPINDLE ORIENTATION; CHROMOSOME SEGREGATION; MICROTUBULE BUNDLES; SELF-ORGANIZATION; PROTEIN DIVIVA; AURORA-A; KINASE; LOCALIZATION; SHAPE		[Moseley, James B.; Nurse, Paul] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Moseley, JB (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	jmoseley@rockefeller.edu			Wellcome Trust [093917] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Daga RR, 2008, J CELL SCI, V121, P1973, DOI 10.1242/jcs.011825; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lutkenhaus J, 2008, ADV EXP MED BIOL, V641, P49; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Maruyama R, 2007, CURR BIOL, V17, P1555, DOI 10.1016/j.cub.2007.08.011; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; Stitzel ML, 2007, CURR BIOL, V17, P1545, DOI 10.1016/j.cub.2007.08.049; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vogel SK, 2007, CURR BIOL, V17, P438, DOI 10.1016/j.cub.2007.01.047; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	52	36	39	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					189	193		10.1016/j.cell.2010.07.004	http://dx.doi.org/10.1016/j.cell.2010.07.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655459	Bronze			2022-12-24	WOS:000280204300007
J	Swierczek, M; Cieluch, E; Sarewicz, M; Borek, A; Moser, CC; Dutton, PL; Osyczka, A				Swierczek, Monika; Cieluch, Ewelina; Sarewicz, Marcin; Borek, Arkadiusz; Moser, Christopher C.; Dutton, P. Leslie; Osyczka, Artur			An Electronic Bus Bar Lies in the Core of Cytochrome bc(1)	SCIENCE			English	Article							Q(O) SITE; Q-CYCLE; RHODOBACTER-CAPSULATUS; SUPEROXIDE-PRODUCTION; COMPLEX; MITOCHONDRIAL; MECHANISM; DOMAIN; OXIDATION; MOVEMENT	The ubiquinol-cytochrome c oxidoreductases, central to cellular respiration and photosynthesis, are homodimers. High symmetry has frustrated resolution of whether cross-dimer interactions are functionally important. This has resulted in a proliferation of contradictory models. Here, we duplicated and fused cytochrome b subunits, and then broke symmetry by introducing independent mutations into each monomer. Electrons moved freely within and between monomers, crossing an electron-transfer bridge between two hemes in the core of the dimer. This revealed an H-shaped electron-transfer system that distributes electrons between four quinone oxidation-reduction terminals at the corners of the dimer within the millisecond time scale of enzymatic turnover. Free and unregulated distribution of electrons acts like a molecular-scale bus bar, a design often exploited in electronics.	[Swierczek, Monika; Cieluch, Ewelina; Sarewicz, Marcin; Borek, Arkadiusz; Osyczka, Artur] Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	Jagiellonian University; University of Pennsylvania	Osyczka, A (corresponding author), Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	artur.osyczka@uj.edu.pl	Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Borek, Arkadiusz/0000-0003-3195-3579; Osyczka, Artur/0000-0002-1637-2365; Sarewicz, Marcin/0000-0001-6813-5997	Wellcome Trust; United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041048, R01GM027309] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to F. Daldal (University of Pennsylvania, Philadelphia, USA) for the genetic system for cytochrome bc1 in R. capsulatus. This work was supported by The Wellcome Trust International Senior Research Fellowship (A.O.) and by the United States National Institutes of Health (P.L.D.)	Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Borek A, 2008, BIOCHEMISTRY-US, V47, P12365, DOI 10.1021/bi801207f; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Castellani M, 2010, J BIOL CHEM, V285, P502, DOI 10.1074/jbc.M109.072959; Cooley JW, 2009, BIOCHEMISTRY-US, V48, P1888, DOI 10.1021/bi802216h; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gopta OA, 1998, FEBS LETT, V431, P291, DOI 10.1016/S0014-5793(98)00768-6; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sarewicz M, 2008, J BIOL CHEM, V283, P24826, DOI 10.1074/jbc.M802174200; Shinkarev VP, 2007, FEBS LETT, V581, P1535, DOI 10.1016/j.febslet.2007.03.037; Yu CA, 2008, BBA-BIOENERGETICS, V1777, P1038, DOI 10.1016/j.bbabio.2008.03.033; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004	27	100	100	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					451	454		10.1126/science.1190899	http://dx.doi.org/10.1126/science.1190899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651150	Green Accepted			2022-12-24	WOS:000280196500040
J	Paal, P; Braun, P; Brugger, H; Strappazzon, G; Falk, M				Paal, Peter; Braun, Patrick; Brugger, Hermann; Strappazzon, Giacomo; Falk, Markus			Medicine and the Media How the media and animal rights activists put avalanche burial study on ice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL; HYPOTHERMIA		[Paal, Peter; Braun, Patrick] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria; [Brugger, Hermann; Strappazzon, Giacomo] EURAC Inst Mt Emergency Med, Bolzano, Italy; [Falk, Markus] Inova Q, Brunico, Italy	Medical University of Innsbruck; European Academy of Bozen-Bolzano	Paal, P (corresponding author), Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria.	peter.paal@uki.at	Paal, Peter/E-2110-2011	Brugger, Hermann/0000-0003-2752-6929; Paal, Peter/0000-0002-2939-4782; Falk, Markus/0000-0002-5297-0776				Boyd J, 2009, CAN MED ASSOC J, V180, P507, DOI 10.1503/cmaj.081327; Brugger H, 2003, RESUSCITATION, V58, P81, DOI 10.1016/S0300-9572(03)00113-8; Brugger H, 2001, RESUSCITATION, V51, P7, DOI 10.1016/S0300-9572(01)00383-5; Brugger H, 2010, NATURE, V463, P877, DOI 10.1038/463877a; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; GRAY R, LORD DRAYSON WINNING; Gunga HC, 2009, RESP PHYSIOL NEUROBI, V169, pS63, DOI 10.1016/j.resp.2009.04.005; Han YS, 2010, AM J PHYSIOL-HEART C, V298, pH890, DOI 10.1152/ajpheart.00805.2009; Oberhammer R, 2008, RESUSCITATION, V76, P474, DOI 10.1016/j.resuscitation.2007.09.004; *PROT, PROT STAND UP SCI	10	7	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2010	341								c3778	10.1136/bmj.c3778	http://dx.doi.org/10.1136/bmj.c3778			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XC	20630957				2022-12-24	WOS:000280156700013
J	D'Angiolella, V; Donato, V; Vijayakumar, S; Saraf, A; Florens, L; Washburn, MP; Dynlacht, B; Pagano, M				D'Angiolella, Vincenzo; Donato, Valerio; Vijayakumar, Sangeetha; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Dynlacht, Brian; Pagano, Michele			SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation	NATURE			English	Article							PROTEOMIC ANALYSIS; UBIQUITIN LIGASE; CYCLIN-F; IDENTIFICATION; BIOGENESIS; MECHANISMS; SUBSTRATE	Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins(1,2). Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions(3,4). The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the similar to 40-amino-acid domain required for binding to Skp1) was first described(5). Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)(5-7). However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein-substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.	[D'Angiolella, Vincenzo; Donato, Valerio; Vijayakumar, Sangeetha; Dynlacht, Brian; Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pagano, Michele] Howard Hughes Med Inst, Chevy Chase, MD USA	New York University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	michele.pagano@nyumc.org		Florens, Laurence/0000-0002-9310-6650; pagano, michele/0000-0003-3210-2442; Washburn, Michael/0000-0001-7568-2585	American Italian Cancer Foundation; March of Dimes [1-FY08-372]; National Institutes of Health [R01-GM057587, R37-CA076584, R21-AG032560]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	American Italian Cancer Foundation; March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Elledge for Cyclin F<SUP>Flox/-</SUP> and Cyclin F<SUP>-/-</SUP> MEFs, J.R. Skaar for reading the manuscript and F. M. Forrester for technical help. M. P. is grateful to T. M. Thor for continuous support. This work was funded by fellowships from the American Italian Cancer Foundation to V.D'A. and V. D., a grant from the March of Dimes (1-FY08-372) to B. D. and grants from the National Institutes of Health (R01-GM057587, R37-CA076584 and R21-AG032560) to M. P. A. S., L. F. and M. P. W. are supported by the Stowers Institute for Medical Research. V.D'A. is a Leukemia & Lymphoma Society Fellow. M. P. is an Investigator with the Howard Hughes Medical Institute.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	34	174	180	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					138	U161		10.1038/nature09140	http://dx.doi.org/10.1038/nature09140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596027	Green Accepted			2022-12-24	WOS:000279343800050
J	Smith, J; Van Dyken, JD; Zee, PC				Smith, Jeff; Van Dyken, J. David; Zee, Peter C.			A Generalization of Hamilton's Rule for the Evolution of Microbial Cooperation	SCIENCE			English	Article							SOCIAL EVOLUTION; KIN SELECTION; BACTERIAL-POPULATIONS; CONFLICT; MICROORGANISMS; COMPETITION; AMEBA; MODEL	Hamilton's rule states that cooperation will evolve if the fitness cost to actors is less than the benefit to recipients multiplied by their genetic relatedness. This rule makes many simplifying assumptions, however, and does not accurately describe social evolution in organisms such as microbes where selection is both strong and nonadditive. We derived a generalization of Hamilton's rule and measured its parameters in Myxococcus xanthus bacteria. Nonadditivity made cooperative sporulation remarkably resistant to exploitation by cheater strains. Selection was driven by higher-order moments of population structure, not relatedness. These results provide an empirically testable cooperation principle applicable to both microbes and multicellular organisms and show how nonlinear interactions among cells insulate bacteria against cheaters.	[Smith, Jeff; Van Dyken, J. David; Zee, Peter C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Smith, J (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA.	smith74@indiana.edu	smith, jeff/A-7486-2011	smith, jeff/0000-0001-8445-586X	NIH [GM07690, R01GM084238]; Genetics, Cellular and Molecular Sciences Training Grant [T32GM007757]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079690, R01GM084238, T32GM007757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics, Cellular and Molecular Sciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Velicer for funding and laboratory support through NIH grant GM07690 and S. Alizon, W. Castle, D. Queller, and W. Ratcliff for discussion and comments on the manuscript. J.D.V.D. was supported by NIH grant R01GM084238 to M.J. Wade. P.C.Z. was supported by the Genetics, Cellular and Molecular Sciences Training Grant (T32GM007757). All authors conceived the project, discussed the results, and commented on the paper. j.s. and D. V. D. designed the theoretical approach. j.s. did the math, designed and performed the experiments, and wrote the paper. j.s. and P.C.Z. analyzed the data.	Brown SP, 2009, PHILOS T R SOC B, V364, P3157, DOI 10.1098/rstb.2009.0055; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Godfrey-Smith P, 2009, AM NAT, V174, P906, DOI 10.1086/646605; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Keller L, 1999, LEVELS SELECTION EVO; Kummerli R, 2010, J EVOLUTION BIOL, V23, P699, DOI 10.1111/j.1420-9101.2010.01936.x; Leimar O, 2006, J EVOLUTION BIOL, V19, P1403, DOI 10.1111/j.1420-9101.2006.01156.x; LEIMAR O, 2006, J EVOLUTION BIOL, V19, P1426; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI 10.1111/j.1558-5646.1992.tb02045.x; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Szathmary E, 1995, MAJOR TRANSITIONS EV; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Wenseleers T, 2006, J EVOLUTION BIOL, V19, P1419, DOI 10.1111/j.1420-9101.2006.01144.x; WENSELEERS T, 2006, J EVOLUTION BIOL, V19, P1426; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Whitlock MC, 2002, GENETICS, V160, P1191; Wright S, 1931, GENETICS, V16, P0097	30	56	58	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1700	1703		10.1126/science.1189675	http://dx.doi.org/10.1126/science.1189675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576891	Green Accepted			2022-12-24	WOS:000279107400045
J	Spence, D				Spence, Des			From the Frontline Compulsive doing: sport in childhood	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2010	340								c3071	10.1136/bmj.c3071	http://dx.doi.org/10.1136/bmj.c3071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534680				2022-12-24	WOS:000278818500008
J	Valentine, DL				Valentine, David L.			Measure methane to quantify the oil spill	NATURE			English	Editorial Material									[Valentine, David L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Valentine, DL (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	valentine@geol.ucsb.edu	Valentine, David/E-5594-2012	Valentine, David/0000-0001-5914-9107	Directorate For Geosciences [0950600] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))			0	5	5	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					421	421		10.1038/465421a	http://dx.doi.org/10.1038/465421a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601FM	20495546	Bronze			2022-12-24	WOS:000278043700015
J	Berkley, JA; Munywoki, P; Ngama, M; Kazungu, S; Abwao, J; Bett, A; Lassauniere, R; Kresfelder, T; Cane, PA; Venter, M; Scott, JAG; Nokes, DJ				Berkley, James A.; Munywoki, Patrick; Ngama, Mwanajuma; Kazungu, Sidi; Abwao, John; Bett, Anne; Lassauniere, Ria; Kresfelder, Tina; Cane, Patricia A.; Venter, Marietjie; Scott, J. Anthony G.; Nokes, D. James			Viral Etiology of Severe Pneumonia Among Kenyan Infants and Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFLUENZAE TYPE-B; GAMBIAN CHILDREN; VACCINE CANDIDATE; CONJUGATE VACCINE; TRACT INFECTIONS; KILIFI DISTRICT; IMMUNIZATION; DISEASE; LIVE	Context Pneumonia is the leading cause of childhood death in sub-Saharan Africa. Comparative estimates of the contribution of causative pathogens to the burden of disease are essential for targeted vaccine development. Objective To determine the viral etiology of severe pneumonia among infants and children at a rural Kenyan hospital using comprehensive and sensitive molecular diagnostic techniques. Design, Setting, and Participants Prospective observational and case-control study during 2007 in a rural Kenyan district hospital. Participants were children aged 1 day to 12 years, residing in a systematically enumerated catchment area, and who either were admitted to Kilifi District Hospital meeting World Health Organization clinical criteria for severe pneumonia or very severe pneumonia; (2) presented with mild upper respiratory tract infection but were not admitted; or (3) were well infants and children attending for immunization. Main Outcome Measures The presence of respiratory viruses and the odds ratio for admission with severe disease. Results Of 922 eligible admitted patients, 759 were sampled (82% [median age, 9 months]). One or more respiratory viruses were detected in 425 of the 759 sampled (56% [95% confidence interval {CI}, 52%-60%]). Respiratory syncytial virus (RSV) was detected in 260 participants (34% [95% CI, 31%-38%]) and other respiratory viruses were detected in 219 participants (29%; 95% CI, 26%-32%), the most common being Human coronavirus 229E (n=51 [6.7%]), influenza type A (n=44 [5.8%]), Parainfluenza type 3 (n=29 [3.8%]), Human adenovirus (n=29 [3.8%]), and Human metapneumovirus (n=23 [3.0%]). Compared with well control participants, detection of RSV was associated with severe disease (5% in control participants; adjusted odds ratio, 6.11 [95% CI, 1.65-22.6]) while collectively, other respiratory viruses were not associated with severe disease (23% in control participants; adjusted odds ratio, 1.27 [95% CI, 0.64-2.52]). Conclusion In a sample of Kenyan infants and children admitted with severe pneumonia to a rural hospital, RSV was the predominant viral pathogen. JAMA. 2010;303(20):2051-2057 www.jama.com	[Berkley, James A.; Munywoki, Patrick; Ngama, Mwanajuma; Kazungu, Sidi; Abwao, John; Bett, Anne; Scott, J. Anthony G.; Nokes, D. James] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Berkley, James A.; Scott, J. Anthony G.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Lassauniere, Ria; Kresfelder, Tina; Venter, Marietjie] Univ Pretoria, Dept Med Virol, Fac Hlth Sci, Resp & Zoonot Virus Programme, ZA-0001 Pretoria, South Africa; [Cane, Patricia A.] Hlth Protect Agcy, Ctr Infect, London, England; [Venter, Marietjie] Natl Inst Communicable Dis, Resp Virus Unit, Johannesburg, South Africa; [Nokes, D. James] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Kenya Medical Research Institute; University of Oxford; University of Pretoria; Health Protection Agency; National Institute for Communicable Diseases (NICD); University of Warwick	Berkley, JA (corresponding author), POB 230, Kilifi 80108, Kenya.	jberkley@kilifi.kemri-wellcome.org	Venter, Marietjie/H-3032-2011; Munywoki, Patrick K./GQP-4775-2022; Lassaunière, Ria/AAM-2324-2021; Venter, Marietjie/P-9604-2016	Munywoki, Patrick K./0000-0001-9419-7155; Lassaunière, Ria/0000-0002-3910-7185; Venter, Marietjie/0000-0003-2696-824X; Berkley, James/0000-0002-1236-849X	Wellcome Trust (Great Britain) [081186]	Wellcome Trust (Great Britain)(Wellcome Trust)	The study was funded by a project grant (081186) from the Wellcome Trust (Great Britain). Drs Berkley, Scott, and Nokes report receipt of support by fellowships from the Wellcome Trust (Great Britain).	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Albargish K A, 1999, East Mediterr Health J, V5, P941; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DAGAN R, 1993, PEDIATR INFECT DIS J, V12, P381, DOI 10.1097/00006454-199305000-00006; FLIESS JL, 1981, STAT METHODS RATES P; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Johnson B R, 1993, West Afr J Med, V12, P11; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Kuypers J, 2004, J CLIN VIROL, V31, P123, DOI 10.1016/j.jcv.2004.03.018; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1997, LANCET, V350, P524; *NAT I HLTH CLIN T, STUD EV SAF TOL IMM; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Nokes JD, 2008, CURR OPIN INFECT DIS, V21, P639, DOI 10.1097/QCO.0b013e3283184245; PHILLIPS P A, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P373; Schmidt AC, 2001, J VIROL, V75, P4594, DOI 10.1128/JVI.75.10.4594-4603.2001; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; SOBESLAVSKY O, 1977, B WORLD HEALTH ORGAN, V55, P625; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; Vieira Sandra E., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P125, DOI 10.1590/S0036-46652001000300002; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859	33	221	238	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2051	2057		10.1001/jama.2010.675	http://dx.doi.org/10.1001/jama.2010.675			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501927	Bronze, Green Accepted			2022-12-24	WOS:000278018200029
J	Mahecha, MD; Reichstein, M; Carvalhais, N; Lasslop, G; Lange, H; Seneviratne, SI; Vargas, R; Ammann, C; Arain, MA; Cescatti, A; Janssens, IA; Migliavacca, M; Montagnani, L; Richardson, AD				Mahecha, Miguel D.; Reichstein, Markus; Carvalhais, Nuno; Lasslop, Gitta; Lange, Holger; Seneviratne, Sonia I.; Vargas, Rodrigo; Ammann, Christof; Arain, M. Altaf; Cescatti, Alessandro; Janssens, Ivan A.; Migliavacca, Mirco; Montagnani, Leonardo; Richardson, Andrew D.			Global Convergence in the Temperature Sensitivity of Respiration at Ecosystem Level	SCIENCE			English	Article							ORGANIC-MATTER DECOMPOSITION; SOIL RESPIRATION; CARBON; CLIMATE; DEPENDENCE; MODEL; EXCHANGE; ASSIMILATION; INTEGRATION; SEPARATION	The respiratory release of carbon dioxide (CO2) from the land surface is a major flux in the global carbon cycle, antipodal to photosynthetic CO2 uptake. Understanding the sensitivity of respiratory processes to temperature is central for quantifying the climate-carbon cycle feedback. We approximated the sensitivity of terrestrial ecosystem respiration to air temperature (Q(10)) across 60 FLUXNET sites with the use of a methodology that circumvents confounding effects. Contrary to previous findings, our results suggest that Q(10) is independent of mean annual temperature, does not differ among biomes, and is confined to values around 1.4 +/- 0.1. The strong relation between photosynthesis and respiration, by contrast, is highly variable among sites. The results may partly explain a less pronounced climate-carbon cycle feedback than suggested by current carbon cycle climate models.	[Mahecha, Miguel D.; Reichstein, Markus; Carvalhais, Nuno; Lasslop, Gitta] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Mahecha, Miguel D.; Seneviratne, Sonia I.] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, P-2829516 Caparica, Portugal; [Lange, Holger] Norsk Inst Skog Landskap, N-1431 As, Norway; [Vargas, Rodrigo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Ammann, Christof] Agroscope ART, Fed Res Stn, CH-8046 Zurich, Switzerland; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON L8S 4L8, Canada; [Cescatti, Alessandro] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [Janssens, Ivan A.] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Migliavacca, Mirco] Univ Milano Bicocca, DISAT, Remote Sensing Environm Dynam Lab, I-20126 Milan, Italy; [Montagnani, Leonardo] Prov Autonoma Bolzano, Serv Forestali Agenzia Ambiente, I-39100 Bolzano, Italy; [Montagnani, Leonardo] Free Univ Bozen Bolzano, Fac Sci & Technol, I-39100 Bolzano, Italy; [Richardson, Andrew D.] Harvard Univ Herbaria, Harvard Univ Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Nova de Lisboa; University of California System; University of California Berkeley; Swiss Federal Research Station Agroscope; McMaster University; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Antwerp; University of Milano-Bicocca; Free University of Bozen-Bolzano; Harvard University	Mahecha, MD (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	mmahecha@bgc-jena.mpg.de	Seneviratne, Sonia I./G-8761-2011; Janssens, Ivan A/P-1331-2014; Migliavacca, mirco/C-1260-2011; Arain, M. Altaf/ABA-9750-2020; Migliavacca, Mirco/J-9986-2019; Mahecha, Miguel D/F-2443-2010; Cescatti, Alessandro/ABE-6319-2020; Montagnani, Leonardo/F-1837-2016; Richardson, Andrew/F-5691-2011; Lange, Holger/A-2458-2012; Reichstein, Markus/A-7494-2011; Vargas, Rodrigo/C-4720-2008	Seneviratne, Sonia I./0000-0001-9528-2917; Janssens, Ivan A/0000-0002-5705-1787; Arain, M. Altaf/0000-0002-1433-5173; Migliavacca, Mirco/0000-0003-3546-8407; Mahecha, Miguel D/0000-0003-3031-613X; Montagnani, Leonardo/0000-0003-2957-9071; Richardson, Andrew/0000-0002-0148-6714; Lange, Holger/0000-0001-7099-8740; Reichstein, Markus/0000-0001-5736-1112; Vargas, Rodrigo/0000-0001-6829-5333; Lasslop, Gitta/0000-0001-9939-1459; Ammann, Christof/0000-0002-0783-5444; Carvalhais, Nuno/0000-0003-0465-1436	CarboEuropeIP; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS); Max Planck Institute for Biogeochemistry; NSF; University of Tuscia; U.S. Department of Energy; U.S. Department of Energy, Biological and Environmental Research [DE-FG02-04ER63917]; European Research Council; European Commission [FP7-ENV2008-1-226701]; Max Planck Society	CarboEuropeIP(European Commission); FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS); Max Planck Institute for Biogeochemistry; NSF(National Science Foundation (NSF)); University of Tuscia; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Biological and Environmental Research(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work is the outcome of the La Thuile FLUXNET workshop 2007, which would not have been possible without the support provided by CarboEuropeIP, FAO-GTOS-TCO, the Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS, a core project of IGBP), Max Planck Institute for Biogeochemistry, NSF, University of Tuscia, and U.S. Department of Energy. Moreover, we acknowledge databasing and technical support from the Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, and University of Virginia. The following networks provided flux data: AmeriFlux, AsiaFlux, CarboEuropeIP, ChinaFlux, FluxnetCanada, Canadian Carbon Program, LBA, NECC, OzFlux, TCOS-Siberia, and USCCC. AmeriFlux is supported by U.S. Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program grant DE-FG02-04ER63917. This work was also supported by the European Research Council via the ERC-Staring Grant QUASOM, the European Commission project CARBO-Extreme (FP7-ENV2008-1-226701), and a grant by the Max Planck Society establishing the MPRG Biogeochemical Model-Data Integration. We appreciate the collaboration of the FLUXNET synthesis team as documented at (23), and we thank M. Bahn, D. Baldocchi, H.-R. Kunsch, D. Papale, P. Rayner, M. Rodeghiero, and S. Zaehle for very valuable comments. M.D.M., M.R., N.C., and G.L. conceived the study and developed the methodology with substantial input from H.L.M.D.M. performed the analysis and co-wrote the paper with M.R. All other authors gave substantial scientific input during the analysis and/or writing phase.	Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heinemeyer A, 2006, NEW PHYTOL, V171, P159, DOI 10.1111/j.1469-8137.2006.01730.x; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; KNORR W, 1995, TELLUS B, V47, P471, DOI 10.1034/j.1600-0889.47.issue4.7.x; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; KUZYAKOV Z, 2010, GLOBAL CHANGE BIOL, DOI DOI 10.1111/J.1365-2486.2010.02179.X; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Lenton TM, 2003, GLOBAL CHANGE BIOL, V9, P1333, DOI 10.1046/j.1365-2486.2003.00674.x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Migliavacca M, 2011, GLOBAL CHANGE BIOL, V17, P390, DOI 10.1111/j.1365-2486.2010.02243.x; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9	34	351	367	20	374	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					838	840		10.1126/science.1189587	http://dx.doi.org/10.1126/science.1189587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20603495				2022-12-24	WOS:000280809900050
J	Buschmann, S; Warkentin, E; Xie, H; Langer, JD; Ermler, U; Michel, H				Buschmann, Sabine; Warkentin, Eberhard; Xie, Hao; Langer, Julian D.; Ermler, Ulrich; Michel, Hartmut			The Structure of cbb(3) Cytochrome Oxidase Provides Insights into Proton Pumping	SCIENCE			English	Article							C-OXIDASE; ACTIVE-SITE; ENERGY TRANSDUCTION; RESPIRATORY-CHAIN; INPUT CHANNEL; OXYGEN; RESOLUTION; REDUCTASES; IDENTIFICATION; MECHANISM	The heme-copper oxidases (HCOs) accomplish the key event of aerobic respiration; they couple O-2 reduction and transmembrane proton pumping. To gain new insights into the still enigmatic process, we structurally characterized a C-family HCO-essential for the pathogenicity of many bacteria-that differs from the two other HCO families, A and B, that have been structurally analyzed. The x-ray structure of the C-family cbb(3) oxidase from Pseudomonas stutzeri at 3.2 angstrom resolution shows an electron supply system different from families A and B. Like family-B HCOs, C HCOs have only one pathway, which conducts protons via an alternative tyrosine-histidine cross-link. Structural differences around hemes b and b(3) suggest a different redox-driven proton-pumping mechanism and provide clues to explain the higher activity of family-C HCOs at low oxygen concentrations.	[Buschmann, Sabine; Warkentin, Eberhard; Xie, Hao; Langer, Julian D.; Ermler, Ulrich; Michel, Hartmut] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	hartmut.michel@mpibp-frankfurt.mpg.de		Xie, Hao/0000-0002-2422-2527; Langer, Julian David/0000-0002-5190-577X	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 472]; Cluster of Excellence Macromolecular Complexes Frankfurt	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Macromolecular Complexes Frankfurt	This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SFB 472), and the Cluster of Excellence Macromolecular Complexes Frankfurt. We thank the staffs of the Swiss Light Source and the European Synchrotron Radiation Facility for assistance. Coordinates and structure factors of cbb<INF>3</INF> oxidase of P. stutzeri have been deposited under the pdb accession code 3MK7, the nucleotide sequences under gene bank accession number HM130676.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Forte E, 2001, EUR J BIOCHEM, V268, P6486, DOI 10.1046/j.0014-2956.2001.02597.x; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hemp J, 2006, BIOCHEMISTRY-US, V45, P15405, DOI 10.1021/bi062026u; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Huang YF, 2008, P NATL ACAD SCI USA, V105, P20257, DOI 10.1073/pnas.0805429106; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Ozturk M, 2007, MOL BIOL REP, V34, P165, DOI 10.1007/s11033-006-9031-9; Pereira MM, 2008, BBA-BIOENERGETICS, V1777, P929, DOI 10.1016/j.bbabio.2008.05.441; Peters A, 2008, J BACTERIOL, V190, P5576, DOI 10.1128/JB.00534-08; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, J BIOL CHEM, V277, P31474, DOI 10.1074/jbc.M204103200; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rauhamaki V, 2006, P NATL ACAD SCI USA, V103, P16135, DOI 10.1073/pnas.0606254103; Rauhamaki V, 2009, J BIOL CHEM, V284, P11301, DOI 10.1074/jbc.M808839200; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Richter OMH, 2009, BBA-BIOENERGETICS, V1787, P626, DOI 10.1016/j.bbabio.2009.02.020; Sharma V, 2008, BIOCHEMISTRY-US, V47, P4221, DOI 10.1021/bi702088r; Sharma V, 2006, BIOCHEMISTRY-US, V45, P5754, DOI 10.1021/bi060169a; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Urbani A, 2001, FEBS LETT, V508, P29, DOI 10.1016/S0014-5793(01)03006-X; Verkhovsky MI, 1996, NATURE, V380, P268, DOI 10.1038/380268a0; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wikstrom M, 2007, BBA-BIOENERGETICS, V1767, P1200, DOI 10.1016/j.bbabio.2007.06.008; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	34	193	198	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					327	330		10.1126/science.1187303	http://dx.doi.org/10.1126/science.1187303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576851				2022-12-24	WOS:000279925900043
J	Wu, YK; Yang, Y; Ye, S; Jiang, YX				Wu, Yunkun; Yang, Yi; Ye, Sheng; Jiang, Youxing			Structure of the gating ring from the human large-conductance Ca2+-gated K+ channel	NATURE			English	Article							DEPENDENT ACTIVATION; VOLTAGE SENSOR; LIPID-MEMBRANE; BKCA CHANNEL; ION-BINDING; RCK DOMAIN; CA2+; SENSITIVITY; MECHANISM; MG2+	Large-conductance Ca2+-gated K+ (BK) channels are essential for many biological processes such as smooth muscle contraction and neurotransmitter release(1-4). This group of channels can be activated synergistically by both voltage and intracellular Ca2+, with the large carboxy-terminal intracellular portion being responsible for Ca2+ sensing(5-13). Here we present the crystal structure of the entire cytoplasmic region of the human BK channel in a Ca2+-free state. The structure reveals four intracellular subunits, each comprising two tandem RCK domains, assembled into a gating ring similar to that seen in the MthK channel 14 and probably representing its physiological assembly. Three Ca2+ binding sites including the Ca2+ bowl are mapped onto the structure based on mutagenesis data. The Ca2+ bowl, located within the second RCK domain, forms an EF-hand-like motif and is strategically positioned close to the assembly interface between two subunits. The other two Ca2+ (or Mg2+) binding sites, Asp 367 and Glu 374/Glu 399, are located on the first RCK domain. The Asp 367 site has high Ca2+ sensitivity and is positioned in the groove between the amino-and carboxyterminal subdomains of RCK1, whereas the low-affinity Mg2+-binding Glu 374/Glu 399 site is positioned on the upper plateau of the gating ring and close to the membrane. Our structure also contains the linker connecting the transmembrane and intracellular domains, allowing us to dock a voltage-gated K+ channel pore of known structure onto the gating ring with reasonable accuracy and generate a structural model for the full BK channel.	[Wu, Yunkun; Yang, Yi; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wu, Yunkun; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Zhejiang University	Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu			Howard Hughes Medical Institute; NIH/NIGMS [RO1 GM071621]; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071621] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Alam and M. Derebe for manuscript preparation; A. Pico for discussion in the early stages of this study; and X. Zhang for help in structure determination. Use of the Advanced Photon Source (APS) was supported by the US Department of Energy, Office of Energy Research. We thank the beamline (23ID and 19ID) staff for assistance in data collection. This work was supported by Howard Hughes Medical Institute and by grants from the NIH/NIGMS (RO1 GM071621) and Welch Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Lingle CJ, 2002, J GEN PHYSIOL, V120, P261, DOI 10.1085/jgp.20028689; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	39	152	156	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					393	U148		10.1038/nature09252	http://dx.doi.org/10.1038/nature09252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20574420	Green Accepted			2022-12-24	WOS:000279867100054
J	Brenner, DJ; Hricak, H				Brenner, David J.; Hricak, Hedvig			Radiation Exposure From Medical Imaging Time to Regulate?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTED-TOMOGRAPHY; CANCER		[Brenner, David J.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10024 USA; [Hricak, Hedvig] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	Columbia University; Memorial Sloan Kettering Cancer Center	Brenner, DJ (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, 630 W 168th St, New York, NY 10024 USA.	djb3@columbia.edu		Hricak, Hedvig/0000-0003-2240-9694				Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Destouet Judy M, 2005, J Am Coll Radiol, V2, P585; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; U.S. Food and Drug Administration website, WHIT PAP IN RED UNN	10	150	158	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					208	209		10.1001/jama.2010.973	http://dx.doi.org/10.1001/jama.2010.973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628137				2022-12-24	WOS:000279811000030
J	O'Hare, AM; Rodriguez, RA; Hailpern, SM; Larson, EB; Tamura, MK				O'Hare, Ann M.; Rodriguez, Rudolph A.; Hailpern, Susan M.; Larson, Eric B.; Tamura, Manjula Kurella			Regional Variation in Health Care Intensity and Treatment Practices for End-stage Renal Disease in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; DECISION-MAKING; NATIONAL-SURVEY; UNITED-STATES; DIALYSIS; POPULATION	Context An increasing number of older adults are being treated for end-stage renal disease (ESRD) with long-term dialysis. Objectives To determine how ESRD treatment practices for older adults vary across regions with differing end-of-life intensity of care. Design, Setting, and Participants Retrospective observational study using a national ESRD registry to identify a cohort of 41 420 adults (of white or black race), aged 65 years or older, who started long-term dialysis or received a kidney transplant between June 1, 2005, and May 31, 2006. Regional end-of-life intensity of care was defined using an index from the Dartmouth Atlas of Healthcare. Main Outcome Measures Incidence of treated ESRD (dialysis or transplant), preparedness for ESRD (under the care of a nephrologist, having a fistula [vs graft or catheter] at time of hemodialysis initiation), and end-of-life care practices. Results Among whites, the incidence of ESRD was progressively higher in regions with greater intensity of care and this trend was most pronounced at older ages. Among blacks, a similar relationship was present only at advanced ages (men aged >= 80 years and women aged >= 85 years). Patients living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to be under the care of a nephrologist before the onset of ESRD (62.3% [95% confidence interval {CI}, 61.3%-63.3%] vs 71.1% [95% CI, 69.9%-72.2%], respectively) and less likely to have a fistula (vs graft or catheter) at the time of hemodialysis initiation (11.2% [95% CI, 10.6%-11.8%] vs 16.9% [95% CI, 15.9%-17.8%]). Among patients who died within 2 years of ESRD onset (n=21 190), those living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to have discontinued dialysis before death (22.2% [95% CI, 21.1%-23.4%] vs 44.3% [95% CI, 42.5%-46.1%], respectively), less likely to have received hospice care (20.7% [95% CI, 19.5%-21.9%] vs 33.5% [95% CI, 31.7%-35.4%]), and more likely to have died in the hospital (67.8% [95% CI, 66.5%-69.1%] vs 50.3% [95% CI, 48.5%-52.1%]). These differences persisted in adjusted analyses. Conclusion There are pronounced regional differences in treatment practices for ESRD in older adults that are not explained by differences in patient characteristics. JAMA. 2010; 304(2): 180-186 www.jama.com	[O'Hare, Ann M.; Rodriguez, Rudolph A.] VA Puget Sound Healthcare Syst, Dept Med, Seattle, WA 98108 USA; [O'Hare, Ann M.] VA Puget Sound Healthcare Syst, HSR&D Ctr Excellence, Seattle, WA 98108 USA; [O'Hare, Ann M.; Rodriguez, Rudolph A.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Tamura, Manjula Kurella] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Tamura, Manjula Kurella] VA Palo Alto Healthcare Syst, Dept Med, Palo Alto, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Group Health Cooperative; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	O'Hare, AM (corresponding author), VA Puget Sound Healthcare Syst, Dept Med, 111J Nephrol,1660 S Columbian Way, Seattle, WA 98108 USA.	Ann.OHare@va.gov	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479	Beeson Career Development Award [K23AG28980, K23AG028952]; National Institutes of Health; Satellite Research; Amgen; American Society of Nephrology; Association of Subspecialty Professors; University of California, San Francisco; NATIONAL INSTITUTE ON AGING [K23AG028952, K23AG028980] Funding Source: NIH RePORTER	Beeson Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Research; Amgen(Amgen); American Society of Nephrology; Association of Subspecialty Professors; University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr O'Hare reported receiving royalties from UpToDate, an honorarium from the Japanese Society for Foot Care, and a Career Development Award from the Department of Veterans Affairs' Health Services Research and Development Service and serving as the principal investigator on an interagency agreement between the Centers for Disease Control and Prevention and the VA Puget Sound Healthcare System. Dr Hailpern reported being employed by LipoScience (Raleigh, North Carolina) during the time frame that she was working on this study but her work on the project was completed during her free time and was not part of her work for the company. Dr Larson reported receiving research support from the National Institutes of Health, royalties from UpToDate, Springer, and Elsevier, and speaker honoraria from universities and other nonprofit organizations. Dr Kurella Tamura reported receiving research funding from Satellite Research, Amgen, a Junior Development Award in Geriatric Nephrology from the American Society of Nephrology and Association of Subspecialty Professors, and an intramural grant from the University of California, San Francisco. The financial disclosures listed herein for Drs O'Hare and Kurella Tamura are for the last 5 years.; Dr O'Hare is supported by Beeson Career Development Award K23AG28980. Dr Kurella Tamura is supported by Beeson Career Development Award K23AG028952.	Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Davison SN, 2006, CLIN J AM SOC NEPHRO, V1, P1256, DOI 10.2215/CJN.02040606; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Galla JH, 2000, J AM SOC NEPHROL, V11, P1340, DOI 10.1681/ASN.V1171340; Holley JL, 2003, AM J KIDNEY DIS, V42, P813, DOI 10.1016/S0272-6386(03)00868-0; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Mau LW, 2010, AM J KIDNEY DIS, V55, P549, DOI 10.1053/j.ajkd.2009.11.014; Murray AM, 2006, CLIN J AM SOC NEPHRO, V1, P1248, DOI 10.2215/CJN.00970306; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Sekkarie MA, 1998, AM J KIDNEY DIS, V31, P464, DOI 10.1053/ajkd.1998.v31.pm9506683; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Teno JM, 2010, JAMA-J AM MED ASSOC, V303, P544, DOI 10.1001/jama.2010.79	13	96	96	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					180	186		10.1001/jama.2010.924	http://dx.doi.org/10.1001/jama.2010.924			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628131	Green Accepted			2022-12-24	WOS:000279811000024
J	Levison, HF; Duncan, MJ; Brasser, R; Kaufmann, DE				Levison, Harold F.; Duncan, Martin J.; Brasser, Ramon; Kaufmann, David E.			Capture of the Sun's Oort Cloud from Stars in Its Birth Cluster	SCIENCE			English	Article							SOLAR-SYSTEM; ORIGIN; EVOLUTION; OBJECTS; COMETS	Oort cloud comets are currently believed to have formed in the Sun's protoplanetary disk and to have been ejected to large heliocentric orbits by the giant planets. Detailed models of this process fail to reproduce all of the available observational constraints, however. In particular, the Oort cloud appears to be substantially more populous than the models predict. Here we present numerical simulations that show that the Sun captured comets from other stars while it was in its birth cluster. Our results imply that a substantial fraction of the Oort cloud comets, perhaps exceeding 90%, are from the protoplanetary disks of other stars.	[Levison, Harold F.; Kaufmann, David E.] SW Res Inst, Boulder, CO 80302 USA; [Duncan, Martin J.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Brasser, Ramon] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Dept Cassiope, Nice, France	Queens University - Canada; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Levison, HF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	hal@boulder.swri.edu	Levison, Harold F/C-6061-2013	Levison, Harold F/0000-0001-5847-8099	NASA's Astrobiology Institute; NASA; Isaac Newton Institute at Cambridge University; Natural Sciences and Engineering Research Council, Canada; Germany's Helmholz Alliance	NASA's Astrobiology Institute; NASA(National Aeronautics & Space Administration (NASA)); Isaac Newton Institute at Cambridge University; Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Germany's Helmholz Alliance	We thank A. Morbidelli and L. Dones for useful discussions. This work was supported by NASA's Astrobiology Institute through a grant to the Goddard Center for Astrobiology. H. F. L. is grateful to NASA for funding through its Operational Support Services and Outer Planets Research programs. M.J.D. is grateful for the hospitality and financial support of the Isaac Newton Institute at Cambridge University, where some of this work was performed. M.J.D. acknowledges the continuing financial support of the Natural Sciences and Engineering Research Council, Canada. R. B. thanks Germany's Helmholz Alliance for financial support.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; CLARKE CJ, 1993, MON NOT R ASTRON SOC, V261, P190, DOI 10.1093/mnras/261.1.190; Dones L, 2004, SPACE SCI S, P153; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; Eggers S, 1997, PLANET SPACE SCI, V45, P1099, DOI 10.1016/S0032-0633(97)00065-2; Kaib NA, 2009, SCIENCE, V325, P1234, DOI 10.1126/science.1172676; Kenyon SJ, 2004, NATURE, V432, P598, DOI 10.1038/nature03136; Kouwenhoven MBN, 2010, MON NOT R ASTRON SOC, V404, P1835, DOI 10.1111/j.1365-2966.2010.16399.x; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Paulech T, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912712; Thommes EW, 1999, NATURE, V402, P635, DOI 10.1038/45185; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; WEISSMAN PR, 1996, ASTRONOMICAL SOC PAC, V265, P106; Zheng JQ, 1990, CELEST MECH DYN ASTR, V49, P265, DOI 10.1007/BF00049417	17	122	124	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					187	190		10.1126/science.1187535	http://dx.doi.org/10.1126/science.1187535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20538912				2022-12-24	WOS:000279635200040
J	Kimber, J; Copeland, L; Hickman, M; Macleod, J; McKenzie, J; De Angelis, D; Robertson, JR				Kimber, Jo; Copeland, Lorraine; Hickman, Matthew; Macleod, John; McKenzie, James; De Angelis, Daniela; Robertson, James Roy			Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; MAINTENANCE TREATMENT; CHANGING PATTERNS; AMSTERDAM COHORT; METHADONE; MORTALITY; RELAPSE; PREVENTION; DEPENDENCE; EPIDEMIC	Objectives To examine survival and long term cessation of injecting in a cohort of drug users and to assess the influence of opiate substitution treatment on these outcomes. Design Prospective open cohort study. Setting A single primary care facility in Edinburgh. Participants 794 patients with a history of injecting drug use presenting between 1980 and 2007; 655 (82%) were followed up by interview or linkage to primary care records and mortality register, or both, and contributed 10 390 person years at risk; 557 (85%) had received opiate substitution treatment. Main outcome measures Duration of injecting: years from first injection to long term cessation, defined as last injection before period of five years of non-injecting; mortality before cessation; overall survival. Results In the entire cohort 277 participants achieved long term cessation of injecting, and 228 died. Half of the survivors had poor health related quality of life. Median duration from first injection to death was 24 years for participants with HIV and 41 years for those without HIV. For each additional year of opiate substitution treatment the hazard of death before long term cessation fell 13% (95% confidence interval 17% to 9%) after adjustment for HIV, sex, calendar period, age at first injection, and history of prison and overdose. Conversely exposure to opiate substitution treatment was inversely related to the chances of achieving long term cessation. Conclusions Opiate substitution treatment in injecting drug users in primary care reduces this risk of mortality, with survival benefits increasing with cumulative exposure to treatment. Treatment does not reduce the overall duration of injecting.	[Kimber, Jo; Hickman, Matthew] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Kimber, Jo; Macleod, John] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2052, Australia; [Copeland, Lorraine; McKenzie, James; Robertson, James Roy] Muirhouse Med Grp, Edinburgh EH4 4P, Midlothian, Scotland; [De Angelis, Daniela] Univ Cambridge, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 1TN, England; [De Angelis, Daniela] Ctr Infect, Hlth Protect Agcy, London, England; [Robertson, James Roy] Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Bristol; University of New South Wales Sydney; Kirby Institute; MRC Biostatistics Unit; University of Cambridge; Health Protection Agency; University of Edinburgh	Hickman, M (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	matthew.hickman@bristol.ac.uk	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Kimber, Jo/0000-0002-8608-7906; De Angelis, Daniela/0000-0001-6619-6112; Macleod, John/0000-0001-8202-1144	Chief Scientist Office for Scotland [CZH/4/318]; National Institute of Health Research; Australian National Health and Medical Research (NHMRC); Australian Government Department of Health and Ageing; Health Protection Agency; Medical Research Council [U.1052.00.007]; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508, MC_U105260556] Funding Source: researchfish; Chief Scientist Office [CZH/4/440] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_U105260556] Funding Source: UKRI	Chief Scientist Office for Scotland; National Institute of Health Research(National Institute for Health Research (NIHR)); Australian National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present follow-up study of the Edinburgh Addiction Cohort was supported by the Chief Scientist Office for Scotland (CZH/4/318). At the time they undertook this work JM and MH were supported by career scientist fellowship awards from the National Institute of Health Research. JK is supported by an Australian National Health and Medical Research (NHMRC) postdoctoral training fellowship. The National Centre in HIV Epidemiology and Clinical Research is core-funded by the Australian Government Department of Health and Ageing. LC and JMcK were funded by the chief scientist office grant (CZH/4/318), with the latter being seconded to the study by the community drug problem service, (CDPS), Lothian. DDA is funded by Health Protection Agency and the Medical Research Council (grant No U.1052.00.007).	*ADV COUNC MISS DR, 1982, TREATM REH; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; Berrington A, 2000, J ROY STAT SOC A STA, V163, P127, DOI 10.1111/1467-985X.00162; Blane DB, 1996, SOC SCI MED, V42, P751, DOI 10.1016/0277-9536(95)00340-1; Collet D., 2003, MODELLING SURVIVAL D; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; Darke S, 2005, J SUBST ABUSE TREAT, V28, P255, DOI 10.1016/j.jsat.2005.01.006; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Department of Health (England) and the devolved administrations, 2007, DRUG MIS DEP UK GUID; Fugelstad A, 2007, ADDICTION, V102, P406, DOI 10.1111/j.1360-0443.2006.01714.x; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Gowing LR, 2006, J GEN INTERN MED, V21, P193, DOI 10.1111/j.1525-1497.2005.00287.x; HARTSOCK P, 1991, LONGITUDINAL STUDIES; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hubbard RL, 2003, J SUBST ABUSE TREAT, V25, P125, DOI 10.1016/S0740-5472(03)00130-2; Kind P, 1999, 172 CTR HLTH EC; Langendam MW, 2000, ADDICTION, V95, P591, DOI 10.1046/j.1360-0443.2000.95459110.x; Macleod J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-101; McCowan C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2225; McKeganey N, 2006, ADDICT RES THEORY, V14, P557, DOI 10.1080/16066350601002369; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rathod NH, 2005, BRIT J PSYCHIAT, V187, P421, DOI 10.1192/bjp.187.5.421; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; ROBERTSON JR, 1986, BRIT MED J, V292, P527, DOI 10.1136/bmj.292.6519.527; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; SKIDMORE CA, 1990, BRIT MED J, V300, P219, DOI 10.1136/bmj.300.6719.219; Sweeting MJ, 2009, STAT METHODS MED RES, V18, P381, DOI 10.1177/0962280208094704; Termorshuizen F, 2005, AM J EPIDEMIOL, V161, P271, DOI 10.1093/aje/kwi035; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; VAILLANT GE, 1988, BRIT J ADDICT, V83, P1147; Ward J., 1997, METHADONE MAINTENANC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	140	140	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2010	341								c3172	10.1136/bmj.c3172	http://dx.doi.org/10.1136/bmj.c3172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621NW	20595255	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000279586600002
J	Johnson, KS; Riser, SC; Karl, DM				Johnson, Kenneth S.; Riser, Stephen C.; Karl, David M.			Nitrate supply from deep to near-surface waters of the North Pacific subtropical gyre	NATURE			English	Article							NITROGEN-FIXATION; OXYGEN; FLUX; STOICHIOMETRY; CHLOROPHYLL; PHOSPHORUS; CYCLE; ZONE	Concentrations of dissolved inorganic carbon (DIC) decrease in the surface mixed layers during spring and summer in most of the oligotrophic ocean. Mass balance calculations require that the missing DIC is converted into particulate carbon by photosynthesis(1-3). This DIC uptake represents one of the largest components of net community production in the world ocean(2,4). However, mixed-layer waters in these regions of the ocean typically contain negligible concentrations of plant nutrients such as nitrate and phosphate(3,5). Combined nutrient supply mechanisms including nitrogen fixation, diffusive transport and vertical entrainment are believed to be insufficient to supply the required nutrients for photosynthesis(6,7). The basin-scale potential for episodic nutrient transport by eddy events is unresolved(8,9). As a result, it is not understood how biologically mediated DIC uptake can be supported in the absence of nutrients. Here we report on high-resolution measurements of nitrate (NO3-) and oxygen (O-2) concentration made over 21 months using a profiling float deployed near the Hawaii Ocean Time-series station in the North Pacific subtropical gyre. Our measurements demonstrate that as O-2 was produced and DIC was consumed over two annual cycles, a corresponding seasonal deficit in dissolved NO3- appeared in water at depths from 100 to 250 m. The deep-water deficit in NO3- was in near-stoichiometric balance with the fixed nitrogen exported to depth. Thus, when the water column from the surface to 250 m is considered as a whole, there is near equivalence between nutrient supply and demand. Short-lived transport events (<10 days) that connect deep stocks of nitrate to nutrient-poor surface waters were clearly present in 12 of the 127 vertical profiles.	[Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Riser, Stephen C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Karl, David M.] Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Monterey Bay Aquarium Research Institute; University of Washington; University of Washington Seattle; University of Hawaii System	Johnson, KS (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	johnson@mbari.org	Karl, David/AFP-3837-2022; Johnson, Kenneth S/F-9742-2011	Johnson, Kenneth S/0000-0001-5513-5584; Karl, David/0000-0002-6660-6721	David and Lucile Packard Foundation; National Science Foundation; National Oceanic and Atmospheric Administration; US Office of Naval Research; Gordon and Betty Moore Foundation; Center for Microbial Oceanography: Research and Education; Directorate For Geosciences [0824990] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); US Office of Naval Research(Office of Naval Research); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Oceanography: Research and Education; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible by the engineering efforts of L. Coletti, H. Jannasch and D. Swift to integrate ISUS with the APEX float. C. Sakamoto performed ISUS sensor calibration. This work was supported by the David and Lucile Packard Foundation, the National Science Foundation, the National Oceanic and Atmospheric Administration and the US Office of Naval Research through the National Oceanographic Partnership Program. Funding was also provided by the Gordon and Betty Moore Foundation and the Center for Microbial Oceanography: Research and Education.	Abell J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002285; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EMERSON S, 1995, J MAR RES, V53, P499, DOI 10.1357/0022240953213179; Emerson S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003095; Hannides CCS, 2009, DEEP-SEA RES PT I, V56, P73, DOI 10.1016/j.dsr.2008.08.003; Jenkins WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002085; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Karl DM, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P705, DOI 10.1016/B978-0-12-372522-6.00016-5; Karl DM, 2003, GLO CH IGBP, P239; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Keeling CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002227; Kortzinger A, 2005, J ATMOS OCEAN TECH, V22, P302, DOI 10.1175/JTECH1701.1; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Martin AP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001841; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1994, NATURE, V372, P537, DOI 10.1038/372537a0; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Sakamoto CM, 2009, LIMNOL OCEANOGR-METH, V7, P132, DOI 10.4319/lom.2009.7.132; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Williams RG, 2003, GLO CH IGBP, P19	30	168	172	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1062	1065		10.1038/nature09170	http://dx.doi.org/10.1038/nature09170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577212				2022-12-24	WOS:000279056900049
J	Zheng, JM; Jia, ZC				Zheng, Jimin; Jia, Zongchao			Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; X-RAY ANALYSIS; PHOSPHORYLATION CYCLE; CRYSTAL-STRUCTURE; PHOSPHATASE; SUBSTRATE; PURIFICATION; ENZYME; CRYSTALLIZATION; RECOGNITION	The Escherichia coli isocitrate dehydrogenase kinase/phosphatase (AceK) is a unique bifunctional enzyme that phosphorylates or dephosphorylates isocitrate dehydrogenase (ICDH) in response to environmental changes, resulting in the inactivation or, respectively, activation of ICDH1. ICDH inactivation short-circuits the Krebs cycle by enabling the glyoxlate bypass(2,3). It was the discovery of AceK and ICDH that established the existence of protein phosphorylation regulation in prokaryotes(1,4). As a 65-kDa protein, AceK is significantly larger than typical eukaryotic protein kinases. Apart from the ATP-binding motif, AceK does not share sequence homology with any eukaryotic protein kinase or phosphatase(5,6). Most intriguingly, AceK possesses the two opposing activities of protein kinase and phosphatase within one protein, and specifically recognizes only intact ICDH7,8. Additionally, AceK has strong ATPase activity(9). It has been shown that AceK kinase, phosphatase and ATPase activities reside at the same site(6,10), although the molecular basis of such multifunctionality and its regulation remains completely unknown. Here we report the structures of AceK and its complex with ICDH. The AceK structure reveals a eukaryotic protein-kinase-like domain containing ATP and a regulatory domain with a novel fold. As an AceK phosphatase activator and kinase inhibitor, AMP is found to bind in an allosteric site between the two AceK domains. An AMP-mediated conformational change exposes and shields ATP, acting as a switch between AceK kinase and phosphatase activities, and ICDH-binding induces further conformational change for AceK activation. The substrate recognition loop of AceK binds to the ICDH dimer, allowing higher-order substrate recognition and interaction, and inducing critical conformational change at the phosphorylation site of ICDH.	[Zheng, Jimin; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Zheng, Jimin] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	Queens University - Canada; Beijing Normal University	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors would like to thank M. Cygler and A. Matte for help in cloning, L. Li and R. Theiss for help in mutagenesis and activity measurements, and J. Allingham and G. Cote for critical reading of the manuscript. We would also like to thank the staff of the Cornell High Energy Synchrotron Source for helping with the collection of synchrotron X-ray data. This work was supported by the Canadian Institutes of Health Research (Z.J.). Z.J. is a Canada Research Chair in Structural Biology.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNETT PM, 1975, J GEN MICROBIOL, V87, P37, DOI 10.1099/00221287-87-1-37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HB, 2008, P NATL ACAD SCI USA, V105, P19660, DOI 10.1073/pnas.0807752105; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; GARNAK M, 1979, J BIOL CHEM, V254, P7915; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOYT JC, 1988, BIOCHEM BIOPH RES CO, V153, P875, DOI 10.1016/S0006-291X(88)81177-X; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; IKEDA T, 1991, J BACTERIOL, V173, P1801, DOI 10.1128/jb.173.5.1801-1806.1991; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KLUMPP DJ, 1988, J BACTERIOL, V170, P2763, DOI 10.1128/jb.170.6.2763-2769.1988; KORNBERG HL, 1966, BIOCHEM J, V99, P1; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LAPORTE DC, 1989, BIOCHIMIE, V71, P1051, DOI 10.1016/0300-9084(89)90110-7; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; MCKEE JS, 1989, BIOCHIMIE, V71, P1059, DOI 10.1016/0300-9084(89)90111-9; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller SP, 1996, J BIOL CHEM, V271, P19124, DOI 10.1074/jbc.271.32.19124; Miller SP, 2000, J BIOL CHEM, V275, P833, DOI 10.1074/jbc.275.2.833; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STUELAND CS, 1988, J BIOL CHEM, V263, P19475; STUELAND CS, 1987, J BIOL CHEM, V262, P16095; STUELAND CS, 1989, J BIOL CHEM, V264, P13775; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P1153, DOI 10.1107/S1744309109038718; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	39	54	57	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					961	U16		10.1038/nature09088	http://dx.doi.org/10.1038/nature09088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20505668				2022-12-24	WOS:000278804500045
J	Brown, JR; O'Connor, GT				Brown, Jeremiah R.; O'Connor, Gerald T.			Focus on Research: Coronary Heart Disease and Prevention in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material															AHRQ HHS [K01 HS018443] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018443] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Centers for Disease Control and Prevention, 2005, MOV ACT PROM HEART H; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; van Dam RM, 2009, CIRCULATION, V120, P1171, DOI 10.1161/CIRCULATIONAHA.109.891507	4	51	52	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2150	2153		10.1056/NEJMp1003880	http://dx.doi.org/10.1056/NEJMp1003880			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608AL	20558365				2022-12-24	WOS:000278551500003
J	Whitaker, DL; Edwards, J				Whitaker, Dwight L.; Edwards, Joan			Sphagnum Moss Disperses Spores with Vortex Rings	SCIENCE			English	Article									[Whitaker, Dwight L.] Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; [Edwards, Joan] Williams Coll, Dept Biol, Williamstown, MA 01267 USA	Claremont Colleges; Pomona College; Williams College	Whitaker, DL (corresponding author), Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA.	dwight.whitaker@pomona.edu; joan.edwards@williams.edu			NSF [0722532]	NSF(National Science Foundation (NSF))	This work was supported in part by NSF Major Research Instrumentation award 0722532. The authors thank D. C. Smith and C. D. Mitescu for comments; R. Andrus for species identification; and E. Chang, A. Conwill, C. Hard, M. Hirai, N. Mitchell, and N. Piatczyc for technical assistance.	Batchelor G., 1967, INTRO FLUID DYNAMICS; Clymo RS, 1982, BRYOPHYTE ECOLOGY; Dabiri JO, 2009, ANNU REV FLUID MECH, V41, P17, DOI 10.1146/annurev.fluid.010908.165232; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Jeglum J., 2006, BIOL PEATLANDS; MAXWORTHY T, 1974, J FLUID MECH, V64, P227, DOI 10.1017/S0022112074002370; McQueen C. B., 2007, FLORA N AM N MEXICO, V27, P45; Nawaschin S., 1897, FLORA, V83, P151; Sundberg S, 2010, ANN BOT-LONDON, V105, P291, DOI 10.1093/aob/mcp288	9	45	49	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					406	406		10.1126/science.1190179	http://dx.doi.org/10.1126/science.1190179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651145				2022-12-24	WOS:000280196500027
J	Orkin, SH; Higgs, DR				Orkin, Stuart H.; Higgs, Douglas R.			MEDICINE Sickle Cell Disease at 100 Years	SCIENCE			English	Editorial Material							FETAL-HEMOGLOBIN; BETA-THALASSEMIA; RISK-FACTORS; ANEMIA; BCL11A; EXPRESSION; BURDEN		[Orkin, Stuart H.] Childrens Hosp, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Higgs, Douglas R.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford 0X3 9DS, England	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu		Higgs, Douglas/0000-0003-3579-8705	Medical Research Council [G1000801b] Funding Source: researchfish; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bradner JE, 2006, NAT PROTOC, V1, P2344, DOI 10.1038/nprot.2006.282; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; Kaiser J, 2009, SCIENCE, V326, P1468, DOI 10.1126/science.326.5959.1468-b; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Tanguturi S. K., 2010, P NATL ACAD SCI US; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; WATSON J, 1948, AM J MED SCI, V215, P419, DOI 10.1097/00000441-194804000-00008; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	21	27	29	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					291	292		10.1126/science.1194035	http://dx.doi.org/10.1126/science.1194035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647458				2022-12-24	WOS:000279925900030
J	Alic, J; Sarewitz, D; Weiss, C; Bonvillian, W				Alic, John; Sarewitz, Daniel; Weiss, Charles; Bonvillian, William			A new strategy for energy innovation	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA; [Weiss, Charles] Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA; [Bonvillian, William] MIT, Washington Off, Washington, DC 20002 USA	Arizona State University; Arizona State University-Tempe; Georgetown University; Massachusetts Institute of Technology (MIT)		john_alic@earthlink.net						Alic JA, 2007, TRILLIONS FOR MILITARY TECHNOLOGY: HOW THE PENTAGON INNOVATES AND WHY IT COSTS SO MUCH, P1, DOI 10.1057/9780230606876; [Anonymous], 2009, INN POL CLIM CHANG; BIRKLER JL, 1982, DEV PRODUCTION COST; BONVILLIAN WB, 2009, INNOVATIONS, P289; Vane HR, 2009, J ECON PERSPECT, V23, P109, DOI 10.1257/jep.23.3.109; Weiss C., 2009, STRUCT EN TECHN REV; YOUNOSSI O, 2002, MILITARY JET ENGINE, P66	7	20	20	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					316	317		10.1038/466316a	http://dx.doi.org/10.1038/466316a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625BP	20631780				2022-12-24	WOS:000279867100018
J	Halevy, I; Johnston, DT; Schrag, DP				Halevy, Itay; Johnston, David T.; Schrag, Daniel P.			Explaining the Structure of the Archean Mass-Independent Sulfur Isotope Record	SCIENCE			English	Article							FRACTIONATION; ATMOSPHERE; GREENHOUSE; VOLCANISM; CYCLE	Sulfur isotopes in ancient sediments provide a record of past environmental conditions. The long-time-scale variability and apparent asymmetry in the magnitude of minor sulfur isotope fractionation in Archean sediments remain unexplained. Using an integrated biogeochemical model of the Archean sulfur cycle, we find that the preservation of mass-independent sulfur is influenced by a variety of extra-atmospheric mechanisms, including biological activity and continental crust formation. Preservation of atmospherically produced mass-independent sulfur implies limited metabolic sulfur cycling before similar to 2500 million years ago; the asymmetry in the record indicates that bacterial sulfate reduction was geochemically unimportant at this time. Our results suggest that the large-scale structure of the record reflects variability in the oxidation state of volcanic sulfur volatiles.	[Halevy, Itay; Johnston, David T.; Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Halevy, I (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	itay.halevy@gmail.com	Halevy, Itay/W-9850-2019; HALEVY, ITAY/K-1364-2012	Halevy, Itay/0000-0002-7325-8139; HALEVY, ITAY/0000-0002-7325-8139; Johnston, David/0000-0002-2487-1084	Harvard University Origins of Life Initiative; NASA	Harvard University Origins of Life Initiative; NASA(National Aeronautics & Space Administration (NASA))	I.H. was supported by the Harvard University Origins of Life Initiative, and D.T.J. was supported by NASA Exobiology. D. P. S. thanks H. Breck and W. Breck for support. We also thank three anonymous reviewers.	Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; Cleaves HJ, 2008, PRECAMBRIAN RES, V164, P111, DOI 10.1016/j.precamres.2008.04.002; Danielache SO, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009695; Domagal-Goldman SD, 2008, EARTH PLANET SC LETT, V269, P29, DOI 10.1016/j.epsl.2008.01.040; Emmanuel S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030532; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Halmer MM, 2002, J VOLCANOL GEOTH RES, V115, P511, DOI 10.1016/S0377-0273(01)00318-3; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; Holland HD., 2004, TREATISE GEOCHEMISTR, VVol. 6, P583; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Lyons JR, 2009, CHEM GEOL, V267, P164, DOI 10.1016/j.chemgeo.2009.03.027; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Ran H, 2007, CHEM PHYS LETT, V439, P280, DOI 10.1016/j.cplett.2007.03.103; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Van Ark E, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002949; von Paris P, 2008, PLANET SPACE SCI, V56, P1244, DOI 10.1016/j.pss.2008.04.008; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	27	109	110	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					204	207		10.1126/science.1190298	http://dx.doi.org/10.1126/science.1190298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20508089				2022-12-24	WOS:000279635200045
J	Loxterkamp, DA				Loxterkamp, David A.			Old Men and the Sea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dr.loxterkamp@myfairpoint.net							0	1	1	4	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					18	19		10.1001/jama.2010.902	http://dx.doi.org/10.1001/jama.2010.902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606138				2022-12-24	WOS:000279519600001
J	Carter, J; Poulet, F; Bibring, JP; Murchie, S				Carter, J.; Poulet, F.; Bibring, J. -P.; Murchie, S.			Detection of Hydrated Silicates in Crustal Outcrops in the Northern Plains of Mars	SCIENCE			English	Article							SPECTRAL EVIDENCE; PHYLLOSILICATES; DIVERSITY; EVOLUTION; LOWLANDS; HISTORY; WATER	The composition of the ancient martian crust is a key ingredient in deciphering the environment and evolution of early Mars. We present an analysis of the composition of large craters in the martian northern plains based on data from spaceborne imaging spectrometers. Nine of the craters have excavated assemblages of phyllosilicates from ancient, Noachian crust buried beneath the plains' cover. The phyllosilicates are indistinguishable from those exposed in widespread locations in the southern highlands, demonstrating that liquid water once altered both hemispheres of Mars.	[Carter, J.; Poulet, F.; Bibring, J. -P.] Univ Paris 11, CNRS, IAS, F-91405 Orsay, France; [Murchie, S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Carter, J (corresponding author), Univ Paris 11, CNRS, IAS, F-91405 Orsay, France.	John.carter@ias.u-psud.fr	Murchie, Scott L/E-8030-2015	Murchie, Scott L/0000-0002-1616-8751				Abramov O, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002453; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001510; Baratoux D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002890; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bishop JL, 2008, CLAY MINER, V43, P35, DOI 10.1180/claymin.2008.043.1.03; CARTER J, 2009, P LUNAR PLANET SCI C, V40; Christensen PR, 2005, NATURE, V436, P504, DOI 10.1038/nature03639; Clark R.N., 2007, USGS DIGITAL DATA SE, V231; Dickson JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037472; Ehlmann BL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003339; Frey M., 1999, LOW GRADE METAMORPHI; GONDET B, 2007, 7 INT C MARS LUN PLA; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; Kreslavsky MA, 2006, METEORIT PLANET SCI, V41, P1633, DOI 10.1111/j.1945-5100.2006.tb00441.x; Kreslavsky MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015392; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003344; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Pelkey SM, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002831; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Rogers D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001913; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; SALVATORE MR, 2009, P LUNAR PLANET SCI C, V40; Schwenzer SP, 2009, GEOLOGY, V37, P1091, DOI 10.1130/G30340A.1; Stockstill-Cahill KR, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003036; Tanaka KL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001908; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	35	115	116	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1682	1686		10.1126/science.1189013	http://dx.doi.org/10.1126/science.1189013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576889				2022-12-24	WOS:000279107400040
J	Heidenreich, KD				Heidenreich, Katherine D.			Benign Paroxysmal Positional Vertigo.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan Hlth Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Heidenreich, KD (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI USA.	kheidenr@med.umich.edu							0	1	1	5	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					e70	e70		10.1056/NEJMicm0907386	http://dx.doi.org/10.1056/NEJMicm0907386			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20573921				2022-12-24	WOS:000279043800011
J	Dang, L; White, DW; Gross, S; Bennett, BD; Bittinger, MA; Driggers, EM; Fantin, VR; Jang, HG; Jin, SF; Keenan, MC; Marks, KM; Prins, RM; Ward, PS; Yen, KE; Liau, LM; Rabinowitz, JD; Cantley, LC; Thompson, CB; Vander Heiden, MG; Su, SM				Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.			Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)	NATURE			English	Correction													Prins, Robert/AAX-1155-2021; Cantley, Lewis C/D-1800-2014; Ward, Patrick/H-2361-2014	Cantley, Lewis C/0000-0002-1298-7653; Dang, Lenny/0000-0002-2073-6109; Ward, Patrick/0000-0001-6437-8174; Prins, Robert/0000-0002-6282-6583; Liau, Linda/0000-0002-4053-0052	NCI NIH HHS [R01 CA105463] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105463] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890	2	310	322	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					966	966		10.1038/nature09132	http://dx.doi.org/10.1038/nature09132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559394	Green Accepted, Bronze			2022-12-24	WOS:000278804500046
J	Hayes, KS; Bancroft, AJ; Goldrick, M; Portsmouth, C; Roberts, IS; Grencis, RK				Hayes, K. S.; Bancroft, A. J.; Goldrick, M.; Portsmouth, C.; Roberts, I. S.; Grencis, R. K.			Exploitation of the Intestinal Microflora by the Parasitic Nematode Trichuris muris	SCIENCE			English	Article							ESCHERICHIA-COLI; HYGIENE HYPOTHESIS; IMMUNE-SYSTEM; MATURATION; CELLS; GUT; ADHERENCE; RESPONSES; BACTERIA	The inhabitants of the mammalian gut are not always relatively benign commensal bacteria but may also include larger and more parasitic organisms, such as worms and protozoa. At some level, all these organisms are capable of interacting with each other. We found that successful establishment of the chronically infecting parasitic nematode Trichuris muris in the large intestine of mice is dependent on microflora and coincident with modulation of the host immune response. By reducing the number of bacteria in the host animal, we significantly reduced the number of hatched T. muris eggs. Critical interactions between bacteria (microflora) and parasites (macrofauna) introduced a new dynamic to the intestinal niche, which has fundamental implications for our current concepts of intestinal homeostasis and regulation of immunity.	[Hayes, K. S.; Bancroft, A. J.; Goldrick, M.; Portsmouth, C.; Roberts, I. S.; Grencis, R. K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	ian.s.roberts@manchester.ac.uk; richard.k.grencis@manchester.ac.uk	hayes, kelly/GVT-8455-2022		UK Biotechnology and Biological Sciences Research Council; Wellcome Trust [083620Z]; University of Manchester; UK Medical Research Council [G0601205]; MRC [G0601205] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Cliffe for numerous helpful discussions; J. Kott and R. Fernandez for help with microscopy; the staff in the Faculty of Life Sciences EM Facility for their assistance, particularly A. Mironov and the Wellcome Trust for equipment grant support to the EM Facility; the Faculty of Life Sciences Mass Spectrometry Unit and E. Keevill for help with protein identification; and P. Klemm for bacterial strains and plasmids. The Bioimaging Facility microscopes used in this study were purchased with grants from the UK Biotechnology and Biological Sciences Research Council, Wellcome, and the University of Manchester Strategic Fund. Accession numbers for proteins identified by mass spectrometry are Q9N5A6 CAEEL, TMP00496_1, TMP00827_1, TMP00007_1, and TMP00821_1 and can be found at www.nematodes.org/nembase4. Supported by Wellcome Trust grant 083620Z and UK Medical Research Council grant G0601205.	[Anonymous], [No title captured]; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; BREINES DM, 1994, J ANTIMICROB CHEMOTH, V34, P205, DOI 10.1093/jac/34.2.205; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Edelman SM, 2008, CURR OPIN GASTROEN, V24, P720, DOI 10.1097/MOG.0b013e32830c4355; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Yazdanbakhsh M, 2004, CLIN REV ALLERG IMMU, V26, P15, DOI 10.1385/CRIAI:26:1:15	22	203	209	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1391	1394		10.1126/science.1187703	http://dx.doi.org/10.1126/science.1187703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538949	Green Accepted			2022-12-24	WOS:000278598400037
J	Bardisa-Ezcurra, L; Ullman, R; Gordon, J				Bardisa-Ezcurra, Lauren; Ullman, Roz; Gordon, Jenny		Guideline Dev Grp	Guidelines Diagnosis and management of idiopathic childhood constipation: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bardisa-Ezcurra, Lauren; Ullman, Roz] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Gordon, Jenny] Royal Coll Nursing Inst, Oxford OX4 2JY, England		Bardisa-Ezcurra, L (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	lbardisa-ezcurra@ncc-wch.org.uk	; Tinelli, Michela/C-3008-2016	Cave, James/0000-0003-0721-9534; Tinelli, Michela/0000-0002-8816-4389	National Collaborating Centre for Women's and Children's Health; National Institute for Health and Clinical Excellence	National Collaborating Centre for Women's and Children's Health; National Institute for Health and Clinical Excellence	Funding: The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Borowitz SM, 2003, J AM BOARD FAM PRACT, V16, P213, DOI 10.3122/jabfm.16.3.213; Candelli M, 2001, HEPATO-GASTROENTEROL, V48, P1050; CROFFIE JM, 2000, PEDIAT GASTROINTESTI, P830; Farrell M, 2003, J ADV NURS, V44, P479, DOI 10.1046/j.0309-2402.2003.02831.x; National Institute for Health and Clinical Excellence, 2010, CONST DIAGN MAN ID C; van den Berg MM, 2006, AM J GASTROENTEROL, V101, P2401, DOI 10.1111/j.1572-0241.2006.00771.x; Youssef NN, 2001, J CLIN GASTROENTEROL, V33, P199, DOI 10.1097/00004836-200109000-00006	7	47	49	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2010	340								c2585	10.1136/bmj.c2585	http://dx.doi.org/10.1136/bmj.c2585			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BK	20516006				2022-12-24	WOS:000278556300003
J	Moore, CI; Carlen, M; Knoblich, U; Cardin, JA				Moore, Christopher I.; Carlen, Marie; Knoblich, Ulf; Cardin, Jessica A.			Neocortical Interneurons: From Diversity, Strength	CELL			English	Article							RAT SOMATOSENSORY CORTEX; GAMMA-OSCILLATIONS; CORTICAL INTERNEURONS; BASKET CELLS; INHIBITION; NETWORKS; DYNAMICS; HIPPOCAMPUS; NEURONS; SCHIZOPHRENIA		[Moore, Christopher I.; Carlen, Marie; Knoblich, Ulf; Cardin, Jessica A.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cim@mit.edu	Carlen, Marie Carlen/C-9112-2014; Knoblich, Ulf/A-1762-2010	Carlen, Marie Carlen/0000-0003-1658-1631; Knoblich, Ulf/0000-0002-0756-5587; Moore, Christopher/0000-0003-4534-1602	NINDS NIH HHS [R01 NS045130] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	42	63	63	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					184	188		10.1016/j.cell.2010.07.005	http://dx.doi.org/10.1016/j.cell.2010.07.005			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655460	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000280204300008
J	Reulen, RC; Winter, DL; Frobisher, C; Lancashire, ER; Stiller, CA; Jenney, ME; Skinner, R; Stevens, MC; Hawkins, MM				Reulen, Raoul C.; Winter, David L.; Frobisher, Clare; Lancashire, Emma R.; Stiller, Charles A.; Jenney, Meriel E.; Skinner, Roderick; Stevens, Michael C.; Hawkins, Michael M.		British Childhood Canc Survivor	Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; 5-YEAR SURVIVORS; LATE DEATHS; ADOLESCENCE; OUTCOMES; COHORT	Context Survivors of childhood cancer are at increased risk of premature mortality compared with the general population, but little is known about the long-term risks of specific causes of death, particularly beyond 25 years from diagnosis at ages when background mortality in the general population starts to increase substantially. Objective To investigate long-term cause-specific mortality among 5-year survivors of childhood cancer in a large-scale population-based cohort. Design, Setting, and Patients British Childhood Cancer Survivor Study, a population-based cohort of 17 981 5-year survivors of childhood cancer diagnosed with cancer before age 15 years between 1940 and 1991 in Britain and followed up until the end of 2006. Main Outcome Measures Cause-specific standardized mortality ratios (SMRs) and absolute excess risks (AERs). Results Overall, 3049 deaths were observed, which was 11 times the number expected (SMR, 10.7; 95% confidence interval [CI], 10.3-11.1). The SMR declined with follow-up but was still 3-fold higher than expected (95% CI, 2.5-3.9) 45 years from diagnosis. The AER for deaths from recurrence declined from 97 extra deaths (95% CI, 92-101) per 10 000 person-years at 5 to 14 years from diagnosis, to 8 extra deaths (95% CI, 3-22) beyond 45 years from diagnosis. In contrast, during the same periods of follow-up, the AER for deaths from second primary cancers and circulatory causes increased from 8 extra deaths (95% CI, 7-10) and 2 extra deaths (95% CI, 2-3) to 58 extra deaths (95% CI, 38-90) and 29 extra deaths (95% CI, 16-56), respectively. Beyond 45 years from diagnosis, recurrence accounted for 7% of the excess number of deaths observed while second primary cancers and circulatory deaths together accounted for 77%. Conclusion Among a cohort of British survivors of childhood cancer, excess mortality from second primary cancers and circulatory diseases continued to occur beyond 25 years from diagnosis. JAMA. 2010; 304(2): 172-179 www.jama.com	[Reulen, Raoul C.; Winter, David L.; Frobisher, Clare; Lancashire, Emma R.; Hawkins, Michael M.] Univ Birmingham, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Jenney, Meriel E.] Childrens Hosp Wales, Cardiff, Wales; [Skinner, Roderick] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Paediat & Adolescent Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Stevens, Michael C.] Univ Bristol, Inst Child Life & Hlth, Bristol, Avon, England	University of Birmingham; University of Oxford; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Bristol	Reulen, RC (corresponding author), Univ Birmingham, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.c.reulen@bham.ac.uk	Frobisher, Clare/AAC-5728-2020; Reulen, Raoul/AAO-1033-2020; Pritchard-Jones, Kathy/F-4286-2014	Frobisher, Clare/0000-0003-1099-163X; Reulen, Raoul/0000-0002-7328-0467; Pritchard-Jones, Kathy/0000-0002-2384-9475; Stevens, Michael/0000-0001-6466-551X; Stiller, Charles/0000-0002-3006-7869	Cancer Research UK; Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	This work was supported by Cancer Research UK and the Kay Kendall Leukaemia Fund. Dr Reulen was supported by a Cancer Research UK Graduate Training Fellowship. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers.; Cancer Research UK, the Kay Kendall Leukaemia Fund, the Department of Health, and the Scottish Ministers had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Bowers DC, 2006, J CLIN ONCOL, V24, P5277, DOI 10.1200/JCO.2006.07.2884; Breslow NE., 1987, STAT METHODS CANC RE, P81; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dama E, 2006, HAEMATOLOGICA, V91, P1084; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; HAWKINS MM, 1990, ARCH DIS CHILD, V65, P1356, DOI 10.1136/adc.65.12.1356; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mertens AC, 2007, PEDIATR BLOOD CANCER, V48, P723, DOI 10.1002/pbc.21114; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Morris B, 2009, NEUROLOGY, V73, P1906, DOI 10.1212/WNL.0b013e3181c17ea8; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; *OFF NAT STAT, 2006, MORT STAT; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; ROBERTSON CM, 1994, BRIT MED J, V309, P162, DOI 10.1136/bmj.309.6948.162; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; Yeh JM, 2010, ANN INTERN MED, V152, P409, DOI 10.7326/0003-4819-152-7-201004060-00005; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	26	295	297	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					172	179		10.1001/jama.2010.923	http://dx.doi.org/10.1001/jama.2010.923			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628130	Bronze			2022-12-24	WOS:000279811000023
J	Chakraborty, K; Chatila, M; Sinha, J; Shi, QY; Poschner, BC; Sikor, M; Jiang, GX; Lamb, DC; Hartl, FU; Hayer-Hartl, M				Chakraborty, Kausik; Chatila, Manal; Sinha, Jyoti; Shi, Qiaoyun; Poschner, Bernhard C.; Sikor, Martin; Jiang, Guoxin; Lamb, Don C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Chaperonin-Catalyzed Rescue of Kinetically Trapped States in Protein Folding	CELL			English	Article							IN-VIVO; ENTROPIC BARRIERS; MALTOSE-BINDING; DISULFIDE BONDS; GROEL; CONFINEMENT; MECHANISM; TMAO	GroEL and GroES form a chaperonin nano-cage for single protein molecules to fold in isolation. The folding properties that render a protein chaperonin dependent are not yet understood. Here, we address this question using a double mutant of the maltose-binding protein DM-MBP as a substrate. Upon spontaneous refolding, DM-MBP populates a kinetically trapped intermediate that is collapsed but structurally disordered. Introducing two long-range disulfide bonds into DM-MBP reduces the entropic folding barrier of this intermediate and strongly accelerates native state formation. Strikingly, steric confinement of the protein in the chaperonin cage mimics the kinetic effect of constraining disulfides on folding, in a manner mediated by negative charge clusters in the cage wall. These findings suggest that chaperonin dependence correlates with the tendency of proteins to populate entropically stabilized folding intermediates. The capacity to rescue proteins from such folding traps may explain the uniquely essential role of chaperonin cages within the cellular chaperone network.	[Chakraborty, Kausik; Chatila, Manal; Sinha, Jyoti; Shi, Qiaoyun; Poschner, Bernhard C.; Jiang, Guoxin; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Sikor, Martin; Lamb, Don C.] Univ Munich, Dept Chem, Ctr Nanosci, D-81377 Munich, Germany; [Sikor, Martin; Lamb, Don C.] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Lamb, Don C.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Max Planck Society; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Lamb, Don C/G-9501-2014; Chakraborty, Kausik/AAL-5748-2021; Sinha, Jyoti/AAW-6161-2020; Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Lamb, Don C/0000-0002-0232-1903; Sinha, Jyoti/0000-0001-9202-1789; Hayer-Hartl, Manajit/0000-0001-8213-6742; chakraborty, kausik/0000-0001-6000-8379	Deutsche Forschungsgemeinschaft [SFB 596, SFB 749]; Ludwig-Maximi-lians-University Munich; Nanosystems Initiative Munich (NIM); Ernst-Jung Foundation; Korber Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ludwig-Maximi-lians-University Munich; Nanosystems Initiative Munich (NIM); Ernst-Jung Foundation; Korber Foundation	We thank J.R. Engen for sharing with us the blueprints of his home-built micro-flow HPLC system and A.R. Lange for technical assistance. We gratefully acknowledge financial support from Deutsche Forschungsgemeinschaft (SFB 596 to F.U.H. and M.H.-H., and SFB 749 to D.C.L.), the Ludwig-Maximi-lians-University Munich (LMUInnovativ BioImaging Network), Nanosystems Initiative Munich (NIM), the Ernst-Jung Foundation, and the Korber Foundation.	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; CHUN SY, 1993, J BIOL CHEM, V268, P20855; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; England JL, 2008, BIOPHYS J, V95, P3391, DOI [10.1529/biophysj.108.131037, 10.1529/biophysj.l08.131037]; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl M, 2006, BIOCHEMISTRY-US, V45, P13356, DOI 10.1021/bi061597j; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lucent D, 2007, P NATL ACAD SCI USA, V104, P10430, DOI 10.1073/pnas.0608256104; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Qu YX, 2003, BIOCHEMISTRY-US, V42, P5837, DOI 10.1021/bi0206457; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Vendruscolo M, 2003, P NATL ACAD SCI USA, V100, P14817, DOI 10.1073/pnas.2036516100; Wallin S, 2006, J PHYS-CONDENS MAT, V18, pS307, DOI 10.1088/0953-8984/18/14/S14; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	39	105	108	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					112	122		10.1016/j.cell.2010.05.027	http://dx.doi.org/10.1016/j.cell.2010.05.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603018	Bronze			2022-12-24	WOS:000279637300017
J	Lambert, O; Bianucci, G; Post, K; de Muizon, C; Salas-Gismondi, R; Urbina, M; Reumer, J				Lambert, Olivier; Bianucci, Giovanni; Post, Klaas; de Muizon, Christian; Salas-Gismondi, Rodolfo; Urbina, Mario; Reumer, Jelle			The giant bite of a new raptorial sperm whale from the Miocene epoch of Peru	NATURE			English	Article							MARINE MAMMALS; CETACEA	The modern giant sperm whale Physeter macrocephalus, one of the largest known predators, preys upon cephalopods at great depths(1,2). Lacking a functional upper dentition, it relies on suction for catching its prey(3); in contrast, several smaller Miocene sperm whales (Physeteroidea) have been interpreted as raptorial (versus suction) feeders(4,5), analogous to the modern killer whale Orcinus orca. Whereas very large physeteroid teeth have been discovered in various Miocene localities, associated diagnostic cranial remains have not been found so far(6-8). Here we report the discovery of a new giant sperm whale from the Middle Miocene of Peru (approximately 12-13 million years ago), Leviathan melvillei, described on the basis of a skull with teeth and mandible. With a 3-m-long head, very large upper and lower teeth (maximum diameter and length of 12 cm and greater than 36 cm, respectively), robust jaws and a temporal fossa considerably larger than in Physeter, this stem physeteroid represents one of the largest raptorial predators and, to our knowledge, the biggest tetrapod bite ever found. The appearance of gigantic raptorial sperm whales in the fossil record coincides with a phase of diversification and size-range increase of the baleen-bearing mysticetes in the Miocene. We propose that Leviathan fed mostly on high-energy content medium-size baleen whales. As a top predator, together with the contemporaneous giant shark Carcharocles megalodon, it probably had a profound impact on the structuring of Miocene marine communities. The development of a vast supracranial basin in Leviathan, extending on the rostrum as in Physeter, might indicate the presence of an enlarged spermaceti organ in the former that is not associated with deep diving or obligatory suction feeding.	[Lambert, Olivier] Inst Royal Sci Nat Belgique, Dept Paleontol, B-1000 Brussels, Belgium; [Bianucci, Giovanni] Univ Pisa, Dipartimento Sci Terra, I-56126 Pisa, Italy; [Post, Klaas; Reumer, Jelle] Nat Hist Museum Rotterdam, NL-3001 KL Rotterdam, Netherlands; [de Muizon, Christian] Museum Natl Hist Nat, Dept Hist Terre, F-75005 Paris, France; [Salas-Gismondi, Rodolfo; Urbina, Mario] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima 14, Peru; [Reumer, Jelle] Univ Utrecht, Dept Geosci, NL-3508 TA Utrecht, Netherlands	University of Pisa; Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Mayor de San Marcos; Utrecht University	Lambert, O (corresponding author), Museum Natl Hist Nat, Dept Hist Terre, F-75005 Paris, France.	olambert@mnhn.fr; bianucci@dst.unipi.it	De Muizon, Christian/Q-7986-2019; Lambert, Olivier/AEN-2469-2022; De Muizon, Christian/P-4335-2017	De Muizon, Christian/0000-0002-1247-8867; Lambert, Olivier/0000-0003-0740-5791; De Muizon, Christian/0000-0002-1247-8867; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	Board of the Natuurhistorisch Museum Rotterdam Foundation; Belgian Federal Science Policy Office	Board of the Natuurhistorisch Museum Rotterdam Foundation; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	We thank W. Aguirre, A. Altamirano, E. Diaz, A. Martinez and N. Valencia for assistance during fieldwork and preparation of the specimen; C. Letenneur for the reconstruction of Leviathan; P. Loubry for the photo of the tooth of Orcinus; D. J. Bohaska, G. Lenglet, J. G. Mead, C. Potter, H. van der Es, R. van Zelst and A. Varola for access to collections; M. D. Uhen for his compilation of cetacean data in The Paleobiology Database, and the Board of the Natuurhistorisch Museum Rotterdam Foundation for financial support of our research on fossil cetaceans in Peru. The work of O.L. at IRSNB was funded by the Belgian Federal Science Policy Office.	Abel O., 1905, MEMOIRES MUSEE ROYAL, V3, P1; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Brand LR, 2004, GEOLOGY, V32, P165, DOI 10.1130/G20079.1; Caldwell D.K., 1989, P235; Carrier DR, 2002, J EXP BIOL, V205, P1755; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; DALHEIM ME, 1999, HDB MARINE MAMMALS, V6, P281; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; HIROTA K, 1996, ISL ARC, V3, P453; Hohn AA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P11; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; KATO S, 1984, BIOPHYS J, V46, P35, DOI 10.1016/S0006-3495(84)83996-X; Kellogg AR, 1925, CONTRIBUTIONS PALAEO, V348, P1; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Leidy J., 1877, J ACAD NATURAL SCI P, V8, P209; Lindberg DR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P67; Marx FG, 2009, P ROY SOC B-BIOL SCI, V276, P887, DOI 10.1098/rspb.2008.1473; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P174; RICE DW, 1989, HDB MARINE MAMMALS, V56, P177; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; TAYLOR MA, 1992, PHILOS T ROY SOC B, V335, P247, DOI 10.1098/rstb.1992.0022; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth Alexander J., 2004, Aquatic Mammals, V30, P405, DOI 10.1578/AM.30.3.2004.405; Whitehead H., 2003, SPERM WHALES SOCIAL; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	138	144	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					105	108		10.1038/nature09067	http://dx.doi.org/10.1038/nature09067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596020				2022-12-24	WOS:000279343800043
J	Binder, A; Ellis, S				Binder, Allan; Ellis, Spencer			Rational Testing Investigating symmetrical polyarthritis of recent origin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RHEUMATOID-ARTHRITIS; DISEASE; RECOMMENDATIONS; PROTEIN				Binder, A (corresponding author), Lister Hosp, Stevenage SG1 4AB, Herts, England.	allan.binder@nhs.net						ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Mjaavatten MD, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2820; Mjaavatten MD, 2009, J RHEUMATOL, V36, P1401, DOI 10.3899/jrheum.081217; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HTLH, V79; Ostergaard M, 2008, BEST PRACT RES CL RH, V22, P1019, DOI 10.1016/j.berh.2008.09.014; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Soderlin MK, 2002, ANN RHEUM DIS, V61, P911, DOI 10.1136/ard.61.10.911; Sokka T, 2009, J RHEUMATOL, V36, P1387, DOI 10.3899/jrheum.080770; SYMMONS DPM, 1994, BRIT J RHEUMATOL, V33, P735; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117	14	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2010	340								c3110	10.1136/bmj.c3110	http://dx.doi.org/10.1136/bmj.c3110			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591966				2022-12-24	WOS:000279586300014
J	Kmech, J				Kmech, Jonn			A blow to the fight against snakebite	LANCET			English	Editorial Material									Univ Alberta, Edmonton, AB T6G 2J7, Canada	University of Alberta	Kmech, J (corresponding author), Univ Alberta, Edmonton, AB T6G 2J7, Canada.							Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, VEN SNAK DISTR SPEC; World Health Organization, 2016, WHO GUID PROD CONTR; 2010, FIRE DESTROYS WORLDS	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2061	2061		10.1016/S0140-6736(10)60941-5	http://dx.doi.org/10.1016/S0140-6736(10)60941-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20542157				2022-12-24	WOS:000279069300009
J	Baylis, F				Baylis, Francoise			Pregnant women deserve better	NATURE			English	Editorial Material									[Baylis, Francoise] Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 3P7, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Philosophy, Halifax, NS B3H 3P7, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3H 3P7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Baylis, F (corresponding author), Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 3P7, Canada.	francoise.baylis@dal.ca	Baylis, Francoise/AAP-4565-2021	Baylis, Francoise/0000-0003-2961-5802				Baylis F, 2010, J OBSTET GYNAECOL CA, V32, P473, DOI 10.1016/S1701-2163(16)34502-9; Council for International Organizations of Medical Sciences (CIOMS), INT ETH GUID BIOM RE; Lyerly Anne Drapkin, 2008, Int J Fem Approaches Bioeth, V1, P5, DOI 10.2979/FAB.2008.1.2.5	3	62	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					689	690		10.1038/465689a	http://dx.doi.org/10.1038/465689a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535185				2022-12-24	WOS:000278551800019
J	Sims, M; Maxwell, R; Bauld, L; Gilmore, A				Sims, Michelle; Maxwell, Roy; Bauld, Linda; Gilmore, Anna			Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PARTICULATE AIR-POLLUTION; PASSIVE SMOKING; SECONDHAND SMOKE; YOUNG-ADULTS; SEASONAL-VARIATION; EUROPEAN-SOCIETY; WORKING GROUP; BAN; MORTALITY	Objective To measure the short term impact on hospital admissions for myocardial infarction of the introduction of smoke-free legislation in England on 1 July 2007. Design An interrupted time series design with routinely collected hospital episode statistics data. Analysis of admissions from July 2002 to September 2008 (providing five years' data from before the legislation and 15 months' data from after) using segmented Poisson regression. Setting England. Population All patients aged 18 or older living in England with an emergency admission coded with a primary diagnosis of myocardial infarction. Main outcome measures Weekly number of completed hospital admissions. Results After adjustment for secular and seasonal trends and variation in population size, there was a small but significant reduction in the number of emergency admissions for myocardial infarction after the implementation of smoke-free legislation (-2.4%, 95% confidence interval -4.06% to -0.66%, P=0.007). This equates to 1200 fewer emergency admissions for myocardial infarction (1600 including readmissions) in the first year after legislation. The reduction in admissions was significant in men (3.1%, P=0.001) and women (3.8%, P=0.007) aged 60 and over, and men (3.5%, P<0.01) but not women (2.5% P=0.38) aged under 60. Conclusion This study adds to a growing body of evidence that smoke-free legislation leads to reductions in myocardial infarctions. It builds on previous work by showing that such declines are observed even when underlying reductions in admissions and potential confounders are controlled for. The considerably smaller decline in admissions observed in England compared with many other jurisdictions probably reflects aspects of the study design and the relatively low levels of exposure to secondhand smoke in England before the legislation.	[Sims, Michelle; Gilmore, Anna] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England; [Sims, Michelle; Bauld, Linda; Gilmore, Anna] Univ Bath, UK Ctr Tobacco Control Studies, Bath BA2 7AY, Avon, England; [Maxwell, Roy] SW Publ Hlth Observ, Bristol BS8 2RA, Avon, England; [Bauld, Linda] Univ Bath, Dept Social & Policy Sci, Bath BA2 7AY, Avon, England; [Gilmore, Anna] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Bath; University of Bath; University of Bath; University of London; London School of Hygiene & Tropical Medicine	Gilmore, A (corresponding author), Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England.	a.gilmore@bath.ac.uk	gilmore, anna B/I-7130-2012	gilmore, anna B/0000-0003-0281-1248	Department of Health; Health Foundation; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish	Department of Health; Health Foundation; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was undertaken by the University of Bath, which received funding from the Department of Health's Policy Research Programme. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. AG is supported by a Health Foundation Clinician Scientist Fellowship. MS, LB, and AG are members of the UK Centre for Tobacco Control, a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council and the Department of Health, under the auspices of the UK Clinical Research Collaboration is gratefully acknowledged. The funders played no role in the study design, analysis, and interpretation of data nor in the writing of the report or the decision to submit the article for publication.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Crawford VLS, 2003, QJM-INT J MED, V96, P45, DOI 10.1093/qjmed/hcg005; Croxton PJ, 2006, INT J CLIMATOL, V26, P2287, DOI 10.1002/joc.1378; *DEP HLTH, 2009, SMOK ENGL ON YEAR; Dinno A, 2007, PREV MED, V45, P9, DOI 10.1016/j.ypmed.2007.03.013; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Edwards E, 2006, SMOKE HAS CLEARED EV; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Fox KAA, 2004, HEART, V90, P603, DOI 10.1136/hrt.2004.038679; Gemmell I, 2000, INT J EPIDEMIOL, V29, P274, DOI 10.1093/ije/29.2.274; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; *IARC, 2009, IARC HDB CANC PREV T; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Kloner RA, 2004, CIRCULATION, V110, P3744, DOI 10.1161/01.CIR.0000151786.03797.18; Koek HL, 2006, HEART, V92, P162, DOI 10.1136/hrt.2004.054486; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P62, DOI 10.1007/BF03403743; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MacIntyre K, 2006, HEART, V92, P691, DOI 10.1136/hrt.2005.068742; Marques-Vidal P, 2000, HEART, V84, P171, DOI 10.1136/heart.84.2.171; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Murphy NF, 2004, BMJ-BRIT MED J, V328, P1413, DOI 10.1136/bmj.38111.650741.F7; *NHS INF CTR HLTH, 2010, HOSP EP STAT ONL; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; OFARRELL AM, 2004, HOSP DISCHARGE RATES; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Pell JP, 1999, QJM-INT J MED, V92, P689, DOI 10.1093/qjmed/92.12.689; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Richiardi L, 2009, PREV MED, V48, P167, DOI 10.1016/j.ypmed.2008.11.013; Royal College of Physicians, 2005, GOING SMOK FREE MED; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; SEMPLE S, 2010, ANN OCCUP HYG   0219; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; *UK MET OFF, 2009, HIST CENTR ENGL TEMP; Vasselli S, 2008, Minerva Cardioangiol, V56, P197; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WARDIE H, 2008, HLTH SURVEY ENGLAND, V1; WARDLE H, 2009, IMPACT SMOKEFREE LEG; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization, 1992, INT STAT CLASS DIS R	63	110	114	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2010	340								c2161	10.1136/bmj.c2161	http://dx.doi.org/10.1136/bmj.c2161			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530563	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000278818300002
J	Jensen, V; Rappaport, BA				Jensen, Valerie; Rappaport, Bob A.			The Reality of Drug Shortages - The Case of the Injectable Agent Propofol	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jensen, Valerie] Ctr Drug Evaluat & Res, Drug Shortage Program, FDA, Silver Spring, MD USA; [Rappaport, Bob A.] Ctr Drug Evaluat & Res, Div Anesthesia & Analgesia Prod, FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Jensen, V (corresponding author), Ctr Drug Evaluat & Res, Drug Shortage Program, FDA, Silver Spring, MD USA.							Food and Drug Administration, CURR DRUG SHORT; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P727, DOI 10.1001/jama.298.7.727; *NAT LIB MED, PROP DRUG LAB; Steinbrook R, 2009, NEW ENGL J MED, V361, P1525, DOI 10.1056/NEJMp0906922; 2008, MMWR MORB MORTAL WKL, V57, P513	5	64	65	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					806	807		10.1056/NEJMp1005849	http://dx.doi.org/10.1056/NEJMp1005849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20554977				2022-12-24	WOS:000281196600003
J	Ouchi, N; Higuchi, A; Ohashi, K; Oshima, Y; Gokce, N; Shibata, R; Akasaki, Y; Shimono, A; Walsh, K				Ouchi, Noriyuki; Higuchi, Akiko; Ohashi, Koji; Oshima, Yuichi; Gokce, Noyan; Shibata, Rei; Akasaki, Yuichi; Shimono, Akihiko; Walsh, Kenneth			Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity	SCIENCE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; SIGNALING PATHWAY; INFLAMMATION; JNK; ADIPOGENESIS; ADIPONECTIN; INHIBITION; MECHANISMS; DISEASE	Adipose tissue secretes proteins referred to as adipokines, many of which promote inflammation and disrupt glucose homeostasis. Here we show that secreted frizzled-related protein 5 (Sfrp5), a protein previously linked to the Wnt signaling pathway, is an anti-inflammatory adipokine whose expression is perturbed inmodels of obesity and type 2 diabetes. Sfrp5-deficient mice fed a high-calorie diet developed severe glucose intolerance and hepatic steatosis, and their adipose tissue showed an accumulation of activated macrophages that was associated with activation of the c-Jun N-terminal kinase signaling pathway. Adenovirus-mediated delivery of Sfrp5 to mouse models of obesity ameliorated glucose intolerance and hepatic steatosis. Thus, in the setting of obesity, Sfrp5 secretion by adipocytes exerts salutary effects on metabolic dysfunction by controlling inflammatory cells within adipose tissue.	[Ouchi, Noriyuki; Higuchi, Akiko; Ohashi, Koji; Oshima, Yuichi; Gokce, Noyan; Akasaki, Yuichi; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Gokce, Noyan] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Shimono, Akihiko] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117456, Singapore	Boston University; Boston University; Nagoya University; National University of Singapore	Ouchi, N (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	nouchi@bu.edu; kxwalsh@bu.edu	OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Walsh, Kenneth/0000-0001-7580-2276; Gokce, Noyan/0000-0003-2920-3445	National Institutes of Health [AG34972, HL86785, AG15052, HL81587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587, R01HL086785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG015052, R01AG015052, R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Sono-Romanelli for technical assistance. Funded by National Institutes of Health grants (AG34972, HL86785, AG15052, and HL81587) to K.W.	Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	21	336	376	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					454	457		10.1126/science.1188280	http://dx.doi.org/10.1126/science.1188280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558665	Green Accepted			2022-12-24	WOS:000280196500041
J	Dray, N; Tessmar-Raible, K; Le Gouar, M; Vibert, L; Christodoulou, F; Schipany, K; Guillou, A; Zantke, J; Snyman, H; Behague, J; Vervoort, M; Arendt, D; Balavoine, G				Dray, Nicolas; Tessmar-Raible, Kristin; Le Gouar, Martine; Vibert, Laura; Christodoulou, Foteini; Schipany, Katharina; Guillou, Aurelien; Zantke, Juliane; Snyman, Heidi; Behague, Julien; Vervoort, Michel; Arendt, Detlev; Balavoine, Guillaume			Hedgehog Signaling Regulates Segment Formation in the Annelid Platynereis	SCIENCE			English	Article							DROSOPHILA EMBRYONIC EPIDERMIS; EXPRESSION PATTERNS; SPATIAL REGULATION; HOMEOBOX GENES; POLARITY GENE; PROTEIN; WINGLESS; ENCODES	Annelids and arthropods share a similar segmented organization of the body whose evolutionary origin remains unclear. The Hedgehog signaling pathway, prominent in arthropod embryonic segment patterning, has not been shown to have a similar function outside arthropods. We show that the ligand Hedgehog, the receptor Patched, and the transcription factor Gli are all expressed in striped patterns before the morphological appearance of segments in the annelid Platynereis dumerilii. Treatments with small molecules antagonistic to Hedgehog signaling disrupt segment formation. Platynereis Hedgehog is not necessary to establish early segment patterns but is required to maintain them. The molecular similarity of segment patterning functions of the Hedgehog pathway in an annelid and in arthropods supports a common origin of segmentation in protostomes.	[Dray, Nicolas; Le Gouar, Martine; Vibert, Laura; Behague, Julien; Vervoort, Michel; Balavoine, Guillaume] CNRS, Ctr Genet Mol, FRE 3144, F-91189 Gif Sur Yvette, France; [Tessmar-Raible, Kristin; Schipany, Katharina; Zantke, Juliane] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Tessmar-Raible, Kristin; Christodoulou, Foteini; Snyman, Heidi; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Guillou, Aurelien; Behague, Julien; Vervoort, Michel; Balavoine, Guillaume] Univ Paris Diderot, CNRS, Inst Jacques Monod, F-75205 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Balavoine, G (corresponding author), CNRS, Ctr Genet Mol, FRE 3144, Ave Terrasse, F-91189 Gif Sur Yvette, France.	balavoine.guillaume@ijm.univ-paris-diderot.fr	Tessmar-Raible, Kristin/F-9642-2011; Vervoort, Michel/S-1448-2019; Dray, Nicolas/E-1610-2011; dray, nicolas/B-6854-2009	Tessmar-Raible, Kristin/0000-0002-8038-1741; Dray, Nicolas/0000-0002-2632-6004; 	CNRS, University Paris-Diderot; Agence Nationale de la Recherche (France) [BLAN-0294]; Max F. Perutz Laboratories (MFPL); Austrian Science Fund (FWF) [AY0041321]; French Research Ministry; Fondation pour la recherche medicale (FRM); Boehringer Ingelheim Foundation; Marie Curie Research Training Networks [MRTN-CT-2004-005624]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	CNRS, University Paris-Diderot(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Max F. Perutz Laboratories (MFPL); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); French Research Ministry(Ministry of Research, France); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Marie Curie Research Training Networks(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge the following agencies for funding: the CNRS, University Paris-Diderot and the Agence Nationale de la Recherche (France) (ANR grant BLAN-0294); the Max F. Perutz Laboratories (MFPL) funds and the Austrian Science Fund (FWF) START award (AY0041321), the French Research Ministry and the Fondation pour la recherche medicale (FRM) for fellowships (N.D.); the Boehringer Ingelheim Foundation and the Marie Curie Research Training Networks ZOONET (MRTN-CT-2004-005624) for fellowships (K. T. R.). We also thank the platform ImagoSeine staff for help in confocal imagery. GenBank accession numbers for the gene sequences newly identified in this study are HM179271 to HM179276.	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WB, 2001, DEVELOPMENT, V128, P2385; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Farzana L, 2008, DEV GENES EVOL, V218, P181, DOI 10.1007/s00427-008-0207-2; Hatini V, 2001, TRENDS GENET, V17, P574, DOI 10.1016/S0168-9525(01)02448-9; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Jagla K, 1997, DEVELOPMENT, V124, P91; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Pechmann M, 2009, P NATL ACAD SCI USA, V106, P1468, DOI 10.1073/pnas.0811150106; Prud'homme B, 2003, CURR BIOL, V13, P1876, DOI 10.1016/j.cub.2003.10.006; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Steinmetz PRH, 2007, P NATL ACAD SCI USA, V104, P2727, DOI 10.1073/pnas.0606589104; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0	21	76	78	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					339	342		10.1126/science.1188913	http://dx.doi.org/10.1126/science.1188913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647470	Green Accepted			2022-12-24	WOS:000279925900047
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling The case of the sugar sweetened beverage tax	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	11	11	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2010	341								c3719	10.1136/bmj.c3719	http://dx.doi.org/10.1136/bmj.c3719			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XC	20630952				2022-12-24	WOS:000280156700006
J	Ikawa, T; Hirose, S; Masuda, K; Kakugawa, K; Satoh, R; Shibano-Satoh, A; Kominami, R; Katsura, Y; Kawamoto, H				Ikawa, Tomokatsu; Hirose, Satoshi; Masuda, Kyoko; Kakugawa, Kiyokazu; Satoh, Rumi; Shibano-Satoh, Asako; Kominami, Ryo; Katsura, Yoshimoto; Kawamoto, Hiroshi			An Essential Developmental Checkpoint for Production of the T Cell Lineage	SCIENCE			English	Article							PROGENITORS; COMMITMENT; GENE; EXPRESSION; THYMUS; BCL11B; MICE; PAX5	In early T cell development, progenitors retaining the potential to generate myeloid and natural killer lineages are eventually determined to a specific T cell lineage. The molecular mechanisms that drive this determination step remain unclarified. We show that, when murine hematopoietic progenitors were cultured on immobilized Notch ligand DLL4 protein in the presence of a cocktail of cytokines including interleukin-7, progenitors developing toward T cells were arrested and the arrested cells entered a self-renewal cycle, maintaining non-T lineage potentials. Reduced concentrations of interleukin-7 promoted T cell lineage determination. A similar arrest and self-renewal of progenitors were observed in thymocytes of mice deficient in the transcription factor Bcl11b. Our study thus identifies the earliest checkpoint during T cell development and shows that it is Bcl11b-dependent.	[Ikawa, Tomokatsu; Masuda, Kyoko; Kakugawa, Kiyokazu; Satoh, Rumi; Shibano-Satoh, Asako; Katsura, Yoshimoto; Kawamoto, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Hirose, Satoshi; Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata 9518510, Japan; [Katsura, Yoshimoto] Nihon Univ, Sch Med, Adv Med Res Ctr, Div Cell Regenerat & Transplantat, Tokyo 1738610, Japan	RIKEN; Niigata University; Nihon University	Kawamoto, H (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan.	kawamoto@rcai.riken.jp	Hirose, Satoshi/CAF-1500-2022	Hirose, Satoshi/0000-0001-7825-501X; Kakugawa, Kiyokazu/0000-0002-2560-5562	Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to C. Murre, T. Kadesch, Y. Agata, and S. Yamasaki for providing us with reagents and protocols, and to P. Burrows for critical reading of the manuscript. This work was partially supported by Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Science, Sports, and Culture, Japan.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Masuda K, 2007, J IMMUNOL, V179, P3699, DOI 10.4049/jimmunol.179.6.3699; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183	21	228	230	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					93	96		10.1126/science.1188995	http://dx.doi.org/10.1126/science.1188995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595615				2022-12-24	WOS:000279402700040
J	Li, P; Burke, S; Wang, JX; Chen, XF; Ortiz, M; Lee, SC; Lu, D; Campos, L; Goulding, D; Ng, BL; Dougan, G; Huntly, B; Gottgens, B; Jenkins, NA; Copeland, NG; Colucci, F; Liu, PT				Li, Peng; Burke, Shannon; Wang, Juexuan; Chen, Xiongfeng; Ortiz, Mariaestela; Lee, Song-Choon; Lu, Dong; Campos, Lia; Goulding, David; Ng, Bee Ling; Dougan, Gordon; Huntly, Brian; Gottgens, Bertie; Jenkins, Nancy A.; Copeland, Neal G.; Colucci, Francesco; Liu, Pentao			Reprogramming of T Cells to Natural Killer-Like Cells upon Bcl11b Deletion	SCIENCE			English	Article							H-2-DEFICIENT LYMPHOMA VARIANTS; IN-VITRO; NK CELLS; DIFFERENTIATION; RECOGNITION; EXPRESSION; SURVIVAL; PATHWAY; VIVO	T cells develop in the thymus and are critical for adaptive immunity. Natural killer (NK) lymphocytes constitute an essential component of the innate immune system in tumor surveillance, reproduction, and defense against microbes and viruses. Here, we show that the transcription factor Bcl11b was expressed in all T cell compartments and was indispensable for T lineage development. When Bcl11b was deleted, T cells from all developmental stages acquired NK cell properties and concomitantly lost or decreased T cell-associated gene expression. These induced T-to-natural killer (ITNK) cells, which were morphologically and genetically similar to conventional NK cells, killed tumor cells in vitro, and effectively prevented tumor metastasis in vivo. Therefore, ITNKs may represent a new cell source for cell-based therapies.	[Li, Peng; Burke, Shannon; Wang, Juexuan; Ortiz, Mariaestela; Lee, Song-Choon; Lu, Dong; Campos, Lia; Goulding, David; Ng, Bee Ling; Dougan, Gordon; Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Burke, Shannon; Colucci, Francesco] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Chen, Xiongfeng] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Huntly, Brian; Gottgens, Bertie] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Jenkins, Nancy A.; Copeland, Neal G.] Inst Mol & Cell Biol, Proteos 138673, Singapore	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liu, PT (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	pl2@sanger.ac.uk	Colucci, Francesco/F-2844-2010; huntly, brian JP/E-6725-2014; Li, Peng/AER-7520-2022	Colucci, Francesco/0000-0001-5193-6376; huntly, brian JP/0000-0003-0312-161X; Li, Peng/0000-0003-4530-2400; Gottgens, Berthold/0000-0001-6302-5705	Wellcome Trust; MRC; BBSRC; Medical Research Council [G116/187, G0800784, G0501150, G0800784B] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; MRC [G0501150, G0800784, G116/187] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Wellcome Trust to P. Liu, from MRC and BBSRC to F. Colucci, and by MRC to B. Huntly. We thank core facilities at Sanger Institute (RSF and microarray), Babraham Institute and CIMR for technical support. Microarray data have been submitted to GEO (Gene Expression Ominibus). Accession number: GSE21016. A patent application has been filed by the Wellcome Trust for production and application of ITNKs (U. K. patent application No. 0912287. U. S. Provisional Application No. 61/225779), and P. L. and P. L. are listed as authors on this application. A Mouse/Tissue Transfer Agreement is required for the use of PLBD mice.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Boos MD, 2008, IMMUNOL RES, V40, P193, DOI 10.1007/s12026-007-8006-9; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Colucci F, 1999, J IMMUNOL, V162, P2761; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KAWANO YI, 1986, J IMMUNOL, V136, P4729; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104	26	236	243	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					85	89		10.1126/science.1188063	http://dx.doi.org/10.1126/science.1188063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20538915	Green Accepted			2022-12-24	WOS:000279402700038
J	El-Bassel, N; Terlikbaeva, A; Pinkham, S				El-Bassel, Nabila; Terlikbaeva, Assel; Pinkham, Sophie			HIV and women who use drugs: double neglect, double risk	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; PREVENTION; METHADONE		[El-Bassel, Nabila] Columbia Univ, Sch Social Work, New York, NY 10025 USA; [El-Bassel, Nabila; Terlikbaeva, Assel] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan; [Pinkham, Sophie] AIDS Fdn EW, Kiev, Ukraine	Columbia University	El-Bassel, N (corresponding author), Columbia Univ, Sch Social Work, 622 W 113th St, New York, NY 10025 USA.							Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Bryant J, 2010, DRUG ALCOHOL DEPEN, V107, P182, DOI 10.1016/j.drugalcdep.2009.10.007; Carael M, 2009, JAIDS-J ACQ IMM DEF, V52, pS111, DOI 10.1097/QAI.0b013e3181baeec2; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; El-Bassel N, 2005, AM J PUBLIC HEALTH, V95, P465, DOI 10.2105/AJPH.2003.023200; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; *OP SOC I, 2009, WOM HARM RED HIV KEY; Pinkham S, 2008, REPROD HEALTH MATTER, V16, P168, DOI 10.1016/S0968-8080(08)31345-7; Wechsberg WM, 2008, SUBST USE MISUSE, V43, P1186, DOI 10.1080/10826080801918247	11	78	82	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2010	376	9738					312	314		10.1016/S0140-6736(10)61026-4	http://dx.doi.org/10.1016/S0140-6736(10)61026-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20650519				2022-12-24	WOS:000280717900008
J	O'Reilly, J; Jones, MM; Parnham, J; Lovibond, K; Rudolf, M				O'Reilly, John; Jones, Melvyn M.; Parnham, Jill; Lovibond, Kate; Rudolf, Michael		Guideline Dev Grp	Guidelines Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AIR-FLOW OBSTRUCTION; DIAGNOSIS; COPD		[O'Reilly, John] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Jones, Melvyn M.] UCL, Sch Med, Dept Primary Care & Populat Hlth, London N19 5LW, England; [Jones, Melvyn M.] Warden Lodge Surg, Cheshunt EN8 8NW, England; [Parnham, Jill; Lovibond, Kate] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Rudolf, Michael] Ealing Hosp NHS Trust, Ealing UB1 3HW, England	Aintree University Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School	O'Reilly, J (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England.	john.oreilly@aintree.nhs.uk	Jones, Melvyn/C-2300-2008	Jones, Melvyn/0000-0002-8766-7443; O'Reilly, John/0000-0001-6708-2459; GRUFFYDD-JONES, KEVIN/0000-0002-4651-5961				[Anonymous], 2008, GLOB STRAT DIAGN MAN; British Lung Foundation, 2007, INV LIV CHRON OBSTR; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cerveri I, 2008, THORAX, V63, P1040, DOI 10.1136/thx.2008.095554; Department of Health, 2010, CONS STRAT SERV COPD; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; *HC, 2006, CLEAN AIR NAT STUD C; Hnizdo Eva, 2006, COPD, V3, P95, DOI 10.1080/15412550600651552; *NAT I HLTH CLIN E, 2008, PUBL HLTH GUID NAT I, V10; *NAT I HLTH CLIN E, 2007, 123 NAT I HLTH CLIN; *NAT I HLTH CLIN E, 2010, CLIN GUID NAT I HLTH, V101; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; 2008, THORAX S7, V63; 2004, THORAX S1, V59	20	55	56	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2010	340								c3134	10.1136/bmj.c3134	http://dx.doi.org/10.1136/bmj.c3134			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IR	20581031				2022-12-24	WOS:000279346600002
J	Biggs, ML; Mukamal, KJ; Luchsinger, JA; Ix, JH; Carnethon, MR; Newman, AB; de Boer, IH; Strotmeyer, ES; Mozaffarian, D; Siscovick, DS				Biggs, Mary L.; Mukamal, Kenneth J.; Luchsinger, Jose A.; Ix, Joachim H.; Carnethon, Mercedes R.; Newman, Anne B.; de Boer, Ian H.; Strotmeyer, Elsa S.; Mozaffarian, Dariush; Siscovick, David S.			Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; WAIST CIRCUMFERENCE; TISSUE DISTRIBUTION; LIFE-STYLE; WEIGHT CHANGE; VISCERAL FAT; MELLITUS; HEALTH; WOMEN	Context Adiposity is a well-recognized risk factor for type 2 diabetes among young and middle-aged adults, but the relationship between body composition and type 2 diabetes is not well described among older adults. Objective To examine the relationship between adiposity, changes in adiposity, and risk of incident type 2 diabetes in adults 65 years of age and older. Design, Setting, and Participants Prospective cohort study (1989-2007) of 4193 men and women 65 years of age and older in the Cardiovascular Health Study. Measures of adiposity were derived from anthropometry and bioelectrical impedance data at baseline and anthropometry repeated 3 years later. Main Outcome Measure Incident diabetes was ascertained based on use of antidiabetic medication or a fasting glucose level of 126 mg/dL or greater. Results Over median follow-up of 12.4 years (range, 0.9-17.8 years), 339 cases of incident diabetes were ascertained (7.1/1000 person-years). The adjusted hazard ratio (HR) (95% confidence interval [CI]) of type 2 diabetes for participants in the highest quintile of baseline measures compared with those in the lowest was 4.3 (95% CI, 2.9-6.5) for body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]), 3.0 (95% CI, 2.0-4.3) for BMI at 50 years of age, 4.2 (95% CI, 2.8-6.4) for weight, 4.0 (95% CI, 2.6-6.0) for fat mass, 4.2 (95% CI, 2.8-6.2) for waist circumference, 2.4 (95% CI, 1.6-3.5) for waist-hip ratio, and 3.8 (95% CI, 2.6-5.5) for waist-height ratio. However, when stratified by age, participants 75 years of age and older had HRs approximately half as large as those 65 to 74 years of age. Compared with weight-stable participants (+/- 2 kg), those who gained the most weight from 50 years of age to baseline (>= 9 kg), and from baseline to the third follow-up visit (>= 6 kg), had HRs for type 2 diabetes of 2.8 (95% CI, 1.9-4.3) and 2.0 (95% CI, 1.1-3.7), respectively. Participants with a greater than 10-cm increase in waist size from baseline to the third follow-up visit had an HR of type 2 diabetes of 1.7 (95% CI, 1.1-2.8) compared with those who gained or lost 2 cm or less. Conclusion Among older adults, overall and central adiposity, and weight gain during middle age and after the age of 65 years are associated with risk of diabetes. JAMA. 2010; 303(24): 2504-2512	[Biggs, Mary L.] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Mukamal, Kenneth J.] Harvard Univ, Sch Med, Boston, MA USA; [Luchsinger, Jose A.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Luchsinger, Jose A.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Carnethon, Mercedes R.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Strotmeyer, Elsa S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Mozaffarian, Dariush] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiolf, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Columbia University; Columbia University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Biggs, ML (corresponding author), Bldg 29,Ste 310,6200 NE 74th St, Seattle, WA 98115 USA.	mlbiggs@u.washington.edu	Mozaffarian, Dariush/B-2276-2008; de Boer, Ian/GYJ-3282-2022; Newman, Anne B./C-6408-2013; Mukamal, Kenneth/GVR-7978-2022	Newman, Anne B./0000-0002-0106-1150; Carnethon, Mercedes/0000-0001-7035-0848; Strotmeyer, Elsa/0000-0002-4093-6036; Luchsinger, Jose/0000-0002-5886-3648	National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL-075366, R01 HL-094555]; National Institute on Aging [R01 AG-023629, R01 AG-15928, R01 AG-20098, AG-027058]; University of Pittsburgh Claude; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center [P30-AG-024827]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC085081, N01HC085083, N01HC075150, N01HC085080, N01HC035129, N01HC085084, N01HC085085, N01HC085086, N01HC085082, N01HC015103, N01HC055222, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094555, R01HL075366, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R01AG015928, R01AG023629, R01AG027058, P30AG024827] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh Claude; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295, R01 HL-075366, and R01 HL-094555 from the National Heart, Lung, and Blood Institute; R01 AG-023629, R01 AG-15928, R01 AG-20098, and AG-027058 from the National Institute on Aging; the University of Pittsburgh Claude. D. Pepper Older Americans Independence Center P30-AG-024827, with additional contribution from the National Institute of Neurological Disorders and Stroke.	[Anonymous], 1995, WHO TECH REP SER, V854, P1; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CASSANO PA, 1992, AM J EPIDEMIOL, V136, P1474, DOI 10.1093/oxfordjournals.aje.a116468; *CDCP, 2008, DIAB DAT TRENDS; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Deurenberg P, 1990, Basic Life Sci, V55, P391; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Harris TB, 2002, AM J EPIDEMIOL, V156, P122, DOI 10.1093/aje/kwf024; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; LUNDGREN H, 1989, INT J OBESITY, V13, P413; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; *NAT CHOL ED PROGR, 2002, NIH PUBL; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Poehlman ET, 2000, J CLIN ENDOCR METAB, V85, P2463, DOI 10.1210/jc.85.7.2463; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Storti KL, 2006, OBESITY, V14, P244, DOI 10.1038/oby.2006.31; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang ZM, 2007, EUR J CARDIOV PREV R, V14, P172, DOI 10.1097/01.hjr.0000220580.34763.fb; Wedick NM, 2001, AM J EPIDEMIOL, V153, P1199, DOI 10.1093/aje/153.12.1199; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x	41	107	108	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2504	2512		10.1001/jama.2010.843	http://dx.doi.org/10.1001/jama.2010.843			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571017	Green Accepted, Bronze			2022-12-24	WOS:000279010900028
J	Joly, CA; Rodrigues, RR; Metzger, JP; Haddad, CFB; Verdade, LM; Oliveira, MC; Bolzani, VS				Joly, Carlos A.; Rodrigues, Ricardo R.; Metzger, Jean Paul; Haddad, Celio F. B.; Verdade, Luciano M.; Oliveira, Mariana C.; Bolzani, Vanderlan S.			Biodiversity Conservation Research, Training, and Policy in Sao Paulo	SCIENCE			English	Editorial Material									[Joly, Carlos A.] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, BR-13083970 Campinas, SP, Brazil; [Rodrigues, Ricardo R.; Verdade, Luciano M.] State Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Biol Sci, Piracicaba, SP, Brazil; [Metzger, Jean Paul] Univ Sao Paulo, Inst Biol Sci, Dept Ecol, Sao Paulo, Brazil; [Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biosci, Dept Zool, Rio Claro, SP, Brazil; [Oliveira, Mariana C.] Univ Sao Paulo, Inst Biosci, Dept Bot, Sao Paulo, Brazil; [Bolzani, Vanderlan S.] Univ Estadual Paulista, Dept Organ Chem, Araraquara, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Joly, CA (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Plant Biol, BR-13083970 Campinas, SP, Brazil.	cjoly@unicamp.br	Verdade, Luciano M./H-5549-2012; Rodrigues, Ricardo Ribeiro/D-5557-2012; JOLY, Carlos A./C-4523-2012; Haddad, Célio F. B./C-4267-2012; Metzger, Jean Paul/C-2514-2012; Bolzani, Vanderlan S/C-2111-2012; JOLY, Carlos A/H-7925-2012; de Oliveira, Mariana Cabral/G-2512-2012; Bolzani, Vanderlan/C-2111-2012	Verdade, Luciano M./0000-0002-1326-0886; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; JOLY, Carlos A./0000-0002-7945-2805; Haddad, Célio F. B./0000-0002-7044-5764; Metzger, Jean Paul/0000-0002-0087-5240; Bolzani, Vanderlan S/0000-0003-0615-8776; de Oliveira, Mariana Cabral/0000-0001-8495-2962; Bolzani, Vanderlan/0000-0001-7019-5825				Durigan G., 2006, Edinburgh Journal of Botany, V63, P119, DOI 10.1017/S0960428606000357; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RODRIGUES RR, 2008, DIRETRIZES CONSERVAC; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x	5	66	71	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1358	1359		10.1126/science.1188639	http://dx.doi.org/10.1126/science.1188639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538935				2022-12-24	WOS:000278598400022
J	Morris, RV; Ruff, SW; Gellert, R; Ming, DW; Arvidson, RE; Clark, BC; Golden, DC; Siebach, K; Klingelhofer, G; Schroder, C; Fleischer, I; Yen, AS; Squyres, SW				Morris, Richard V.; Ruff, Steven W.; Gellert, Ralf; Ming, Douglas W.; Arvidson, Raymond E.; Clark, Benton C.; Golden, D. C.; Siebach, Kirsten; Klingelhoefer, Goestar; Schroeder, Christian; Fleischer, Iris; Yen, Albert S.; Squyres, Steven W.			Identification of Carbonate-Rich Outcrops on Mars by the Spirit Rover	SCIENCE			English	Article							MARTIAN METEORITE ALH84001; TERRESTRIAL ANALOG; MINERALS; SPITSBERGEN; GLOBULES; SVALBARD; OLIVINE; ORIGIN; ROCKS; AGE	Decades of speculation about a warmer, wetter Mars climate in the planet's first billion years postulate a denser CO2-rich atmosphere than at present. Such an atmosphere should have led to the formation of outcrops rich in carbonate minerals, for which evidence has been sparse. Using the Mars Exploration Rover Spirit, we have now identified outcrops rich in magnesium-iron carbonate (16 to 34 weight percent) in the Columbia Hills of Gusev crater. Its composition approximates the average composition of the carbonate globules in martian meteorite ALH 84001. The Gusev carbonate probably precipitated from carbonate-bearing solutions under hydrothermal conditions at near-neutral pH in association with volcanic activity during the Noachian era.	[Morris, Richard V.; Ming, Douglas W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Ruff, Steven W.] Arizona State Univ, Tempe, AZ 85287 USA; [Gellert, Ralf] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Arvidson, Raymond E.; Siebach, Kirsten] Washington Univ, St Louis, MO 63130 USA; [Clark, Benton C.] Space Sci Inst, Boulder, CO 80301 USA; [Golden, D. C.] Engn & Sci Contract Grp Hamilton Sundstrand, Houston, TX 77058 USA; [Klingelhoefer, Goestar; Fleischer, Iris] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Schroeder, Christian] Univ Bayreuth, Tubingen, Germany; [Schroeder, Christian] Univ Tubingen, Tubingen, Germany; [Yen, Albert S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Squyres, Steven W.] Cornell Univ, Ithaca, NY 14853 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Arizona State University; Arizona State University-Tempe; University of Guelph; Washington University (WUSTL); Johannes Gutenberg University of Mainz; University of Bayreuth; Eberhard Karls University of Tubingen; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University	Morris, RV (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	richard.v.morris@nasa.gov	Schröder, Christian/B-3870-2009	Schröder, Christian/0000-0002-7935-6039; Siebach, Kirsten/0000-0002-6628-6297	NASA Johnson Space Center; NASA; NASA Ames Astrobiology Institute; German Space Agency DLR [50QM9902]	NASA Johnson Space Center(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); NASA Ames Astrobiology Institute; German Space Agency DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	R.V.M. and D.W.M. acknowledge the NASA Johnson Space Center and the NASA Mars Exploration Program for support. R. V. M. acknowledges the NASA Ames Astrobiology Institute for support. S. W. R. acknowledges the NASA Mars Data Analysis Program for support. G. K. and I. F. acknowledge support by the German Space Agency DLR under contract 50QM9902. A portion of the research described in this paper was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. We thank P. B. Niles for carbonate samples, L. Le for carbonate microprobe analyses, and J. L. Campbell for calculation of excess light-element concentrations from APXS data.	AMUNDSEN HEF, 1987, TECTONOPHYSICS, V139, P169, DOI 10.1016/0040-1951(87)90095-3; Arvidson RE, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003183; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Banks D, 1999, GEOTHERMICS, V28, P713, DOI 10.1016/S0375-6505(99)00019-X; Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Campbell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002959; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Ehlmann BL, 2008, SCIENCE, V322, P1828, DOI 10.1126/science.1164759; GAFFEY SJ, 1987, J GEOPHYS RES-SOLID, V92, P1429, DOI 10.1029/JB092iB02p01429; Golden DC, 2000, METEORIT PLANET SCI, V35, P457, DOI 10.1111/j.1945-5100.2000.tb01428.x; Golombek MP, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002503; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; GOODING JL, 1986, SOLAR SYSTEM OBSERVA, V4, P208; Hamilton VE, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002501; Hamilton VE, 2005, GEOLOGY, V33, P433, DOI 10.1130/G21258.1; Harvey RP, 1996, NATURE, V382, P49, DOI 10.1038/382049a0; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; KINGELHOFER G, 2003, J GEOPHYS RES, V108, P8067; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Mccoy TJ, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003041; Ming DW, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003195; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Morris RV, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003201; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2008, SCIENCE, V320, P1063, DOI 10.1126/science.1155429; Squyres SW, 2007, SCIENCE, V316, P738, DOI 10.1126/science.1139045; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002562; Steele A, 2007, METEORIT PLANET SCI, V42, P1549, DOI 10.1111/j.1945-5100.2007.tb00590.x; TREIMAN AH, 1995, METEORITICS, V30, P294, DOI 10.1111/j.1945-5100.1995.tb01127.x; Treiman AH, 2002, EARTH PLANET SC LETT, V204, P323, DOI 10.1016/S0012-821X(02)00998-6; Usui T, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003225; Yen AS, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002978	38	283	289	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					421	424		10.1126/science.1189667	http://dx.doi.org/10.1126/science.1189667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20522738				2022-12-24	WOS:000280196500032
J	Maxmen, A				Maxmen, Amy			Fighting the monster	NATURE			English	Editorial Material							TUBERCULOSIS THERAPY; ANTIRETROVIRAL DRUGS											Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Garcia-Vidal C, 2010, NEW ENGL J MED, V362, P2137; Kadhiravan T, 2010, NEW ENGL J MED, V362, P2138; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Wilson D, 2010, NEW ENGL J MED, V362, P2137, DOI 10.1056/NEJMc1003767	7	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S18	S19		10.1038/nature09243	http://dx.doi.org/10.1038/nature09243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631699	Bronze			2022-12-24	WOS:000279867100032
J	Harvey, J; Warwick, I				Harvey, Julie; Warwick, Ian			A Patient's Journey Endometriosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Warwick, Ian] Lisburn Hlth Ctr, Lisburn BT28 1LU, England			julesharvey@yahoo.co.uk							0	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2010	340								c2661	10.1136/bmj.c2661	http://dx.doi.org/10.1136/bmj.c2661			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MF	20538637				2022-12-24	WOS:000278818700006
J	Abraham, T				Abraham, Thomas			Personal View The price of poor pandemic communication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Journalism & Media Studies Ctr, Publ Hlth Commun Programme, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Abraham, T (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Publ Hlth Commun Programme, Hong Kong, Hong Kong, Peoples R China.	thomas@hku.hk						[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249	1	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2010	340								c2952	10.1136/bmj.c2952	http://dx.doi.org/10.1136/bmj.c2952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534678	Green Submitted			2022-12-24	WOS:000278818500021
J	Cohen, D; Carter, P				Cohen, Deborah; Carter, Philip			WHO and the pandemic flu "conspiracies"	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; INFLUENZA; OSELTAMIVIR; INFECTION; PREVENTION		[Carter, Philip] Bur Investigat Journalism, London, England			dcohen@bmj.com						Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3471; *EUR SCI WORK GROU, REV POL PLAN 2006 20; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2003, J INFECT DIS, V188, P1355, DOI 10.1086/379049; *HOLM REP, TAM LAUNCH MED CAMP; *INF DIS SOC AM, CONGR 2009 SOC AW RE; *INT FED PHARM MAN, 2008, WHO INFL VIR SURV SY; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Monto AS, 2004, CLIN INFECT DIS, V39, P459, DOI 10.1086/422646; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OSTERHAUS A, PROPHYLACTIC ROLE; *US FDA, FDA APPR DRUGS INFL; World Health Organization, 2003, GUID WHO GUID	19	84	88	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2912	10.1136/bmj.c2912	http://dx.doi.org/10.1136/bmj.c2912			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BM	20525679				2022-12-24	WOS:000278556500017
J	Hu, QC; Milenkovic, L; Jin, H; Scott, MP; Nachury, MV; Spiliotis, ET; Nelson, WJ				Hu, Qicong; Milenkovic, Ljiljana; Jin, Hua; Scott, Matthew P.; Nachury, Maxence V.; Spiliotis, Elias T.; Nelson, W. James			A Septin Diffusion Barrier at the Base of the Primary Cilium Maintains Ciliary Membrane Protein Distribution	SCIENCE			English	Article							CHLAMYDOMONAS-REINHARDTII; PLASMA-MEMBRANE; COMPARTMENTALIZATION; TRANSPORT; ORGANIZATION; POLARITY	In animal cells, the primary cilium transduces extracellular signals through signaling receptors localized in the ciliary membrane, but how these ciliary membrane proteins are retained in the cilium is unknown. We found that ciliary membrane proteins were highly mobile, but their diffusion was impeded at the base of the cilium by a diffusion barrier. Septin 2 (SEPT2), a member of the septin family of guanosine triphosphatases that form a diffusion barrier in budding yeast, localized at the base of the ciliary membrane. SEPT2 depletion resulted in loss of ciliary membrane protein localization and Sonic hedgehog signal transduction, and inhibited ciliogenesis. Thus, SEPT2 is part of a diffusion barrier at the base of the ciliary membrane and is essential for retaining receptor-signaling pathways in the primary cilium.	[Spiliotis, Elias T.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Hu, Qicong; Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Milenkovic, Ljiljana; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Milenkovic, Ljiljana; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Jin, Hua; Nachury, Maxence V.; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Drexel University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Spiliotis, ET (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	ets33@drexel.edu; wjnelson@stanford.edu	Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562	NIH [GM35527, GM089933]; Department of Defense [BC083077]; State of Pennsylvania Tobacco Settlement Funds; American Heart Association; March of Dimes; Sloan Foundation; Klingenstein Foundation; Searle Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM089933, R01GM035527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); State of Pennsylvania Tobacco Settlement Funds; American Heart Association(American Heart Association); March of Dimes(March of Dimes); Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Foundation(Klingenstein Philanthropies); Searle Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kinoshita, S. Munro, G. J. Pazour, K. Mykytyn, D. R. Beier, C. Janke, J. Christianson, R. Kopito, and T. Stearns for reagents, and J. Atkins (Applied Precision, Inc.) for technical support. Supported by NIH grant GM35527 (W.J.N.), Department of Defense Breast Cancer Research Program Predoctoral Fellowship BC083077 (Q. H.), and Drexel CURE award from the State of Pennsylvania Tobacco Settlement Funds (E. T. S.). Supported in part by grants (M.V.N.) from the American Heart Association, the March of Dimes, NIH (GM089933), and the Sloan, Klingenstein and Searle Foundations. L. M. is a Research Specialist, and M. P. S. an Investigator of the Howard Hughes Medical Institute.	Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; MUSGRAVE A, 1986, PLANTA, V167, P544, DOI 10.1007/BF00391231; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sloboda RD, 2007, J CELL BIOL, V179, P575, DOI 10.1083/jcb.200709039; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	30	332	344	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					436	439		10.1126/science.1191054	http://dx.doi.org/10.1126/science.1191054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558667	Green Accepted			2022-12-24	WOS:000280196500036
J	Utne-Palm, AC; Salvanes, AGV; Currie, B; Kaartvedt, S; Nilsson, GE; Braithwaite, VA; Stecyk, JAW; Hundt, M; van der Bank, M; Flynn, B; Sandvik, GK; Klevjer, TA; Sweetman, AK; Bruchert, V; Pittman, K; Peard, KR; Lunde, IG; Strandabo, RAU; Gibbons, MJ				Utne-Palm, Anne C.; Salvanes, Anne G. V.; Currie, Bronwen; Kaartvedt, Stein; Nilsson, Goran E.; Braithwaite, Victoria A.; Stecyk, Jonathan A. W.; Hundt, Matthias; van der Bank, Megan; Flynn, Bradley; Sandvik, Guro K.; Klevjer, Thor A.; Sweetman, Andrew K.; Bruchert, Volker; Pittman, Karin; Peard, Kathleen R.; Lunde, Ida G.; Strandabo, Ronnaug A. U.; Gibbons, Mark J.			Trophic Structure and Community Stability in an Overfished Ecosystem	SCIENCE			English	Article							COASTAL UPWELLING SYSTEM; HYDROGEN-SULFIDE; BENGUELA ECOSYSTEM; NAMIBIAN SHELF; HYPOXIA; OCEAN; DETOXIFICATION; ASSOCIATION; EMISSIONS; ERUPTIONS	Since the collapse of the pelagic fisheries off southwest Africa in the late 1960s, jellyfish biomass has increased and the structure of the Benguelan fish community has shifted, making the bearded goby (Sufflogobius bibarbatus) the new predominant prey species. Despite increased predation pressure and a harsh environment, the gobies are thriving. Here we show that physiological adaptations and antipredator and foraging behaviors underpin the success of these fish. In particular, body-tissue isotope signatures reveal that gobies consume jellyfish and sulphidic diatomaceous mud, transferring "dead-end" resources back into the food chain.	[Utne-Palm, Anne C.; Salvanes, Anne G. V.; Braithwaite, Victoria A.; Hundt, Matthias; Pittman, Karin] Univ Bergen, Dept Biol, Bergen, Norway; [Currie, Bronwen] Natl Marine Informat & Res Ctr, Swakopmund, Namibia; [Kaartvedt, Stein; Klevjer, Thor A.] Univ Oslo, Dept Biol, Oslo, Norway; [Nilsson, Goran E.; Stecyk, Jonathan A. W.; Sandvik, Guro K.; Lunde, Ida G.; Strandabo, Ronnaug A. U.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Braithwaite, Victoria A.] Penn State Univ, Sch Forest Resources, State Coll, PA USA; [Braithwaite, Victoria A.] Penn State Univ, Dept Biol, State Coll, PA USA; [Peard, Kathleen R.] Minist Fisheries & Marine Resources, Luderitz, Namibia; [van der Bank, Megan; Flynn, Bradley; Gibbons, Mark J.] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa; [Sweetman, Andrew K.] Norwegian Inst Water Res NIVA, Reg Off Bergen, Bergen, Norway; [Bruchert, Volker] Stockholm Univ, Dept Sci, S-10691 Stockholm, Sweden; [Kaartvedt, Stein] King Abdullah Univ Sci & Technol, Thuwai, Saudi Arabia	University of Bergen; University of Oslo; University of Oslo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of the Western Cape; Norwegian Institute for Water Research (NIVA); Stockholm University; King Abdullah University of Science & Technology	Utne-Palm, AC (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	anne.palm@bio.uib.no	Gibbons, Mark/A-8806-2008; Nilsson, Göran Erik/Q-6129-2019; Nilsson, Goran E/K-7668-2012; Stecyk, Jonathan/B-4530-2013; Lunde, Ida Gjervold/ABN-5567-2022	Gibbons, Mark/0000-0002-8320-8151; Nilsson, Goran E/0000-0002-3195-3053; Stecyk, Jonathan/0000-0002-0973-9472; Bruchert, Volker/0000-0002-8956-3840; Lunde, Ida Gjervold/0000-0001-9502-6841	National Research Foundation of South Africa; Research Council of Norway; Natural Sciences and Engineering Reserach Council of Canada	National Research Foundation of South Africa(National Research Foundation - South Africa); Research Council of Norway(Research Council of Norway); Natural Sciences and Engineering Reserach Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the crew of the G. O. Sars; F. Midtoy for assistance; and P. Ellitson, M. Hordnes, R. Jones, R. Amundsen and the rest of the scientific crew. We thank the National Research Foundation of South Africa, the Research Council of Norway, and our home institutions for funding and support. We thank BENEFIT (Benguela Environment Fisheries Interaction and Training), S. Sundby, D. C. Boyer, J. Otto Krakstad, and the crew of the research vessel Dr. Fridtjof Nansen for support with earlier goby cruises, laying the basis for the present study. We thank K. Helge Jensen for statistical support. We appreciate the comments on this manuscript by J. Giske, C. Jorgensen, M. P. Heino, and the anonymous reviewers. Care and handling of experimental animals were performed in accordance with institutional guidelines. J. A. W. S. was a postdoctoral researcher funded by the Natural Sciences and Engineering Reserach Council of Canada at the time when the research was conducted.	BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; BAGARINAO T, 1990, J COMP PHYSIOL B, V160, P519; Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Boyer DC, 2001, S AFR J MARINE SCI, V23, P5; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Bruchert V, 2009, PROG OCEANOGR, V83, P169, DOI 10.1016/j.pocean.2009.07.017; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Domenici P, 2007, PHILOS T R SOC B, V362, P2105, DOI 10.1098/rstb.2007.2103; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Gibbons MJ, 2000, S AFR J MARINE SCI, V22, P1, DOI 10.2989/025776100784125708; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Heymans JJ, 2004, ECOL MODEL, V172, P175, DOI 10.1016/j.ecolmodel.2003.09.006; Kaartvedt S, 2009, MAR ECOL PROG SER, V390, P237, DOI 10.3354/meps08196; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lynam CP, 2006, CURR BIOL, V16, P1976, DOI 10.1016/j.cub.2006.09.012; MATIKAINEN N, 1992, J EXP BIOL, V167, P203; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Monteiro PMS, 2008, DEEP-SEA RES PT I, V55, P435, DOI 10.1016/j.dsr.2007.12.010; Pang HP, 2005, AM J PHYSIOL-CELL PH, V289, pC982, DOI 10.1152/ajpcell.00364.2004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Prosser C.L., 1961, COMP ANIMAL PHYSL; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; ROGERS J, 1991, OCEANOGR MAR BIOL, V29, P1; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; TODD ES, 1976, COPEIA, P374; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	34	106	109	2	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					333	336		10.1126/science.1190708	http://dx.doi.org/10.1126/science.1190708			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647468				2022-12-24	WOS:000279925900045
J	Chodavarapu, RK; Feng, SH; Bernatavichute, YV; Chen, PY; Stroud, H; Yu, YC; Hetzel, JA; Kuo, F; Kim, J; Cokus, SJ; Casero, D; Bernal, M; Huijser, P; Clark, AT; Kramer, U; Merchant, SS; Zhang, XY; Jacobsen, SE; Pellegrini, M				Chodavarapu, Ramakrishna K.; Feng, Suhua; Bernatavichute, Yana V.; Chen, Pao-Yang; Stroud, Hume; Yu, Yanchun; Hetzel, Jonathan A.; Kuo, Frank; Kim, Jin; Cokus, Shawn J.; Casero, David; Bernal, Maria; Huijser, Peter; Clark, Amander T.; Kraemer, Ute; Merchant, Sabeeha S.; Zhang, Xiaoyu; Jacobsen, Steven E.; Pellegrini, Matteo			Relationship between nucleosome positioning and DNA methylation	NATURE			English	Article							GENOME; ORGANIZATION; PLANTS; RESOLUTION; SEQUENCE; PARTICLE; ANIMALS; REVEALS; H2A.Z; MARKS	Nucleosomes compact and regulate access to DNA in the nucleus, and are composed of approximately 147 bases of DNA wrapped around a histone octamer(1,2). Here we report a genome-wide nucleosome positioning analysis of Arabidopsis thaliana using massively parallel sequencing of mononucleosomes. By combining this data with profiles of DNA methylation at single base resolution, we identified 10-base periodicities in the DNA methylation status of nucleosome-bound DNA and found that nucleosomal DNA was more highly methylated than flanking DNA. These results indicate that nucleosome positioning influences DNA methylation patterning throughout the genome and that DNA methyltransferases preferentially target nucleosome-bound DNA. We also observed similar trends in human nucleosomal DNA, indicating that the relationships between nucleosomes and DNA methyltransferases are conserved. Finally, as has been observed in animals, nucleosomes were highly enriched on exons, and preferentially positioned at intron-exon and exon-intron boundaries. RNA polymerase II (Pol II) was also enriched on exons relative to introns, consistent with the hypothesis that nucleosome positioning regulates Pol II processivity. DNA methylation is also enriched on exons, consistent with the targeting of DNA methylation to nucleosomes, and suggesting a role for DNA methylation in exon definition.	[Chodavarapu, Ramakrishna K.; Feng, Suhua; Bernatavichute, Yana V.; Chen, Pao-Yang; Stroud, Hume; Hetzel, Jonathan A.; Kuo, Frank; Kim, Jin; Cokus, Shawn J.; Casero, David; Clark, Amander T.; Jacobsen, Steven E.; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Bernatavichute, Yana V.; Merchant, Sabeeha S.; Jacobsen, Steven E.; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Yu, Yanchun; Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Bernal, Maria; Kraemer, Ute] Univ Heidelberg, D-69120 Heidelberg, Germany; [Huijser, Peter] Max Planck Inst Plant Breeding Res, Dept Mol Plant Genet, D-50829 Cologne, Germany; [Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; Ruprecht Karls University Heidelberg; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; matteop@mcdb.ucla.edu	Bernal, Maria/AAA-4068-2020; Kraemer, Ute/C-5025-2008; Zhang, xiaoyu/GXA-3206-2022; Chen, Pao-Yang/ABG-9939-2020; Casero, David/E-7365-2010	Bernal, Maria/0000-0001-9585-4268; Kraemer, Ute/0000-0001-7870-4508; Chen, Pao-Yang/0000-0002-7402-3075; Casero, David/0000-0002-7347-3330; Pellegrini, Matteo/0000-0001-9355-9564	Department of Energy, Institute for Genomics and Proteomics; NIH [GM07104, GM60398, GM42143]; Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA; Alexander-von-Humboldt Fellowship; Heisenberg Fellowship; University of Georgia [JR-040]; NSF [0701745]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042143, R37GM060398, T32GM007104, R37GM042143, R01GM060398, R29GM042143] Funding Source: NIH RePORTER	Department of Energy, Institute for Genomics and Proteomics(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA; Alexander-von-Humboldt Fellowship(Alexander von Humboldt Foundation); Heisenberg Fellowship(German Research Foundation (DFG)); University of Georgia; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our laboratories for input and guidance, and the Department of Energy, Institute for Genomics and Proteomics for support. R. K. C. is supported by NIH training grant GM07104. S. F. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. P.-Y.C. is funded by Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA. M. B. was supported by an Alexander-von-Humboldt Fellowship and U. K. by a Heisenberg Fellowship. X.Z. was supported by a Faculty Research Grant (JR-040) from the University of Georgia. Research was supported by an Innovation Award from the Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA, NIH grants GM60398 and GM42143, and NSF Plant Genome Research Program #0701745. S.E.J. is an Investigator of the Howard Hughes Medical Institute.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kobor MS, 2009, TRENDS BIOCHEM SCI, V34, P158, DOI 10.1016/j.tibs.2008.12.006; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Ponts N, 2010, GENOME RES, V20, P228, DOI 10.1101/gr.101063.109; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; ZEMACH A, 2010, SCIENCE         0415, DOI DOI 10.1126/SCIENCE.1186366; Zhang J, 2007, J HUAZHONG U SCI-MED, V27, P5, DOI 10.1007/s11596-007-0102-5	29	510	526	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					388	392		10.1038/nature09147	http://dx.doi.org/10.1038/nature09147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20512117	Green Accepted			2022-12-24	WOS:000279867100053
J	Muoio, DM				Muoio, Deborah M.			Metabolism and Vascular Fatty Acid Transport.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VEGF		[Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Muoio, Deborah M.] Duke Univ, Dept Med & Pharmacol, Durham, NC USA; [Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Muoio, DM (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA.		Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277				Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384	5	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					291	293		10.1056/NEJMcibr1005397	http://dx.doi.org/10.1056/NEJMcibr1005397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647206				2022-12-24	WOS:000279864200016
J	Rhodes, T; Sarang, A; Vickerman, P; Hickman, M				Rhodes, Tim; Sarang, Anya; Vickerman, Peter; Hickman, Matthew			Policy resistance to harm reduction for drug users and potential effect of change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RUSSIAN-FEDERATION; TOGLIATTI CITY; INJECT DRUGS; HIV; PEOPLE; RISK; CARE		[Rhodes, Tim; Vickerman, Peter] London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 8HT, England; [Sarang, Anya] Andrey Rylkov Fdn Hlth & Social Justice, Moscow, Russia; [Vickerman, Peter; Hickman, Matthew] Univ Bristol, Bristol BS8 1TH, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Rhodes, T (corresponding author), London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 8HT, England.	tim.rhodes@lshtm.ac.uk	Sarang, Anya/K-3359-2015; Hickman, Matthew/Y-2400-2019; Rhodes, Tim/DNJ-9679-2022	Sarang, Anya/0000-0003-0361-1264; Hickman, Matthew/0000-0001-9864-459X; Rhodes, Tim/0000-0003-2400-9838; Vickerman, Peter/0000-0002-8291-5890	ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0701627] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0701627] Funding Source: Medline; Department of Health Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		[Anonymous], 2007, PREV HIV INF INJ DRU; BABAYAN EA, 1985, TXB ALCOHOLISM DRUG; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; DEGENHARDT L, 2010, LANCET IN PRESS; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Human Rights Watch, 2007, REH REQ RUSS HUM RIG; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; LATYPOV A, 2010, INT J DRUG POLI 0223; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mendelevich Vladimir, 2006, HIV AIDS Policy Law Rev, V11, P82; PLAVINSKY SL, 2009, SEXUALLY TRANSMITTED; PLAVINSKY SL, 2008, GLOBUS PROJECT NEWSL, V7; Rhodes T, 2004, JAIDS-J ACQ IMM DEF, V35, P293, DOI 10.1097/00126334-200403010-00011; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; *SEC COUNC RUSS FE, 2009, STEN M IMPR STAT POL; STRATHDEE SA, 2010, LANCET IN PRESS; *UNAIDS, 2009, AIDS EP UPD; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; VICKERMAN P, 2006, J ACQ IMMUN DEF SYND, V42, P255; Wood E, 2009, LANCET, V373, P989, DOI 10.1016/S0140-6736(09)60455-4	24	36	36	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3439	10.1136/bmj.c3439	http://dx.doi.org/10.1136/bmj.c3439			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XB	20627977	Green Accepted			2022-12-24	WOS:000280156600006
J	Jernelov, A				Jernelov, Arne			How to defend against future oil spills	NATURE			English	Editorial Material									Inst Futures Studies, SE-10131 Stockholm, Sweden		Jernelov, A (corresponding author), Inst Futures Studies, Box 591, SE-10131 Stockholm, Sweden.	arne.jernelov@chello.at						JERNELOV A, 1981, NATURE, V10, P299	1	143	150	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					182	183		10.1038/466182a	http://dx.doi.org/10.1038/466182a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613822				2022-12-24	WOS:000279580800017
J	Steele, A; McCubbin, FM; Fries, M; Glamoclija, M; Kater, L; Nekvasil, H				Steele, A.; McCubbin, F. M.; Fries, M.; Glamoclija, M.; Kater, L.; Nekvasil, H.			Graphite in an Apollo 17 Impact Melt Breccia	SCIENCE			English	Article							LUNAR REGOLITH; WHISKERS		[Steele, A.; McCubbin, F. M.; Glamoclija, M.] Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; [Fries, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kater, L.] Witec GmbH, D-89081 Ulm, Germany; [Nekvasil, H.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); WITec; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Steele, A (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	asteele@ciw.edu	McCubbin, Francis/D-1698-2009; McCubbin, Francis/AAG-1095-2020; Steele, Andrew/A-3573-2013; Glamoclija, Mihaela/GWQ-3360-2022	Steele, Andrew/0000-0001-9643-2841; Glamoclija, Mihaela/0000-0003-4327-6480	NASA Astrobiology Science and Technology; Sample Return Laboratory; Data Analysis; Lunar Advanced Science and Exploration Research; Mars Fundamental Research	NASA Astrobiology Science and Technology; Sample Return Laboratory; Data Analysis; Lunar Advanced Science and Exploration Research; Mars Fundamental Research	We acknowledge support from NASA Astrobiology Science and Technology for Exploring Planets, Sample Return Laboratory Instrument and Data Analysis, Lunar Advanced Science and Exploration Research, and Mars Fundamental Research programs and thank Witec, J. Alton, and G. Lofgren. Dedicated to the memory of Annie Steele.	Dikov YP, 2002, SOLAR SYST RES+, V36, P1, DOI 10.1023/A:1014297009479; Fries M, 2008, SCIENCE, V320, P91, DOI 10.1126/science.1153578; Meyer C., 2009, LUNAR SAMPLE COMPEND; PILLINGER CT, 1977, PHILOS T R SOC A, V285, P369, DOI 10.1098/rsta.1977.0076; RYDER G, 1993, JSC PUBLICATION; Tan PH, 2004, PHILOS T R SOC A, V362, P2289, DOI 10.1098/rsta.2004.1442	6	35	35	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					51	51		10.1126/science.1190541	http://dx.doi.org/10.1126/science.1190541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595608				2022-12-24	WOS:000279402700027
J	McPhee, CK; Logan, MA; Freeman, MR; Baehrecke, EH				McPhee, Christina K.; Logan, Mary A.; Freeman, Marc R.; Baehrecke, Eric H.			Activation of autophagy during cell death requires the engulfment receptor Draper	NATURE			English	Article							STARVATION-INDUCED AUTOPHAGY; DROSOPHILA FAT-BODY; GENE-EXPRESSION; GROWTH ARREST; PHAGOCYTOSIS; DEGRADATION; INDUCTION; OOGENESIS; PATHWAY	Autophagy degrades cytoplasmic components that are required for cell survival in response to starvation(1). Autophagy has also been associated with cell death, but it is unclear how this is distinguished from autophagy during cell survival. Drosophila salivary glands undergo programmed cell death that requires autophagy genes(2), and engulfment of salivary gland cells by phagocytes does not appear to occur(3). Here we show that Draper (Drpr), the Drosophila melanogaster orthologue of the Caenorhabditis elegans engulfment receptor CED-1, is required for autophagy during cell death. Null mutations in, and salivary gland-specific knockdown of, drpr inhibit salivary gland degradation. Knockdown of drpr prevents the induction of autophagy in dying salivary glands, and expression of the Atg1 autophagy regulator in drpr mutants suppresses the failure in degradation of salivary glands. Surprisingly, drpr is required in the same dying salivary gland cells in which it regulates autophagy induction, but drpr knockdown does not prevent starvation-induced autophagy in the fat body, which is associated with survival. In addition, components of the conserved engulfment pathway are required for clearance of dying salivary glands. To our knowledge, this is the first example of an engulfment factor that is required for self-clearance of cells. Further, Drpr is the first factor that distinguishes autophagy that is associated with cell death from autophagy associated with cell survival.	[McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [McPhee, Christina K.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Logan, Mary A.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland College Park; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Eric.Baehrecke@umassmed.edu		Kary, Christina/0000-0002-2586-4185; Freeman, Marc/0000-0003-3481-3715	American Cancer Society [PF-07-258-01-CSM]; NIH [NS053538, GM079431]; Merck and Co. Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538, R37NS053538] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and Co. Inc.(Merck & Company); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Bergmann, U. Gaul, H. Kramer, E. Kurant, T. P. Neufeld, T. E. Rusten, H. Stenmark, the Bloomington Stock Center, the VDRC, and the Developmental Studies Hybridoma Bank for flies and antibodies, and R. Simin, T. Fortier and A. Sheehan for technical support. This work was supported by American Cancer Society Postdoctoral Fellowship PF-07-258-01-CSM to MAL, NIH grants NS053538 to M. R. F. and GM079431 to E. H. B., and Merck and Co. Inc. for E. H. B. E. H. B. is a member of the UMass DERC (DK32520).	Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; BRAND AH, 1993, DEVELOPMENT, V118, P401; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mohseni N, 2009, AUTOPHAGY, V5, P329, DOI 10.4161/auto.5.3.7444; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Nezis IP, 2009, AUTOPHAGY, V5, P298, DOI 10.4161/auto.5.3.7454; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; YU L, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09076; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	29	108	109	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1093	U159		10.1038/nature09127	http://dx.doi.org/10.1038/nature09127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577216	Green Accepted, Green Submitted			2022-12-24	WOS:000279056900056
J	Garcia, MS; De la Torre, MA; Morales, G; Pelaez, B; Tolon, MJ; Domingo, S; Candel, FJ; Andrade, R; Arribi, A; Garcia, N; Sagasti, FM; Fereres, J; Picazo, J				Sanchez Garcia, Miguel; Angeles De la Torre, Maria; Morales, Gracia; Pelaez, Beatriz; Jose Tolon, Maria; Domingo, Sara; Javier Candel, Francisco; Andrade, Raquel; Arribi, Ana; Garcia, Nicolas; Martinez Sagasti, Fernando; Fereres, Jose; Picazo, Juan			Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIELD GEL-ELECTROPHORESIS; ENTEROCOCCUS-FAECALIS; RIBOSOMAL-RNA; 1ST REPORT; GENE; EMERGENCE; INFECTION; EPIDERMIDIS; SITUATION; STRAINS	Context Linezolid resistance is extremely uncommon in Staphylococcus aureus. Objective To report an outbreak with linezolid and methicillin-resistant S aureus (LRSA) in an intensive care department and the effective control measures taken. Design, Setting, and Patients Outbreak study of consecutive critically ill patients colonized and/or infected with LRSA at an intensive care department of a 1000-bed tertiary care university teaching hospital in Madrid, Spain. Patients were placed under strict contact isolation. Daily updates of outbreak data and recommendations for the use of linezolid were issued. Extensive environmental sampling and screening of the hands of health care workers were performed. Main Outcome Measures Linezolid use and clinical and epidemiological characteristics and outcomes using minimal inhibitory concentrations, pulsed-field gel electrophoresis, and polymerase chain reaction of LRSA isolates. Results Between April 13 and June 26, 2008, 12 patients with LRSA were identified. In 6 patients, LRSA caused ventilator-associated pneumonia and in 3 patients it caused bacteremia. Isolates were susceptible to trimethoprim-sulfamethoxazole, glycopeptides, tigecycline, and daptomycin. Genotyping identified 1 predominant clone and 3 other types. Cfr-mediated linezolid resistance was demonstrated in all isolates. Potential hospital staff carriers and environmental samples were negative except for one. Six patients died, 5 of them in the intensive care unit, with 1 death attributed to LRSA infection. Linezolid use decreased from 202 defined daily doses in April 2008 to 25 defined daily doses in July 2008. Between July 2008 and April 2010, no new cases have been identified in the weekly surveillance cultures or diagnostic samples. Conclusions The first clinical outbreak, to our knowledge, with LRSA mediated by the cfr gene developed at our center, was associated with nosocomial transmission and extensive usage of linezolid. Reduction of linezolid use and infection-control measures were associated with the termination of the outbreak. JAMA. 2010; 303(22): 2260-2264	[Sanchez Garcia, Miguel; Angeles De la Torre, Maria; Jose Tolon, Maria; Domingo, Sara; Martinez Sagasti, Fernando] Hosp Clin San Carlos, Dept Intens Care, Madrid 28040, Spain; [Morales, Gracia; Javier Candel, Francisco; Arribi, Ana; Picazo, Juan] Hosp Clin San Carlos, Microbiol Serv, Madrid 28040, Spain; [Pelaez, Beatriz; Andrade, Raquel; Garcia, Nicolas; Fereres, Jose] Hosp Clin San Carlos, Prevent Med Serv, Madrid 28040, Spain; Univ Complutense, E-28040 Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid	Garcia, MS (corresponding author), Hosp Clin San Carlos, Dept Intens Care, Madrid 28040, Spain.	msanchezga.hcsc@salud.madrid.org	González, Francisco Javier Candel/Z-5068-2019	González, Francisco Javier Candel/0000-0002-9840-6556; arribi, ana/0000-0003-0716-1897; Martinez-Sagasti, Fernando/0000-0001-8599-1250	Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos	Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos	Dr Morales has a research contract of the Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos.	Álvarez-Lerma F., 2007, Med. Intensiva, V31, P6; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Burleson BS, 2004, PHARMACOTHERAPY, V24, P1225, DOI 10.1592/phco.24.13.1225.38086; CABEZASMARTIN MH, 2006, MED INTENSIVA, V30; *CLIN LAB STAND I, 2008, 17 INF SUPPL DOC; Cuevas O, 2008, ENFERM INFEC MICR CL, V26, P269, DOI 10.1157/13120413; Diekema DJ, 2001, LANCET, V358, P1975, DOI 10.1016/S0140-6736(01)06964-1; Gales AC, 2006, INT J ANTIMICROB AG, V27, P300, DOI 10.1016/j.ijantimicag.2005.11.008; Hentschke M, 2008, INFECTION, V36, P85, DOI 10.1007/s15010-007-7220-7; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; Jones RN, 2009, DIAGN MICR INFEC DIS, V64, P191, DOI 10.1016/j.diagmicrobio.2009.03.001; Jones RN, 2008, DIAGN MICR INFEC DIS, V62, P416, DOI 10.1016/j.diagmicrobio.2008.10.010; Kelly S, 2008, J ANTIMICROB CHEMOTH, V61, P901, DOI 10.1093/jac/dkn043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kola A, 2007, SCAND J INFECT DIS, V39, P463, DOI 10.1080/00365540601071875; Kollef MH, 2004, INTENS CARE MED, V30, P388, DOI 10.1007/s00134-003-2088-1; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; Meka VG, 2004, J INFECT DIS, V190, P311, DOI 10.1086/421471; Meka VG, 2004, J ANTIMICROB CHEMOTH, V54, P818, DOI 10.1093/jac/dkh423; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Miller K, 2008, ANTIMICROB AGENTS CH, V52, P1940, DOI 10.1128/AAC.01302-07; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Paterson DL, 2003, ANN INTERN MED, V139, P863, DOI 10.7326/0003-4819-139-10-200311180-00017; Peeters MJ, 2005, AM J MED SCI, V330, P102, DOI 10.1097/00000441-200508000-00007; Rahim S, 2003, CLIN INFECT DIS, V36, pE146, DOI 10.1086/374929; Roberts SM, 2006, PEDIATR INFECT DIS J, V25, P562, DOI 10.1097/01.inf.0000219401.70804.1a; Ruggero KA, 2003, DIAGN MICR INFEC DIS, V47, P511, DOI 10.1016/S0732-8893(03)00153-6; Scheetz MH, 2008, ANTIMICROB AGENTS CH, V52, P2256, DOI 10.1128/AAC.00070-08; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Trevino M, 2009, EUR J CLIN MICROBIOL, V28, P527, DOI 10.1007/s10096-008-0657-5; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104	38	173	176	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2260	2264		10.1001/jama.2010.757	http://dx.doi.org/10.1001/jama.2010.757			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530779	Bronze			2022-12-24	WOS:000278496800024
J	Pogach, L; Aron, D				Pogach, Leonard; Aron, David			Balancing Hypoglycemia and Glycemic Control A Public Health Approach for Insulin Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE DRUG EVENTS; HEMOGLOBIN A(1C); TYPE-2		[Pogach, Leonard] Dept Vet Affairs New Jersey Healthcare Syst, Res Serv 15, E Orange, NJ 07018 USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Aron, David] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Cleveland, OH USA; [Aron, David] Case Western Reserve Univ, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Pogach, L (corresponding author), Dept Vet Affairs New Jersey Healthcare Syst, Res Serv 15, 385 Tremont Ave, E Orange, NJ 07018 USA.	leonard.pogach@va.gov						Aron D, 2009, JAMA-J AM MED ASSOC, V301, P210, DOI 10.1001/jama.2008.930; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Holmes EW, 2008, AM J CLIN PATHOL, V129, P540, DOI 10.1309/U3GPPTCBP1VLL8AW; Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; *NGSP, 2009 NGSP CLIN ADV C; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012	10	27	27	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2076	2077		10.1001/jama.2010.655	http://dx.doi.org/10.1001/jama.2010.655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501929				2022-12-24	WOS:000278018200033
J	Jaffer, AK; Campo, RE; Gaski, G; Reyes, M; Gebhard, R; Ginzburg, E; Kolber, MA; Macdonald, J; Falcone, S; Green, BA; Barreras-Pagan, L; O'Neill, WW				Jaffer, Amir K.; Campo, Rafael E.; Gaski, Greg; Reyes, Mario; Gebhard, Ralf; Ginzburg, Enrique; Kolber, Michael A.; Macdonald, John; Falcone, Steven; Green, Barth A.; Barreras-Pagan, Lazara; O'Neill, William W.			An Academic Center's Delivery of Care After the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Article								The Miller School of Medicine of the University of Miami and Project Medishare, an affiliated not-for-profit organization, provided a large-scale relief effort in Haiti after the earthquake of 12 January 2010. Their experience demonstrates that academic medical centers in proximity to natural disasters can help deliver effective medical care through a coordinated process involving mobilization of their own resources, establishment of focused management teams at home and on the ground with formal organizational oversight, and partnership with governmental and nongovernmental relief agencies. Proximity to the disaster area allows for prompt arrival of medical personnel and equipment. The recruitment and organized deployment of large numbers of local and national volunteers are indispensable parts of this effort. Multidisciplinary teams on short rotations can form the core of the medical response.	[O'Neill, William W.] Univ Miami Hlth Syst, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Miami Childrens Hosp, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami	O'Neill, WW (corresponding author), Univ Miami Hlth Syst, 1600 NW 10th Ave,RMSB 1122A, Miami, FL 33136 USA.	WONeill@med.miami.edu						Ginzburg E, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1002026; Mulvey JM, 2008, INJURY, V39, P554, DOI 10.1016/j.injury.2007.07.025; Yang C, 2009, INJURY, V40, P488, DOI 10.1016/j.injury.2009.01.102	3	16	16	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2010	153	4					262	265		10.7326/0003-4819-153-4-201008170-00266	http://dx.doi.org/10.7326/0003-4819-153-4-201008170-00266			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639KF	20643974				2022-12-24	WOS:000280973000007
J	Cai, WJ; Chen, LQ; Chen, BS; Gao, ZY; Lee, SH; Chen, JF; Pierrot, D; Sullivan, K; Wang, YC; Hu, XP; Huang, WJ; Zhang, YH; Xu, SQ; Murata, A; Grebmeier, JM; Jones, EP; Zhang, HS				Cai, Wei-Jun; Chen, Liqi; Chen, Baoshan; Gao, Zhongyong; Lee, Sang H.; Chen, Jianfang; Pierrot, Denis; Sullivan, Kevin; Wang, Yongchen; Hu, Xinping; Huang, Wei-Jen; Zhang, Yuanhui; Xu, Suqing; Murata, Akihiko; Grebmeier, Jacqueline M.; Jones, E. Peter; Zhang, Haisheng			Decrease in the CO2 Uptake Capacity in an Ice-Free Arctic Ocean Basin	SCIENCE			English	Article							SPATIAL VARIABILITY; CARBON-DIOXIDE; ACIDIFICATION; SHELF; PHYTOPLANKTON	It has been predicted that the Arctic Ocean will sequester much greater amounts of carbon dioxide (CO2) from the atmosphere as a result of sea ice melt and increasing primary productivity. However, this prediction was made on the basis of observations from either highly productive ocean margins or ice-covered basins before the recent major ice retreat. We report here a high-resolution survey of sea-surface CO2 concentration across the Canada Basin, showing a great increase relative to earlier observations. Rapid CO2 invasion from the atmosphere and low biological CO2 drawdown are the main causes for the higher CO2, which also acts as a barrier to further CO2 invasion. Contrary to the current view, we predict that the Arctic Ocean basin will not become a large atmospheric CO2 sink under ice-free conditions.	[Cai, Wei-Jun; Chen, Baoshan; Wang, Yongchen; Hu, Xinping; Huang, Wei-Jen] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Chen, Liqi; Gao, Zhongyong; Zhang, Yuanhui; Xu, Suqing] SOA, Inst Oceanog 3, Key Lab Global Change & Marine Atmospher Chem, Xiamen 361005, Peoples R China; [Lee, Sang H.] Korea Polar Res Inst, Inchon 406840, South Korea; [Chen, Jianfang; Zhang, Haisheng] SOA, Inst Oceanog 2, Lab Marine Ecosyst & Biogeochem, Hangzhou 310012, Zhejiang, Peoples R China; [Pierrot, Denis; Sullivan, Kevin] NOAA, Atlantic Oceanog & Meteorol Lab, Ocean Chem Div, Miami, FL 33149 USA; [Pierrot, Denis; Sullivan, Kevin] Univ Miami, Cooperat Inst Marine & Atmospher Sci, Miami, FL 33149 USA; [Murata, Akihiko] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Grebmeier, Jacqueline M.] Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Jones, E. Peter] Bedford Inst Oceanog, Ocean Sci Div, Dept Fisheries & Oceans, Dartmouth, NS B2Y 4A2, Canada	University System of Georgia; University of Georgia; State Oceanic Administration; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); State Oceanic Administration; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University System of Maryland; University of Maryland Center for Environmental Science; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Cai, WJ (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	wcai@uga.edu	Cai, Wei-Jun/C-1361-2013; Hu, Xinping/F-6282-2011; Pierrot, Denis/A-7459-2014; Grebmeier, Jacqueline/L-9805-2013; Pierrot, Denis/AAH-7687-2020	Cai, Wei-Jun/0000-0003-3606-8325; Hu, Xinping/0000-0002-0613-6545; Pierrot, Denis/0000-0002-0374-3825; Grebmeier, Jacqueline/0000-0001-7624-3568; Huang, Wei-Jen/0000-0002-1713-2515	Ministry of Science and Technology of China [2009DFA22920]; Natural Science Foundation of China [40531007]; U.S. National Oceanic and Atmospheric Administration [NA05OAR4311161, NA09OAR4310078]; NSF [ARC-0909330]; Korean Arctic Research project [PM09020]; Chinese Arctic and Antarctic Administration; Polar Research Institute of China; Division Of Polar Programs [0909330] Funding Source: National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Korean Arctic Research project; Chinese Arctic and Antarctic Administration; Polar Research Institute of China; Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank R. Wanninkhof, P. Yager, and N. Bates for discussions; J. Zhao for the salinity and temperature data; and H. Li and S. Gao for sample collection. Funding for the CHINARE CO<INF>2</INF> survey and subsequent synthesis was provided by the Ministry of Science and Technology of China (2009DFA22920), the Natural Science Foundation of China (40531007), and the U.S. National Oceanic and Atmospheric Administration (NA05OAR4311161 and NA09OAR4310078) and NSF (ARC-0909330). The measurements for primary production of phytoplankton were funded by a Korean Arctic Research project (PM09020). We also thank the Chinese Arctic and Antarctic Administration and the Polar Research Institute of China for their support. We are grateful to the captain and crew of icebreaker Xuelong.	Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003083; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Codispoti LA, 2009, DEEP-SEA RES PT II, V56, P1144, DOI 10.1016/j.dsr2.2008.10.013; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Fransson A, 2009, CONT SHELF RES, V29, P1317, DOI 10.1016/j.csr.2009.03.008; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Guo LD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002593; Hansell DA, 2004, SCIENCE, V304, P858, DOI 10.1126/science.1096175; Kaltin S, 2005, MAR CHEM, V94, P67, DOI 10.1016/j.marchem.2004.07.010; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Chen LQ, 2007, DEEP-SEA RES PT II, V54, P2619, DOI 10.1016/j.dsr2.2007.08.010; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murata A, 2003, CONT SHELF RES, V23, P753, DOI 10.1016/S0278-4343(03)00046-3; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Rysgaard S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003572; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Yager PL, 1999, LIMNOL OCEANOGR, V44, P1882, DOI 10.4319/lo.1999.44.8.1882; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190	25	169	200	6	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					556	559		10.1126/science.1189338	http://dx.doi.org/10.1126/science.1189338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20651119				2022-12-24	WOS:000280483500034
J	Scurlock, D				Scurlock, Donna			Vaccine, Please	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dscurlockmd@comcast.net						*KEN MOD HIV TRANS, 2009, KEN HIV PREV RESP MO; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					250	251		10.1001/jama.2010.751	http://dx.doi.org/10.1001/jama.2010.751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639552				2022-12-24	WOS:000280107500001
J	Pallares-Sanmartin, A; Leiro-Fernandez, V; Cebreiro, TL; Botana-Rial, M; Fernandez-Villar, A				Pallares-Sanmartin, Abel; Leiro-Fernandez, Virginia; Lourido Cebreiro, Tamara; Botana-Rial, Maribel; Fernandez-Villar, Alberto			Validity and Reliability of the Schamroth Sign for the Diagnosis of Clubbing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Pallares-Sanmartin, Abel; Leiro-Fernandez, Virginia; Lourido Cebreiro, Tamara; Botana-Rial, Maribel; Fernandez-Villar, Alberto] Complexo Hosp Univ Vigo, Pulmonol Serv, Vigo, Spain	Complexo Hospitalario Universitario de Vigo	Pallares-Sanmartin, A (corresponding author), Complexo Hosp Univ Vigo, Pulmonol Serv, Vigo, Spain.	alberto.fernandez.villar@sergas.es	Fernandez, Virginia Leiro/B-9679-2018	Fernandez, Virginia Leiro/0000-0001-9613-430X; Lourido Cebreiro, Tamara/0000-0002-0391-898X; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249				[Anonymous], 2007, EVIDENCE BASED PHYS; LAMPE RM, 1983, CLIN PEDIATR, V22, P125, DOI 10.1177/000992288302200207; Martinez-Lavin M, 2007, SEMIN ARTHRITIS RHEU, V36, P380, DOI 10.1016/j.semarthrit.2006.11.004; Maslovsky I, 2005, AM J MED, V118, P1350, DOI 10.1016/j.amjmed.2005.09.036; Myers KA, 2001, JAMA-J AM MED ASSOC, V286, P341, DOI 10.1001/jama.286.3.341; SCHAMROTH L, 1976, S AFR MED J, V50, P297	6	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					159	161		10.1001/jama.2010.935	http://dx.doi.org/10.1001/jama.2010.935			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628128				2022-12-24	WOS:000279811000020
J	Boiko, AD; Razorenova, OV; van de Rijn, M; Swetter, SM; Johnson, DL; Ly, DP; Butler, PD; Yang, GP; Joshua, B; Kaplan, MJ; Longaker, MT; Weissman, IL				Boiko, Alexander D.; Razorenova, Olga V.; van de Rijn, Matt; Swetter, Susan M.; Johnson, Denise L.; Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Joshua, Benzion; Kaplan, Michael J.; Longaker, Michael T.; Weissman, Irving L.			Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271	NATURE			English	Article							CANCER STEM-CELLS; PROSPECTIVE IDENTIFICATION; PROGENITORS	The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the last few years(1). Here we show that in melanomas, tumour stem cells (MTSCs, for melanoma tumour stem cells) can be isolated prospectively as a highly enriched CD271(+) MTSC population using a process that maximizes viable cell transplantation(1,2). The tumours sampled in this study were taken from a broad spectrum of sites and stages. High-viability cells isolated by fluorescence-activated cell sorting and re-suspended in a matrigel vehicle were implanted into T-, B- and natural-killer-deficient Rag2(-/-) gamma c(-/-) mice. The CD271(+) subset of cells was the tumour-initiating population in 90% (nine out of ten) of melanomas tested. Transplantation of isolated CD271(+) melanoma cells into engrafted human skin or bone in Rag2(-/-) gamma c(-/-) mice resulted in melanoma; however, melanoma did not develop after transplantation of isolated CD271(-) cells. We also show that in mice, tumours derived from transplanted human CD271(-) melanoma cells were capable of metastatsis in vivo. CD271(+) melanoma cells lacked expression of TYR, MART1 and MAGE in 86%, 69% and 68% of melanoma patients, respectively, which helps to explain why T-cell therapies directed at these antigens usually result in only temporary tumour shrinkage.	[Boiko, Alexander D.; Longaker, Michael T.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94304 USA; [Razorenova, Olga V.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA; [van de Rijn, Matt; Weissman, Irving L.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Pathol, Stanford, CA 94305 USA; [Swetter, Susan M.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Dermatol,Pigmented Les & Melanoma Program, Stanford, CA 94305 USA; [Swetter, Susan M.; Yang, George P.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Johnson, Denise L.; Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Longaker, Michael T.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Surg, Stanford, CA 94305 USA; [Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Pediat Regenerat Med,Div Plast & Recons, Stanford, CA 94305 USA; [Joshua, Benzion; Kaplan, Michael J.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford Cancer Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Boiko, AD (corresponding author), Stanford Univ, Sch Med, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94304 USA.	aboiko@stanford.edu; irv@stanford.edu	Ferris, Laura/I-7689-2012; Razorenova, Olga V/A-6400-2014	Joshua, Ben-Zion/0000-0002-2010-892X; Rinner, Beate/0000-0002-6340-4905; van de Rijn, Matt/0000-0002-1909-9739	American Cancer Society; NIH [F32 CA126252, 1RC2 DE02077-01]; Virginia & D.K. Ludwig Fund for Cancer Research; NIH/NCRR [UL1 RR025744]; Oak Foundation; Ellenburg Faculty Scholar Endowment; NATIONAL CANCER INSTITUTE [F32CA126252] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia & D.K. Ludwig Fund for Cancer Research; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oak Foundation; Ellenburg Faculty Scholar Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Bueno and S. Hicks for obtaining patient consent and specimens; K. Montgomery for immunohistochemistry analyses; D. Kim for NSG bone-grafted mice; K. Chan, L. Ailles and C. Park for advice and help in FACS and tumour transplantation assays; L. Cohen for MAGE antibodies; L. Jerabek, T. Storm and A. Mosley for laboratory and mouse management; P. Lovelace for FACS management; A. Olson for help with microscopy; all members of the Weissman Laboratory for experimental suggestions; and M. Clarke and members of his laboratory for critical discussions and reading. This research was initially supported in part by the American Cancer Society fellowship and in part by NIH F32 CA126252 NRSA fellowship to A. D. B.; the Virginia & D.K. Ludwig Fund for Cancer Research to I. L. W.; NIH/NCRR CTSA grant UL1 RR025744 to Stanford Spectrum M.v.d.R.; The Oak Foundation and NIH 1RC2 DE02077-01 to M. T. L.; the Oak Foundation and Ellenburg Faculty Scholar Endowment to G.P.Y.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Cormier JN, 1997, CANCER J, V3, P37; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; Iwamoto S, 1996, J AM ACAD DERMATOL, V35, P725, DOI 10.1016/S0190-9622(96)90728-8; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; La Porta C, 2009, STEM CELL REV REP, V5, P61, DOI 10.1007/s12015-008-9048-7; MARCHETTI D, 1993, INT J CANCER, V55, P692, DOI 10.1002/ijc.2910550430; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Passegue E, 2009, NAT MED, V15, P612, DOI [10.1038/nm0109-23, 10.1038/nm0609-612]; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosenberg SA, 1996, J NATL CANCER I, V88, P1635, DOI 10.1093/jnci/88.22.1635; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scheibenbogen C, 2000, J IMMUNOTHER, V23, P275, DOI 10.1097/00002371-200003000-00012; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2003, CANCER RES, V63, P5821; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359	30	537	556	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					133	U155		10.1038/nature09161	http://dx.doi.org/10.1038/nature09161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596026	Green Accepted, Green Submitted			2022-12-24	WOS:000279343800049
J	Llopis, PM; Jackson, AF; Sliusarenko, O; Surovtsev, I; Heinritz, J; Emonet, T; Jacobs-Wagner, C				Llopis, Paula Montero; Jackson, Audrey F.; Sliusarenko, Oleksii; Surovtsev, Ivan; Heinritz, Jennifer; Emonet, Thierry; Jacobs-Wagner, Christine			Spatial organization of the flow of genetic information in bacteria	NATURE			English	Article							CELL-CYCLE PROGRESSION; MESSENGER-RNA DECAY; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; TRANSCRIPTION; TRANSLATION; EXPRESSION; DNA; VISUALIZATION; LOCALIZATION	Eukaryotic cells spatially organize mRNA processes such as translation and mRNA decay. Much less is clear in bacterial cells where the spatial distribution of mature mRNA remains ambiguous. Using a sensitive method based on quantitative fluorescence in situ hybridization, we show here that in Caulobacter crescentus and Escherichia coli, chromosomally expressed mRNAs largely display limited dispersion from their site of transcription during their lifetime. We estimate apparent diffusion coefficients at least two orders of magnitude lower than expected for freely diffusing mRNA, and provide evidence in C. crescentus that this mRNA localization restricts ribosomal mobility. Furthermore, C. crescentus RNase E appears associated with the DNA independently of its mRNA substrates. Collectively, our findings show that bacteria can spatially organize translation and, potentially, mRNA decay by using the chromosome layout as a template. This chromosome-centric organization has important implications for cellular physiology and for our understanding of gene expression in bacteria.	[Llopis, Paula Montero; Jackson, Audrey F.; Sliusarenko, Oleksii; Emonet, Thierry; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Sliusarenko, Oleksii; Surovtsev, Ivan; Heinritz, Jennifer; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Emonet, Thierry] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	Emonet, Thierry/AAI-3740-2020; Llopis, Paula Montero/AAG-2853-2019	Jacobs-Wagner, Christine/0000-0003-0980-5334	Howard Hughes Medical Institute; National Institutes of Health [GM065835]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Angelastro, N. Ausmees, T. Cox, I. Golding, H. Lam, D. S. Peabody, D Leach, D. J. Sherratt and P. Viollier for strains and constructs, M. Cabeen for editorial help, and S. R. Kushner, J. Belasco, K. C. Huang, the Lambda lunch group at NIH, and the Jacobs-Wagner laboratory for valuable discussions. This work was funded in part by a Howard Hughes Medical Institute Predoctoral Fellowship (to A. F. J.), the National Institutes of Health (GM065835 to C.J.-W.) and the Howard Hughes Medical Institute.	Avedissian M, 1996, MOL MICROBIOL, V19, P79, DOI 10.1046/j.1365-2958.1996.347879.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Derman AI, 2008, MOL MICROBIOL, V67, P935, DOI 10.1111/j.1365-2958.2007.06066.x; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ELY B, 1991, METHOD ENZYMOL, V204, P372; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Fang G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-4; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Guet CC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn329; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mangan EK, 1999, J BACTERIOL, V181, P6160, DOI 10.1128/JB.181.19.6160-6170.1999; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pilhofer M, 2009, SYST APPL MICROBIOL, V32, P186, DOI 10.1016/j.syapm.2008.12.007; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Tamames J, 2001, GENOME BIOL, V2; Valencia-Burton M, 2007, NAT METHODS, V4, P421, DOI 10.1038/NMETH1023; Valencia-Burton M, 2009, P NATL ACAD SCI USA, V106, P16399, DOI 10.1073/pnas.0907495106; Viollier PH, 2004, CURR OPIN MICROBIOL, V7, P572, DOI 10.1016/j.mib.2004.10.005; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	38	275	279	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					77	U90		10.1038/nature09152	http://dx.doi.org/10.1038/nature09152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20562858	Green Accepted			2022-12-24	WOS:000279343800037
J	Hanotte, O; Dessie, T; Kemp, S				Hanotte, Olivier; Dessie, Tadelle; Kemp, Steve			Time to Tap Africa's Livestock Genomes	SCIENCE			English	Editorial Material							LANDSCAPE GENOMICS; SELECTION		[Hanotte, Olivier] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Dessie, Tadelle] ILRI, Addis Ababa, Ethiopia; [Kemp, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Kemp, Steve] ILRI, Nairobi, Kenya	University of Nottingham; CGIAR; International Livestock Research Institute (ILRI); University of Liverpool; CGIAR; International Livestock Research Institute (ILRI)	Hanotte, O (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	olivier.hanotte@nottingham.ac.uk	Hanotte, Olivier/B-4669-2013	Hanotte, Olivier/0000-0002-2877-4767				Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KEMP S, DAGRIS 2007 DOMESTIC; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7	7	36	38	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1640	1641		10.1126/science.1186254	http://dx.doi.org/10.1126/science.1186254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576875				2022-12-24	WOS:000279107400025
J	Eaves, CJ; Humphries, RK				Eaves, Connie J.; Humphries, R. Keith			Acute Myeloid Leukemia and the Wnt Pathway	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; LEUKEMOGENESIS; HEMATOPOIESIS; CATENIN		[Eaves, Connie J.; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.			Eaves, Connie/0000-0002-3452-1926; Humphries, Richard/0000-0003-0540-7005				Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	5	41	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2326	2327		10.1056/NEJMcibr1003522	http://dx.doi.org/10.1056/NEJMcibr1003522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554989				2022-12-24	WOS:000278816300015
J	Papai, G; Tripathi, MK; Ruhlmann, C; Layer, JH; Weil, PA; Schultz, P				Papai, Gabor; Tripathi, Manish K.; Ruhlmann, Christine; Layer, Justin H.; Weil, P. Anthony; Schultz, Patrick			TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation	NATURE			English	Article							YEAST TFIIA/TBP/DNA COMPLEX; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PROMOTER; ACTIVATION; PROTEIN; TAFS; DISTINCT	Transcription of eukaryotic messenger RNA (mRNA) encoding genes by RNA polymerase II (Pol II) is triggered by the binding of transactivating proteins to enhancer DNA, which stimulates the recruitment of general transcription factors (TFIIA, B, D, E, F, H) and Pol II on the cis-linked promoter, leading to pre-initiation complex formation and transcription(1). In TFIID-dependent activation pathways, this general transcription factor containing TATA-box-binding protein is first recruited on the promoter through interaction with activators(1-3) and cooperates with TFIIA to form a committed pre-initiation complex(4). However, neither the mechanisms by which activation signals are communicated between these factors nor the structural organization of the activated pre-initiation complex are known. Here we used cryo-electron microscopy to determine the architecture of nucleoprotein complexes composed of TFIID, TFIIA, the transcriptional activator Rap1 and yeast enhancer-promoter DNA. These structures revealed the mode of binding of Rap1 and TFIIA to TFIID, as well as a reorganization of TFIIA induced by its interaction with Rap1. We propose that this change in position increases the exposure of TATA-box-binding protein within TFIID, consequently enhancing its ability to interact with the promoter. A large Rap1-dependent DNA loop forms between the activator-binding site and the proximal promoter region. This loop is topologically locked by a TFIIA-Rap1 protein bridge that folds over the DNA. These results highlight the role of TFIIA in transcriptional activation, define a molecular mechanism for enhancer-promoter communication and provide structural insights into the pathways of intramolecular communication that convey transcription activation signals through the TFIID complex.	[Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] IGBMC, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] INSERM, U964, F-67400 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] Univ Strasbourg, F-67000 Strasbourg, France; [Tripathi, Manish K.; Layer, Justin H.; Weil, P. Anthony] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Vanderbilt University	Schultz, P (corresponding author), IGBMC, Dept Struct Biol & Genom, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	tony.weil@vanderbilt.edu; patrick.schultz@igbmc.fr		schultz, patrick/0000-0002-7310-6186; Papai, Gabor/0000-0002-2779-8679	Institut National de la Sante et de la Recherche Medicale; Centre National pour la Recherche Scientifique; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Agence Nationale pour le Recherche; EU [QLG2-CT-00988]; National Institutes of Health [GM52461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052461, R56GM052461] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour le Recherche(French National Research Agency (ANR)); EU(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Centre National pour la Recherche Scientifique, the Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Medicale, the Agence Nationale pour le Recherche and the European SPINE program (G. P., C. R. and P. S., EU contract number QLG2-CT-00988), and the National Institutes of Health (M. K. T., J.H.L. and P. A. W., National Institutes of Health grant number GM52461).	Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RATHJEN J, 1990, NUCLEIC ACIDS RES, V18, P3219, DOI 10.1093/nar/18.11.3219; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716	38	49	49	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					956	U14		10.1038/nature09080	http://dx.doi.org/10.1038/nature09080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559389	Green Accepted			2022-12-24	WOS:000278804500044
J	Bonneux, L; Van Damme, W				Bonneux, Luc; Van Damme, Wim			Personal View Preventing iatrogenic pandemics of panic. Do it in a NICE way	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA; EPIDEMICS; VIRUS		[Bonneux, Luc] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); Institute of Tropical Medicine (ITM)	Bonneux, L (corresponding author), Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands.	bonneux@nidi.nl	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Bonneux L, 2006, BMJ-BRIT MED J, V332, P786, DOI 10.1136/bmj.332.7544.786; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Institute of Medicine, 2009, CONFL INT MED RES ED; Kickbusch I, 2008, HEALTH PROMOT INT, V23, P1, DOI 10.1093/heapro/dan006; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Van Damme W, 2000, TROP MED INT HEALTH, V5, P511; Watson R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c641	10	6	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2010	340								c3065	10.1136/bmj.c3065	http://dx.doi.org/10.1136/bmj.c3065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534667				2022-12-24	WOS:000278818500019
J	Bohlen, CJ; Priel, A; Zhou, S; King, D; Siemens, J; Julius, D				Bohlen, Christopher J.; Priel, Avi; Zhou, Sharleen; King, David; Siemens, Jan; Julius, David			A Bivalent Tarantula Toxin Activates the Capsaicin Receptor, TRPV1, by Targeting the Outer Pore Domain	CELL			English	Article							GATING MODIFIER TOXINS; SPIDER SELENOCOSMIA-HUWENA; DEPENDENT K+ CHANNELS; VOLTAGE-SENSOR; POTASSIUM CHANNEL; ION-CHANNEL; MOLECULAR DETERMINANTS; SODIUM-CHANNELS; PEPTIDE TOXINS; SENSITIVITY	Toxins have evolved to target regions of membrane ion channels that underlie ligand binding, gating, or ion permeation, and have thus served as invaluable tools for probing channel structure and function. Here, we describe a peptide toxin from the Earth Tiger tarantula that selectively and irreversibly activates the capsaicin- and heat-sensitive channel, TRPV1. This high-avidity interaction derives from a unique tandem repeat structure of the toxin that endows it with an antibody-like bivalency. The "double-knot" toxin traps TRPV1 in the open state by interacting with residues in the presumptive pore-forming region of the channel, highlighting the importance of conformational changes in the outer pore region of TRP channels during activation.	[Bohlen, Christopher J.; Priel, Avi; Siemens, Jan; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Zhou, Sharleen; King, David] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Siemens, J (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	jan.siemens@mdc-berlin.de; julius@cmp.ucsf.edu	Priel, Avi/ABB-1721-2020	Priel, Avi/0000-0002-6105-5035; Siemens, Jan/0000-0001-9051-9217	National Institutes of Health (NIH) National Center for Research Resources; NIH/National Institute of Neurological Disorders and Stroke (NINDS); Damon Runyon Cancer Research Foundation; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047723, R01NS065071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Damon Runyon Cancer Research Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ben Myers for cloning the frog TRPV1 cDNA and making it available for this study, and Roger Nicoll, Alex Chesler, Julio Cordero, Erhu Cao, and other members of our lab for helpful criticism and reading of the manuscript. We also thank the University of California, San Francisco, Mass Spectrometry Resource for instrumentation and technical assistance, supported by the National Institutes of Health (NIH) National Center for Research Resources. This work was supported by a NIH/National Institute of Neurological Disorders and Stroke (NINDS) Ruth Kirschstein predoctoral fellowship (C.B.), postdoctoral fellowships from the Damon Runyon Cancer Research Foundation (A.P.) and the International Human Frontier Science Program Organization (J.S.), and grants from the NIH/NINDS (D.J.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Roy A, 2010, J BIOL CHEM, V285, P8302, DOI 10.1074/jbc.M109.074161; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	49	228	245	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					834	845		10.1016/j.cell.2010.03.052	http://dx.doi.org/10.1016/j.cell.2010.03.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510930	Green Accepted, Bronze			2022-12-24	WOS:000278132900018
J	Fulzele, K; Riddle, RC; DiGirolamo, DJ; Cao, XM; Wan, C; Chen, DQ; Faugere, MC; Aja, S; Hussain, MA; Bruning, JC; Clemens, TL				Fulzele, Keertik; Riddle, Ryan C.; DiGirolamo, Douglas J.; Cao, Xuemei; Wan, Chao; Chen, Dongquan; Faugere, Marie-Claude; Aja, Susan; Hussain, Mehboob A.; Bruening, Jens C.; Clemens, Thomas L.			Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition	CELL			English	Article							TRANSCRIPTION FACTOR FOXO1; BETA-CELL FUNCTION; DIABETES-MELLITUS; COLLAGEN-SYNTHESIS; GLUCOSE-TOLERANCE; ENERGY-METABOLISM; RAT BONE; BB RATS; OSTEOCALCIN; GROWTH	Global energy balance in mammals is controlled by the actions of circulating hormones that coordinate fuel production and utilization in metabolically active tissues. Bone-derived osteocalcin, in its undercarboxylated, hormonal form, regulates fat deposition and is a potent insulin secretagogue. Here, we show that insulin receptor (IR) signaling in osteoblasts controls osteoblast development and osteocalcin expression by suppressing the Runx2 inhibitor Twist2. Mice lacking IR in osteoblasts have low circulating undercarboxylated osteocalcin and reduced bone acquisition due to decreased bone formation and deficient numbers of osteoblasts. With age, these mice develop marked peripheral adiposity and hyperglycemia accompanied by severe glucose intolerance and insulin resistance. The metabolic abnormalities in these mice are improved by infusion of undercarboxylated osteocalcin. These results indicate the existence of a bone-pancreas endocrine loop through which insulin signaling in the osteoblast ensures osteoblast differentiation and stimulates osteocalcin production, which in turn regulates insulin sensitivity and pancreatic insulin secretion.	[Fulzele, Keertik; Riddle, Ryan C.; DiGirolamo, Douglas J.; Wan, Chao; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Faugere, Marie-Claude] Univ Kentucky, Dept Med, Lexington, KY 40536 USA; [Cao, Xuemei] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Dongquan] W Virginia Univ, Sch Med, Dept Med, Clin Translat Sci Inst, Morgantown, WV 26506 USA; [Bruening, Jens C.] Univ Cologne, Cologne Excellence Ctr Cellular Stress Responses, Ctr Mol Med, Inst Genet,Dept Mouse Genet & Metab, D-50937 Cologne, Germany; [Bruening, Jens C.] Univ Hosp Cologne, Dept Internal Med, D-50937 Cologne, Germany; [Bruening, Jens C.] Max Planck Inst Biol Aging, D-50937 Cologne, Germany; [Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Kentucky; University of Alabama System; University of Alabama Birmingham; West Virginia University; University of Cologne; University of Cologne; Max Planck Society; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Clemens, TL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA.	tclemen5@jhmi.edu	Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006	Veterans Administration; NIH [DK081472]; Baltimore Diabetes Research and Training Center [DK079637]; DFG [Br1492/7-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081472, P60DK079637, P30DK079637] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Diabetes Research and Training Center; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the assistance of the Small Animal Phenotyping Core and Metabolism Core Laboratory at the University of Alabama at Birmingham. We thank Dr. D. Accili for providing the tTR-IRKO mice and Dr. M. Bouxsein for assistance in analyzing the skeletal phenotype by micro-CT. We also thank Drs. T. Nagy and T. Garvey for helpful suggestions during the completion of this work. Support was provided by a Merit Review Grant from the Veterans Administration (T. L. C.) and grants from the NIH (M. H., DK081472), the Baltimore Diabetes Research and Training Center (M. H., DK079637), and DFG (J.C.B., Br1492/7-1). T. L. C. is also the recipient of a Research Career Scientist Award from the Veterans Administration.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; DELMAS PD, 1983, J CLIN ENDOCR METAB, V57, P1028, DOI 10.1210/jcem-57-5-1028; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; Herrero S, 1998, CALCIFIED TISSUE INT, V62, P260, DOI 10.1007/s002239900427; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hussain MA, 2006, MOL CELL BIOL, V26, P7747, DOI 10.1128/MCB.02353-05; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Irwin R, 2006, ENDOCRINOLOGY, V147, P5760, DOI 10.1210/en.2006-0700; ITUARTE EA, 1989, CALCIFIED TISSUE INT, V45, P27, DOI 10.1007/BF02556657; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Lusk G, 1928, ELEMENTS SCI NUTR; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; PUN KK, 1989, J BONE MINER RES, V4, P853; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; ROSEN DM, 1983, ENDOCRINOLOGY, V112, P992, DOI 10.1210/endo-112-3-992; SHIRES R, 1981, J LAB CLIN MED, V97, P231; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thrailkill K M, 2000, Diabetes Technol Ther, V2, P69, DOI 10.1089/152091599316775; VERHAEGHE J, 1992, J ENDOCRINOL, V134, P485, DOI 10.1677/joe.0.1340485; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	43	529	563	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					309	319		10.1016/j.cell.2010.06.002	http://dx.doi.org/10.1016/j.cell.2010.06.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655471	Green Accepted, Bronze			2022-12-24	WOS:000280204300021
J	Minamishima, YA; Kaelin, WG				Minamishima, Yoji Andrew; Kaelin, William G., Jr.			Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss	SCIENCE			English	Article							INACTIVATION; ERYTHROPOIESIS; FAILURE		[Kaelin, William G., Jr.] Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Minamishima, Yoji Andrew/E-5380-2010	Minamishima, Yoji Andrew/0000-0001-7995-9318	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA068490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068490] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561	8	131	137	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					407	407		10.1126/science.1192811	http://dx.doi.org/10.1126/science.1192811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651146	Green Accepted			2022-12-24	WOS:000280196500028
J	Jaenike, J; Unckless, R; Cockburn, SN; Boelio, LM; Perlman, SJ				Jaenike, John; Unckless, Robert; Cockburn, Sarah N.; Boelio, Lisa M.; Perlman, Steve J.			Adaptation via Symbiosis: Recent Spread of a Drosophila Defensive Symbiont	SCIENCE			English	Article							MYCOPHAGOUS DROSOPHILA; IMMUNE-SYSTEM; EVOLUTION; WOLBACHIA; NEMATODE; HOST; ASSOCIATIONS; ENDOSYMBIONT; SPIROPLASMA; PROTECTION	Recent studies have shown that some plants and animals harbor microbial symbionts that protect them against natural enemies. Here we demonstrate that a maternally transmitted bacterium, Spiroplasma, protects Drosophila neotestacea against the sterilizing effects of a parasitic nematode, both in the laboratory and the field. This nematode parasitizes D. neotestacea at high frequencies in natural populations, and, until recently, almost all infections resulted in complete sterility. Several lines of evidence suggest that Spiroplasma is spreading in North American populations of D. neotestacea and that a major adaptive change to a symbiont-based mode of defense is under way. These findings demonstrate the profound and potentially rapid effects of defensive symbionts, which are increasingly recognized as major players in the ecology of species interactions.	[Jaenike, John; Unckless, Robert; Boelio, Lisa M.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Cockburn, Sarah N.; Perlman, Steve J.] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	University of Rochester; University of Victoria	Jaenike, J (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	john.jaenike@rochester.edu			NSF [DEB-0542094, DEB-0918872]; Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [0918872] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grants DEB-0542094 and DEB-0918872 to J.J. and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to S.J.P. S.J.P. is a Scholar in the Canadian Institute for Advanced Research. We thank C. Cornish, P. Gibas, and K. Dyer for collecting some of the North American D. neotestacea used in this study; A. Marshall and L. Harris for technical assistance; N. Polet for the cloning work; D. Grimaldi for providing museum specimens of D. neotestacea; and J. Coyne, R. Minckley, K. Oliver, and D. Presgraves for comments on the manuscript. Sequences have been deposited in GenBank under accession numbers GU552299 to GU552304, HM126644 to HM126667, and HM133591 to HM133593.	Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dyer KA, 2005, EVOLUTION, V59, P1518; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hughes AL, 1997, MOL BIOL EVOL, V14, P1, DOI 10.1093/oxfordjournals.molbev.a025694; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jaenike J, 2002, ECOLOGY, V83, P917, DOI 10.2307/3071901; Jaenike J, 2002, AM NAT, V160, pS23, DOI 10.1086/342137; Jaenike J, 2010, MOL ECOL, V19, P414, DOI 10.1111/j.1365-294X.2009.04448.x; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; MONTAGUE JR, 1985, ECOLOGY, V66, P624, DOI 10.2307/1940412; NICKLE W.R., 1974, INSECT DISEASES, VII, P327; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Perlman SJ, 2003, EVOLUTION, V57, P1543, DOI 10.1111/j.0014-3820.2003.tb00362.x; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Poinar GO., 1983, NATURAL HIST NEMATOD; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; Rosenstiel P, 2009, J INNATE IMMUN, V1, P291, DOI 10.1159/000211193; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; WILLIAMSON DL, 1965, J INVERTEBR PATHOL, V7, P493, DOI 10.1016/0022-2011(65)90126-6	36	358	370	1	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					212	215		10.1126/science.1188235	http://dx.doi.org/10.1126/science.1188235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616278				2022-12-24	WOS:000279635200048
J	Haga, S; Hattori, T; Sato, T; Sato, K; Matsuda, S; Kobayakawa, R; Sakano, H; Yoshihara, Y; Kikusui, T; Touhara, K				Haga, Sachiko; Hattori, Tatsuya; Sato, Toru; Sato, Koji; Matsuda, Soichiro; Kobayakawa, Reiko; Sakano, Hitoshi; Yoshihara, Yoshihiro; Kikusui, Takefumi; Touhara, Kazushige			The male mouse pheromone ESP1 enhances female sexual receptive behaviour through a specific vomeronasal receptor	NATURE			English	Article							GENES; ORGANIZATION; EXPRESSION; NUCLEUS; NEURONS; CONVERGENCE; PROJECTIONS; PATHWAYS; FAMILIES; PEPTIDE	Various social behaviours in mice are regulated by chemical signals called pheromones that act through the vomeronasal system(1-3). Exocrine gland-secreting peptide 1 (ESP1) is a 7-kDa peptide that is released intomale tear fluids and stimulates vomeronasal sensory neurons in female mice(4). Here, we describe the molecular and neural mechanisms that are involved in the decoding of ESP1 signals in the vomeronasal system, which leads to behavioural output in female mice. ESP1 is recognized by a specific vomeronasal receptor, V2Rp5, and the ligand-receptor interaction results in sex-specific signal transmission to the amygdaloid and hypothalamic nuclei via the accessory olfactory bulb. Consequently, ESP1 enhances female sexual receptive behaviour upon male mounting (lordosis), allowing successful copulation. In V2Rp5-deficient mice, ESP1 induces neither neural activation nor sexual behaviour. These findings show that ESP1 is a crucial male pheromone that regulates female reproductive behaviour through a specific receptor in the mouse vomeronasal system.	[Haga, Sachiko; Sato, Toru; Sato, Koji; Matsuda, Soichiro; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Hattori, Tatsuya; Kikusui, Takefumi] Azabu Univ, Sch Vet Med, Kanagawa 2298501, Japan; [Kobayakawa, Reiko] Osaka Biosci Inst, Dept Funct Neurosci, Suita, Osaka 5650874, Japan; [Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	University of Tokyo; Azabu University; University of Tokyo; RIKEN	Touhara, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp	Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166; xing zhi, zuo teng/0000-0001-6198-6406; Kobayakawa, Reiko/0000-0001-6613-5969	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Axel, C. R. Yu, M. Cappechi, M. Sugita and T. Shiroishi for mice and plasmids; RIKEN BSI Research Resource Center, Y. Zhang, J. He, C. R. Yu, H. Kimoto, N. Matsumoto, M. Ohmoto, K. Abe, S. Mitsui, T. Kaneko-Goto, and T. Abe for experimental help and advice; and Y. Sakuma, Y. Mori, M. Ichikawa and H. Terasawa for valuable comments and discussions. This work was supported by grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences, Japan Society for the Promotion of Science, and Ministry of Education, Culture, Sports, Science and Technology, Japan.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Haga S, 2007, PURE APPL CHEM, V79, P775, DOI 10.1351/pac200779040775; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kudwa AE, 2005, P NATL ACAD SCI USA, V102, P4608, DOI 10.1073/pnas.0500752102; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Touhara K, 2007, ADV GENET, V59, P147, DOI 10.1016/S0065-2660(07)59006-1; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	35	261	267	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					118	U136		10.1038/nature09142	http://dx.doi.org/10.1038/nature09142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596023				2022-12-24	WOS:000279343800046
J	Sendoel, A; Kohler, I; Fellmann, C; Lowe, SW; Hengartner, MO				Sendoel, Ataman; Kohler, Ines; Fellmann, Christof; Lowe, Scott W.; Hengartner, Michael O.			HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR; DAMAGE-INDUCED APOPTOSIS; CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-LINES; PROTEIN; P53; PATHWAY; CANCER; GENE	Hypoxia-inducible factor (HIF) is a transcription factor that regulates fundamental cellular processes in response to changes in oxygen concentration. HIF alpha protein levels are increased in most solid tumours and correlate with patient prognosis. The link between HIF and apoptosis, a major determinant of cancer progression and treatment outcome, is poorly understood. Here we show that Caenorhabditis elegans HIF-1 protects against DNA-damage-induced germ cell apoptosis by antagonizing the function of CEP-1, the homologue of the tumour suppressor p53. The antiapoptotic property of HIF-1 is mediated by means of transcriptional upregulation of the tyrosinase family member TYR-2 in the ASJ sensory neurons. TYR-2 is secreted by ASJ sensory neurons to antagonize CEP-1-dependent germline apoptosis. Knock down of the TYR-2 homologue TRP2 (also called DCT) in human melanoma cells similarly increases apoptosis, indicating an evolutionarily conserved function. Our findings identify a novel link between hypoxia and programmed cell death, and provide a paradigm for HIF-1 dictating apoptotic cell fate at a distance.	[Sendoel, Ataman; Kohler, Ines; Fellmann, Christof; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Sendoel, Ataman] Univ Zurich, PhD Program Canc Biol, CH-8057 Zurich, Switzerland; [Sendoel, Ataman] Univ Zurich, MD PhD Program, CH-8057 Zurich, Switzerland; [Lowe, Scott W.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Fellmann, Christof] Univ Zurich, PhD Program Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Zurich	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Hengartner, Michael O/E-6235-2011	Sendoel, Ataman/0000-0002-0381-9965; Fellmann, Christof/0000-0002-9545-5723; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation; Kanton of Zurich; Josef-Steiner Foundation; Oncosuisse; NIH National Center for Research Resources (NCRR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton of Zurich; Josef-Steiner Foundation; Oncosuisse; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Y. Lazebnik, A. Gartner, A. Hajnal, J. Jiricny, R. Wenger and C. Mosimann for critical reading of the manuscript. We are grateful to S. Schrimpf, L. Stergiou, E. Bogan, S. Egger, O. Georgiev, M. Moser and Hengartner, Hajnal and Lowe laboratory members for help and discussions. We thank Y. Auchli and P. Hunziker from the Functional Genomics Center Zurich for protein analysis. We are grateful to V. Hearing and J. Valencia for the TRP2 antibody and help. This work was supported by the Swiss National Science Foundation, the Kanton of Zurich and the Josef-Steiner Foundation. M.O.H. is Ernst Hadorn endowed Professor of Molecular Biology. A.S. was supported by Oncosuisse and the Swiss National Science Foundation. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; BRENNER S, 1974, GENETICS, V77, P71; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; ITO S, 1984, BIOCHEM J, V222, P407, DOI 10.1042/bj2220407; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MONTANO X, 1994, ONCOGENE, V9, P1455; PALUMBO A, 1987, BIOCHIM BIOPHYS ACTA, V925, P203, DOI 10.1016/0304-4165(87)90110-3; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Xu YQ, 1997, J INVEST DERMATOL, V109, P788, DOI 10.1111/1523-1747.ep12340971; Ying-Tao Z, 2005, EUR J GASTROEN HEPAT, V17, P725, DOI 10.1097/00042737-200507000-00006; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhong H, 1999, CANCER RES, V59, P5830; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	46	138	159	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					577	U69		10.1038/nature09141	http://dx.doi.org/10.1038/nature09141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520707	Green Accepted			2022-12-24	WOS:000278249000033
J	Beltrao, P; Cagney, G; Krogan, NJ				Beltrao, Pedro; Cagney, Gerard; Krogan, Nevan J.			Quantitative Genetic Interactions Reveal Biological Modularity	CELL			English	Article							PROTEIN COMPLEXES; HIGH-THROUGHPUT; NETWORKS; CELL; EPISTASIS; CONSERVATION; PERTURBATION; ORGANIZATION; METHYLATION; STRATEGY		[Beltrao, Pedro; Cagney, Gerard; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Belfield, Ireland	University of California System; University of California San Francisco; University College Dublin	Krogan, NJ (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA.	krogan@cmp.ucsf.edu		Cagney, Gerard/0000-0001-7189-9496; Beltrao, Pedro/0000-0002-2724-7703	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM084448-02, R01 GM084448] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	57	112	113	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					739	745		10.1016/j.cell.2010.05.019	http://dx.doi.org/10.1016/j.cell.2010.05.019			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510918	Green Accepted, Bronze			2022-12-24	WOS:000278132900006
J	Coffman, RL				Coffman, Robert L.			The Origin of T(H)2 Responses	SCIENCE			English	Editorial Material							IMMUNE-RESPONSES; CYTOKINES; INNATE		Dynavax Technol Corp, Berkeley, CA 94710 USA		Coffman, RL (corresponding author), Dynavax Technol Corp, 2929 7th St,Suite 100, Berkeley, CA 94710 USA.	RCoffman@dynavax.com						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015	10	22	23	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1116	1117		10.1126/science.1192009	http://dx.doi.org/10.1126/science.1192009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508120				2022-12-24	WOS:000278104700031
J	Geisbert, TW; Lee, ACH; Robbins, M; Geisbert, JB; Honko, AN; Sood, V; Johnson, JC; de Jong, S; Tavakoli, I; Judge, A; Hensley, LE; MacLachlan, I				Geisbert, Thomas W.; Lee, Amy C. H.; Robbins, Marjorie; Geisbert, Joan B.; Honko, Anna N.; Sood, Vandana; Johnson, Joshua C.; de Jong, Susan; Tavakoli, Iran; Judge, Adam; Hensley, Lisa E.; MacLachlan, Ian			Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study	LANCET			English	Article							SYNTHETIC SIRNA; GUINEA-PIGS; INFECTION; STIMULATION; MODEL; MICE	Background We previously showed that small interfering RNAs (siRNAs) targeting the Zaire Ebola virus (ZEBOV) RNA polymerase L protein formulated in stable nucleic acid-lipid particles (SNALPs) completely protected guineapigs when administered shortly after a lethal ZEBOV challenge. Although rodent models of ZEBOV infection are useful for screening prospective countermeasures, they are frequently not useful for prediction of efficacy in the more stringent non-human primate models. We therefore assessed the efficacy of modified non-immunostimulatory siRNAs in a uniformly lethal non-human primate model of ZEBOV haemorrhagic fever. Methods A combination of modified siRNAs targeting the ZEBOV L polymerase (EK-1 mod), viral protein (VP) 24 (VP24-1160 mod), and VP35 (VP35-855 mod) were formulated in SNALPs. A group of macaques (n=3) was given these pooled anti-ZEBOV siRNAs (2 mg/kg per dose, bolus intravenous infusion) after 30 min, and on days 1, 3, and 5 after challenge with ZEBOV. A second group of macaques (n=4) was given the pooled anti-ZEBOV siRNAs after 30 min, and on days 1, 2, 3, 4, 5, and 6 after challenge with ZEBOV. Findings Two (66%) of three rhesus monkeys given four postexposure treatments of the pooled anti-ZEBOV siRNAs were protected from lethal ZEBOV infection, whereas all macaques given seven postexposure treatments were protected. The treatment regimen in the second study was well tolerated with minor changes in liver enzymes that might have been related to viral infection. Interpretation This complete postexposure protection against ZEBOV in non-human primates provides a model for the treatment of ZEBOV-induced haemorrhagic fever. These data show the potential of RNA interference as an effective postexposure treatment strategy for people infected with Ebola virus, and suggest that this strategy might also be useful for treatment of other emerging viral infections.	[Geisbert, Thomas W.; Geisbert, Joan B.] Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, Boston, MA 02118 USA; [Geisbert, Thomas W.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Geisbert, Thomas W.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Honko, Anna N.; Johnson, Joshua C.; Hensley, Lisa E.] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Lee, Amy C. H.; Robbins, Marjorie; Sood, Vandana; de Jong, Susan; Tavakoli, Iran; Judge, Adam; MacLachlan, Ian] Tekmira Pharmaceut, Burnaby, BC, Canada	Boston University; Boston University; Boston University	Geisbert, TW (corresponding author), Boston Univ, Sch Med, Natl Emerging Infect Dis Labs Inst, 620 Albany St,Room 401B, Boston, MA 02118 USA.	geisbert@bu.edu	Honko, Anna/H-9539-2019	Honko, Anna/0000-0001-9165-148X; Hensley, Lisa/0000-0003-1188-4342; Robbins, Marjorie/0000-0002-4123-7106; Johnson, Joshua/0000-0002-5677-3841	Defense Threat Reduction Agency [04-4-7J-012]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Work on filoviruses at US Army Medical Research Institute of Infectious Diseases was funded by the Defense Threat Reduction Agency (project number 04-4-7J-012). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by Boston University or the US Army.	Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Enterlein S, 2006, ANTIMICROB AGENTS CH, V50, P984, DOI 10.1128/AAC.50.3.984-993.2006; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2006, J INFECT DIS, V193, P1650, DOI 10.1086/504267; Geisbert TW, 2004, EBOLA AND MARBURG VIRUSES: MOLECULAR AND CELLULAR BIOLOGY, P203; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Grimm D, 2007, MOL THER, V15, P878, DOI 10.1038/sj.mt.6300116; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Heyes J, 2005, J CONTROL RELEASE, V107, P276, DOI 10.1016/j.jconrel.2005.06.014; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; *INT SOC INF DIS, EB LAB ACC DEATH RUS; *INT SOC INF DIS, EB NEEDL INJ GERM HA; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kortepeter MG, 2008, EMERG INFECT DIS, V14, P881, DOI 10.3201/eid1406.071489; Prins KC, 2010, J VIROL, V84, P3004, DOI 10.1128/JVI.02459-09; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Robbins M, 2008, HUM GENE THER, V19, P991, DOI 10.1089/hum.2008.131; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Sanchez A, 2006, FIELDS VIROLOGY, P1409; Tang Qingquan, 2008, V442, P139, DOI 10.1007/978-1-59745-191-8_11; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; Warfield Kelly L., 2006, PLoS Pathogens, V2, P5; Yokota T, 2007, BIOCHEM BIOPH RES CO, V361, P294, DOI 10.1016/j.bbrc.2007.06.182	30	341	424	1	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1896	1905		10.1016/S0140-6736(10)60357-1	http://dx.doi.org/10.1016/S0140-6736(10)60357-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20511019	Bronze, Green Published			2022-12-24	WOS:000278628800031
J	Guenther, MG; Young, RA				Guenther, Matthew G.; Young, Richard A.			Repressive Transcription	SCIENCE			English	Editorial Material							GENE-EXPRESSION; NONCODING RNAS; CHROMATIN; POLYCOMB; PROTEINS; CELLS		[Guenther, Matthew G.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Guenther, MG (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NHGRI NIH HHS [R01 HG002668, R01 HG002668-07] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; TSAI MC, 2010, SCIENCE         0708, DOI DOI 10.1126/SCIENCE.1192002; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	17	39	40	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					150	151		10.1126/science.1193995	http://dx.doi.org/10.1126/science.1193995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616255	Green Accepted, Green Submitted			2022-12-24	WOS:000279635200022
J	Einfeld, SL; Brown, R				Einfeld, Stewart L.; Brown, Rebecca			Down Syndrome-New Prospects for an Ancient Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOWN-SYNDROME; CHROMOSOME-21; RESCUE		[Einfeld, Stewart L.] Univ Sydney, Fac Hlth Sci, Camperdown, NSW 2050, Australia; [Einfeld, Stewart L.; Brown, Rebecca] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney	Einfeld, SL (corresponding author), Univ Sydney, Fac Hlth Sci, BMRI Level 3,94 Mallett St, Camperdown, NSW 2050, Australia.	stewart.einfeld@sydney.edu.au						Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Down J.L., 1866, OBSERVATION ETHNIC C, DOI DOI 10.1038/HDY.1966.69; Guedj F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004606; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Richard F, 1998, CHROMOSOME RES, V6, P263, DOI 10.1023/A:1009262622325; Shin M, 2009, PEDIATRICS, V124, P1565, DOI 10.1542/peds.2009-0745; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	10	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2525	2526		10.1001/jama.2010.842	http://dx.doi.org/10.1001/jama.2010.842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571021				2022-12-24	WOS:000279010900033
J	Engemise, S; Gordon, C; Konje, JC				Engemise, Samuel; Gordon, Cerys; Konje, Justin C.			Easily Missed Endometriosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; WOMEN; ACCURACY		[Engemise, Samuel; Konje, Justin C.] Univ Hosp Leicester NHS Trust, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England; [Engemise, Samuel; Konje, Justin C.] Univ Leicester, Leicester LE2 7LX, Leics, England; [Gordon, Cerys] S Wigston Hlth Ctr, Wigston LE18 4SE, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester	Konje, JC (corresponding author), Univ Hosp Leicester NHS Trust, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England.	jck4@le.ac.uk						Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Barnard A., 2001, PAIN OBSTET GYNAECOL, P145; CARTER JE, 1994, J AM ASSOC GYN LAP, V2, P43, DOI 10.1016/S1074-3804(05)80830-8; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; *EUR NETW END, INTR; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Laufer M R, 1997, J Pediatr Adolesc Gynecol, V10, P199; Lockhat FB, 2005, HUM REPROD, V20, P789, DOI 10.1093/humrep/deh650; Louden Sally F., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P307, DOI 10.3109/01443619509030929; MEURSSZOJDA MM, 2009, COLORECTAL DIS  1013; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; *NHS EV, WOM HLTH ANN EV UPD; Rosa-e-Silva JC, 2008, CLIMACTERIC, V11, P525, DOI 10.1080/13697130802490256; *ROYAL COLL OBST G, 2007, INV MAN END; Winkel CA, 2003, OBSTET GYNECOL, V102, P397, DOI 10.1016/S0029-7844(03)00474-5; Wykes CB, 2004, BJOG-INT J OBSTET GY, V111, P1204, DOI 10.1111/j.1471-0528.2004.00433.x	16	14	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2010	340								c2168	10.1136/bmj.c2168	http://dx.doi.org/10.1136/bmj.c2168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IP	20573761				2022-12-24	WOS:000279346400001
J	Bartsch, T; Schonfeld, R; Muller, FJ; Alfke, K; Leplow, B; Aldenhoff, J; Deuschl, G; Koch, JM				Bartsch, T.; Schoenfeld, R.; Mueller, F. J.; Alfke, K.; Leplow, B.; Aldenhoff, J.; Deuschl, G.; Koch, J. M.			Focal Lesions of Human Hippocampal CA1 Neurons in Transient Global Amnesia Impair Place Memory	SCIENCE			English	Article							SPATIAL MEMORY; RECOGNITION MEMORY; DAMAGE; RATS; REPRESENTATIONS; CLASSIFICATION; NAVIGATION; DEFICITS; SYSTEM; SECTOR	A critical role in place learning has been attributed to place cells within the cornu ammonis 1 (CA1) sector of the hippocampus in rodents. The role of CA1 cells in the human hippocampus with regard to place learning remains elusive. Using a virtual Morris water maze, we investigated patients with acute transient global amnesia (TGA), a rare self-limiting dysfunction of the hippocampal system. Fourteen individuals with selective and focal lesions in the CA1 sector of the hippocampus showed a profound impairment in place learning. The size of the lesions and the duration of the TGA correlated with the deficit in the performance.	[Bartsch, T.; Deuschl, G.] Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Schoenfeld, R.; Leplow, B.] Univ Halle Wittenberg, Inst Psychol, Halle, Germany; [Mueller, F. J.; Aldenhoff, J.; Koch, J. M.] Univ Kiel, Dept Psychiat, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Alfke, K.] Univ Kiel, Inst Neuroradiol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; Martin Luther University Halle Wittenberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Bartsch, T (corresponding author), Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany.	t.bartsch@neurologie.uni-kiel.de	Bartsch, Thorsten/F-9950-2010; Aldenhoff, Josef/E-9469-2010; Müller, Franz-Josef/E-3336-2010; Bartsch, Thorsten/AAR-5564-2021; Deuschl, Gunther/A-7986-2010	Bartsch, Thorsten/0000-0001-8387-5731; Müller, Franz-Josef/0000-0001-9478-8430; Bartsch, Thorsten/0000-0001-8387-5731; Deuschl, Gunther/0000-0002-4176-9196	Deutsche Forschungsgemeinschaft [SFB 654, KO 2067/1-2]; Faculty of Medicine, University of Kiel, Germany; Else Kroner-Fresenius-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, University of Kiel, Germany; Else Kroner-Fresenius-Stiftung	We thank O. Jansen for helpful input and support and R. Rosentrager for technical assistance. This study has been supported by the Deutsche Forschungsgemeinschaft [to T.B., grant SFB 654 (TP A14); to J.M.K., grant KO 2067/1-2]; the Faculty of Medicine, University of Kiel, Germany (to T. B. and F.J.M.); and the Else Kroner-Fresenius-Stiftung (to F.J.M.). K.A. is currently affiliated with the Institute of Radiology and Neuroradiology, HELIOS Kliniken, Schwerin, Germany.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; AUER RN, 1989, J NEUROSCI, V9, P1641; BACHEVALIER J, 1989, NEUROPSYCHOLOGIA, V27, P83, DOI 10.1016/0028-3932(89)90092-4; Bartsch T, 2008, NEUROLOGY, V70, P1030, DOI 10.1212/01.wnl.0000306633.06027.33; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2007, ANN NEUROL, V62, P475, DOI 10.1002/ana.21189; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cianfoni A, 2005, ARCH NEUROL-CHICAGO, V62, P1468, DOI 10.1001/archneur.62.9.1468; Clark RE, 2000, J NEUROSCI, V20, P8853; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Lee HY, 2007, NEURORADIOLOGY, V49, P481, DOI 10.1007/s00234-007-0213-5; Maguire EA, 1997, PHILOS T R SOC B, V352, P1475, DOI 10.1098/rstb.1997.0134; McNaughton BL, 1996, J EXP BIOL, V199, P173; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Schoenfeld R, 2010, BEHAV BRAIN RES, V208, P169, DOI 10.1016/j.bbr.2009.11.022; Sedlaczek O, 2004, NEUROLOGY, V62, P2165, DOI 10.1212/01.WNL.0000130504.88404.C9; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Weon YC, 2008, AM J NEURORADIOL, V29, P1324, DOI 10.3174/ajnr.A1105; WHISHAW IQ, 1994, BRAIN RES BULL, V34, P283, DOI 10.1016/0361-9230(94)90065-5; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	33	118	122	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1412	1415		10.1126/science.1188160	http://dx.doi.org/10.1126/science.1188160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538952				2022-12-24	WOS:000278598400043
J	Compston, A				Compston, Alastair			Commentary: Scheme has benefited patients	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England	University of Cambridge	Compston, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England.	alastair.compston@medschl.cam.ac.uk						Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; *HLTH SERV CIRC, 2002, COST EFF PROV DIS MO; MCCABE C, 2010, BRIT MED J, V339, pC1786; RAFTERY J, 2010, BRIT MED J, V339, pC1672	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2707	10.1136/bmj.c2707	http://dx.doi.org/10.1136/bmj.c2707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BM	20522660				2022-12-24	WOS:000278556500009
J	Wagner, TH; Subak, LL				Wagner, Todd H.; Subak, Leslee L.			Talking About Incontinence The First Step Toward Prevention and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							URINARY-INCONTINENCE; WOMEN; LIFE		[Wagner, Todd H.] VA Hlth Econ Resource Ctr, Menlo Pk, CA 94025 USA; [Wagner, Todd H.] Stanford Univ, Dept Hlth Res & Policy, Menlo Pk, CA 94025 USA; [Subak, Leslee L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci Epidemiol & Urol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Wagner, TH (corresponding author), VA Hlth Econ Resource Ctr, 795 Willow Rd MPD-152, Menlo Pk, CA 94025 USA.	twagner@stanford.edu		Wagner, Todd/0000-0001-7625-3504	NIDDK NIH HHS [K24 DK080775] Funding Source: Medline; HSRD VA [I01 HX001056] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080775] Funding Source: NIH RePORTER; Veterans Affairs [I01HX001056] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HSRD VA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)		[Anonymous], 2007, NIH Consens State Sci Statements, V24, P1; Goode PS, 2010, JAMA-J AM MED ASSOC, V303, P2172, DOI 10.1001/jama.2010.749; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; Hu TW, 2004, UROLOGY, V63, P461, DOI 10.1016/j.urology.2003.10.037; Huang AJ, 2006, ARCH INTERN MED, V166, P2000, DOI 10.1001/archinte.166.18.2000; Milsom I, 2009, INCONTINENCE; MITTENESS LS, 1995, MED ANTHROPOL Q, V9, P188, DOI 10.1525/maq.1995.9.2.02a00050; Morrison A, 2006, VALUE HEALTH, V9, P272, DOI 10.1111/j.1524-4733.2006.00109.x; Subak LL, 2009, NEW ENGL J MED, V360, P481, DOI 10.1056/NEJMoa0806375	9	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2184	2185		10.1001/jama.2010.747	http://dx.doi.org/10.1001/jama.2010.747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603BE	20516420	Green Accepted			2022-12-24	WOS:000278182100028
J	Baudouin, S; Scheiffele, P				Baudouin, Stephane; Scheiffele, Peter			SnapShot: Neuroligin-Neurexin Complexes	CELL			English	Editorial Material									[Baudouin, Stephane; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Baudouin, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.			baudouin, stephane/0000-0001-6902-6071				BOURGERON T, 2009, NEURON, V19, P231, DOI DOI 10.1016/J.CONB.2009.06.003; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094	8	44	44	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					908	U187	908.e1	10.1016/j.cell.2010.05.024	http://dx.doi.org/10.1016/j.cell.2010.05.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510934	Bronze			2022-12-24	WOS:000278132900024
J	Schneider, T; Kruse, T; Wimmer, R; Wiedemann, I; Sass, V; Pag, U; Jansen, A; Nielsen, AK; Mygind, PH; Ravents, DS; Neve, S; Ravn, B; Bonvin, AMJJ; De Maria, L; Andersen, AS; Gammelgaard, LK; Sahl, HG; Kristensen, HH				Schneider, Tanja; Kruse, Thomas; Wimmer, Reinhard; Wiedemann, Imke; Sass, Vera; Pag, Ulrike; Jansen, Andrea; Nielsen, Allan K.; Mygind, Per H.; Ravents, Dorotea S.; Neve, Soren; Ravn, Birthe; Bonvin, Alexandre M. J. J.; De Maria, Leonardo; Andersen, Anders S.; Gammelgaard, Lora K.; Sahl, Hans-Georg; Kristensen, Hans-Henrik			Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II	SCIENCE			English	Article							BACILLUS-SUBTILIS; PEPTIDES; MECHANISM; BIOSYNTHESIS; EXPRESSION; NISIN	Host defense peptides such as defensins are components of innate immunity and have retained antibiotic activity throughout evolution. Their activity is thought to be due to amphipathic structures, which enable binding and disruption of microbial cytoplasmic membranes. Contrary to this, we show that plectasin, a fungal defensin, acts by directly binding the bacterial cell-wall precursor Lipid II. A wide range of genetic and biochemical approaches identify cell-wall biosynthesis as the pathway targeted by plectasin. In vitro assays for cell-wall synthesis identified Lipid II as the specific cellular target. Consistently, binding studies confirmed the formation of an equimolar stoichiometric complex between Lipid II and plectasin. Furthermore, key residues in plectasin involved in complex formation were identified using nuclear magnetic resonance spectroscopy and computational modeling.	[Nielsen, Allan K.; Mygind, Per H.; Ravents, Dorotea S.; Neve, Soren; Ravn, Birthe; De Maria, Leonardo; Andersen, Anders S.; Gammelgaard, Lora K.; Kristensen, Hans-Henrik] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Schneider, Tanja; Wiedemann, Imke; Sass, Vera; Pag, Ulrike; Jansen, Andrea; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Kruse, Thomas; Andersen, Anders S.] Statens Serum Inst, DK-2300 Copenhagen S, Denmark; [Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Dept Chem, Fac Sci, NL-3584 CH Utrecht, Netherlands	Novozymes; University of Bonn; Statens Serum Institut; Aalborg University; Utrecht University	Kristensen, HH (corresponding author), Novozymes AS, DK-2880 Bagsvaerd, Denmark.	hahk@novozymes.com	Wimmer, Reinhard/M-2346-2019; Wimmer, Reinhard/A-7901-2012; Schneider, Tanja/L-8049-2013; De Maria, Leonardo/AAH-1026-2021; Bonvin, Alexandre M.J.J./A-5420-2009	Wimmer, Reinhard/0000-0001-6942-5056; De Maria, Leonardo/0000-0002-8061-4242; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Kruse, Thomas/0000-0002-2619-7388; Schneider, Tanja/0000-0001-7269-4716	Obel Foundation; European Union [PIAP-GA-2008-218191]; German Research Foundation [SA 292/10-2, SA 292/13-1]; Bundesministerium fur Bildung und Forschung (SkinStaph); Medical Faculty, University of Bonn; Netherlands Organization for Scientific Research [700.56.442]; Danish Research Council for Technology and Production [274-05-0435]	Obel Foundation; European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (SkinStaph)(Federal Ministry of Education & Research (BMBF)); Medical Faculty, University of Bonn; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Danish Research Council for Technology and Production	We thank M. Josten, A. Hansen, and M. R. Markvardsen for expert technical assistance and acknowledge the Carlsberg Research Center for use of the 800-MHz NMR spectrometer and the Obel Foundation for supporting the NMR laboratory at Aalborg University. H. G. S. acknowledges financial support by the European Union (PIAP-GA-2008-218191), the German Research Foundation (SA 292/10-2 and SA 292/13-1), the Bundesministerium fur Bildung und Forschung (SkinStaph), and by the BONFOR program of the Medical Faculty, University of Bonn. A.M.J.J.B. acknowledges financial support from the Netherlands Organization for Scientific Research (VICI grant 700.56.442). A. S. A. acknowledges financial support from the Danish Research Council for Technology and Production (274-05-0435). Novozymes AS holds a patent on plectasin (patent number WO2003/044049/044049) and has filed patent applications on improved variants of plectasin. L. D. M., A.K.N., and D. S. R. hold stock options in Novozymes AS. DNA microarray data can be accessed through ArrayExpress, accession number E-MTAB-60. NMR assignment of <SUP>1</SUP>H, <SUP>15</SUP>N, and <SUP>13</SUP>C atoms of plectasin have been deposited in the BioMagResBank (accession number 16739).	Allen NE, 2003, FEMS MICROBIOL REV, V26, P511, DOI 10.1111/j.1574-6976.2003.tb00628.x; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	19	382	397	2	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1168	1172		10.1126/science.1185723	http://dx.doi.org/10.1126/science.1185723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508130	Green Published			2022-12-24	WOS:000278104700047
J	Bedau, M; Church, G; Rasmussen, S; Caplan, A; Benner, S; Fussenegger, M; Collins, J; Deamer, D				Bedau, Mark; Church, George; Rasmussen, Steen; Caplan, Arthur; Benner, Steven; Fussenegger, Martin; Collins, Jim; Deamer, David			Life after the synthetic cell	NATURE			English	Editorial Material									[Bedau, Mark] Reed Coll, Portland, OR USA; [Church, George] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Rasmussen, Steen] Univ So Denmark, Odense, Denmark; [Caplan, Arthur] Univ Penn, Philadelphia, PA 19104 USA; [Benner, Steven] Fdn Appl Mol Evolut, Gainesville, FL USA; [Fussenegger, Martin] Swiss Fed Inst Technol, Basel, Switzerland; [Collins, Jim] Boston Univ, Boston, MA 02215 USA; [Deamer, David] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Reed College - Oregon; Harvard University; University of Southern Denmark; University of Pennsylvania; Swiss Federal Institutes of Technology Domain; ETH Zurich; Boston University; University of California System; University of California Santa Cruz	Bedau, M (corresponding author), Reed Coll, Portland, OR USA.			church, george/0000-0001-6232-9969					0	31	34	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					422	424		10.1038/465422a	http://dx.doi.org/10.1038/465422a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601FM	20495545				2022-12-24	WOS:000278043700016
J	Donahue, DA; Carmona, RH				Donahue, Donald A., Jr.; Carmona, Richard H.			Retooling the Uniformed US Public Health Service for the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Donahue, Donald A., Jr.] Potomac Inst Policy Studies, Ctr Hlth Policy & Preparedness, Arlington, VA 22203 USA; [Donahue, Donald A., Jr.] Univ Pittsburgh, Ctr Natl Preparedness, Pittsburgh, PA USA; [Carmona, Richard H.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Arizona	Donahue, DA (corresponding author), Potomac Inst Policy Studies, Ctr Hlth Policy & Preparedness, 901 N Stuart St,Ste 200, Arlington, VA 22203 USA.	ddonahue@potomacinstitute.org	Donahue, Donald/M-2116-2018	Donahue, Donald/0000-0001-8390-1303				Board on Health Promotion and Disease Prevention Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; de Kruif Paul, 1938, FIGHT LIFE; James Locher, 1996, TAKING STOCK GOLDWAT; Merrill Jacqueline, 2003, J Public Health Manag Pract, V9, P459; SHAW GB, 1919, HEARTBREAK HOUSE FAN; SIDEL VW, 2002, BIOL WARFARE DISARMA, P86; World Health Organization, 2007, WORLD HLTH REP 2007	7	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2080	2081		10.1001/jama.2010.673	http://dx.doi.org/10.1001/jama.2010.673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501931				2022-12-24	WOS:000278018200035
J	Signore, LB; Mulvihill, JJ; Green, DM; Munro, HM; Stovall, M; Weathers, RE; Mertens, AC; Whitton, JA; Robison, LL; Boice, JD				Signore, Lisa B.; Mulvihill, John J.; Green, Daniel M.; Munro, Heather M.; Stovall, Marilyn; Weathers, Rita E.; Mertens, Ann C.; Whitton, John A.; Robison, Leslie L.; Boice, John D., Jr.			Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study	LANCET			English	Article							CHILDHOOD-CANCER SURVIVORS; ATOMIC-BOMB SURVIVORS; POPULATION-BASED COHORT; WILMS-TUMOR; CONGENITAL-MALFORMATIONS; RADIOTHERAPY; CHILDREN; PREGNANCY; WORKERS	Background The reproductive implications of mutagenic treatments given to children with cancer are not clear. By studying the risk of untoward pregnancy outcomes, we indirectly assessed the risk of transmission of germline damage to the offspring of survivors of childhood cancer who were given radiotherapy and chemotherapy. Methods We did a retrospective cohort analysis, within the Childhood Cancer Survivor Study (CCSS), of the risk of stillbirth and neonatal death among the offspring of men and women who had survived childhood cancer. Patients in CCSS were younger than 21 years at initial diagnosis of an eligible cancer, were treated at 25 US institutions and one Canadian institution, and had survived for at least 5 years after diagnosis. We quantified the chemotherapy given to patients, and the preconception radiation doses to the testes, ovaries, uterus, and pituitary gland, and related these to the risk of stillbirth or neonatal death using Poisson regression analysis. Findings Among 1148 men and 1657 women who had survived childhood cancer, there were 4946 pregnancies. Irradiation of the testes (16 [1%] of 1270; adjusted relative risk 0.8 [95% CI 0.4-1.6]; mean dose 0.53 Gy [SD 1.40]) and pituitary gland (17 [3%] of 510, 1.1 [0.5-2.4] for more than 20.00 Gy; mean dose 10.20 Gy [13.0] for women), and chemotherapy with alkylating drugs (26 [2%] of 1195 women, 0.9 [0.5-1.5]; ten [1%] of 732 men, 1.2 [0.5-2.5]) were not associated with an increased risk of stillbirth or neonatal death. Uterine and ovarian irradiation significantly increased risk of stillbirth and neonatal death at doses greater than 10.00 Gy (five [18%] of 28, 9.1 [3.4-24.6]). For girls treated before menarche, irradiation of the uterus and ovaries at doses as low as 1.00-2.49 Gy significantly increased the risk of stillbirth or neonatal death (three [4%] of 69, 4.7 [1.2-19.0]). Interpretation Our findings do not support concern about heritable genetic changes affecting the risk of stillbirth and neonatal death in the offspring of men exposed to gonadal irradiation. However, uterine and ovarian irradiation had serious adverse effects on the offspring that were probably related to uterine damage. Careful management is warranted of pregnancies in women given high doses of pelvic irradiation before puberty.	[Signore, Lisa B.; Munro, Heather M.; Boice, John D., Jr.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Signore, Lisa B.; Boice, John D., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Signore, Lisa B.; Boice, John D., Jr.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Mulvihill, John J.] Univ Oklahoma, Dept Pediat, Oklahoma City, OK USA; [Green, Daniel M.; Robison, Leslie L.] St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Stovall, Marilyn; Weathers, Rita E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Mertens, Ann C.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Whitton, John A.] Fred Hutchinson Canc Res Ctr, Dept Biostat, Seattle, WA 98104 USA	Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; St Jude Children's Research Hospital; University of Texas System; UTMD Anderson Cancer Center; Emory University; Fred Hutchinson Cancer Center	Signore, LB (corresponding author), Int Epidemiol Inst, 1455 Res Blvd,Suite 550, Rockville, MD 20850 USA.	lisa@iei.us	Robison, Leslie/N-8122-2018		Westlakes Research Institute [01/12/99 DC]; National Cancer Institute [U24 CA55727, 5RO1 CA104666]; University of Minnesota, Minneapolis, MN, USA; NATIONAL CANCER INSTITUTE [R01CA104666, U24CA055727] Funding Source: NIH RePORTER	Westlakes Research Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Minnesota, Minneapolis, MN, USA(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partly supported by contracts and grants from Westlakes Research Institute (agreement number 01/12/99 DC), the National Cancer Institute (U24 CA55727 and 5RO1 CA104666), and the Children's Cancer Research Fund (University of Minnesota, Minneapolis, MN, USA). The programme of studies would not have been possible without the efforts of the many participating survivors of cancer, data abstractors, a large field staff, central clerical and data-processing staff, and clinical collaborators. We gratefully acknowledge the advice and guidance of Gerald Draper (Childhood Cancer Research Group, Oxford, UK) and Godfrey Oakley (Emory University, Atlanta, GA, USA) during the preparation of this report.	Abrahamson Seymour, 2001, Journal of Radiological Protection, V21, P133, DOI 10.1088/0952-4746/21/2/303; Boice JD, 2003, HEALTH PHYS, V85, P65, DOI 10.1097/00004032-200307000-00013; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; *COMARE, 2004, PAR OCC EXP RAD PRIO; Doll R, 2000, LANCET, V355, P493, DOI 10.1016/S0140-6736(00)82044-9; Doyle P, 2000, LANCET, V356, P1293, DOI 10.1016/S0140-6736(00)02812-9; Doyle P, 2000, LANCET, V355, P492, DOI 10.1016/S0140-6736(00)82041-3; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Inskip H, 1999, LANCET, V354, P1400, DOI 10.1016/S0140-6736(99)00289-5; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Leisenring WM, 2009, J CLIN ONCOL, V27, P2319, DOI 10.1200/JCO.2008.21.1813; LI FP, 1987, JAMA-J AM MED ASSOC, V257, P216, DOI 10.1001/jama.257.2.216; Nakamura N, 2006, J RADIAT RES, V47, pB67, DOI 10.1269/jrr.47.B67; NEEL JV, 1990, ANNU REV GENET, V24, P327; Nicholson HS, 1996, CANCER, V78, P887; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Russell WL, 1998, GENETICS, V148, P1567; Schull WJ, 2003, J RADIOL PROT, V23, P369, DOI 10.1088/0952-4746/23/4/R302; Selby PB, 2000, LANCET, V355, P492, DOI 10.1016/S0140-6736(00)82042-5; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; Stovall M, 2004, INT J RADIAT ONCOL, V60, P542, DOI 10.1016/j.ijrobp.2004.03.017; Tawn EJ, 2000, LANCET, V355, P493, DOI 10.1016/S0140-6736(00)82045-0; United Nations Scientific Committee on the Effects of Atomic Radiation, 2001, REP GEN ASS SCI ANN; Winther JF, 2009, CLIN GENET, V75, P50, DOI 10.1111/j.1399-0004.2008.01109.x; Winther JF, 2008, J CLIN ONCOL, V26, P4340, DOI 10.1200/JCO.2007.15.2884; Winther JF, 2004, AM J HUM GENET, V74, P1282, DOI 10.1086/421473; Wo JY, 2009, INT J RADIAT ONCOL, V73, P1304, DOI 10.1016/j.ijrobp.2008.12.016; Wyrobek AJ, 2007, ENVIRON MOL MUTAGEN, V48, P71, DOI 10.1002/em.20284	30	103	107	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					624	630		10.1016/S0140-6736(10)60752-0	http://dx.doi.org/10.1016/S0140-6736(10)60752-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20655585	Green Accepted			2022-12-24	WOS:000281309100033
J	Petersen, TH; Calle, EA; Zhao, LP; Lee, EJ; Gui, LQ; Raredon, MB; Gavrilov, K; Yi, T; Zhuang, ZW; Breuer, C; Herzog, E; Niklason, LE				Petersen, Thomas H.; Calle, Elizabeth A.; Zhao, Liping; Lee, Eun Jung; Gui, Liqiong; Raredon, MichaSam B.; Gavrilov, Kseniya; Yi, Tai; Zhuang, Zhen W.; Breuer, Christopher; Herzog, Erica; Niklason, Laura E.			Tissue-Engineered Lungs for in Vivo Implantation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; II CELLS; VITRO; TRANSPLANTATION; MATRIX; ACID	Because adult lung tissue has limited regeneration capacity, lung transplantation is the primary therapy for severely damaged lungs. To explore whether lung tissue can be regenerated in vitro, we treated lungs from adult rats using a procedure that removes cellular components but leaves behind a scaffold of extracellular matrix that retains the hierarchical branching structures of airways and vasculature. We then used a bioreactor to culture pulmonary epithelium and vascular endothelium on the acellular lung matrix. The seeded epithelium displayed remarkable hierarchical organization within the matrix, and the seeded endothelial cells efficiently repopulated the vascular compartment. In vitro, the mechanical characteristics of the engineered lungs were similar to those of native lung tissue, and when implanted into rats in vivo for short time intervals (45 to 120 minutes) the engineered lungs participated in gas exchange. Although representing only an initial step toward the ultimate goal of generating fully functional lungs in vitro, these results suggest that repopulation of lung matrix is a viable strategy for lung regeneration.	[Petersen, Thomas H.; Calle, Elizabeth A.; Raredon, MichaSam B.; Niklason, Laura E.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Petersen, Thomas H.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Zhao, Liping; Lee, Eun Jung; Gui, Liqiong; Niklason, Laura E.] Yale Univ, Dept Anesthesia, New Haven, CT 06520 USA; [Gavrilov, Kseniya] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Yi, Tai; Breuer, Christopher] Yale Univ, Dept Surg, New Haven, CT 06520 USA; [Zhuang, Zhen W.; Herzog, Erica] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Duke University; Yale University; Yale University; Yale University; Yale University	Niklason, LE (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	laura.niklason@yale.edu	aksel, hacer/H-1572-2015	Raredon, Micha Sam/0000-0003-1441-6122; Breuer, Christopher/0000-0003-0987-3898; Petersen, Thomas/0000-0002-4667-7493	Yale University Department of Anesthesia; NIH [HL 098220, T32 GM007171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	Yale University Department of Anesthesia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Colehour for help with bioreactor development and Western blotting, R. Homer for histologic assessment, and B. Stripp for the CCSP antibody. This work was funded by Yale University Department of Anesthesia and by NIH grant HL 098220 (to L.E.N.). T.H.P. is supported by NIH T32 GM007171. L.E.N. holds stock in Humacyte, a regenerative medicine company. The authors (L.E.N., T.H.P., and E.A.C.) and Yale University have filed a patent application related to tissue engineering of lungs.	*AM LUNG ASS, LUND DIS DAT 2008; Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006; Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145; Bittar EE, 2002, PULMONARY BIOL HLTH; Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213; DEFOUW DO, 1983, AM REV RESPIR DIS, V127, pS9; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Inanlou MR, 2005, HISTOL HISTOPATHOL, V20, P1261, DOI 10.14670/HH-20.1261; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lin YM, 2006, J BIOMATER APPL, V21, P109, DOI 10.1177/0885328206057952; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717; Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Rippon Helen J, 2008, Proc Am Thorac Soc, V5, P717, DOI 10.1513/pats.200801-008AW; Roszell B, 2009, TISSUE ENG PT A, V15, P3351, DOI 10.1089/ten.TEA.2008.0664; Sporty JL, 2008, EXPERT OPIN DRUG MET, V4, P333, DOI [10.1517/17425255.4.4.333, 10.1517/17425255.4.4.333 ]; STAUB NC, 1998, PHYSIOLOGY, pCH32; SUGIHARA H, 1993, AM J PATHOL, V142, P783; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	836	884	2	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					538	541		10.1126/science.1189345	http://dx.doi.org/10.1126/science.1189345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20576850	Green Accepted			2022-12-24	WOS:000280483500028
J	Furukawa, H; Ko, N; Go, YB; Aratani, N; Choi, SB; Choi, E; Yazaydin, AO; Snurr, RQ; O'Keeffe, M; Kim, J; Yaghi, OM				Furukawa, Hiroyasu; Ko, Nakeun; Go, Yong Bok; Aratani, Naoki; Choi, Sang Beom; Choi, Eunwoo; Yazaydin, A. Oezguer; Snurr, Randall Q.; O'Keeffe, Michael; Kim, Jaheon; Yaghi, Omar M.			Ultrahigh Porosity in Metal-Organic Frameworks	SCIENCE			English	Article							HYDROGEN STORAGE; SURFACE-AREAS; COORDINATION POLYMERS; ADSORPTION; DESIGN; ROUTE; SITES	Crystalline solids with extended non-interpenetrating three-dimensional crystal structures were synthesized that support well-defined pores with internal diameters of up to 48 angstroms. The Zn(4)O(CO(2))(6) unit was joined with either one or two kinds of organic link, 4,4',4 ''-[benzene-1,3,5-triyl-tris (ethyne-2,1-diyl)]tribenzoate (BTE), 4,4',44 ''-[benzene-1,3,5-triyl-tris(benzene-4,1-diyl)]tribenzoate (BBC), 4,4',44 ''-benzene-1,3,5-triyl-tribenzoate (BTB)/2,6-naphthalenedicarboxylate (NDC), and BTE/biphenyl-4,4'-dicarboxylate (BPDC), to give four metal-organic frameworks (MOFs), MOF-180, -200, -205, and -210, respectively. Members of this series of MOFs show exceptional porosities and gas (hydrogen, methane, and carbon dioxide) uptake capacities. For example, MOF-210 has Brunauer-Emmett-Teller and Langmuir surface areas of 6240 and 10,400 square meters per gram, respectively, and a total carbon dioxide storage capacity of 2870 milligrams per gram. The volume-specific internal surface area of MOF-210 (2060 square meters per cubic centimeter) is equivalent to the outer surface of nanoparticles (3-nanometer cubes) and near the ultimate adsorption limit for solid materials.	[Ko, Nakeun; Choi, Sang Beom; Kim, Jaheon] Soongsil Univ, Dept Chem, Seoul 156743, South Korea; [Furukawa, Hiroyasu; Go, Yong Bok; Aratani, Naoki; Choi, Eunwoo; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Calif NanoSyst Inst, Ctr Reticular Chem, Los Angeles, CA 90095 USA; [Furukawa, Hiroyasu; Go, Yong Bok; Aratani, Naoki; Choi, Eunwoo; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yazaydin, A. Oezguer; Snurr, Randall Q.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Yaghi, Omar M.] Univ Calif Los Angeles, Inst Genom & Prote, Dept Energy, Los Angeles, CA 90095 USA	Soongsil University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; University of California System; University of California Los Angeles	Kim, J (corresponding author), Soongsil Univ, Dept Chem, Seoul 156743, South Korea.	jaheon@ssu.ac.kr; yaghi@chem.ucla.edu	Snurr, Randall Q/B-6699-2009; Furukawa, Hiroyasu/C-5910-2008; Aratani, Naoki/D-1626-2011; Yazaydin, A. Ozgur/F-4075-2019; Yaghi, Omar M/C-6749-2013; Snurr, Randall Q/E-4900-2011	Furukawa, Hiroyasu/0000-0002-6082-1738; Aratani, Naoki/0000-0002-3181-6526; Yazaydin, A. Ozgur/0000-0001-8562-723X; Snurr, Randall Q/0000-0003-2925-9246; Yaghi, Omar/0000-0002-5611-3325	BASF SE; DOE Office of Basic Energy Sciences [DE-FG02-08ER15935]; DOE [FG36-05GO15001]; Ministry of Education, Science and Technology of Korea; Defense Threat Reduction Agency [HDTRA1-08-C-005]	BASF SE(BASF); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work is partially supported by BASF SE. The synthesis, characterization of MOF-200, and nitrogen, methane, and carbon dioxide adsorption measurements of the MOFs are supported by the DOE Office of Basic Energy Sciences (DE-FG02-08ER15935 to O.M.Y.), and hydrogen adsorption measurements are supported by the DOE (DE-FG36-05GO15001 to O.M.Y.). We thank the Hydrogen Energy R&D Center, one of the 21st Century Frontier R&D Programs (the Ministry of Education, Science and Technology of Korea to J.K.), and the Defense Threat Reduction Agency (HDTRA1-08-C-005 to R. Q. S.). We thank N. W. Ockwig (Sandia National Laboratories) for his initial work, S. Khan (UCLA) for his help in single-crystal x-ray structure collection and analysis of MOF-200, Y. K. Park and E. Jo (Soongsil University) for their synthesis work of organic links, Accelrys Korea for MS Modeling support, and Pohang Accelerator Laboratory, Korea (2009-2063-12, 2009-2063-18). Crystallographic data for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre under reference numbers CCDC 775690 to 775693. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK).	Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Chae HK, 2003, ANGEW CHEM INT EDIT, V42, P3907, DOI 10.1002/anie.200351546; Chen BL, 2001, SCIENCE, V291, P1021, DOI 10.1126/science.1056598; Dinca M, 2008, ANGEW CHEM INT EDIT, V47, P6766, DOI 10.1002/anie.200801163; Doonan CJ, 2009, J AM CHEM SOC, V131, P9492, DOI 10.1021/ja903251e; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Furukawa H, 2007, J MATER CHEM, V17, P3197, DOI 10.1039/b703608f; Kaye SS, 2007, J AM CHEM SOC, V129, P14176, DOI 10.1021/ja076877g; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Klein N, 2009, ANGEW CHEM INT EDIT, V48, P9954, DOI 10.1002/anie.200904599; Koh K, 2009, J AM CHEM SOC, V131, P4184, DOI 10.1021/ja809985t; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Lin X, 2007, CRYSTENGCOMM, V9, P438, DOI 10.1039/b706207a; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; Mueller U, 2006, J MATER CHEM, V16, P626, DOI 10.1039/b511962f; Nelson AP, 2009, J AM CHEM SOC, V131, P458, DOI 10.1021/ja808853q; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Schnobrich JK, 2010, LANGMUIR, V26, P5808, DOI 10.1021/la9037292; Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k; Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yan Y, 2009, CHEM COMMUN, P1025, DOI 10.1039/b900013e; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	27	2869	2982	90	3746	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					424	428		10.1126/science.1192160	http://dx.doi.org/10.1126/science.1192160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595583				2022-12-24	WOS:000280196500033
J	Ye, J; Lenain, C; Bauwens, S; Rizzo, A; Saint-Leger, A; Poulet, A; Benarroch, D; Magdinier, F; Morere, J; Amiard, S; Verhoeyen, E; Britton, S; Calsou, P; Salles, B; Bizard, A; Nadal, M; Salvati, E; Sabatier, L; Wu, YL; Biroccio, A; Londono-Vallejo, A; Giraud-Panis, MJ; Gilson, E				Ye, Jing; Lenain, Christelle; Bauwens, Serge; Rizzo, Angela; Saint-Leger, Adelaide; Poulet, Anais; Benarroch, Delphine; Magdinier, Frederique; Morere, Julia; Amiard, Simon; Verhoeyen, Els; Britton, Sebastien; Calsou, Patrick; Salles, Bernard; Bizard, Anna; Nadal, Marc; Salvati, Erica; Sabatier, Laure; Wu, Yunlin; Biroccio, Annamaria; Londono-Vallejo, Arturo; Giraud-Panis, Marie-Josephe; Gilson, Eric			TRF2 and Apollo Cooperate with Topoisomerase 2 alpha to Protect Human Telomeres from Replicative Damage	CELL			English	Article							DNA-REPLICATION; ATM; MAINTENANCE; INTERACTS; NUCLEASE; BINDING; END	Human telomeres are protected from DNA damage by a nucleoprotein complex that includes the repeat-binding factor TRF2. Here, we report that TRF2 regulates the 5' exonuclease activity of its binding partner, Apollo, a member of the metallo-beta-lactamase family that is required for telomere integrity during S phase. TRF2 and Apollo also suppress damage to engineered interstitial telomere repeat tracts that were inserted far away from chromosome ends. Genetic data indicate that DNA topoisomerase 2 alpha acts in the same pathway of telomere protection as TRF2 and Apollo. Moreover, TRF2, which binds preferentially to positively supercoiled DNA substrates, together with Apollo, negatively regulates the amount of TOP1, TOP2 alpha, and TOP2 beta at telomeres. Our data are consistent with a model in which TRF2 and Apollo relieve topological stress during telomere replication. Our work also suggests that cellular senescence may be caused by topological problems that occur during the replication of the inner portion of telomeres.	[Ye, Jing; Lenain, Christelle; Bauwens, Serge; Saint-Leger, Adelaide; Poulet, Anais; Benarroch, Delphine; Magdinier, Frederique; Morere, Julia; Amiard, Simon; Salvati, Erica; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Biol Mol Cellule,UMR 5239, F-69364 Lyon, France; [Ye, Jing; Wu, Yunlin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China; [Ye, Jing; Saint-Leger, Adelaide; Benarroch, Delphine; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Nice Sophia Antipolis, CNRS, UMR 6267, Lab Biol & Pathol Genomes,INSERM,U998, F-06107 Nice, France; [Rizzo, Angela; Amiard, Simon; Salvati, Erica; Biroccio, Annamaria] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, I-00158 Rome, Italy; [Poulet, Anais; Benarroch, Delphine; Amiard, Simon; Giraud-Panis, Marie-Josephe] Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Joliot Curie,USR 3010, F-69364 Lyon, France; [Verhoeyen, Els] Univ Lyon, Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; [Britton, Sebastien; Calsou, Patrick; Salles, Bernard] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Bizard, Anna; Nadal, Marc] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Sabatier, Laure] Inst Radiobiol Cellulaire & Mol, Direct Sci Vivant, Commissariat Energie Atom, Lab Radiobiol & Oncol, F-92265 Fontenay Aux Roses, France; [Londono-Vallejo, Arturo] Univ Paris 06, CNRS, UMR 3244, Inst Curie,Telomeres & Canc Lab, F-75248 Paris, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, F-06202 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; CHU Nice	Gilson, E (corresponding author), Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Biol Mol Cellule,UMR 5239, F-69364 Lyon, France.	eric.gilson@ens-lyon.fr	Benarroch, Delphine/E-9983-2017; Magdinier, Frederique/I-4735-2016; Rizzo, Angela/ABH-6753-2020; Benarroch-Popivker, Delphine/T-1990-2019; Biroccio, Annamaria/B-2861-2018; Verhoeyen, Els/H-6360-2016; calsou, patrick/AAB-5123-2020; amiard, simon/J-6951-2015; Londono-Vallejo, Arturo/ABH-5555-2020; Britton, Sébastien/AAL-1862-2020; Verhoeyen, Els/AAW-4853-2021	Magdinier, Frederique/0000-0002-0159-9559; Rizzo, Angela/0000-0001-5421-3085; Biroccio, Annamaria/0000-0003-3198-3532; amiard, simon/0000-0002-0427-1647; Londono-Vallejo, Arturo/0000-0003-3535-7563; Britton, Sébastien/0000-0002-7008-5316; Verhoeyen, Els/0000-0001-9224-5491; Giraud-Panis, Marie-Josephe/0000-0001-7941-2873; ye, jing/0000-0002-9471-3321; NADAL, Marc/0000-0001-9637-7694; Calsou, Patrick/0000-0001-7951-9806; Sabatier, Laure/0000-0003-0552-6549; Bizard, Anna/0000-0003-1858-3999; Salvati, Erica/0000-0002-3373-7442	Ligue Nationale contre le Cancer; Institut National du Cancer; Agence Nationale de la Recherche; European Community [RISC-RAD FI6R-CT-2003-508842, TELOMARKER Health-F2-2007-200950]; Italian Association for Cancer Research; Association pour la Recherche sur le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank S. Gasser and F. Palladino for critical reading and also M. Foiani and T. Weinert for stimulating discussions. We are also grateful to E. Giulotto for advice concerning the choice of the natural ITS sequences, J.P. de Villartay for the primary fibroblast cells, and J.P. Murnane for SNG28 cell line. This work was supported by grants from the Ligue Nationale contre le Cancer (E. G., "equipe labellisee"), from the Institut National du Cancer (E. G., B. S., A. L. V., and L. S., program TELINCA), from Agence Nationale de la Recherche (E. G., programs TELOREG and TELOREP) and from the European Community (E. G. and L. S., RISC-RAD FI6R-CT-2003-508842; E. G., TELOMARKER Health-F2-2007-200950). The work of A. Biroccio's group was supported by grants from Italian Association for Cancer Research. Microscopy and image processing and analysis were performed at the imaging facility Plateau Technique Imagerie/Microscopie of IFR128. J.Y. and C. L. were supported by a fellowship from the Association pour la Recherche sur le Cancer.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; ARNOULT N, 2009, GENE DEV, V15, P1915; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Desmaze C, 2004, CYTOGENET GENOME RES, V104, P123, DOI 10.1159/000077476; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Freibaum BD, 2008, J BIOL CHEM, V283, P23671, DOI 10.1074/jbc.M800388200; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Mignon-Ravix C, 2002, EUR J HUM GENET, V10, P107, DOI 10.1038/sj.ejhg.5200775; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vannier JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000380; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	51	136	140	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					230	242		10.1016/j.cell.2010.05.032	http://dx.doi.org/10.1016/j.cell.2010.05.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655466	Bronze			2022-12-24	WOS:000280204300015
J	Behr, MA; Divangahi, M; Lalande, JD				Behr, Marcel A.; Divangahi, Maziar; Lalande, Jean-Daniel			What's in a name? The (mis)labelling of Crohn's as an autoimmune disease	LANCET			English	Editorial Material							ACUTE-INFLAMMATION; AUTOANTIBODIES; INFECTIONS; ANTIBODIES		[Behr, Marcel A.; Divangahi, Maziar; Lalande, Jean-Daniel] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Divangahi, Maziar] McGill Univ, Meakins Christie Labs, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Behr, MA (corresponding author), McGill Univ, Dept Med, Ctr Hlth, A5-156,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	marcel.behr@mcgill.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Desplat-Jego S, 2007, WORLD J GASTROENTERO, V13, P2312, DOI 10.3748/wjg.v13.i16.2312; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Dos KM, 2008, INFLAMM BOWEL DIS, V14, pS97, DOI 10.1002/ibd.20723; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Lowe AM, 2008, LANCET INFECT DIS, V8, P720, DOI 10.1016/S1473-3099(08)70257-3; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1358, DOI 10.1002/ibd.20892; Seibold F, 1997, GUT, V40, P481, DOI 10.1136/gut.40.4.481; Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Stetson DB, 2007, IMMUNITY, V27, P546, DOI 10.1016/j.immuni.2007.10.005; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816	20	18	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					202	203		10.1016/S0140-6736(10)60282-6	http://dx.doi.org/10.1016/S0140-6736(10)60282-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638565				2022-12-24	WOS:000280313100028
J	Wozny, M				Wozny, Michael			The biological passport and doping in athletics	LANCET			English	Editorial Material									Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA	Loma Linda University	Wozny, M (corresponding author), Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA.	mwozny@llu.edu						MCGRATH M, 2010, BBC NEWS CHANNE 0701; NIILER E, 2010, DISCOVERY NEWS  0507; *WORLD AN AG, 2009, QUEST ANSW ATHL BIOL; 2010, BRIT ATHLETES GET BI	4	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					79	79		10.1016/S0140-6736(10)61058-6	http://dx.doi.org/10.1016/S0140-6736(10)61058-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20621224				2022-12-24	WOS:000279943200009
J	Kratz, K; Schopf, B; Kaden, S; Sendoel, A; Eberhard, R; Lademann, C; Cannavo, E; Sartori, AA; Hengartner, MO; Jiricny, J				Kratz, Katja; Schoepf, Barbara; Kaden, Svenja; Sendoel, Ataman; Eberhard, Ralf; Lademann, Claudio; Cannavo, Elda; Sartori, Alessandro A.; Hengartner, Michael O.; Jiricny, Josef			Deficiency of FANCD2-Associated Nuclease KIAA1018/FAN1 Sensitizes Cells to Interstrand Crosslinking Agents	CELL			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASE; FANCONI-ANEMIA PATHWAY; DNA; PROTEINS; REPAIR; IDENTIFICATION; REPLICATION; RECOMBINATION; BREAKS; ALPHA	Cytotoxicity of cisplatin and mitomycin C (MMC) is ascribed largely to their ability to generate interstrand crosslinks (ICLs) in DNA, which block the progression of replication forks. The processing of ICLs requires the Fanconi anemia (FA) pathway, excision repair, and translesion DNA synthesis (TLS). It also requires homologous recombination (HR), which repairs double-strand breaks (DSBs) generated by cleavage of the blocked replication forks. Here we describe KIAA1018, an evolutionarily conserved protein that has an N-terminal ubiquitin-binding zinc finger (UBZ) and a C-terminal nuclease domain. KIAA1018 is a 5' -> 3' exonuclease and a structure-specific endonuclease that preferentially incises 50 flaps. Like cells from FA patients, human cells depleted of KIAA1018 are sensitized to ICL-inducing agents and display chromosomal instability. The link of KIAA1018 to the FA pathway is further strengthened by its recruitment to DNA damage through interaction of its UBZ domain with monoubiquitylated FANCD2. We therefore propose to name KIAA1018 FANCD2-associated nuclease, FAN1.	[Kratz, Katja; Schoepf, Barbara; Kaden, Svenja; Lademann, Claudio; Cannavo, Elda; Sartori, Alessandro A.; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Sendoel, Ataman; Eberhard, Ralf; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Jiricny, Josef] ETH, Dept Biol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch	Hengartner, Michael O/E-6235-2011; Sartori, Alessandro/AAK-7840-2021	Sartori, Alessandro/0000-0003-2770-0333; Sendoel, Ataman/0000-0002-0381-9965; Hengartner, Michael/0000-0002-7584-596X; Port, Barbara/0000-0002-8941-954X	Swiss National Science Foundation [3100A0-118158, 3100A0-128675]; Bonizzi-Theler; Ernst Hadorn	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler; Ernst Hadorn	We express our gratitude to John Rouse for the KIAA1018 antibody and for sharing unpublished information, to Milica Enoiu for discussions and for critical reading of the manuscript, Stephanie Felscher for help with evaluation of chromosomal instability, Myriam Marti for help with western blot analyses, Ian Hickson for MUS81/EME1, Ulrich Hubscher for FEN1, Pavel Janscak and Rajakrishnan Kanagaraj for the oligonucleotides, Jordi Surralles for the FANCD2-deficient and WT- or K561R- complemented PD20 cells, Petr Cejka for the Sf9 expression system, and Stefano Ferrari for MG132. We also acknowledge collaborations with Johan de Winter and Hans Joenje and with the group of Shunichi Takeda. The C01G5.8(tm423) deletion allele was kindly provided by Dr. Shohei Mitani (Japanese National Bioresource Project). This work was supported by Swiss National Science Foundation grants nr. 3100A0-118158 (J.J.) and 3100A0-128675 (M.H.). The generous support of the Bonizzi-Theler (J.J.) and Ernst Hadorn (M.H.) Foundations is also gratefully acknowledged.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Ermolova NV, 2003, PROTEIN EXPRES PURIF, V29, P123, DOI 10.1016/S1046-5928(03)00014-7; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002	29	204	213	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					77	88		10.1016/j.cell.2010.06.022	http://dx.doi.org/10.1016/j.cell.2010.06.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603016	Bronze			2022-12-24	WOS:000279637300014
J	Yi, JJ; Barnes, AP; Hand, R; Polleux, F; Ehlers, MD				Yi, Jason J.; Barnes, Anthony P.; Hand, Randal; Polleux, Franck; Ehlers, Michael D.			TGF-beta Signaling Specifies Axons during Brain Development	CELL			English	Article							GROWTH-FACTOR-BETA; POLARITY PROTEIN PAR6; TRANSFORMING GROWTH-FACTOR-BETA-1; TARGETED DISRUPTION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; CELL-POLARITY; RECEPTOR; NEURONS; EXPRESSION	In the mammalian brain, the specification of a single axon and multiple dendrites occurs early in the differentiation of most neuron types. Numerous intracellular signaling events for axon specification have been described in detail. However, the identity of the extracellular factor(s) that initiate neuronal polarity in vivo is unknown. Here, we report that transforming growth factor beta (TGF-beta) initiates signaling pathways both in vivo and in vitro to fate naive neurites into axons. Neocortical neurons lacking the type II TGF-beta receptor (T beta R2) fail to initiate axons during development. Exogenous TGF-beta is sufficient to direct the rapid growth and differentiation of an axon, and genetic enhancement of receptor activity promotes the formation of multiple axons. Finally, we show that the bulk of these TGF-beta-dependent events are mediated by site-specific phosphorylation of Par6. These results define an extrinsic cue for neuronal polarity in vivo that patterns neural circuits in the developing brain.	[Yi, Jason J.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yi, Jason J.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Barnes, Anthony P.; Hand, Randal; Polleux, Franck] Univ N Carolina, Dept Pharmacol, Ctr Neurosci, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Polleux, Franck/H-9948-2014	Barnes, Anthony/0000-0002-4598-9591; Polleux, Franck/0000-0003-4313-0481	NIMH; NINDS; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Irina Lebedeva and Marguerita Klein for excellent technical assistance and Ben Arenkiel, Ian Davison, Juliet Hernandez, Matt Kennedy, and Fan Wang for helpful discussion and critical review of the manuscript. We thank Irwin Liu and Xiao-Fan Wang for the Tgfbr1 shRNA constructs. This work was supported by grants from the NIMH and NINDS to M.D.E. and a Ruth K. Broad Biomedical Foundation fellowship to J.J.Y. M.D.E. is an Investigator of the Howard Hughes Medical Institute.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; Hung TJ, 1999, DEVELOPMENT, V126, P127; Ikegami R, 2004, DEV CELL, V6, P383, DOI 10.1016/S1534-5807(04)00057-7; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Mecha M, 2008, DEV DYNAM, V237, P1709, DOI 10.1002/dvdy.21558; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Polleux F, 1997, J COMP NEUROL, V385, P95; POLLEUX F, 2002, SCI STKE, pPL9; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; SONG Y, 2002, TECHNOL CANCER RES T, V1, P1; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242; Vicario-Abejon C, 2004, NEUROREPORT, V15, P2769; WALTER J, 1987, DEVELOPMENT, V101, P685; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	51	199	201	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					144	157		10.1016/j.cell.2010.06.010	http://dx.doi.org/10.1016/j.cell.2010.06.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603020	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000279637300020
J	Budd, AF; Pandolfi, JM				Budd, Ann F.; Pandolfi, John M.			Evolutionary Novelty Is Concentrated at the Edge of Coral Species Distributions	SCIENCE			English	Article							MONTASTRAEA-ANNULARIS; REEF CORAL; CLIMATE-CHANGE; BIODIVERSITY HOTSPOTS; HYBRIDIZATION; CONSERVATION; SPECIATION; COMPLEX; PLEISTOCENE; POPULATIONS	Conservation priorities are calculated on the basis of species richness, endemism, and threats. However, areas ranked highly for these factors may not represent regions of maximal evolutionary potential. The relationship between geography and evolutionary innovation was analyzed in a dominant complex of Caribbean reef corals, in which morphological and genetic data concur on species differences. Based on geometric morphometrics of Pleistocene corals and genetically characterized modern colonies, we found that morphological disparity varies from the center to the edge of the Caribbean, and we show that lineages are static at well-connected central locations but split or fuse in edge zones where gene flow is limited. Thus, conservation efforts in corals should focus not only on the centers of diversity but also on peripheral areas of species ranges and population connectivity.	[Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Ctr Marine Studies, Brisbane, Qld, Australia; [Pandolfi, John M.] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia	University of Iowa; University of Queensland; University of Queensland	Budd, AF (corresponding author), Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA.	ann-budd@uiowa.edu	Pandolfi, John M/A-3121-2009	Pandolfi, John M/0000-0003-3047-6694	NSF [EAR97-25273, DEB-0343208]; Smithsonian Institution Marine Science Network; Smithsonian Tropical Research Institute; Australian Research Council Centre of Excellence	NSF(National Science Foundation (NSF)); Smithsonian Institution Marine Science Network; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Australian Research Council Centre of Excellence(Australian Research Council)	We thank T. Fadiga for assistance with measurements; N. Knowlton and H. Fukami for genetic analyses; and D. Carlon, N. Knowlton, and R. Steneck for comments. The specimens that were analyzed are listed in appendix S1. This research was supported by NSF grants EAR97-25273 and DEB-0343208 to A. F. B. and Smithsonian Institution Marine Science Network and Biodiversity grants, a Smithsonian Tropical Research Institute Tupper Fellowship, and an Australian Research Council Centre of Excellence grant to J.M.P.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Budd AE, 2004, PALEOBIOLOGY, V30, P396, DOI 10.1666/0094-8373(2004)030<0396:OSBAHW>2.0.CO;2; Budd AF, 2001, J PALEONTOL, V75, P527, DOI 10.1666/0022-3360(2001)075<0527:TOAEEO>2.0.CO;2; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chiba S, 2005, EVOLUTION, V59, P1712, DOI 10.1111/j.0014-3820.2005.tb01820.x; Draper G., 1994, CARIBBEAN GEOLOGY IN, P129; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; KNOWLTON N, 1992, SCIENCE, V255, P330, DOI 10.1126/science.255.5042.330; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lister A, 2004, PHILOS T R SOC B, V359, P195; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; MANN P, 1999, SED BAS WOR, V4, P3; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2002, EVOLUTION, V56, P479; Pandolfi JM, 2008, MAR ECOL PROG SER, V369, P89, DOI 10.3354/meps07570; Pandolfi JM, 2007, J PALEONTOL, V81, P472, DOI 10.1666/pleo05046.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136	35	72	74	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1558	1561		10.1126/science.1188947	http://dx.doi.org/10.1126/science.1188947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558718				2022-12-24	WOS:000278859200046
J	Swain, S; Krause, T; Laramee, P; Stewart, S				Swain, Sharon; Krause, Taryn; Laramee, Phillipe; Stewart, Stephen		Guideline Dev Grp	Guidelines Diagnosis and clinical management of alcohol related physical complications: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							WITHDRAWAL		[Swain, Sharon; Krause, Taryn; Laramee, Phillipe] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Stewart, Stephen] Freeman Rd Hosp, Liver Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Swain, S (corresponding author), Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England.	Sharon.swain@rcplondon.co.uk		Mortimore, Gerri/0000-0001-6890-4346	National Institute for Health and Clinical Excellence; NIHR-HTA; National Institute for Health Research	National Institute for Health and Clinical Excellence; NIHR-HTA; National Institute for Health Research(National Institute for Health Research (NIHR))	The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) All of the authors have no financial support for the submitted work from anyone other than their employers; (2) In the previous three years S Stewart has been a member of the trial management group for a study (steroids or pentoxifylline in alcoholic hepatitis) funded by the NIHR-HTA, the Health Technology Assessment programme, which is part of the National Institute for Health Research; (3) All authors have no spouses, partners, or children with financial relationships that may be relevant to the submitted work; and (4) All authors were members of the Guideline Development Group for the NICE guideline (S Swain the systematic reviewer, PL the health economist, TK the project manager, and S Stewart the clinical lead) but have no other non-financial interests that may be relevant to the submitted work.	CARITHERS RL, 1989, ANN INTERN MED, V110, P685, DOI 10.7326/0003-4819-110-9-685; *CTR PUBL HLTH EXC, 2010, ALC US DIS PREV DEV; *CTR PUBL HLTH EXC, ALC US DIS IN PRESS; Department of Health, 2003, COST ALC HARM NHS EN; *INF CTR HLTH SOC, 2009, STAT ALC ENGL; National Institute for Health and Clinical Excellence, 2010, ALC US DIS DIAGN CLI; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; UK Liver Transplant Group, 2005, LIV ADV GROUP ALC GU; Ward D, 2009, QJM-INT J MED, V102, P773, DOI 10.1093/qjmed/hcp116; 2010, BRIT NATL FORMULARLY	10	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c2942	10.1136/bmj.c2942	http://dx.doi.org/10.1136/bmj.c2942			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JB	20554661				2022-12-24	WOS:000279051900003
J	Ferner, RE; Lenney, W; Marriott, JF				Ferner, R. E.; Lenney, Warren; Marriott, John F.			Controversy over generic substitution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUGS; BIOEQUIVALENCE; ADHERENCE		[Ferner, R. E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [Ferner, R. E.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Lenney, Warren] Univ Hosp N Staffordshire, Acad Dept Child Hlth, Stoke On Trent ST4 6QG, Staffs, England; [Lenney, Warren] Keele Univ, Stoke On Trent ST4 6QG, Staffs, England; [Marriott, John F.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Birmingham; University of Birmingham; Keele University; Keele University; Aston University	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346	GlaxoSmithKline; Novartis; Astra Zeneca; Abbott	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Astra Zeneca(AstraZeneca); Abbott(Abbott Laboratories)	Competing interests: All authors have completed the unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare (1) no financial support for the submitted work from anyone other than their employer; (2) WL has received research grants, lecture fees, or travel expenses for meetings from GlaxoSmithKline, Novartis, Astra Zeneca, and Abbott; (3) no spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; and (4) REF chairs a healthcare-wide drug and therapeutics committee that encourages generic prescribing.	Borgherini G, 2003, CLIN THER, V25, P1578, DOI 10.1016/S0149-2918(03)80157-1; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; *DAN MED AG, BIOEQ LAB MED PROD R; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; Department of Health, 2009, PROP IMPL GEN SUBST; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; *FOOD DRUG ADM, 2010, GEN COMP DRUG PRIC; Kalisch LM, 2008, PHARMACOEPIDEM DR S, V17, P620, DOI 10.1002/pds.1580; Kanazawa S, 2001, EUR J CLIN PHARMACOL, V56, P799, DOI 10.1007/s002280000229; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; McCartney M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1514; *UK DEP HLTH ASS B, 2009, PHARM PRIC REG SCHEM; Vogler S., 2008, PHARM PRICING REIMBU; Vrijens B, 2008, BMJ-BRIT MED J, V336, P1114, DOI 10.1136/bmj.39553.670231.25; WELLING PG, 1977, ANTIMICROB AGENTS CH, V11, P462, DOI 10.1128/AAC.11.3.462	16	32	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2010	340								c2548	10.1136/bmj.c2548	http://dx.doi.org/10.1136/bmj.c2548			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BK	20516014				2022-12-24	WOS:000278556300002
J	Lam, CK; Yoo, T; Hiner, B; Liu, ZQ; Grutzendler, J				Lam, Carson K.; Yoo, Taehwan; Hiner, Bennett; Liu, Zhiqiang; Grutzendler, Jaime			Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization	NATURE			English	Article							BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; MATRIX METALLOPROTEINASES; ALZHEIMERS-DISEASE; IN-VIVO; VESSELS; STROKE; CAPILLARIES; ISCHEMIA; DECLINE	Cerebral microvascular occlusion is a common phenomenon throughout life 1,2 that might require greater recognition as a mechanism of brain pathology. Failure to recanalize microvessels promptly may lead to the disruption of brain circuits and significant functional deficits(3). Haemodynamic forces and the fibrinolytic system(4) are considered to be the principal mechanisms responsible for recanalization of occluded cerebral capillaries and terminal arterioles. Here we identify a previously unrecognized cellular mechanism that may also be critical for this recanalization. By using high-resolution fixed-tissue microscopy and two-photon imaging in living mice we observed that a large fraction of microemboli infused through the internal carotid artery failed to be lysed or washed out within 48 h. Instead, emboli were found to translocate outside the vessel lumen within 2-7 days, leading to complete re-establishment of blood flow and sparing of the vessel. Recanalization occurred by a previously unknown mechanism of microvascular plasticity involving the rapid envelopment of emboli by endothelial membrane projections that subsequently form a new vessel wall. This was followed by the formation of an endothelial opening through which emboli translocated into the perivascular parenchyma. The rate of embolus extravasation was significantly decreased by pharmacological inhibition of matrix metalloproteinase 2/9 activity. In aged mice, extravasation was markedly delayed, resulting in persistent tissue hypoxia, synaptic damage and cell death. Alterations in the efficiency of the protective mechanism that we have identified may have important implications in microvascular pathology, stroke recovery and age-related cognitive decline.	[Lam, Carson K.; Yoo, Taehwan; Hiner, Bennett; Liu, Zhiqiang; Grutzendler, Jaime] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Grutzendler, J (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	grutzj@northwestern.edu	Grutzendler, Jaime/F-3691-2010	Lam, Carson/0000-0002-8255-4423	National Institutes of Health/National Institute on Aging [AG027855]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [R01AG027855] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Lo, C. Freitas, D. Choi and C. Whiteus for help with experiments; A. Schain for suggesting the use of ACTB-eGFP mice; E. Mugnaini for advice with transmission electron microscopy experiments; and G. D'avossa, J. Garcia-Anoveros, J. Kessler and P. Opal for helpful discussions and critical review of the manuscript. This work was supported by National Institutes of Health/National Institute on Aging grant AG027855 (J.G.) and a Howard Hughes Medical Institute medical student research fellowship ( C. K. L.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; GLEERUP G, 1995, ANGIOLOGY, V46, P715, DOI 10.1177/000331979504600810; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; LEVIN EG, 1994, AM J PATHOL, V144, P855; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; MARKUS HS, 1995, BRAIN, V118, P1005, DOI 10.1093/brain/118.4.1005; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; Rapp JH, 2000, J VASC SURG, V32, P68, DOI 10.1067/mva.2000.107315; SIEBLER M, 1994, NEUROLOGY, V44, P615, DOI 10.1212/WNL.44.4.615; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; ZLOKOVIC BV, 1995, NEUROSURGERY, V37, P955, DOI 10.1227/00006123-199511000-00015	30	115	121	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					478	U101		10.1038/nature09001	http://dx.doi.org/10.1038/nature09001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505729	Green Accepted			2022-12-24	WOS:000278043700035
J	Buscher, AL; Giordano, TP				Buscher, April L.; Giordano, Thomas P.			Gaps in Knowledge in Caring for HIV Survivors Long-term	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; POPULATION		Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Giordano, TP (corresponding author), Michael E DeBakey VA Med Ctr 152, Hlth Serv Res & Dev Ctr Excellence, 2002 Holcombe Blvd, Houston, TX 77030 USA.	tpg@bcm.tmc.edu		Giordano, Thomas/0000-0002-9346-5530				Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Handford C. D., 2006, COCHRANE DB SYST REV, V3; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	9	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					340	341		10.1001/jama.2010.870	http://dx.doi.org/10.1001/jama.2010.870			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628HV	20639568				2022-12-24	WOS:000280107500024
J	Holmes, CB; Coggin, W; Jamieson, D; Mihm, H; Granich, R; Savio, P; Hope, M; Ryan, C; Moloney-Kitts, M; Goosby, EP; Dybul, M				Holmes, Charles B.; Coggin, William; Jamieson, David; Mihm, Heidi; Granich, Reuben; Savio, Phillip; Hope, Michael; Ryan, Caroline; Moloney-Kitts, Michele; Goosby, Eric P.; Dybul, Mark			Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENOFOVIR	Context One of the biggest hurdles to the rapid scale-up of antiretroviral therapy in the developing world was the price of antiretroviral drugs (ARVs). Modification of an existing US Food and Drug Administration (FDA) process to expedite review and approval of generic ARVs quickly resulted in a large number of FDA-tentatively approved ARVs available for use by the US President's Emergency Plan for AIDS Relief (PEPFAR). Objective To evaluate the uptake of generic ARVs among PEPFAR-supported programs in Guyana, Haiti, Vietnam, and 13 countries in Africa, and changes over time in ARV use and costs. Design, Setting, and Participants An annual survey from 2005 to 2008 of ARVs purchased in 16 countries by PEPFAR implementing and procurement partners (organizations using PEPFAR funding to purchase ARVs). Main Outcome Measures Drug expenditures, ARV types and volumes (assessed per pack, a 1-month supply), proportion of generic procurement across years and countries, and cost savings from generic procurement. Results ARV expenditures increased from $116.8 million (2005) to $202.2 million (2008); and procurement increased from 6.2 million to 22.1 million monthly packs. The proportion spent on generic ARVs increased from 9.17% (95% confidence interval [CI], 9.17%-9.18%) in 2005 to 76.41% (95% CI, 76.41%-76.42%) in 2008 (P<.001), and the proportion of generic packs procured increased from 14.8% (95% CI, 14.79%-14.84%) in 2005 to 89.33% (95% CI, 89.32%-89.34%) in 2008 (P similar to. 001). In 2008, there were 8 PEPFAR programs that procured at least 90.0% of ARV packs in generic form; South Africa had the lowest generic procurement (24.7%; 95% CI, 24.6%-24.8%). Procurement of generic fixed-dose combinations increased from 33.3% (95% CI, 33.24%-33.43%) in 2005 to 42.73% (95% CI, 42.71%-42.75%) in 2008. Estimated yearly savings generated through generic ARV use were $8 108 444 in 2005, $24 940 014 in 2006, $75 645 816 in 2007, and $214 648 982 in 2008, a total estimated savings of $323 343 256. Conclusion Among PEPFAR-supported programs in 16 countries, availability of generic ARVs was associated with increased ARV procurement and substantial estimated cost savings. JAMA. 2010;304(3):313-320 www.jama.com	[Holmes, Charles B.; Coggin, William; Granich, Reuben; Ryan, Caroline; Moloney-Kitts, Michele; Goosby, Eric P.; Dybul, Mark] US Dept State, Off US Global AIDS Coordinator, Washington, DC 20522 USA; [Jamieson, David; Savio, Phillip] Supply Chain Management Syst, Arlington, VA USA; [Mihm, Heidi; Hope, Michael] US Agcy Int Dev, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Holmes, CB (corresponding author), US Dept State, Off US Global AIDS Coordinator, 2100 Penn Ave, Washington, DC 20522 USA.	holmescb@state.gov			US government	US government	This study was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) of the US government.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; El-Khatib Z, 2009, SAMJ S AFR MED J, V99, P412; Ford N, 2008, S AFR J HIV MED, P8; Husain M, 2009, INDIAN J CHEM B, V48, P1174; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; *MIN HLTH ZAMB, ANT THER CHRON HIV I; MSF Campaign for Access to Essential Medicines, UNT WEB ANT PRIC RED; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; *SUPPL CHAIN MAN S, US; US Food and Drug Administration, PRES EM PLAN AIDS RE; *US PRES PLAN AIDS, 2008, REP C US GLOB AIDS C; *US PRES PLAN AIDS, WORLD AIDS DAY 2009; *WHO, WHO HLTH SYST SERV P; World Health Organization, 2009, RAP ADV ANT THER HIV	16	66	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					313	320		10.1001/jama.2010.993	http://dx.doi.org/10.1001/jama.2010.993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639565	Bronze			2022-12-24	WOS:000280107500021
J	Lamont, T; Dougall, A; Johnson, S; Mathew, D; Scarpello, J; Morris, E				Lamont, Tara; Dougall, Anita; Johnson, Sara; Mathew, Dinah; Scarpello, John; Morris, Edward			Safety Alerts Reducing the risk of retained swabs after vaginal birth: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							INSTRUMENTS		[Lamont, Tara; Dougall, Anita; Johnson, Sara; Mathew, Dinah; Scarpello, John] Natl Patient Safety Agcy, London, England; [Morris, Edward] Norfolk & Norwich Univ Hosp, Norfolk, VA USA		Lamont, T (corresponding author), Natl Patient Safety Agcy, London, England.	tara.lamont@npsa.nhs.uk						*ASS PRE PRACT, 2007, SWAB INSTR NEEDL COU; Egorova NN, 2008, ANN SURG, V247, P13, DOI 10.1097/SLA.0b013e3180f633be; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; *I CLIN SYST IMPR, 2009, PREV UN RET FOR OBJ; National Institute for Health and Clinical Excellence, 2007, INTR CAR CAR HLTH WO	5	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2010	341								c3679	10.1136/bmj.c3679	http://dx.doi.org/10.1136/bmj.c3679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GU	20643710				2022-12-24	WOS:000280411500001
J	Kondo, T; Plaza, S; Zanet, J; Benrabah, E; Valenti, P; Hashimoto, Y; Kobayashi, S; Payre, F; Kageyama, Y				Kondo, T.; Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Hashimoto, Y.; Kobayashi, S.; Payre, F.; Kageyama, Y.			Small Peptides Switch the Transcriptional Activity of Shavenbaby During Drosophila Embryogenesis	SCIENCE			English	Article							POLYCISTRONIC MESSENGER-RNA; OPEN READING FRAMES; EPIDERMIS DIFFERENTIATION; GENOME; IDENTIFICATION; MORPHOGENESIS; EVOLUTION; GENES	A substantial proportion of eukaryotic transcripts are considered to be noncoding RNAs because they contain only short open reading frames (sORFs). Recent findings suggest, however, that some sORFs encode small bioactive peptides. Here, we show that peptides of 11 to 32 amino acids encoded by the polished rice (pri) sORF gene control epidermal differentiation in Drosophila by modifying the transcription factor Shavenbaby (Svb). Pri peptides trigger the amino-terminal truncation of the Svb protein, which converts Svb from a repressor to an activator. Our results demonstrate that during Drosophila embryogenesis, Pri sORF peptides provide a strict temporal control to the transcriptional program of epidermal morphogenesis.	[Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Payre, F.] Univ Toulouse 3, Univ Toulouse, Ctr Dev Biol, F-31062 Toulouse, France; [Kondo, T.; Hashimoto, Y.; Kobayashi, S.; Kageyama, Y.] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Kondo, T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Payre, F.] CBD, CNRS, UMR 5547, F-31062 Toulouse, France; [Kobayashi, S.] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Hashimoto, Y.; Kageyama, Y.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Nara Institute of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Payre, F (corresponding author), Univ Toulouse 3, Univ Toulouse, Ctr Dev Biol, Batiment 4R3,118 Route Narbonne, F-31062 Toulouse, France.	payre@cict.fr; kageyama@nibb.ac.jp	plaza, serge/F-5290-2015	Kondo, Takefumi/0000-0001-8127-1141; PAYRE, Francois/0000-0002-8144-6711	Japan Society for the Promotion of Science; JST; Ministry of Education, Culture, Sports, Science and Technology [20370091]; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer [1111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank the Kyoto Drosophila Genetic Resource Center (DGRC); Bloomington Drosophila Stock Center for fly strains; the Indiana DGRC; G. Patterson, J. Lippincott-Schwartz, and C. Hill for plasmids; S. Takada and T. Okubo (NIBB) for technical advice; Y. Latapie and B. Ronsin (CBD) and J. D'Alayer (Institut Pasteur) for excellent technical assistance; and members of the Kobayashi laboratory for helpful comments and discussion. This work was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science; the JST PRESTO program; the Ministry of Education, Culture, Sports, Science and Technology KAKENHI (20370091); Agence Nationale de la Recherche (Programme Blanc "Netoshape"); Fondation pour la Recherche Medicale (Equipe 2005); and Association pour la Recherche sur le Cancer (1111).	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Andrews J, 2000, DEVELOPMENT, V127, P881; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102	21	238	257	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					336	339		10.1126/science.1188158	http://dx.doi.org/10.1126/science.1188158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647469				2022-12-24	WOS:000279925900046
J	Padma, TV				Padma, T. V.			Developing solutions	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S16	S17		10.1038/nature09242	http://dx.doi.org/10.1038/nature09242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631698				2022-12-24	WOS:000279867100031
J	Willyard, C				Willyard, Cassandra			Joining forces	NATURE			English	Editorial Material							MICROBICIDES											Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Saxena BB, 2009, AIDS, V23, P917, DOI 10.1097/QAD.0b013e32832af57c; Watts C, 2001, AIDS, V15, pS43, DOI 10.1097/00002030-200102001-00064	3	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S9	S10		10.1038/nature09239	http://dx.doi.org/10.1038/nature09239			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631707	Bronze			2022-12-24	WOS:000279867100028
J	Roehr, B				Roehr, Bob			Drug laws in Latin America	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2010	341								c3752	10.1136/bmj.c3752	http://dx.doi.org/10.1136/bmj.c3752			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627981				2022-12-24	WOS:000280156600019
J	Lamont, T; Coates, T; Mathew, D; Scarpello, J; Slater, A				Lamont, Tara; Coates, Tracy; Mathew, Dinah; Scarpello, John; Slater, Andrew			Safety Alerts Checking for pregnancy before surgery: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Coates, Tracy; Mathew, Dinah; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Slater, Andrew] E Sussex Hosp Trust, Eastbourne BN21 2UD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						*DEP HLTH, 2004, BEST PRACT GUID DOCT; Kahn RL, 2008, ANESTH ANALG, V106, P1127, DOI 10.1213/ane.0b013e31816788df; National Collaborating Centre for Acute Care, 2003, PREOP TESTS US ROUT; Royal College of Obstetricians and Gynaecologists, 2008, OBT VAL CONS; The National Patient Safety Agency, 2009, WHO SURG SAF CHECKL; Twersky RS, 1996, ANESTH ANALG, V83, P438, DOI 10.1097/00000539-199608000-00059; WALL BF, 2009, 9 RCE HLTH PROT AG; Wilcox AJ, 2001, JAMA-J AM MED ASSOC, V286, P1759, DOI 10.1001/jama.286.14.1759	8	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2010	341								c3402	10.1136/bmj.c3402	http://dx.doi.org/10.1136/bmj.c3402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DK	20605880				2022-12-24	WOS:000279874200004
J	Cadwell, K; Patel, KK; Maloney, NS; Liu, TC; Ng, ACY; Storer, CE; Head, RD; Xavier, R; Stappenbeck, TS; Virgin, HW				Cadwell, Ken; Patel, Khushbu K.; Maloney, Nicole S.; Liu, Ta-Chiang; Ng, Aylwin C. Y.; Storer, Chad E.; Head, Richard D.; Xavier, Ramnik; Stappenbeck, Thaddeus S.; Virgin, Herbert W.			Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine	CELL			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; MURINE NOROVIRUS; MURINE-NOROVIRUS-1 INFECTION; MONOCLONAL-ANTIBODIES; INFLUENZA-VIRUS; CELIAC-DISEASE; MOUSE MODEL; IN-VITRO; KEY ROLE	It is unclear why disease occurs in only a small proportion of persons carrying common risk alleles of disease susceptibility genes. Here we demonstrate that an interaction between a specific virus infection and a mutation in the Crohn's disease susceptibility gene Atg16L1 induces intestinal pathologies in mice. This virus-plus-susceptibility gene interaction generated abnormalities in granule packaging and unique patterns of gene expression in Paneth cells. Further, the response to injury induced by the toxic substance dextran sodium sulfate was fundamentally altered to include pathologies resembling aspects of Crohn's disease. These pathologies triggered by virus-plus-susceptibility gene interaction were dependent on TNF alpha and IFN gamma and were prevented by treatment with broad spectrum antibiotics. Thus, we provide a specific example of how a virus-plus-susceptibility gene interaction can, in combination with additional environmental factors and commensal bacteria, determine the phenotype of hosts carrying common risk alleles for inflammatory disease.	[Cadwell, Ken; Patel, Khushbu K.; Maloney, Nicole S.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Ctr Computat & Integrat Biol, Sch Med, Boston, MA 02114 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Cambridge, MA 02142 USA; [Storer, Chad E.; Head, Richard D.] Pfizer Global Res & Dev, Inflammat & Immunol Res Unit, St Louis, MO 63017 USA; [Virgin, Herbert W.] Midwest Reg Ctr Excellence Biodefense & Emerging, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Pfizer	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu; virgin@wustl.edu	Storer, Chad/GZM-2678-2022; Ng, Aylwin/AAQ-6478-2020	Storer, Chad/0000-0002-0139-0819; Cadwell, Ken/0000-0002-5860-0661; Liu, Ta-Chiang/0000-0002-2800-9360; Virgin, Herbert/0000-0001-8580-7628	Project 5 [U54 AI057160]; Broad Foundation [R01 AI084887]; Damon Runyon Cancer Research Foundation [DRG-1972-08]; NIH [T32-AI007172]; Pew Foundation; Washington University Digestive Diseases Research Core Center [DK52574]; Crohn's and Colitis Foundation of America [DK83756, DK086502, DK043351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R01AI084887, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, RC1DK086502, R01DK083756, P30DK043351, P30DK052574] Funding Source: NIH RePORTER	Project 5; Broad Foundation; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; Washington University Digestive Diseases Research Core Center; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grant U54 AI057160 Project 5 and the Broad Foundation (K. C., N.M., and H. W. V.), R01 AI084887 (T. S. S. and H. W. V.), the Lallage Feazel Wall Fellowship DRG-1972-08 from the Damon Runyon Cancer Research Foundation (K. C.), training grant NIH T32-AI007172 (N.M.), the Pew Foundation (K. K. P. and T. S. S.), Washington University Digestive Diseases Research Core Center DK52574, Pfizer biomedical agreement with Washington University, fellowship award from the Crohn's and Colitis Foundation of America (A.C.Y.N), and grants DK83756, DK086502, and DK043351 (R.J.X.). Washington University holds U. S. patents 7,041,444 B2, 7,264,923, and US 7,455,972 related to growth and detection of MNV. Washington University and H. W. V. receive income based on licenses for MNV technology.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brem-Exner BG, 2008, J IMMUNOL, V180, P335, DOI 10.4049/jimmunol.180.1.335; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chand N, 2006, J CLIN GASTROENTEROL, V40, P3, DOI 10.1097/01.mcg.0000190644.01661.2b; Day DW, 2003, MORSON DAWSONS GASTR; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; DYRBERG T, 1988, J CLIN INVEST, V81, P928, DOI 10.1172/JCI113405; FAIS S, 1991, GUT, V32, P403, DOI 10.1136/gut.32.4.403; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Goto K, 2009, EXP ANIM TOKYO, V58, P135, DOI 10.1538/expanim.58.135; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ju JS, 2009, AUTOPHAGY, V5, P511, DOI 10.4161/auto.5.4.7761; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Piguet PF, 1999, LAB INVEST, V79, P495; Porter CK, 2008, GASTROENTEROLOGY, V135, P781, DOI 10.1053/j.gastro.2008.05.081; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROBERTS ME, 2009, SURG PATHOLOGY GI TR; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Scholtens D, 2004, J MULTIVARIATE ANAL, V90, P19, DOI 10.1016/j.jmva.2004.02.004; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; TONIETTI G, 1970, J EXP MED, V132, P89, DOI 10.1084/jem.132.1.89; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	71	666	674	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1135	U64		10.1016/j.cell.2010.05.009	http://dx.doi.org/10.1016/j.cell.2010.05.009			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602997	Green Accepted, Bronze			2022-12-24	WOS:000279148100011
J	Smith, LN; James, R; Barber, M; Ramsay, S; Gillespie, D; Chung, C				Smith, Lorraine N.; James, Roberta; Barber, Mark; Ramsay, Scott; Gillespie, David; Chung, Charlie		Guideline Dev Grp	Guidelines Rehabilitation of patients with stroke: summary of SIGN guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECOVERY; PAIN		[Smith, Lorraine N.] Univ Glasgow, Fac Med, Glasgow G12 8LL, Lanark, Scotland; [James, Roberta] SIGN, Edinburgh EH7 5EA, Midlothian, Scotland; [Ramsay, Scott] St Johns Hosp, Livingston EH54 6PP, Scotland; [Gillespie, David] Astley Ainslie Hosp, Dept Clin Psychol, Edinburgh EH9 2HL, Midlothian, Scotland	University of Glasgow	Smith, LN (corresponding author), Univ Glasgow, Fac Med, Glasgow G12 8LL, Lanark, Scotland.	l.n.smith@clinmed.gla.ac.uk		Barber, Mark/0000-0002-2893-1566; Todhunter-Brown, Alex/0000-0003-4941-7985				[Anonymous], 1988, USERS GUIDE GEN HLTH; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; De Wit L, 2007, STROKE, V38, P2101, DOI 10.1161/STROKEAHA.107.482869; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Jensen MP, 2003, J PAIN, V4, P2, DOI 10.1054/jpai.2003.1; Kalra L, 2007, J REHABIL MED, V39, P97, DOI 10.2340/16501977-0043; Langhorne P, 2007, J REHABIL MED, V39, P103, DOI 10.2340/16501977-0042; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; *NHS NAT SERV SCOT, ANN PUBL SUMM NHS NA; Saunders DH, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003316.PUB2; Scottish Intercollegiate Guidelines Network (SIGN), 2008, SIGN PUBL, V108; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V119; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V118; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Teasell RW, 2005, STROKE, V36, P215, DOI 10.1161/01.STR.0000153061.02375.04	16	6	7	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2845	10.1136/bmj.c2845	http://dx.doi.org/10.1136/bmj.c2845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551122	Green Accepted			2022-12-24	WOS:000279051800005
J	Parmet, WE				Parmet, Wendy E.			Pandemic Vaccines -- The Legal Landscape.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northeastern Univ, Sch Law, Boston, MA 02115 USA	Northeastern University	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							DUCHIN JS, 2009, SPRING 2009 INFLUENZ; Fisher B. L., 2009, POLITICS PROFITS PAN; MCNEIL DG, 2010, NY TIMES        0313, pA11; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477	4	14	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1949	1952		10.1056/NEJMp1000938	http://dx.doi.org/10.1056/NEJMp1000938			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601JI	20505176				2022-12-24	WOS:000278054000001
J	Young, RC				Young, Robert C.			Cancer Clinical Trials - A Chronic but Curable Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									RCY Med, Philadelphia, PA USA		Young, RC (corresponding author), RCY Med, Philadelphia, PA USA.							Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Editorial, 2010, NY TIMES        0424; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Nass S, 2010, NATL CANC CLIN TRIAL; National Cancer Institute, 1997, REP NAT CANC I CLIN	5	35	35	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					306	309		10.1056/NEJMp1005843	http://dx.doi.org/10.1056/NEJMp1005843			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628RU	20554976				2022-12-24	WOS:000280139300003
J	Chiao, EY; Dezube, BJ; Krown, SE; Wachsman, W; Brock, MV; Giordano, TP; Mitsuyasu, R; Pantanowitz, L				Chiao, Elizabeth Y.; Dezube, Bruce J.; Krown, Susan E.; Wachsman, William; Brock, Malcolm V.; Giordano, Thomas P.; Mitsuyasu, Ronald; Pantanowitz, Liron			Time for Oncologists to Opt In for Routine Opt-Out HIV Testing?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-RELATED MALIGNANCIES; SQUAMOUS-CELL CARCINOMA; HEALTH-CARE SETTINGS; LUNG-CANCER; INFECTED PATIENTS; UNITED-STATES; ANAL CANCER; DEFINING CANCERS	Human immunodeficiency virus (HIV)-infected individuals are at high risk of malignancies. However, it is not currently the standard of care to routinely test cancer patients for HIV. In 2006, the Centers for Disease Control and Prevention recommended HIV testing in all health care settings, calling for standard nontargeted "opt-out" HIV screening. For a variety of reasons, routine opt-out HIV testing is still not widely used in the United States. Although many barriers to routine opt-out HIV testing have been addressed, such opt-out HIV testing continues to be conducted primarily in venues that target specific patient populations such as pregnant women. Although opt-out testing has been piloted in emergency departments, less emphasis has been placed on opt-out HIV testing in other clinical settings. In this article, the background, rationale, and evidence for supporting opt-out HIV testing as routine care for cancer patients are presented. In addition, evidence is discussed for the potential of opt-out HIV testing to improve clinical outcomes by facilitating appropriate HIV management during cancer treatment for individuals who are found to be HIV positive. JAMA. 2010;304(3):334-339 www.jama.com	[Chiao, Elizabeth Y.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Chiao, Elizabeth Y.; Giordano, Thomas P.] Dept Vet Affairs Med Ctr, Houston, TX USA; [Dezube, Bruce J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA; [Krown, Susan E.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wachsman, William] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Brock, Malcolm V.] Johns Hopkins Med Ctr, Baltimore, MD USA; [Mitsuyasu, Ronald] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles Ctr Clin AIDS Res & Educ, Los Angeles, CA 90095 USA; [Pantanowitz, Liron] Tufts Univ, Sch Med, Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baystate Medical Center; Tufts University	Chiao, EY (corresponding author), Michael E DeBakey VA Med Ctr 152, Houston VA Hlth Serv Res & Dev, 2002 Holcombe Blvd, Houston, TX 77030 USA.	echiao@bcm.edu	Pantanowitz, Liron/AFP-8163-2022	Chiao, Elizabeth/0000-0001-5752-2916; Giordano, Thomas/0000-0002-9346-5530	National Cancer Institute [UO1 CA 121947]; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]; National Cancer Institute, National Institutes of Health [K23CA124318]; NATIONAL CANCER INSTITUTE [U01CA121947, K23CA124318] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Houston VA Health Services Research and Development Center of Excellence; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based on work supported by National Cancer Institute grant UO1 CA 121947 to the AIDS Malignancy Consortium. This work was also supported in part by the Houston VA Health Services Research and Development Center of Excellence (grant HFP90-020). Dr Chiao received support from the National Cancer Institute, National Institutes of Health, grant K23CA124318.	Abramowitz L, 2009, ALIMENT PHARM THER, V30, P414, DOI 10.1111/j.1365-2036.2009.04026.x; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Berenguer J, 2008, JAIDS-J ACQ IMM DEF, V47, P422, DOI 10.1097/QAI.0b013e31815e722b; Besson C, 2001, BLOOD, V98, P2339, DOI 10.1182/blood.V98.8.2339; Bower M, 2004, JAIDS-J ACQ IMM DEF, V37, P1563, DOI 10.1097/00126334-200412150-00004; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brock MV, 2006, JAIDS-J ACQ IMM DEF, V43, P47, DOI 10.1097/01.qai.0000232260.95288.93; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Cave J, 2009, CLIN MED, V9, P320, DOI 10.7861/clinmedicine.9-4-320; *CDCP, 2005, HIV AIDS SURV REP CA, V16; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Clarke CA, 2004, JAIDS-J ACQ IMM DEF, V36, P1083, DOI 10.1097/00126334-200408150-00012; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Deeken JF, 2009, CURR OPIN ONCOL, V21, P445, DOI 10.1097/CCO.0b013e32832f3e04; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hakimian R, 2007, J THORAC ONCOL, V2, P268, DOI 10.1097/01.JTO.0000263707.31202.d7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hoffmann C, 2004, BRIT J HAEMATOL, V125, P455, DOI 10.1111/j.1365-2141.2004.04934.x; Hogg ME, 2009, DIS COLON RECTUM, V52, P891, DOI 10.1007/DCR.0b013e31819eefa6; KAPLAN L D, 1989, Journal of the American Medical Association, V261, P719, DOI 10.1001/jama.261.5.719; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KNOWLES DM, 1988, ANN INTERN MED, V108, P744, DOI 10.7326/0003-4819-108-5-744; Lavole A, 2009, LUNG CANCER, V65, P345, DOI 10.1016/j.lungcan.2008.11.018; Levine AM, 2008, CURR OPIN ONCOL, V20, P522, DOI 10.1097/CCO.0b013e3283094ec7; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Oehler-Jaenne C, 2008, J CLIN ONCOL, V26, P2550, DOI 10.1200/JCO.2007.15.2348; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Powles T, 2003, BRIT J CANCER, V89, P457, DOI 10.1038/sj.bjc.6601111; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Remick SC, 1996, HEMATOL ONCOL CLIN N, V10, P1203, DOI 10.1016/S0889-8588(05)70394-4; Seo Y, 2009, INT J RADIAT ONCOL, V75, P143, DOI 10.1016/j.ijrobp.2008.10.046; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Spano JP, 2008, J CLIN ONCOL, V26, P4834, DOI 10.1200/JCO.2008.16.8252; SRIDHAR KS, 1992, CHEST, V102, P1704, DOI 10.1378/chest.102.6.1704; Stadler RF, 2004, DIS COLON RECTUM, V47, P1305, DOI 10.1007/s10350-004-0584-1; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sturtevant D, 2009, CAN J PUBLIC HEALTH, V100, P116, DOI 10.1007/BF03405519; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Tirelli U, 2000, CANCER-AM CANCER SOC, V88, P563, DOI 10.1002/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D; *US DEP HHS, 2009, MED EXP LIST COV PRE	50	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					334	339		10.1001/jama.2010.752	http://dx.doi.org/10.1001/jama.2010.752			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639567	Green Submitted, Green Accepted			2022-12-24	WOS:000280107500023
J	Sabin, M; Lo, YR				Sabin, Miriam; Lo, Ying-Ru			Progress in Providing HIV Testing and Counseling in Health Facilities WHO/UNAIDS Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sabin, Miriam; Lo, Ying-Ru] WHO, HIV Dept, CH-1211 Geneva, Switzerland	World Health Organization	Sabin, M (corresponding author), WHO, HIV Dept, 20 Ave Apia, CH-1211 Geneva, Switzerland.	sabinm@unaids.org		Sabin, Miriam/0000-0002-7758-8338				Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Leon N, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-8; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; *WHO, 2009, PREV MOTH TO CHILD T; WHO, 2011, DEL HIV TEST RES MES; WHO, UN ACC; *WHO, HIV TEST COUNS PRIS; WHO, GUID PROV IN HIV TES	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					342	343		10.1001/jama.2010.995	http://dx.doi.org/10.1001/jama.2010.995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639569				2022-12-24	WOS:000280107500025
J	Pronovost, PJ				Pronovost, Peter J.			Learning Accountability for Patient Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; QUALITY; SAFETY		[Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Qual & Safety Res Grp, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; *COMM QUAL HLTH CA, 1999, ERR IS HUM BUID SAF; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V301, P1273, DOI 10.1001/jama.2009.388; U.S. Department of Health and Human Services Office of the Secretary Office of the Assistant Secretary for Health, HHS ACT PLAN PREV HE; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885	10	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					204	205		10.1001/jama.2010.979	http://dx.doi.org/10.1001/jama.2010.979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628135				2022-12-24	WOS:000279811000028
J	Baarlink, C; Brandt, D; Grosse, R				Baarlink, Christian; Brandt, Dominique; Grosse, Robert			SnapShot: Formins	CELL			English	Editorial Material							ACTIN; ASSOCIATION; NUCLEATION; MECHANISM; PROFILIN		[Baarlink, Christian; Brandt, Dominique; Grosse, Robert] Univ Marburg, D-35032 Marburg, Germany	Philipps University Marburg	Baarlink, C (corresponding author), Univ Marburg, D-35032 Marburg, Germany.			Grosse, Robert/0000-0002-3380-5273				Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044	10	22	22	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1							172.e1	10.1016/j.cell.2010.06.030	http://dx.doi.org/10.1016/j.cell.2010.06.030			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603022	Bronze			2022-12-24	WOS:000279637300023
J	Jewkes, R				Jewkes, Rachel			Gender Inequities Must Be Addressed in HIV Prevention	SCIENCE			English	Editorial Material							INTIMATE-PARTNER VIOLENCE; SEXUALLY-TRANSMITTED INFECTION; RURAL SOUTH-AFRICA; RELATIONSHIP POWER; WOMEN; RISK; ABUSE; HIV/AIDS; TRIAL; MEN		MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267				Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; DUDE AM, 2009, AIDS BEHAV; Dude A, 2007, STUD FAMILY PLANN, V38, P89, DOI 10.1111/j.1728-4465.2007.00120.x; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Gielen AC, 2007, TRAUMA VIOLENCE ABUS, V8, P178, DOI 10.1177/1524838007301476; *GLOB COAL WOM AID, VIOL WOM; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; JEWKES RK, CHILD ABUSE IN PRESS; JEWKES RK, LANCET; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2010, AG ACC COUNTR ACT WO; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; Nascimento, 2007, ENGAGING MEN BOYS TR; PETTIFOR AE, 1996, EMERG INFECT DIS, V10, P2004; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wang S. K., 2007, RAPE WOMEN COMMUNITY; Wingood GM, 1997, AM J PREV MED, V13, P380, DOI 10.1016/S0749-3797(18)30158-2; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI	28	54	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					145	147		10.1126/science.1193794	http://dx.doi.org/10.1126/science.1193794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616253				2022-12-24	WOS:000279635200020
J	Smith-Bindman, R				Smith-Bindman, Rebecca			Is Computed Tomography Safe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.							Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Eisenberg RL, 2010, RADIOLOGY, V255, P218, DOI 10.1148/radiol.09091556; Giovagnoni A, 2007, EUR RADIOL, V17, pB18, DOI 10.1007/s10406-007-0209-6; *MED PAYM ADV COMM, 2009, HEALTHC SPEND MED PR; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427	5	220	224	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					1	4		10.1056/NEJMp1002530	http://dx.doi.org/10.1056/NEJMp1002530			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20573919				2022-12-24	WOS:000279343000001
J	Kwon, OH; Zewail, AH				Kwon, Oh-Hoon; Zewail, Ahmed H.			4D Electron Tomography	SCIENCE			English	Article							CARBON NANOTUBES; YOUNGS MODULUS; MICROSCOPY; 3D; RECONSTRUCTION; IRRADIATION; MICROGRAPHS; SCIENCES; CELLS; BEAM	Electron tomography provides three-dimensional (3D) imaging of noncrystalline and crystalline equilibrium structures, as well as elemental volume composition, of materials and biological specimens, including those of viruses and cells. We report the development of 4D electron tomography by integrating the fourth dimension (time resolution) with the 3D spatial resolution obtained from a complete tilt series of 2D projections of an object. The different time frames of tomograms constitute a movie of the object in motion, thus enabling studies of nonequilibrium structures and transient processes. The method was demonstrated using carbon nanotubes of a bracelet-like ring structure for which 4D tomograms display different modes of motion, such as breathing and wiggling, with resonance frequencies up to 30 megahertz. Applications can now make use of the full space-time range with the nanometer-femtosecond resolution of ultrafast electron tomography.	[Kwon, Oh-Hoon; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Kwon, Oh-Hoon/B-3324-2015	Kwon, Oh-Hoon/0000-0001-7114-8617; gaber, sarah/0000-0002-5995-7291	NSF [DMR-0964886]; Air Force Office of Scientific Research [FA9550-07-1-0484]; Gordon and Betty Moore Foundation at Caltech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gordon and Betty Moore Foundation at Caltech(Gordon and Betty Moore Foundation)	Supported by NSF (grant DMR-0964886) and Air Force Office of Scientific Research (grant FA9550-07-1-0484) in the Physical Biology Center for Ultrafast Science and Technology supported by Gordon and Betty Moore Foundation at Caltech. A patent application has been filed by Caltech based on the methodology presented	Banhart F, 2006, J MATER SCI, V41, P4505, DOI 10.1007/s10853-006-0081-0; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Cha JJ, 2007, NANO LETT, V7, P3770, DOI 10.1021/nl072251c; Colliex C, 2009, PHILOS T R SOC A, V367, P3845, DOI 10.1098/rsta.2009.0128; Crespi VH, 1996, PHYS REV B, V54, P5927, DOI 10.1103/PhysRevB.54.5927; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; Frank J., 2010, ELECT TOMOGRAPHY MET; Friedrich H, 2009, CHEM REV, V109, P1613, DOI 10.1021/cr800434t; Gass MH, 2006, NANO LETT, V6, P376, DOI [10.1021/nl052120g, 10.1021/nl521020g]; HART RG, 1968, SCIENCE, V159, P1464, DOI 10.1126/science.159.3822.1464; Hartland GV, 2006, ANNU REV PHYS CHEM, V57, P403, DOI 10.1146/annurev.physchem.57.032905.104533; HAWKES PW, 2006, SCI MICROSCOPY, V1; HOPPE W, 1968, NATURWISSENSCHAFTEN, V55, P333, DOI 10.1007/BF00600449; Jonic S, 2009, CURR OPIN PHARMACOL, V9, P636, DOI 10.1016/j.coph.2009.04.006; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meirovich L, 1986, ELEMENTS VIBRATION A; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Midgley PA, 2007, CHEM SOC REV, V36, P1477, DOI 10.1039/b701569k; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Nakamiya T, 2009, THIN SOLID FILMS, V517, P3854, DOI 10.1016/j.tsf.2009.01.097; Ni C, 2009, CARBON, V47, P2898, DOI 10.1016/j.carbon.2009.06.038; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Sorzano COS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-124; Thomas JM, 2004, ANGEW CHEM INT EDIT, V43, P6745, DOI 10.1002/anie.200461453; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Wei XL, 2008, ADV FUNCT MATER, V18, P1555, DOI 10.1002/adfm.200701105; Zewail A H, 2009, 4D ELECT MICROSCOPY; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005	34	89	94	7	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1668	1673		10.1126/science.1190470	http://dx.doi.org/10.1126/science.1190470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576886				2022-12-24	WOS:000279107400036
J	Clarke, OB; Caputo, AT; Hill, AP; Vandenberg, JI; Smith, BJ; Gulbis, JM				Clarke, Oliver B.; Caputo, Alessandro T.; Hill, Adam P.; Vandenberg, Jamie I.; Smith, Brian J.; Gulbis, Jacqueline M.			Domain Reorientation and Rotation of an Intracellular Assembly Regulate Conduction in Kir Potassium Channels	CELL			English	Article							RECTIFIER K+ CHANNEL; CRYSTAL-STRUCTURE; MOLECULAR DETERMINANTS; INWARD RECTIFICATION; QUATERNARY AMMONIUM; SELECTIVITY FILTER; ION CONDUCTION; BINDING-SITES; GATING HINGES; C-TERMINUS	Potassium channels embedded in cell membranes employ gates to regulate K+ current. While a specific constriction in the permeation pathway has historically been implicated in gating, recent reports suggest that the signature ion selectivity filter located in the outer membrane leaflet may be equally important. Inwardly rectifying K+ channels also control the directionality of flow, using intracellular polyamines to stem ion efflux by a valve-like action. This study presents crystallographic evidence of interdependent gates in the conduction pathway and reveals the mechanism of polyamine block. Reorientation of the intracellular domains, concomitant with activation, instigates polyamine release from intracellular binding sites to block the permeation pathway. Conformational adjustments of the slide helices, achieved by rotation of the cytoplasmic assembly relative to the pore, are directly correlated to the ion configuration in the selectivity filter. Ion redistribution occurs irrespective of the constriction, suggesting a more expansive role of the selectivity filter in gating than previously appreciated.	[Clarke, Oliver B.; Caputo, Alessandro T.; Smith, Brian J.; Gulbis, Jacqueline M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Clarke, Oliver B.; Caputo, Alessandro T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Victor Chang Cardiac Research Institute	Gulbis, JM (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	jgulbis@wehi.edu.au	Caputo, Alessandro/AFM-4954-2022; Vandenberg, Jamie I/B-6608-2013; Smith, Brian J/F-8282-2011	Caputo, Alessandro/0000-0001-5007-6896; Vandenberg, Jamie I/0000-0002-3859-3716; Smith, Brian J/0000-0003-0498-1910	Australian National Health and Medical Research Council (NHMRC) [361646]; Victorian State Government; Wellcome Trust; Australian Research Council Centre of Excellence	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Wellcome Trust(Wellcome TrustEuropean Commission); Australian Research Council Centre of Excellence(Australian Research Council)	We thank Janet Newman at the Bio21 C3 crystallization facility, Clemens Schulze-Briese, support staff at the Swiss Light Source, support staff at the Australian Synchrotron, Marc Kvansakul and Peter Czabotar for help with data collection, Peter Colman, Pauline Crewther, and James Blake for input on the manuscript, and Declan Doyle for the KirBac3.1 construct. We acknowledge assistance from the Australian Synchrotron Research Program for travel to the Swiss Light Source, the Australian National Health and Medical Research Council (NHMRC) for project funding, NHMRC Independent Research Institutes Infrastructure Support Scheme grant number 361646, and Victorian State Government Operational Infrastructure Support grants. J.M.G. thanks the Wellcome Trust for an International Senior Research Fellowship and the Australian Research Council Centre of Excellence in Coherent X-ray Science for travel assistance. O.B.C. is supported by an Australian Postgraduate Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; Battle AR, 2009, FEBS LETT, V583, P407, DOI 10.1016/j.febslet.2008.12.033; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jones PA, 2001, FEBS LETT, V508, P85, DOI 10.1016/S0014-5793(01)03023-X; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MILLER C, 1987, BIOPHYS J, V52, P123, DOI 10.1016/S0006-3495(87)83196-X; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shin HG, 2005, J GEN PHYSIOL, V126, P123, DOI 10.1085/jgp.200509296; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	119	120	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1018	1029		10.1016/j.cell.2010.05.003	http://dx.doi.org/10.1016/j.cell.2010.05.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20564790	Bronze			2022-12-24	WOS:000278618800016
J	Lu, WJ; Chapo, J; Roig, I; Abrams, JM				Lu, Wan-Jin; Chapo, Joseph; Roig, Ignasi; Abrams, John M.			Meiotic Recombination Provokes Functional Activation of the p53 Regulatory Network	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; DNA-DAMAGE; SUPPRESSOR GENE; MICE; CHECKPOINT; OOGENESIS; SYNAPSIS; HOMOLOG; COMPLEX; REPAIR	The evolutionary appearance of p53 protein probably preceded its role in tumor suppression, suggesting that there may be unappreciated functions for this protein. Using genetic reporters as proxies to follow in vivo activation of the p53 network in Drosophila, we discovered that the process of meiotic recombination instigates programmed activation of p53 in the germ line. Specifically, double-stranded breaks in DNA generated by the topoisomerase Spo11 provoked functional p53 activity, which was prolonged in cells defective for meiotic DNA repair. This intrinsic stimulus for the p53 regulatory network is highly conserved because Spo11-dependent activation of p53 also occurs in mice. Our findings establish a physiological role for p53 in meiosis and suggest that tumor-suppressive functions may have been co-opted from primordial activities linked to recombination.	[Lu, Wan-Jin; Chapo, Joseph; Abrams, John M.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Roig, Ignasi] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center	Abrams, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu	Roig, Ignasi/A-9697-2012	Roig, Ignasi/0000-0003-0313-3581; Lu, Wan-Jin/0000-0002-2186-9800	National Institute of General Medical Sciences [R01GM072124]; National Institute on Alcohol Abuse and Alcoholism [R01AA017328]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017328] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Keeney for helpful discussions and reading of the manuscript and A. Ali, A. D'Brot, and A. Olivo for assisting experiments. We also thank the following individuals, laboratories, or facilities for helpful discussions, access to instruments, or providing reagents: S. Barolo, M. Buszczak, D. Castrillon, O. Cleaver, K. Hamra, J. Maines, D. McKearin, T. Schupbach, Y. Rong, J. Shelton, T. Wilkie, R. Bachoo, T. Mashimo, B. Thaden, Live Cell Imaging Facility (Univ. of Texas Southwestern), Bloomington Stock Center (Indiana Univ.), Developmental Studies Hybridoma Bank (Univ. of Iowa). This work was supported by the National Institute of General Medical Sciences (grant R01GM072124) and the National Institute on Alcohol Abuse and Alcoholism (grant R01AA017328).	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; Aranda-Anzaldo A, 2007, MECH AGEING DEV, V128, P293, DOI 10.1016/j.mad.2007.01.001; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Gersten KM, 1997, NAT GENET, V17, P378, DOI 10.1038/ng1297-378; Ghafari F, 2009, HUM REPROD, V24, P1460, DOI 10.1093/humrep/dep022; Habu T, 2004, CARCINOGENESIS, V25, P889, DOI 10.1093/carcin/bgh099; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Nedelcu AM, 2007, DEV GENES EVOL, V217, P801, DOI 10.1007/s00427-007-0185-9; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	29	70	70	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1278	1281		10.1126/science.1185640	http://dx.doi.org/10.1126/science.1185640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522776	Green Accepted			2022-12-24	WOS:000278318600035
J	Ebers, GC				Ebers, G. C.			Commentary: Outcome measures were flawed	BRITISH MEDICAL JOURNAL			English	Editorial Material							REMITTING MULTIPLE-SCLEROSIS; PLACEBO-CONTROLLED TRIAL; INTERFERON BETA-1B; CLINICAL-TRIALS; DOUBLE-BLIND; DISABILITY; MS; MULTICENTER; THERAPY		Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford	Ebers, GC (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England.	George.Ebers@clneuro.ox.ac.uk		Ebers, George/0000-0003-4771-4177				Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; Daumer M, 2009, NEUROLOGY, V72, P705, DOI 10.1212/01.wnl.0000336916.38629.43; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Ebers GC, 2001, LANCET, V357, P1547, DOI 10.1016/S0140-6736(00)04778-4; Ebers GC, 2009, CLIN THER, V31, P1724, DOI 10.1016/j.clinthera.2009.08.003; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; Ford C, 2010, MULT SCLER, V16, P342, DOI 10.1177/1352458509358088; GOODKIN DE, 1992, NEUROLOGY, V42, P859, DOI 10.1212/WNL.42.4.859; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2006, NEUROLOGY, V67, P944, DOI 10.1212/01.wnl.0000237994.95410.ce; Panitch H, 2004, NEUROLOGY, V63, P1788; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419	14	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2693	10.1136/bmj.c2693	http://dx.doi.org/10.1136/bmj.c2693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BM	20522659				2022-12-24	WOS:000278556500007
J	Lambert, L; Brown, K; Segal, E; Brophy, J; Rodes-Cabau, J; Bogaty, P				Lambert, Laurie; Brown, Kevin; Segal, Eli; Brophy, James; Rodes-Cabau, Josep; Bogaty, Peter			Association Between Timeliness of Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS-CORONARY-INTERVENTION; SEGMENT-ELEVATION; PROPENSITY-SCORE; NATIONAL REGISTRY; SELECTION BIAS; STEMI REGISTRY; MORTALITY; GUIDELINES; THROMBOLYSIS; STRATEGIES	Context Guidelines emphasize the importance of rapid reperfusion of patients with ST-elevation myocardial infarction (STEMI) and specify a maximum delay of 30 minutes for fibrinolysis and 90 minutes for primary percutaneous coronary intervention (PPCI). However, randomized trials and selective registries are limited in their ability to assess the effect of timeliness of reperfusion on outcomes in real-world STEMI patients. Objectives To obtain a complete interregional portrait of contemporary STEMI care and to investigate timeliness of reperfusion and outcomes. Design, Setting, and Patients Systematic evaluation of STEMI care for 6 months during 2006-2007 in 80 hospitals that treated more than 95% of patients with acute myocardial infarction in the province of Quebec, Canada (population, 7.8 million). Main Outcome Measures Death at 30 days and at 1 year and the combined end point of death or hospital readmission for acute myocardial infarction or congestive heart failure at 1 year by linkage to Quebec's medicoadministrative databases. Results Of 1832 patients treated with reperfusion, 392 (21.4%) received fibrinolysis and 1440 (78.6%) received PPCI. Fibrinolysis was untimely (>30 minutes) in 54% and PPCI was untimely (>90 minutes) in 68%. Death or readmission for acute myocardial infarction or heart failure at 1 year occurred in 13.5% of fibrinolysis patients and 13.6% of PPCI patients. When the 2 treatment groups were combined, patients treated outside of recommended delays had an adjusted higher risk of death at 30 days (6.6% vs 3.3%; odds ratio [OR], 2.14; 95% confidence interval [CI], 1.21-3.93) and a statistically nonsignificant increase in risk of death at 1 year (9.3% vs 5.2%; OR, 1.61; 95% CI, 1.00-2.66) compared with patients who received timely treatment. Patients treated outside of recommended delays also had an adjusted higher risk for the combined outcome of death or hospital readmission for congestive heart failure or acute myocardial infarction at 1 year (15.0% vs 9.2%; OR, 1.57; 95% CI, 1.08-2.30). At the regional level, after adjustment, each 10% increase in patients treated within the recommended time was associated with a decrease in the region-level odds of overall 30-day mortality (OR, 0.80; 95% CI, 0.65-0.98). Conclusion Among patients in Quebec with STEMI, reperfusion delivered outside guideline-recommend delays was associated with significantly increased 30-day mortality, a statistically nonsignificant increase in 1-year mortality, and significantly increased risk of the composite of mortality or readmission for acute myocardial infarction or heart failure at 1 year. JAMA. 2010; 303(21): 2148-2155	[Lambert, Laurie] Agence Evaluat Technol & Modes Intervent Sante Qu, Cardiol Evaluat Unit, Montreal, PQ H3A 2S9, Canada; [Segal, Eli] McGill Univ Urgences Sante, Jewish Gen Hosp, Montreal, PQ, Canada; [Brophy, James] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Rodes-Cabau, Josep] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	McGill University; McGill University	Lambert, L (corresponding author), Agence Evaluat Technol & Modes Intervent Sante Qu, Cardiol Evaluat Unit, 2021 Union Ave, Montreal, PQ H3A 2S9, Canada.	laurie.lambert@aetmis.gouv.qc.ca	brophy, james/H-6673-2019; Segal, Eli/GPW-8146-2022	brophy, james/0000-0001-8049-6875; Brown, Kevin Antoine/0000-0002-1483-2188	Ministry of Health of the province of Quebec; Boston Scientific; Abbott; Cordis	Ministry of Health of the province of Quebec; Boston Scientific(Boston Scientific); Abbott(Abbott Laboratories); Cordis	This evaluation was funded by the Ministry of Health of the province of Quebec.; Dr Rodes-Cabau reports that he is recipient of a research grant from Boston Scientific and lecture fees from Abbott, Cordis, and Boston Scientific. No other disclosures were reported.	Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1218, DOI 10.1002/pds.1674; Bates D., 2009, IME4 LINEAR MIXED EF; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Ferreira-Gonzalez I, 2009, CIRC-CARDIOVASC QUAL, V2, P540, DOI 10.1161/CIRCOUTCOMES.108.844399; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Huynh T, 2009, CIRCULATION, V119, P3101, DOI 10.1161/CIRCULATIONAHA.108.793745; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P517, DOI 10.1161/CIRCOUTCOMES.109.916601; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lambert LJ, 2009, CIRC-CARDIOVASC QUAL, V2, pe40; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Mehta RH, 2008, AM HEART J, V155, P1059, DOI 10.1016/j.ahj.2008.01.010; Nallamothu BK, 2007, HEART, V93, P1552, DOI 10.1136/hrt.2006.112847; Nallamothu BK, 2006, CIRCULATION, V113, P222, DOI 10.1161/CIRCULATIONAHA.105.578195; R Development Core Team, 2009, R FDN STAT COMP; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; SAS Institute. Inc, 2005, SAS VERS 9 1 3; SEKHON JS, 2009, MATCHING MULTIVARIAT; So DYF, 2006, AM J CARDIOL, V97, P458, DOI 10.1016/j.amjcard.2005.08.069; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; THIBAULT N, 2007, SUIVI CYCLE NAISSANC; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Westfall JM, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-22; Wiviott SD, 2004, J AM COLL CARDIOL, V44, P783, DOI 10.1016/j.jacc.2004.05.045	29	172	177	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2148	2155		10.1001/jama.2010.712	http://dx.doi.org/10.1001/jama.2010.712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516415	Bronze			2022-12-24	WOS:000278182100023
J	Brenner, H; Altenhofen, L; Hoffmeister, M				Brenner, Hermann; Altenhofen, Lutz; Hoffmeister, Michael			Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms A Cohort Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER INCIDENCE; RISK; COLONOSCOPY; PARTICIPATION; PREVALENCE; POLYPS	Background: Prevalence of advanced colorectal neoplasms increases with age and is higher among men than women. Cross-sectional analyses estimated that men reach an equivalent prevalence at a much younger age than women. However, cross-sectional estimates may be confounded by birth cohort effects. Objective: To estimate age and cohort effects in advanced colorectal neoplasms and to adjust risk-advancement periods for men compared with women for birth cohort effects. Design: Age-cohort analyses. Setting: German screening colonoscopy program, 2003 to 2007. Participants: 2 185 153 participants aged 55 to 75 years. Measurements: Sex-and age-specific prevalence of colorectal cancer (CRC) and advanced neoplasms (CRC or advanced adenoma) were plotted with and without stratification by birth cohort. Risk-advancement periods with 95% CI for men compared with women were estimated from log-binomial regression models with and without cross-sectional analysis adjustment for birth cohort effects. Results: Overall, 17 196 participants (0.8%) had CRC and 152 429 (7.0%) had any advanced neoplasm. Age-specific prevalence was higher in men than in women and in later birth cohorts. The apparent modest increase in prevalence by age in cross-sectional analysis was much steeper after birth cohort effects were controlled for. In cross-sectional analysis, risk-advancement periods (95% CI) for men compared with women were 8.4 years (CI, 7.7 to 9.0 years) and 16.1 years (CI, 15.8 to 16.5 years) for CRC and any advanced neoplasm, respectively, and 3.4 years (CI, 2.6 to 4.3 years) and 6.9 years (CI, 6.4 to 7.4 years) after controlling for birth cohort effects. Limitation: Information on covariates that could explain cohort effects was lacking. Conclusion: In this population, strong cohort effects reduced age gradients in advanced colorectal neoplasms and inflated risk-advancement periods for men compared with women, but major risk advancement persisted, even after birth cohort effects were controlled for.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69115 Heidelberg, Germany; Cent Res Inst Ambulatory Hlth Care Germany, D-10623 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Bergheimer Str 20, D-69115 Heidelberg, Germany.		Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022; Hoffmeister, Michael/B-5745-2012	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197				Blom J, 2008, INT J CANCER, V122, P1618, DOI 10.1002/ijc.23208; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; BOYLE P, 1985, INT J CANCER, V36, P9, DOI 10.1002/ijc.2910360103; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; BRENNER H, 1993, EPIDEMIOLOGY, V4, P229, DOI 10.1097/00001648-199305000-00006; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2009, EUR J CANCER, V45, P2027, DOI 10.1016/j.ejca.2009.02.017; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; *CENTR I AMB HLTH, SCI EV SCREEN COL GE; Cress RD, 2006, CANCER, V107, P1142, DOI 10.1002/cncr.22011; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Larsen IK, 2006, EUR J CANCER PREV, V15, P10, DOI 10.1097/01.cej.0000186636.27496.bb; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; McCaffery K, 2002, J MED SCREEN, V9, P104, DOI 10.1136/jms.9.3.104; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Pan Sai Yi, 2009, V472, P191, DOI 10.1007/978-1-60327-492-0_8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raum E, 2007, EUR J CARDIOV PREV R, V14, P809, DOI 10.1097/HJR.0b013e3282eeb308; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Thorpe LE, 2005, CANCER-AM CANCER SOC, V104, P1075, DOI 10.1002/cncr.21274; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x	26	36	37	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					697	W288		10.7326/0003-4819-152-11-201006010-00002	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20513827				2022-12-24	WOS:000278560000002
J	Ohiorhenuan, IE; Mechler, F; Purpura, KP; Schmid, AM; Hu, Q; Victor, JD				Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.			Sparse coding and high-order correlations in fine-scale cortical networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; NEURONS; CONNECTIVITY; INFORMATION; POPULATION; RESPONSES; RETINA	Connectivity in the cortex is organized at multiple scales(1-5), suggesting that scale-dependent correlated activity is particularly important for understanding the behaviour of sensory cortices and their function in stimulus encoding. We analysed the scale-dependent structure of cortical interactions by using maximum entropy models(6-9) to characterize multiple-tetrode recordings from primary visual cortex of anaesthetized macaque monkeys (Macaca mulatta). We compared the properties of firing patterns among local clusters of neurons (<300 mm apart) with those of neurons separated by larger distances (600-2,500 mu m). Here we report that local firing patterns are distinctive: whereas multi-neuronal firing patterns at larger distances can be predicted by pairwise interactions, patterns within local clusters often show evidence of high-order correlations. Surprisingly, these local correlations are flexible and rapidly reorganized by visual input. Although they modestly reduce the amount of information that a cluster conveys, they also modify the format of this information, creating sparser codes by increasing the periods of total quiescence, and concentrating information into briefer periods of common activity. These results imply a hierarchical organization of neuronal correlations: simple pairwise correlations link neurons over scales of tens to hundreds of minicolumns, but on the scale of a few minicolumns, ensembles of neurons form complex subnetworks whose moment-to-moment effective connectivity is dynamically reorganized by the stimulus.	[Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Cornell University	Ohiorhenuan, IE (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA.	ifo2001@med.cornell.edu	Victor, Jonathan D./D-2931-2009	Victor, Jonathan D./0000-0002-9293-0111	National Institutes of Health [EY19454, GM07739, EY09314]; NATIONAL EYE INSTITUTE [F31EY019454, R01EY009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Nirenberg for comments on a draft of the manuscript. This work was supported by National Institutes of Health grants EY19454 and GM07739 (to I.E.O.) and EY09314 (to J.D.V.).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cover TM, 1991, ELEMENTS INFORM THEO; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Kennel MB, 2005, NEURAL COMPUT, V17, P1531, DOI 10.1162/0899766053723050; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Samonds JM, 2006, J NEUROPHYSIOL, V95, P2602, DOI 10.1152/jn.01070.2005; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Victor JD, 2006, J NEUROPHYSIOL, V95, P379, DOI 10.1152/jn.00498.2005; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	30	220	221	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					617	U4		10.1038/nature09178	http://dx.doi.org/10.1038/nature09178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20601940	Green Accepted			2022-12-24	WOS:000280412100052
J	Evans, J; Rzhetsky, A				Evans, James; Rzhetsky, Andrey			Machine Science	SCIENCE			English	Editorial Material							HYPOTHESIS GENERATION; KNOWLEDGE; SYSTEMS; NETWORK		[Evans, James; Rzhetsky, Andrey] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago	Evans, J (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NIGMS NIH HHS [R01 GM061372-09, R01 GM061372, R01 GM061372-08] Funding Source: Medline; NIMH NIH HHS [P50 MH094267] Funding Source: Medline; NLM NIH HHS [R01 LM010132-02, R01 LM010132-01, R01 LM010132] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BLAKE J, 2009, COMMUNICATION   0205; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Feret J, 2009, P NATL ACAD SCI USA, V106, P6453, DOI 10.1073/pnas.0809908106; Golub TR, 2010, NATURE, V464, P679, DOI 10.1038/464679a; Harris Z., 1989, FORM INFORM SCI ANAL; Harris Zellig, 1982, SUBLANGUAGE STUDIES, P231; HOOD L, 2004, BIOCOMMERCE WEE 0909; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; O'Malley MA, 2009, CELL, V138, P611, DOI 10.1016/j.cell.2009.08.008; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Ruths DA, 2006, J COMPUT BIOL, V13, P1546, DOI 10.1089/cmb.2006.13.1546; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Twain Mark., 1889, CONNECTICUT YANKEE K; Weeber M, 2003, J AM MED INFORM ASSN, V10, P252, DOI 10.1197/jamia.M1158; Wren JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-145	24	39	40	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					399	400		10.1126/science.1189416	http://dx.doi.org/10.1126/science.1189416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KJ	20651141	Green Accepted			2022-12-24	WOS:000280196500023
J	Hughes, V				Hughes, Virginia			The outlook for a cure	NATURE			English	Editorial Material							COMBINATION THERAPY; HIV-1 INFECTION											Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939	5	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S11	S13		10.1038/nature09240	http://dx.doi.org/10.1038/nature09240			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631696				2022-12-24	WOS:000279867100029
J	Maxmen, A				Maxmen, Amy			Grassroots initiatives	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S20	S20		10.1038/nature09244	http://dx.doi.org/10.1038/nature09244			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631701	Bronze			2022-12-24	WOS:000279867100033
J	Mulherin, TC				Mulherin, Timothy C.			Personal View Don't forget the family	BRITISH MEDICAL JOURNAL			English	Editorial Material									Deakin Univ, Melbourne, Vic, Australia	Deakin University	Mulherin, TC (corresponding author), Deakin Univ, Melbourne, Vic, Australia.	tmulherin1@hotmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2010	341								c3486	10.1136/bmj.c3486	http://dx.doi.org/10.1136/bmj.c3486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DL	20610495				2022-12-24	WOS:000279874300007
J	Langley, JA; Megonigal, JP				Langley, J. Adam; Megonigal, J. Patrick			Ecosystem response to elevated CO2 levels limited by nitrogen-induced plant species shift	NATURE			English	Article							SOIL NUTRIENT; CLIMATE; COMPETITION; LIMITATION; FEEDBACKS; DIVERSITY	Terrestrial ecosystems gain carbon through photosynthesis and lose it mostly in the form of carbon dioxide (CO2). The extent to which the biosphere can act as a buffer against rising atmospheric CO2 concentration in global climate change projections remains uncertain at the present stage(1-4). Biogeochemical theory predicts that soil nitrogen (N) scarcity may limit natural ecosystem response to elevated CO2 concentration, diminishing the CO2-fertilization effect on terrestrial plant productivity in unmanaged ecosystems(3-7). Recent models have incorporated such carbon-nitrogen interactions and suggest that anthropogenic N sources could help sustain the future CO2-fertilization effect(8,9). However, conclusive demonstration that added N enhances plant productivity in response to CO2-fertilization in natural ecosystems remains elusive. Here we manipulated atmospheric CO2 concentration and soil N availability in a herbaceous brackish wetland where plant community composition is dominated by a C-3 sedge and C-4 grasses, and is capable of responding rapidly to environmental change(10). We found that N addition enhanced the CO2-stimulation of plant productivity in the first year of a multi-year experiment, indicating N-limitation of the CO2 response. But we also found that N addition strongly promotes the encroachment of C-4 plant species that respond less strongly to elevated CO2 concentrations. Overall, we found that the observed shift in the plant community composition ultimately suppresses the CO2-stimulation of plant productivity by the third and fourth years. Although extensive research has shown that global change factors such as elevated CO2 concentrations and N pollution affect plant species differently(11-13), and that they may drive plant community changes(14-17), we demonstrate that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated CO2 concentrations. Moreover, we suggest that trade-offs between the abilities of plant taxa to respond positively to different perturbations may constrain natural ecosystem response to global change.	[Langley, J. Adam; Megonigal, J. Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Langley, J. Adam] Villanova Univ, Dept Biol, Villanova, PA 19084 USA	Smithsonian Institution; Smithsonian Environmental Research Center; Villanova University	Langley, JA (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	langleya@si.edu		Megonigal, Patrick/0000-0002-2018-7883	USGS [06ERAG0011]; US Department of Energy [DE-FG02-97ER62458]; US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University; Smithsonian Institution; Direct For Biological Sciences [0950080] Funding Source: National Science Foundation	USGS(United States Geological Survey); US Department of Energy(United States Department of Energy (DOE)); US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University(United States Department of Energy (DOE)); Smithsonian Institution(Smithsonian Institution); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge the support of D. Cahoon, our primary US Geological Survey collaborator, who co-developed the experimental design of this study. We thank J. Duls, J. Keller, M. Sigrist, G. Peresta, B. Drake, E. Sage, A. Martin, D. McKinley, N. Mudd and K. White for the construction and maintenance of the field site at the Smithsonian Climate Change Facility. We appreciate comments from S. Chapman, A. Classen, J. Hines, B. Hungate, T. Mozdzer, A. Sutton-Grier and D. Whigham. The field study was supported by the USGS Global Change Research Program (cooperative agreement 06ERAG0011), the US Department of Energy (grant DE-FG02-97ER62458), the US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University, and the Smithsonian Institution.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; Craine JM., 2009, RESOURCE STRATEGIES; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Erickson JE, 2007, GLOBAL CHANGE BIOL, V13, P202, DOI 10.1111/j.1365-2486.2006.01285.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keller JK, 2009, BIOGEOCHEMISTRY, V96, P101, DOI 10.1007/s10533-009-9347-3; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; REYNOLDS HL, 1993, AM NAT, V141, P51, DOI 10.1086/285460; Schneider MK, 2004, GLOBAL CHANGE BIOL, V10, P1377, DOI 10.1111/j.1365-2486.2004.00803.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; TILMAN D, 1988; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053	30	174	183	4	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					96	99		10.1038/nature09176	http://dx.doi.org/10.1038/nature09176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596018				2022-12-24	WOS:000279343800041
J	Levy, C; Khaled, M; Robinson, KC; Veguilla, RA; Chen, PH; Yokoyama, S; Makino, E; Lu, J; Larue, L; Beermann, F; Chin, L; Bosenberg, M; Song, JS; Fisher, DE				Levy, Carmit; Khaled, Mehdi; Robinson, Kathleen C.; Veguilla, Rosa A.; Chen, Po-Hao; Yokoyama, Satoru; Makino, Eiichi; Lu, Jun; Larue, Lionel; Beermann, Friedrich; Chin, Lynda; Bosenberg, Marcus; Song, Jun. S.; Fisher, David E.			Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes	CELL			English	Article							POSTTRANSCRIPTIONAL REGULATION; MICRORNA BIOGENESIS; BCL-2 DEFICIENCY; MASTER REGULATOR; EXPRESSION; MICROPHTHALMIA; MELANOMA; GENE; SURVIVAL; FAMILY	DICER is a central regulator of microRNA maturation. However, little is known about mechanisms regulating its expression in development or disease. While profiling miRNA expression in differentiating melanocytes, two populations were observed: some upregulated at the pre-miRNA stage, and others upregulated as mature miRNAs (with stable pre-miRNA levels). Conversion of pre-miRNAs to fully processed miRNAs appeared to be dependent upon stimulation of DICER expression-an event found to occur via direct transcriptional targeting of DICER by the melanocyte master transcriptional regulator MITF. MITF binds and activates a conserved regulatory element upstream of DICER's transcriptional start site upon melanocyte differentiation. Targeted KO of DICER is lethal to melanocytes, at least partly via DICER-dependent processing of the pre-miRNA-17 similar to 92 cluster thus targeting BIM, a known proapoptotic regulator of melanocyte survival. These observations highlight a central mechanism underlying lineage-specific miRNA regulation which could exist for other cell types during development.	[Levy, Carmit; Khaled, Mehdi; Robinson, Kathleen C.; Veguilla, Rosa A.; Yokoyama, Satoru; Makino, Eiichi; Fisher, David E.] Harvard Univ, Sch Med, Dept Dermatol, Cutaneous Biol Res Ctr,Mass Gen Hosp, Boston, MA 02115 USA; [Chen, Po-Hao] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lu, Jun] Broad Inst, Cambridge, MA 02141 USA; [Lu, Jun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lu, Jun] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Larue, Lionel] UMR CNRS 146, Inst Curie, F-91405 Orsay, France; [Beermann, Friedrich] Swiss Inst Expt Canc Res, EPFL SV ISREC, CH-1015 Lausanne, Switzerland; [Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Song, Jun. S.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Yale University; Institute for Advanced Study - USA	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Cutaneous Biol Res Ctr,Mass Gen Hosp, Boston, MA 02115 USA.	dfisher3@partners.org	Song, Jun S/E-2526-2016; Fisher, David/AAH-2878-2019; Yokoyama, Satoru/AAT-3254-2021; khaled, mehdi/C-4854-2012; Larue, Lionel/F-7355-2013; Larue, Lionel/I-6532-2016	Song, Jun S/0000-0002-0422-2175; khaled, mehdi/0000-0002-9880-858X; Yokoyama, Satoru/0000-0001-8336-486X	Martin A. and Helen Chooljian Membership; NIH; Melanoma Research Alliance; Doris Duke Charitable Foundation; Adelson Medical Research Foundation; Israel-US Binational Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Martin A. and Helen Chooljian Membership; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Adelson Medical Research Foundation; Israel-US Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully acknowledge help from Dr. Rod Bronson with mouse pathology; Dr. Carl Novina for useful discussions; Dr. Ian Jackson for Dct-LacZ transgenic mice; Dr. T. Kunisada for K14-SCF transgenic mice; Dr. Clifford J. Tabin for Dicer Floxed mice; Dr. Ruth Halaban for 501mel melanoma cells; Maja Janas, Ana Hernandez, Dr. Jacob Hanna, and members of the Fisher lab for help with numerous aspects of this work. JSS was supported in part by the Martin A. and Helen Chooljian Membership. D.E.F. gratefully acknowledges grant support from NIH, The Melanoma Research Alliance, The Doris Duke Charitable Foundation, The Adelson Medical Research Foundation, and the Israel-US Binational Science Foundation.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Barbato C, 2007, BRAIN RES, V1175, P17, DOI 10.1016/j.brainres.2007.07.088; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; KAMADA S, 1995, CANCER RES, V55, P354; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Maroney PA, 2006, COLD SPRING HARB SYM, V71, P531, DOI 10.1101/sqb.2006.71.043; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schier AF, 2006, COLD SPRING HARB SYM, V71, P195, DOI 10.1101/sqb.2006.71.055; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; STEINGRIMSSON E, 2004, ANNU REV GENET, V365, P411; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamamura K, 1996, CANCER RES, V56, P3546; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeng Yan, 2006, V342, P49, DOI 10.1385/1-59745-123-1:49; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	79	92	97	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					994	1005		10.1016/j.cell.2010.05.004	http://dx.doi.org/10.1016/j.cell.2010.05.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550935	Green Accepted, Bronze			2022-12-24	WOS:000278618800014
J	Egan, BM; Zhao, YM; Axon, RN				Egan, Brent M.; Zhao, Yumin; Axon, R. Neal			US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES ADULTS; BLOOD-PRESSURE; HEALTH	Context Hypertension is a major risk factor for cardiovascular disease and treatment and control of hypertension reduces risk. The Healthy People 2010 goal was to achieve blood pressure (BP) control in 50% of the US population. Objective To assess progress in treating and controlling hypertension in the United States from 1988-2008. Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2008 in five 2-year blocks included 42 856 adults aged older than 18 years, representing a probability sample of the US civilian population. Main Outcome Measures Hypertension was defined as systolic BP of at least 140 mm Hg and diastolic BP of at least 90 mm Hg, self-reported use of antihypertensive medications, or both. Hypertension control was defined as systolic BP values of less than 140 mm Hg and diastolic BP values of less than 90 mm Hg. All survey periods were age-adjusted to the year 2000 US population. Results Rates of hypertension increased from 23.9% (95% confidence interval [CI], 22.7%-25.2%) in 1988-1994 to 28.5% (95% CI, 25.9%-31.3%; P<.001) in 1999-2000, but did not change between 1999-2000 and 2007-2008 (29.0%; 95% CI, 27.6%-30.5%; P=.24). Hypertension control increased from 27.3% (95% CI, 25.6%-29.1%) in 19881994 to 50.1%(95% CI, 46.8%-53.5%; P=.006) in 2007-2008, and BP among patients with hypertension decreased from 143.0/80.4 mm Hg (95% CI, 141.9-144.2/79.6-81.1 mm Hg) to 135.2/74.1 mm Hg (95% CI, 134.2-136.2/73.2-75.0 mm Hg; P=.02/P<.001). Blood pressure control improved significantly more in absolute percentages between 1999-2000 and 2007-2008 vs 1988-1994 and 1999-2000 (18.6%; 95% CI, 13.3%-23.9%; vs 4.1%; 95% CI, -0.5% to 8.8%; P<.001). Better BP control reflected improvements in awareness (69.1%; 95% CI, 67.1%-71.1%; vs 80.7%; 95% CI, 78.1%-83.0%; P for trend=.03), treatment (54.0%; 95% CI, 52.0%-56.1%; vs 72.5%; 95% CI, 70.1%-74.8%; P=.004), and proportion of patients who were treated and had controlled hypertension (50.6%; 95% CI, 48.0%-53.2%; vs 69.1%; 95% CI, 65.7%-72.3%; P=.006). Hypertension control improved significantly between 1988-1994 and 2007-2008, across age, race, and sex groups, but was lower among individuals aged 18 to 39 years vs 40 to 59 years(P<.001) and 60 years or older(P<.001), and in Hispanic vs white individuals (P=.004). Conclusions Blood pressure was controlled in an estimated 50.1% of all patients with hypertension in NHANES 2007-2008, with most of the improvement since 1988 occurring after 1999-2000. Hypertension control was significantly lower among younger than middle-aged individuals and older adults, and Hispanic vs white individuals. JAMA. 2010;303(20):2043-2050 www.jama.com	[Egan, Brent M.; Zhao, Yumin; Axon, R. Neal] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina	Egan, BM (corresponding author), Med Univ S Carolina, Dept Med, 135 Rutledge Ave,1230 RT, Charleston, SC 29425 USA.	eganbm@musc.edu			NIH [NIH R0107080684, NIH R01DK067615, NIH R01NS058728]; State of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants NIH R0107080684, NIH R01DK067615, and NIH R01NS058728 and the State of South Carolina.	*ACC STUD GROUP, EFF INT BLOOD PRESS; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1988, ARCH INTERN MED, V148, P1023; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; [Anonymous], 2007, NATL HLTH NUTR EXAMI; [Anonymous], NATL HLTH NUTR EXAMI; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Egan BM, 2003, J INVEST MED, V51, P373, DOI 10.1136/jim-51-06-34; Ford ES, 2008, AM J HYPERTENS, V21, P1124, DOI 10.1038/ajh.2008.246; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; *HLTH PEOPL 2010, HEART DIS STROK; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kannel WB, 2009, MED CLIN N AM, V93, P541, DOI 10.1016/j.mcna.2009.02.006; Khosla N, 2009, MED CLIN N AM, V93, P697, DOI 10.1016/j.mcna.2009.02.001; MANCIA G, 1987, HYPERTENSION, V9, P209, DOI 10.1161/01.HYP.9.2.209; Mellen PB, 2008, ARCH INTERN MED, V168, P308, DOI 10.1001/archinternmed.2007.119; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Miller Nancy Houston, 2003, Manag Care, V12, P51; National Center for Health Statistics, 1988, 3 NAT HLTH NUTR EX S; National Center for Health Statistics, HLTH PEOPL 2000 FIN; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; OSTCHEGA Y, 2005, HYPERTENSION AWARENE; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; ROCCELLA EJ, 1985, PUBLIC HEALTH REP, V100, P652; United States Census Bureau, STAT COUNT QUICKF; Wong ND, 2003, AM HEART J, V145, P888, DOI 10.1016/S0002-8703(02)94787-3; 1997, ARCH INTERN MED, V157, P2413; 2003, NATL HLTH NUTR EXAMI	31	1395	1442	1	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2043	2050		10.1001/jama.2010.650	http://dx.doi.org/10.1001/jama.2010.650			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501926	Bronze			2022-12-24	WOS:000278018200028
J	Bai, XY; Kim, J; Yang, ZA; Jurynec, MJ; Akie, TE; Lee, J; LeBlanc, J; Sessa, A; Jiang, H; DiBiase, A; Zhou, Y; Grunwald, DJ; Lin, S; Cantor, AB; Orkin, SH; Zon, LI				Bai, Xiaoying; Kim, Jonghwan; Yang, Zhongan; Jurynec, Michael J.; Akie, Thomas E.; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; Jiang, Hong; DiBiase, Anthony; Zhou, Yi; Grunwald, David J.; Lin, Shuo; Cantor, Alan B.; Orkin, Stuart H.; Zon, Leonard I.			TIF1 gamma Controls Erythroid Cell Fate by Regulating Transcription Elongation	CELL			English	Article							POLYMERASE-II ELONGATION; RNA-POLYMERASE; P-TEFB; PAF1 COMPLEX; GATA-1; GENES; DSIF; IDENTIFICATION; HEMATOPOIESIS; METHYLATION	Recent genome-wide studies have demonstrated that pausing of RNA polymerase II (Pol II) occurred on many vertebrate genes. By genetic studies in the zebrafish tif1 gamma mutant moonshine we found that loss of function of Pol II-associated factors PAF or DSIF rescued erythroid gene transcription in tif1 gamma-deficient animals. Biochemical analysis established physical interactions among TIF1 gamma, the blood-specific SCL transcription complex, and the positive elongation factors p-TEFb and FACT. Chromatin immunoprecipitation assays in human CD34(+) cells supported a TIF1 gamma-dependent recruitment of positive elongation factors to erythroid genes to promote transcription elongation by counteracting Pol II pausing. Our study establishes a mechanism for regulating tissue cell fate and differentiation through transcription elongation.	[Bai, Xiaoying; Kim, Jonghwan; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Orkin, Stuart H.; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Bai, Xiaoying; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Bai, Xiaoying; Kim, Jonghwan; Akie, Thomas E.; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Cantor, Alan B.; Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Div Hematol Oncol,Childrens Hosp Boston, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yang, Zhongan; Jiang, Hong; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jurynec, Michael J.; Grunwald, David J.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Zon, LI (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Kim, Jonghwan/AAR-2815-2021; Jurynec, Michael/AAH-8765-2020	Cantor, Alan/0000-0002-5136-028X; Kim, Jonghwan/0000-0002-9919-9843	National Institutes of Health [5PO1HL32262-28, 5R37 DK55381-010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK055381, P30DK049216, R01DK053298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. H. Chen, S. Guo, S. Takada, E.H. Bresnick, and S.J. Brandt for providing regents, Y. Huang, A. Chen, and R. Mathieu for technical assistance. We are grateful to Drs. T.V. Bowman, C. Ceol, and R. White for helpful discussion and critical comments. This study was supported by National Institutes of Health grants 5PO1HL32262-28 and 5R37 DK55381-010. X. Bai and J. Kim are Howard Hughes Medical Institute (HHMI) research fellows. L.I. Zon and S.H. Orkin are HHMI investigators. L.I.Z. is a founder and stock holder of Fate, Inc. and a scientific advisor for Stemgent.	Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Elagib KE, 2008, BLOOD, V112, P4884, DOI 10.1182/blood-2008-03-145722; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; LeDouarin B, 1996, PHILOS T R SOC B, V351, P569, DOI 10.1098/rstb.1996.0056; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Long QM, 1997, DEVELOPMENT, V124, P4105; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	51	158	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					133	143		10.1016/j.cell.2010.05.028	http://dx.doi.org/10.1016/j.cell.2010.05.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603019	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000279637300019
J	Moiseff, A; Copeland, J				Moiseff, Andrew; Copeland, Jonathan			Firefly Synchrony: A Behavioral Strategy to Minimize Visual Clutter	SCIENCE			English	Article									[Moiseff, Andrew] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Copeland, Jonathan] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University of Connecticut; University System of Georgia; Georgia Southern University	Moiseff, A (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	Andrew.Moiseff@UConn.edu			Georgia Southern University Department of Biology; University of Connecticut Research Foundation	Georgia Southern University Department of Biology; University of Connecticut Research Foundation	Support for portions of this study were provided by the Georgia Southern University Department of Biology and the University of Connecticut Research Foundation. We thank L. Faust for assistance in the field, E. Lechowicz for technical support, and W. Chapple for commenting on the manuscript. K. Langdon and the Great Smoky Mountain National Park provided logistical support.	ADAMS G, 1981, FLA ENTOMOL, V64, P66, DOI 10.2307/3494601; BUCK J, 1981, J COMP PHYSIOL, V144, P287, DOI 10.1007/BF00612560; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Buck JB, 1938, Q REV BIOL, V13, P301, DOI 10.1086/394562; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; LLOYD JAMES E., 1966, MISC PUBLICATIONS MUS ZOOL UNIV MICH, V130, P1; LLOYD JE, 1989, BIOTROPICA, V21, P373, DOI 10.2307/2388290; Morse E. S., 1916, Science, V43, DOI 10.1126/science.43.1101.169; OTTE D, 1980, AM NAT, V116, P587, DOI 10.1086/283648; Strogatz S.H., 2003, SYNC EMERGING SCI SP	11	55	55	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					181	181		10.1126/science.1190421	http://dx.doi.org/10.1126/science.1190421			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616271				2022-12-24	WOS:000279635200038
J	Ackerman, JM; Nocera, CC; Bargh, JA				Ackerman, Joshua M.; Nocera, Christopher C.; Bargh, John A.			Incidental Haptic Sensations Influence Social Judgments and Decisions	SCIENCE			English	Article							TOUCH; EMBODIMENT; EMOTION; CHOICE; MIND	Touch is both the first sense to develop and a critical means of information acquisition and environmental manipulation. Physical touch experiences may create an ontological scaffold for the development of intrapersonal and interpersonal conceptual and metaphorical knowledge, as well as a springboard for the application of this knowledge. In six experiments, holding heavy or light clipboards, solving rough or smooth puzzles, and touching hard or soft objects nonconsciously influenced impressions and decisions formed about unrelated people and situations. Among other effects, heavy objects made job candidates appear more important, rough objects made social interactions appear more difficult, and hard objects increased rigidity in negotiations. Basic tactile sensations are thus shown to influence higher social cognitive processing in dimension-specific and metaphor-specific ways.	[Ackerman, Joshua M.] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA; [Nocera, Christopher C.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bargh, John A.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Harvard University; Yale University	Ackerman, JM (corresponding author), MIT, Alfred P Sloan Sch Management, 77 Massachusetts Ave,E62, Cambridge, MA 02142 USA.		Ackerman, Joshua/A-9315-2013		Sloan School of Management; National Institute of Mental Health [MH60767]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060767] Funding Source: NIH RePORTER	Sloan School of Management; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Sloan School of Management and by National Institute of Mental Health grant MH60767 to J.B. We thank L. Williams, E. Morsella, the Yale ACME lab, and many research assistants for their feedback and aid.	Anderson ML, 2007, PHILOS PSYCHOL, V20, P143, DOI 10.1080/09515080701197163; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Clark H.H., 1996, USING LANGUAGE; DeYoung CG, 2002, PERS INDIV DIFFER, V33, P533, DOI 10.1016/S0191-8869(01)00171-4; Gallace A, 2008, CONSCIOUS COGN, V17, P370, DOI 10.1016/j.concog.2007.01.005; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Goldinger SD, 2005, PSYCHOL SCI, V16, P525, DOI 10.1111/j.0956-7976.2005.01569.x; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Kovecses Zoltan, 2005, METAPHOR CULTURE UNI; Krishna A, 2008, J CONSUM RES, V34, P807, DOI 10.1086/523286; Lakoff G., 2003, METAPHORS WE LIVE; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Mortensen CR, 2010, PSYCHOL SCI, V21, P440, DOI 10.1177/0956797610361706; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Schacter DL, 2007, CURR OPIN NEUROBIOL, V17, P171, DOI 10.1016/j.conb.2007.02.001; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Wegner D. M., 1998, HDB SOCIAL PSYCHOL, P446; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665	28	285	311	3	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1712	1715		10.1126/science.1189993	http://dx.doi.org/10.1126/science.1189993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576894	Green Accepted			2022-12-24	WOS:000279107400049
J	Petherick, A				Petherick, Anna			Country by country	NATURE			English	Editorial Material							CHAGAS-DISEASE; OUTBREAK; SCHOOL											Ache Alberto, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P37, DOI 10.1590/S0036-46652001000100008; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Miles MA, 2010, J INFECT DIS, V201, P1282, DOI 10.1086/651609	4	24	24	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S10	S11		10.1038/nature09223	http://dx.doi.org/10.1038/nature09223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571547	Bronze			2022-12-24	WOS:000279056900027
J	Hui, E; Bravis, V; Hassanein, M; Hanif, W; Malik, R; Chowdhury, TA; Suliman, M; Devendra, D				Hui, E.; Bravis, V.; Hassanein, M.; Hanif, W.; Malik, R.; Chowdhury, T. A.; Suliman, M.; Devendra, D.			Management of people with diabetes wanting to fast during Ramadan	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INSULIN GLARGINE; TYPE-2; REPAGLINIDE; ACARBOSE; MUSLIMS; SAFETY; LISPRO		[Hui, E.; Bravis, V.; Devendra, D.] Univ London Imperial Coll Sci Technol & Med, Dept Investigat Sci, London, England; [Hanif, W.] Univ Hosp Birmingham, Dept Endocrinol & Diabet, Birmingham, W Midlands, England; [Hassanein, M.] Glan Clwyd Gen Hosp, Dept Diabet, Rhyl, Wales; [Malik, R.] Univ Manchester, Cardiovasc Res Grp, Manchester, Lancs, England; [Chowdhury, T. A.] Barts & London NHS Trust, Dept Diabet, London, England; [Suliman, M.] Royal Preston Hosp, Dept Med, Preston, Lancs, England; [Devendra, D.] NW London NHS Trust & Brent Community Serv, London, England	Imperial College London; University of Birmingham; University of Manchester; Barts Health NHS Trust; Royal Preston Hospital	Devendra, D (corresponding author), Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, London NW10 7NS, England.	d.devendra@imperial.ac.uk	Malik, Rayaz/H-9231-2019	Malik, Rayaz/0000-0002-7188-8903	National Institute for Health Research [ACF-2007-21-021] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Al-Arouj M, 2005, DIABETES CARE, V28, P2305, DOI 10.2337/diacare.28.9.2305; [Anonymous], KORAN, V2, P256; Anwar A, 2006, Med J Malaysia, V61, P28; Azar Sami T, 2008, J Med Liban, V56, P46; Bakiner O, 2009, ACTA DIABETOL, V46, P63, DOI 10.1007/s00592-008-0062-7; BELKHADIR J, 1993, BRIT MED J, V307, P292, DOI 10.1136/bmj.307.6899.292; Benaji B, 2006, DIABETES RES CLIN PR, V73, P117, DOI 10.1016/j.diabres.2005.10.028; Beshyah SA, 2009, IBNOSINA J MED BIOME, V1, P58; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bravis V, 2010, DIABETIC MED, V27, P327, DOI 10.1111/j.1464-5491.2010.02948.x; Cesur M, 2007, DIABETES RES CLIN PR, V75, P141, DOI 10.1016/j.diabres.2006.05.012; Devendra D, 2009, INT J CLIN PRACT, V63, P1446, DOI 10.1111/j.1742-1241.2009.02171.x; HUI E, 2010, INT J CLIN PRAC 0310; Kadiri A, 2001, DIABETES METAB, V27, P482; Mafauzy M, 2002, DIABETES RES CLIN PR, V58, P45, DOI 10.1016/S0168-8227(02)00104-3; Mattoo V, 2003, DIABETES RES CLIN PR, V59, P137, DOI 10.1016/S0168-8227(02)00202-4; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mojaddidi M, 2006, PRESCRIBER, P38; *MUSL SPIR CAR DIV, RAM HLTH FACTSH 2009; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG PA; Norris SL, 2009, DIABETIC MED, V26, P837, DOI 10.1111/j.1464-5491.2009.02790.x; Pan C, 2008, DIABETIC MED, V25, P435, DOI 10.1111/j.1464-5491.2008.02391.x; RASHED AH, 1992, BRIT MED J, V304, P521, DOI 10.1136/bmj.304.6826.521; Rohban T, 2005, DIABETES CARE, V28, P421; Rosak C, 2009, CURR DIABETES REV, V5, P157, DOI 10.2174/157339909788920910; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Sari R, 2004, ENDOCR RES, V30, P169, DOI 10.1081/ERC-200027375; Senthil Vasan, 2006, International Journal of Diabetes in Developing Countries, V26, P70; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Uysal AR, 1998, DIABETES CARE, V21, P2033, DOI 10.2337/diacare.21.11.2033	30	67	68	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3053	10.1136/bmj.c3053	http://dx.doi.org/10.1136/bmj.c3053			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IO	20570867				2022-12-24	WOS:000279346300003
J	Cowling, BJ; Chan, KH; Fang, VJ; Lau, LLH; So, HC; Fung, ROP; Ma, ESK; Kwong, ASK; Chan, C; Tsui, WWS; Ngai, H; Chu, DWS; Lee, PWY; Chiu, M; Leung, GM; Peiris, JSM				Cowling, Benjamin J.; Chan, Kwok Hung; Fang, Vicky J.; Lau, Lincoln L. H.; So, Hau Chi; Fung, Rita O. P.; Ma, Edward S. K.; Kwong, Alfred S. K.; Chan, Chi-Wai; Tsui, Wendy W. S.; Ngai, Ho-Yin; Chu, Daniel W. S.; Lee, Paco W. Y.; Chiu, Ming-Chee; Leung, Gabriel M.; Peiris, Joseph S. M.			Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OSELTAMIVIR TREATMENT; CLINICAL ILLNESS; TRANSMISSION; VIRUS; INFECTION; DIAGNOSIS; CHILDREN; DURATION; A(H1N1); DISEASE	Background: There are few data on the comparative epidemiology and virology of the pandemic 2009 influenza A (H1N1) virus and cocirculating seasonal influenza A viruses in community settings. Methods: We recruited 348 index patients with acute respiratory illness from 14 outpatient clinics in Hong Kong in July and August 2009. We then prospectively followed household members of 99 patients who tested positive for influenza A virus on rapid diagnostic testing. We collected nasal and throat swabs from all household members at three home visits within 7 days for testing by means of quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay and viral culture. Using hemagglutination-inhibition and viral-neutralization assays, we tested baseline and convalescent serum samples from a subgroup of patients for antibody responses to the pandemic and seasonal influenza A viruses. Results: Secondary attack rates (as confirmed on RT-PCR assay) among household contacts of index patients were similar for the pandemic influenza virus (8%; 95% confidence interval [CI], 3 to 14) and seasonal influenza viruses (9%; 95% CI, 5 to 15). The patterns of viral shedding and the course of illness among index patients were also similar for the pandemic and seasonal influenza viruses. In a subgroup of patients for whom baseline and convalescent serum samples were available, 36% of household contacts who had serologic evidence of pandemic influenza virus infection did not shed detectable virus or report illness. Conclusions: Pandemic 2009 H1N1 virus has characteristics that are broadly similar to those of seasonal influenza A viruses in terms of rates of viral shedding, clinical illness, and transmissibility in the household setting. N Engl J Med 2010;362:2175-84.	[Cowling, Benjamin J.; Fang, Vicky J.; Lau, Lincoln L. H.; So, Hau Chi; Fung, Rita O. P.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China; [Chan, Kwok Hung; Ma, Edward S. K.; Peiris, Joseph S. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Kwong, Alfred S. K.; Chan, Chi-Wai; Tsui, Wendy W. S.; Ngai, Ho-Yin; Chu, Daniel W. S.] Govt Hong Kong Special Adm Reg, Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Lee, Paco W. Y.] St Pauls Hosp, Hong Kong, Hong Kong, Peoples R China; [Chiu, Ming-Chee] St Teresas Hosp, Hong Kong, Hong Kong, Peoples R China; [Peiris, Joseph S. M.] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong St. Paul's Hospital; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Units 624-7,Core F Cyberport 3, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Cowling, Benjamin John/C-4263-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; So, Hau Chi/0000-0003-3119-1527; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Lau, Lincoln/0000-0002-7386-4104	National Institute of Allergy and Infectious Diseases [HHS-N266200700005C, N01-AI-70005]; Hong Kong University Grants Committee [AoE/M-12/06]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hong Kong University Grants Committee	Supported by grants from the National Institute of Allergy and Infectious Diseases (HHS-N266200700005C and N01-AI-70005) and the Hong Kong University Grants Committee (AoE/M-12/06).	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2009, GUID BUS EMPL PLAN R; *CDCP, 2009, HOM CAR GUID PHYS DI; *CDCP, 2009, CDC REC AM TIM PERS; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chen TH, 2009, COMPUT ELECTR ENG, V35, P41, DOI 10.1016/j.compeleceng.2008.05.003; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Shao J, 1995, JACKKNIFE BOOTSTRAP, P129; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	38	266	278	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2175	2184		10.1056/NEJMoa0911530	http://dx.doi.org/10.1056/NEJMoa0911530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558368	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000278551500006
J	Haukoos, JS; Hopkins, E; Conroy, AA; Silverman, M; Byyny, RL; Eisert, S; Thrun, MW; Wilson, ML; Hutchinson, AB; Forsyth, J; Johnson, SC; Heffelfinger, JD				Haukoos, Jason S.; Hopkins, Emily; Conroy, Amy A.; Silverman, Morgan; Byyny, Richard L.; Eisert, Sheri; Thrun, Mark W.; Wilson, Michael L.; Hutchinson, Angela B.; Forsyth, Jessica; Johnson, Steven C.; Heffelfinger, James D.		Denver Emergency Dept HIV Opt-Out	Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in Emergency Department Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOR-DISEASE-CONTROL; CARE; PROGRAM; HEALTH; RECOMMENDATIONS; IMPLEMENTATION; EXPERIENCE; TESTS; MODEL	Context The Centers for Disease Control and Prevention (CDC) recommends routine (nontargeted) opt-out HIV screening in health care settings, including emergency departments (EDs), where the prevalence of undiagnosed infection is 0.1% or greater. The utility of this approach in EDs remains unknown. Objective To determine whether nontargeted opt-out rapid HIV screening in the ED was associated with identification of more patients with newly diagnosed HIV infection than physician-directed diagnostic rapid HIV testing. Design, Setting, and Patients Quasi-experimental equivalent time-samples design in an urban public safety-net hospital with an approximate annual ED census of 55 000 patient visits. Patients were 16 years or older and capable of providing consent for rapid HIV testing. Interventions Nontargeted opt-out rapid HIV screening and physician-directed diagnostic rapid HIV testing alternated in sequential 4-month time intervals between April 15, 2007, and April 15, 2009. Main Outcome Measures Number of patients with newly identified HIV infection and the association between nontargeted opt-out rapid HIV screening and identification of HIV infection. Results In the opt-out phase, of 28 043 eligible ED patients, 6933 patients (25%) completed HIV testing (6702 patients were screened; 231 patients were diagnostically tested). Ten of 6702 patients (0.15%; 95% CI, 0.07%-0.27%) who did not decline HIV screening in the opt-out phase had new HIV diagnoses, and 5 of 231 patients (2.2%; 95% CI, 0.7%-5.0%) who were diagnostically tested during the opt-out phase had new HIV diagnoses. In the diagnostic phase, of 29 925 eligible patients, 243 (0.8%) completed HIV testing. Of these, 4 patients (1.6%; 95% CI, 0.5%-4.2%) had new diagnoses. The prevalence of new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 15 in 28 043 (0.05%; 95% CI, 0.03%-0.09%) and 4 in 29 925 (0.01%; 95% CI, 0.004%-0.03%), respectively. Nontargeted opt-out HIV screening was independently associated with new HIV diagnoses (risk ratio, 3.6; 95% CI, 1.2-10.8) when adjusting for patient demographics, insurance status, and whether diagnostic testing was performed in the opt-out phase. The median CD4 cell count for those with new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 69/mu L (IQR, 17-430) and 13/mu L (IQR, 11-15), respectively (P=.02). Conclusion Nontargeted opt-out rapid HIV screening in the ED, vs diagnostic testing, was associated with identification of a modestly increased number of patients with new HIV diagnoses, most of whom were identified late in the course of disease. JAMA. 2010;304(3):284-292 www.jama.com	[Haukoos, Jason S.; Hopkins, Emily; Byyny, Richard L.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; [Silverman, Morgan] Denver Hlth Med Ctr, Dept Clin Social Work, Denver, CO 80204 USA; [Eisert, Sheri] Denver Hlth Med Ctr, Dept Hlth Serv Res, Denver, CO 80204 USA; [Wilson, Michael L.] Denver Hlth Med Ctr, Dept Pathol, Denver, CO 80204 USA; [Haukoos, Jason S.; Byyny, Richard L.; Thrun, Mark W.; Wilson, Michael L.; Johnson, Steven C.] Univ Colorado, Sch Med, Aurora, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Eisert, Sheri] Colorado Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA; [Conroy, Amy A.] Univ Colorado Denver, Dept Hlth & Behav Sci, Denver, CO USA; [Thrun, Mark W.] Denver Publ Hlth, Denver, CO USA; [Hutchinson, Angela B.; Heffelfinger, James D.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Forsyth, Jessica] Childrens Hosp, Childrens Immunodeficiency Program, Aurora, CO USA; [Johnson, Steven C.] Univ Colorado, Univ Colorado Hosp, HIV AIDS Clin Program, Aurora, CO USA	Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centers for Disease Control & Prevention - USA; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Hospital	Haukoos, JS (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA.	jason.haukoos@dhha.org		Byyny, Richard/0000-0002-9145-7457	Abbott Laboratories; Centers for Disease Control and Prevention (CDC) [U18 PS000314]; Agency for Healthcare Research and Quality (AHRQ) [K02 HS017526]; Colorado Department of Public Health and Environment (CDPHE); Colorado Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Colorado Department of Public Health and Environment (CDPHE); Colorado Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Dr Haukoos reported receiving unrestricted research support from Abbott Laboratories and being supported in part by the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ). Ms Hopkins reported being supported previously by an unrestricted research grant from Abbott Laboratories and supported in full during the course of this project by the CDC. Dr Thrun reported receiving support from the Colorado Department of Public Health and Environment (CDPHE) and the CDC and having been a paid consultant for the CDC on issues related to HIV prevention. Dr Johnson reported participating in advisory boards and serving as a consultant for both ViiV Healthcare and Gilead Sciences Inc. No other disclosures were reported.; This study was funded by a cooperative agreement (U18 PS000314) with the CDC (J.S.H.) and supported in part by an Independent Scientist Award (K02 HS017526) from the AHRQ (J.S.H.) and a Career Development Award from the Colorado Center for AIDS Research (R.L.B.).	Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bernstein SL, 2003, ACAD EMERG MED, V10, P938, DOI 10.1197/S1069-6563(03)00311-7; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Campbell D., 1963, EXPT QUASIEXPERIMENT; *CDCP, 2006, NEW EST US HIV PREV; Chou R, 2007, SCREENING HUMAN IMMU; Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x; Gabow P, 2003, ANN INTERN MED, V138, P143, DOI 10.7326/0003-4819-138-2-200301210-00016; Glick NR, 2004, AIDS EDUC PREV, V16, P126, DOI 10.1521/aeap.16.2.126.29391; Goggin MA, 2000, J EMERG MED, V19, P13, DOI 10.1016/S0736-4679(00)00175-X; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; Haukoos JS, 2009, ACAD EMERG MED, V16, P1044, DOI 10.1111/j.1553-2712.2009.00556.x; Haukoos JS, 2009, ACAD EMERG MED, V16, P800, DOI 10.1111/j.1553-2712.2009.00477.x; Hsieh YH, 2008, AIDS, V22, P2127, DOI 10.1097/QAD.0b013e328310e066; Irvin CB, 2007, ANN EMERG MED, V49, P722, DOI 10.1016/j.annemergmed.2007.03.011; Kelen GD, 2009, ANN EMERG MED, V54, P65, DOI 10.1016/j.annemergmed.2009.03.027; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Kelen GD, 1996, ANN EMERG MED, V27, P687, DOI 10.1016/S0196-0644(96)70184-1; KELEN GD, 1991, AM J EMERG MED, V9, P416, DOI 10.1016/0735-6757(91)90205-X; Lyons MS, 2009, J MED SCREEN, V16, P29, DOI 10.1258/jms.2009.008086; Lyons MS, 2005, ANN EMERG MED, V46, P22, DOI 10.1016/j.annemergmed.2004.12.022; Lyss S, 2004, ANN EMERG MED, V44, pS56, DOI 10.1016/j.annemergmed.2004.07.184; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Mollen C, 2008, AIDS PATIENT CARE ST, V22, P505, DOI 10.1089/apc.2007.0098; Owens SD, 2008, VET CLIN PATH, V37, P49, DOI 10.1111/j.1939-165X.2008.00003.x; Rothman RE, 2007, ACAD EMERG MED, V14, P653, DOI 10.1197/j.aem.2007.04.004; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Torres GW, 2009, PUBLIC HEALTH REP, V124, P400, DOI 10.1177/003335490912400309; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027	34	138	139	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					284	292		10.1001/jama.2010.953	http://dx.doi.org/10.1001/jama.2010.953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639562	Bronze			2022-12-24	WOS:000280107500018
J	Karagas, MR; Waterboer, T; Li, ZZ; Nelson, HH; Michael, KM; Bavinck, JNB; Perry, AE; Spencer, SK; Daling, J; Green, AC; Pawlita, M				Karagas, Margaret R.; Waterboer, Tim; Li, Zhongze; Nelson, Heather H.; Michael, Kristina M.; Bavinck, Jan Nico Bouwes; Perry, Ann E.; Spencer, Steven K.; Daling, Janet; Green, Adele C.; Pawlita, Michael		New Hampshire Skin Canc Study Grp	Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							GLUTATHIONE-S-TRANSFERASE; VIRUS-LIKE PARTICLES; ACTINIC KERATOSES; SUN EXPOSURE; CANCER; RISK; ANTIBODIES; INFECTION; PROTEINS; SEROREACTIVITY	Objective To investigate the association between genus beta human papillomaviruses and the incidence of nonmelanocytic skin cancer in the general population. Design Population based case-control study. Setting New Hampshire, USA. Participants 2366 skin cancer cases and controls from the general population aged 25 to 74 years (663 squamous cell carcinoma, 898 basal cell carcinoma, 805 controls), with plasma samples tested for L1 antibodies to 16 genus beta human papillomaviruses by multiplex serology. Main outcome measures Odds ratios for squamous cell carcinoma and basal cell carcinoma associated with seropositivity to beta human papillomaviruses. Results Squamous cell carcinoma, but not basal cell carcinoma, cases had a higher prevalence of each of the individual beta human papillomaviruses assayed compared with controls. The odds ratios for squamous cell carcinoma increased with the number of beta types positive (odds ratio for one type positive 0.99 (95% confidence interval 0.74 to 1.33); two to three types positive 1.44 (1.03 to 2.01); four to eight types positive 1.51 (1.03 to 2.20); more than eight types positive 1.71 (1.12 to 2.62); P for trend (categorical)<0.001; P for trend (continuous)=0.003). With limited statistical power, the association was stronger among long term users of systemic glucocorticoids (odds ratio 3.21, 1.22 to 8.44) than among non-users (1.23, 0.97 to 1.55). Conclusions These findings support a relation between genus beta human papillomavirus infection and the incidence of squamous cell carcinoma of the skin in the general population, as well as potential enhancement of risk by immunosuppression.	[Karagas, Margaret R.; Li, Zhongze; Perry, Ann E.; Spencer, Steven K.] Dartmouth Med Sch, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH 03756 USA; [Karagas, Margaret R.; Li, Zhongze; Perry, Ann E.; Spencer, Steven K.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Waterboer, Tim; Michael, Kristina M.; Pawlita, Michael] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Nelson, Heather H.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bavinck, Jan Nico Bouwes] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Daling, Janet] Univ Washington, Seattle, WA 98109 USA; [Green, Adele C.] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Daling, Janet] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Fred Hutchinson Cancer Center	Karagas, MR (corresponding author), Dartmouth Med Sch, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH 03756 USA.	margaret.karagas@dartmouth.edu	Waterboer, Tim/G-1252-2010; Green, Adele C/B-5324-2011; Green, Adele C/P-2736-2014; Pawlita, Labor/C-9720-2011	Green, Adele C/0000-0002-2753-4841; Mittleman, Murray/0000-0001-9788-7274; Pawlita, Michael/0000-0002-4720-8306; Nelson, Heather/0000-0003-1901-9513	US National Institutes of Health, National Cancer Institute [CA118443, CA57494]; European Community [QLK2-CT-2002-01179]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA118443, R01CA057494] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded in part by grants CA118443 and CA57494 of the US National Institutes of Health, National Cancer Institute and grant QLK2-CT-2002-01179 of the European Community. The NCI and the EC were not involved in the design and conduct of the study or the collection, management, analysis, and interpretation of the data. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, NCI or the EC.	Andersson K, 2008, CANCER EPIDEM BIOMAR, V17, P189, DOI 10.1158/1055-9965.EPI-07-0405; Bavinck JNB, 1996, TRANSPLANTATION, V61, P715, DOI 10.1097/00007890-199603150-00008; Bavinck JNB, 2000, BRIT J DERMATOL, V142, P103, DOI 10.1046/j.1365-2133.2000.03248.x; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; Casabonne D, 2007, INT J CANCER, V121, P1862, DOI 10.1002/ijc.22885; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dondog B, 2008, CANCER EPIDEM BIOMAR, V17, P1731, DOI 10.1158/1055-9965.EPI-07-2796; Feltkamp MCW, 2003, CANCER RES, V63, P2695; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; *INT AG RES CTR, 2007, IARC MON, V90; Karagas M, 2006, CANC EPIDEMIOLOGY PR; Karagas MR, 2007, AM J EPIDEMIOL, V165, P719, DOI 10.1093/aje/kwk055; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karagas MR, 2001, BRIT J CANCER, V85, P683, DOI 10.1054/bjoc.2001.1931; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Karagas MR, 2001, AM J EPIDEMIOL, V153, P559, DOI 10.1093/aje/153.6.559; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Masini C, 2003, ARCH DERMATOL, V139, P890, DOI 10.1001/archderm.139.7.890; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Sorensen HT, 2004, JNCI-J NATL CANCER I, V96, P709, DOI 10.1093/jnci/djh118; Stark S, 1998, J INVEST DERMATOL, V111, P696, DOI 10.1046/j.1523-1747.1998.00360.x; STEGER G, 1990, J VIROL, V64, P4399, DOI 10.1128/JVI.64.9.4399-4406.1990; Struijk L, 2006, CANCER EPIDEM BIOMAR, V15, P529, DOI 10.1158/1055-9965.EPI-05-0747; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381	32	64	64	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 8	2010	341								c2986	10.1136/bmj.c2986	http://dx.doi.org/10.1136/bmj.c2986			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DM	20616098	Green Published, hybrid			2022-12-24	WOS:000279874400001
J	Martin, DF; Maguire, MG; Fine, SL				Martin, Daniel F.; Maguire, Maureen G.; Fine, Stuart L.			Identifying and Eliminating the Roadblocks to Comparative-Effectiveness Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MACULAR DEGENERATION; RANIBIZUMAB		[Martin, Daniel F.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Maguire, Maureen G.; Fine, Stuart L.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; University of Pennsylvania	Martin, DF (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.							Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481	4	29	29	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					105	107		10.1056/NEJMp1001201	http://dx.doi.org/10.1056/NEJMp1001201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20519677				2022-12-24	WOS:000279574100003
J	Zeng, L; Zhang, Q; Li, S; Plotnikov, AN; Walsh, MJ; Zhou, MM				Zeng, Lei; Zhang, Qiang; Li, Side; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming			Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b	NATURE			English	Article							LYSINE-4 TRIMETHYLATION; AUTOIMMUNE REGULATOR; PLANT HOMEODOMAIN; H3; RECOGNITION; METHYLATION; BROMODOMAIN; NMR; DOMAIN; H3K4ME3	Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context(1,2). Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains(1). Recently, a tandem plant homeodomain (PHD) finger(3) (PHD1-PHD2, or PHD12) of human DPF3b, which functions in association with the BAF chromatin remodelling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner(4), making it the first alternative to bromodomains for acetyl-lysine binding(5). Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b. Our three-dimensional solution structures and biochemical analysis of DPF3b highlight the molecular basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac). Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c. Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.	[Zeng, Lei; Zhang, Qiang; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Li, Side; Walsh, Martin J.] Mt Sinai Sch Med, Dept Paediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zhou, MM (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu			National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the use of the NMR Facility at the New York Structural Biology Center. We thank S. Hearn of Cold Spring Harbor Laboratory microscopy facility for help with confocal microscopy study, and A. Buku and G. Gerona-Navarro for technical advice on peptide binding analysis. This work was supported by grants from the National Institutes of Health (M.-M.Z.).	Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Portier GL, 1999, IN VITRO CELL DEV-AN, V35, P219, DOI 10.1007/s11626-999-0030-8; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416	30	211	214	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					258	U138		10.1038/nature09139	http://dx.doi.org/10.1038/nature09139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613843	Green Accepted			2022-12-24	WOS:000279580800041
J	Jena, AB; Goldman, DP; Kamdar, A; Lakdawalla, DN; Lu, Y				Jena, Anupam B.; Goldman, Dana P.; Kamdar, Amee; Lakdawalla, Darius N.; Lu, Yang			Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; SILDENAFIL USE; RISK BEHAVIORS; HIV-INFECTION; SAN-FRANCISCO; OLDER-PEOPLE; MEN; ATTITUDES; VIAGRA; ADULTS	Background: Pharmacologic treatments for erectile dysfunction (ED) have gained popularity among middle-aged and older men. Increased sexual activity among those who use these drugs raises concerns about sexually transmitted diseases (STDs). Objective: To examine the rates of STDs in men who use and do not use ED drugs. Design: Retrospective cohort study. Setting: Database of claims from 1997 to 2006 for 1 410 806 men older than age 40 years with private, employer-based insurance from 44 large companies. Patients: 33 968 men with at least 1 filled prescription for an ED drug and 1 376 838 patients with no prescription. Measurements: STD prevalence among users and nonusers of ED drugs. Results: Users of ED drugs had higher rates of STDs than nonusers the year before initiating ED drug therapy (214 vs. 106 annually per 100 000 persons; P = 0.003) and the year after (105 vs. 65; P = 0.004). After adjustment for age and other comorbid conditions, users of ED drugs had an odds ratio (OR) for an STD of 2.80 (95% CI, 2.10 to 3.75) in the year before initiating drug therapy; the OR was 2.65 (CI, 1.84 to 3.81) in the year after. These differences were largely due to infections with HIV. The OR for HIV infection was 3.32 (CI, 2.38 to 4.36) in the year before and 3.19 (CI, 2.11 to 4.83) in the year after an ED drug prescription was filled. Significant changes in STD rates from the year before to the year after the first ED drug prescription was filled were not documented (adjusted OR for STD for users before vs. after the first ED drug prescription was filled, 0.96 [CI, 0.87 to 1.06]). Limitation: Selection bias precludes conclusions about whether use of ED treatments directly leads to increases in STDs. Conclusion: Men who use ED drugs have higher rates of STDs, particularly HIV infection, both in the year before and after use of these drugs. The observed association between ED drug use and STDs may have more to do with the types of patients using ED drugs rather than a direct effect of ED drug availability on STD rates. Counseling about safe sexual practices and screening for STDs should accompany the prescription of ED drugs.	Harvard Univ, Sch Med, Boston, MA USA; Univ So Calif, Los Angeles, CA USA; Univ Chicago, Booth Grad Sch Business, Chicago, IL 60637 USA; RAND Corp, Santa Monica, CA USA	Harvard University; Harvard Medical School; University of Southern California; University of Chicago; RAND Corporation	Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Wang Ambulatory Care Ctr, 15 Parkman St, Boston, MA 02114 USA.	jena.anupam@mgh.harvard.edu	Goldman, Dana P/E-7667-2013; Lakdawalla, Darius/B-4409-2011	Goldman, Dana P/0000-0001-8498-6396; Lakdawalla, Darius/0000-0001-5934-8042; Lu, Yang/0000-0003-2905-7302	RAND Roybal Center; National Institutes of Health; Agency for Healthcare Research and Quality; Bing Center for Health Economics; RAND Roybal Center for Health Policy Simulation [P30AG024968]; National Institutes of Health [5 T32 GM07281]; Agency for Healthcare Research and Quality through a University of California, Los Angeles [T32 HS 000046]; National Institute for Child Health and Human Development [1R01HD054877]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000046, F32HS000046] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	RAND Roybal Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Bing Center for Health Economics; RAND Roybal Center for Health Policy Simulation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality through a University of California, Los Angeles; National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: RAND Roybal Center, National Institutes of Health, and Agency for Healthcare Research and Quality.; By the Bing Center for Health Economics and RAND Roybal Center for Health Policy Simulation (grant P30AG024968), a National Institutes of Health Medical Scientist National Research Award (grant 5 T32 GM07281 to Dr. Jena), the Agency for Healthcare Research and Quality through a University of California, Los Angeles/RAND Training Grant (grant T32 HS 000046 to Dr. Jena), and the National Institute for Child Health and Human Development (grant 1R01HD054877 to Dr. Jena).	Araujo AB, 2004, J AM GERIATR SOC, V52, P1502, DOI 10.1111/j.0002-8614.2004.52413.x; Armstrong K, 1999, NEW ENGL J MED, V341, P1389, DOI 10.1056/NEJM199910283411810; BACON CG, 2003, ANN INTERN MED, V50, P139; Bodley-Tickell AT, 2008, SEX TRANSM INFECT, V84, P312, DOI 10.1136/sti.2007.027847; Cachay E, 2004, AIDS PATIENT CARE ST, V18, P349, DOI 10.1089/1087291041444050; Chu PL, 2003, JAIDS-J ACQ IMM DEF, V33, P191, DOI 10.1097/00126334-200306010-00012; Delate T, 2004, INT J IMPOT RES, V16, P313, DOI 10.1038/sj.ijir.3901191; Enzlin P, 2004, INT J IMPOT RES, V16, P512, DOI 10.1038/sj.ijir.3901221; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Karlovsky M, 2004, SCAND J UROL NEPHROL, V38, P247, DOI 10.1080/00365590410025488; Kim AA, 2002, AIDS, V16, P1425, DOI 10.1097/00002030-200207050-00017; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P1285, DOI 10.1001/jama.300.11.1285; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2006, J WOMENS HEALTH, V15, P747, DOI 10.1089/jwh.2006.15.747; Moreira ED, 2005, INT J CLIN PRACT, V59, P6, DOI 10.1111/j.1742-1241.2005.00382.x; Nicolosi A, 2004, UROLOGY, V64, P991, DOI 10.1016/j.urology.2004.06.055; Ory MG, 1998, RES AGING, V20, P653, DOI 10.1177/0164027598206002; Patel D, 2003, SEX TRANSM DIS, V30, P216, DOI 10.1097/00007435-200303000-00008; Paul JP, 2005, SEX TRANSM DIS, V32, P531, DOI 10.1097/01.olq.0000175294.76494.77; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; SHARPLES T, 2008, TIME            0702; Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289; Smith KP, 2009, AM J PUBLIC HEALTH, V99, P2055, DOI 10.2105/AJPH.2009.160119; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; Swearingen SG, 2005, AM J MED, V118, P571, DOI 10.1016/j.amjmed.2005.01.042	30	39	40	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					1	+		10.7326/0003-4819-153-1-201007060-00003	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620GS	20621899				2022-12-24	WOS:000279487700001
J	Wang, ZX; Song, JK; Milne, TA; Wang, GG; Li, HT; Allis, CD; Patel, DJ				Wang, Zhanxin; Song, Jikui; Milne, Thomas A.; Wang, Gang G.; Li, Haitao; Allis, C. David; Patel, Dinshaw J.			Pro Isomerization in MLL1 PHD3-Bromo Cassette Connects H3K4me Readout to CyP33 and HDAC-Mediated Repression	CELL			English	Article							HISTONE MODIFICATIONS; PHD FINGERS; PROLINE ISOMERIZATION; CIS/TRANS ISOMERASES; BINDING MODULES; PROTEIN; METHYLTRANSFERASE; RECOGNITION; BROMODOMAIN; LEUKEMIA	The MLL1 gene is a frequent target for recurrent chromosomal translocations, resulting in transformation of hematopoietic precursors into leukemia stem cells. Here, we report on structure-function studies that elucidate molecular events in MLL1 binding of histone H3K4me3/2 marks and recruitment of the cyclophilin CyP33. CyP33 contains a PPIase and a RRM domain and regulates MLL1 function through HDAC recruitment. We find that the PPIase domain of CyP33 regulates the conformation of MLL1 through proline isomerization within the PHD3-Bromo linker, thereby disrupting the PHD3-Bromo interface and facilitating binding of the MLL1-PHD3 domain to the CyP33-RRM domain. H3K4me3/2 and CyP33-RRM target different surfaces of MLL1-PHD3 and can bind simultaneously to form a ternary complex. Furthermore, the MLL1-CyP33 interaction is required for repression of HOXA9 and HOXC8 genes in vivo. Our results highlight the role of PHD3-Bromo cassette as a regulatory platform, orchestrating MLL1 binding of H3K4me3/2 marks and cyclophilin-mediated repression through HDAC recruitment.	[Wang, Zhanxin; Song, Jikui; Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Milne, Thomas A.; Wang, Gang G.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org	Milne, Tom/E-1872-2016; Wang, G Greg/L-6666-2014; Li, Haitao/B-2668-2012	Milne, Tom/0000-0002-0413-4271; Wang, G Greg/0000-0002-7210-9940; Li, Haitao/0000-0001-6741-293X	Leukemia and Lymphoma Society [LLS-SCOR 7132-08]; Starr Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, K99CA151683] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Leukemia and Lymphoma Society Program Project grant LLS-SCOR 7132-08 and a Starr Foundation grant, both of them jointly to D.J.P. and C.D.A. D.J.P. is a consultant in GlaxoSmithKline's epigenetic programs.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linggi BE, 2005, J CELL BIOCHEM, V96, P938, DOI 10.1002/jcb.20604; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Milne Thomas A., 2009, V538, P409, DOI 10.1007/978-1-59745-418-6_21; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang T, 2005, BIOCHEM BIOPH RES CO, V333, P845, DOI 10.1016/j.bbrc.2005.06.006; Wang Y, 2008, FEBS LETT, V582, P835, DOI 10.1016/j.febslet.2008.01.055; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	47	137	142	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1183	U151		10.1016/j.cell.2010.05.016	http://dx.doi.org/10.1016/j.cell.2010.05.016			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20541251	Green Accepted, Bronze			2022-12-24	WOS:000279148100015
J	Ayoya, MA				Ayoya, Mohamed Ag			Personal View G8 leaders must seize their chance to tackle undernutrition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Unicef Country Off, New Delhi, India		Ayoya, MA (corresponding author), Unicef Country Off, New Delhi, India.	mayoya@unicef.org						Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Unicef, 2009, TRACK PROGR CHILD MA; United Nations, 2008, MILL DEV GOALS REP; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; *WHO STAT INF SYST, 2008, DAT AN	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2010	340								c3289	10.1136/bmj.c3289	http://dx.doi.org/10.1136/bmj.c3289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IP	20573765				2022-12-24	WOS:000279346400007
J	Goldkind, SF; Sahin, L; Gallauresi, B				Goldkind, Sara F.; Sahin, Leyla; Gallauresi, Beverly			Enrolling Pregnant Women in Research - Lessons from the H1N1 Influenza Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldkind, Sara F.; Gallauresi, Beverly] US FDA, Off Commissioner, Silver Spring, MD USA; [Goldkind, Sara F.] US FDA, Off Good Clin Practice, Silver Spring, MD USA; [Sahin, Leyla] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Sahin, Leyla] US FDA, Maternal Hlth Team, Silver Spring, MD USA; [Gallauresi, Beverly] US FDA, Off Womens Hlth, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Goldkind, SF (corresponding author), US FDA, Off Commissioner, Silver Spring, MD USA.							Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Andrew MA, 2007, CLIN PHARMACOL THER, V81, P547, DOI 10.1038/sj.clpt.6100126; Coverdale JH, 2008, OBSTET GYNECOL, V112, P1361, DOI 10.1097/AOG.0b013e31818c2a27; McCullough LB, 2005, AM J OBSTET GYNECOL, V193, P901, DOI 10.1016/j.ajog.2005.06.020; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb	5	63	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2241	2243		10.1056/NEJMp1003462	http://dx.doi.org/10.1056/NEJMp1003462			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20554981				2022-12-24	WOS:000278816300001
J	McCartney, M				McCartney, Margaret			Medical Screening Smear fears	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				*AM C OBST GYNC, 2009, ACOG PRACT B, P109	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2010	340								c2830	10.1136/bmj.c2830	http://dx.doi.org/10.1136/bmj.c2830			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614IZ	20547686				2022-12-24	WOS:000279051600002
J	Baker, M				Baker, Monya			STRUCTURAL BIOLOGY The gatekeepers revealed	NATURE			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; RESOLUTION; MEMBRANE; RHODOPSIN											Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	12	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					823	828		10.1038/465823a	http://dx.doi.org/10.1038/465823a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535212				2022-12-24	WOS:000278551800054
J	Parvatiyar, K; Harhaj, EW				Parvatiyar, Kislay; Harhaj, Edward W.			Anchors Away for Ubiquitin Chains	SCIENCE			English	Editorial Material							UNANCHORED POLYUBIQUITIN CHAINS; ANTIVIRAL RESPONSES; RIG-I; ACTIVATION; KINASES; LIGASE		[Parvatiyar, Kislay; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami	Parvatiyar, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	eharhaj@med.miami.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083143, R01 GM083143-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*EWH, RO1CA135362 EWH NIH; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	11	7	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1244	1245		10.1126/science.1192296	http://dx.doi.org/10.1126/science.1192296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522767	Green Accepted			2022-12-24	WOS:000278318600024
J	de Oliveira, C; Watt, R; Hamer, M				de Oliveira, Cesar; Watt, Richard; Hamer, Mark			Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PERIODONTAL-DISEASE; ORAL-HEALTH; CHLAMYDIA-PNEUMONIAE; ATHEROSCLEROSIS; MARKERS; METAANALYSIS; CHOLESTEROL; MORTALITY	Objective To examine if self reported toothbrushing behaviour is associated with cardiovascular disease and markers of inflammation (C reactive protein) and coagulation (fibrinogen). Design National population based survey. Setting Scottish Health Survey, which draws a nationally representative sample of the general population living in households in Scotland. Participants 11 869 men and women, mean age 50 (SD 11). Main outcome measures Oral hygiene assessed from self reported frequency of toothbrushing. Surveys were linked prospectively to clinical hospital records, and Cox proportional hazards models were used to estimate the risk of cardiovascular disease events or death according to oral hygiene. The association between oral hygiene and inflammatory markers and coagulation was examined in a subsample of participants (n=4830) by using general linear models with adjustments. Results There were a total of 555 cardiovascular disease events over an average of 8.1 (SD 3.4) years of follow-up, of which 170 were fatal. In about 74% (411) of cardiovascular disease events the principal diagnosis was coronary heart disease. Participants who reported poor oral hygiene (never/rarely brushed their teeth) had an increased risk of a cardiovascular disease event (hazard ratio 1.7, 95% confidence interval 1.3 to 2.3; P<0.001) in a fully adjusted model. They also had increased concentrations of both C reactive protein (beta 0.04, 0.01 to 0.08) and fibrinogen (0.08, -0.01 to 0.18). Conclusions Poor oral hygiene is associated with higher levels of risk of cardiovascular disease and low grade inflammation, though the causal nature of the association is yet to be determined.	[de Oliveira, Cesar; Watt, Richard; Hamer, Mark] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Watt, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	r.watt@ucl.ac.uk	Hamer, Mark/C-1602-2008; de Oliveira, Cesar/B-5251-2019; Hamer, Mark/AAJ-6814-2021	Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Watt, Richard/0000-0001-6229-8584; De Oliveira, Cesar/0000-0002-4099-4762	National Institute of Aging/National Institute of Health and British government departments; British Heart Foundation; Scottish Executive	National Institute of Aging/National Institute of Health and British government departments(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Scottish Executive	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CdeO is funded by the National Institute of Aging/National Institute of Health and British government departments. MH is funded by the British Heart Foundation. The Scottish Health Survey is funded by the Scottish Executive. The funders had no role in the present study.	Astrom AN, 2004, COMMUNITY DENT ORAL, V32, P354, DOI 10.1111/j.1600-0528.2004.00174.x; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Nardin E, 2001, Ann Periodontol, V6, P30, DOI 10.1902/annals.2001.6.1.30; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Emberson JR, 2003, EUR HEART J, V24, P1719, DOI 10.1016/S0195-668X(03)00471-8; Hamer M, 2008, ARCH INTERN MED, V168, P2474, DOI 10.1001/archinte.168.22.2474; *INF SERV DIV, 2010, NHS NAT SERV SCOTL; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Miller K, 2007, J PERIODONTOL, V78, P1455, DOI 10.1902/jop.2007.060384; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Persson GR, 2008, J CLIN PERIODONTOL, V35, P362, DOI 10.1111/j.1600-051X.2008.01281.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; *SCOTT GOV STAT, SCOTT HLTH SURV PUBL; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Stone AFM, 2002, CIRCULATION, V106, P1219, DOI 10.1161/01.CIR.0000027820.66786.CF; Wiesli P, 2002, CIRCULATION, V105, P2646, DOI 10.1161/01.CIR.0000017862.08503.15; Wu TJ, 2000, AM J EPIDEMIOL, V151, P273, DOI 10.1093/oxfordjournals.aje.a010203	30	191	199	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2010	340								c2451	10.1136/bmj.c2451	http://dx.doi.org/10.1136/bmj.c2451			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	604LD	20508025	hybrid, Green Published			2022-12-24	WOS:000278279600001
J	Efremov, RG; Baradaran, R; Sazanov, LA				Efremov, Rouslan G.; Baradaran, Rozbeh; Sazanov, Leonid A.			The architecture of respiratory complex I	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI NDH-1; UBIQUINONE OXIDOREDUCTASE; MEMBRANE DOMAIN; ELECTRON-TRANSFER; BINDING-SITE; SUBUNIT; MITOCHONDRIAL; TOPOLOGY; NUOM	Complex I is the first enzyme of the respiratory chain and has a central role in cellular energy production, coupling electron transfer between NADH and quinone to proton translocation by an unknown mechanism. Dysfunction of complex I has been implicated in many human neurodegenerative diseases. We have determined the structure of its hydrophilic domain previously. Here, we report the alpha-helical structure of the membrane domain of complex I from Escherichia coli at 3.9 angstrom resolution. The antiporter-like subunits NuoL/M/N each contain 14 conserved transmembrane (TM) helices. Two of them are discontinuous, as in some transporters. Unexpectedly, subunit NuoL also contains a 110-angstrom long amphipathic alpha-helix, spanning almost the entire length of the domain. Furthermore, we have determined the structure of the entire complex I from Thermus thermophilus at 4.5 angstrom resolution. The L-shaped assembly consists of the alpha-helical model for the membrane domain, with 63 TM helices, and the known structure of the hydrophilic domain. The architecture of the complex provides strong clues about the coupling mechanism: the conformational changes at the interface of the two main domains may drive the long amphipathic alpha-helix of NuoL in a piston-like motion, tilting nearby discontinuous TM helices, resulting in proton translocation.	[Efremov, Rouslan G.; Baradaran, Rozbeh; Sazanov, Leonid A.] Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Wellcome Trust Sanger Institute	Sazanov, LA (corresponding author), Wellcome Trust Res Labs, MRC, Mitochondrial Biol Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Efremov, Rouslan/P-9085-2015; Sazanov, Leonid A/ABF-2125-2021	Efremov, Rouslan/0000-0001-7516-8658; Sazanov, Leonid A/0000-0002-0977-7989	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council. We thank the European Synchrotron Radiation Facility and the Swiss Light Source for provision of synchrotron radiation facilities. We are grateful to the staff of beamlines ID23, ID29 (ESRF, Grenoble) and X06SA (Swiss Light Source, Villigen) for assistance. We thank J. E. Walker and A. Leslie for discussions of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; GONDAL JA, 1985, J BIOL CHEM, V260, P2690; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kao MC, 2002, BIOCHEMISTRY-US, V41, P4377, DOI 10.1021/bi025525d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roth R, 2001, BBA-BIOENERGETICS, V1504, P352, DOI 10.1016/S0005-2728(00)00265-6; Rudolph MG, 2004, ACTA CRYSTALLOGR D, V60, P656, DOI 10.1107/S0907444904002239; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Sekiguchi K, 2009, BBA-BIOENERGETICS, V1787, P1106, DOI 10.1016/j.bbabio.2009.02.016; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i	57	457	470	8	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					441	U61		10.1038/nature09066	http://dx.doi.org/10.1038/nature09066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505720				2022-12-24	WOS:000278043700026
J	Sigmund, K; De Silva, H; Traulsen, A; Hauert, C				Sigmund, Karl; De Silva, Hannelore; Traulsen, Arne; Hauert, Christoph			Social learning promotes institutions for governing the commons	NATURE			English	Article							PUBLIC-GOODS GAMES; ALTRUISTIC PUNISHMENT; COSTLY PUNISHMENT; COOPERATION; EVOLUTION; RECIPROCITY; ADVANTAGE; SOCIETIES; HUMANS	Theoretical and empirical research highlights the role of punishment in promoting collaborative efforts(1-5). However, both the emergence and the stability of costly punishment are problematic issues. It is not clear how punishers can invade a society of defectors by social learning or natural selection, or how second-order free-riders (who contribute to the joint effort but not to the sanctions) can be prevented from drifting into a coercion-based regime and subverting cooperation. Here we compare the prevailing model of peer-punishment(6-8) with pool-punishment, which consists in committing resources, before the collaborative effort, to prepare sanctions against free-riders. Pool-punishment facilitates the sanctioning of second-order free-riders, because these are exposed even if everyone contributes to the common good. In the absence of such second-order punishment, peer-punishers do better than pool-punishers; but with second-order punishment, the situation is reversed. Efficiency is traded for stability. Neither other-regarding tendencies or preferences for reciprocity and equity, nor group selection or prescriptions from higher authorities, are necessary for the emergence and stability of rudimentary forms of sanctioning institutions regulating common pool resources and enforcing collaborative efforts.	[Sigmund, Karl] Univ Vienna, Fac Math, A-1090 Vienna, Austria; [Sigmund, Karl] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [De Silva, Hannelore] WU Vienna Univ Econ & Business, A-1090 Vienna, Austria; [Traulsen, Arne] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany; [Hauert, Christoph] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada	University of Vienna; International Institute for Applied Systems Analysis (IIASA); Vienna University of Economics & Business; Max Planck Society; University of British Columbia	Sigmund, K (corresponding author), Univ Vienna, Fac Math, Waehringer Guertel 18, A-1090 Vienna, Austria.	karl.sigmund@univie.ac.at	Hauert, Christoph/E-5369-2011; Traulsen, Arne/A-4955-2009	Hauert, Christoph/0000-0002-1239-281X; Traulsen, Arne/0000-0002-0669-5267				Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Falk A, 2002, DRAMA COMMONS, P157; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kiyonari T, 2004, INT J PSYCHOL, V39, P329; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; Levin SA, 2009, SPRINGER SER GAME TH, P1, DOI 10.1007/978-3-540-85436-4; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; ORBELL JM, 1993, AM SOCIOL REV, V58, P787, DOI 10.2307/2095951; Ostrom E., 1990, GOVERNING COMMONS EV; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Smith J. M., 1997, MAJOR TRANSITIONS EV; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	30	334	340	7	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					861	863		10.1038/nature09203	http://dx.doi.org/10.1038/nature09203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20631710	Green Submitted			2022-12-24	WOS:000280766100035
J	Rama, P; Matuska, S; Paganoni, G; Spinelli, A; De Luca, M; Pellegrini, G				Rama, Paolo; Matuska, Stanislav; Paganoni, Giorgio; Spinelli, Alessandra; De Luca, Michele; Pellegrini, Graziella			Limbal Stem-Cell Therapy and Long-Term Corneal Regeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN OCULAR SURFACE; CULTURED EPITHELIUM; TRANSPLANTATION; FIBRIN; BURNS; P63; KERATINOCYTES; ISOFORMS; CYCLE	BACKGROUND Corneal renewal and repair are mediated by stem cells of the limbus, the narrow zone between the cornea and the bulbar conjunctiva. Ocular burns may destroy the limbus, causing limbal stem-cell deficiency. We investigated the long-term clinical results of cell therapy in patients with burn-related corneal destruction associated with limbal stem-cell deficiency, a highly disabling ocular disease. METHODS We used autologous limbal stem cells cultivated on fibrin to treat 112 patients with corneal damage, most of whom had burn-dependent limbal stem-cell deficiency. Clinical results were assessed by means of Kaplan-Meier, Kruskal-Wallis, and univariate and multivariate logistic-regression analyses. We also assessed the clinical outcome according to the percentage of holoclone-forming stem cells, detected as cells that stain intensely (p63-bright cells) in the cultures. RESULTS Permanent restoration of a transparent, renewing corneal epithelium was attained in 76.6% of eyes. The failures occurred within the first year. Restored eyes remained stable over time, with up to 10 years of follow-up (mean, 2.91 +/- 1.99; median, 1.93). In post hoc analyses, success - that is, the generation of normal epithelium on donor stroma - was associated with the percentage of p63-bright holoclone-forming stem cells in culture. Cultures in which p63-bright cells constituted more than 3% of the total number of clonogenic cells were associated with successful transplantation in 78% of patients. In contrast, cultures in which such cells made up 3% or less of the total number of cells were associated with successful transplantation in only 11% of patients. Graft failure was also associated with the type of initial ocular damage and postoperative complications. CONCLUSIONS Cultures of limbal stem cells represent a source of cells for transplantation in the treatment of destruction of the human cornea due to burns.	[De Luca, Michele; Pellegrini, Graziella] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy; [Rama, Paolo; Matuska, Stanislav; Paganoni, Giorgio; Spinelli, Alessandra] Ist Sci San Raffaele, Ophthalmol Unit, I-20132 Milan, Italy	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pellegrini, G (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Via Glauco Gottardi 100, Modena, Italy.	graziella.pellegrini@unimore.it	De Luca, Michele/N-5883-2014; Spinelli, Antonello E/K-1256-2018; Pellegrini, Graziella/E-1189-2015; Rama, Paolo/S-5150-2019	De Luca, Michele/0000-0002-0850-8445; Spinelli, Antonello E/0000-0001-5762-3426; Pellegrini, Graziella/0000-0001-9861-0736; Rama, Paolo/0000-0002-2429-159X	Italian Ministry for Education, University and Research and Ministry of Health; l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon; European Commission; Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem) [HEALTH-F5-2009-223098]; Regione Emilia-Romagna	Italian Ministry for Education, University and Research and Ministry of Health(Ministry of Education, Universities and Research (MIUR)); l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon(Association Francaise contre les Myopathies); European Commission(European CommissionEuropean Commission Joint Research Centre); Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem); Regione Emilia-Romagna(Regione Emilia Romagna)	Supported by grants from the Italian Ministry for Education, University and Research and Ministry of Health; l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon; the European Commission Sixth Framework Program for Research and Technological Development (corneal engineering) and Seventh Framework Program; Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem, HEALTH-F5-2009-223098); Regione Emilia-Romagna (area 1b, medicina rigenerativa); and the Italian Ministry of Health.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Daya SM, 2005, OPHTHALMOLOGY, V112, P470, DOI 10.1016/j.ophtha.2004.09.023; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; DELUCA M, 1989, BURNS, V15, P303, DOI 10.1016/0305-4179(89)90007-7; DELUCA M, 1992, ARCH DERMATOL, V128, P633, DOI 10.1001/archderm.128.5.633; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Di Iorio E, 2006, MICROSC RES TECHNIQ, V69, P983, DOI 10.1002/jemt.20375; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Henderson TRM, 2001, BRIT J OPHTHALMOL, V85, P604, DOI 10.1136/bjo.85.5.604; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Pellegrini G, 2004, NEW ENGL J MED, V351, P1170, DOI 10.1056/NEJMp048199; Pellegrini G, 2009, J PATHOL, V217, P217, DOI 10.1002/path.2441; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Schwab IR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1734, DOI 10.1001/archopht.124.12.1734; Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	30	777	814	2	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					147	155		10.1056/NEJMoa0905955	http://dx.doi.org/10.1056/NEJMoa0905955			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20573916	Green Published			2022-12-24	WOS:000279574100007
J	Glover, JD; Reganold, JP; Bell, LW; Borevitz, J; Brummer, EC; Buckler, ES; Cox, CM; Cox, TS; Crews, TE; Culman, SW; DeHaan, LR; Eriksson, D; Gill, BS; Holland, J; Hu, F; Hulke, BS; Ibrahim, AMH; Jackson, W; Jones, SS; Murray, SC; Paterson, AH; Ploschuk, E; Sacks, EJ; Snapp, S; Tao, D; Van Tassel, DL; Wade, LJ; Wyse, DL; Xu, Y				Glover, J. D.; Reganold, J. P.; Bell, L. W.; Borevitz, J.; Brummer, E. C.; Buckler, E. S.; Cox, C. M.; Cox, T. S.; Crews, T. E.; Culman, S. W.; DeHaan, L. R.; Eriksson, D.; Gill, B. S.; Holland, J.; Hu, F.; Hulke, B. S.; Ibrahim, A. M. H.; Jackson, W.; Jones, S. S.; Murray, S. C.; Paterson, A. H.; Ploschuk, E.; Sacks, E. J.; Snapp, S.; Tao, D.; Van Tassel, D. L.; Wade, L. J.; Wyse, D. L.; Xu, Y.			Increased Food and Ecosystem Security via Perennial Grains	SCIENCE			English	Editorial Material									[Glover, J. D.; Cox, C. M.; Cox, T. S.; DeHaan, L. R.; Jackson, W.; Van Tassel, D. L.] Land Inst, Salina, KS 67401 USA; [Reganold, J. P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Bell, L. W.] Commonwealth Sci & Ind Res Org Australia, Sustainable Ecosyst Agr Prod Syst Res Unit, Toowoomba, Qld 4350, Australia; [Borevitz, J.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Brummer, E. C.] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Buckler, E. S.] ARS, USDA, Ithaca, NY 14853 USA; [Buckler, E. S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Crews, T. E.] Prescott Coll, Prescott, AZ 86301 USA; [Culman, S. W.; Snapp, S.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Eriksson, D.] Swedish Univ Agr Sci, Dept Plant Breeding & Biotechnol, Alnarp, Sweden; [Gill, B. S.] Kansas State Univ, Wheat Genet & Genom Resources Ctr, Manhattan, KS 66506 USA; [Holland, J.] N Carolina State Univ, USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA; [Hu, F.; Tao, D.] Yunnan Acad Agr Sci, Food Crops Res Inst, Kunming 650205, Peoples R China; [Hulke, B. S.] USDA ARS, Sunflower Res Unit, No Crop Sci Lab, Fargo, ND 58105 USA; [Ibrahim, A. M. H.; Murray, S. C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Jones, S. S.] Washington State Univ, Dept Crop & Soil Sci, Mt Vernon, WA 98273 USA; [Paterson, A. H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Ploschuk, E.] Univ Buenos Aires, Fac Agron, Catedra Cultivos Ind, Buenos Aires, DF, Argentina; [Sacks, E. J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wade, L. J.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia; [Wyse, D. L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Xu, Y.] Int Maize & Wheat Improvement Ctr, Global Maize Program, Mexico City, DF, Mexico	Washington State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Chicago; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Cornell University; Michigan State University; Swedish University of Agricultural Sciences; Kansas State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Yunnan Academy of Agricultural Sciences; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Washington State University; University System of Georgia; University of Georgia; University of Buenos Aires; University of Illinois System; University of Illinois Urbana-Champaign; Charles Sturt University; University of Minnesota System; University of Minnesota Twin Cities; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Glover, JD (corresponding author), Land Inst, Salina, KS 67401 USA.	glover@landinstitute.org	Eriksson, Dennis/ABF-5510-2020; Ploschuk, Edmundo/AAO-7875-2020; Snapp, Sieg/GWQ-5774-2022; Hulke, Brent/GZG-4449-2022; Borevitz, Justin/B-5423-2012; Snapp, Sieglinde S/D-5109-2013; Bell, Lindsay/B-9769-2008; Buckler, Edward/L-7651-2019; DeHaan, Lee R./AAF-5048-2019; Eriksson, Dennis/J-4592-2012; Buckler, Edward/GPS-4932-2022; Tao, Dayun/AAI-8321-2020; Wade, Len J/A-8872-2008; Snapp, Sieglinde/AAU-8121-2020	Eriksson, Dennis/0000-0002-5205-3396; Borevitz, Justin/0000-0001-8408-3699; Buckler, Edward/0000-0002-3100-371X; DeHaan, Lee R./0000-0002-6368-5241; Wade, Len J/0000-0002-1321-4310; Snapp, Sieglinde/0000-0002-9738-0649; Culman, Steve/0000-0003-3985-257X; Tao, Dayun/0000-0002-8884-1589; Murray, Seth/0000-0002-2960-8226; Holland, James/0000-0002-4341-9675; Bell, Lindsay/0000-0002-5064-2947				Bell LW, 2008, AGR SYST, V96, P166, DOI 10.1016/j.agsy.2007.07.007; Cox CM, 2005, PLANT DIS, V89, P1235, DOI 10.1094/PD-89-1235; Cox TS, 2006, BIOSCIENCE, V56, P649, DOI 10.1641/0006-3568(2006)56[649:PFDPGC]2.0.CO;2; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Eriksson D., 2009, THESIS SWEDISH U AGR; Eswaran H., 1999, American Journal of Alternative Agriculture, V14, P129, DOI 10.1017/S0889189300008250; Food and Agriculture Organization of the United Nations (FAO), 2009, STAT FOOD INS WORLD; Glover JD, 2007, SCI AM, V297, P82, DOI 10.1038/scientificamerican0807-82; Glover JD, 2010, AGR ECOSYST ENVIRON, V137, P3, DOI 10.1016/j.agee.2009.11.001; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Pimm SL, 2001, WORLD ACCORDING PIMM; Ploschuk EL, 2005, ANN BOT-LONDON, V96, P127, DOI 10.1093/aob/mci158; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Randall GW, 1997, J ENVIRON QUAL, V26, P1240, DOI 10.2134/jeq1997.00472425002600050007x; Sacks EJ, 2003, CROP SCI, V43, P120, DOI 10.2135/cropsci2003.0120; Snapp S, 2003, HORTSCIENCE, V38, P187, DOI 10.21273/HORTSCI.38.2.187; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Wallace JS, 2000, AGR ECOSYST ENVIRON, V82, P105, DOI 10.1016/S0167-8809(00)00220-6; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191	20	282	294	15	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1638	1639		10.1126/science.1188761	http://dx.doi.org/10.1126/science.1188761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576874				2022-12-24	WOS:000279107400024
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling What I learnt from Mom	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2010	340								c2973	10.1136/bmj.c2973	http://dx.doi.org/10.1136/bmj.c2973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530558				2022-12-24	WOS:000278818300011
J	Renehan, A; Smith, U; Kirkman, MS				Renehan, Andrew; Smith, Ulf; Kirkman, M. Sue			Linking diabetes and cancer: a consensus on complexity	LANCET			English	Editorial Material							METAANALYSIS; MELLITUS; RISK; MORTALITY		[Kirkman, M. Sue] Amer Diabet Assoc, Alexandria, VA 22311 USA; [Renehan, Andrew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Smith, Ulf] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	American Diabetes Association; Christie NHS Foundation Trust; University of Manchester; Sahlgrenska University Hospital	Kirkman, MS (corresponding author), Amer Diabet Assoc, Alexandria, VA 22311 USA.	skirkman@diabetes.org	Renehan, Andrew/K-5992-2015	Renehan, Andrew/0000-0003-4309-4396				*AM CANC SOC, 2008, CANC STAT 2008; Barone BB, 2010, DIABETES CARE, V33, P931, DOI 10.2337/dc09-1721; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; *ECCO, 2007, CANC SCAL PROBL; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; International Diabetes Federation, 2009, IDF DIAB ATL; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Larsson SC, 2008, EUR J CANCER, V44, P2655, DOI 10.1016/j.ejca.2008.07.012; Lipscombe LL, 2005, ARCH INTERN MED, V165, P2090, DOI 10.1001/archinte.165.18.2090; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	19	72	76	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2201	2202		10.1016/S0140-6736(10)60706-4	http://dx.doi.org/10.1016/S0140-6736(10)60706-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609959				2022-12-24	WOS:000279652900008
J	Babour, A; Bicknell, AA; Tourtellotte, J; Niwa, M				Babour, Anna; Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho			A Surveillance Pathway Monitors the Fitness of the Endoplasmic Reticulum to Control Its Inheritance	CELL			English	Article							CELL-WALL INTEGRITY; CORTICAL ER INHERITANCE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSMEMBRANE PROTEIN; SEPTIN RING; MAP KINASE; YEAST; STRESS; GENE	The endoplasmic reticulum (ER) plays an essential role in the production of lipids and secretory proteins. Because the ER cannot be generated de novo, it must be faithfully transmitted or divided at each cell division. Little is known of how cells monitor the functionality of the ER during the cell cycle or how this regulates inheritance. We report here that ER stress in S. cerevisiae activates the MAP kinase Slt2 in a new ER stress surveillance (ERSU) pathway, independent of the unfolded protein response. Upon ER stress, ERSU alters the septin complex to delay ER inheritance and cytokinesis. In the absence of Slt2 kinase, the stressed ER is transmitted to the daughter cell, causing the death of both mother and daughter cells. Furthermore, Slt2 is activated via the cell surface receptor Wsc1 by a previously undescribed mechanism. We conclude that the ERSU pathway ensures inheritance of a functional ER.	[Babour, Anna; Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Niwa, M (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	niwa@ucsd.edu		Babour, Anna/0000-0002-0212-3528	American Cancer Society [RSG-05-01GMC]; CRCC [6-447140-34384]; NIH [RO1GM087415]; Searle [03-G107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); CRCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Douglass Forbes for critical reading, many insightful suggestions, and support throughout the study. We also thank Lorraine Pillus and Rei Otsuka for their help for generating a strain critical for the experiments and Lorraine Pillus for support throughout the study. We thank Randy Hampton, Jason Brickner, and Jim Umen for their suggestion and careful reading of the manuscript, David E. Levin, for providing the bck1 Delta, mkk1 Delta mkk2 Delta yeast strains, pkc1 Delta yeast strain, and plasmids p2188, p2190, and p2193, and Enrique Herrero for providing the pkc1D strain. We also thank Peter Novick for providing the sec1-1 strain and Yves Barral for providing the cdc12-6 strain and Gregory Payne for wsc1<SUP>AAA</SUP> mutant strain. We thank Randy Hampton, Jodi Nunnari, and Svetlana Dokudovskaya for providing plasmids pRH475 and pRH1827, pVT100-ds-RedT1, and Vph1-mCherry, respectively. A. B. was partially supported by the ARC. This work was supported by the American Cancer Society RSG-05-01GMC), CRCC (6-447140-34384), NIH (RO1GM087415), and Searle 03-G107 to M.N.	Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bicknell A.A., 2009, HDB CELL SIGNALING, P2511; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cid VJ, 1998, MICROBIOL-SGM, V144, P3463, DOI 10.1099/00221287-144-12-3463; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; de Martin PE, 2005, BIOCHEM CELL BIOL, V83, P752, DOI 10.1139/O05-159; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Du YR, 2001, MOL BIOL CELL, V12, P2614, DOI 10.1091/mbc.12.9.2614; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Essary BD, 2009, J MICROBIOL METH, V78, P208, DOI 10.1016/j.mimet.2009.05.018; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; HUANG KN, 1995, GENETICS, V141, P1275; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Jimenez J, 1998, J CELL BIOL, V143, P1617, DOI 10.1083/jcb.143.6.1617; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Koning AJ, 2002, GENETICS, V160, P1335; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; McMaster CR, 2001, BIOCHEM CELL BIOL, V79, P681, DOI 10.1139/bcb-79-6-681; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MORI K, 1993, CELL, V74, P743; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Nanduri J, 2001, MOL CELL, V8, P281, DOI 10.1016/S1097-2765(01)00312-4; NOVICK P, 1983, J CELL BIOL, V96, P541, DOI 10.1083/jcb.96.2.541; Peng YT, 2008, DEV CELL, V15, P478, DOI 10.1016/j.devcel.2008.07.007; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Piao HL, 2007, MOL BIOL CELL, V18, P57, DOI 10.1091/mbc.e06-08-0721; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Roeder AD, 1998, MOL BIOL CELL, V9, P917, DOI 10.1091/mbc.9.4.917; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Wiederkehr A, 2003, MOL BIOL CELL, V14, P4770, DOI 10.1091/mbc.E03-04-0229; Zu T, 2001, MOL GENET GENOMICS, V266, P142, DOI 10.1007/s004380100537	71	75	78	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					256	269		10.1016/j.cell.2010.06.006	http://dx.doi.org/10.1016/j.cell.2010.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20619447	Green Accepted, Bronze			2022-12-24	WOS:000280204300017
J	Mueller, M; Ban, N				Mueller, Marcus; Ban, Nenad			SnapShot: Pore-Forming Toxins	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; HEMOLYSIN; MECHANISM; ATTACK		[Mueller, Marcus; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Mueller, Marcus] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Mueller, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.							CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Lukoyanova N, 2008, TRENDS IMMUNOL, V29, P51, DOI 10.1016/j.it.2007.11.003; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, BACTERIAL PROTEIN TO, V24, P302; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0	10	8	8	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					334	U169		10.1016/j.cell.2010.07.010	http://dx.doi.org/10.1016/j.cell.2010.07.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655473	Bronze			2022-12-24	WOS:000280204300023
J	Kwon, ES; Narasimhan, D; Yen, K; Tissenbaum, HA				Kwon, Eun-Soo; Narasimhan, Devi; Yen, Kelvin; Tissenbaum, Heidi A.			A new DAF-16 isoform regulates longevity	NATURE			English	Article							C-ELEGANS DAF-16; LIFE-SPAN; CAENORHABDITIS-ELEGANS; STRESS; GENE; INSULIN/IGF-1; RESISTANCE	The insulin/IGF-1 signalling (IIS) pathway has diverse roles from metabolism to longevity(1-5). In Caenorhabditis elegans, the single forkhead box O (FOXO) homologue, DAF-16, functions as the major target of the IIS pathway(2,3,6,7). One of two isoforms(4,5,8), DAF-16a, is known to regulate longevity, stress response and dauer diapause(8-11). However, it remains unclear how DAF-16 achieves its specificity in regulating these various biological processes. Here we identify a new isoform, DAF-16d/f, as an important isoform regulating longevity. We show that DAF-16 isoforms functionally cooperate to modulate IIS-mediated processes through differential tissue enrichment, preferential modulation by upstream kinases, and regulating distinct and overlapping target genes. Promoter-swapping experiments show both the promoter and the coding region of DAF-16 are important for its function. Importantly, in mammals, four FOXO genes have overlapping and different functions(6,12), and in C. elegans, a single FOXO/DAF-16 uses distinct isoforms to fine-tune the IIS-mediated processes in the context of a whole organism.	[Kwon, Eun-Soo; Narasimhan, Devi; Yen, Kelvin; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Yen, Kelvin/J-5378-2019	Yen, Kelvin/0000-0003-4595-971X	National Institutes of Health National Center for Research Resources; National Institute of Aging [AG025891, AG031237]; Glenn Foundation for Medical Research; Ellison Medical Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING [R01AG025891, R01AG031237] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Mukhopadhyay and S. Padmanabhan for advice, M. Green and M. Walhout for advice and comments on the manuscript and N. Bhabhalia for technical support. We thank M. Grabowski Auclair for generating several strains used in this manuscript and G. Ruvkun and M. Walhout for plasmids and strains. We apologize to all those whose original work was not cited because of space limitations. Some of the strains were provided by T. Stiernagle at the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. H. A. T. is a William Randolph Hearst Young Investigator. This project was funded in part by grants from the National Institute of Aging AG025891 and AG031237), the Glenn Foundation for Medical Research, the Ellison Medical Foundation and an endowment from the William Randolph Hearst Foundation.	Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herman RK, 1995, METHOD CELL BIOL, V48, P123; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Riddle DL, 1997, C ELEGANS, P739; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stiernagle Theresa, 2006, WormBook, P1	30	122	140	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					498	502		10.1038/nature09184	http://dx.doi.org/10.1038/nature09184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20613724	Green Accepted			2022-12-24	WOS:000280141200038
J	Vijeyarasa, R; Stein, RA				Vijeyarasa, Ramona; Stein, Richard A.			HIV and Human Trafficking-Related Stigma Health Interventions for Trafficked Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stein, Richard A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Vijeyarasa, Ramona] Univ New S Wales, Sch Social Sci & Int Studies, Sydney, NSW, Australia	Princeton University; University of New South Wales Sydney	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, 1 Washington Rd,LTL320, Princeton, NJ 08544 USA.	ras2@princeton.edu	Vijeyarasa, Ramona/HHZ-6618-2022	Vijeyarasa, Dr Ramona/0000-0003-4581-4924				Dharmadhikari AS, 2009, INT J INFECT DIS, V13, P543, DOI 10.1016/j.ijid.2008.11.010; Gupta J, 2009, INT J GYNECOL OBSTET, V107, P30, DOI 10.1016/j.ijgo.2009.06.009; *HIV MED ASS INF D, 2007, HIV TB COINF BAS FAC; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Tachover D, 2011, WORLD MED HEALTH POL, V3, DOI 10.2202/1948-4682.1135; UN, 2000, PROTOCOL PREVENT SUP; Vijeyarasa R, 2010, CULT HEALTH SEX, V12, pS89, DOI 10.1080/13691050903359257; Zimmerman C., 2003, HLTH RISKS CONSEQUEN	10	7	7	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					344	345		10.1001/jama.2010.964	http://dx.doi.org/10.1001/jama.2010.964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639570				2022-12-24	WOS:000280107500026
J	McClellan, J; King, MC				McClellan, Jon; King, Mary-Claire			Genomic Analysis of Mental Illness A Changing Landscape	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMON VARIANTS; SCHIZOPHRENIA; ASSOCIATION; RISK		[McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McClellan, J (corresponding author), Univ Washington, Dept Psychiat, Box 356560, Seattle, WA 98195 USA.	drjack@uw.edu		King, Mary-Claire/0000-0001-9426-1743				McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	10	48	49	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2523	2524		10.1001/jama.2010.869	http://dx.doi.org/10.1001/jama.2010.869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571020				2022-12-24	WOS:000279010900032
J	Wills, TJ; Cacucci, F; Burgess, N; O'Keefe, J				Wills, Tom J.; Cacucci, Francesca; Burgess, Neil; O'Keefe, John			Development of the Hippocampal Cognitive Map in Preweanling Rats	SCIENCE			English	Article							FREELY MOVING RATS; ENTORHINAL CORTEX; SPATIAL REPRESENTATION; THETA-RHYTHM; GRID CELLS; NAVIGATION	Orienting in large-scale space depends on the interaction of environmental experience and preconfigured, possibly innate, constructs. Place, head-direction, and grid cells in the hippocampal formation provide allocentric representations of space. Here we show how these cognitive representations emerge and develop as rat pups first begin to explore their environment. Directional, locational, and rhythmic organization of firing are present during initial exploration, including adultlike directional firing. The stability and precision of place cell firing continue to develop throughout juvenility. Stable grid cell firing appears later but matures rapidly to adult levels. Our results demonstrate the presence of three neuronal representations of space before extensive experience and show how they develop with age.	[Wills, Tom J.; Cacucci, Francesca; O'Keefe, John] UCL, London WC1E 6BT, England; [Cacucci, Francesca] UCL, Div Psychol & Language Sci, UC Inst Behav Neurosci, London WC1H 0AP, England; [Burgess, Neil] UCL, UC Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL, UC Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Wills, TJ (corresponding author), UCL, Gower St, London WC1E 6BT, England.	t.wills@ucl.ac.uk; f.cacucci@ucl.ac.uk	Wills, Tom J/B-3621-2011; Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Wills, Thomas/0000-0002-1331-2869; Cacucci, Francesca/0000-0002-1968-5156	European Union; Wellcome Trust; U.K. Medical Research Council; U.K. Royal Society; Research Councils U.K.; MRC [G0501672] Funding Source: UKRI; Medical Research Council [G0501672] Funding Source: researchfish	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.K. Royal Society(Royal Society of London); Research Councils U.K.(UK Research & Innovation (UKRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Barry for use of adult grid cell data, A. Jeewajee and C. Barry for assistance with data analysis, S. Burton and R. Varriale for technical assistance, and C. Lever and J. Krupic for helpful discussions. This work was supported by the European Union SpaceBrain grant, the Wellcome Trust, the U.K. Medical Research Council, the U.K. Royal Society and a Research Councils U.K. academic fellowship to F. C.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burton BG, 2008, J NEUROPHYSIOL, V100, P3144, DOI 10.1152/jn.90424.2008; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Gerrish CJ, 1996, DEV PSYCHOBIOL, V29, P483, DOI 10.1002/(SICI)1098-2302(199609)29:6<483::AID-DEV1>3.0.CO;2-I; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; LEBLANC MO, 1979, EXP NEUROL, V66, P220, DOI 10.1016/0014-4886(79)90076-1; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Martin PD, 2002, HIPPOCAMPUS, V12, P465, DOI 10.1002/hipo.10021; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; NADEL L, 2009, DEV TIME TIMING, P233; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rivas J, 1996, EXP BRAIN RES, V108, P113; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; SCHENK F, 1985, BEHAV NEURAL BIOL, V43, P69, DOI 10.1016/S0163-1047(85)91510-9; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANCAUTER T, 1933, EUR J NEUROSCI, V27, P2008	29	365	371	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1573	1576		10.1126/science.1188224	http://dx.doi.org/10.1126/science.1188224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558720	Green Accepted			2022-12-24	WOS:000278859200051
J	Tahirov, TH; Babayeva, ND; Varzavand, K; Cooper, JJ; Sedore, SC; Price, DH				Tahirov, Tahir H.; Babayeva, Nigar D.; Varzavand, Katayoun; Cooper, Jeffrey J.; Sedore, Stanley C.; Price, David H.			Crystal structure of HIV-1 Tat complexed with human P-TEFb	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; HUMAN CYCLIN T1; DEPENDENT KINASE REGULATION; CARBOXYL-TERMINAL DOMAIN; ELONGATION-FACTOR-B; RNA-POLYMERASE; MUTATIONAL ANALYSIS; VIRUS-REPLICATION; 7SK SNRNA; IN-VITRO	Regulation of the expression of the human immunodeficiency virus (HIV) genome is accomplished in large part by controlling transcription elongation. The viral protein Tat hijacks the host cell's RNA polymerase II elongation control machinery through interaction with the positive transcription elongation factor, P-TEFb, and directs the factor to promote productive elongation of HIV mRNA. Here we describe the crystal structure of the Tat center dot P-TEFb complex containing HIV-1 Tat, human Cdk9 (also known as CDK9), and human cyclin T1 (also known as CCNT1). Tat adopts a structure complementary to the surface of P-TEFb and makes extensive contacts, mainly with the cyclin T1 subunit of P-TEFb, but also with the T-loop of the Cdk9 subunit. The structure provides a plausible explanation for the tolerance of Tat to sequence variations at certain sites. Importantly, Tat induces significant conformational changes in P-TEFb. This finding lays a foundation for the design of compounds that would specifically inhibit the Tat center dot P-TEFb complex and block HIV replication.	[Tahirov, Tahir H.; Babayeva, Nigar D.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Varzavand, Katayoun; Cooper, Jeffrey J.; Sedore, Stanley C.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Nebraska System; University of Nebraska Medical Center; University of Iowa	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Price, David H/F-6173-2010	Tahirov, Tahir/0000-0002-1238-0069; Price, David/0000-0002-5597-385X	NIH [GM35500, AI074392, GM082923]; Department of Health and Human Services [LB506]; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Cancer Center [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074392, R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923, R01GM035500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lovelace and G. E. Borgstahl for maintenance and management of the Eppley Institute's X-ray Crystallography facility; D. G. Vassylyev for the zonal scaling instruction files. This work is supported by the NIH grants GM35500 and AI074392 to D. H. P., by Nebraska Department of Health and Human Services grant LB506 and in part by NIH grant GM082923 to T. H. T. This work is also based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The Eppley Institute's X-ray Crystallography facility is supported by Cancer Center Support Grant P30CA036727.	Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; DERSE D, 1993, VIROLOGY, V194, P530, DOI 10.1006/viro.1993.1291; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kuiken C, 2009, LAUR0903280 LOS AL N; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Letvin NL, 2009, SCIENCE, V326, P1196, DOI 10.1126/science.1183278; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Michels Annemieke A., 2008, Biotechnology Journal, V3, P1022, DOI 10.1002/biot.200800104; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; RICE AP, 1990, J VIROL, V64, P1864, DOI 10.1128/JVI.64.4.1864-1868.1990; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; RUBEN S, 1989, J VIROL, V63, P1; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; SADAIE MR, 1990, AIDS RES HUM RETROV, V6, P1257, DOI 10.1089/aid.1990.6.1257; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Tahirov TH, 1998, J STRUCT BIOL, V121, P68, DOI 10.1006/jsbi.1997.3940; Taube R, 2000, J VIROL, V74, P892, DOI 10.1128/JVI.74.2.892-898.2000; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang Y, 2009, MINI-REV MED CHEM, V9, P379, DOI 10.2174/1389557510909030379; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	48	214	222	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					747	U2		10.1038/nature09131	http://dx.doi.org/10.1038/nature09131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535204	Green Accepted			2022-12-24	WOS:000278551800037
J	Raftery, J				Raftery, James			Multiple sclerosis risk sharing scheme: a costly failure	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCESS; DRUGS		Univ Southampton, Sch Med, Wessex Inst, Southampton SO16 7NS, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Sch Med, Wessex Inst, Southampton SO16 7NS, Hants, England.	raftery@soton.ac.uk						Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; Department of Health, 2009, PHARM PRIC REG SCHEM; *HC HLTH COMM, 2009, HOUS COMM HLTH COMM; *HSC, 2002, COST EFF PROV DIS MO; KEEN A, 2008, MULTIPLE SCLEROSIS D; KEEN A, 2008, PARLIAMENTARY WRITTE; Keogh A, 2009, INTERN MED J; MCCABE C, 2009, BRIT MED J, V340, pC1786; McCabe CJ, 2010, PHARMACOECONOMICS, V28, P143, DOI 10.2165/11530850-000000000-00000; Menon D, 2010, PHARMACOECONOMICS, V28, P109, DOI 10.2165/11530860-000000000-00000; *MULT SCLER SOC, 2007, RISK SHAR SCHEM DIS; *NICE, 2002, 32 NICE; *NICE, 2007, 27 NICE; Owen Aj, 2008, J Med Econ, V11, P235, DOI 10.3111/13696990802034525; Pickin M, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-1; Sudlow CLM, 2003, BRIT MED J, V326, P388, DOI 10.1136/bmj.326.7385.388; WARLOW C, 2003, PRACT NEUROL, V3, P194	17	42	42	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c1672	10.1136/bmj.c1672	http://dx.doi.org/10.1136/bmj.c1672			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BM	20522654				2022-12-24	WOS:000278556500001
J	Rothberg, MB; Pekow, PS; Lahti, M; Brody, O; Skiest, DJ; Lindenauer, PK				Rothberg, Michael B.; Pekow, Penelope S.; Lahti, Maureen; Brody, Oren; Skiest, Daniel J.; Lindenauer, Peter K.			Antibiotic Therapy and Treatment Failure in Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGEMENT; DIAGNOSIS; COPD	Context Guidelines recommend antibiotic therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), but the evidence is based on small, heterogeneous trials, few of which include hospitalized patients. Objective To compare the outcomes of patients treated with antibiotics in the first 2 hospital days with those treated later or not at all. Design, Setting, and Patients Retrospective cohort of patients aged 40 years or older who were hospitalized from January 1, 2006, through December 31, 2007, for acute exacerbations of COPD at 413 acute care facilities throughout the United States. Main Outcome Measures A composite measure of treatment failure, defined as the initiation of mechanical ventilation after the second hospital day, inpatient mortality, or readmission for acute exacerbations of COPD within 30 days of discharge; length of stay, and hospital costs. Results Of 84 621 patients, 79% received at least 2 consecutive days of antibiotic treatment. Treated patients were less likely than nontreated patients to receive mechanical ventilation after the second hospital day (1.07%; 95% confidence interval [CI], 1.06%-1.08% vs 1.80%; 95% CI, 1.78%-1.82%), had lower rates of inpatient mortality (1.04%; 95% CI, 1.03%-1.05% vs 1.59%; 95% CI, 1.57%-1.61%), and had lower rates of readmission for acute exacerbations of COPD (7.91%; 95% CI, 7.89%-7.94% vs 8.79%; 95% CI, 8.74%-8.83%). Patients treated with antibiotic agents had a higher rate of readmissions for Clostridium difficile (0.19%; 95% CI, 0.187%-0.193%) than those who were not treated (0.09%; 95% CI, 0.086%-0.094%). After multivariable adjustment, including the propensity for antibiotic treatment, the risk of treatment failure was lower in antibiotic-treated patients (odds ratio, 0.87; 95% CI, 0.82-0.92). A grouped treatment approach and hierarchical modeling to account for potential confounding of hospital effects yielded similar results. Analysis stratified by risk of treatment failure found similar magnitudes of benefit across all subgroups. Conclusion Early antibiotic administration was associated with improved outcomes among patients hospitalized for acute exacerbations of COPD regardless of the risk of treatment failure. JAMA. 2010;303(20):2035-2042 www.jama.com	[Rothberg, Michael B.; Brody, Oren] Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA; [Rothberg, Michael B.; Pekow, Penelope S.; Lindenauer, Peter K.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Skiest, Daniel J.] Baystate Med Ctr, Div Infect Dis, Springfield, MA 01199 USA; [Rothberg, Michael B.; Brody, Oren; Lindenauer, Peter K.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Pekow, Penelope S.; Lahti, Maureen] Univ Massachusetts, Sch Publ Hlth, Amherst, MA 01003 USA	Baystate Medical Center; Baystate Medical Center; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Rothberg, MB (corresponding author), Baystate Med Ctr, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	michael.rothberg@bhs.org						ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Groenewegen KH, 2003, RESP MED, V97, P770, DOI 10.1016/S0954-6111(03)00026-X; Johnston SC, 2002, AM J EPIDEMIOL, V156, P753, DOI 10.1093/aje/kwf095; Lieberman D, 2001, DIAGN MICR INFEC DIS, V40, P95, DOI 10.1016/S0732-8893(01)00255-3; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Moody A, 2004, THORAX, V59, P1; *NAT HEART LUNG BL, TAK 1 STEP BREATH BE; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nouira S, 2001, LANCET, V358, P2020, DOI 10.1016/S0140-6736(01)07097-0; O'Donnell DE, 2008, CAN RESPIR J, V15, p1A, DOI 10.1155/2008/641965; Parsons L, 2001, REDUCING BIAS PROPEN; Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ram FSF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004403.pub2; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; SACHS APE, 1995, THORAX, V50, P758, DOI 10.1136/thx.50.7.758; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, AM J RESP CRIT CARE, V177, P491, DOI 10.1164/rccm.200708-1234OC; Snow V, 2001, ANN INTERN MED, V134, P595, DOI 10.7326/0003-4819-134-7-200104030-00015; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278	25	149	159	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2035	2042		10.1001/jama.2010.672	http://dx.doi.org/10.1001/jama.2010.672			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	600VY	20501925	Bronze			2022-12-24	WOS:000278018200027
J	Bungard, D; Fuerth, BJ; Zeng, PY; Faubert, B; Maas, NL; Viollet, B; Carling, D; Thompson, CB; Jones, RG; Berger, SL				Bungard, David; Fuerth, Benjamin J.; Zeng, Ping-Yao; Faubert, Brandon; Maas, Nancy L.; Viollet, Benoit; Carling, David; Thompson, Craig B.; Jones, Russell G.; Berger, Shelley L.			Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation	SCIENCE			English	Article							PROTEIN-KINASE; METABOLIC CHECKPOINT; METHYLATION; COMPLEX; ENERGY; LKB1	The mammalian adenosine monophosphate-activated protein kinase (AMPK) is a serine-threonine kinase protein complex that is a central regulator of cellular energy homeostasis. However, the mechanisms by which AMPK mediates cellular responses to metabolic stress remain unclear. We found that AMPK activates transcription through direct association with chromatin and phosphorylation of histone H2B at serine 36. AMPK recruitment and H2B Ser(36) phosphorylation colocalized within genes activated by AMPK-dependent pathways, both in promoters and in transcribed regions. Ectopic expression of H2B in which Ser(36) was substituted by alanine reduced transcription and RNA polymerase II association to AMPK-dependent genes, and lowered cell survival in response to stress. Our results place AMPK-dependent H2B Ser(36) phosphorylation in a direct transcriptional and chromatin regulatory pathway leading to cellular adaptation to stress.	[Bungard, David; Zeng, Ping-Yao; Maas, Nancy L.; Berger, Shelley L.] Univ Penn, Sch Med, Dept Cellular & Dev Biol, Philadelphia, PA 19104 USA; [Fuerth, Benjamin J.; Faubert, Brandon; Jones, Russell G.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Fuerth, Benjamin J.; Faubert, Brandon; Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Zeng, Ping-Yao] Fudan Univ, Inst Biomed Sci Epigenet Program, Shanghai 200032, Peoples R China; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] INSERM, U1016, F-75014 Paris, France; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC,Cellular Stress Grp, London W12 0NN, England; [Thompson, Craig B.; Jones, Russell G.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Thompson, Craig B.; Jones, Russell G.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; McGill University; McGill University; Fudan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Jones, RG (corresponding author), Univ Penn, Sch Med, Dept Cellular & Dev Biol, Philadelphia, PA 19104 USA.	russell.jones@mcgill.ca; bergers@mail.med.upenn.edu	Jones, Russell/AAC-2861-2022; Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019; Jones, Russell Graham/ABD-5261-2021; Carling, David/F-1943-2014	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Jones, Russell Graham/0000-0003-2250-4675; Carling, David/0000-0002-2316-1830; Faubert, Brandon/0000-0002-2886-886X; Berger, Shelley/0000-0001-5398-4400	NIH [CA078831, CA105463, CA09171]; Canadian Institutes of Health Research [MOP-93799]; McGill Integrated Cancer Research Training Program; Leukemia and Lymphoma Society, NIH, National Cancer Institute; American Association for Cancer Research (AACR); NATIONAL CANCER INSTITUTE [R01CA078831, T32CA009171, P01CA104838, R55CA078831, R01CA105463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER; Medical Research Council [MC_U120027537] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Integrated Cancer Research Training Program; Leukemia and Lymphoma Society, NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Leukemia and Lymphoma Society); American Association for Cancer Research (AACR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by NIH grants CA078831 (S. L. B.) and CA105463 (C. B. T.), NIH Training Program in Basic Cancer Research grant CA09171 (D. B.), Canadian Institutes of Health Research grant MOP-93799 (R.G.J.), the McGill Integrated Cancer Research Training Program (B. F.), and the Leukemia and Lymphoma Society, NIH, National Cancer Institute, and American Association for Cancer Research (AACR)/Stand Up to Cancer (C. B. T.). C. B. T. reports the filing of patent applications exploiting the use of AMPK activators in cancer therapy. He is also a member of the board of directors of Merck, the scientific advisory board of Agios Pharmaceuticals, and the medical advisory board of the Howard Hughes Medical Institute.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 2000, METH MOL B, V99, P63; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	19	267	295	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1201	1205		10.1126/science.1191241	http://dx.doi.org/10.1126/science.1191241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20647423	Green Accepted			2022-12-24	WOS:000281485600035
J	Stringer, EM; Ekouevi, DK; Coetzee, D; Tih, PM; Creek, TL; Stinson, K; Giganti, MJ; Welty, TK; Chintu, N; Chi, BH; Wilfert, CM; Shaffer, N; Dabis, F; Stringer, JSA				Stringer, Elizabeth M.; Ekouevi, Didier K.; Coetzee, David; Tih, Pius M.; Creek, Tracy L.; Stinson, Kathryn; Giganti, Mark J.; Welty, Thomas K.; Chintu, Namwinga; Chi, Benjamin H.; Wilfert, Catherine M.; Shaffer, Nathan; Dabis, Francois; Stringer, Jeffrey S. A.		PEARL Study Team	Coverage of Nevirapine-Based Services to Prevent Mother-to-Child HIV Transmission in 4 African Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-DOSE NEVIRAPINE; RANDOMIZED-TRIAL; MASS-SPECTROMETRY; PROGRAMS; UGANDA; WOMEN; QUANTIFICATION; SURVEILLANCE; PERFORMANCE	Context Few studies have objectively evaluated the coverage of services to prevent transmission of human immunodeficiency virus (HIV) from mother to child. Objective To measure the coverage of services to prevent mother-to-child HIV transmission in 4 African countries. Design, Setting, and Patients Cross-sectional surveillance study of mother-infant pairs using umbilical cord blood samples collected between June 10, 2007, and October 30, 2008, from 43 randomly selected facilities (grouped as 25 service clusters) providing delivery services in Cameroon, Cote d'Ivoire, South Africa, and Zambia. All sites used at least single-dose nevirapine to prevent mother-to-child HIV transmission and some sites used additional prophylaxis drugs. Main Outcome Measure Population nevirapine coverage, defined as the proportion of HIV-exposed infants in the sample with both maternal nevirapine ingestion (confirmed by cord blood chromatography) and infant nevirapine ingestion (confirmed by direct observation). Results A total of 27 893 cord blood specimens were tested, of which 3324 were HIV seropositive (12%). Complete data for cord blood nevirapine results were available on 3196 HIV-seropositive mother-infant pairs. Nevirapine coverage varied significantly by site (range: 0%-82%). Adjusted for country, the overall coverage estimate was 51% (95% confidence interval [CI], 49%-53%). In multivariable analysis, failed coverage of nevirapine-based services was significantly associated with maternal age younger than 20 years (adjusted odds ratio [AOR], 1.44; 95% CI, 1.18-1.76) and maternal age between 20 and 25 years (AOR, 1.28; 95% CI, 1.07-1.54) vs maternal age of older than 30 years; 1 or fewer antenatal care visits (AOR, 2.91; 95% CI, 2.40-3.54), 2 or 3 antenatal care visits (AOR, 1.93; 95% CI, 1.60-2.33), and 4 or 5 antenatal care visits (AOR, 1.56; 95% CI, 1.34-1.80) vs 6 or more antenatal care visits; vaginal delivery (AOR, 1.22; 95% CI, 1.03-1.44) vs cesarean delivery; and infant birth weight of less than 2500 g (AOR, 1.34; 95% CI, 1.11-1.62) vs birth weight of 3500 g or greater. Conclusion In this random sampling of sites with services to prevent mother-to-child HIV transmission, only 51% of HIV-exposed infants received the minimal regimen of single-dose nevirapine. JAMA. 2010;304(3):293-302 www.jama.com	[Stringer, Elizabeth M.; Giganti, Mark J.; Chintu, Namwinga; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Ekouevi, Didier K.] Programme PAC CI, Abidjan, Cote Ivoire; [Coetzee, David; Stinson, Kathryn] Univ Cape Town, Sch Publ Hlth & Community Med, Infect Dis & Epidemiol Unit, ZA-7925 Cape Town, South Africa; [Tih, Pius M.; Welty, Thomas K.] Cameroon Baptist Hlth Convent Hlth Board, Bamenda, Cameroon; [Creek, Tracy L.] Ctr Dis Control & Prevent, Ctr HIV AIDS Viral Hepatitis STD & TB Prevent, Global AIDS Program, Atlanta, GA USA; [Wilfert, Catherine M.] Elizabeth Glaser Pediat AIDS Fdn, Santa Monica, CA USA; [Shaffer, Nathan] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Dabis, Francois] Univ Bordeaux 2, Inst Sante Publ Epidemiol & Dev, F-33076 Bordeaux, France	University of Cape Town; Centers for Disease Control & Prevention - USA; World Health Organization; UDICE-French Research Universities; Universite de Bordeaux	Stringer, JSA (corresponding author), Ctr Infect Dis Res Zambia, Plot 1275,Lubutu Rd,POB 34681, Lusaka, Zambia.	stringer@cidrz.org	DABIS, FRANCOIS/S-9298-2019; EKOUEVI, Didier K/E-7960-2014; Stringer, Jeffrey S. A./AAU-2342-2021	DABIS, FRANCOIS/0000-0002-1614-8857; Stringer, Jeffrey/0000-0002-9590-7216	US Centers for Disease Control and Prevention [T0906150021]; Bill and Melinda Gates Foundation [351-07]; Elizabeth Glaser Pediatric AIDS Foundation	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Elizabeth Glaser Pediatric AIDS Foundation	The Zambia, South Africa, and Cote d'Ivoire work was supported by contract T0906150021 from the US Centers for Disease Control and Prevention Global AIDS Program. The Cameroon work was supported by the Bill and Melinda Gates Foundation grant 351-07, which was awarded to the Elizabeth Glaser Pediatric AIDS Foundation.	Chi BH, 2006, HIV CLIN TRIALS, V7, P263, DOI 10.1310/hct0705-263; Cressey TR, 2007, ANTIMICROB AGENTS CH, V51, P3361, DOI 10.1128/AAC.00445-07; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, REP GLOB HIV AIDS EP; Kagaayi J, 2005, JAIDS-J ACQ IMM DEF, V39, P121, DOI 10.1097/01.qai.0000148530.66587.7c; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Laurito TL, 2002, J MASS SPECTROM, V37, P434, DOI 10.1002/jms.300; Mate KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005483; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Megazzini KM, 2010, AIDS, V24, P447, DOI 10.1097/QAD.0b013e328334b285; Mirochnick M, 2000, CLIN PHARMACOKINET, V39, P281, DOI 10.2165/00003088-200039040-00004; *OFF US GLOB AIDS, CEL LIF; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; Plipat T, 2007, AIDS, V21, P145, DOI 10.1097/QAD.0b013e328010e02d; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Songok EM, 2003, AM J TROP MED HYG, V69, P8, DOI 10.4269/ajtmh.2003.69.8; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Stringer JSA, 2004, AIDS, V18, P939, DOI 10.1097/00002030-200404090-00012; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; *UNAIDS, 2001, UN GEN ASS SPEC SESS; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WEERAHANDI S, 2006, WILEY SERIES PROBABI; *WHO, 2006, ANT DRUGS TREAT WOM; WHO, RAP ADV US ANT DRUGS; WHO, UN ACC	30	113	114	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					293	302		10.1001/jama.2010.990	http://dx.doi.org/10.1001/jama.2010.990			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639563				2022-12-24	WOS:000280107500019
J	Chen, M; Galvao, RM; Li, MN; Burger, B; Bugea, J; Bolado, J; Chory, J				Chen, Meng; Galvao, Rafaelo M.; Li, Meina; Burger, Brian; Bugea, Jane; Bolado, Jack; Chory, Joanne			Arabidopsis HEMERA/pTAC12 Initiates Photomorphogenesis by Phytochromes	CELL			English	Article							BHLH TRANSCRIPTION FACTORS; E3 UBIQUITIN LIGASE; LIGHT CONTROL; INTERACTING FACTORS; BINDING PROTEIN; NUCLEAR-BODIES; DEGRADATION; DNA; PROTEASOME; EXPRESSION	Light plays a profound role in plant development, yet how photoreceptor excitation directs phenotypic plasticity remains elusive. One of the earliest effects of light is the regulated translocation of the red/far-red photoreceptors, phytochromes, from the cytoplasm to subnuclear foci called phytochrome nuclear bodies. The function of these nuclear bodies is unknown. We report the identification of hemera, a seedling lethal mutant of Arabidopsis with altered phytochrome nuclear body patterns. hemera mutants are impaired in all phytochrome responses examined, including proteolysis of phytochrome A and phytochrome-interacting transcription factors. HEMERA was identified previously as pTAC12, a component of a plastid complex associated with transcription. Here, we show that HEMERA has a function in the nucleus, where it acts specifically in phytochrome signaling, is predicted to be structurally similar to the multiubiquitin-binding protein, RAD23, and can partially rescue yeast rad23mutants. Together, these results implicate phytochrome nuclear bodies as sites of proteolysis.	[Chen, Meng; Burger, Brian; Bugea, Jane; Bolado, Jack; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Bolado, Jack; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chen, Meng; Galvao, Rafaelo M.; Li, Meina] Duke Univ, Dept Biol, Durham, NC 27708 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Duke University	Chen, M (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chen.meng@duke.edu; chory@salk.edu	Chen, Meng/C-7109-2014	Chen, Meng/0000-0003-0351-5897	National Institutes of Health [R01GM52413]; Duke University [4314268]; National Science Foundation [IOS-0923722]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413, R01GM087388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Akira Nagatani for providing the PBG line, Clark Lagarias for the PHYBYH line, Peter Quail and Sabine Heinhorst for anti-PHYA and anti-SiR antibodies, Kiran Madura for the yeast rad23 Delta rpn10 Delta double mutant, and Enamul Huq for pif1-2 seeds. Benjamin Cole and Kazumasa Nito made critical comments and suggestions regarding this manuscript. The work was supported by a grant from the National Institutes of Health (R01GM52413) to J.C., the Howard Hughes Medical Institute (J.C.), a startup fund (4314268) to M. C. from Duke University, and a grant from the National Science Foundation to M. C. (IOS-0923722).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; Chi-Ham CL, 2002, PLANT MOL BIOL, V49, P621, DOI 10.1023/A:1015500431421; CHORY J, 1993, TRENDS GENET, V9, P167, DOI 10.1016/0168-9525(93)90163-C; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jeong SY, 2003, NUCLEIC ACIDS RES, V31, P5175, DOI 10.1093/nar/gkg693; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lambertson D, 1999, GENETICS, V153, P69; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MACKENZIE JM, 1975, P NATL ACAD SCI USA, V72, P799, DOI 10.1073/pnas.72.3.799; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Meier I, 1996, PLANT CELL, V8, P2105, DOI 10.1105/tpc.8.11.2105; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; PRATT LH, 1974, BIOCHIM BIOPHYS ACTA, V365, P93, DOI 10.1016/0005-2795(74)90253-0; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Reed Jason W., 1994, Seminars in Cell Biology, V5, P327, DOI 10.1006/scel.1994.1039; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yoo HH, 2007, PLANT J, V49, P442, DOI 10.1111/j.1365-313X.2006.02974.x; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yu XH, 2009, PLANT CELL, V21, P118, DOI 10.1105/tpc.108.061663; Zhang Y, 2008, PLANT CELL, V20, P1437, DOI 10.1105/tpc.108.058891	59	166	176	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1230	U237		10.1016/j.cell.2010.05.007	http://dx.doi.org/10.1016/j.cell.2010.05.007			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603003	Green Accepted, Bronze			2022-12-24	WOS:000279148100019
J	Clayton, J				Clayton, Julie			The promise of T-cruzi genomics	NATURE			English	Editorial Material																		ELSAYED NM, SCIENCE, V309, P409; ELSAYED NM, SCIENCE, V309, P404	2	6	6	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S16	S17		10.1038/nature09225	http://dx.doi.org/10.1038/nature09225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571549	Bronze			2022-12-24	WOS:000279056900029
J	Lubchenco, J; Sutley, N				Lubchenco, Jane; Sutley, Nancy			Proposed US Policy for Ocean, Coast, and Great Lakes Stewardship	SCIENCE			English	Editorial Material							MANAGEMENT		[Lubchenco, Jane] Under Secretary Commerce Oceans & Atmosphere, Washington, DC 20230 USA; [Lubchenco, Jane] NOAA, Washington, DC 20230 USA; [Sutley, Nancy] Council Environm Qual & Interagency Ocean Policy, Washington, DC 20050 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Lubchenco, J (corresponding author), Under Secretary Commerce Oceans & Atmosphere, Washington, DC 20230 USA.	jane.lubchenco@noaa.gov						[Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2006, MARINE COASTAL ECOSY; *COUNC ENV QUAL, 2009, INT OC POL TASK FORC; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Daily GC., 1997, ISSUES ECOL, V2, P1; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lubchenco J, 2010, OCEANOGRAPHY, V23, P115, DOI 10.5670/oceanog.2010.55; McLeod K., 2009, ECOSYSTEM BASED MANA; Murawski SA, 2007, MAR POLICY, V31, P681, DOI 10.1016/j.marpol.2007.03.011; Obama B., 2009, COMMUNICATION   0612; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Rosenberg A. A., 2009, ECOSYSTEM BASED MANA, P294; Stokstad E, 2009, SCIENCE, V326, P1618, DOI 10.1126/science.326.5960.1618; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI	15	70	72	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1485	1486		10.1126/science.1190041	http://dx.doi.org/10.1126/science.1190041			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	611XW	20558691				2022-12-24	WOS:000278859200019
J	Lee, VJ; Yap, J; Cook, AR; Chen, MI; Tay, JK; Tan, BH; Loh, JP; Chew, SW; Koh, WH; Lin, R; Cui, L; Lee, CWH; Sung, W; Wong, CW; Hibberd, ML; Kang, WL; Seet, B; Tambyah, PA				Lee, Vernon J.; Yap, Jonathan; Cook, Alex R.; Chen, Mark I.; Tay, Joshua K.; Tan, Boon Huan; Loh, Jin Phang; Chew, Seok Wei; Koh, Wee Hong; Lin, Raymond; Cui, Lin; Lee, Charlie W. H.; Sung, Wing-Kin; Wong, Christopher W.; Hibberd, Martin L.; Kang, Wee Lee; Seet, Benjamin; Tambyah, Paul A.			Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANDEMIC INFLUENZA; AMANTADINE	Background: From June 22 through June 25, 2009, four outbreaks of infection with the pandemic influenza A (H1N1) virus occurred in Singapore military camps. We report the efficacy of ring chemoprophylaxis (geographically targeted containment by means of prophylaxis) with oseltamivir to control outbreaks of 2009 H1N1 influenza in semiclosed environments. Methods: All personnel with suspected infection were tested and clinically isolated if infection was confirmed. In addition, we administered postexposure ring chemoprophylaxis with oseltamivir and segregated the affected military units to contain the spread of the virus. All personnel were screened three times weekly both for virologic infection, by means of nasopharyngeal swabs and reverse-transcriptase-polymerase-chain-reaction assay with sequencing, and for clinical symptoms, by means of questionnaires. Results: A total of 1175 personnel were at risk across the four sites, with 1100 receiving oseltamivir prophylaxis. A total of 75 personnel (6.4%) were infected before the intervention, and 7 (0.6%) after the intervention. There was a significant reduction in the overall reproductive number (the number of new cases attributable to the index case), from 1.91 (95% credible interval, 1.50 to 2.36) before the intervention to 0.11 (95% credible interval, 0.05 to 0.20) after the intervention. Three of the four outbreaks showed a significant reduction in the rate of infection after the intervention. Molecular analysis revealed that all four outbreaks were derived from the New York lineage of the 2009 H1N1 virus and that cases within each outbreak were due to transmission rather than unrelated episodes of infection. Of the 816 personnel treated with oseltamivir who were surveyed, 63 (7.7%) reported mild, nonrespiratory side effects of the drug, with no severe adverse events. Conclusions: Oseltamivir ring chemoprophylaxis, together with prompt identification and isolation of infected personnel, was effective in reducing the impact of outbreaks of 2009 H1N1 influenza in semiclosed settings. N Engl J Med 2010;362:2166-74.	[Lee, Vernon J.; Yap, Jonathan; Tay, Joshua K.] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Lee, Vernon J.; Chen, Mark I.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore; [Chen, Mark I.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Tan, Boon Huan; Loh, Jin Phang; Chew, Seok Wei; Koh, Wee Hong] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Lin, Raymond; Cui, Lin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Lee, Charlie W. H.; Sung, Wing-Kin; Wong, Christopher W.; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Kang, Wee Lee; Seet, Benjamin] Headquarters Med Corps, Singapore Armed Forces, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital; Ministry of Health-Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Australian National University	Lee, VJ (corresponding author), 42 How Sun Dr, Singapore 538611, Singapore.	vernonljm@hotmail.com	Cook, Alex/S-3576-2019; Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020; Chen, Mark/AGC-5338-2022; Hibberd, Martin L/D-5050-2009; Wong, Christopher/C-5830-2008; Tan, Boon Huan/ABB-8381-2021; Cook, Alex/B-5941-2011	Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536; Chen, Mark/0000-0001-9369-5830; Tan, Boon Huan/0000-0002-4976-7988; Cook, Alex/0000-0002-6271-5832; Sung, Wing-Kin/0000-0001-7806-7086; Hibberd, Martin/0000-0001-8587-1849	Singapore Ministry of Defence; National University of Singapore; Singapore Agency for Science, Research, and Technology	Singapore Ministry of Defence(Ministry of Defence, Singapore); National University of Singapore(National University of Singapore); Singapore Agency for Science, Research, and Technology	Supported by the Singapore Ministry of Defence, the National University of Singapore (for the statistical analysis), and the Singapore Agency for Science, Research, and Technology (for the genetic sequencing).	Anderson RM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2897; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P213; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; *CDC DEP HLTH ROC, 2009, INFL PAND STRAT PLAN; *CDCP, 2009, INT GUID ANT REC PAT; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; DAVIES JR, 1988, J ROY COLL GEN PRACT, V38, P346; DELBIN DJ, 1979, J R COLL GEN PRACT, V29, P151; Earhart KC, 2001, EMERG INFECT DIS, V7, P463, DOI 10.3201/eid0703.017320; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; LEE CW, 2010, NUCL ACIDS RES  0225; Lee PM, 2009, BAYESIAN STAT INTRO; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Liu PY, 2009, J MICROBIOL IMMUNOL, V42, P114; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MILNE DG, 1949, BRIT MED J, V1, P571, DOI 10.1136/bmj.1.4604.571; *MIN HLTH SING, 2009, 16 NEW CONF CAS INFL; *MIN HLTH SING, 2009, 1 CONF CAS INFL A H1; *MIN HLTH SING, 2009, CONF NEW CAS INFL H1; Ministry of Health Singapore, 2009, INFL PAND READ RESP; *MOH SING, 2009, 792009 MOH; *MOH SING, CAS DEF MAN HUM INF; *MOH SING, 2009, 442009 MOH; R Core Team, 2021, R LANG ENV STAT COMP; Rubin MS, 2008, CLIN INFECT DIS, V47, P47, DOI 10.1086/588658; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; *STAT SING, KEY ANN IND; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; *WHO, 2009, DG DIR GEN STAT FOLL; WHO, 2009, CDC PROT REALT RT PC; World Health Organization, 2009, PROD AV PAND H1N1 20	36	64	65	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2166	2174		10.1056/NEJMoa0908482	http://dx.doi.org/10.1056/NEJMoa0908482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558367	Green Accepted			2022-12-24	WOS:000278551500005
J	Shawcross, DL; O'Grady, JG				Shawcross, Debbie L.; O'Grady, John G.			The 6-month abstinence rule in liver transplantation	LANCET			English	Editorial Material							ALCOHOLIC HEPATITIS; DISEASE; SURVIVAL; STEROIDS; RELAPSE		[Shawcross, Debbie L.; O'Grady, John G.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	O'Grady, JG (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	john.o'grady@kcl.ac.uk	Shawcross, Debbie Lindsay/H-9669-2012	Shawcross, Debbie Lindsay/0000-0001-6133-4619				Beresford TP, 2000, LIVER TRANSPLANT, V6, P777, DOI 10.1053/jlts.2000.19027; BIRD GLA, 1990, BRIT MED J, V301, P15, DOI 10.1136/bmj.301.6742.15; Castel H, 2009, HEPATOLOGY, V50, p307A; Dureja P, 2010, J HEPATOL, V52, P759, DOI 10.1016/j.jhep.2009.12.021; KUMAR S, 1990, HEPATOLOGY, V11, P159, DOI 10.1002/hep.1840110202; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Neuberger J, 2002, J HEPATOL, V36, P130, DOI 10.1016/S0168-8278(01)00278-1; O'Grady JG, 2006, GUT, V55, P1529, DOI 10.1136/gut.2005.090506; OSORIO RW, 1994, HEPATOLOGY, V20, P105, DOI 10.1016/0270-9139(94)90141-4; SHAWCROSS D, 2009, BRIT MED J, V338, P1081; Tandon P, 2009, AM J GASTROENTEROL, V104, P1700, DOI 10.1038/ajg.2009.226	12	40	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					216	217		10.1016/S0140-6736(10)60487-4	http://dx.doi.org/10.1016/S0140-6736(10)60487-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20656110				2022-12-24	WOS:000280457200009
J	Brashares, JS				Brashares, Justin S.			Filtering Wildlife	SCIENCE			English	Editorial Material							EXTINCTION; MAMMALS; DECLINE		Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Brashares, JS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	brashares@berkeley.edu						Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Marton-Lefevre J, 2010, SCIENCE, V327, P1179, DOI 10.1126/science.1188424; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; White J, 2003, MATER WORLD, V11, P2; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; WRIGHT GM, 1934, US DEP INT WILD DIV, V2	16	17	20	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					402	403		10.1126/science.1190095	http://dx.doi.org/10.1126/science.1190095			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651143				2022-12-24	WOS:000280196500025
J	Kale, SD; Gu, BA; Capelluto, DGS; Dou, DL; Feldman, E; Rumore, A; Arredondo, FD; Hanlon, R; Fudal, I; Rouxel, T; Lawrence, CB; Shan, WX; Tyler, BM				Kale, Shiv D.; Gu, Biao; Capelluto, Daniel G. S.; Dou, Daolong; Feldman, Emily; Rumore, Amanda; Arredondo, Felipe D.; Hanlon, Regina; Fudal, Isabelle; Rouxel, Thierry; Lawrence, Christopher B.; Shan, Weixing; Tyler, Brett M.			External Lipid PI3P Mediates Entry of Eukaryotic Pathogen Effectors into Plant and Animal Host Cells	CELL			English	Article							PHYTOPHTHORA-SOJAE; PLASMODIUM-FALCIPARUM; MOLECULAR-BASIS; PROTEINS; AVIRULENCE; GENE; RESISTANCE; VIRULENCE; RECOGNITION; DYNAMICS	Pathogens of plants and animals produce effector proteins that are transferred into the cytoplasm of host cells to suppress host defenses. One type of plant pathogens, oomycetes, produces effector proteins with N-terminal RXLR and dEER motifs that enable entry into host cells. We show here that effectors of another pathogen type, fungi, contain functional variants of the RXLR motif, and that the oomycete and fungal RXLR motifs enable binding to the phospholipid, phosphatidylinositol-3-phosphate (PI3P). We find that PI3P is abundant on the outer surface of plant cell plasma membranes and, furthermore, on some animal cells. All effectors could also enter human cells, suggesting that PI3P-mediated effector entry may be very widespread in plant, animal and human pathogenesis. Entry into both plant and animal cells involves lipid raft-mediated endocytosis. Blocking PI3P binding inhibited effector entry, suggesting new therapeutic avenues.	[Gu, Biao; Shan, Weixing] NW A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China; [Gu, Biao; Shan, Weixing] NW A&F Univ, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China; [Kale, Shiv D.; Gu, Biao; Dou, Daolong; Feldman, Emily; Rumore, Amanda; Arredondo, Felipe D.; Hanlon, Regina; Lawrence, Christopher B.; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Capelluto, Daniel G. S.; Rumore, Amanda; Lawrence, Christopher B.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Fudal, Isabelle; Rouxel, Thierry] INRA Bioger, F-78850 Thiverval Grignon, France	Northwest A&F University - China; Northwest A&F University - China; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Shan, WX (corresponding author), NW A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China.	wxshan@nwsuaf.edu.cn; bmtyler@vt.edu	Gu, Biao/AAT-8220-2021; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642; Shan, Weixing/0000-0001-7286-4041; Fudal, Isabelle/0000-0002-9105-9432	National Research Initiative of the USDA National Institute of Food and Agriculture [2007-35319-18100]; U.S. National Science Foundation [IOS-0924861]; Ministry of Science and Technology of China [2006CB101901]; Earmarked Fund for Modern Agro-industry Technology Research System of China; China Scholarship Council via NW A F University [2007U27066]; Direct For Biological Sciences [0924861] Funding Source: National Science Foundation	National Research Initiative of the USDA National Institute of Food and Agriculture; U.S. National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Earmarked Fund for Modern Agro-industry Technology Research System of China; China Scholarship Council via NW A F University(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The project was conceived by B. M. T, W. S., and D. D., and the experiments were planned by all authors. S. D. K. and B. G. conducted most of the experiments with contributions from D. G. S. C., D. D., E. F., A. C., R. H., and F. A. S. D. K and B. M. T wrote the paper with input from all authors. We thank Furong Sun and Vincenzo Antignani for technical assistance; Rays Jiang (Broad Institute) for bioinformatics assistance; John McDowell, Ryan Anderson (Virginia Tech), and Frank Takken (University of Amsterdam) for useful discussions; Joop Vermeer and Teun Munnik (University of Amsterdam) for the Hrs-2xFYVE biosensor gene; Michael Klemba (Virginia Tech) for human erythrocytes, Saghai Maroof (Virginia Tech) for soybean seed and Maureen Lawrence, Lisa Gunderman and Emily Alberts for manuscript preparation. This work was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture, grant number #2007-35319-18100 (to B. M. T), by the U.S. National Science Foundation, grant number IOS-0924861 (to B. M. T), in part by the 973 program of the Ministry of Science and Technology of China, grant #2006CB101901 and by grant 15 from the Earmarked Fund for Modern Agro-industry Technology Research System of China (to W. S.). S. D. K. was supported in part by a U.S. National Science Foundation predoctoral fellowship and B. G. was supported by a China Scholarship Council fellowship, #2007U27066, via NW A & F University.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Boon JM, 2002, MED RES REV, V22, P251, DOI 10.1002/med.10009; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Fudal I, 2007, MOL PLANT MICROBE IN, V20, P459, DOI 10.1094/MPMI-20-4-0459; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KALE SD, 2009, METHODS MOL BIOL PLA; KHANG CH, 2010, PLANT CELL, V22, DOI DOI 10.1105/TPC.1109.069666; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Langel U., 2006, HDB CELL PENETRATING; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lord JM, 1999, CELL MICROBIOL, V1, P85, DOI 10.1046/j.1462-5822.1999.00015.x; Lou Y, 2006, PLANT MOL BIOL, V60, P729, DOI 10.1007/s11103-005-5548-x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; QUINN PJ, 2002, SUBCELLULAR BIOCH, P39; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x; Vermeer JEM, 2009, PLANT J, V57, P356, DOI 10.1111/j.1365-313X.2008.03679.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	44	286	309	6	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					284	295		10.1016/j.cell.2010.06.008	http://dx.doi.org/10.1016/j.cell.2010.06.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655469	Bronze			2022-12-24	WOS:000280204300019
J	Fouyas, IP; Sandercock, PAG; Statham, PFX; Nikolaidis, I				Fouyas, Ioannis P.; Sandercock, Peter A. G.; Statham, Patrick F. X.; Nikolaidis, Ioannis			Uncertainties Page How beneficial is surgery for cervical radiculopathy and myelopathy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONDYLOTIC MYELOPATHY; SURGICAL-TREATMENT; NATURAL-HISTORY; MULTICENTER; DISORDER		[Fouyas, Ioannis P.; Sandercock, Peter A. G.; Statham, Patrick F. X.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Nikolaidis, Ioannis] Tzaneio Gen State Hosp, Piraeus, Greece	University of Edinburgh	Fouyas, IP (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	ioannisfouyas@nhs.net		Sandercock, Peter/0000-0001-8484-0135	Biomet	Biomet	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) no authors have support from any company for the submitted work; (2) PFXS has received consultancy fees for the development of a cervical disc replacement, and has had travel and accommodation expenses covered by Biomet, which might have an interest in the submitted work in the previous three years; (3) none of the authors' spouses, partners, or children have financial relationships that may be relevant to the submitted work; and (4) no authors have non-financial interests that may be relevant to the submitted work.	BARNES MP, 1984, J NEUROL NEUROSUR PS, V47, P17, DOI 10.1136/jnnp.47.1.17; CAMPBELL AMG, 1960, BRIT MED J, V2, P481, DOI 10.1136/bmj.2.5197.481; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; IRVINE DH, 1965, LANCET, V1, P1089; Kadanka Z, 2002, SPINE, V27, P2205, DOI 10.1097/00007632-200210150-00003; King JT, 2005, J NEUROSURG-SPINE, V2, P526, DOI 10.3171/spi.2005.2.5.0526; LEES F, 1963, BRIT MED J, P1607, DOI 10.1136/bmj.2.5373.1607; Nikolaidis I, 2010, COCHRANE DB SYST REV, V1; NURICK S, 1972, BRAIN, V95, P101, DOI 10.1093/brain/95.1.101; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; ROWLAND LP, 1992, NEUROLOGY, V42, P5, DOI 10.1212/WNL.42.1.5; Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004; Sampath P, 1999, SPINE, V24, P591, DOI 10.1097/00007632-199903150-00021; Singh A, 2001, J NEUROSURG, V94, P189, DOI 10.3171/spi.2001.94.2.0189; TERESI LM, 1987, RADIOLOGY, V164, P83, DOI 10.1148/radiology.164.1.3588931	16	8	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3108	10.1136/bmj.c3108	http://dx.doi.org/10.1136/bmj.c3108			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627982				2022-12-24	WOS:000280156600002
J	Aaen, AM; Moller, K				Aaen, Anne-Marie; Moller, Kirsten			A Patient's Journey Through and beyond anaesthesia awareness	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moller, Kirsten] Rigshosp, Dept Intens Care, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen		aaen@webspeed.dk; kirsten.moller@dadlnet.dk	Moller, Kirsten/A-4751-2009	Moller, Kirsten/0000-0003-3058-1072					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2010	341								c3669	10.1136/bmj.c3669	http://dx.doi.org/10.1136/bmj.c3669			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628WY	20624831				2022-12-24	WOS:000280156300001
J	Hidvegi, T; Ewing, M; Hale, P; Dippold, C; Beckett, C; Kemp, C; Maurice, N; Mukherjee, A; Goldbach, C; Watkins, S; Michalopoulos, G; Perlmutter, DH				Hidvegi, Tunda; Ewing, Michael; Hale, Pamela; Dippold, Christine; Beckett, Caroline; Kemp, Carolyn; Maurice, Nicholas; Mukherjee, Amitava; Goldbach, Christina; Watkins, Simon; Michalopoulos, George; Perlmutter, David H.			An Autophagy-Enhancing Drug Promotes Degradation of Mutant alpha 1-Antitrypsin Z and Reduces Hepatic Fibrosis	SCIENCE			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; LIVER-DISEASE; PROTEIN; INHIBITOR; PATHWAYS; DISPOSAL	In the classical form of alpha(1)-antitrypsin (AT) deficiency, a point mutation in AT alters the folding of a liver-derived secretory glycoprotein and renders it aggregation-prone. In addition to decreased serum concentrations of AT, the disorder is characterized by accumulation of the mutant alpha(1)-antitrypsin Z (ATZ) variant inside cells, causing hepatic fibrosis and/or carcinogenesis by a gain-of-toxic function mechanism. The proteasomal and autophagic pathways are known to mediate degradation of ATZ. Here we show that the autophagy-enhancing drug carbamazepine (CBZ) decreased the hepatic load of ATZ and hepatic fibrosis in a mouse model of AT deficiency-associated liver disease. These results provide a basis for testing CBZ, which has an extensive clinical safety profile, in patients with AT deficiency and also provide a proof of principle for therapeutic use of autophagy enhancers.	[Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perlmutter, DH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.	david.perlmutter@chp.edu	Mukherjee, Amitava/AAK-4002-2020; Watkins, Simon/ABG-2590-2021	Mukherjee, Amitava/0000-0001-5603-5147; Watkins, Simon/0000-0003-4092-1552	NIH [HL037784, DK076918, RR022241]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084512, R01DK076918] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to J. Englert for the hydroxyproline assay and to G. Silverman and J. Brodsky for critical review of the manuscript. The work was partially supported by NIH grants HL037784, DK076918, and RR022241.	Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2007, J BIOL CHEM, V282, P27769, DOI 10.1074/jbc.M704330200; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Perlmutter DH, 2009, CELL DEATH DIFFER, V16, P39, DOI 10.1038/cdd.2008.103; Piitulainen E, 2005, CHEST, V128, P2076, DOI 10.1378/chest.128.4.2076; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Ravikumar Brinda, 2008, V445, P195, DOI 10.1007/978-1-59745-157-4_13; Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	14	439	467	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					229	232		10.1126/science.1190354	http://dx.doi.org/10.1126/science.1190354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20522742				2022-12-24	WOS:000279635200053
J	Knight, I; Bird, HA				Knight, Isobel; Bird, H. A.			A Patient's Journey Joint hypermobility syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bird, H. A.] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds		IKnight@laban.org; Howard.Bird@leedsth.nhs.uk							0	1	2	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2010	341								c3044	10.1136/bmj.c3044	http://dx.doi.org/10.1136/bmj.c3044			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DJ	20603316				2022-12-24	WOS:000279874000001
J	Bonetta, L				Bonetta, Laura			Whole-Genome Sequencing Breaks the Cost Barrier	CELL			English	Editorial Material																			0	37	38	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					917	919		10.1016/j.cell.2010.05.034	http://dx.doi.org/10.1016/j.cell.2010.05.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550926	Bronze			2022-12-24	WOS:000278618800005
J	Newman, RD				Newman, Robert D.			Malaria control beyond 2010	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; MICROSCOPY; RESISTANCE; MANAGEMENT; CHILDREN		WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Newman, RD (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	newmanr@who.int						Amin AA, 2007, J CLIN PHARM THER, V32, P429, DOI 10.1111/j.1365-2710.2007.00847.x; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2008, MAL RAP DIAGN TEST P; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Roll Back Malaria, 2010, MAL FUND RES UT 1 DE; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, WORLD MAL REP 2009; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x	15	6	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 11	2010	340								c2714	10.1136/bmj.c2714	http://dx.doi.org/10.1136/bmj.c2714			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MH	20543011				2022-12-24	WOS:000278818900002
J	Hirsch, IB; Brownlee, M				Hirsch, Irl B.; Brownlee, Michael			Beyond Hemoglobin A(1c)-Need for Additional Markers of Risk for Diabetic Microvascular Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE VARIABILITY; INTENSIVE TREATMENT; PROGRESSION; MELLITUS		[Hirsch, Irl B.] Univ Washington, Med Ctr Roosevelt, Div Metab Endocrinol & Nutr, Sch Med, Seattle, WA 98105 USA; [Hirsch, Irl B.] Univ Washington, Diabet Care Ctr, Seattle, WA 98105 USA; [Brownlee, Michael] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hirsch, IB (corresponding author), Univ Washington, Med Ctr Roosevelt, Div Metab Endocrinol & Nutr, Sch Med, 4225 Roosevelt Way NE,Ste 101, Seattle, WA 98105 USA.	ihirsch@uw.edu						Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Cohen RA, 1999, AM J MED, V107, P45, DOI 10.1016/S0002-9343(99)00165-5; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105	10	118	123	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2291	2292		10.1001/jama.2010.785	http://dx.doi.org/10.1001/jama.2010.785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530784				2022-12-24	WOS:000278496800030
J	Ismail, SA; Vetter, IR; Sot, B; Wittinghofer, A				Ismail, Shehab A.; Vetter, Ingrid R.; Sot, Begona; Wittinghofer, Alfred			The Structure of an Arf-ArfGAP Complex Reveals a Ca2+ Regulatory Mechanism	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEOTIDE EXCHANGE; CRYSTAL-STRUCTURE; MEMBRANE; GAP; BINDING; IDENTIFICATION; MICRODOMAINS; VESICLES; ENZYME	Arfs are small G proteins that have a key role in vesicle trafficking and cytoskeletal remodeling. Arf-GAP proteins stimulate Arf intrinsic GTP hydrolysis by a mechanism that is still unresolved. Using a fusion construct we solved the structure of the ArfGAP ASAP3 in complex with Arf6 in the transition state. This structure clarifies the ArfGAP catalytic mechanism and shows a glutamine((Arf6)) and an arginine finger((ASAP3)) as the important catalytic residues. Unexpectedly the structure shows a calcium ion, liganded by both proteins in the complex interface, stabilizing the interaction and orienting the catalytic machinery. Calcium stimulates the GAP activity of ASAPs, but not other members of the ArfGAP family. This type of regulation is unique for GAPs and any other calcium-regulated processes and hints at a crosstalk between Ca2+ and Arf signaling.	[Ismail, Shehab A.; Vetter, Ingrid R.; Sot, Begona; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Sot, Begoña/H-2882-2015	Sot, Begoña/0000-0001-8763-0651; Ismail, Shehab/0000-0002-4150-1077	Alexander Von Humboldt Stiftung; DFG [SFB 642]	Alexander Von Humboldt Stiftung(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG))	We thank Paul Randazzo for ASAP1 and AGAP1 clones; Maraget Chou for the Arf6 clone; and Michael Sporner for ARNO proteins; Wulf Blankenfeldt, Eck-hard Hoffman, and Ilme Schlichting for data collection at the Swiss Light Source, beamline X10SA, Paul Scherrer Institut, Villigen, Switzerland. We thank Ola Sabet, Raphael Gasper, and Simon Meyer for scientific discussions and Carolin Koerner for scientific discussion and expert technical support. S.A.I. is sponsored by the Alexander Von Humboldt Stiftung. A. W. thanks the DFG (SFB 642) for financial support.	Andreev J, 1999, MOL CELL BIOL, V19, P2338; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Berry H, 2002, BIOPHYS J, V83, P1891, DOI 10.1016/S0006-3495(02)73953-2; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; FRALEY R, 1980, BIOCHEMISTRY-US, V19, P6021, DOI 10.1021/bi00567a012; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOMPERTS BD, 2002, SIGNAL TRANSDUCTION; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Krebs J, 2007, N COMP BIOC, V41, P1; Laude AJ, 2009, FEBS J, V276, P1800, DOI 10.1111/j.1742-4658.2009.06927.x; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; McNeil BD, 2009, NEURON, V63, P419, DOI 10.1016/j.neuron.2009.08.001; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Okabe H, 2004, INT J ONCOL, V24, P43; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; TAKAKUWA Y, 1994, J BIOL CHEM, V269, P27889; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093	43	53	56	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					812	821		10.1016/j.cell.2010.03.051	http://dx.doi.org/10.1016/j.cell.2010.03.051			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510928	Bronze, Green Accepted			2022-12-24	WOS:000278132900016
J	Luzzatto, L				Luzzatto, Lucio			The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics	LANCET			English	Editorial Material							UNCOMPLICATED FALCIPARUM-MALARIA; CHLORPROGUANIL-DAPSONE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; RANDOMIZED-TRIAL; AFRICAN CHILDREN; PLUS ARTESUNATE; DEHYDROGENASE; LEPROSY		Ist Toscano Tumori, I-50139 Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Luzzatto, L (corresponding author), Ist Toscano Tumori, Via Taddeo Alderotti 26N, I-50139 Florence, Italy.							Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 1967, World Health Organ Tech Rep Ser, V366, P1; BIENZLE U, 1972, LANCET, V1, P107; BRUCECHWATT LJ, 1982, BRIT MED J, V284, P767, DOI 10.1136/bmj.284.6318.767; Bukirwa H, 2004, COCHRANE DB SYST REV, V4; BYRD SR, 1991, LEPROSY REV, V62, P171; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; *DAC LAPD, UPD GSKS MAL TREATM; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; Fanello CI, 2008, T ROY SOC TROP MED H, V102, P412, DOI 10.1016/j.trstmh.2008.01.013; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Jalloh A, 2004, TROP MED INT HEALTH, V9, P615, DOI 10.1111/j.1365-3156.2004.01237.x; Krattiger A., 2007, EXECUTIVE GUIDE INTE, P11; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; PONNAMPALAM JT, 1981, TROP GEOGR MED, V33, P401; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; PUAVILAI S, 1984, J MED ASSOC THAILAND, V67, P404; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x; WOODRUFF AW, 1981, BMJ-BRIT MED J, V282, P988; [No title captured]; 2004, REV SAFETY CHLORPROG	24	44	44	3	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					739	741		10.1016/S0140-6736(10)60396-0	http://dx.doi.org/10.1016/S0140-6736(10)60396-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20599264				2022-12-24	WOS:000281582900033
J	Horton, R; Das, P				Horton, Richard; Das, Pam			Rescuing people with HIV who use drugs	LANCET			English	Editorial Material									[Horton, Richard; Das, Pam] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Colfax G, 2010, LANCET, V376, P458, DOI 10.1016/S0140-6736(10)60753-2; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; *HUM RIGHTS WATCH, 2009, CAMB STOP FORC PART; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	9	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					207	208		10.1016/S0140-6736(10)61025-2	http://dx.doi.org/10.1016/S0140-6736(10)61025-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650525				2022-12-24	WOS:000280457200004
J	Lassance, JM; Groot, AT; Lienard, MA; Antony, B; Borgwardt, C; Andersson, F; Hedenstrom, E; Heckel, DG; Lofstedt, C				Lassance, Jean-Marc; Groot, Astrid T.; Lienard, Marjorie A.; Antony, Binu; Borgwardt, Christin; Andersson, Fredrik; Hedenstrom, Erik; Heckel, David G.; Lofstedt, Christer			Allelic variation in a fatty-acyl reductase gene causes divergence in moth sex pheromones	NATURE			English	Article							EUROPEAN CORN-BORER; DESATURASE GENE; LEPIDOPTERA; POLYMORPHISM; EVOLUTION; SPECIFICITY; SPECIATION; SOFTWARE; LINKAGE; SYSTEM	Pheromone-based behaviours are crucial in animals from insects to mammals(1,2), and reproductive isolation is often based on pheromone differences(1-4). However, the genetic mechanisms by which pheromone signals change during the evolution of new species are largely unknown(4). In the sexual communication system of moths (Insecta: Lepidoptera), females emit a species-specific pheromone blend that attracts males over long distances(1,2,4). The European corn borer, Ostrinia nubilalis, consists of two sex pheromone races, Z and E, that use different ratios of the cis and trans isomers of acetate pheromone components(5). This subtle difference leads to strong reproductive isolation in the field between the two races(6,7), which could represent a first step in speciation. Female sex pheromone production and male behavioural response are under the control of different major genes(8,9), but the identity of these genes is unknown. Here we show that allelic variation in a fatty-acyl reductase gene essential for pheromone biosynthesis accounts for the phenotypic variation in female pheromone production, leading to race-specific signals. Both the cis and trans isomers of the pheromone precursors are produced by both races, but the precursors are differentially reduced to yield opposite ratios in the final pheromone blend as a result of the substrate specificity of the enzymes encoded by the Z and E alleles. This is the first functional characterization of a gene contributing to intraspecific behavioural reproductive isolation in moths, highlighting the importance of evolutionary diversification in a lepidopteran-specific family of reductases. Accumulation of substitutions in the coding region of a single biosynthetic enzyme can produce pheromone differences resulting in reproductive isolation, with speciation as a potential end result.	[Lassance, Jean-Marc; Lienard, Marjorie A.; Antony, Binu; Lofstedt, Christer] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Groot, Astrid T.; Borgwardt, Christin; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany; [Andersson, Fredrik; Hedenstrom, Erik] Mid Sweden Univ, Dept Nat Sci Engn & Math, S-85170 Sundsvall, Sweden	Lund University; Max Planck Society; Mid-Sweden University	Lassance, JM (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.	jean-marc.lassance@ekol.lu.se; christer.lofstedt@ekol.lu.se	Groot, Astrid/A-8954-2013; Lassance, Jean-Marc/AAF-3933-2020; Löfstedt, Christer/G-2016-2014; Heckel, David G/K-2138-2013; Antony, Binu/M-8562-2015	Groot, Astrid/0000-0001-9595-0161; Lassance, Jean-Marc/0000-0002-3675-6956; Löfstedt, Christer/0000-0002-3116-6922; Heckel, David G/0000-0001-8991-2150; Antony, Binu/0000-0002-6292-620X; Lienard, Marjorie/0000-0003-3193-3666	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Max-Planck-Gesellschaft	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Max-Planck-Gesellschaft(Max Planck Society)	We thank R.G. Harrison for his comments and advice. This research was funded by the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and the Max-Planck-Gesellschaft.	Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; CARDE RT, 1978, SCIENCE, V199, P555, DOI 10.1126/science.199.4328.555; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Coyne JA, 2004, SPECIATION; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; GUTHRIE W. D., 1965, ANN ENTOMOL SOC AMER, V58, P100, DOI 10.1093/aesa/58.1.100; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; HECKEL DG, 1993, ANNU REV ENTOMOL, V38, P381, DOI 10.1146/annurev.en.38.010193.002121; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; KLUN JA, 1979, ENVIRON ENTOMOL, V8, P423, DOI 10.1093/ee/8.3.423; Knipple DC, 2002, GENETICS, V162, P1737; Kochansky J, 1975, J CHEM ECOL, V1, P225, DOI 10.1007/BF00987871; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lienard MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-270; LOFSTEDT C, 1989, GENETICS, V123, P553; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; WOLF WA, 1987, J CHEM ECOL, V13, P1019, DOI 10.1007/BF01020535; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Zhu JW, 1996, INSECT BIOCHEM MOLEC, V26, P171, DOI 10.1016/0965-1748(95)00079-8	37	151	160	0	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					486	U7		10.1038/nature09058	http://dx.doi.org/10.1038/nature09058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20592730				2022-12-24	WOS:000280141200035
J	Basu, P				Basu, Paroma			Forgotten lessons	NATURE			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S14	S15		10.1038/nature09241	http://dx.doi.org/10.1038/nature09241			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631697	Bronze			2022-12-24	WOS:000279867100030
J	Sastre, EA				Sastre, Elizabeth Ann			The Hike	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												elizabeth.a.sastre@vanderbilt.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					134	135		10.1001/jama.2010.882	http://dx.doi.org/10.1001/jama.2010.882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628118				2022-12-24	WOS:000279811000001
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Listen up: deafness and personal audio players	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2010	341								c3539	10.1136/bmj.c3539	http://dx.doi.org/10.1136/bmj.c3539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DL	20610496				2022-12-24	WOS:000279874300011
J	Sasson, C; Keirns, CC; Smith, D; Sayre, M; Macy, M; Meurer, W; McNally, BF; Kellermann, AL; Iwashyna, TJ				Sasson, Comilla; Keirns, Carla C.; Smith, Dylan; Sayre, Michael; Macy, Michelle; Meurer, William; McNally, Bryan F.; Kellermann, Arthur L.; Iwashyna, Theodore J.		Cardiac Arrest Registry Enhance Su	Small Area Variations in Out-of-Hospital Cardiac Arrest: Does the Neighborhood Matter?	ANNALS OF INTERNAL MEDICINE			English	Article							RESUSCITATION	Background: The incidence and outcomes of out-of-hospital cardiac arrest vary widely across cities. It is unknown whether similar differences exist at the neighborhood level. Objective: To determine the extent to which neighborhoods have persistently high rates of cardiac arrest but low rates of bystander cardiopulmonary resuscitation (CPR). Design: Multilevel Poisson regression of 1108 cardiac arrests from 161 census tracts as captured by the Cardiac Arrest Registry to Enhance Survival (CARES). Setting: Fulton County, Georgia, between 1 October 2005 to 30 November 2008. Measurements: Incidence of cardiac arrest, by census tract and year and by rates of bystander CPR. Results: Adjusted rates of cardiac arrest varied across neighborhoods (interquartile range [IQR], 0.57 to 0.73 per 1000 persons; mean, 0.64 per 1000 persons [SD, 0.11]) but were stable from year to year (intraclass correlation, 0.36 [95% CI, 0.26 to 0.50]; P < 0.001). Adjusted bystander CPR rates also varied by census tract (IQR, 19% to 29%; mean, 25% [SD, 10%]). Limitation: Analysis was based on data from a single county. Conclusion: Surveillance data can identify neighborhoods with a persistently high incidence of cardiac arrest and low rates of bystander CPR. These neighborhoods are promising targets for community-based interventions.	Univ Michigan, Ann Arbor, MI 48109 USA; SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA; Ohio State Univ, Columbus, OH 43210 USA; Emory Univ, Sch Med, Atlanta, GA USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio State University; Emory University	Sasson, C (corresponding author), Robert Wood Johnson Fdn, Clin Scholars Program, 1150 W Med Ctr Dr,6312 Med Sci Bldg 1,Campus Box, Ann Arbor, MI 48109 USA.	comilla@umich.edu	Meurer, William J/A-7547-2010; Keirns, Carla/AAT-9384-2020; Sayre, Michael R/E-8383-2017; Macy, Michelle/AAV-7528-2020; McNally, Bryan/AAE-9332-2020	Meurer, William J/0000-0002-1158-5302; Sayre, Michael R/0000-0003-0322-3181; Macy, Michelle/0000-0003-4401-7384; Iwashyna, Theodore/0000-0002-4226-9310	Robert Wood Johnson Foundation; National Institutes of Health [K08 HL091249]; Centers for Disease Control and Prevention [MM-0917-05/05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Robert Wood Johnson Foundation Clinical Scholars Program, National Institutes of Health (grant K08 HL091249), and Centers for Disease Control and Prevention (grant MM-0917-05/05).	*CARD ARR REG ENH, IRB APPR MOD; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lerner EB, 2005, ACAD EMERG MED, V12, P81, DOI 10.1197/j.aem.2004.08.044; McCarthy M, 2000, Rev Environ Health, V15, P97; McNally B, 2009, ANN EMERG MED, V54, P674, DOI 10.1016/j.annemergmed.2009.03.018; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576	12	66	67	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					19	W12		10.7326/0003-4819-153-1-201007060-00255	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00255			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620GS	20516307	Green Accepted			2022-12-24	WOS:000279487700003
J	Jewkes, RK; Dunkle, K; Nduna, M; Shai, N				Jewkes, Rachel K.; Dunkle, Kristin; Nduna, Mzikazi; Shai, Nwabisa			Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study	LANCET			English	Article							STEPPING STONES; SEXUAL-BEHAVIOR; AMERICAN WOMEN; RISK; GENDER; RAKAI; TRANSMISSION; HEALTH	Background Cross-sectional studies have shown that intimate partner violence and gender inequity in relationships are associated with increased prevalence of HIV in women. Yet temporal sequence and causality have been questioned, and few HIV prevention programmes address these issues. We assessed whether intimate partner violence and relationship power inequity increase risk of incident HIV infection in South African women. Methods We did a longitudinal analysis of data from a previously published cluster-randomised controlled trial undertaken in the Eastern Cape province of South Africa in 2002-06. 1099 women aged 15-26 years who were HIV negative at baseline and had at least one additional HIV test over 2 years of follow-up were included in the analysis. Gender power equity and intimate partner violence were measured by a sexual relationship power scale and the WHO violence against women instrument, respectively. Incidence rate ratios (IRRs) of HIV acquisition at 2 years were derived from Poisson models, adjusted for study design and herpes simplex virus type 2 infection, and used to calculate population attributable fractions. Findings 128 women acquired HIV during 2076 person-years of follow-up (incidence 6.2 per 100 person-years). 51 of 325 women with low relationship power equity at baseline acquired HIV (8.5 per 100 person-years) compared with 73 of 704 women with medium or high relationship power equity (5.5 per 100 person-years); adjusted multivariable Poisson model IRR 1-51, 95% CI 1.05-2.17, p=0.027. 45 of 253 women who reported more than one episode of intimate partner violence at baseline acquired HIV (9.6 per 100 person-years) compared with 83 of 846 who reported one or no episodes (5.2 per 100 person-years); adjusted multivariable Poisson model IRR 1.51, 1.04-2-21, p=0.032. The population attributable fractions were 13.9% (95% CI 2.0-22-2) for relationship power equity and 11.9% (1.4-19.3) for intimate partner violence. Interpretation Relationship power inequity and intimate partner violence increase risk of incident HIV infection in young South African women. Policy, interventions, and programmes for HIV prevention must address both of these risk factors and allocate appropriate resources.	[Jewkes, Rachel K.; Shai, Nwabisa] MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa; [Jewkes, Rachel K.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Nduna, Mzikazi] Univ Witwatersrand, Dept Psychol, Johannesburg, South Africa; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Ctr AIDS Res, Atlanta, GA 30322 USA	University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health	Jewkes, RK (corresponding author), MRC, Gender & Hlth Res Unit, Private Bag X385, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Jewkes, Rachel/0000-0002-4330-6267; Shai, Nwabisa/0000-0003-4171-9129	National Institute of Mental Health [MH 64882-01, MH 64882-04S1A1, 1R03MH085599]; South African Medical Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064882, R03MH085599] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health (grant numbers MH 64882-01, MH 64882-04S1A1, and 1R03MH085599) and the South African Medical Research Council. We thank all the members of the Stepping Stones study team and the National Institute for Communicable Diseases for quality control, testing, and storage of specimens; the staff who worked on the project; and members of the community advisory board and data safety and monitoring board. Carl Lombard assisted with data analysis.	Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Christofides N, 2010, AIDS CARE, V22, P279, DOI 10.1080/09540120903193617; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Doll R, 2002, PERSPECT BIOL MED, V45, P499, DOI 10.1353/pbm.2002.0067; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 1998, Violence Vict, V13, P377; Garcia-Allan C, 2000, J BIOCHEM MOL TOXIC, V14, P65, DOI 10.1002/(SICI)1099-0461(2000)14:2<65::AID-JBT1>3.0.CO;2-#; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenland S, 1998, MODERN EPIDEMIOLOGY; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Johnson SD, 2003, DRUG ALCOHOL DEPEN, V70, P169, DOI 10.1016/S0376-8716(02)00345-9; Lindsey JC, 1998, STAT MED, V17, P219, DOI 10.1002/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Nascimento, 2007, ENGAGING MEN BOYS TR; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Pulerwitz J, 2006, PROMOTING MORE GENDE; SHISANA O, 2005, S AFRICAN NATL HIV P; SOLORZANO I, 2006, POSITIVE IMPACT HIV; *SYN PROJ, 2003, MEN REPR HLTH PROGR; *UNAIDS, 2005, AIDS EP UPD 2005; *UNAIDS JOINT ACT, 2009, UNAIDS OUTC FRAM 200; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wang S. K., 2007, RAPE MEN COMMUNITY H; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wingood GM, 1998, J WOMENS HEALTH, V7, P77, DOI 10.1089/jwh.1998.7.77; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; World Health Organization, 2004, RAP HIV TESTS GUID U; World Health Organization, 2000, WHO MULTICOUNTRY STU; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	39	832	843	2	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					41	48		10.1016/S0140-6736(10)60548-X	http://dx.doi.org/10.1016/S0140-6736(10)60548-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20557928	Bronze			2022-12-24	WOS:000279841600023
J	[Anonymous]				[Anonymous]			Who, how, what and where?	NATURE			English	Editorial Material																			0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S8	S9		10.1038/nature09222	http://dx.doi.org/10.1038/nature09222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571555	Bronze			2022-12-24	WOS:000279056900026
J	Winickoff, JP; Gottlieb, M; Mello, MM				Winickoff, Jonathan P.; Gottlieb, Mark; Mello, Michelle M.			Regulation of Smoking in Public Housing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENTAL TOBACCO-SMOKE; GAS-PHASE ORGANICS; RESTRICTIONS; HOME; HOUSEHOLD; EXPOSURE; CESSATION; INFANTS		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp Children, Dept Pediat, Boston, MA USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gottlieb, Mark] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Northeastern University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu	Gottlieb, Mark A./ABI-1826-2020	Gottlieb, Mark A./0000-0001-8679-307X; Mello, Michelle/0000-0003-2877-4270	NCI NIH HHS [R01 CA127127-03, R01 CA127127, R01-CA127127] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aligne CA, 1997, ARCH PEDIAT ADOL MED, V151, P648, DOI 10.1001/archpedi.1997.02170440010002; American Society of Heating Refrigerating and Air Conditioning Engineers, 2005, ENV TOB SMOK POS DOC; [Anonymous], 2009, SURG GEN CALL ACT PR; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1199; Blackburn C, 2003, BRIT MED J, V327, P257, DOI 10.1136/bmj.327.7409.257; BUSK C, 2009, CHICAGO SUN TIM 0426, pE1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; COOPER K, 2006, WYOMING TRIBUNE 0508, pA1; *COUNC LARG PUBL H, 2004, PORTR PUBL HOUS RES; *DEP HOUS URB DEV, 2010, CURR STAT; *DEP HOUS URB DEV, 2009, HUDS FISC YEAR FY 20; *DEP HOUS URB DEV, TEN ADD SECT 8 PROJ; *DEP HOUS URB DEV, 2009, NONSM POL PUBL HOUS; *DEP HOUS URB DEV, 2010, MULT TEN CHAR SYST; Ditre JW, 2008, NICOTINE TOB RES, V10, P975, DOI 10.1080/14622200802087549; Epstein JA, 1999, TOB CONTROL, V8, P45, DOI 10.1136/tc.8.1.45; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; GARCIA C, 2008, AUGUSTA CHRONIC 0722, pA1; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Gilpin EA, 2006, NICOTINE TOB RES, V8, P661, DOI 10.1080/14622200600910801; GRONEWOLD SJ, 2007, COMMUNICATION   0801; Hecht SS, 2006, CANCER EPIDEM BIOMAR, V15, P988, DOI 10.1158/1055-9965.EPI-05-0596; Hennrikus D, 2003, TOB CONTROL, V12, P189, DOI 10.1136/tc.12.2.189; Hill SC, 2008, TOB CONTROL, V17, P32, DOI 10.1136/tc.2007.020990; Institute of Medicine Committee on Secondhand Smoke Exposure and Acute Coronary Effects, 2010, SEC SMOK EXP CARD EF; Jarvie JA, 2008, AM J PUBLIC HEALTH, V98, P2140, DOI 10.2105/AJPH.2007.130856; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; KOCH W, 2007, US TODAY        1003, pA3; Kraev TA, 2009, TOB CONTROL, V18, P438, DOI 10.1136/tc.2009.029728; LARSON J, TACOMA WEEKLY; Laws MB, 2002, TOB CONTROL, V11, pII71; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; *LIV SMOK FREE, 2009, REST SMOK DAM AP; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; MCDONALD J, 2009, SAN DIEGO UNION 0209, pA1; Mello MM, 2008, NEW ENGL J MED, V359, P192, DOI 10.1056/NEJMhle0801929; *OFF SURG GEN, 2006, HLTH CONS INV TOB SM; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Pizacani BA, 2003, PREV MED, V36, P99, DOI 10.1006/pmed.2002.1123; Pizacani BA, 2008, NICOTINE TOB RES, V10, P533, DOI 10.1080/14622200801902003; Proescholdbell R J, 2000, Nicotine Tob Res, V2, P159, DOI 10.1080/713688125; *PUBL HLTH SERV OF, 2007, CHILDR SEC SMOK EXP; SCHNEIDER P, 2009, CAPITAL TIMES   0309; Schoenmarklin S, 2005, ANAL AUTHORITY HOUSI; SCHOENMARKLIN S, 2004, INFILTRATION SECONDH; Siahpush M, 2003, NICOTINE TOB RES, V5, P597, DOI 10.1080/1462220031000118711; Singer BC, 2003, ATMOS ENVIRON, V37, P5551, DOI 10.1016/j.atmosenv.2003.07.015; Singer BC, 2002, ENVIRON SCI TECHNOL, V36, P846, DOI 10.1021/es011058w; *SMOK FREE ENV LAW, 2010, HOUS AUTH COMM WHICH; *SMOK FREE HOUS CO, 2004, MUCH DOES SEC SMOK C; Spengler JD, 1999, ENVIRON HEALTH PERSP, V107, P313, DOI 10.2307/3434423; STRANDE MF, 2007, SMOKE FREE MULTIUNIT; Szabo E, 2006, ADDICT BEHAV, V31, P2298, DOI 10.1016/j.addbeh.2006.02.025; URIE H, 2008, BOULDER DAILY C 0320; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Wakefield MA, 2000, BRIT MED J, V31, P623; WALKER SY, 2003, COMMUNICATION   0718; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Whitehead T, 2009, AM J EPIDEMIOL, V169, P1113, DOI 10.1093/aje/kwp021; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184	60	60	60	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2319	2325		10.1056/NEJMhle1000941	http://dx.doi.org/10.1056/NEJMhle1000941			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20554988	Green Accepted, Bronze			2022-12-24	WOS:000278816300014
J	Bernard, A; Lecuyer, C; Vincent, P; Amiot, R; Bardet, N; Buffetaut, E; Cuny, G; Fourel, F; Martineau, F; Mazin, JM; Prieur, A				Bernard, Aurelien; Lecuyer, Christophe; Vincent, Peggy; Amiot, Romain; Bardet, Nathalie; Buffetaut, Eric; Cuny, Gilles; Fourel, Francois; Martineau, Francois; Mazin, Jean-Michel; Prieur, Abel			Regulation of Body Temperature by Some Mesozoic Marine Reptiles	SCIENCE			English	Article							OXYGEN ISOTOPES; BONE; EVOLUTION; FISH; ENDOTHERMY; PHOSPHATE; METABOLISM; SPEED; WATER	What the body temperature and thermoregulation processes of extinct vertebrates were are central questions for understanding their ecology and evolution. The thermophysiologic status of the great marine reptiles is still unknown, even though some studies have suggested that thermoregulation may have contributed to their exceptional evolutionary success as apex predators of Mesozoic aquatic ecosystems. We tested the thermal status of ichthyosaurs, plesiosaurs, and mosasaurs by comparing the oxygen isotope compositions of their tooth phosphate to those of coexisting fish. Data distribution reveals that these large marine reptiles were able to maintain a constant and high body temperature in oceanic environments ranging from tropical to cold temperate. Their estimated body temperatures, in the range from 35 degrees +/- 2 degrees C to 39 degrees +/- 2 degrees C, suggest high metabolic rates required for predation and fast swimming over large distances offshore.	[Bernard, Aurelien; Lecuyer, Christophe; Amiot, Romain; Fourel, Francois; Martineau, Francois; Mazin, Jean-Michel; Prieur, Abel] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Lecuyer, Christophe] Inst Univ France, F-75005 Paris, France; [Vincent, Peggy; Bardet, Nathalie] Museum Natl Hist Nat, CNRS, UMR 5143, Dept Hist Terre, F-75231 Paris, France; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75231 Paris, France; [Cuny, Gilles] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Copenhagen	Lecuyer, C (corresponding author), Univ Lyon 1, CNRS, UMR 5125, 2 Rue Raphael Dubois, F-69622 Villeurbanne, France.	clecuyer@univ-lyonl.fr	BARDET, Nathalie/N-8670-2019; Amiot, Romain/C-8132-2012; Lecuyer, Christophe/C-8297-2012; FOUREL, Francois/G-6734-2015; Cuny, Gilles/F-8949-2017; Bardet, Nathalie/I-3805-2015; Lecuyer, Christophe/AAO-8154-2021	Cuny, Gilles/0000-0001-7680-1697; Bardet, Nathalie/0000-0001-7881-7107; Lecuyer, Christophe/0000-0001-9513-2492	CNRS; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	The authors thank M. Sander, B. McNab, and R. Seymour for preliminary discussions of these data during the workshop dedicated to "Sauropod gigantism" that was held in Bonn, Germany, in November 2008. We are also grateful to D. Brinkman and J. Gardner (Royal Tyrrell Museum), S. Etches and J. Clarke, G. Suan, J. Lindgren (Lund University), B. Kear (La Trobe University), and A. Schulp (Maastricht University) for providing samples. L. Simon and G. Escarguel helped us in the statistical treatment of data. This study was funded by both CNRS and the Institut Universitaire de France.	Amiot R, 2007, PALAEOGEOGR PALAEOCL, V243, P412, DOI 10.1016/j.palaeo.2006.08.013; ANDERSON TF, 1994, J GEOL SOC LONDON, V151, P125, DOI 10.1144/gsjgs.151.1.0125; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Barrick RE, 1999, PALAIOS, V14, P186, DOI 10.2307/3515374; Bennett AF, 2000, EVOLUTION, V54, P1768; Benton M.J., 2005, VERTEBRATE PALAEONTO; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Carlson JK, 2004, CRC MAR BIOL SER, P203; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; HEINRICH B, 1989, AM ZOOL, V29, P1157; HICKMAN CP, 2000, INTEGRATED PRINCIPLE; Kear BP, 2005, CRETACEOUS RES, V26, P769, DOI 10.1016/j.cretres.2005.04.006; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Kolodny Y, 1991, GEOCHEM SOC SPEC PUB, V3, P105; Lecuyer C, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000863; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUTCAVAGE ME, 1992, CAN J ZOOL, V70, P348, DOI 10.1139/z92-051; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; MORRISON P, 1962, BIOL BULL, V123, P154, DOI 10.2307/1539512; Motani R, 2002, PALEOBIOLOGY, V28, P251, DOI 10.1666/0094-8373(2002)028<0251:SSEOEM>2.0.CO;2; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; SEYMOUR RS, 1976, NATURE, V262, P207, DOI 10.1038/262207a0; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; Seymour RS, 2004, PLANT CELL ENVIRON, V27, P1014, DOI 10.1111/j.1365-3040.2004.01206.x; Sharp ZD, 2000, AM J SCI, V300, P222, DOI 10.2475/ajs.300.3.222; Wadley MR, 2002, GLOBAL PLANET CHANGE, V32, P89, DOI 10.1016/S0921-8181(01)00084-4; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	32	100	109	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1379	1382		10.1126/science.1187443	http://dx.doi.org/10.1126/science.1187443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538946				2022-12-24	WOS:000278598400033
J	Scheller, S; Goenrich, M; Boecher, R; Thauer, RK; Jaun, B				Scheller, Silvan; Goenrich, Meike; Boecher, Reinhard; Thauer, Rudolf K.; Jaun, Bernhard			The key nickel enzyme of methanogenesis catalyses the anaerobic oxidation of methane	NATURE			English	Article							COENZYME-M REDUCTASE; BACTERIA; ARCHAEA; F430; FACTOR-F430; ACTIVATION; CONSORTIA; SEDIMENT; PROTEIN	Large amounts (estimates range from 70 Tg per year to 300 Tg per year) of the potent greenhouse gas methane are oxidized to carbon dioxide in marine sediments by communities of methanotrophic archaea and sulphate-reducing bacteria(1-3), and thus are prevented from escaping into the atmosphere. Indirect evidence indicates that the anaerobic oxidation of methane might proceed as the reverse of archaeal methanogenesis from carbon dioxide with the nickel-containing methyl-coenzyme M reductase (MCR) as the methane-activating enzyme(4,5). However, experiments showing that MCR can catalyse the endergonic back reaction have been lacking. Here we report that purified MCR from Methanothermobacter marburgensis converts methane into methyl-coenzyme M under equilibrium conditions with apparent V-max (maximum rate) and Km (Michaelis constant) values consistent with the observed in vivo kinetics of the anaerobic oxidation of methane with sulphate(6-8). This result supports the hypothesis of 'reverse methanogenesis'(4,9) and is paramount to understanding the still-unknown mechanism of the last step of methanogenesis. The ability of MCR to cleave the particularly strong C-H bond of methane without the involvement of highly reactive oxygen-derived intermediates is directly relevant to catalytic C-H activation, currently an area of great interest in chemistry(10-13).	[Scheller, Silvan; Jaun, Bernhard] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Goenrich, Meike; Boecher, Reinhard; Thauer, Rudolf K.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Jaun, B (corresponding author), ETH, Organ Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	jaun@org.chem.ethz.ch	Scheller, Silvan/M-8899-2017	Scheller, Silvan/0000-0002-0667-9224	Swiss National Science Foundation [200020-119752]; Max Planck Society; Fonds der Chemischen Industrie	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank the Swiss National Science Foundation (S.S. and B.J.; grant 200020-119752) and the Max Planck Society and the Fonds der Chemischen Industrie (M.G., R.B. and R.K.T.) for financial support.	ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; BONACKER LG, 1993, EUR J BIOCHEM, V217, P587, DOI 10.1111/j.1432-1033.1993.tb18281.x; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Chistoserdova L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-208; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Crabtree RH, 2004, J ORGANOMET CHEM, V689, P4083, DOI 10.1016/j.jorganchem.2004.07.034; Duan ZH, 2006, GEOCHIM COSMOCHIM AC, V70, P3369, DOI 10.1016/j.gca.2006.03.018; FARBER G, 1991, HELV CHIM ACTA, V74, P697, DOI 10.1002/hlca.19910740404; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2009, ENV MICROBIOL REP, V1, P370, DOI 10.1111/j.1758-2229.2009.00074.x; JAUN B, 2007, METAL IONS LIFE SCI, V0002, P00323; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; LIVINGSTON DA, 1984, HELV CHIM ACTA, V67, P334, DOI 10.1002/hlca.19840670141; Mahlert F, 2002, J BIOL INORG CHEM, V7, P101, DOI 10.1007/s007750100270; Mayr S, 2008, J AM CHEM SOC, V130, P10758, DOI 10.1021/ja802929z; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Nauhaus K, 2002, ENVIRON MICROBIOL, V4, P296, DOI 10.1046/j.1462-2920.2002.00299.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; PFALTZ A, 1982, HELV CHIM ACTA, V65, P828, DOI 10.1002/hlca.19820650320; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; ROSPERT S, 1991, FEBS LETT, V291, P371, DOI 10.1016/0014-5793(91)81323-Z; Schroder D, 2008, P NATL ACAD SCI USA, V105, P18114, DOI 10.1073/pnas.0801849105; SHILOV AE, 2000, CATAL MET C, V21, pR11; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, ANN NY ACAD SCI, V1125, P158, DOI 10.1196/annals.1419.000	32	236	244	7	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					606	U97		10.1038/nature09015	http://dx.doi.org/10.1038/nature09015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520712				2022-12-24	WOS:000278249000039
J	Holzel, M; Huang, SD; Koster, J; Ora, I; Lakeman, A; Caron, H; Nijkamp, W; Xie, J; Callens, T; Asgharzadeh, S; Seeger, RC; Messiaen, L; Versteeg, R; Bernards, R				Holzel, Michael; Huang, Sidong; Koster, Jan; Ora, Ingrid; Lakeman, Arjan; Caron, Huib; Nijkamp, Wouter; Xie, Jing; Callens, Tom; Asgharzadeh, Shahab; Seeger, Robert C.; Messiaen, Ludwine; Versteeg, Rogier; Bernards, Rene			NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome	CELL			English	Article							HIGH-RISK NEUROBLASTOMA; NEUROFIBROMATOSIS TYPE-1; NOONAN-SYNDROME; INDUCED DIFFERENTIATION; 13-CIS-RETINOIC ACID; GENE-MUTATIONS; CHROMOSOME 1P; NIH3T3 CELLS; RAR-ALPHA; EXPRESSION	Retinoic acid (RA) induces differentiation of neuroblastoma cells in vitro and is used with variable success to treat aggressive forms of this disease. This variability in clinical response to RA is enigmatic, as no mutations in components of the RA signaling cascade have been found. Using a large-scale RNAi genetic screen, we identify crosstalk between the tumor suppressor NF1 and retinoic acid-induced differentiation in neuroblastoma. Loss of NF1 activates RAS-MEK signaling, which in turn represses ZNF423, a critical transcriptional coactivator of the retinoic acid receptors. Neuroblastomas with low levels of both NF1 and ZNF423 have extremely poor outcome. We find NF1 mutations in neuroblastoma cell lines and in primary tumors. Inhibition of MEK signaling downstream of NF1 restores responsiveness to RA, suggesting a therapeutic strategy to overcome RA resistance in NF1-deficient neuroblastomas.	[Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [Koster, Jan; Ora, Ingrid; Lakeman, Arjan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; [Caron, Huib] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1100 DE Amsterdam, Netherlands; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Childrens Hosp Los Angeles, Div Hematol Oncol, Dept Pediat, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Xie, Jing; Callens, Tom; Messiaen, Ludwine] Univ Alabama, Med Genom Lab, Dept Genet, Birmingham, AL 35294 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Alabama System; University of Alabama Birmingham	Bernards, R (corresponding author), Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Versteeg, Rogier/AAQ-1765-2020; Øra, Ingrid/J-2596-2013; Koster, Jan/C-5934-2008	Øra, Ingrid/0000-0002-3931-4125; Koster, Jan/0000-0002-0890-7585; Huang, Sidong/0000-0002-2838-4726; Asgharzadeh, Shahab/0000-0002-0510-3848; Versteeg, Rogier/0000-0001-7172-0388; Bernards, Rene/0000-0001-8677-3423	Netherlands Genomics Initiative (NGI); US National Institutes of Health [R01-CA60104, K12-CA60104]; Dutch Cancer Society; NATIONAL CANCER INSTITUTE [R01CA060104] Funding Source: NIH RePORTER	Netherlands Genomics Initiative (NGI); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Hauptmann for statistical advice, the NKI microarray facility for supporting gene expression studies, and C. Sun for assistance. This work was supported by The Netherlands Genomics Initiative (NGI), grants from the US National Institutes of Health R01-CA60104 (R.C.S.) and K12-CA60104 (S.A.), and a grant from the Dutch Cancer Society (KWF).	Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; COTTON JL, 1995, ARCH PEDIAT ADOL MED, V149, P1280, DOI 10.1001/archpedi.1995.02170240098019; Delaune A, 2008, J NEUROCHEM, V104, P89, DOI 10.1111/j.1471-4159.2007.05019.x; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Griffiths S, 2007, FAM CANCER, V6, P21, DOI 10.1007/s10689-006-9001-3; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; KOSA K, 1995, CANCER RES, V55, P4850; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Martinsson T, 1997, CANCER GENET CYTOGEN, V95, P183, DOI 10.1016/S0165-4608(96)00259-2; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; MOLEY JF, 1991, CANCER RES, V51, P1596; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Origone P, 2003, AM J MED GENET A, V118A, P309, DOI 10.1002/ajmg.a.10167; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Verheijen MHG, 1999, J BIOL CHEM, V274, P1487, DOI 10.1074/jbc.274.3.1487; Wimmer K, 2006, GENE CHROMOSOME CANC, V45, P265, DOI 10.1002/gcc.20289; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103	45	130	137	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					218	229		10.1016/j.cell.2010.06.004	http://dx.doi.org/10.1016/j.cell.2010.06.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655465	Green Accepted, Bronze			2022-12-24	WOS:000280204300014
J	Wang, J; Chen, PJ; Wang, GJ; Keller, L				Wang, John; Chen, Pei-Jiun; Wang, George J.; Keller, Laurent			Chromosome Size Differences May Affect Meiosis and Genome Size	SCIENCE			English	Article									[Wang, John; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Chen, Pei-Jiun] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Wang, George J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wang, George J.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Lausanne; University of Lausanne; Howard Hughes Medical Institute; Stanford University; Stanford University	Wang, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	John.Wang@unil.ch; Laurent.Keller@unil.ch	keller, laurent/AAI-7175-2020; Wang, John/C-3690-2012	Wang, John/0000-0002-6179-775X; keller, laurent/0000-0002-5046-9953	NIH National Center for Research Resources; University of Lausanne Cellular Imaging Facility; Vital-IT Center for high-performance computing; Swiss National Science Foundation	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Lausanne Cellular Imaging Facility; Vital-IT Center for high-performance computing; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank W. Herr, P. Gonczy, A. W. Murray, and A. M. Villeneuve for comments on the manuscript; S. K. Kim and R. E. Ellis for discussions; W. Herr, in whose laboratory the experiments were performed; the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains; the University of Lausanne Cellular Imaging Facility; and the Vital-IT Center for high-performance computing. Supported by grants from the Swiss National Science Foundation to L.K. and W. Herr. L.K. thanks S. Leibler for hosting him during his sabbatical at Rockefeller University.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Haag ES, 2007, TRENDS GENET, V23, P101, DOI 10.1016/j.tig.2007.01.002; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045	6	27	30	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					293	293		10.1126/science.1190130	http://dx.doi.org/10.1126/science.1190130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647459	Green Published			2022-12-24	WOS:000279925900031
J	Trivedi, B				Trivedi, Bijal			Learning from the elite	NATURE			English	Editorial Material																		Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609	3	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S4	S4		10.1038/nature09235	http://dx.doi.org/10.1038/nature09235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631703				2022-12-24	WOS:000279867100024
J	Girard, F; Ford, N; Montaner, J; Cahn, P; Katabira, E				Girard, Francoise; Ford, Nathan; Montaner, Julio; Cahn, Pedro; Katabira, Elly			Universal Access in the Fight Against HIV/AIDS	SCIENCE			English	Editorial Material							GLOBAL HEALTH INITIATIVES; ANTIRETROVIRAL THERAPY; PROSPECTIVE COHORT; HIV TRANSMISSION; SYSTEMS; CHILDREN; POLICY		[Girard, Francoise] Open Soc Inst, Publ Hlth Program, New York, NY 10019 USA; [Ford, Nathan] Med Sans Frontieres, ZA-2017 Cape Town, South Africa; [Montaner, Julio] Univ British Columbia, Div Aids, Vancouver, BC V6Z 1Y6, Canada; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Katabira, Elly] Makerere Med Sch, Dept Res, Kampala, Uganda	University of British Columbia; Makerere University	Girard, F (corresponding author), Open Soc Inst, Publ Hlth Program, New York, NY 10019 USA.	fgirard@sorosny.org	Montaner, Julio/K-7621-2012		NIDA NIH HHS [DP1 DA026182] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; BUFFERY V, 2010, REUTERS         0217; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; *GFATM, GFATM REP SPEND 30 I; *GFATM, 2009, SCAL IMP RES REP; *GFATM, 2010, RES SCEN 2011 2013 F; *GFATM, 2010, GLOB FUND 2010 INN I; Goemaere E, 2002, LANCET, V360, P86, DOI 10.1016/S0140-6736(02)09343-1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Mccoy D, 2010, B WORLD HEALTH ORGAN, V88, P478, DOI 10.2471/BLT.09.074419; MCNEILL DG, 2010, NY TIMES        0510, pA10; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; MIDDELKOOP K, 2009, 5 INT AIDS SOC C HIV; MSF, 2009, PUN SUCC EARL SIGNS; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; STOCKMAN F, 2010, BOSTON GLOBE    0411, pA1; UNAIDS, 2009, WHAT COUNTR NEED INV; United Nations, 2006, ARES60262 UN; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; *WHO UNAIDS UNICEF, 2009, UN ACC SCAL PRIOR IN, P26; World Bank, 2009, IMPROVING EFFECTIVENESS AND OUTCOMES FOR THE POOR IN HEALTH, NUTRITION, AND POPULATION: AN EVALUATION OF WORLD BANK GROUP SUPPORT SINCE 1997, P1, DOI 10.1596/978-0-8213-7542-6; World Health Organisation (WHO), 2007, TOP 10 CAUS DEATH FA	32	5	6	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					147	149		10.1126/science.1193294	http://dx.doi.org/10.1126/science.1193294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616254				2022-12-24	WOS:000279635200021
J	Cahill, JF; McNickle, GG; Haag, JJ; Lamb, EG; Nyanumba, SM; Clair, CCS				Cahill, James F., Jr.; McNickle, Gordon G.; Haag, Joshua J.; Lamb, Eric G.; Nyanumba, Samson M.; Clair, Colleen Cassady St.			Plants Integrate Information About Nutrients and Neighbors	SCIENCE			English	Article							ROOT; COMMUNICATION		[Cahill, James F., Jr.; McNickle, Gordon G.; Haag, Joshua J.; Nyanumba, Samson M.; Clair, Colleen Cassady St.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Lamb, Eric G.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK S7N 5A8, Canada	University of Alberta; University of Saskatchewan	Cahill, JF (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	jc.cahill@ualberta.ca; joshua.j.haag@gmail.com	McNickle, Gordon G/F-3699-2017; McNickle, Gord/AAB-4871-2019; Lamb, Eric G/D-9319-2011; St. Clair, Colleen Cassady/A-3756-2014; Cahill, James/B-6147-2015	McNickle, Gordon G/0000-0002-7188-7265; McNickle, Gord/0000-0002-7188-7265; Lamb, Eric G/0000-0001-5201-4541; Cahill, James/0000-0002-4110-1516	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank G. Law for assistance with the Biotron plant growth facility, C. Wild for explanations of behavioral theory and trait correlations, and three anonymous reviewers for helpful comments. Supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to J.F.C.	Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Stephens D., 2007, FORAGING BEHAV ECOLO	7	208	234	15	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1657	1657		10.1126/science.1189736	http://dx.doi.org/10.1126/science.1189736			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576883				2022-12-24	WOS:000279107400033
J	Cho, EJ; Senecal, TD; Kinzel, T; Zhang, Y; Watson, DA; Buchwald, SL				Cho, Eun Jin; Senecal, Todd D.; Kinzel, Tom; Zhang, Yong; Watson, Donald A.; Buchwald, Stephen L.			The Palladium-Catalyzed Trifluoromethylation of Aryl Chlorides	SCIENCE			English	Article							FORMING REDUCTIVE ELIMINATION; CONVENIENT METHOD; ACTIVE CATALYST; PD; (TRIFLUOROMETHYL)COPPER; REACTIVITY; COMPLEXES; HALIDES	The trifluoromethyl group can dramatically influence the properties of organic molecules, thereby increasing their applicability as pharmaceuticals, agrochemicals, or building blocks for organic materials. Despite the importance of this substituent, no general method exists for its installment onto functionalized aromatic substrates. Current methods either require the use of harsh reaction conditions or suffer from a limited substrate scope. Here we report the palladium-catalyzed trifluoromethylation of aryl chlorides under mild conditions, allowing the transformation of a wide range of substrates, including heterocycles, in excellent yields. The process tolerates functional groups such as esters, amides, ethers, acetals, nitriles, and tertiary amines and, therefore, should be applicable to late-stage modifications of advanced intermediates. We have also prepared all the putative intermediates in the catalytic cycle and demonstrated their viability in the process.	[Cho, Eun Jin; Senecal, Todd D.; Kinzel, Tom; Zhang, Yong; Watson, Donald A.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu	Cho, Eun Jin/F-2406-2013	Senecal, Todd/0000-0002-5673-5538	NIH [GM46059]; Merck; Nippon Chemical; Boehringer Ingelheim; BASF; Alexander von Humboldt Foundation; NSF [CHE 9808061, DBI 9729592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046059, R01GM046059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Nippon Chemical; Boehringer Ingelheim(Boehringer Ingelheim); BASF(BASF); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH for financial support of this project (grant GM46059) and Merck, Nippon Chemical, Boehringer Ingelheim, and BASF for gifts of chemicals and additional funds. T. K. thanks the Alexander von Humboldt Foundation for a Feodor Lynen postdoctoral fellowship. The Varian NMR instrument that we used was supported by the NSF (grants CHE 9808061 and DBI 9729592). We also thank P. Muller (MIT Chemistry Department, X-Ray Diffraction Facility) for obtaining the crystal structures of 13a and 13b. Cambridge Crystallographic Data Centre (CCDC) 771779 and 771780 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif.	Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; CARR GE, 1988, PERKIN T 1, P921; Cartwright D., 1994, ORGANOFLUORINE CHEM, P237; Chen Q.-Y., 1989, CHEM COMMUN, P705; CLARK JH, 1988, CHEM COMMUN, P638; Cottet F, 2002, EUR J ORG CHEM, V2002, P327; Culkin DA, 2004, ORGANOMETALLICS, V23, P3398, DOI 10.1021/om049726k; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Frisch M., 2016, GAUSSIAN 16 REVISION; Grushin VV, 2006, J AM CHEM SOC, V128, P12644, DOI 10.1021/ja064935c; Grushin VV, 2006, J AM CHEM SOC, V128, P4632, DOI 10.1021/ja0602389; Kirsch P., 2004, MODERN FLUOROORGANIC; KOBAYASHI Y, 1969, TETRAHEDRON LETT, P4095; KONDRATENKO NV, 1980, SYNTHESIS-STUTTGART, P932; MATSUI K, 1981, CHEM LETT, P1719, DOI 10.1246/cl.1981.1719; MCLOUGHL.VC, 1969, TETRAHEDRON, V25, P5921, DOI 10.1016/S0040-4020(01)83100-8; Milne JE, 2004, J AM CHEM SOC, V126, P13028, DOI 10.1021/ja0474493; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Naumann D, 2004, Z ANORG ALLG CHEM, V630, P746, DOI 10.1002/zaac.200400020; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Swarts F., 1892, B ACAD R BELG, V24, P309; Thayer AM, 2006, CHEM ENG NEWS, V84, P15, DOI 10.1021/cen-v084n033.p015; Tyrra W, 2005, CHEM-EUR J, V11, P6514, DOI 10.1002/chem.200500799; URATA H, 1991, TETRAHEDRON LETT, V32, P91, DOI 10.1016/S0040-4039(00)71226-3; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; WIEMERS DM, 1986, J AM CHEM SOC, V108, P832, DOI 10.1021/ja00264a043	28	593	603	2	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1679	1681		10.1126/science.1190524	http://dx.doi.org/10.1126/science.1190524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	615BY	20576888	Green Submitted, Green Accepted			2022-12-24	WOS:000279107400039
J	Silverstein, TD; Johnson, RE; Jain, R; Prakash, L; Prakash, S; Aggarwal, AK				Silverstein, Timothy D.; Johnson, Robert E.; Jain, Rinku; Prakash, Louise; Prakash, Satya; Aggarwal, Aneel K.			Structural basis for the suppression of skin cancers by DNA polymerase eta	NATURE			English	Article							XERODERMA-PIGMENTOSUM-VARIANT; CRYSTAL-STRUCTURE; LESION-BYPASS; NUCLEOTIDE INCORPORATION; MOLECULAR ANALYSIS; YEAST; MECHANISM; REPLICATION; MUTATIONS; TEMPLATE	DNA polymerase eta (Pol eta) is unique among eukaryotic polymerases in its proficient ability for error-free replication through ultraviolet-induced cyclobutane pyrimidine dimers, and inactivation of Pol eta (also known as POLH) in humans causes the variant form of xeroderma pigmentosum (XPV). We present the crystal structures of Saccharomyces cerevisiae Pol eta (also known as RAD30) in ternary complex with a cis-syn thymine-thymine (T-T) dimer and with undamaged DNA. The structures reveal that the ability of Pol eta to replicate efficiently through the ultraviolet-induced lesion derives from a simple and yet elegant mechanism, wherein the two Ts of the T-T dimer are accommodated in an active site cleft that is much more open than in other polymerases. We also show by structural, biochemical and genetic analysis that the two Ts are maintained in a stable configuration in the active site via interactions with Gln 55, Arg 73 and Met 74. Together, these features define the basis for Pol eta's action on ultraviolet-damaged DNA that is crucial in suppressing the mutagenic and carcinogenic consequences of sun exposure, thereby reducing the incidence of skin cancers in humans.	[Silverstein, Timothy D.; Jain, Rinku; Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Johnson, Robert E.; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77755 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	saprakas@utmb.edu; aneel.aggarwal@mssm.edu	Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444; Silverstein, Timothy/0000-0003-0931-6274	NIH; NATIONAL CANCER INSTITUTE [R01CA107650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the staff at Brookhaven National Laboratory (beamlines X6A and X29) and the Advanced Photon Source (24ID) for facilitating X-ray data collection. We thank D. T. Nair, S. Lone, R. Vasquez-Del Carpio and M. Swan for discussions. This work was supported by NIH grants to A.K.A., S.P. and L.P.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gratchev A, 2003, EXP DERMATOL, V12, P529, DOI 10.1034/j.1600-0625.2003.00124.x; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kondratick CM, 2001, MOL CELL BIOL, V21, P2018, DOI 10.1128/MCB.21.6.2018-2025.2001; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	31	119	120	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1039	U96		10.1038/nature09104	http://dx.doi.org/10.1038/nature09104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577207	Green Accepted			2022-12-24	WOS:000279056900044
J	Carvajal-Vergara, X; Sevilla, A; D'Souza, SL; Ang, YS; Schaniel, C; Lee, DF; Yang, L; Kaplan, AD; Adler, ED; Rozov, R; Ge, YC; Cohen, N; Edelmann, LJ; Chang, B; Waghray, A; Su, J; Pardo, S; Lichtenbelt, KD; Tartaglia, M; Gelb, BD; Lemischka, IR				Carvajal-Vergara, Xonia; Sevilla, Ana; D'Souza, Sunita L.; Ang, Yen-Sin; Schaniel, Christoph; Lee, Dung-Fang; Yang, Lei; Kaplan, Aaron D.; Adler, Eric D.; Rozov, Roye; Ge, YongChao; Cohen, Ninette; Edelmann, Lisa J.; Chang, Betty; Waghray, Avinash; Su, Jie; Pardo, Sherly; Lichtenbelt, Klaske D.; Tartaglia, Marco; Gelb, Bruce D.; Lemischka, Ihor R.			Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome	NATURE			English	Article							SOMATIC PTPN11 MUTATIONS; SHP2 MUTATIONS; HUMAN ES; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION; LEUKEMIA	The generation of reprogrammed induced pluripotent stem cells (iPSCs) from patients with defined genetic disorders holds the promise of increased understanding of the aetiologies of complex diseases and may also facilitate the development of novel therapeutic interventions. We have generated iPSCs from patients with LEOPARD syndrome (an acronym formed from its main features; that is, lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary valve stenosis, abnormal genitalia, retardation of growth and deafness), an autosomal-dominant developmental disorder belonging to a relatively prevalent class of inherited RAS-mitogen-activated protein kinase signalling diseases, which also includes Noonan syndrome, with pleomorphic effects on several tissues and organ systems(1,2). The patient-derived cells have a mutation in the PTPN11 gene, which encodes the SHP2 phosphatase. The iPSCs have been extensively characterized and produce multiple differentiated cell lineages. A major disease phenotype in patients with LEOPARD syndrome is hypertrophic cardiomyopathy. We show that in vitro-derived cardiomyocytes from LEOPARD syndrome iPSCs are larger, have a higher degree of sarcomeric organization and preferential localization of NFATC4 in the nucleus when compared with cardiomyocytes derived from human embryonic stem cells or wild-type iPSCs derived from a healthy brother of one of the LEOPARD syndrome patients. These features correlate with a potential hypertrophic state. We also provide molecular insights into signalling pathways that may promote the disease phenotype.	[Carvajal-Vergara, Xonia; Sevilla, Ana; D'Souza, Sunita L.; Ang, Yen-Sin; Schaniel, Christoph; Lee, Dung-Fang; Yang, Lei; Rozov, Roye; Chang, Betty; Waghray, Avinash; Su, Jie; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, Dept Gene & Cell Med, New York, NY 10029 USA; [Carvajal-Vergara, Xonia] Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid 28029, Spain; [Kaplan, Aaron D.; Adler, Eric D.] Mt Sinai Sch Med, Dept Med, Cardiovasc Inst, New York, NY 10029 USA; [Ge, YongChao] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Cohen, Ninette; Edelmann, Lisa J.; Pardo, Sherly; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Pardo, Sherly; Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Lichtenbelt, Klaske D.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; [Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Utrecht University; Utrecht University Medical Center; Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai	Carvajal-Vergara, X (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, Dept Gene & Cell Med, New York, NY 10029 USA.		Yang, Lei/D-7462-2015; Waghray, Avinash/AAD-5292-2021; Schaniel, Christoph/P-3836-2019; Carvajal-Vergara, Xonia/ABD-1094-2021; Ge, Yongchao/AAG-9317-2021; Sevilla, Ana/N-8579-2017; CARVAJAL-VERGARA, XONIA/N-2939-2014; Schaniel, Chrisoph/C-9655-2012; Tartaglia, Marco/K-2955-2018	Waghray, Avinash/0000-0003-3242-2227; Schaniel, Christoph/0000-0002-1343-4858; Carvajal-Vergara, Xonia/0000-0002-6475-3701; Ge, Yongchao/0000-0001-6448-5703; Sevilla, Ana/0000-0002-9251-4759; CARVAJAL-VERGARA, XONIA/0000-0002-6475-3701; Tartaglia, Marco/0000-0001-7736-9672; Lee, Dung-Fang/0000-0003-2387-597X; Su, Jie/0000-0002-3071-7139	National Institutes of Health (NIH) [5R01GM078465]; New York State Department of Health (NYSTEM) [C024410, C024176, C024407]; American College of Cardiology/Pfizer; ERA; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III; New York Stem Cell Foundation; Ruth L. Kirschstein National Research Service Award (NRSA) [T32]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSTEM); American College of Cardiology/Pfizer(Pfizer); ERA; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); New York Stem Cell Foundation; Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. James, X. Niu and D. York for their technical support and laboratory management, and B. MacArthur for support in microarray analysis. We also would like to thank K. Moore and her laboratory, and S. Mulero-Navarro from B.D.G.'s laboratory for their help, and V. Fuster and A. Bernad for their support. This research was funded by grants from the National Institutes of Health (NIH) to I. R. L (5R01GM078465), the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) C024410 to I. R. L. and C.S., C024176 (HESC-SRF) to I.R.L. and S.L.D., C024407 to B D.G., American College of Cardiology/Pfizer Research Fellowship to E. D. A., and ERA-Net for research programmes on rare diseases 2009 to M. T. X. C.-V. is a recipient of a Postdoctoral Fellowship from the Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III, D.-F.L. is a New York Stem Cell Foundation Stanley and Fiona Druckenmiller Fellow and S. P. is a recipient of a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32).	Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; GORLIN R J, 1971, Birth Defects Original Article Series, V7, P110; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Laux D, 2008, J PEDIAT HEMATOL ONC, V30, P602, DOI 10.1097/MPH.0b013e31817588fb; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Ucar C, 2006, J PEDIAT HEMATOL ONC, V28, P123; Wu CJ, 2005, BLOOD, V106, P3639, DOI 10.1182/blood-2005-04-1376; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406	31	516	541	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					808	U12		10.1038/nature09005	http://dx.doi.org/10.1038/nature09005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535210	Green Accepted			2022-12-24	WOS:000278551800051
J	Petronis, A				Petronis, Arturas			Epigenetics as a unifying principle in the aetiology of complex traits and diseases	NATURE			English	Article							DNA METHYLATION; TWINS; ENVIRONMENT; HERITABILITY; INHERITANCE; GENETICS; CLONING; ANTICIPATION; EPIMUTATION; EXPRESSION	Epigenetic modifications of DNA and histones might be crucial for understanding the molecular basis of complex phenotypes. One reason for this is that epigenetic factors are sometimes malleable and plastic enough to react to cues from the external and internal environments. Such induced epigenetic changes can be solidified and propagated during cell division, resulting in permanent maintenance of the acquired phenotype. In addition, the finding that there is partial epigenetic stability in somatic and germline cells allows insight into the molecular mechanisms of heritability. Epigenetics can provide a new framework for the search of aetiological factors in complex traits and diseases.	Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Petronis, A (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, 250 Coll St, Toronto, ON M5T 1R8, Canada.	arturas_petronis@camh.net	Petronis, Art/AAD-4491-2019		Canadian Institutes of Health Research [199170, 186007]; US National Institutes of Health [MH074127, MH088413, DP3DK085698, HG004535]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074127, R01MH088413] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	I thank A. Wong, I. Gottesman, A. Paterson and C. Ptak for editorial suggestions, A. Schumacher for figure design, and the reviewers for their comments. Work in my laboratory has been supported by the Canadian Institutes of Health Research (grants 199170 and 186007) and the US National Institutes of Health (grants MH074127, MH088413, DP3DK085698 and HG004535). I am Tapscott Chair in Schizophrenia Studies at the University of Toronto and a senior fellow of the Ontario Mental Health Foundation.	ALBERG AJ, 2003, CHEST S1, V123, P21; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Austin Jehannine, 2005, J Genet Couns, V14, P329, DOI 10.1007/s10897-005-1622-4; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Chong S, 2007, NAT GENET, V39, P574, DOI 10.1038/ng0507-574; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; De Vries H., 1904, SPECIES VARIETIES TH; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Finch C, 2000, CHANCE DEV AGING; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; GARTNER K, 1981, NATURE, V292, P646, DOI 10.1038/292646a0; Gottesman II, 1997, SCIENCE, V276, P1522, DOI 10.1126/science.276.5318.1522; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; HARRIS JR, 1999, NURTURE ASSUMPTION W, P462; Heath A C, 1998, Twin Res, V1, P119, DOI 10.1375/136905298320566249; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Hong LE, 2008, ARCH GEN PSYCHIAT, V65, P1008, DOI 10.1001/archpsyc.65.9.1008; Jablonka E., 2007, BEHAV BRAIN SCI, V30, P365; Jablonka E, 2007, BEHAV BRAIN SCI, V30, P353, DOI 10.1017/S0140525X07002221; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jockin V, 1996, J PERS SOC PSYCHOL, V71, P288, DOI 10.1037/0022-3514.71.2.288; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kuhn, 1962, STRUCTURE SCI REVOLU, P172; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McFaul CD, 2006, GUT, V55, P252, DOI 10.1136/gut.2005.065045; Pal C, 1999, J THEOR BIOL, V200, P19, DOI 10.1006/jtbi.1999.0974; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; Petronis A, 1997, LANCET, V350, P1403, DOI 10.1016/S0140-6736(05)65184-7; Pigliucci M, 1996, HEREDITY, V77, P453, DOI 10.1038/hdy.1996.171; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; PLOMIN R, 1989, AM PSYCHOL, V44, P105, DOI 10.1037/0003-066X.44.2.105; Rhind SM, 2003, NAT BIOTECHNOL, V21, P744, DOI 10.1038/nbt0703-744; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, NATURE REV GENET, V7, P17; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stokstad E, 1997, SCIENCE, V275, P1882, DOI 10.1126/science.275.5308.1882; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Suter CM, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573a; Suter CM, 2007, NAT GENET, V39, P575, DOI 10.1038/ng0507-575; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Timshel S, 2009, CANCER EPIDEMIOL, V33, P231, DOI 10.1016/j.canep.2009.06.007; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Turkheimer E, 2000, PSYCHOL BULL, V126, P78, DOI 10.1037/0033-2909.126.1.78; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; VOGEL F, 1997, HUMAN GENETICS PROBL, P851; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yanagimachi R, 2002, MOL CELL ENDOCRINOL, V187, P241, DOI 10.1016/S0303-7207(01)00697-9; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	77	480	497	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					721	727		10.1038/nature09230	http://dx.doi.org/10.1038/nature09230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535201				2022-12-24	WOS:000278551800034
J	Beyrer, C; Malinowska-Sempruch, K; Kamarulzaman, A; Strathdee, SA				Beyrer, Chris; Malinowska-Sempruch, Kasia; Kamarulzaman, Adeeba; Strathdee, Steffanie A.			12 myths about HIV/AIDS and people who use drugs	LANCET			English	Editorial Material							INJECTION; EFFICACY		[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Malinowska-Sempruch, Kasia] Open Soc Inst, Drug Policy Program, Warsaw, Poland; [Kamarulzaman, Adeeba] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Epidemiol, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; University of California System; University of California San Diego	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhsph.edu	KAMARULZAMAN, ADEEBA/B-5216-2010; Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X				Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Fisher DG, 2003, JAIDS-J ACQ IMM DEF, V33, P199, DOI 10.1097/00126334-200306010-00014; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Institute of Medicine, 2006, PREV HIV INF INJ DRU; Kerr T., 2007, PUBLIC HLTH HUMAN RI, P11; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; Mauer M., 2007, UNEVEN JUSTICE STATE; Mausbach BT, 2007, ANN BEHAV MED, V34, P263, DOI 10.1007/BF02874551; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; *OFF NAT DRUG CONT, MIN DRUGS FACTS FIG; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Stoltz JA, 2007, J PUBLIC HEALTH, V29, P35, DOI 10.1093/pubmed/fdl090; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; VLAHOV D, 2009, CLIN INFECT DIS, V104, P796; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550	18	19	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					208	211		10.1016/S0140-6736(10)61005-7	http://dx.doi.org/10.1016/S0140-6736(10)61005-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650524				2022-12-24	WOS:000280457200005
J	Erba, E; Bottini, C; Weissert, HJ; Keller, CE				Erba, Elisabetta; Bottini, Cinzia; Weissert, Helmut J.; Keller, Christina E.			Calcareous Nannoplankton Response to Surface-Water Acidification Around Oceanic Anoxic Event 1a	SCIENCE			English	Article							PLANKTON EVOLUTION; CALCIFICATION; NANNOFOSSILS; CARBON; STRATIGRAPHY; EXTINCTION; GREENHOUSE; SEDIMENTS; PULSE; EARTH	Ocean acidification induced by atmospheric CO2 may be a major threat to marine ecosystems, particularly to calcareous nannoplankton. We show that, during the Aptian (similar to 120 million years ago) Oceanic Anoxic Event 1a, which resulted from a massive addition of volcanic CO2, the morphological features of calcareous nannofossils traced the biological response to acidified surface waters. We observe the demise of heavily calcified nannoconids and reduced calcite paleofluxes at the beginning of a pre-anoxia calcification crisis. Ephemeral coccolith dwarfism and malformation represent species-specific adjustments to survive lower pH, whereas later, abundance peaks indicate intermittent alkalinity recovery. Deepwater acidification occurred with a delay of 25,000 to 30,000 years. After the dissolution climax, nannoplankton and carbonate recovery developed over similar to 160,000 years under persisting global dysoxia-anoxia.	[Erba, Elisabetta; Bottini, Cinzia] Univ Milan, Dipartimento Sci Terra Ardito Desio, I-20133 Milan, Italy; [Weissert, Helmut J.; Keller, Christina E.] ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland	University of Milan; Swiss Federal Institutes of Technology Domain; ETH Zurich	Erba, E (corresponding author), Univ Milan, Dipartimento Sci Terra Ardito Desio, Via Mangiagalli 34, I-20133 Milan, Italy.	elisabetta.erba@unimi.it	bottini, cinzia/T-1478-2017	bottini, cinzia/0000-0003-1287-5579; Allam, Sherif/0000-0002-5555-7928	MIUR (Italian Ministry of University and Research) [2007-2007W9B2WE 001]; Swiss Science Foundation [200021-113687]; ETH Zurich	MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	E.E. and C.B. were funded through MIUR (Italian Ministry of University and Research), Research Programs of National Interest (PRIN) grant 2007-2007W9B2WE 001. H.J.W. and C. E. K. were funded by the Swiss Science Foundation (project 200021-113687) and by ETH Zurich. E. E. and C. B. investigated calcareous nannofossil assemblages, H.J.W. and C. E. K. analyzed C and O isotopes. All authors contributed to the synthesis and paleoceanographic model. Samples from DSDP site 463 were supplied by the Integrated Ocean Drilling Program.	Ando A, 2008, PALAEOGEOGR PALAEOCL, V260, P463, DOI 10.1016/j.palaeo.2007.12.007; Ramos JBE, 2010, BIOGEOSCIENCES, V7, P177, DOI 10.5194/bg-7-177-2010; Bernoulli D, 2009, SEDIMENTOLOGY, V56, P149, DOI 10.1111/j.1365-3091.2008.01017.x; Bown P, 2009, MAR MICROPALEONTOL, V71, P60, DOI 10.1016/j.marmicro.2009.01.005; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Erba E, 2004, MAR MICROPALEONTOL, V52, P85, DOI 10.1016/j.marmicro.2004.04.007; Erba E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000884; ERBA E, 1994, PALEOCEANOGRAPHY, V9, P483, DOI 10.1029/94PA00258; Erba E, 1999, J FORAMIN RES, V29, P371; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; Larson RL, 1999, PALEOCEANOGRAPHY, V14, P663, DOI 10.1029/1999PA900040; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Malinverno A, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001769; Mehay S, 2009, GEOLOGY, V37, P819, DOI 10.1130/G30100A.1; Menegatti AP, 1998, PALEOCEANOGRAPHY, V13, P530, DOI 10.1029/98PA01793; Millan MI, 2009, EARTH PLANET SC LETT, V287, P392, DOI 10.1016/j.epsl.2009.08.023; Raffi I, 2008, MAR MICROPALEONTOL, V69, P119, DOI 10.1016/j.marmicro.2008.07.002; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Tejada MLG, 2009, GEOLOGY, V37, P855, DOI 10.1130/G25763A.1; Weissert H, 2004, J GEOL SOC LONDON, V161, P695, DOI 10.1144/0016-764903-087; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	29	173	178	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					428	432		10.1126/science.1188886	http://dx.doi.org/10.1126/science.1188886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651148				2022-12-24	WOS:000280196500034
J	ten Hacken, NHT; van der Molen, T				ten Hacken, Nick H. T.; van der Molen, Thys			Easily Missed? Bronchiectasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[ten Hacken, Nick H. T.; van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands	University of Groningen	ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands.	n.h.t.ten.hacken@long.umcg.nl						BARKER AF, 2008, CLIN MANIFESTATIONS; Chang AB, 2002, MED J AUSTRALIA, V177, P200, DOI 10.5694/j.1326-5377.2002.tb04733.x; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001392.pub2; GUDBJERG CE, 1955, ACTA RADIOL, V43, P209, DOI 10.3109/00016925509172763; JONES AP, 2000, COCHRANE DB SYST REV; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; King PT, 2009, COPD, V6, P130, DOI 10.1080/15412550902766934; Li AM, 2005, EUR RESPIR J, V26, P8, DOI 10.1183/09031936.05.00127704; NICOTRA MB, 1995, CHEST, V108, P955, DOI 10.1378/chest.108.4.955; Parr DG, 2007, AM J RESP CRIT CARE, V176, P1215, DOI 10.1164/rccm.200703-489OC; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Rosen MJ, 2006, CHEST, V129, p122S, DOI 10.1378/chest.129.1_suppl.122S; Smith IE, 1996, BRIT J RADIOL, V69, P589, DOI 10.1259/0007-1285-69-823-589; TENHACKEN N, 2008, CLIN EVID; vanderBruggenBogaarts BAHA, 1996, CHEST, V109, P608, DOI 10.1378/chest.109.3.608; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed	17	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2010	341								c2766	10.1136/bmj.c2766	http://dx.doi.org/10.1136/bmj.c2766			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XC	20630967				2022-12-24	WOS:000280156700002
J	Bayon, R; Jenkins, M				Bayon, Ricardo; Jenkins, Michael			The business of biodiversity	NATURE			English	Editorial Material									[Bayon, Ricardo] EKO Asset Management Partners, New York, NY 10019 USA; [Jenkins, Michael] Forest Trends, Washington, DC 20007 USA		Bayon, R (corresponding author), EKO Asset Management Partners, 1350 Ave Amer,29th Floor, New York, NY 10019 USA.	rbayon@ekoamp.com; mjenkins@Forest-trends.org						BAYON R, 2008, WORLD 2008 INNOVATIO, P123; *BUS BIOD OFFS PRO, 2009, BBOP PIL PROJ CAS ST; Hamilton K., 2010, BUILDING BRIDGES STA; Madsen B., 2010, STATE BIODIVERSITY M; PERROTMAITRE D, 2010, MOUNTAIN FORUM B; Stanton T, 2010, STATE WATERSHED PAYM	6	44	45	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					184	185		10.1038/466184a	http://dx.doi.org/10.1038/466184a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621LR	20613823				2022-12-24	WOS:000279580800018
J	Petherick, A				Petherick, Anna			Chagas disease in the Chaco	NATURE			English	Editorial Material							TRIATOMA-INFESTANS											Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Vazquez-Prokopec GM, 2006, MED VET ENTOMOL, V20, P273, DOI 10.1111/j.1365-2915.2006.00637.x	5	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					S18	S20		10.1038/nature09226	http://dx.doi.org/10.1038/nature09226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571550	Bronze			2022-12-24	WOS:000279056900030
J	Shen, B; Makley, DM; Johnston, JN				Shen, Bo; Makley, Dawn M.; Johnston, Jeffrey N.			Umpolung reactivity in amide and peptide synthesis	NATURE			English	Article							NITROALDOL HENRY REACTION; CHIRAL PROTON CATALYSIS; STAUDINGER LIGATION; ENANTIOSELECTIVE SYNTHESIS; OXIDATIVE AMIDATION; ACID-DERIVATIVES; BOND FORMATION; BRONSTED ACID; CATHEPSIN-K; ALDEHYDES	The amide bond is one of nature's most common functional and structural elements, as the backbones of all natural peptides and proteins are composed of amide bonds. Amides are also present in many therapeutic small molecules. The construction of amide bonds using available methods relies principally on dehydrative approaches, although oxidative and radical-based methods are representative alternatives. In nearly every example, carbon and nitrogen bear electrophilic and nucleophilic character, respectively, during the carbon-nitrogen bond-forming step. Here we show that activation of amines and nitroalkanes with an electrophilic iodine source can lead directly to amide products. Preliminary observations support a mechanism in which the polarities of the two reactants are reversed (German, umpolung) during carbon-nitrogen bond formation relative to traditional approaches. The use of nitroalkanes as acyl anion equivalents provides a conceptually innovative approach to amide and peptide synthesis, and one that might ultimately provide for efficient peptide synthesis that is fully reliant on enantioselective methods.	[Shen, Bo; Makley, Dawn M.; Johnston, Jeffrey N.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University	Johnston, JN (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA.	jeffrey.n.johnston@vanderbilt.edu	Johnston, Jeff/AAW-1271-2021; Shen, Bo/D-6294-2011	Johnston, Jeff/0000-0002-0885-636X; 	Vanderbilt Institute of Chemical Biology; NIH [GM084333, T32 GM065086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063557, T32GM065086, R56GM063557, R01GM084333] Funding Source: NIH RePORTER	Vanderbilt Institute of Chemical Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Vanderbilt Institute of Chemical Biology, and in part (catalyst preparation and development) by the NIH (GM084333 and Chemistry-Biology Interface training grant T32 GM065086 in support of D.M.M.).	Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; Bode JW, 2006, CURR OPIN DRUG DISC, V9, P765; Bode JW, 2006, ANGEW CHEM INT EDIT, V45, P1248, DOI 10.1002/anie.200503991; Cassidy MP, 2006, ANGEW CHEM INT EDIT, V45, P3154, DOI 10.1002/anie.200503805; Chan WK, 2006, J AM CHEM SOC, V128, P14796, DOI 10.1021/ja064479s; Cho SH, 2005, J AM CHEM SOC, V127, P16046, DOI 10.1021/ja056399e; Davis TA, 2010, J AM CHEM SOC, V132, P2880, DOI 10.1021/ja908814h; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; ERDIK E, 1989, CHEM REV, V89, P1947, DOI 10.1021/cr00098a014; Gao J, 2008, J ORG CHEM, V73, P2955, DOI 10.1021/jo800075t; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Grayson EJ, 2005, ORG LETT, V7, P2361, DOI 10.1021/ol050624f; GROBEL BT, 1977, SYNTHESIS-STUTTGART, P357; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Katoh T, 2008, TETRAHEDRON LETT, V49, P598, DOI 10.1016/j.tetlet.2007.11.162; Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744; KOVACIC P, 1970, CHEM REV, V70, P639, DOI 10.1021/cr60268a002; Li XC, 2008, J AM CHEM SOC, V130, P5446, DOI 10.1021/ja800612r; Marques-Lopez E, 2009, EUR J ORG CHEM, V2009, P2401, DOI 10.1002/ejoc.200801097; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MERRIFIELD RB, 1964, J AM CHEM SOC, V86, P304, DOI 10.1021/ja01056a056; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Nugent BM, 2004, J AM CHEM SOC, V126, P3418, DOI 10.1021/ja031906i; Ono N., 2001, NITRO GROUP ORGANIC; Palmer JT, 2005, J MED CHEM, V48, P7520, DOI 10.1021/jm058198r; Palomo C, 2004, ANGEW CHEM INT EDIT, V43, P5442, DOI 10.1002/anie.200460506; Palomo C, 2007, EUR J ORG CHEM, V2007, P2561, DOI 10.1002/ejoc.200700021; Pinnick H. W., 1990, ORG REACT, V38, P655, DOI [10.1002/0471264180.or038.03, DOI 10.1002/0471264180.0R038.03]; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; SEEBACH D, 1975, J ORG CHEM, V40, P231, DOI 10.1021/jo00890a018; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Shen B, 2008, ORG LETT, V10, P4397, DOI 10.1021/ol801797h; Singh A, 2008, J AM CHEM SOC, V130, P5866, DOI 10.1021/ja8011808; Singh A, 2007, J AM CHEM SOC, V129, P3466, DOI 10.1021/ja068073r; Stenmark HG, 2000, J ORG CHEM, V65, P3875, DOI 10.1021/jo000055j; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Westermann B, 2003, ANGEW CHEM INT EDIT, V42, P151, DOI 10.1002/anie.200390071; WILLIAMS RM, 1992, CHEM REV, V92, P889, DOI 10.1021/cr00013a007; Wilt JC, 2008, CHEM COMMUN, P4177, DOI 10.1039/b808393b; Wong FT, 2008, ORG LETT, V10, P2333, DOI 10.1021/ol8004276; Yoo WJ, 2006, J AM CHEM SOC, V128, P13064, DOI 10.1021/ja064315b; Zhong YL, 2005, TETRAHEDRON LETT, V46, P1099, DOI 10.1016/j.tetlet.2004.12.088	45	238	239	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1027	U82		10.1038/nature09125	http://dx.doi.org/10.1038/nature09125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	614KI	20577205	Green Accepted			2022-12-24	WOS:000279056900042
J	Ahmad, M; McCallum, IJD; Mercer-Jones, M				Ahmad, Mukhtar; McCallum, Iain J. D.; Mercer-Jones, Mark			Management of faecal incontinence in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANAL-SPHINCTER; PREVALENCE		[Ahmad, Mukhtar; Mercer-Jones, Mark] Queen Elizabeth Hosp, Gateshead NE9 6SX, England; [McCallum, Iain J. D.] N Tyneside Gen Hosp, N Shields NE29 8NH, England		Mercer-Jones, M (corresponding author), Queen Elizabeth Hosp, Gateshead NE9 6SX, England.	mark.mercer-jones@ghnt.nhs.uk						Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7; Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745; BROWN SR, 2007, COCHRANE DB SYST REV, V2, P1757, DOI DOI 10.1002/14651858.CD00157.PUB2; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x; CHEETHAM MJ, 2002, COCHRANE DB SYST REV, V3; Chelvanayagam S, 2000, Nurs Times, V96, P15; Christensen P, 2009, DIS COLON RECTUM, V52, P286, DOI 10.1007/DCR.0b013e3181979341; Collings Sarah, 2004, Br J Community Nurs, V9, P520; Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x; Collinson R, 2009, COLORECTAL DIS, V11, P77, DOI 10.1111/j.1463-1318.2008.01539.x; DEUTEKOM M, 2005, COCHRANE DB SYST REV, V3; Fader M, 2008, HEALTH TECHNOL ASSES, V12, P1; Fader M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007408; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Guise JM, 2007, OBSTET GYNECOL, V109, P281, DOI 10.1097/01.AOG.0000254164.67182.78; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; KAMM MA, 1994, LANCET, V344, P730, DOI 10.1016/S0140-6736(94)92213-6; Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x; Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0; Maeda Y, 2010, COCHRANE DB SYST REV, V5; Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2; *NAT I HLTH CLIN E, 2007, CG49 NAT I HLTH CLIN; Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x; NORTON CC, 2009, COCHRANE DB SYST REV, V1; O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6; Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862; Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Thekkinkattil DK, 2009, BRIT J SURG, V96, P680, DOI 10.1002/bjs.6597; Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X; WORSOE J, 2007, DIS COLON RECTUM, V50, P1023	31	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2964	10.1136/bmj.c2964	http://dx.doi.org/10.1136/bmj.c2964			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551123				2022-12-24	WOS:000279051800006
J	Ziemer, DC; Kolm, P; Weintraub, WS; Vaccarino, V; Rhee, MK; Twombly, JG; Narayan, V; Koch, DD; Phillips, LS				Ziemer, David C.; Kolm, Paul; Weintraub, William S.; Vaccarino, Viola; Rhee, Mary K.; Twombly, Jennifer G.; Narayan, Venkat; Koch, David D.; Phillips, Lawrence S.			Glucose-Independent, Black-White Differences in Hemoglobin A(1c) Levels	ANNALS OF INTERNAL MEDICINE			English	Article							MEAN BLOOD-GLUCOSE; HEALTH-CARE ACCESS; GLYCEMIC CONTROL; GLYCATED HEMOGLOBIN; ETHNIC DISPARITIES; MICROVASCULAR COMPLICATIONS; DIABETIC-RETINOPATHY; BIOLOGICAL VARIATION; RACIAL DISPARITIES; HBA(1C) LEVELS	Background: A previous study of participants with prediabetes found that hemoglobin A(1c) (HbA(1c)) levels differed between black and white participants with no differences in glucose concentration. Objective: To determine whether black-white differences in HbA(1c) level are present in other populations and across the full spectrum of glycemia. Design: Cross-sectional, retrospective. Setting: Outpatient. Participants: 1581 non-Hispanic black and white participants between 18 and 87 years of age without known diabetes in the SIGT (Screening for Impaired Glucose Tolerance) study and 1967 non-Hispanic black and white participants older than 40 years without known diabetes in the NHANES III (Third National Health and Nutrition Examination Survey). Measurements: HbA(1c) levels, anthropometry, and plasma glucose levels during oral glucose tolerance testing. Results: Hemoglobin A(1c) levels were higher in black than in white participants with normal glucose tolerance (0.13 percentage point [P < 0.001] in the SIGT sample and 0.21 percentage point [P < 0.001] in the NHANES III sample), prediabetes (0.26 percentage point [P < 0.001] and 0.30 percentage point [P < 0.001], respectively), or diabetes (0.47 percentage point [P < 0.020] and 0.47 percentage point [P < 0.013], respectively) after adjustment for plasma glucose levels and other characteristics known to correlate with HbA(1c) levels. Limitation: The mechanism for the differences is unknown. Conclusion: Black persons have higher HbA(1c) levels than white persons across the full spectrum of glycemia, and the differences increase as glucose intolerance worsens. These findings could limit the use of HbA(1c) to screen for glucose intolerance, indicate the risk for complications, measure quality of care, and evaluate disparities in health.	[Ziemer, David C.] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA 30303 USA; Med Ctr, US Dept Vet Affairs, Atlanta, GA USA; Christiana Care Hlth Syst, Newark, DE USA	Emory University; US Department of Veterans Affairs; Christiana Care Health System	Ziemer, DC (corresponding author), Emory Univ, Sch Med, Div Endocrinol, 49 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.		, Viola/AAW-5600-2020		National Institutes of Health and National Center for Research Resources [DK07298, DK062668, RR017643, DK066204, RR00039]; U.S. Department of Veterans Affairs Health Services Research and Development Service [SHP 08-144, IIR 07-138]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK062668, R18DK066204] Funding Source: NIH RePORTER	National Institutes of Health and National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health and National Center for Research Resources (awards DK07298, DK062668, RR017643, DK066204, and RR00039) and U.S. Department of Veterans Affairs Health Services Research and Development Service (awards SHP 08-144 and IIR 07-138).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; *CDCP, 2006, NHANES 3 LAB DAT FIL; Chou AF, 2007, WOMEN HEALTH ISS, V17, P150, DOI 10.1016/j.whi.2007.03.003; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; Cohen RM, 2008, DIABETES CARE, V31, P151, DOI 10.2337/dc07-1465; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986; Delamater AM, 1999, DIABETES CARE, V22, P700, DOI 10.2337/diacare.22.5.700; Dyck PJ, 2006, DIABETES CARE, V29, P2282, DOI 10.2337/dc06-0525; EBERHARDT MS, 1994, J CLIN EPIDEMIOL, V47, P1181, DOI 10.1016/0895-4356(94)90105-8; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; GOLDSTEIN DE, 1987, CLIN CHEM, V33, P2267; Gould BJ, 1997, CLIN CHIM ACTA, V260, P49, DOI 10.1016/S0009-8981(96)06508-4; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454; Hashimoto K, 2008, DIABETES CARE, V31, P1945, DOI 10.2337/dc08-0352; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Hozumi M, 1998, J NUTR SCI VITAMINOL, V44, P1, DOI 10.3177/jnsv.44.1; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kilpatrick ES, 2008, DIABETOLOGIA, V51, P365, DOI 10.1007/s00125-007-0883-x; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Maney M, 2007, DIABETES CARE, V30, P245, DOI 10.2337/dc06-0771; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P982, DOI 10.1210/jc.2008-1211; MARTINA WV, 1993, CLIN CHEM, V39, P2259; McCarter RJ, 2006, DIABETES CARE, V29, P352, DOI 10.2337/diacare.29.02.06.dc05-1594; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Nathan DM, 2007, DIABETOLOGIA, V50, P2239, DOI 10.1007/s00125-007-0803-0; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN DM, 1983, CLIN CHEM, V29, P466; Quandt SA, 2005, ETHNIC DIS, V15, P656; Rhee MK, 2008, DIABETES EDUCATOR, V34, P655, DOI 10.1177/0145721708320903; Rhee MK, 2005, J HEALTH CARE POOR U, V16, P734; Roberts WL, 2002, CLIN CHEM, V48, P383; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; SCHNEIDER RG, 1976, BLOOD, V48, P629; SIMON M, 1980, DIABETES, V29, P467, DOI 10.2337/diabetes.29.6.467; Snieder H, 2001, DIABETES, V50, P2858, DOI 10.2337/diabetes.50.12.2858; STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043; Tarim O, 1999, PEDIATR INT, V41, P357; Wang X, 2004, J ENDOCRINOL INVEST, V27, P733, DOI 10.1007/BF03347514; Weykamp CW, 1999, CLIN CHEM, V45, P438; Ziemer DC, 2008, J GEN INTERN MED, V23, P528, DOI 10.1007/s11606-008-0524-1	51	247	249	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					770	+		10.7326/0003-4819-152-12-201006150-00004	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547905				2022-12-24	WOS:000278827700002
J	Kahn, JM; Benson, NM; Appleby, D; Carson, SS; Iwashyna, TJ				Kahn, Jeremy M.; Benson, Nicole M.; Appleby, Dina; Carson, Shannon S.; Iwashyna, Theodore J.			Long-term Acute Care Hospital Utilization After Critical Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL VENTILATION; RACIAL VARIATION; UNITED-STATES; SEVERE SEPSIS; OUTCOMES; MEDICARE; MORTALITY; PATIENT; COSTS; EPIDEMIOLOGY	Context Long-term acute care hospitals have emerged as a novel approach for the care of patients recovering from severe acute illness, but the extent and increases in their activity at the national level are unknown. Objective To examine temporal trends in long-term acute care hospital utilization after an episode of critical illness among fee-for-service Medicare beneficiaries aged 65 years or older. Design, Setting, and Patients Retrospective cohort study using the Medicare Provider Analysis and Review files from 1997 to 2006. We included all Medicare hospitalizations involving admission to an intensive care unit of an acute care, nonfederal hospital within the continental United States. Main Outcome Measures Overall long-term acute care utilization, associated costs, and survival following transfer. Results The number of long-term acute care hospitals in the United States increased at a mean rate of 8.8% per year, from 192 in 1997 to 408 in 2006. During that time, the annual number of long-term acute care admissions after critical illness increased from 13 732 to 40 353, with annual costs increasing from $484 million to $1.325 billion. The age-standardized population incidence of long-term acute care utilization after critical illness increased from 38.1 per 100 000 in 1997 to 99.7 per 100 000 in 2006, with greater use among male individuals and black individuals in all periods. Over time, transferred patients had higher numbers of comorbidities (5.0 in 19972000 vs 5.8 in 2004-2006, P<.001) and were more likely to receive mechanical ventilation at the long-term acute care hospital (16.4% in 1997-2000 vs 29.8% in 20042006, P<.001). One-year mortality after long-term acute care hospital admission was high throughout the study period: 50.7% in 1997-2000 and 52.2% in 2004-2006. Conclusions Long-term acute care hospital utilization after critical illness is common and increasing. Survival among Medicare beneficiaries transferred to long-term acute care after critical illness is poor. JAMA. 2010; 303(22): 2253-2259	[Kahn, Jeremy M.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Kahn, Jeremy M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Carson, Shannon S.] Univ N Carolina, Sch Med, Div Pulm & Crit Care, Chapel Hill, NC USA; [Iwashyna, Theodore J.] Univ Michigan, Sch Med, Div Pulm & Crit Care, Ann Arbor, MI USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Michigan System; University of Michigan	Kahn, JM (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care, Blockley Hall 723,423 Guardian Dr, Philadelphia, PA 19104 USA.	jmkahn@mail.med.upenn.edu		Benson, Nicole/0000-0001-5361-4311; Iwashyna, Theodore/0000-0002-4226-9310; Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health (NIH) [R01HL096651, K08HL091249]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096651, K08HL091249] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant R01HL096651 from the National Institutes of Health (NIH) (Dr Kahn). Dr Iwashyna is supported by NIH grant K08HL091249. This project was also funded, in part, under a grant from the Pennsylvania Department of Health, which specifically disclaims responsibility for any analyses, interpretations, or conclusions.	AIKEN LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], CLIN CLASS SOFTW ICD; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2007, CHEST, V131, P2, DOI 10.1378/chest.06-2513; Carson SS, 1999, AM J RESP CRIT CARE, V159, P1568, DOI 10.1164/ajrccm.159.5.9809002; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Engoren M, 2004, CHEST, V125, P220, DOI 10.1378/chest.125.1.220; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Horwitz JR, 2009, J HEALTH ECON, V28, P924, DOI 10.1016/j.jhealeco.2009.06.008; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; Iglehart JK, 2005, NEW ENGL J MED, V352, P78, DOI 10.1056/NEJMhpr043631; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Kahn JM, 2007, CURR OPIN CRIT CARE, V13, P514, DOI 10.1097/MCC.0b013e3282efb7c9; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2010, INTENS CARE MED, V36, P8, DOI 10.1007/s00134-009-1672-4; LAUDERDALE DS, 1993, EPIDEMIOL REV, V15, P319, DOI 10.1093/oxfordjournals.epirev.a036123; Liu K, 2001, HEALTH CARE FINANC R, V23, P1; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Medicare Payment Advisory Commission, 2004, REP C NEW APPR MED; Medicare Payment Advisory Commission, 2010, REP C MED PAYM POL; Pilcher DV, 2005, THORAX, V60, P187, DOI 10.1136/thx.2004.026500; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Riley GF, 2009, MED CARE, V47, pS51, DOI 10.1097/MLR.0b013e31819c95aa; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Scheinhorn DJ, 2007, CHEST, V131, P85, DOI 10.1378/chest.06-1081; Scheinhorn DJ, 2007, CHEST, V131, P76, DOI 10.1378/chest.06-1079; Schonhofer B, 2002, INTENS CARE MED, V28, P908, DOI 10.1007/s00134-002-1287-5; Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216	41	207	212	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2253	2259		10.1001/jama.2010.761	http://dx.doi.org/10.1001/jama.2010.761			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530778	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000278496800023
J	Cheng, MH				Cheng, Margaret Harris			Asia-Pacific faces diabetes challenge	LANCET			English	News Item																		2010, N ENGL J MED, V362, P1090	1	33	35	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2207	2210		10.1016/S0140-6736(10)61014-8	http://dx.doi.org/10.1016/S0140-6736(10)61014-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20626091				2022-12-24	WOS:000279652900012
J	Chen, L; Park, SM; Tumanov, AV; Hau, A; Sawada, K; Feig, C; Turner, JR; Fu, YX; Romero, IL; Lengyel, E; Peter, ME				Chen, Lina; Park, Sun-Mi; Tumanov, Alexei V.; Hau, Annika; Sawada, Kenjiro; Feig, Christine; Turner, Jerrold R.; Fu, Yang-Xin; Romero, Iris L.; Lengyel, Ernst; Peter, Marcus E.			CD95 promotes tumour growth	NATURE			English	Article							OVARIAN-CANCER; PARTIAL-HEPATECTOMY; CELLS; RECEPTOR; DEATH; PROLIFERATION; ACTIVATION; EXPRESSION; RESISTANT; MOUSE	CD95 (also called Fas and APO-1) is a prototypical death receptor that regulates tissue homeostasis mainly in the immune system through the induction of apoptosis(1-3). During cancer progression CD95 is frequently downregulated or cells are rendered apoptosis resistant(4,5), raising the possibility that loss of CD95 is part of a mechanism for tumour evasion. However, complete loss of CD95 is rarely seen in human cancers(4) and many cancer cells express large quantities of CD95 and are highly sensitive to CD95-mediated apoptosis in vitro. Furthermore, cancer patients frequently have elevated levels of the physiological ligand for CD95, CD95L(6). These data raise the possibility that CD95 could actually promote the growth of tumours through its non-apoptotic activities(7). Here we show that cancer cells in general, regardless of their CD95 apoptosis sensitivity, depend on constitutive activity of CD95, stimulated by cancer-produced CD95L, for optimal growth. Consistently, loss of CD95 in mouse models of ovarian cancer and liver cancer reduces cancer incidence as well as the size of the tumours. The tumorigenic activity of CD95 is mediated by a pathway involving JNK and Jun. These results demonstrate that CD95 has a growth-promoting role during tumorigenesis and indicate that efforts to inhibit its activity rather than to enhance it should be considered during cancer therapy.	[Chen, Lina; Park, Sun-Mi; Hau, Annika; Feig, Christine; Peter, Marcus E.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Tumanov, Alexei V.; Turner, Jerrold R.; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Sawada, Kenjiro; Romero, Iris L.; Lengyel, Ernst] Univ Chicago, Gynecol Oncol Sect, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Peter, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St, Chicago, IL 60611 USA.	m-peter@northwestern.edu	Turner, Jerrold/H-1502-2019; Lengyel, Ernst/D-9220-2014; Tumanov, Alexei/AAR-1607-2021; Hau, Annika/Q-2131-2015; Romero, Iris/N-8451-2018; Turner, Jerrold R/A-6895-2009	Lengyel, Ernst/0000-0001-8624-1507; Tumanov, Alexei/0000-0001-6042-0152; Hau, Annika/0000-0002-3388-3394; Romero, Iris/0000-0001-5849-5024; Turner, Jerrold R/0000-0003-0627-9455; Peter, Marcus Ernst/0000-0003-3216-036X; fu, yang-xin/0000-0001-8441-6617; Feig, Christine/0000-0003-1385-7049	NCI [CA112240, CA11182]; Crohn's and Colitis Foundation of America [CCFA 1661]; Burroughs Wellcome Fund; Ovarian Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA112240, R01CA095319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068271, R01DK061931, R56DK094954, P01DK067887] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ovarian Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to A. Chervonsky and D. Dinulescu for providing the CD95 loxP/loxP mice and the Kras G12D/<SUP>+</SUP>Pten<SUP>fl/fl</SUP> mice, respectively, and to S. Ahmed for help with one experiment. We are grateful to T. Li for performing the immunohistochemistry and to Y.-J. Hua for analysing the gene array data. This work was funded by grants CA112240 from the NCI and CCFA 1661 from the Crohn's and Colitis Foundation of America ( to M. E. P.) and the Burroughs Wellcome Fund, the Ovarian Cancer Research Fund and RO1 CA11182 from the NCI ( to E. L.).	Abrahams VM, 2003, CANCER RES, V63, P5573; Baldwin RL, 1999, GYNECOL ONCOL, V74, P265, DOI 10.1006/gyno.1999.5448; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Romero IL, 2009, CANCER PREV RES, V2, P792, DOI 10.1158/1940-6207.CAPR-08-0236; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Taylor DD, 2002, GYNECOL ONCOL, V84, P443, DOI 10.1006/gyno.2001.6551	30	288	301	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					492	496		10.1038/nature09075	http://dx.doi.org/10.1038/nature09075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505730	Green Accepted			2022-12-24	WOS:000278043700038
J	Wei, CJ; Boyington, JC; McTamney, PM; Kong, WP; Pearce, MB; Xu, L; Andersen, H; Rao, S; Tumpey, TM; Yang, ZY; Nabel, GJ				Wei, Chih-Jen; Boyington, Jeffrey C.; McTamney, Patrick M.; Kong, Wing-Pui; Pearce, Melissa B.; Xu, Ling; Andersen, Hanne; Rao, Srinivas; Tumpey, Terrence M.; Yang, Zhi-Yong; Nabel, Gary J.			Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination	SCIENCE			English	Article							RECOMBINANT ADENOVIRAL VECTORS; VIRUS; IMMUNIZATION; IMMUNOGENICITY; IMMUNITY; HIV-1	The rapid dissemination of the 2009 pandemic influenza virus underscores the need for universal influenza vaccines that elicit protective immunity to diverse viral strains. Here, we show that vaccination with plasmid DNA encoding H1N1 influenza hemagglutinin (HA) and boosting with seasonal vaccine or replication-defective adenovirus 5 vector encoding HA stimulated the production of broadly neutralizing influenza antibodies. This prime/boost combination increased the neutralization of diverse H1N1 strains dating from 1934 to 2007 as compared to either component alone and conferred protection against divergent H1N1 viruses in mice and ferrets. These antibodies were directed to the conserved stem region of HA and were also elicited in nonhuman primates. Cross-neutralization of H1N1 subtypes elicited by this approach provides a basis for the development of a universal influenza vaccine for humans.	[Wei, Chih-Jen; Boyington, Jeffrey C.; McTamney, Patrick M.; Kong, Wing-Pui; Xu, Ling; Rao, Srinivas; Yang, Zhi-Yong; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Pearce, Melissa B.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Andersen, Hanne] BIOQUAL, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; BIOQUAL Inc.	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022	Elyard, Hanne/0000-0003-1103-9608	Vaccine Research Center, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ault, J.-P. Todd, A. Zajac, and C. Chiedi for help with the animal studies; K. Dai, W. Shi, and S. Y. Ko for technical support; M. Lewis (BIOQUAL), B. Sanders (BIOQUAL), and members of the Nabel lab for helpful discussions; A. Tislerics and B. Hartman for manuscript preparation; and Y. Okuno for providing the C179 mAb. NIH has filed a patent application (U.S. patent E-341-2008l; international patent WO 2010/036958 A2) on this work (authors: C-J.W., Z-y.Y, and G.J.N.), related to gene-and protein-based approaches to influenza vaccination. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Mascola JR, 2005, J VIROL, V79, P771, DOI 10.1128/JVI.79.2.771-779.2005; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; *WHO, 2010, WHO GLOB INFL PROGR; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004	18	284	330	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1060	1064		10.1126/science.1192517	http://dx.doi.org/10.1126/science.1192517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20647428				2022-12-24	WOS:000281253500036
J	Graham, DJ; Ouellet-Hellstrom, R; MaCurdy, TE; Ali, F; Sholley, C; Worrall, C; Kelman, JA				Graham, David J.; Ouellet-Hellstrom, Rita; MaCurdy, Thomas E.; Ali, Farzana; Sholley, Christopher; Worrall, Christopher; Kelman, Jeffrey A.			Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE PREDICTIVE-VALUE; CARDIOVASCULAR OUTCOMES; ADMINISTRATIVE DATA; CODING ACCURACY; UNITED-STATES; DATABASE; DISEASE; EVENTS; COHORT; THIAZOLIDINEDIONES	Context Studies have suggested that the use of rosiglitazone may be associated with an increased risk of serious cardiovascular events compared with other treatments for type 2 diabetes. Objective To determine if the risk of serious cardiovascular harm is increased by rosiglitazone compared with pioglitazone, the other thiazolidinedione marketed in the United States. Design, Setting, and Patients Nationwide, observational, retrospective, inception cohort of 227 571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. Main Outcome Measures Individual end points of acute myocardial infarction (AMI), stroke, heart failure, and all-cause mortality (death), and composite end point of AMI, stroke, heart failure, or death, assessed using incidence rates by thiazolidinedione, attributable risk, number needed to harm, Kaplan-Meier plots of time to event, and Cox proportional hazard ratios for time to event, adjusted for potential confounding factors, with pioglitazone as reference. Results A total of 8667 end points were observed during the study period. The adjusted hazard ratio for rosiglitazone compared with pioglitazone was 1.06 (95% confidence interval [CI], 0.96-1.18) for AMI; 1.27 (95% CI, 1.12-1.45) for stroke; 1.25 (95% CI, 1.16-1.34) for heart failure; 1.14 (95% CI, 1.05-1.24) for death; and 1.18 (95% CI, 1.12-1.23) for the composite of AMI, stroke, heart failure, or death. The attributable risk for this composite end point was 1.68 (95% CI, 1.27-2.08) excess events per 100 person-years of treatment with rosiglitazone compared with pioglitazone. The corresponding number needed to harm was 60 (95% CI, 48-79) treated for 1 year. Conclusion Compared with prescription of pioglitazone, prescription of rosiglitazone was associated with an increased risk of stroke, heart failure, and all-cause mortality and an increased risk of the composite of AMI, stroke, heart failure, or all-cause mortality in patients 65 years or older. JAMA. 2010;304(4):411-418 www.jama.com	[Graham, David J.; Ouellet-Hellstrom, Rita] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [MaCurdy, Thomas E.] Stanford Univ, Stanford, CA 94305 USA; [MaCurdy, Thomas E.; Ali, Farzana; Sholley, Christopher] Acumen LLC, Burlingame, CA USA; [Worrall, Christopher; Kelman, Jeffrey A.] Ctr Medicare Serv, Washington, DC USA; [Worrall, Christopher; Kelman, Jeffrey A.] Ctr Medicaid Serv, Washington, DC USA	US Food & Drug Administration (FDA); Stanford University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Graham, DJ (corresponding author), US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,Bldg 22,Room 4314, Silver Spring, MD 20993 USA.	david.graham1@fda.hhs.gov			Office of the Assistant Secretary for Planning and Evaluation (ASPE); Centers for Medicare & Medicaid Services (CMS); US Food and Drug Administration (FDA); Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services	Office of the Assistant Secretary for Planning and Evaluation (ASPE); Centers for Medicare & Medicaid Services (CMS); US Food and Drug Administration (FDA); Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services	This study was funded by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), the Centers for Medicare & Medicaid Services (CMS), and the US Food and Drug Administration (FDA).; We thank the Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services for scientific contributions and financial support of this study and the SafeRx Project. We also extend special thanks to Mark Levenson, PhD, and Stephine Keeton, PhD (both with the FDA Office of Biostatistics), for providing statistical advice and to Pallavi Mukherji, MSc, Richard Domurat, BS, Jonathan Gibbs, BA, and Konrad Turski, MSc ( all with Acumen LLC), for assistance with programming and data analysis. These individuals are salaried employees of their respective organizations and received no additional compensation related to their contributions to this study.	Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barsheshet A, 2010, EUR J HEART FAIL, V12, P833, DOI 10.1093/eurjhf/hfq079; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Centers for Medicare and Medicaid Services, MED PROGR GEN INF OV; Centers for Medicare & Medicaid Services, PRESCR DRUG COV GEN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; *CTR DIS CONTR PRE, 2007, NAT DIAB FACT SHEET; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormuth CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006080; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; *GLAXOSMITHKLINE, 2008, AV ROS PROD LAB; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Habib ZA, 2009, PHARMACOEPIDEM DR S, V18, P437, DOI 10.1002/pds.1722; Hennessy S, 2007, MED CARE, V45, P1216, DOI 10.1097/MLR.0b013e318148435a; Hill ME, 2001, SOC SECUR BULL, V64, P45; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; *OFF ASS SECR PLAN, OV UN US AN 2005 CUR; Pantalone KM, 2009, ACTA DIABETOL, V46, P145, DOI 10.1007/s00592-008-0090-3; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; *TAK PHARM AM INC, 2008, ACT PIOGL HYDR PROD; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Walker AM, 2008, PHARMACOEPIDEM DR S, V17, P760, DOI 10.1002/pds.1598; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Ziyadeh N, 2009, CLIN THER, V31, P2665, DOI 10.1016/j.clinthera.2009.11.003	39	386	405	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					411	418		10.1001/jama.2010.920	http://dx.doi.org/10.1001/jama.2010.920			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20584880	Bronze			2022-12-24	WOS:000280350100024
J	Kher, U				Kher, Unmesh			A call for collaboration	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S21	S22		10.1038/nature09245	http://dx.doi.org/10.1038/nature09245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631702	Bronze			2022-12-24	WOS:000279867100034
J	Chase, JM				Chase, Jonathan M.			Stochastic Community Assembly Causes Higher Biodiversity in More Productive Environments	SCIENCE			English	Article							SPECIES-RICHNESS; SCALE-DEPENDENCE; BETA-DIVERSITY; NEUTRAL THEORY; SPATIAL SCALE; DISPERSAL; ABUNDANCE; PATTERNS; NICHES	Net primary productivity is a principal driver of biodiversity; large-scale regions with higher productivity generally have more species. This pattern emerges because beta-diversity (compositional variation across local sites) increases with productivity, but the mechanisms underlying this phenomenon are unknown. Using data from a long-term experiment in replicate ponds, I show that higher beta-diversity at higher productivity resulted from a stronger role for stochastic relative to deterministic assembly processes with increasing productivity. This shift in the relative importance of stochasticity was most consistent with the hypothesis of more intense priority effects leading to multiple stable equilibria at higher productivity. Thus, shifts in community assembly mechanisms across a productivity gradient may underlie one of the most prominent biodiversity gradients on the planet.	[Chase, Jonathan M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chase, Jonathan M.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Chase, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jchase@wustl.edu	B, A/AHB-5155-2022		Washington University; NSF [DEB-0241080, 0816113]	Washington University; NSF(National Science Foundation (NSF))	I thank T. Knight, E. Marnocha, and C. Goss for help setting up the experiment; R. Shulman, B. Biro, J. Mihjalevic, P. Hanley, A. Strauss, and dozens of Tyson researchers for help sampling organisms; Tyson staff for logistical support; and T. Knight, K. Smith, R. Ricklefs, J. Losos, the reviewers, and my lab group for discussions and comments. Supported by Washington University and by NSF grants DEB-0241080 and 0816113.	Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bonn A, 2004, P ROY SOC B-BIOL SCI, V271, P1685, DOI 10.1098/rspb.2004.2745; BROWN JH, 1981, AM ZOOL, V21, P877; Chalcraft DR, 2008, ECOLOGY, V89, P2165, DOI 10.1890/07-0971.1; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Evans KL, 2008, J ANIM ECOL, V77, P395, DOI 10.1111/j.1365-2656.2007.01332.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fukami T, 2004, POPUL ECOL, V46, P137, DOI 10.1007/s10144-004-0182-z; Gardezi T, 2008, AM NAT, V171, P800, DOI 10.1086/587520; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Grime J. P., 2001, PLANT STRATEGIES VEG; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; He K, 2009, ECOL INFORM, V4, P93, DOI 10.1016/j.ecoinf.2009.01.003; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheffer M., 2009, CRITICAL TRANSITIONS; Steiner CF, 2004, ECOLOGY, V85, P107, DOI 10.1890/03-3010; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211	32	622	637	39	530	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1388	1391		10.1126/science.1187820	http://dx.doi.org/10.1126/science.1187820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20508088				2022-12-24	WOS:000278598400036
J	Murray, SA; Kendall, M; Boyd, K; Grant, L; Highet, G; Sheikh, A				Murray, Scott A.; Kendall, Marilyn; Boyd, Kirsty; Grant, Liz; Highet, Gill; Sheikh, Aziz			Archetypal trajectories of social, psychological, and spiritual wellbeing and distress in family care givers of patients with lung cancer: secondary analysis of serial qualitative interviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SIGNIFICANT OTHERS; PALLIATIVE CARE; HEART-FAILURE; OF-LIFE; CAREGIVERS; ILLNESS; SURVIVORS; PATTERNS; DECLINE; HEALTH	Objective To assess if family care givers of patients with lung cancer experience the patterns of social, psychological, and spiritual wellbeing and distress typical of the patient, from diagnosis to death. Design Secondary analysis of serial qualitative interviews carried out every three months for up to a year or to bereavement. Setting South east Scotland. Participants 19 patients with lung cancer and their 19 family carers, totalling 88 interviews (42 with patients and 46 with carers). Results Carers followed clear patterns of social, psychological, and spiritual wellbeing and distress that mirrored the experiences of those for whom they were caring, with some carers also experiencing deterioration in physical health that impacted on their ability to care. Psychological and spiritual distress were particularly dynamic and commonly experienced. In addition to the "Why us?" response, witnessing suffering triggered personal reflections in carers on the meaning and purpose of life. Certain key time points in the illness tended to be particularly problematic for both carers and patients: at diagnosis, at home after initial treatment, at recurrence, and during the terminal stage. Conclusions Family carers witness and share much of the illness experience of the dying patient. The multidimensional experience of distress suffered by patients with lung cancer was reflected in the suffering of their carers in the social, psychological, and spiritual domains, with psychological and spiritual distress being most pronounced. Carers may need to be supported throughout the period of illness not just in the terminal phase and during bereavement, as currently tends to be the case.	[Murray, Scott A.; Kendall, Marilyn; Boyd, Kirsty; Grant, Liz; Highet, Gill; Sheikh, Aziz] Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	scott.murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078; Grant, Liz/0000-0001-7248-7792	Chief Scientist's Office of the Scottish government	Chief Scientist's Office of the Scottish government	The Chief Scientist's Office of the Scottish government funded the studies.	Bowman KF, 2003, PSYCHO-ONCOLOGY, V12, P226, DOI 10.1002/pon.630; *DEP HLTH, 2008, END LIF STRAT; Department of Health, 2000, NHS CANC PLAN PLAN I; *FOR QUAL SOC RES, 2005, SEC AN QUAL DAT; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; Heaton J, 2004, REWORKING QUALITATIV; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; KIM Y, 2009, PSYCHOONCOLOGY; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Kim Y, 2007, SUPPORT CARE CANCER, V15, P1367, DOI 10.1007/s00520-007-0265-4; KISSANE DW, 1994, PSYCHO-ONCOLOGY, V3, P47, DOI DOI 10.1002/P0N.2960030109; Kurtz ME, 2004, MED SCI MONITOR, V10, pCR447; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.656319.94; Manne S.L., 2007, CANC INVEST, V16, P188; Moore N., 2007, HERITAGE MEMORY AND; MURRAY S, 2009, BRIT MED J, V3009, pB3702; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Northouse L, 1989, Oncol Nurs Forum, V16, P511; Ostlund U, 2010, PSYCHO-ONCOLOGY, V19, P29, DOI 10.1002/pon.1433; Persson C, 2008, PALLIATIVE MED, V22, P239, DOI 10.1177/0269216307085339; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; *QSR, QSR NVIV VERS 7; Ryan PJ, 2008, PALLIATIVE MED, V22, P233, DOI 10.1177/0269216307087145; SAVAGE M, 2007, CHANGING SOCIAL CLAS; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183	33	110	111	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2010	340								c2581	10.1136/bmj.c2581	http://dx.doi.org/10.1136/bmj.c2581			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MF	20538635	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000278818700003
J	Reynolds, LE; Watson, AR; Baker, M; Jones, TA; D'Amico, G; Robinson, SD; Joffre, C; Garrido-Urbani, S; Rodriguez-Manzaneque, JC; Martino-Echarri, E; Aurrand-Lions, M; Sheer, D; Dagna-Bricarelli, F; Nizetic, D; McCabe, CJ; Turnell, AS; Kermorgant, S; Imhof, BA; Adams, R; Fisher, EMC; Tybulewicz, VLJ; Hart, IR; Hodivala-Dilke, KM				Reynolds, Louise E.; Watson, Alan R.; Baker, Marianne; Jones, Tania A.; D'Amico, Gabriela; Robinson, Stephen D.; Joffre, Carine; Garrido-Urbani, Sarah; Carlos Rodriguez-Manzaneque, Juan; Martino-Echarri, Estefania; Aurrand-Lions, Michel; Sheer, Denise; Dagna-Bricarelli, Franca; Nizetic, Dean; McCabe, Christopher J.; Turnell, Andrew S.; Kermorgant, Stephanie; Imhof, Beat A.; Adams, Ralf; Fisher, Elizabeth M. C.; Tybulewicz, Victor L. J.; Hart, Ian R.; Hodivala-Dilke, Kairbaan M.			Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome	NATURE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; GROWTH; MICE; APOPTOSIS; VEGF; ETS2; ADAMTS-1; CADHERIN; DSCR1; GENE	Down's syndrome (DS) is a genetic disorder caused by full or partial trisomy of human chromosome 21 and presents with many clinical phenotypes including a reduced incidence of solid tumours(1,2). Recent work with the Ts65Dn model of DS, which has orthologues of about 50% of the genes on chromosome 21 (Hsa21), has indicated that three copies of the ETS2 (ref. 3) or DS candidate region 1 (DSCR1) genes(4) (a previously known suppressor of angiogenesis(5,6)) is sufficient to inhibit tumour growth. Here we use the Tc1 transchromosomic mouse model of DS(7) to dissect the contribution of extra copies of genes on Hsa21 to tumour angiogenesis. This mouse expresses roughly 81% of Hsa21 genes but not the human DSCR1 region. We transplanted B16F0 and Lewis lung carcinoma tumour cells into Tc1 mice and showed that growth of these tumours was substantially reduced compared with wild-type littermate controls. Furthermore, tumour angiogenesis was significantly repressed in Tc1 mice. In particular, in vitro and in vivo angiogenic responses to vascular endothelial growth factor (VEGF) were inhibited. Examination of the genes on the segment of Hsa21 in Tc1 mice identified putative anti-angiogenic genes (ADAMTS1(8,9) and ERG(10)) and novel endothelial cell-specific genes(11), never previously shown to be involved in angiogenesis (JAM-B(12) and PTTG1IP), that, when overexpressed, are responsible for inhibiting angiogenic responses to VEGF. Three copies of these genes within the stromal compartment reduced tumour angiogenesis, explaining the reduced tumour growth in DS. Furthermore, we expect that, in addition to the candidate genes that we show to be involved in the repression of angiogenesis, the Tc1 mouse model of DS will permit the identification of other endothelium-specific anti-angiogenic targets relevant to a broad spectrum of cancer patients.	[Reynolds, Louise E.; Watson, Alan R.; Baker, Marianne; D'Amico, Gabriela; Robinson, Stephen D.; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, John Vane Sci Ctr, Adhes & Angiogenesis Lab, Barts Inst Canc,Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Joffre, Carine; Kermorgant, Stephanie; Hart, Ian R.] Queen Mary Univ London, John Vane Sci Ctr, Tumor Biol Ctr, Inst Canc,Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Jones, Tania A.; Sheer, Denise] Queen Mary Univ London, Ctr Neurosci, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England; [Nizetic, Dean] Queen Mary Univ London, Paediat Ctr, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England; [Garrido-Urbani, Sarah; Imhof, Beat A.] Univ Geneva, Sch Med CMU, Dept Pathol & Immunol, Ctr Med Univ, CH-1211 Geneva, Switzerland; [Carlos Rodriguez-Manzaneque, Juan; Martino-Echarri, Estefania] GENYO, Granada, Spain; [Aurrand-Lions, Michel] INSERM, F-13009 Marseille, France; [Dagna-Bricarelli, Franca] Galliera Hosp, Inst Human Genet, I-16128 Genoa, Italy; [McCabe, Christopher J.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Turnell, Andrew S.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Adams, Ralf] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Ente Ospedaliero Ospedali Galliera; University of Birmingham; University of Birmingham; Max Planck Society; University of London; University College London; MRC National Institute for Medical Research	Reynolds, LE (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Adhes & Angiogenesis Lab, Barts Inst Canc,Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.	l.reynolds@qmul.ac.uk	Adams, Ralf H/AAE-9274-2019; Sheer, Denise/C-6705-2011; Fisher, Elizabeth MC/C-2168-2008; D'Amico, Gabriela/H-6310-2011; JOFFRE, Carine/P-1551-2014; Nizetic, Dean/F-9509-2015; Aurrand-Lions, Michel/O-9953-2016; Corbett-Jones, Tania A/E-4891-2013; Jones, Tania/C-8912-2011; Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; D'Amico, Gabriela/AAD-1182-2020; Kermorgant, Stephanie/AAB-4931-2020	Sheer, Denise/0000-0001-9067-1796; Fisher, Elizabeth MC/0000-0003-2850-9936; JOFFRE, Carine/0000-0002-7551-356X; Aurrand-Lions, Michel/0000-0002-8361-3034; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Tania/0000-0002-0067-3382; Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Kermorgant, Stephanie/0000-0001-5921-479X; Robinson, Stephen/0000-0002-6606-7588; D'Amico, Gabriela/0000-0002-5619-6749; Tybulewicz, Victor/0000-0003-2439-0798; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Nizetic, Dean/0000-0001-5486-5761	MRC [G0601056, MC_U117527252, G0501003] Funding Source: UKRI; Cancer Research UK [A12007, 12007, A3585] Funding Source: Medline; Medical Research Council [G0901609, G0501003, U.1175.02.001.00001(60485), G0601056, MC_U117527252, G0501003(75694)] Funding Source: Medline; Wellcome Trust [080174] Funding Source: Medline; British Lung Foundation [CAN09-4] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Lung Foundation		Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; MAHADEVAN V, 1989, CANCER RES, V49, P415; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	29	88	91	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					813	U13		10.1038/nature09106	http://dx.doi.org/10.1038/nature09106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535211	Green Accepted, Green Submitted			2022-12-24	WOS:000278551800052
J	Rozenbaum, MH; Sanders, EAM; van Hoek, AJ; Jansen, AGSC; van der Ende, A; van den Dobbelsteen, G; Rodenburg, GD; Hak, E; Postma, MJ				Rozenbaum, Mark H.; Sanders, Elisabeth A. M.; van Hoek, Albert Jan; Jansen, Angelique G. S. C.; van der Ende, Arie; van den Dobbelsteen, Germie; Rodenburg, Gerwin D.; Hak, Eelko; Postma, Maarten J.			Cost effectiveness of pneumococcal vaccination among Dutch infants: an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE; IMMUNOGENICITY; PREVENTION; EFFICACY; IMPACT; SEROTYPES; ERA; AGE	Objectives To update cost effectiveness estimates for the four dose (3+1) schedule of the seven valent pneumococcal conjugated vaccine (PCV-7) in the Netherlands and to explore the impact on cost effectiveness of reduced dose schedules and implementation of 10 valent and 13 valent pneumococcal vaccines (PCV-10 and PCV-13). Design Economic evaluation comparing PCV-7, PCV-10, and PCV-13 with no vaccination using a decision tree analytic model built from data in previous studies. Setting The Netherlands. Population A cohort of 180 000 newborns followed until 5 years of age. Main outcome measures Costs; gains in life years and quality adjusted life years (QALYs); and incremental cost effectiveness ratios. Results Under base case assumptions-that is, assuming a five year protective period of the vaccine and no assumed net indirect effects (herd protection minus serotype replacement) among children aged over 5 years-vaccination with PVC-7 in a four dose (3+1) schedule was estimated to prevent 71 and 5778 cases of invasive and non-invasive pneumococcal disease, respectively, in children aged up to 5 years. This corresponds with a total net gain of 173 life years or 277 QALYs. The incremental cost effectiveness ratio of PCV-7 was estimated at (sic)113 891 (98 pound 300; $145 000) per QALY, well over the ratio of (sic)50 000 per QALY required for PCV-7 to be regarded as potentially cost effective. A three dose (2+1) schedule of PCV-7 reduced the incremental cost effectiveness ratio to (sic)82 975 per QALY. For various assumptions and including 10% of the maximum net indirect effects among individuals aged 5 years and over, PCV-10 and PCV-13 had incremental cost effectiveness ratios ranging from (sic)31 250 to (sic)52 947 per QALY. Conclusions The current Dutch infant vaccination programme of four doses of PCV-7 is not cost effective because of increases in invasive disease caused by nonvaccine serotypes, which reduces the overall direct effects of vaccination and offsets potential positive herd protection benefits in unvaccinated individuals. The 10 valent and 13 valent pneumococcal vaccines could have better net health benefits than PCV-7 through less replacement disease and increased herd protection. Both these effects could substantially reduce the incremental cost effectiveness ratio to possibly acceptable levels, if total programme costs can be lowered by reduced schedules, reductions in vaccine prices, or both.	[Rozenbaum, Mark H.; van Hoek, Albert Jan; Hak, Eelko; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Sanders, Elisabeth A. M.; Jansen, Angelique G. S. C.; Rodenburg, Gerwin D.; Hak, Eelko] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Jansen, Angelique G. S. C.; Hak, Eelko] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Ende, Arie] Univ Amsterdam, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Acad Med Ctr Amsterdam, Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands; [van den Dobbelsteen, Germie] Netherlands Vaccine Inst, Bilthoven, Netherlands; [Hak, Eelko; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Rozenbaum, MH (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands.	m.h.rozenbaum@rug.nl	van der Ende, Arie/A-4346-2012	van der Ende, Arie/0000-0003-1298-3086; Postma, Maarten/0000-0002-6306-3653	Wyeth Hoofddorp; Netherlands Vaccine Institute, Bilthoven; GlaxoSmithKline Netherlands; Wyeth	Wyeth Hoofddorp; Netherlands Vaccine Institute, Bilthoven; GlaxoSmithKline Netherlands(GlaxoSmithKline); Wyeth(Wyeth)	Funding: MHR was funded by an unrestricted grant from Wyeth Hoofddorp. AJvH was financed by the Netherlands Vaccine Institute, Bilthoven. This work has been previously presented at a workshop on pneumococcal vaccines at the European Public Health Association conference in Lisbon, Portugal, which was supported by a research grant from GlaxoSmithKline Netherlands. The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication.; Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: (1) MHR was funded by an unrestricted grant from Wyeth Hoofddorp; and AJvH was financed by the Netherlands Vaccine Institute, Bilthoven; (2) MJP has received travel grants from GlaxoSmithKline and Wyeth to attend expert meetings in Reykjavik, Iceland, and Istanbul, Turkey; EAMS has received unrestricted grants from Wyeth and Baxter for research, consulting fees from Wyeth and GlaxoSmithKline, lecturing fees from Wyeth, and grant support from Wyeth and GlaxoSmithKline for vaccine studies; and AvdE has received unrestricted grants from Wyeth and Novartis; (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) No non-financial interests that may be relevant to the submitted work.	Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bos JM, 2003, CLIN THER, V25, P2614, DOI 10.1016/S0149-2918(03)80322-3; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Claes C, 2009, EUR J HEALTH ECON, V10, P25, DOI 10.1007/s10198-008-0098-1; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Giorgi-Rossi P, 2009, HEALTH POLICY, V89, P225, DOI 10.1016/j.healthpol.2008.05.016; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; *HLTH COUNC NETH, 2005, VACC INF PNEUM INF; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Hubben GAA, 2007, VACCINE, V25, P3669, DOI 10.1016/j.vaccine.2007.01.088; Jansen AGSC, 2009, VACCINE, V27, P2394, DOI 10.1016/j.vaccine.2009.01.127; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; LEPOUTRE A, 2008, EURO SURVEILL, V13; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; McIntosh EDG, 2005, VACCINE, V23, P1739, DOI 10.1016/j.vaccine.2004.08.051; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Oostenbrink JB, 2004, GUIDELINES COSTING R; Prosser LA, 2004, PEDIATRICS, V113, P283, DOI 10.1542/peds.113.2.283; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Rozenbaum MH, 2008, EXPERT REV VACCINES, V7, P753, DOI 10.1586/14760584.7.6.753; Silfverdal SA, 2009, VACCINE, V27, P1601, DOI 10.1016/j.vaccine.2008.12.033; Tilson L, 2008, VALUE HEALTH, V11, P898, DOI 10.1111/j.1524-4733.2008.00341.x; Tilson L, 2008, EUR J PUBLIC HEALTH, V18, P275, DOI 10.1093/eurpub/ckm123; Vespa G, 2009, REV PANAM SALUD PUBL, V26, P518, DOI 10.1590/S1020-49892009001200007; Vestrheim DF, 2008, VACCINE, V26, P3277, DOI 10.1016/j.vaccine.2008.03.087; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; [No title captured]	41	72	74	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2010	340								c2509	10.1136/bmj.c2509	http://dx.doi.org/10.1136/bmj.c2509			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608BL	20519267	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000278556400001
J	Yoshida, S; Maruyama, S; Nozaki, H; Shirasu, K				Yoshida, Satoko; Maruyama, Shinichiro; Nozaki, Hisayoshi; Shirasu, Ken			Horizontal Gene Transfer by the Parasitic Plant Striga hermonthica	SCIENCE			English	Article									[Yoshida, Satoko; Shirasu, Ken] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Maruyama, Shinichiro; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Shirasu, K (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan.	ken.shirasu@psc.riken.jp	Shirasu, Ken/ABF-5306-2020; NOZAKI, HISAYOSHI/G-4926-2014; Maruyama, Shinichiro/AAO-4764-2021; yoshida, satoko/AAO-4892-2020; Yoshida, Satoko/G-5003-2010; Yoshida, Satoko/AAZ-4757-2021; Shirasu, Ken/A-4455-2010	Shirasu, Ken/0000-0002-0349-3870; yoshida, satoko/0000-0002-9999-7861; Yoshida, Satoko/0000-0002-9999-7861; Shirasu, Ken/0000-0002-0349-3870; Nozaki, Hisayoshi/0000-0002-9308-4498	Ministry of Education, Culture, Sports, Science, and Technology [19678001, 20247032, 21780044]; RIKEN president fund; Gatsby Charitable Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN president fund; Gatsby Charitable Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by the Ministry of Education, Culture, Sports, Science, and Technology grants (nos. 19678001 to K. S., 20247032 to H.N., and 21780044 to S.Y.), the RIKEN president fund, and the Gatsby Charitable Foundation. S. M. is supported by a Japan Society for the Promotion of Science fellowship. cDNA and genomic sequences of ShContig9483 and its S. gesnerioides homolog have been deposited in DNA Data Bank of Japan (DDBJ) under accession numbers AB530325, AB530324, and AB542056, respectively.	Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Yoshida S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-55	4	108	118	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1128	1128		10.1126/science.1187145	http://dx.doi.org/10.1126/science.1187145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508124				2022-12-24	WOS:000278104700035
J	Ito, T; Kwon, HY; Zimdahl, B; Congdon, KL; Blum, J; Lento, WE; Zhao, C; Lagoo, A; Gerrard, G; Foroni, L; Goldman, J; Goh, H; Kim, SH; Kim, DW; Chuah, C; Oehler, VG; Radich, JP; Jordan, CT; Reya, T				Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan; Congdon, Kendra L.; Blum, Jordan; Lento, William E.; Zhao, Chen; Lagoo, Anand; Gerrard, Gareth; Foroni, Letizia; Goldman, John; Goh, Harriet; Kim, Soo-Hyun; Kim, Dong-Wook; Chuah, Charles; Oehler, Vivian G.; Radich, Jerald P.; Jordan, Craig T.; Reya, Tannishtha			Regulation of myeloid leukaemia by the cell-fate determinant Musashi	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BINDING PROTEIN MUSASHI-1; CML BLAST CRISIS; STEM-CELLS; BCR-ABL; GENE-EXPRESSION; TRANSLATIONAL REPRESSION; MURINE MODEL; NUMB; RNA	Chronic myelogenous leukaemia (CML) can progress from a slow growing chronic phase to an aggressive blast crisis phase(1), but the molecular basis of this transition remains poorly understood. Here we have used mouse models of CML(2,3) to show that disease progression is regulated by the Musashi-Numb signalling axis(4,5). Specifically, we find that the chronic phase is marked by high levels of Numb expression whereas the blast crisis phase has low levels of Numb expression, and that ectopic expression of Numb promotes differentiation and impairs advanced-phase disease in vivo. As a possible explanation for the decreased levels of Numb in the blast crisis phase, we show that NUP98-HOXA9, an oncogene associated with blast crisis CML(6,7), can trigger expression of the RNA-binding protein Musashi2 (Msi2), which in turn represses Numb. Notably, loss of Msi2 restores Numb expression and significantly impairs the development and propagation of blast crisis CML in vitro and in vivo. Finally we show that Msi2 expression is not only highly upregulated during human CML progression but is also an early indicator of poorer prognosis. These data show that the Musashi-Numb pathway can control the differentiation of CML cells, and raise the possibility that targeting this pathway may provide a new strategy for the therapy of aggressive leukaemias.	[Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan; Congdon, Kendra L.; Blum, Jordan; Lento, William E.; Zhao, Chen; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lagoo, Anand] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gerrard, Gareth; Foroni, Letizia; Goldman, John] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England; [Goh, Harriet; Kim, Soo-Hyun; Kim, Dong-Wook] Catholic Univ Korea, Seoul St Marys Hosp, Div Hematol, Seoul, South Korea; [Chuah, Charles] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Oehler, Vivian G.; Radich, Jerald P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Jordan, Craig T.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	Duke University; Duke University; Imperial College London; Catholic University of Korea; Seoul St. Mary's Hospital; National University of Singapore; Singapore General Hospital; Fred Hutchinson Cancer Center; University of Rochester	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Ito, Takahiro/F-5006-2011; Gerrard, Gareth/B-4375-2009; Kwon, Hyog/T-7915-2019; jordan, craig/D-7666-2014	Ito, Takahiro/0000-0001-7165-0412; Gerrard, Gareth/0000-0002-4614-227X; Kwon, Hyog/0000-0003-1663-5118; jordan, craig/0000-0003-0869-3465	Astellas Foundation for Research on Metabolic Disorders; American Heart Association; Leukemia and Lymphoma Society; ASH; NIH [CA18029, CA140371, CA122206, DK63031, DK072234, AI067798, HL097767, DP1OD006430]; Alexander and Margaret Stewart Fund; Lisa Stafford Research Prize;  [T32 GM007184-33]; NATIONAL CANCER INSTITUTE [R01CA122206, DP1CA174422, R01CA140371, P01CA018029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072234, R01DK063031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006430] Funding Source: NIH RePORTER	Astellas Foundation for Research on Metabolic Disorders; American Heart Association(American Heart Association); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ASH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Fund; Lisa Stafford Research Prize; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. M. Pendergast, J. Chute, K. Itahana, L. Penalva and L. Grimes for advice and reagents; K.-i. Yamamura for the Msi2 gene-trap mice; T. Honjo for the Rbpj conditional mice; N. Gaiano for the TNR mice; D. Baltimore for the lentiviral shRNA constructs; and A. Means and B. Hogan for comments on the manuscript. We also thank M. Cook, B. Harvat and L. Martinek for cell sorting; M. Fereshteh for advice on analysis of patient samples; D. McDonnell and H. Wade for advice on ChIP experiments; S. W. Tian for help in collecting patient samples and A. Chen and S. Honeycutt for technical help. The BCR-ABL construct was a gift from W. Pear and the NUP98-HOXA9 construct a gift from G. Gilliland. T. I. is the recipient of a postdoctoral fellowship from the Astellas Foundation for Research on Metabolic Disorders, K. L. C. is the recipient of an American Heart Association predoctoral award, B.Z. received support from T32 GM007184-33 and T. R. is the recipient of a Leukemia and Lymphoma Society Scholar Award. This work was also supported by an LLS Translational Research grant and an ASH Junior Faculty Award to V.G.O., as well as NIH grants CA18029 to J. P. R., CA140371 to V.G.O., CA122206 to C. T. J. and DK63031, DK072234, AI067798, HL097767, DP1OD006430 and an Alexander and Margaret Stewart Fund grant to T. R. We are grateful for the support received from the Lisa Stafford Research Prize.	Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Goldman JM, 2008, ACTA HAEMATOL-BASEL, V119, P212, DOI 10.1159/000140633; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Justice N, 2003, CURR BIOL, V13, P778, DOI 10.1016/S0960-9822(03)00288-4; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Witte O, 2001, SEMIN HEMATOL, V38, P3, DOI 10.1053/shem.2001.27077; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198	35	260	276	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					765	U13		10.1038/nature09171	http://dx.doi.org/10.1038/nature09171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20639863	Green Accepted			2022-12-24	WOS:000280562500041
J	Cantagrel, V; Lefeber, DJ; Ng, BG; Guan, ZQ; Silhavy, JL; Bielas, SL; Lehle, L; Hombauer, H; Adamowicz, M; Swiezewska, E; De Brouwer, AP; Blumel, P; Sykut-Cegielska, J; Houliston, S; Swistun, D; Ali, BR; Dobyns, WB; Babovic-Vuksanovic, D; van Bokhoven, H; Wevers, RA; Raetz, CRH; Freeze, HH; Morava, E; Al-Gazali, L; Gleeson, JG				Cantagrel, Vincent; Lefeber, Dirk J.; Ng, Bobby G.; Guan, Ziqiang; Silhavy, Jennifer L.; Bielas, Stephanie L.; Lehle, Ludwig; Hombauer, Hans; Adamowicz, Maciej; Swiezewska, Ewa; De Brouwer, Arjan P.; Bluemel, Peter; Sykut-Cegielska, Jolanta; Houliston, Scott; Swistun, Dominika; Ali, Bassam R.; Dobyns, William B.; Babovic-Vuksanovic, Dusica; van Bokhoven, Hans; Wevers, Ron A.; Raetz, Christian R. H.; Freeze, Hudson H.; Morava, Eva; Al-Gazali, Lihadh; Gleeson, Joseph G.			SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder	CELL			English	Article							IONIZATION-MASS-SPECTROMETRY; AUTOSOMAL RECESSIVE SYNDROME; RATE-LIMITING STEP; STEROID 5-ALPHA-REDUCTASE; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; RAT-LIVER; BIOSYNTHESIS; PHOSPHATE; CDG	N-linked glycosylation is the most frequent modification of secreted and membrane-bound proteins in eukaryotic cells, disruption of which is the basis of the congenital disorders of glycosylation (CDGs). We describe a new type of CDG caused by mutations in the steroid 5 alpha-reductase type 3 (SRD5A3) gene. Patients have mental retardation and ophthalmologic and cerebellar defects. We found that SRD5A3 is necessary for the reduction of the alpha-isoprene unit of polyprenols to form dolichols, required for synthesis of dolichol-linked monosaccharides, and the oligosaccharide precursor used for N-glycosylation. The presence of residual dolichol in cells depleted for this enzyme suggests the existence of an unexpected alternative pathway for dolichol de novo biosynthesis. Our results thus suggest that SRD5A3 is likely to be the long-sought polyprenol reductase and reveal the genetic basis of one of the earliest steps in protein N-linked glycosylation.	[Ali, Bassam R.; Al-Gazali, Lihadh] United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pathol, Al Ain 17666, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pediat, Al Ain 17666, U Arab Emirates; [Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci & Pediat, Inst Genom Med,Neurogenet Lab, La Jolla, CA 92093 USA; [Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [De Brouwer, Arjan P.; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; [Ng, Bobby G.; Houliston, Scott; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA; [Guan, Ziqiang; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lehle, Ludwig] Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenbiochem, D-93053 Regensburg, Germany; [Hombauer, Hans] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res,Dept Med, La Jolla, CA 92093 USA; [Hombauer, Hans] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Adamowicz, Maciej] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland; [Sykut-Cegielska, Jolanta] Childrens Mem Hlth Inst, Dept Metab Dis Endocrinol & Diabetol, PL-04730 Warsaw, Poland; [Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Bluemel, Peter] Preyersches Kinderspital, A-1100 Vienna, Austria; [Dobyns, William B.] Univ Chicago, Dept Human Genet Neurol & Pediat, Chicago, IL 60637 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Pediat Neurol, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Lab Genet, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Pediat Endocrinol, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA	United Arab Emirates University; United Arab Emirates University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sanford Burnham Prebys Medical Discovery Institute; Duke University; University of Regensburg; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Memorial Health Institute; Children's Memorial Health Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Chicago; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pathol, Al Ain 17666, U Arab Emirates.	algazali@hotmail.com; jogleeson@ucsd.edu	Guan, Ziqiang/AAE-5110-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; Dobyns, William/AAI-2768-2020; Vincent, Cantagrel/H-8698-2017; de Brouwer, Arjan PM/P-5949-2015; van Bokhoven, Hans/D-8764-2012; Morava, E./L-4529-2015; Sykut-Cegielska, Jolanta/V-4253-2019; Dobyns, William Brian/ABC-6525-2021; Wevers, Ron A./H-8116-2014; Ali, Bassam/J-7014-2012; Lefeber, Dirk DJ/A-2146-2014; lefeber, dirk/G-5063-2012; Hombauer, Hans/B-9712-2019	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Dobyns, William/0000-0002-7681-2844; Vincent, Cantagrel/0000-0002-5180-4848; Sykut-Cegielska, Jolanta/0000-0003-0762-3721; Wevers, Ron A./0000-0003-2278-9746; Ali, Bassam R/0000-0003-1306-6618; Hombauer, Hans/0000-0002-2100-564X; Swiezewska, Ewa/0000-0002-3439-8948; Bielas, Stephanie/0000-0003-0567-5632; Freeze, Hudson/0000-0001-6316-0501	Rocket Fund [R01 DK55615]; Sanford Children's Health Research Center; Euroglycanet [LSHM-CT2005-512131]; Metakids and the Netherlands Brain Foundation; Deutsche Forschungsgemeinschaft; Korber-Stiftung; National Institutes of Health [GM-069338]; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, R01DK055615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS052455, R01NS048453] Funding Source: NIH RePORTER	Rocket Fund; Sanford Children's Health Research Center; Euroglycanet; Metakids and the Netherlands Brain Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Korber-Stiftung; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. R. Fink, A. Jansen, F. Karst, K. Gable, T. M. Dunn, and R. Kolodner for providing yeast strains and helpful advice. We are grateful to J.H. Lin for valuable discussion. We thank D. Matern and the Mayo Clinic for providing complete results of patients' transferrin analysis and also C. Sault for additional clinical results from family CVH-385. We thank the University of California, San Francisco, microscopy core (P30 NS047101 and DK80506) and the Biomedical Genomics Core for help in imaging and microarray data analysis. A. de Rooij and K. Huyben are gratefully acknowledged for technical assistance. H. H. F. is a Sanford Research Professor. He and B.N. are supported by the Rocket Fund, R01 DK55615, and the Sanford Children's Health Research Center. Financial support from Euroglycanet (LSHM-CT2005-512131) to R. W. and Metakids and the Netherlands Brain Foundation to D. L. are kindly acknowledged. L. L. was supported by grants from the Deutsche Forschungsgemeinschaft and the Korber-Stiftung. The mass-spectrometry facility in the Department of Biochemistry of the Duke University Medical Center and Z.G. are supported by the LIPID MAPS Large Scale Collaborative Grant GM-069338 from the National Institutes of Health. V. C. is supported by a fellowship from Fondation pour la Recherche Medicale, and J.G.G. is an Investigator of the Howard Hughes Medical Institute. L.A.-G. ascertained and phenotyped family CVH-385 and MR3 and proposed the collaboration to identify the defective gene. W. B. D. reviewed brain imaging and suggested CDG defects, and H. F. suggested SRD5A3 as the polyprenol reductase. D. S., A. P. D. B., and H. v. B. coordinated homozygosity mapping. J.L.S. identified the SRD5A3 mutation, and S. L. B. performed linkage analysis and initiated generation of the gene trap mouse line. E. M. performed CDG Ix phenotype assessment on the remaining patients. D.J.L. performed biochemical diagnosis, functional studies, and dolichol analysis. R. A. W. coordinated biochemical analysis and homozygosity mapping. L. L. suggested a defect in dolichol biosynthesis and performed dolichol rescue experiments. E. S. helped with dolichol standards. D. B.-V., M. A., P. B., and J.S.C. contributed patients. Mass-spectrometry analysis was performed by Z.G. under the guidance of C.R.H.R. B.G.N. performed lipid extraction and patient LLO analysis. S. H. and B. R. A. provided technical assistance, discussions, and control samples. H. H. provided assistance with standard yeast techniques. V. C. performed all other experiments. J.G.G. directed the project. V. C. and J.G.G. wrote the manuscript, with help from the other authors.	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Al-Gazali L, 2008, AM J MED GENET A, V146A, P813, DOI 10.1002/ajmg.a.32114; ALBER T, 1982, Journal of Molecular and Applied Genetics, V1, P419; ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; BEHRENS NH, 1970, P NATL ACAD SCI USA, V66, P153, DOI 10.1073/pnas.66.1.153; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; D'Alexandri FL, 2006, ANAL BIOCHEM, V355, P189, DOI 10.1016/j.ab.2006.06.014; DEJONG G, 1994, ADV EXP MED BIOL, V356, P51; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eklund Erik A, 2006, NeuroRx, V3, P254; EKSTROM TJ, 1987, J BIOL CHEM, V262, P4090; EKSTROM TJ, 1984, J BIOL CHEM, V259, P460; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Grunewald S, 2000, NEUROPEDIATRICS, V31, P57, DOI 10.1055/s-2000-7487; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; HASILIK A, 1978, EUR J BIOCHEM, V91, P567, DOI 10.1111/j.1432-1033.1978.tb12710.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kahrizi K, 2009, EUR J HUM GENET, V17, P125, DOI 10.1038/ejhg.2008.159; KATO S, 1980, BIOCHEM BIOPH RES CO, V95, P770, DOI 10.1016/0006-291X(80)90853-0; KELLER RK, 1982, J BIOL CHEM, V257, P8985; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Mahendroo MS, 1999, REV REPROD, V4, P179, DOI 10.1530/ror.0.0040179; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Morava E, 2008, J INHERIT METAB DIS, V31, P450, DOI 10.1007/s10545-008-0822-0; Morava E, 2009, BRIT J OPHTHALMOL, V93, P350, DOI 10.1136/bjo.2008.145359; Mosch HU, 1997, GENETICS, V145, P671; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Nishikawa A, 2001, BIOCHEM J, V355, P245, DOI 10.1042/0264-6021:3550245; O'Brien JF, 2007, CURR PROTOC HUM GENE; RENARD JP, 1984, J EXP ZOOL, V230, P443, DOI 10.1002/jez.1402300313; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; ROSENWALD AG, 1993, GLYCOBIOLOGY, V3, P481, DOI 10.1093/glycob/3.5.481; ROSSIGNOL DP, 1983, J BIOL CHEM, V258, P9122; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SAGAMI H, 1993, J BIOL CHEM, V268, P10109; Sagami H, 1996, J BIOL CHEM, V271, P9560, DOI 10.1074/jbc.271.16.9560; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; Sidbury R, 2001, PEDIATR DERMATOL, V18, P252, DOI 10.1046/j.1525-1470.2001.018003252.x; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Vermeer S, 2007, J NEUROL, V254, P1356, DOI 10.1007/s00415-007-0546-3; Vleugels W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/humu.21085; WIGLEY WC, 1994, BIOCHEMISTRY-US, V33, P1265, DOI 10.1021/bi00171a029; WOLF M J, 1991, Glycobiology, V1, P405, DOI 10.1093/glycob/1.4.405; YASUGI E, 1994, BBA-LIPID LIPID MET, V1211, P107, DOI 10.1016/0005-2760(94)90144-9	60	200	212	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					203	217		10.1016/j.cell.2010.06.001	http://dx.doi.org/10.1016/j.cell.2010.06.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20637498	Green Accepted, Bronze			2022-12-24	WOS:000280204300013
J	Contreras, JL				Contreras, Jorge L.			Prepublication Data Release, Latency, and Genome Commons	SCIENCE			English	Editorial Material							GENETICS; PROJECT		Washington Univ, Sch Law, St Louis, MO 63130 USA	Washington University (WUSTL)	Contreras, JL (corresponding author), Washington Univ, Sch Law, St Louis, MO 63130 USA.	jlcontreras@wulaw.wustl.edu		Contreras, Jorge/0000-0002-7899-3060				[Anonymous], 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Brumfiel G, 2008, NATURE, V453, P139, DOI 10.1038/453139a; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Collins F., 2010, LANGUAGE LIFE; DOE, 1993, HUMAN GENOME NEW JAN, P4; *GAIN, DAT US CERT AGR VERS; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEFFERNAN O, NATURE; HESS C., 2007, UNDERSTANDING KNOWLE; Hess C, 2006, INT SOC SCI J, V58, P335, DOI 10.1111/j.1468-2451.2006.00622.x; HOLDEN AL, 2002, BIOTECHNIQUES, V32, pS22; *INT HAPMAP PROJ, DAT REL POL; *ISAEC, INT PROP PROGR; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Madison MJ, 2010, CORNELL LAW REV, V95, P657; Merrill Stephen A., 2006, REAP BEN GEN PROT RE; National Academy of Sciences National Academy of Engineering & Institute of Medicine, 2009, ENS INT ACC STEW RES; National Research Council, 1997, BITS POW ISS GLOB AC; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; *NHGRI, 2008, ENCODE CONS DAT REL; *NHGRI, 2000, POL REL DAT DEP SEQ; *NIH, 2008, NOTOD08033 NIH; Rai Arti K., 2003, LAW CONTEMP PROBL, V66, P289; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; 2007, FED REG, V72, P49290; 2003, WELLC TRUST SHAR DAT; 1996, SUMM PRINC AGR INT S; ENCODE PROJECT DATA	31	19	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					393	394		10.1126/science.1189253	http://dx.doi.org/10.1126/science.1189253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KJ	20651137				2022-12-24	WOS:000280196500019
J	Hunte, C; Zickermann, V; Brandt, U				Hunte, Carola; Zickermann, Volker; Brandt, Ulrich			Functional Modules and Structural Basis of Conformational Coupling in Mitochondrial Complex I	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; YARROWIA-LIPOLYTICA; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; QUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; OXIDATIVE STRESS; 49-KDA SUBUNIT; BINDING; SYSTEM	Proton-pumping respiratory complex I is one of the largest and most complicated membrane protein complexes. Its function is critical for efficient energy supply in aerobic cells, and malfunctions are implicated in many neurodegenerative disorders. Here, we report an x-ray crystallographic analysis of mitochondrial complex I. The positions of all iron-sulfur clusters relative to the membrane arm were determined in the complete enzyme complex. The ubiquinone reduction site resides close to 30 angstroms above the membrane domain. The arrangement of functional modules suggests conformational coupling of redox chemistry with proton pumping and essentially excludes direct mechanisms. We suggest that a similar to 60-angstrom-long helical transmission element is critical for transducing conformational energy to proton-pumping elements in the distal module of the membrane arm.	[Zickermann, Volker; Brandt, Ulrich] Goethe Univ Frankfurt, Ctr Membrane Prote, Sch Med, Mol Bioenerget Grp, D-60596 Frankfurt, Germany; [Hunte, Carola] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Hunte, Carola] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Hunte, Carola] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; University of Freiburg; University of Leeds; Max Planck Society	Brandt, U (corresponding author), Goethe Univ Frankfurt, Ctr Membrane Prote, Sch Med, Mol Bioenerget Grp, D-60596 Frankfurt, Germany.	brandt@zbc.kgu.de	Brandt, Ulrich/GLV-1242-2022; Hunte, Carola/E-4071-2015; Brandt, Ulrich/C-4406-2008	Brandt, Ulrich/0000-0003-1869-6811; Hunte, Carola/0000-0002-0826-3986; Brandt, Ulrich/0000-0003-1869-6811	Deutsche Forschungsgemeinschaft [P2, P17]; Excellence Initiative of the German Federal and State Governments [EXC 115, EXC 294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	Excellent technical assistance by K. Siegmund and technical support by A. Duchene, F. Streb, and B. Wenzel are gratefully acknowledged. We thank S. Kerscher for his essential contributions regarding all aspects of Y. lipolytica genetics and B. Wrzesniewska for testing the impact of antibody fragments to improve crystallization. We are indebted to H. Michel for valuable advice during the initial stages of the project and for his continuous support. We thank the European Synchrotron Radiation Facility and the Swiss Light Source (SLS) for granting beam time, many scientists especially at SLS beamlines X06SA and X10SA for constantly supporting our work, and the staff of the Helmholtz Zentrum fur Infektionsforschung (HZI)/Gesellschaft fur Biotechnologische Forschung, Braunschweig for large-scale fermentation of Y. lipolytica. Funding by the Deutsche Forschungsgemeinschaft (SFB 472 Projects P2 and P17) is gratefully acknowledged. This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 115 and EXC 294). Electron density maps are available on request.	Abdrakhmanova A, 2004, BBA-BIOENERGETICS, V1658, P148, DOI 10.1016/j.bbabio.2004.04.019; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Belevich G, 2007, BIOCHEMISTRY-US, V46, P526, DOI 10.1021/bi062062t; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Kerscher S, 2002, BBA-BIOENERGETICS, V1555, P83, DOI 10.1016/S0005-2728(02)00259-1; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P625, DOI 10.1016/j.bbabio.2010.01.029; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Zickermann V, 2003, J BIOL CHEM, V278, P29072, DOI 10.1074/jbc.M302713200; Zickermann V, 2009, BBA-BIOENERGETICS, V1787, P574, DOI 10.1016/j.bbabio.2009.01.012; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	31	294	300	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					448	451		10.1126/science.1191046	http://dx.doi.org/10.1126/science.1191046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595580				2022-12-24	WOS:000280196500039
J	Marris, E				Marris, Emma			On high alert	NATURE			English	Editorial Material							T-CELL DEPLETION; IMMUNE ACTIVATION; INFECTION											Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7	8	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					S2	S3		10.1038/nature09234	http://dx.doi.org/10.1038/nature09234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631700				2022-12-24	WOS:000279867100023
J	Yuan, P; Leonetti, MD; Pico, AR; Hsiung, YC; MacKinnon, R				Yuan, Peng; Leonetti, Manuel D.; Pico, Alexander R.; Hsiung, Yichun; MacKinnon, Roderick			Structure of the Human BK Channel Ca2+-Activation Apparatus at 3.0 angstrom Resolution	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; CONDUCTANCE-VOLTAGE RELATIONSHIP; DEPENDENT K+ CHANNEL; 2 RCK DOMAINS; CA2+ SENSITIVITY; LIPID-MEMBRANE; SMOOTH-MUSCLE; GATING RING; CALCIUM; MECHANISM	High-conductance voltage-and Ca2+-activated K+ (BK) channels encode negative feedback regulation of membrane voltage and Ca2+ signaling, playing a central role in numerous physiological processes. We determined the x-ray structure of the human BK Ca2+ gating apparatus at a resolution of 3.0 angstroms and deduced its tetrameric assembly by solving a 6 angstrom resolution structure of a Na+-activated homolog. Two tandem C-terminal regulator of K+ conductance (RCK) domains from each of four channel subunits form a 350-kilodalton gating ring at the intracellular membrane surface. A sequence of aspartic amino acids that is known as the Ca2+ bowl, and is located within the second of the tandem RCK domains, creates four Ca2+ binding sites on the outer perimeter of the gating ring at the "assembly interface" between RCK domains. Functionally important mutations cluster near the Ca2+ bowl, near the "flexible interface" between RCK domains, and on the surface of the gating ring that faces the voltage sensors. The structure suggests that the Ca2+ gating ring, in addition to regulating the pore directly, may also modulate the voltage sensor.	[Yuan, Peng; Leonetti, Manuel D.; Pico, Alexander R.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu	Pico, Alexander/HCH-4305-2022; Yuan, Peng/A-7643-2012	Leonetti, Manuel/0000-0002-4881-405X; Pico, Alexander/0000-0001-5706-2163; Yuan, Peng/0000-0002-5660-225X	American Asthma Foundation [07-0127]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	American Asthma Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. R. Rajashankar and K. Perry at beamline 24ID-C (Advanced Photon Source, Argonne National Laboratory) and the staff at beamline X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for advice at the synchrotron; members of the MacKinnon laboratory for assistance; and L. Feng and M. Whorton for comments on the manuscript. R. M. is an Investigator in the Howard Hughes Medical Institute. The research is supported by the American Asthma Foundation grant 07-0127. The x-ray crystallographic coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession code 3MT5.	Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim HJ, 2008, BIOPHYS J, V94, P446, DOI 10.1529/biophysj.107.108738; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; PICO A, 2003, THESIS ROCKEFELLER U; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239	38	217	226	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					182	186		10.1126/science.1190414	http://dx.doi.org/10.1126/science.1190414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20508092	Green Accepted			2022-12-24	WOS:000279635200039
J	Saitz, R				Saitz, Richard			Candidate Performance Measures for Screening for, Assessing, and Treating Unhealthy Substance Use in Hospitals: Advocacy or Evidence-Based Practice?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BRIEF INTERVENTIONS; CONTROLLED-TRIAL; TRAUMA CENTER; ALCOHOL-USE; CARE; DRINKING; INJURY; RISK	The Joint Commission recently proposed candidate performance measures addressing unhealthy substance use in hospitalized patients. The proposed measures of screening and brief intervention (SBI) assume that interventions that work in one setting (primary care outpatient practice) would work in another (hospital); treatment would have the same benefits for persons identified by screening as for those with symptoms who seek help; treatments that work for persons less severely affected by substance use would also work for those with more severe illness; and an approach that works for nondependent, unhealthy alcohol use would work for drug use. However, these assumptions extrapolate evidence of the effectiveness of SBI for primary care outpatients with nondependent, unhealthy alcohol use to the inpatient setting, persons with dependence, and other substances. Although quality of care for unhealthy substance use in all medical settings needs to improve, the evidence base for SBI in the hospital is too limited for the implementation of performance measures assessing this care.	[Saitz, Richard] Boston Univ, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston Med Ctr,Sch Med, Boston, MA 02118 USA; [Saitz, Richard] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston University	Saitz, R (corresponding author), Boston Univ, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston Med Ctr,Sch Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	rsaitz@bu.edu		/0000-0002-2535-1427				*AM COLL SURG COMM, 2006, FAQ RES OPT CAR INJ; [Anonymous], National Drug Control Strategy 2016; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Center for Medicare & Medicaid Services, PHYS QUAL REP IN; De Micheli Denise, 2004, Rev. Assoc. Med. Bras., V50, P305, DOI 10.1590/S0104-42302004000300040; ELVY GA, 1988, BRIT J ADDICT, V83, P83; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; *JOINT COMM, CAND MEAS PROF ASS T; *JOINT COMM, ATTR COR PERF MEAS A; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; McQueen J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005191.pub2; Saitz R, 2007, ANN INTERN MED, V146, P167, DOI 10.7326/0003-4819-146-3-200702060-00005; Schermer CR, 2006, J TRAUMA, V60, P29, DOI 10.1097/01.ta.0000199420.12322.5d; SMITH PC, 2010, ARCH INTERN IN PRESS; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Sommers MS, 2006, J TRAUMA, V61, P523, DOI 10.1097/01.ta.0000221756.67126.91; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498	18	31	31	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					40	43		10.7326/0003-4819-153-1-201007060-00008	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20621901				2022-12-24	WOS:000279487700006
J	Spence, D				Spence, Des			From the Frontline Medicalisation of ageing: plastic people	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 30	2010	340								c3494	10.1136/bmj.c3494	http://dx.doi.org/10.1136/bmj.c3494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591946				2022-12-24	WOS:000279586300016
J	McPherson, K				McPherson, Klim			Screening for breast cancer-balancing the debate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; OVERDIAGNOSIS; WOMEN				McPherson, K (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	klim.mcpherson@obs-gyn.ox.ac.uk						Banks E, 2001, J MED SCREEN, V8, P29, DOI 10.1136/jms.8.1.29; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; *CANC RES UK, BREAST CANC FACTS; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; *EL RESP, 2009, ANN INT MED; Flanders J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b958; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Jorgensen KJ, 2010, BMJ; Kamerow D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5175; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	20	36	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2010	340								c3106	10.1136/bmj.c3106	http://dx.doi.org/10.1136/bmj.c3106			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IQ	20576707				2022-12-24	WOS:000279346500001
J	Tsai, MC; Manor, O; Wan, Y; Mosammaparast, N; Wang, JK; Lan, F; Shi, Y; Segal, E; Chang, HY				Tsai, Miao-Chih; Manor, Ohad; Wan, Yue; Mosammaparast, Nima; Wang, Jordon K.; Lan, Fei; Shi, Yang; Segal, Eran; Chang, Howard Y.			Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes	SCIENCE			English	Article							CHROMATIN-STRUCTURE; GENE-EXPRESSION; X-CHROMOSOME; DEMETHYLATION; PROTEIN; CELLS; STATE; LSD1	Long intergenic noncoding RNAs (lincRNAs) regulate chromatin states and epigenetic inheritance. Here, we show that the lincRNA HOTAIR serves as a scaffold for at least two distinct histone modification complexes. A 5' domain of HOTAIR binds polycomb repressive complex 2 (PRC2), whereas a 3' domain of HOTAIR binds the LSD1/CoREST/REST complex. The ability to tether two distinct complexes enables RNA-mediated assembly of PRC2 and LSD1 and coordinates targeting of PRC2 and LSD1 to chromatin for coupled histone H3 lysine 27 methylation and lysine 4 demethylation. Our results suggest that lincRNAs may serve as scaffolds by providing binding surfaces to assemble select histone modification enzymes, thereby specifying the pattern of histone modifications on target genes.	[Tsai, Miao-Chih; Wan, Yue; Wang, Jordon K.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tsai, Miao-Chih; Wan, Yue; Wang, Jordon K.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Manor, Ohad; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Mosammaparast, Nima; Lan, Fei; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; [Mosammaparast, Nima; Lan, Fei; Shi, Yang] Childrens Hosp Boston, Dept Med, Div New Born Med, Cambridge, MA 02138 USA; [Lan, Fei] Constellat Pharmaceut, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Weizmann Institute of Science; Harvard University; Harvard University; Boston Children's Hospital	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	jia, xu/A-8386-2016; Segal, Eran/AAF-4855-2019	Tsai, Miao-Chih/0000-0003-4471-4825; Wang, Jordon/0000-0003-1108-2534; Segal, Eran/0000-0002-6859-1164	California Institute for Regenerative Medicine [RN1-00529-1]; NIH [R01-HG004361, R01-CA118487]; Susan G. Komen Foundation; Azrieli Foundation; NSF; Agency for Science, Technology, and Research; NATIONAL CANCER INSTITUTE [R01CA118487, R01CA118750, R01CA119176] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Azrieli Foundation; NSF(National Science Foundation (NSF)); Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Microarray data are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE22345. We thank members of the D. Herschlag lab for assistance with RNA footprinting and X. Tan, P. Khavari, and J. Wysocka for critical reading of the manuscript. This work was supported by the California Institute for Regenerative Medicine (RN1-00529-1 to H.Y.C.), NIH (R01-HG004361 to H.Y.C. and E. S and R01-CA118487 to Y.S), the Susan G. Komen Foundation (M.-C. T.), the Azrieli Foundation (O.M.), NSF (J. K. W.), and the Agency for Science, Technology, and Research (Y.W.). E. S. is the incumbent of the Soretta and Henry Shapiro career development chair. Y.S. is co-founder and on the scientific advisory board of Constellation Pharmaceuticals. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	24	2425	2618	25	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					689	693		10.1126/science.1192002	http://dx.doi.org/10.1126/science.1192002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616235	Green Submitted, Green Accepted			2022-12-24	WOS:000280602700041
J	Mangone, M; Manoharan, AP; Thierry-Mieg, D; Thierry-Mieg, J; Han, T; Mackowiak, SD; Mis, E; Zegar, C; Gutwein, MR; Khivansara, V; Attie, O; Chen, K; Salehi-Ashtiani, K; Vidal, M; Harkins, TT; Bouffard, P; Suzuki, Y; Sugano, S; Kohara, Y; Rajewsky, N; Piano, F; Gunsalus, KC; Kim, JK				Mangone, Marco; Manoharan, Arun Prasad; Thierry-Mieg, Danielle; Thierry-Mieg, Jean; Han, Ting; Mackowiak, Sebastian D.; Mis, Emily; Zegar, Charles; Gutwein, Michelle R.; Khivansara, Vishal; Attie, Oliver; Chen, Kevin; Salehi-Ashtiani, Kourosh; Vidal, Marc; Harkins, Timothy T.; Bouffard, Pascal; Suzuki, Yutaka; Sugano, Sumio; Kohara, Yuji; Rajewsky, Nikolaus; Piano, Fabio; Gunsalus, Kristin C.; Kim, John K.			The Landscape of C. elegans 3 ' UTRs	SCIENCE			English	Article							HISTONE MESSENGER-RNA; CAENORHABDITIS-ELEGANS; GENOME; TRANSCRIPTOME; MECHANISMS; EXPRESSION; WORMBASE; RESOURCE; BIOLOGY; PROTEIN	Three-prime untranslated regions (3'UTRs) of metazoan messenger RNAs (mRNAs) contain numerous regulatory elements, yet remain largely uncharacterized. Using polyA capture, 3' rapid amplification of complementary DNA (cDNA) ends, full-length cDNAs, and RNA-seq, we defined similar to 26,000 distinct 3'UTRs in Caenorhabditis elegans for similar to 85% of the 18,328 experimentally supported protein-coding genes and revised similar to 40% of gene models. Alternative 3'UTR isoforms are frequent, often differentially expressed during development. Average 3'UTR length decreases with animal age. Surprisingly, no polyadenylation signal (PAS) was detected for 13% of polyadenylation sites, predominantly among shorter alternative isoforms. Trans-spliced (versus non-trans-spliced) mRNAs possess longer 3'UTRs and frequently contain no PAS or variant PAS. We identified conserved 3'UTR motifs, isoform-specific predicted microRNA target sites, and polyadenylation of most histone genes. Our data reveal a rich complexity of 3'UTRs, both genome-wide and throughout development.	[Mangone, Marco; Mis, Emily; Zegar, Charles; Gutwein, Michelle R.; Attie, Oliver; Chen, Kevin; Piano, Fabio; Gunsalus, Kristin C.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Manoharan, Arun Prasad; Han, Ting; Khivansara, Vishal; Kim, John K.] Univ Michigan, Dept Human Genet, Inst Life Sci, Ann Arbor, MI 48109 USA; [Thierry-Mieg, Danielle; Thierry-Mieg, Jean] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Mackowiak, Sebastian D.; Chen, Kevin; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Salehi-Ashtiani, Kourosh; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Salehi-Ashtiani, Kourosh; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Salehi-Ashtiani, Kourosh; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Harkins, Timothy T.] Roche Appl Sci, Indianapolis, IN 46250 USA; [Bouffard, Pascal] Roche Appl Sci, Life Sci 454, Branford, CT 06405 USA; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 1088639, Japan; [Kohara, Yuji] Natl Inst Genet, Ctr Genet Resource Informat, Genome Biol Lab, Mishima, Shizuoka 4118540, Japan; [Piano, Fabio; Gunsalus, Kristin C.] NYU, Abu Dhabi, U Arab Emirates	New York University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Roche Holding; Roche Holding; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Piano, F (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, 1009 Silver Ctr, New York, NY 10003 USA.	fp1@nyu.edu; kcg1@nyu.edu; jnkim@umich.edu	Chen, Kevin/GYU-8963-2022; KHIVANSARA, VISHAL/P-7702-2019; Mackowiak, Sebastian D/S-3266-2017; THIERRY-MIEG, Jean/F-1975-2017; Mangone, Marco/H-2462-2016	KHIVANSARA, VISHAL/0000-0003-2574-5298; Mackowiak, Sebastian D/0000-0003-1673-5389; THIERRY-MIEG, Jean/0000-0002-0396-6789; Thierry-Mieg, Danielle/0000-0001-9568-4211; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Mangone, Marco/0000-0001-7551-8793; manoharan, arun prasad/0000-0002-7030-7353; Rajewsky, Nikolaus/0000-0002-4785-4332	NIH [U01-HG004276, R00HG004515, R01GM088565]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Muscular Dystrophy Association; Pew Charitable Trusts; DFCI Strategic Initiative; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); NIH; National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004276, R00HG004515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; DFCI Strategic Initiative; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from NIH (U01-HG004276) to F. P., K. C. G., J.K.K., and N.R.; NIH grant (R00HG004515) to K. C.; Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Y.K., S.S., and Y.S.; NIH (R01GM088565), Muscular Dystrophy Association and the Pew Charitable Trusts to J.K.K.; a gift from the Ellison Foundation to M. V. and Institute Sponsored Research funds from the DFCI Strategic Initiative in support of the CCSB; the Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network) to S. D. M.; and the Intramural Research Program of NIH, National Library of Medicine to J.T.-M. and D. T.-M. We thank J. V. Moran, T. Blumenthal, A. Billi, D. Mecenas, and B. Bargmann for discussions; T. Shin'I and Exelixis for C. elegans cDNA traces; and, for technical assistance, T. Nawy and B. Brown (statistical analysis); R. Sachidanandam, R. Lyons, and S. Genik (deep sequencing); P. MacMenamin and D. Schaub (3'UTRome database); M. Morris (data submission); and L. Huang (stage analysis). 3'UTRome data sets are available from NCBI Trace Archive, dbEST, Sequence Read Archive, Gene Expression Omnibus, and modENCODE (8). See supporting online materials and methods for details. Annotations are displayed at NCBI AceView (www.aceview.org) (9) and www.UTRome.org (12).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Keall R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-51; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Liu YM, 2001, RNA, V7, P176, DOI 10.1017/S1355838201002333; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Mangone M, 2008, NUCLEIC ACIDS RES, V36, pD57, DOI 10.1093/nar/gkm946; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; THIEMANN V, 2006, APPL MICROBIOL BIOT, V12, P1; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	23	196	200	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					432	435		10.1126/science.1191244	http://dx.doi.org/10.1126/science.1191244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20522740	Green Accepted			2022-12-24	WOS:000280196500035
J	Maunakea, AK; Nagarajan, RP; Bilenky, M; Ballinger, TJ; D'Souza, C; Fouse, SD; Johnson, BE; Hong, CB; Nielsen, C; Zhao, YJ; Turecki, G; Delaney, A; Varhol, R; Thiessen, N; Shchors, K; Heine, VM; Rowitch, DH; Xing, XY; Fiore, C; Schillebeeckx, M; Jones, SJM; Haussler, D; Marra, MA; Hirst, M; Wang, T; Costello, JF				Maunakea, Alika K.; Nagarajan, Raman P.; Bilenky, Mikhail; Ballinger, Tracy J.; D'Souza, Cletus; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Nielsen, Cydney; Zhao, Yongjun; Turecki, Gustavo; Delaney, Allen; Varhol, Richard; Thiessen, Nina; Shchors, Ksenya; Heine, Vivi M.; Rowitch, David H.; Xing, Xiaoyun; Fiore, Chris; Schillebeeckx, Maximiliaan; Jones, Steven J. M.; Haussler, David; Marra, Marco A.; Hirst, Martin; Wang, Ting; Costello, Joseph F.			Conserved role of intragenic DNA methylation in regulating alternative promoters	NATURE			English	Article							WIDE; ARCHITECTURE; METHYLOME	Although it is known that the methylation of DNA in 5' promoters suppresses gene expression, the role of DNA methylation in gene bodies is unclear(1-5). In mammals, tissue-and cell type-specific methylation is present in a small percentage of 5' CpG island (CGI) promoters, whereas a far greater proportion occurs across gene bodies, coinciding with highly conserved sequences(5-10). Tissue-specific intragenic methylation might reduce(3), or, paradoxically, enhance transcription elongation efficiency(1,2,4,5). Capped analysis of gene expression (CAGE) experiments also indicate that transcription commonly initiates within and between genes(11-15). To investigate the role of intragenic methylation, we generated a map of DNA methylation from the human brain encompassing 24.7 million of the 28 million CpG sites. From the dense, high-resolution coverage of CpG islands, the majority of methylated CpG islands were shown to be in intragenic and intergenic regions, whereas less than 3% of CpG islands in 59 promoters were methylated. The CpG islands in all three locations overlapped with RNA markers of transcription initiation, and unmethylated CpG islands also overlapped significantly with trimethylation of H3K4, a histone modification enriched at promoters 16. The general and CpG-island-specific patterns of methylation are conserved in mouse tissues. An in-depth investigation of the human SHANK3 locus(17,18) and its mouse homologue demonstrated that this tissue-specific DNA methylation regulates intragenic promoter activity in vitro and in vivo. These methylation-regulated, alternative transcripts are expressed in a tissue-and cell type-specific manner, and are expressed differentially within a single cell type from distinct brain regions. These results support a major role for intragenic methylation in regulating cell context-specific alternative promoters in gene bodies.	[Ballinger, Tracy J.; Haussler, David; Wang, Ting] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Maunakea, Alika K.; Nagarajan, Raman P.; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Costello, Joseph F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurosurg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA; [Bilenky, Mikhail; D'Souza, Cletus; Nielsen, Cydney; Zhao, Yongjun; Delaney, Allen; Varhol, Richard; Thiessen, Nina; Jones, Steven J. M.; Marra, Marco A.; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Turecki, Gustavo] Douglas Hosp, Res Ctr, McGill Grp Suicide Studies, Verdun, PQ H4H 1R3, Canada; [Shchors, Ksenya] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Xing, Xiaoyun; Fiore, Chris; Schillebeeckx, Maximiliaan; Wang, Ting] Washington Univ, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; British Columbia Cancer Agency; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Wang, T (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	twang@wustl.edu; jcostello@cc.ucsf.edu	Hirst, Martin/B-7684-2016; Jones, Steven J/C-3621-2009; Marra, Marco A/B-5987-2008; Heine, Vivi M/F-1741-2011; Turecki, Gustavo/K-5100-2015	Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Heine, Vivi M/0000-0003-4416-3875; Turecki, Gustavo/0000-0003-4075-2736; Rowitch, David/0000-0002-0079-0060	NIH [NRSA-F31, NRSA-F32]; National Brain Tumor Society; Goldhirsh Foundation; British Columbia Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; Goldhirsh Foundation; British Columbia Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Vandenberg for technical assistance and The Pleiades Promoter Project and their funders Genome Canada, Genome British Columbia, GlaxoSmithKline R&D Ltd, BC Mental Health and Addiction Services, Child & Family Research Institute, UBC Institute of Mental Health, and the UBC Office of the Vice President Research. This work was supported in part by an NIH NRSA-F31 fellowship to A. K. M. and an NIH NRSA-F32 fellowship to R.P.N., a grant from the National Brain Tumor Society and Goldhirsh Foundation to J.F.C., and by the British Columbia Cancer Foundation. T.W. was a Helen Hay Whitney Fellow and M.A.M. is a Terry Fox Young Investigator and a Michael Smith Senior Research Scholar.	Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Flanagan James M, 2007, Genome Biol, V8, P307, DOI 10.1186/gb-2007-8-6-307; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LORINCZ MC, 2004, NATURE STRUCT MOL BI; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	30	1182	1208	1	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					253	U131		10.1038/nature09165	http://dx.doi.org/10.1038/nature09165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613842	Green Accepted, Green Submitted			2022-12-24	WOS:000279580800040
J	Crowder, DW; Northfield, TD; Strand, MR; Snyder, WE				Crowder, David W.; Northfield, Tobin D.; Strand, Michael R.; Snyder, William E.			Organic agriculture promotes evenness and natural pest control	NATURE			English	Article							PREDATOR DIVERSITY; CURRENT KNOWLEDGE; BIODIVERSITY; METAANALYSIS; COMMUNITIES; SERVICES; ECOLOGY; CONSEQUENCES; EXPLOITATION; LANDSCAPES	Human activity can degrade ecosystem function by reducing species number (richness)(1-4) and by skewing the relative abundance of species (evenness)(5-7). Conservation efforts often focus on restoring or maintaining species number(8,9), reflecting the well-known impacts of richness on many ecological processes(1-4). In contrast, the ecological effects of disrupted evenness have received far less attention(7), and developing strategies for restoring evenness remains a conceptual challenge(7). In farmlands, agricultural pest-management practices often lead to altered food web structure and communities dominated by a few common species, which together contribute to pest outbreaks(6,7,10,11). Here we show that organic farming methods mitigate this ecological damage by promoting evenness among natural enemies. In field enclosures, very even communities of predator and pathogen biological control agents, typical of organic farms, exerted the strongest pest control and yielded the largest plants. In contrast, pest densities were high and plant biomass was low when enemy evenness was disrupted, as is typical under conventional management. Our results were independent of the numerically dominant predator or pathogen species, and so resulted from evenness itself. Moreover, evenness effects among natural enemy groups were independent and complementary. Our results strengthen the argument that rejuvenation of ecosystem function requires restoration of species evenness, rather than just richness. Organic farming potentially offers a means of returning functional evenness to ecosystems.	[Crowder, David W.; Northfield, Tobin D.; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	Washington State University; University System of Georgia; University of Georgia	Crowder, DW (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	dcrowder@wsu.edu	Northfield, Tobin/I-2323-2013	Northfield, Tobin/0000-0002-0563-485X; Crowder, David/0000-0002-3720-1581; Snyder, William/0000-0002-2747-3102	National Research Initiative of the USDA National Institute of Food and Agriculture	National Research Initiative of the USDA National Institute of Food and Agriculture	J. Owen and M. Thomas provided comments on the manuscript. G. Chang, R. Ramirez and A. Snyder provided survey data from potato fields. This project was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture.	Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Donnelly A, 2001, NEW PHYTOL, V149, P265, DOI 10.1046/j.1469-8137.2001.00015.x; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Koss AM, 2005, ENVIRON ENTOMOL, V34, P87, DOI 10.1603/0046-225X-34.1.87; Kutner M., 2005, APPL LINEAR STAT MOD; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Letourneau DK, 2008, FRONT ECOL ENVIRON, V6, P430, DOI 10.1890/070081; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Ramirez RA, 2009, ECOLOGY, V90, P2832, DOI 10.1890/08-1941.1; Ramirez RA, 2009, BIOL CONTROL, V48, P147, DOI 10.1016/j.biocontrol.2008.10.010; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	33	352	376	14	512	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					109	U123		10.1038/nature09183	http://dx.doi.org/10.1038/nature09183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596021				2022-12-24	WOS:000279343800044
J	Sonnenburg, ED; Zheng, HJ; Joglekar, P; Higginbottom, SK; Firbank, SJ; Bolam, DN; Sonnenburg, JL				Sonnenburg, Erica D.; Zheng, Hongjun; Joglekar, Payal; Higginbottom, Steven K.; Firbank, Susan J.; Bolam, David N.; Sonnenburg, Justin L.			Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations	CELL			English	Article							OUTER-MEMBRANE PROTEINS; HUMAN GUT MICROBIOTA; SYMBIOTIC BACTERIA; IN-VIVO; STARCH; INULIN; OLIGOFRUCTOSE; CATABOLISM; PREDICTION; MODEL	The intestinal microbiota impacts many facets of human health and is associated with human diseases. Diet impacts microbiota composition, yet mechanisms that link dietary changes to microbiota alterations remain ill-defined. Here we elucidate the basis of Bacteroides proliferation in response to fructans, a class of fructose-based dietary polysaccharides. Structural and genetic analysis disclosed a fructose-binding, hybrid two-component signaling sensor that controls the fructan utilization locus in Bacteroides thetaiotaomicron. Gene content of this locus differs among Bacteroides species and dictates the specificity and breadth of utilizable fructans. BT1760, an extracellular beta 2-6 endo-fructanase, distinguishes B. thetaiotaomicron genetically and functionally, and enables the use of the beta 2-6-linked fructan levan. The genetic and functional differences between Bacteroides species are predictive of in vivo competitiveness in the presence of dietary fructans. Gene sequences that distinguish species' metabolic capacity serve as potential biomarkers in microbiomic datasets to enable rational manipulation of the microbiota via diet.	[Zheng, Hongjun; Firbank, Susan J.; Bolam, David N.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sonnenburg, Erica D.; Joglekar, Payal; Higginbottom, Steven K.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Newcastle University - UK; Stanford University	Bolam, DN (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.n.bolam@ncl.ac.uk; jsonnenburg@stanford.edu		higginbottom, steven/0000-0002-4609-6840; Bolam, David/0000-0003-0314-3122	National Institutes of Health [DP2-OD006515]; NIDDK [K01-DK077053]; Stanford Digestive Disease Center [PO3-DK56339]; BBSRC [BB/F014163/1]; Biotechnology and Biological Sciences Research Council [BB/F014163/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK077053, P30DK056339, R01DK085025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford Digestive Disease Center; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Karla Kirkegaard and Stanley Falkow for valuable comments and Sara Fisher for editing the manuscript. Inulin and FOS for mouse experiments were a kind gift from Beneo-Orafti. Levan was a kind gift from Montana Polysaccharides. We thank Jeffrey Gordon and members of the Gordon Lab for valuable advice; Carl Morland for excellent technical assistance; and Eric Martens and Andrew Goodman for development of genetic tools used in this paper. Some Bacteroides genomic data were produced by The Genome Center at Washington University School of Medicine in St. Louis (genome.wustl.edu). This work was funded in part by grants from National Institutes of Health through the NIH Director's New Innovator Award Program (DP2-OD006515) the NIDDK (K01-DK077053), the Stanford Digestive Disease Center (PO3-DK56339) and the BBSRC (BB/F014163/1).	[Anonymous], 1994, J RAPID METHOD AUTOM, DOI DOI 10.1111/J.1745-4581.1994.TB00308.X; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2003, APPL ENVIRON MICROB, V69, P1136, DOI 10.1128/AEM.69.2.1136-1142.2003; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2009, STRUCTURE, V17, P1149, DOI 10.1016/j.str.2009.08.005; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEY R, 2006, NATURE, V444, P1023; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Menne E, 2000, J NUTR, V130, P1197, DOI 10.1093/jn/130.5.1197; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; ROBERFROID M, 1993, NUTR REV, V51, P137, DOI 10.1111/j.1753-4887.1993.tb03090.x; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P1006, DOI 10.1128/AEM.72.2.1006-1012.2006; Westover BP, 2005, BIOINFORMATICS, V21, P880, DOI 10.1093/bioinformatics/bti123; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	43	483	502	8	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1241	U256		10.1016/j.cell.2010.05.005	http://dx.doi.org/10.1016/j.cell.2010.05.005			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603004	Bronze, Green Accepted			2022-12-24	WOS:000279148100020
J	Todesco, M; Balasubramanian, S; Hu, TT; Traw, MB; Horton, M; Epple, P; Kuhns, C; Sureshkumar, S; Schwartz, C; Lanz, C; Laitinen, RAE; Huang, Y; Chory, J; Lipka, V; Borevitz, JO; Dangl, JL; Bergelson, J; Nordborg, M; Weigel, D				Todesco, Marco; Balasubramanian, Sureshkumar; Hu, Tina T.; Traw, M. Brian; Horton, Matthew; Epple, Petra; Kuhns, Christine; Sureshkumar, Sridevi; Schwartz, Christopher; Lanz, Christa; Laitinen, Roosa A. E.; Huang, Yu; Chory, Joanne; Lipka, Volker; Borevitz, Justin O.; Dangl, Jeffery L.; Bergelson, Joy; Nordborg, Magnus; Weigel, Detlef			Natural allelic variation underlying a major fitness trade-off in Arabidopsis thaliana	NATURE			English	Article							SALICYLIC-ACID; CELL-DEATH; DISEASE RESISTANCE; ARTIFICIAL MICRORNAS; DEFENSE; COSTS; MUTANTS; INDUCTION; REVEALS; PROTEIN	Plants can defend themselves against a wide array of enemies, from microbes to large animals, yet there is great variability in the effectiveness of such defences, both within and between species. Some of this variation can be explained by conflicting pressures from pathogens with different modes of attack(1). A second explanation comes from an evolutionary 'tug of war', in which pathogens adapt to evade detection, until the plant has evolved new recognition capabilities for pathogen invasion(2-5). If selection is, however, sufficiently strong, susceptible hosts should remain rare. That this is not the case is best explained by costs incurred from constitutive defences in a pest-free environment(6-11). Using a combination of forward genetics and genome-wide association analyses, we demonstrate that allelic diversity at a single locus, ACCELERATED CELL DEATH 6 (ACD6)(12,13), underpins marked pleiotropic differences in both vegetative growth and resistance to microbial infection and herbivory among natural Arabidopsis thaliana strains. A hyperactive ACD6 allele, compared to the reference allele, strongly enhances resistance to a broad range of pathogens from different phyla, but at the same time slows the production of new leaves and greatly reduces the biomass of mature leaves. This allele segregates at intermediate frequency both throughout the worldwide range of A. thaliana and within local populations, consistent with this allele providing substantial fitness benefits despite its marked impact on growth.	[Todesco, Marco; Balasubramanian, Sureshkumar; Sureshkumar, Sridevi; Lanz, Christa; Laitinen, Roosa A. E.; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Hu, Tina T.; Huang, Yu; Nordborg, Magnus] Univ So Calif, Los Angeles, CA 90089 USA; [Traw, M. Brian] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15238 USA; [Horton, Matthew; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Epple, Petra; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Kuhns, Christine; Lipka, Volker] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Kuhns, Christine; Lipka, Volker] Univ Gottingen, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Schwartz, Christopher; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schwartz, Christopher] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Curriculum Genet & Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Nordborg, Magnus] Gregor Mendel Inst, A-1030 Vienna, Austria	Max Planck Society; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Gottingen; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Balasubramanian, Sureshkumar/AAS-6919-2020; Borevitz, Justin/B-5423-2012; Weigel, Detlef/AAR-3312-2021; Huang, Yu/C-2789-2011; Traw, Milton Brian/ABD-3275-2020; Weigel, Detlef/GSJ-0799-2022; Todesco, Marco/HCH-3494-2022	Weigel, Detlef/0000-0002-2114-7963; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Borevitz, Justin/0000-0001-8408-3699; Traw, Milton Brian/0000-0002-3148-2108; Weigel, Detlef/0000-0002-2114-7963; Horton, Matthew/0000-0002-7537-0730; Bergelson, Joy/0000-0001-7893-7387; Todesco, Marco/0000-0002-6227-4096; Nordborg, Magnus/0000-0001-7178-9748; Schwartz, CJ/0000-0001-9295-8504	NSF [DEB-0519961, MCB0603515]; European Arabidopsis Stock Centre (NASC); NIH NRSA [F23-GM65032-1]; EMBO; NIH [GM62932, GM057171, GM057994, GM073822]; HFSPO [RGP0057/2007-C]; DFG [LI 1317/2-1]; Gatsby Foundation; Dropkin Foundation; Howard Hughes Medical Institute; Marie Curie RTN SY-STEM; ERA-PG (BMBF); IP AGRON-OMICS [LSHG-CT-2006-037704]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065032, R01GM057994, R01GM073822, R01GM062932, R01GM057171] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); European Arabidopsis Stock Centre (NASC); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSPO(Human Frontier Science Program); DFG(German Research Foundation (DFG)); Gatsby Foundation; Dropkin Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Marie Curie RTN SY-STEM; ERA-PG (BMBF)(Federal Ministry of Education & Research (BMBF)); IP AGRON-OMICS; Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.-W. Park and D. Klessig for the nahG clone; J. Greenberg, the NSF-supported Arabidopsis Biological Resource Centre (ABRC) and the European Arabidopsis Stock Centre (NASC) for seeds; and S. Atwell, K. Broman and Y.-L. Guo for advice. We are grateful to K. Bomblies and L. Yant for establishing the Tubingen A. thaliana collection. This work was supported by NIH NRSA fellowship F23-GM65032-1 (C. S.), an EMBO Long-Term Fellowship (S. B.), NIH grants GM62932 (J. C. and D. W.), GM057171 (J. L. D.), GM057994 (J. B.) and GM073822 (J.O.B.), NSF grants DEB-0519961 (J. B. and M. N.) and NSF MCB0603515 (J. B.), HFSPO grant RGP0057/2007-C (J. L. D. and D. W.), DFG grant LI 1317/2-1 (V. L.), the Gatsby Foundation (V. L.), the Dropkin Foundation (J. B.), the Howard Hughes Medical Institute (J. C.), Marie Curie RTN SY-STEM (D. W.), ERA-PG (BMBF) grant ARABRAS (D. W.), FP6 IP AGRON-OMICS (contract LSHG-CT-2006-037704, D. W.), a Gottfried Wilhelm Leibniz Award of the DFG (D. W.), and the Max Planck Society (D. W.).	Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ATWELL S, 2010, NATURE          0324, DOI DOI 10.1038/NATURE08800; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hirata Tetsuya, 1996, Mycoscience, V37, P283, DOI 10.1007/BF02461299; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Holub EB, 2007, CURR OPIN PLANT BIOL, V10, P415, DOI 10.1016/j.pbi.2007.05.003; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; KING EO, 1954, J LAB CLIN MED, V44, P301; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Korves T, 2004, AM NAT, V163, P489, DOI 10.1086/382552; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu H, 2005, PLANT J, V44, P798, DOI 10.1111/j.1365-313X.2005.02567.x; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Lu H, 2009, PLANT J, V58, P401, DOI 10.1111/j.1365-313X.2009.03791.x; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rate DN, 1999, PLANT CELL, V11, P1695, DOI 10.1105/tpc.11.9.1695; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Traw MB, 2007, EVOLUTION, V61, P2444, DOI 10.1111/j.1558-5646.2007.00211.x; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weigel D., 2002, ARABIDOPSIS LAB MANU; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zavala Jorge A., 2004, BMC Ecology, V4, P11, DOI 10.1186/1472-6785-4-11	53	249	254	2	164	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					632	U129		10.1038/nature09083	http://dx.doi.org/10.1038/nature09083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520716	Green Accepted, Green Submitted			2022-12-24	WOS:000278249000045
J	Cami, J; Bernard-Salas, J; Peeters, E; Malek, SE				Cami, Jan; Bernard-Salas, Jeronimo; Peeters, Els; Malek, Sarah Elizabeth			Detection of C-60 and C-70 in a Young Planetary Nebula	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SPITZER-SPACE-TELESCOPE; GIANT BRANCH STARS; CIRCUMSTELLAR ENVELOPES; DUST FORMATION; CARBON; EMISSION; FULLERENES; SPECTRUM; FEATURES	In recent decades, a number of molecules and diverse dust features have been identified by astronomical observations in various environments. Most of the dust that determines the physical and chemical characteristics of the interstellar medium is formed in the outflows of asymptotic giant branch stars and is further processed when these objects become planetary nebulae. We studied the environment of Tc 1, a peculiar planetary nebula whose infrared spectrum shows emission from cold and neutral C-60 and C-70. The two molecules amount to a few percent of the available cosmic carbon in this region. This finding indicates that if the conditions are right, fullerenes can and do form efficiently in space.	[Cami, Jan; Peeters, Els; Malek, Sarah Elizabeth] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Cami, Jan; Peeters, Els] SETI Inst, Mountain View, CA 94043 USA; [Bernard-Salas, Jeronimo] Cornell Univ, Ithaca, NY 14853 USA; [Bernard-Salas, Jeronimo] Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France	Western University (University of Western Ontario); Cornell University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Cami, J (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	jcami@uwo.ca	Cami, Jan/AAK-9178-2020	Cami, Jan/0000-0002-2666-9234	National Science and Engineering Research Council of Canada; Spitzer Space Telescope General Observer Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spitzer Space Telescope General Observer Program	We thank M. Houde and A. Tielens for commenting on earlier versions of the manuscript, G. Fanchini for stimulating discussions on various properties of fullerene materials, and G. C. Sloan for discussions on carbonaceous species in PNe. Supported by a Discovery grant from the National Science and Engineering Research Council of Canada (J.C., E. P., and S. E. M.) and by the Spitzer Space Telescope General Observer Program.	Acker A, 2002, ASTRON ASTROPHYS, V384, P620, DOI 10.1051/0004-6361:20020009; Bernard-Salas J, 2009, ASTROPHYS J, V699, P1541, DOI 10.1088/0004-637X/699/2/1541; Cernicharo J, 2001, ASTROPHYS J, V546, pL123, DOI 10.1086/318871; Cherchneff I, 2000, ASTRON ASTROPHYS, V357, P572; CLAYTON GC, 1995, ASTRON J, V109, P2096, DOI 10.1086/117435; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; Fabian J, 1996, PHYS REV B, V53, P13864, DOI 10.1103/PhysRevB.53.13864; FOING BH, 1994, NATURE, V369, P296, DOI 10.1038/369296a0; FRENKLACH M, 1989, ASTROPHYS J, V341, P372, DOI 10.1086/167501; FRUM CI, 1991, CHEM PHYS LETT, V176, P504, DOI 10.1016/0009-2614(91)90245-5; FULARA J, 1993, CHEM PHYS LETT, V211, P227, DOI 10.1016/0009-2614(93)85190-Y; Habing HJ, 1996, ASTRON ASTROPHYS REV, V7, P97, DOI 10.1007/PL00013287; Herbig GH, 2000, ASTROPHYS J, V542, P334, DOI 10.1086/309523; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Herwig F, 2005, ANNU REV ASTRON ASTR, V43, P435, DOI 10.1146/annurev.astro.43.072103.150600; Hony S, 2002, ASTRON ASTROPHYS, V390, P533, DOI 10.1051/0004-6361:20020603; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Kwok S, 2009, INT J ASTROBIOL, V8, P161, DOI 10.1017/S1473550409004492; MARTIN MC, 1993, PHYS REV B, V47, P14607, DOI 10.1103/PhysRevB.47.14607; Milanova YV, 2009, ASTRON LETT+, V35, P518, DOI 10.1134/S1063773709080027; Moutou C, 1999, ASTRON ASTROPHYS, V347, P949; NEMES L, 1994, CHEM PHYS LETT, V218, P295, DOI 10.1016/0009-2614(93)E1488-3; Pardo JR, 2007, ASTROPHYS J, V661, P250, DOI 10.1086/513734; Scott A, 1997, ASTROPHYS J, V489, pL193, DOI 10.1086/316789; Sogoshi N, 2000, J PHYS CHEM A, V104, P3733, DOI 10.1021/jp9938718; Speck AK, 2009, ASTROPHYS J, V691, P1202, DOI 10.1088/0004-637X/691/2/1202; Stratmann RE, 1998, J RAMAN SPECTROSC, V29, P483, DOI 10.1002/(SICI)1097-4555(199806)29:6<483::AID-JRS268>3.0.CO;2-Q; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056; VONCZARNOWSKI A, 1995, CHEM PHYS LETT, V246, P321, DOI 10.1016/0009-2614(95)01106-J; WANG XK, 1995, J MATER RES, V10, P1977, DOI 10.1557/JMR.1995.1977; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992; Willson LA, 2000, ANNU REV ASTRON ASTR, V38, P573, DOI 10.1146/annurev.astro.38.1.573	34	532	536	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1180	1182		10.1126/science.1192035	http://dx.doi.org/10.1126/science.1192035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20651118				2022-12-24	WOS:000281485600028
J	Johansson, M; Relton, C; Ueland, PM; Vollset, SE; Midttun, O; Nygard, O; Slimani, N; Boffetta, P; Jenab, M; Clavel-Chapelon, F; Boutron-Ruault, MC; Fagherazzi, G; Kaaks, R; Rohrmann, S; Boeing, H; Weikert, C; Bueno-de-Mesquita, HB; Ros, MM; van Gils, CH; Peeters, PHM; Agudo, A; Barricarte, A; Navarro, C; Rodriguez, L; Sanchez, MJ; Larranaga, N; Khaw, KT; Wareham, N; Allen, NE; Crowe, F; Gallo, V; Norat, T; Krogh, V; Masala, G; Panico, S; Sacerdote, C; Tumino, R; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Rasmuson, T; Hallmans, G; Riboli, E; Vineis, P; Brennan, P				Johansson, Mattias; Relton, Caroline; Ueland, Per Magne; Vollset, Stein Emil; Midttun, Oivind; Nygard, Ottar; Slimani, Nadia; Boffetta, Paolo; Jenab, Mazda; Clavel-Chapelon, Francoise; Boutron-Ruault, Marie-Christine; Fagherazzi, Guy; Kaaks, Rudolf; Rohrmann, Sabine; Boeing, Heiner; Weikert, Cornelia; Bueno-de-Mesquita, H. Bas; Ros, Martine M.; van Gils, Carla H.; Peeters, Petra H. M.; Agudo, Antonio; Barricarte, Aurelio; Navarro, Carmen; Rodriguez, Laudina; Sanchez, Maria-Jose; Larranaga, Nerea; Khaw, Kay-Tee; Wareham, Nick; Allen, Naomi E.; Crowe, Francesca; Gallo, Valentina; Norat, Teresa; Krogh, Vittorio; Masala, Giovanna; Panico, Salvatore; Sacerdote, Carlotta; Tumino, Rosario; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Rasmuson, Torgny; Hallmans, Goeran; Riboli, Elio; Vineis, Paolo; Brennan, Paul			Serum B Vitamin Levels and Risk of Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ONE-CARBON METABOLISM; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; PLASMA FOLATE; FOLIC-ACID; MICROBIOLOGICAL ASSAY; BREAST-CANCER; NEVER SMOKERS; HOMOCYSTEINE; PREVENTION	Context B vitamins and factors related to 1-carbonmetabolism help to maintain DNA integrity and regulate gene expression and may affect cancer risk. Objective To investigate if 1-carbon metabolism factors are associated with onset of lung cancer. Design, Setting, and Participants The European Prospective Investigation into Cancer and Nutrition (EPIC) recruited 519 978 participants from 10 countries between 1992 and 2000, of whom 385 747 donated blood. By 2006, 899 lung cancer cases were identified and 1770 control participants were individually matched by country, sex, date of birth, and date of blood collection. Serum levels were measured for 6 factors of 1-carbon metabolism and cotinine. Main Outcome Measure Odds ratios (ORs) of lung cancer by serum levels of 4 B vitamins (B-2, B-6, folate [B-9], and B-12), methionine, and homocysteine. Results Within the entire EPIC cohort, the age-standardized incidence rates of lung cancer (standardized to the world population, aged 35-79 years) were 6.6, 44.9, and 156.1 per 100 000 person-years among never, former, and current smokers for men, respectively. The corresponding incidence rates for women were 7.1, 23.9, and 100.9 per 100 000 person-years, respectively. After accounting for smoking, a lower risk for lung cancer was seen for elevated serum levels of B6 (fourth vs first quartile OR, 0.44; 95% confidence interval [CI], 0.33-0.60; P for trend<.000001), as well as for serum methionine (fourth vs first quartile OR, 0.52; 95% CI, 0.39-0.69; P for trend<.000001). Similar and consistent decreases in risk were observed in never, former, and current smokers, indicating that results were not due to confounding by smoking. The magnitude of risk was also constant with increasing length of follow-up, indicating that the associations were not explained by preclinical disease. A lower risk was also seen for serum folate (fourth vs first quartile OR, 0.68; 95% CI, 0.51-0.90; P for trend=.001), although this was apparent only for former and current smokers. When participants were classified by median levels of serum methionine and B6, having above-median levels of both was associated with a lower lung cancer risk overall (OR, 0.41; 95% CI, 0.31-0.54), as well as separately among never (OR, 0.36; 95% CI, 0.18-0.72), former(OR, 0.51; 95% CI, 0.34-0.76), and current smokers(OR, 0.42; 95% CI, 0.27-0.65). Conclusion Serum levels of vitamin B6 and methionine were inversely associated with risk of lung cancer. JAMA. 2010; 303(23): 2377-2385	[Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Brennan, P (corresponding author), Int Agcy Res Canc, Genet Epidemiol Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	Brennan@iarc.fr	Ueland, Per M/C-7340-2013; Fagherazzi, Guy/ABB-2555-2020; Khaw, Kay-Tee/AAZ-3209-2021; Krogh, Vittorio/K-2628-2016; Rohrmann, Sabine/D-2113-2012; Gallo, Valentina/X-1139-2018; Boutron-Ruault, Marie-Christine/H-3936-2014; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Agudo, Antonio/J-1805-2016; Boffetta, Paolo/AAI-7767-2021; Sánchez, Maria-José/D-1087-2011; Johansson, Mattias/ABF-3365-2020; Masala, Giovanna/AAC-5474-2022; Panico, Salvatore/K-6506-2016; Gallo, Valentina/J-3089-2012; Relton, Caroline/AAC-5904-2019; Krogh, Vittorio/AAA-9171-2019; Fagherazzi, Guy/P-3534-2017	Fagherazzi, Guy/0000-0001-5033-5966; Krogh, Vittorio/0000-0003-0122-8624; Rohrmann, Sabine/0000-0002-2215-1200; Gallo, Valentina/0000-0002-1268-8629; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Agudo, Antonio/0000-0001-9900-5677; Boffetta, Paolo/0000-0002-3811-2791; Sánchez, Maria-José/0000-0003-4817-0757; Masala, Giovanna/0000-0002-5758-9069; Panico, Salvatore/0000-0002-5498-8312; Krogh, Vittorio/0000-0003-0122-8624; Fagherazzi, Guy/0000-0001-5033-5966; Navarro, Carmen/0000-0001-8896-7483; Riboli, Elio/0000-0001-6795-6080; Sacerdote, Carlotta/0000-0002-8008-5096; Johansson, Mattias/0000-0002-3116-5081; Ueland, Per Magne/0000-0002-1903-0571; Larranaga, Nerea/0000-0002-9993-9880; Crowe, Francesca/0000-0003-4026-1726; tumino, rosario/0000-0003-2666-414X; Jenab, Mazda/0000-0002-0573-1852; Relton, Caroline/0000-0003-2052-4840	World Cancer Research Fund (United Kingdom); European Commission (SANCO); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; Danish Cancer Society; Spanish Ministry of Health, Spanish Regional Government of Andalucia; Spanish Ministry of Health, Spanish Regional Government of Asturias; Spanish Ministry of Health, Spanish Regional Government of Basque Country; Spanish Ministry of Health, Spanish Regional Government of Murcia; Spanish Ministry of Health, Spanish Regional Government of Navarra; ISCIII Network RCESP, Spain [C03/09]; ISCIII of the Spanish Ministry of Health [RETICC DR06/0020]; Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France; Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; General Councils of France; Medical Research Council [MC_U106179471, G0401527] Funding Source: researchfish	World Cancer Research Fund (United Kingdom); European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research(Deutsche KrebshilfeFederal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Spanish Ministry of Health, Spanish Regional Government of Andalucia; Spanish Ministry of Health, Spanish Regional Government of Asturias; Spanish Ministry of Health, Spanish Regional Government of Basque Country; Spanish Ministry of Health, Spanish Regional Government of Murcia; Spanish Ministry of Health, Spanish Regional Government of Navarra; ISCIII Network RCESP, Spain; ISCIII of the Spanish Ministry of Health(Spanish Government); Cancer Research UK(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Greek Ministry of Health(Greek Ministry of Development-GSRT); Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy(Consiglio Nazionale delle Ricerche (CNR)); Compagnia di San Paolo(Compagnia di San Paolo); Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France(3M); Gustave Roussy Institute (IGR), France; General Councils of France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	World Cancer Research Fund (United Kingdom) funded the biochemical analyses for the study. The EPIC study has been supported by the Europe Against Cancer Program of the European Commission (SANCO); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health, Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; the ISCIII Network RCESP (C03/09), Spain; the ISCIII of the Spanish Ministry of Health (RETICC DR06/0020); Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France; Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; and General Councils of France.	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bray F., 2002, CANC INCIDENCE 5 CON, VVIII; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Dahlin AM, 2008, INT J CANCER, V122, P2057, DOI 10.1002/ijc.23299; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dierkes J, 2007, AM J CLIN NUTR, V86, P214; Drake BF, 2009, JAMA-J AM MED ASSOC, V302, P2152, DOI 10.1001/jama.2009.1691; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Figueiredo JC, 2008, CANCER EPIDEM BIOMAR, V17, P2136, DOI 10.1158/1055-9965.EPI-07-2895; Gibson A, 2008, QJM-INT J MED, V101, P881, DOI 10.1093/qjmed/hcn112; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Johansson M, 2008, CANCER EPIDEM BIOMAR, V17, P279, DOI 10.1158/1055-9965.EPI-07-0657; Johansson M, 2009, CANCER EPIDEM BIOMAR, V18, P1538, DOI 10.1158/1055-9965.EPI-08-1193; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Laufer EM, 2004, EUR J CLIN NUTR, V58, P1518, DOI 10.1038/sj.ejcn.1602002; Le Marchand L, 2009, CANCER EPIDEM BIOMAR, V18, P2195, DOI 10.1158/1055-9965.EPI-09-0141; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1197, DOI 10.1158/1055-9965.EPI-08-1001; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; National Institution of Health Office of Dietary Supplements, DIET SUPPL FACT SHEE; Olsen A, 2009, EUR J CLIN NUTR, V63, pS122, DOI 10.1038/ejcn.2009.78; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rudin CM, 2009, CLIN CANCER RES, V15, P5622, DOI 10.1158/1078-0432.CCR-09-0373; Schernhammer E, 2007, CANCER RES, V67, P5553, DOI 10.1158/0008-5472.CAN-06-4463; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Ueland P., FOLATE SERUM; Ueland PM, 2007, CLIN CHEM LAB MED, V45, P1737, DOI 10.1515/CCLM.2007.339; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Vollset SE, 2007, CANCER EPIDEM BIOMAR, V16, P2416, DOI 10.1158/1055-9965.EPI-07-0256; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Weinstein SJ, 2008, CANCER EPIDEM BIOMAR, V17, P3233, DOI 10.1158/1055-9965.EPI-08-0459; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; WILLET W, 1998, NUTR EPIDEMIOLOGY, P124; Yoshino K, 2010, INT J FOOD SCI NUTR, V61, P61, DOI 10.3109/09637480903286363; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	47	118	120	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2377	2385		10.1001/jama.2010.808	http://dx.doi.org/10.1001/jama.2010.808			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551408	Bronze, Green Accepted			2022-12-24	WOS:000278759200027
J	Doucet, CM; Talamas, JA; Hetzer, MW				Doucet, Christine M.; Talamas, Jessica A.; Hetzer, Martin W.			Cell Cycle-Dependent Differences in Nuclear Pore Complex Assembly in Metazoa	CELL			English	Article							MEMBRANE-PROTEINS; DE-NOVO; ENVELOPE; NUCLEOPORIN; CHROMATIN; NDC1; ARCHITECTURE; RECRUITMENT; CONTAINS; DYNAMICS	In metazoa, nuclear pore complexes (NPCs) assemble from disassembled precursors into a reforming nuclear envelope (NE) at the end of mitosis and into growing intact NEs during interphase. Here, we show via RNAi-mediated knockdown that ELYS, a nucleoporin critical for the recruitment of the essential Nup107/160 complex to chromatin, is required for NPC assembly at the end of mitosis but not during interphase. Conversely, the transmembrane nucleoporin POM121 is critical for the incorporation of the Nup107/160 complex into new assembly sites specifically during interphase. Strikingly, recruitment of the Nup107/160 complex to an intact NE involves a membrane curvature-sensing domain of its constituent Nup133, which is not required for postmitotic NPC formation. Our results suggest that in organisms with open mitosis, NPCs assemble via two distinct mechanisms to accommodate cell cycle-dependent differences in NE topology.	[Doucet, Christine M.; Talamas, Jessica A.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Doucet, Christine/0000-0002-1611-8279	National Institute of General Medical Sciences [R01GM057438];  [CA14195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Hunter lab for antibodies and the H2B-tdTomato reporter construct; and the Hetzer lab for critical discussion and reading of the manuscript, in particular Roberta Schulte for help with the Xenopus egg extract depletion experiments. J.T. performed experiments regarding Pom121 and Elys. C.D. performed live imaging assays and experiments describing the ALPS domain of Nup133. M.H performed Xenopus in vitro experiments. Paper was written by all authors. We also thank Stephane Richard for help with design of the EGFP-ALPS fusion protein. This work was supported by Award Number R01GM057438 from the National Institute of General Medical Sciences and a Core Cancer Grant (CA14195).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2008, CURR OPIN CELL BIOL, V20, P386, DOI 10.1016/j.ceb.2008.03.016; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Antonin W, 2009, CURR BIOL, V19, pR410, DOI 10.1016/j.cub.2009.03.053; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eriksson C, 2004, FEBS LETT, V572, P261, DOI 10.1016/j.febslet.2004.07.044; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; MAUL GG, 1971, J CELL BIOL, V51, P558, DOI 10.1083/jcb.51.2.558; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Schulte R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002061; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	49	175	177	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1030	1041		10.1016/j.cell.2010.04.036	http://dx.doi.org/10.1016/j.cell.2010.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550937	Bronze, Green Accepted			2022-12-24	WOS:000278618800017
J	Busskamp, V; Duebel, J; Balya, D; Fradot, M; Viney, TJ; Siegert, S; Groner, AC; Cabuy, E; Forster, V; Seeliger, M; Biel, M; Humphries, P; Paques, M; Mohand-Said, S; Trono, D; Deisseroth, K; Sahel, JA; Picaud, S; Roska, B				Busskamp, Volker; Duebel, Jens; Balya, David; Fradot, Mathias; Viney, Tim James; Siegert, Sandra; Groner, Anna C.; Cabuy, Erik; Forster, Valerie; Seeliger, Mathias; Biel, Martin; Humphries, Peter; Paques, Michel; Mohand-Said, Saddek; Trono, Didier; Deisseroth, Karl; Sahel, Jose A.; Picaud, Serge; Roska, Botond			Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa	SCIENCE			English	Article							HALORHODOPSIN; CELLS; MODEL; SELECTIVITY; EXPRESSION; SEROTYPES; DIRECTION	Retinitis pigmentosa refers to a diverse group of hereditary diseases that lead to incurable blindness, affecting two million people worldwide. As a common pathology, rod photoreceptors die early, whereas light-insensitive, morphologically altered cone photoreceptors persist longer. It is unknown if these cones are accessible for therapeutic intervention. Here, we show that expression of archaebacterial halorhodopsin in light-insensitive cones can substitute for the native phototransduction cascade and restore light sensitivity in mouse models of retinitis pigmentosa. Resensitized photoreceptors activate all retinal cone pathways, drive sophisticated retinal circuit functions (including directional selectivity), activate cortical circuits, and mediate visually guided behaviors. Using human ex vivo retinas, we show that halorhodopsin can reactivate light-insensitive human photoreceptors. Finally, we identified blind patients with persisting, light-insensitive cones for potential halorhodopsin-based therapy.	[Busskamp, Volker; Duebel, Jens; Balya, David; Viney, Tim James; Siegert, Sandra; Cabuy, Erik; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Busskamp, Volker; Groner, Anna C.; Trono, Didier] Natl Ctr Competence Res Frontiers, Genet Program, CH-1211 Geneva, Switzerland; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] INSERM, UMR S968, Inst Vis, Paris, France; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] CNRS, UMR 7210, F-75012 Paris, France; [Groner, Anna C.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Seeliger, Mathias] Univ Tubingen, Dept Ophthalmol 2, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Biel, Martin] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Biel, Martin] Univ Munich, Dept Pharm, Munich, Germany; [Humphries, Peter] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, Ctr Invest Clin 503, Paris, France; [Paques, Michel; Sahel, Jose A.; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Friedrich Miescher Institute for Biomedical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich; Trinity College Dublin; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Biel, Martin/G-1175-2014; Roska, Botond/AAD-7268-2021; Sahel, Jose-Alain/F-3172-2017; Busskamp, Volker/E-6339-2015; Picaud, Serge/H-4012-2014; Siegert, Sandra/GWC-4507-2022	Biel, Martin/0000-0002-9974-3052; Sahel, Jose-Alain/0000-0002-4831-1153; Busskamp, Volker/0000-0001-7517-8944; Picaud, Serge/0000-0002-0548-5145; Siegert, Sandra/0000-0001-8635-0877; Paques, Michel/0000-0002-9102-9196; Viney, Tim/0000-0001-6444-1188; Duebel, Jens/0000-0002-9906-5597	Friedrich Miescher Institute; U.S. Office of Naval Research; Marie Curie Excellence grant; European Union (EU) [HEALTH-F2-223156]; Agence nationale de la recherche; Foundation Fighting Blindness (U.S); Swiss National Science Foundation; Marie Curie Postdoctoral Fellowship; National Centers of Competence in Research Frontiers in Genetics; Science Foundation Ireland	Friedrich Miescher Institute; U.S. Office of Naval Research(Office of Naval Research); Marie Curie Excellence grant(European Commission); European Union (EU)(CGIAREuropean Commission); Agence nationale de la recherche(French National Research Agency (ANR)); Foundation Fighting Blindness (U.S); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Postdoctoral Fellowship(European Commission); National Centers of Competence in Research Frontiers in Genetics; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank B. G. Scherf, S. Djaffer, and H. Kohler for technical assistance and P. Lagali, K. Farrow, A. Matus, and S. Oakeley for their comments on the manuscript. pAAV2.1-Rho-EGFP was provided by A. Auricchio, and J. Nathans provided the pRed2.1lacZ. Post-mortem human retinas were provided by T. Wesseling and E. Pels at the Cornea Bank in Amsterdam (Netherlands). This study was supported by Friedrich Miescher Institute funds; a U.S. Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant; a Marie Curie Excellence grant and a European Union (EU) HEALTH-F2-223156 grant to B. R.; a grant from the EU (RETICIRC) to B. R. and S. P.; grants from the Agence nationale de la recherche (MEDINAS, RETINE) to S. P.; a Center Grant from Foundation Fighting Blindness (U.S.) to S.M.-S. and J. A. S.; grants from the Swiss National Science Foundation and the EU to D. T.; a grant from the EU (TREATRUSH) to J. A. S., S. P., and B. R.; a Marie Curie Postdoctoral Fellowship to D. B.; and a National Centers of Competence in Research Frontiers in Genetics fellowship to V. B. and A. C. G. The Ocular Genetics Unit at Trinity College Dublin is supported by Science Foundation Ireland. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession no. GSE22338 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22338).	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Banin E, 1999, NEURON, V23, P549, DOI 10.1016/S0896-6273(00)80807-7; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Cronin T, 2007, CURR GENE THER, V7, P121, DOI 10.2174/156652307780363143; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; LI ZY, 1995, J NEUROSCI, V15, P5429; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhu XM, 2002, FEBS LETT, V524, P116, DOI 10.1016/S0014-5793(02)03014-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	33	435	474	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					413	417		10.1126/science.1190897	http://dx.doi.org/10.1126/science.1190897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20576849	Green Submitted			2022-12-24	WOS:000280196500030
J	Ozgul, A; Childs, DZ; Oli, MK; Armitage, KB; Blumstein, DT; Olson, LE; Tuljapurkar, S; Coulson, T				Ozgul, Arpat; Childs, Dylan Z.; Oli, Madan K.; Armitage, Kenneth B.; Blumstein, Daniel T.; Olson, Lucretia E.; Tuljapurkar, Shripad; Coulson, Tim			Coupled dynamics of body mass and population growth in response to environmental change	NATURE			English	Article							YELLOW-BELLIED MARMOTS; RECENT CLIMATE-CHANGE; REPRODUCTIVE STRATEGIES; QUANTITATIVE TRAIT; NATURAL-SELECTION; LIFE-HISTORY; DEMOGRAPHY; EVOLUTION; FLAVIVENTRIS; SURVIVAL	Environmental change has altered the phenology, morphological traits and population dynamics of many species(1,2). However, the links underlying these joint responses remain largely unknown owing to a paucity of long-term data and the lack of an appropriate analytical framework(3). Here we investigate the link between phenotypic and demographic responses to environmental change using a new methodology and a long-term (1976-2008) data set from a hibernating mammal (the yellow-bellied marmot) inhabiting a dynamic subalpine habitat. We demonstrate how earlier emergence from hibernation and earlier weaning of young has led to a longer growing season and larger body masses before hibernation. The resulting shift in both the phenotype and the relationship between phenotype and fitness components led to a decline in adult mortality, which in turn triggered an abrupt increase in population size in recent years. Direct and trait-mediated effects of environmental change made comparable contributions to the observed marked increase in population growth. Our results help explain how a shift in phenology can cause simultaneous phenotypic and demographic changes, and highlight the need for a theory integrating ecological and evolutionary dynamics in stochastic environments(4,5).	[Ozgul, Arpat; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Childs, Dylan Z.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Armitage, Kenneth B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Blumstein, Daniel T.; Olson, Lucretia E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Imperial College London; University of Sheffield; State University System of Florida; University of Florida; University of Kansas; University of California System; University of California Los Angeles; Stanford University	Ozgul, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England.	a.ozgul@imperial.ac.uk	Coulson, Tim/AAL-8148-2021; Ozgul, Arpat/K-2032-2012; Blumstein, Daniel T./B-6199-2012; Childs, Dylan/P-7388-2018	Coulson, Tim/0000-0001-9371-9003; Ozgul, Arpat/0000-0001-7477-2642; Blumstein, Daniel T./0000-0001-5793-9244; Tuljapurkar, Shripad/0000-0001-5549-4245; Olson, Lucretia/0000-0002-5703-3351; Childs, Dylan/0000-0002-0675-4933	NERC; Wellcome Trust; NSF; NIH; NIA; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/G004390/1, NE/E015921/1, NE/E013015/1] Funding Source: researchfish; NERC [NE/E013015/1, NE/E015921/1, NE/G004390/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the 'marmoteers' who participated in collecting the long-term data, Rocky Mountain Biological Laboratory for providing the field facilities, B. Barr and D. Inouye for providing additional information on climate and plant phenology, and L. M. Chevin, J. A. Hostetler, D. Inouye, N. J. Singh and I. M. Smallegange for comments. This work was funded by NERC, the Wellcome Trust, NSF, NIH and NIA.	ANDERSON DC, 1976, ECOLOGY, V57, P552, DOI 10.2307/1936439; [Anonymous], 2008, R LANG ENV STAT COMP; Armitage K. B., 1996, BIODIVERSITY MARMOTS, P223; ARMITAGE KB, 1990, J COMP PHYSIOL B, V160, P491; ARMITAGE KB, 1976, AM MIDL NAT, V96, P36, DOI 10.2307/2424566; ARMITAGE KB, 1981, OECOLOGIA, V48, P36, DOI 10.1007/BF00346986; Armitage KB, 1998, J MAMMAL, V79, P385, DOI 10.2307/1382969; ARMITAGE KB, 1991, ANNU REV ECOL SYST, V22, P379, DOI 10.1146/annurev.es.22.110191.002115; ARMITAGE KB, 1974, ECOLOGY, V55, P1233, DOI 10.2307/1935452; ARMITAGE KB, 2003, WILD MAMMALS N AM BI, P188; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham KP, 2002, MULTIMODEL INFERENCE; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Childs DZ, 2003, P ROY SOC B-BIOL SCI, V270, P1829, DOI 10.1098/rspb.2003.2399; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2008, AM NAT, V172, P599, DOI 10.1086/591693; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Fisher R.A., 1958, GENETICAL THEORY NAT; FRASE BA, 1989, ETHOL ECOL EVOL, V1, P353, DOI 10.1080/08927014.1989.9525505; FRASE BA, 1980, MAMMALIAN SPECIES, V135, P1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Humphries MM, 2004, INTEGR COMP BIOL, V44, P152, DOI 10.1093/icb/44.2.152; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS CONTR W; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; KILGORE DL, 1978, ECOLOGY, V59, P78, DOI 10.2307/1936633; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Laake J., 2022, MARK, P109; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; MELCHER JC, 1989, PHYSIOL ZOOL, V62, P429, DOI 10.1086/physzool.62.2.30156178; Ozgul A, 2009, AM NAT, V173, P517, DOI 10.1086/597225; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Schwartz OA, 1998, J ZOOL, V246, P337, DOI 10.1111/j.1469-7998.1998.tb00163.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Tuljapurkar S., 1997, STRUCTURED POPULATIO; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woods BC, 2003, J MAMMAL, V84, P903, DOI 10.1644/BRG-106	54	445	449	5	392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305					482	U5		10.1038/nature09210	http://dx.doi.org/10.1038/nature09210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651690	Green Accepted, Green Submitted			2022-12-24	WOS:000280141200034
J	Loewer, A; Batchelor, E; Gaglia, G; Lahav, G				Loewer, Alexander; Batchelor, Eric; Gaglia, Giorgio; Lahav, Galit			Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells	CELL			English	Article							P53-MDM2 FEEDBACK LOOP; DNA-DAMAGE; HISTONE H2AX; ACETYLATION; ATM; PHOSPHATASE; PATHWAY; KINASE; WIP1; PHOSPHORYLATION	The tumor suppressor p53 is activated by stress and leads to cellular outcomes such as apoptosis and cell-cycle arrest. Its activation must be highly sensitive to ensure that cells react appropriately to damage. However, proliferating cells often encounter transient damage during normal growth, where cell-cycle arrest or apoptosis may be unfavorable. How does the p53 pathway achieve the right balance between high sensitivity and tolerance to intrinsic damage? Using quantitative time-lapse microscopy of individual human cells, we found that proliferating cells show spontaneous pulses of p53, which are triggered by an excitable mechanism during cell-cycle phases associated with intrinsic DNA damage. However, in the absence of sustained damage, posttranslational modifications keep p53 inactive, preventing it from inducing p21 expression and cell-cycle arrest. Our approach of quantifying basal dynamics in individual cells can now be used to study how other pathways in human cells achieve sensitivity in noisy environments.	[Loewer, Alexander; Batchelor, Eric; Gaglia, Giorgio; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lahav, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	galit@hms.harvard.edu	Loewer, Alexander/AAL-6943-2021	Loewer, Alexander/0000-0002-8819-3040; Batchelor, Eric/0000-0003-3870-5615	National Institutes of Health [GM083303]; German Research Foundation; Charles A. King Trust; American Cancer Society; P. and E. Taft Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Charles A. King Trust; American Cancer Society(American Cancer Society); P. and E. Taft Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hornung and M. Oren for the p21 reporter construct; T. Mitchison for the Lamin A/C antibody and for comments; K. Janes and J. Brugge for MCF10A; B. Vogelstein for HCT p53<SUP>-/-</SUP>; S. Elledge for RPE-hTERT and R. Agami for MCF7+p53shRNA cell lines; O. Gozani and E. Appella for antibodies; Martin Tenniswood for help with obtaining JW1521; J. Alzate and M. DiBona for technical assistance; J. Waters (Nikon Imaging Center at Harvard Medical School) for advice on live-cell imaging; and J. Paulsson, U. Alon, Y. Pilpel, M. Springer, B. Ward, M. Jain, and S. Loewer for comments and discussions. This research was supported by National Institutes of Health grant GM083303. A.L. was supported by fellowships from the German Research Foundation and the Charles A. King Trust. E.B. was supported by the American Cancer Society, P. and E. Taft Postdoctoral Fellowship.	Adams CJ, 2008, EMBO REP, V9, P1222, DOI 10.1038/embor.2008.186; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kaku S, 2001, NUCLEIC ACIDS RES, V29, P1989, DOI 10.1093/nar/29.9.1989; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; SHILOH Y, 1983, CARCINOGENESIS, V4, P1317, DOI 10.1093/carcin/4.10.1317; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	51	179	185	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					89	100		10.1016/j.cell.2010.05.031	http://dx.doi.org/10.1016/j.cell.2010.05.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20598361	Green Accepted, Bronze			2022-12-24	WOS:000279637300015
J	Cuello, LG; Jogini, V; Cortes, DM; Perozo, E				Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Perozo, Eduardo			Structural mechanism of C-type inactivation in K+ channels	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; SELECTIVITY FILTER; SLOW INACTIVATION; ION CONDUCTION; TETRAETHYLAMMONIUM BLOCKADE; CRYSTAL-STRUCTURE; OPEN STATE; KCSA; PORE; MUTATIONS	Interconversion between conductive and non-conductive forms of the K+ channel selectivity filter underlies a variety of gating events, from flicker transitions (at the microsecond timescale) to C-type inactivation (millisecond to second timescale). Here we report the crystal structure of the Streptomyces lividans K+ channel KcsA in its open-inactivated conformation and investigate the mechanism of C-type inactivation gating at the selectivity filter from channels 'trapped' in a series of partially open conformations. Five conformer classes were identified with openings ranging from 12 angstrom in closed KcsA (C alpha-C alpha distances at Thr 112) to 32 angstrom when fully open. They revealed a remarkable correlation between the degree of gate opening and the conformation and ion occupancy of the selectivity filter. We show that a gradual filter backbone reorientation leads first to a loss of the S2 ion binding site and a subsequent loss of the S3 binding site, presumably abrogating ion conduction. These structures indicate a molecular basis for C-type inactivation in K+ channels.	[Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	eperozo@uchicago.edu			NIH [R01-GM57846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Bezanilla, B. Roux, H. Mchaourab and R. Nakamoto for discussions and comments on the manuscript. K. Locher for comments on the manuscripts. R. Mackinnon provided the Fab-expressing hybridoma cells. We also thank S. Chakrapani, J. Cordero-Morales, J. Santos, S. Uysal, O. Dalmas and the members of the Perozo laboratory for discussions and comments on the manuscript. We are thankful to K. R. Rajashankar, R. Sanishvili and the staff at the NE-CAT 24ID and GM-CA 23ID beamlines at the Advanced Photon Source, Argonne National Laboratory. This work was supported in part by NIH grant R01-GM57846 and by a gift from the Palmer family.	Ader C, 2009, J AM CHEM SOC, V131, P170, DOI 10.1021/ja806306e; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cuello LG, 2010, FEBS LETT, V584, P1133, DOI 10.1016/j.febslet.2010.02.015; Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Piskorowski RA, 2006, J GEN PHYSIOL, V127, P557, DOI 10.1085/jgp.200509482; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Schlief T, 1996, PFLUG ARCH EUR J PHY, V431, P483, DOI 10.1007/BF02191894; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	353	357	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					203	U73		10.1038/nature09153	http://dx.doi.org/10.1038/nature09153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613835	Green Accepted			2022-12-24	WOS:000279580800029
J	London, M; Roth, A; Beeren, L; Hausser, M; Latham, PE				London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael; Latham, Peter E.			Sensitivity to perturbations in vivo implies high noise and suggests rate coding in cortex	NATURE			English	Article							PYRAMIDAL NEURONS; VISUAL-CORTEX; NETWORKS; PRECISION; MODEL; COMPUTATION; DENDRITES; NEOCORTEX; PATTERNS; SYSTEMS	It is well known that neural activity exhibits variability, in the sense that identical sensory stimuli produce different responses(1-3), but it has been difficult to determine what this variability means. Is it noise, or does it carry important information-about, for example, the internal state of the organism? Here we address this issue from the bottom up, by asking whether small perturbations to activity in cortical networks are amplified. Based on in vivo whole-cell patch-clamp recordings in rat barrel cortex, we find that a perturbation consisting of a single extra spike in one neuron produces approximately 28 additional spikes in its postsynaptic targets. We also show, using simultaneous intra-and extracellular recordings, that a single spike in a neuron produces a detectable increase in firing rate in the local network. Theoretical analysis indicates that this amplification leads to intrinsic, stimulus-independent variations in membrane potential of the order of +/- 2.2-4.5 mV-variations that are pure noise, and so carry no information at all. Therefore, for the brain to perform reliable computations, it must either use a rate code, or generate very large, fast depolarizing events, such as those proposed by the theory of synfire chains(4,5). However, in our in vivo recordings, we found that such events were very rare. Our findings are thus consistent with the idea that cortex is likely to use primarily a rate code.	[Latham, Peter E.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Latham, PE (corresponding author), UCL, Gatsby Computat Neurosci Unit, Queen Sq, London WC1N 3AR, England.	pel@gatsby.ucl.ac.uk	Hausser, Michael/AAW-6827-2020; London, Michael/B-4175-2010	Hausser, Michael/0000-0002-2673-8957; London, Michael/0000-0001-5137-1707; Roth, Arnd/0000-0003-0325-4287	Gatsby Charitable Foundation; US National Institute of Mental Health [R01 MH62447]; Wellcome Trust; Engineering and Physical Sciences Research Council; Medical Research Council; MRC [G0500244] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish; Medical Research Council [G0500244] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Dayan for discussions, I. van Welie and P. Dayan for comments on the manuscript, and H. Cuntz for comments on the spike detection algorithm. P. E. L. was supported by the Gatsby Charitable Foundation and US National Institute of Mental Health grant R01 MH62447. M. L., A. R., L. B. and M. H. were supported by the Wellcome Trust, the Gatsby Charitable Foundation, the Engineering and Physical Sciences Research Council and the Medical Research Council.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Ariav G, 2003, J NEUROSCI, V23, P7750; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Barbour B, 2007, TRENDS NEUROSCI, V30, P622, DOI 10.1016/j.tins.2007.09.005; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1991, ANATOMY CORTEX; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 1997, J NEUROSCI, V17, P7606; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Herrmann A, 2001, J COMPUT NEUROSCI, V11, P135, DOI 10.1023/A:1012841516004; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Richardson MJE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021919; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; SMALE S, 1967, B AM MATH SOC, V73, P747, DOI 10.1090/S0002-9904-1967-11798-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310	35	270	272	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					123	U142		10.1038/nature09086	http://dx.doi.org/10.1038/nature09086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596024	Green Accepted			2022-12-24	WOS:000279343800047
J	Seligman, HK; Schillinger, D				Seligman, Hilary K.; Schillinger, Dean			Hunger and Socioeconomic Disparities in Chronic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOOD INSECURITY		[Seligman, Hilary K.; Schillinger, Dean] Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Seligman, Hilary K.; Schillinger, Dean] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; [Schillinger, Dean] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94143 USA; [Schillinger, Dean] Calif Dept Publ Hlth, Calif Diabet Program, Sacramento, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; California Department of Public Health	Seligman, HK (corresponding author), Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.							Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Nelson K, 2001, J GEN INTERN MED, V16, P404, DOI 10.1046/j.1525-1497.2001.016006404.x; Nord M, 2009, HOUSEHOLD FOOD SECUR; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573	5	269	277	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					6	9		10.1056/NEJMp1000072	http://dx.doi.org/10.1056/NEJMp1000072			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618HR	20592297				2022-12-24	WOS:000279343000003
J	Huh, D; Matthews, BD; Mammoto, A; Montoya-Zavala, M; Hsin, HY; Ingber, DE				Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.			Reconstituting Organ-Level Lung Functions on a Chip	SCIENCE			English	Article							HUMAN ENDOTHELIAL-CELLS; IN-VITRO MODEL; SILICA NANOPARTICLES; CULTURE; BARRIER; MECHANISMS; SYSTEMS; TISSUE; TOXICITY; CHANNELS	Here, we describe a biomimetic microsystem that reconstitutes the critical functional alveolar-capillary interface of the human lung. This bioinspired microdevice reproduces complex integrated organ-level responses to bacteria and inflammatory cytokines introduced into the alveolar space. In nanotoxicology studies, this lung mimic revealed that cyclic mechanical strain accentuates toxic and inflammatory responses of the lung to silica nanoparticles. Mechanical strain also enhances epithelial and endothelial uptake of nanoparticulates and stimulates their transport into the underlying microvascular channel. Similar effects of physiological breathing on nanoparticle absorption are observed in whole mouse lung. Mechanically active "organ-on-a-chip" microdevices that reconstitute tissue-tissue interfaces critical to organ function may therefore expand the capabilities of cell culture models and provide low-cost alternatives to animal and clinical studies for drug screening and toxicology applications.	[Huh, Dongeun; Montoya-Zavala, Martin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Matthews, Benjamin D.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019; Huh, Dongeun/I-4152-2013; Huh, Dong Eun/J-5715-2012		NIH [R01-ES016665]; American Heart Association [0835618D]; Department of Defense [W81XWH-05-1-0115]; Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. K. Thodeti for his help with ROS assays; G. M. Whitesides and P. Cherukuri for providing carbon nanotubes, gold nanoparticles, and helpful comments; N. Korin for helpful discussions; R. Ruch for providing alveolar epithelial cells; R. Mannix for his imaging assistance; and M. Butte for help with neutrophil isolation. This work was supported by grants from NIH (R01-ES016665), the American Heart Association (0835618D), the Department of Defense (W81XWH-05-1-0115), and the Wyss Institute for Biologically Inspired Engineering at Harvard University; D. H. is a recipient of a Wyss Technology Development Fellowship, and D. E. I. is a recipient of a Department of Defense Breast Cancer Innovator Award. A patent on the device described is pending.	Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Davila JC, 1998, ANNU REV PHARMACOL, V38, P63, DOI 10.1146/annurev.pharmtox.38.1.63; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Frerking I, 2001, INTENS CARE MED, V27, P1699, DOI 10.1007/s00134-001-1121-5; Harris SG, 2003, BIOTECHNOL BIOPROC E, V8, P246, DOI 10.1007/BF02942273; Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL247, DOI 10.1152/ajplung.00235.2002; Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; Takayama S, 2001, ADV MATER, V13, P570, DOI 10.1002/1521-4095(200104)13:8<570::AID-ADMA570>3.0.CO;2-B; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Wagner JG, 2000, PHARMACOL REV, V52, P349; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h	41	2280	2387	90	1693	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1662	1668		10.1126/science.1188302	http://dx.doi.org/10.1126/science.1188302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576885	Green Accepted			2022-12-24	WOS:000279107400035
J	Cykert, S; Dilworth-Anderson, P; Monroe, MH; Walker, P; McGuire, FR; Corbie-Smith, G; Edwards, LJ; Bunton, AJ				Cykert, Samuel; Dilworth-Anderson, Peggye; Monroe, Michael H.; Walker, Paul; McGuire, Franklin R.; Corbie-Smith, Giselle; Edwards, Lloyd J.; Bunton, Audrina Jones			Factors Associated With Decisions to Undergo Surgery Among Patients With Newly Diagnosed Early-Stage Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN COMMUNICATION; RACIAL DISPARITIES; SURGICAL RESECTION; AFRICAN-AMERICANS; CARE; SURVIVAL; RACE; PREDICTION; EDUCATION; QUALITY	Context Lung cancer is the leading cause of cancer death in the United States. Surgical resection for stage I or II non-small cell cancer remains the only reliable treatment for cure. Patients who do not undergo surgery have a median survival of less than 1 year. Despite the survival disadvantage, many patients with early-stage disease do not receive surgical care and rates are even lower for black patients. Objectives To identify potentially modifiable factors regarding surgery in patients newly diagnosed with early-stage lung cancer and to explore why blacks undergo surgery less often than whites. Design, Setting, and Patients Prospective cohort study with patients identified by pulmonary, oncology, thoracic surgery, and generalist practices in 5 communities through study referral or computerized tomography review protocol. A total of 437 patients with biopsy-proven or probable early-stage lung cancer were enrolled between December 2005 and December 2008. Before establishment of treatment plans, patients were administered a survey including questions about trust, patient-physician communication, attitudes toward cancer, and functional status. Information about comorbid illnesses was obtained through chart audits. Main Outcome Measure Lung cancer surgery within 4 months of diagnosis. Results A total of 386 patients met full eligibility criteria for lung resection surgery. The median age was 66 years (range, 26-90 years) and 29% of patients were black. The surgical rate was 66% for white patients (n=179/273) compared with 55% for black patients (n=62/113; P=.05). Negative perceptions of patient-physician communication manifested by a 5-point decrement on a 25-point communication scale (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.32-0.74) and negative perception of 1-year prognosis postsurgery (OR, 0.27; 95% CI, 0.14-0.50; absolute risk, 34%) were associated with decisions against surgery. Surgical rates for blacks were particularly low when they had 2 or more comorbid illnesses (13% vs 62% for <2 comorbidities; OR, 0.04 [95% CI, 0.01-0.25]; absolute risk, 49%) and when blacks lacked a regular source of care (42% with no regular care vs 57% with regular care; OR, 0.20 [95% CI, 0.10-0.43]; absolute risk, 15%). Conclusions A decision not to undergo surgery by patients with newly diagnosed lung cancer was independently associated with perceptions of communication and prognosis, older age, multiple comorbidities, and black race. Interventions to optimize surgery should consider these factors. JAMA. 2010; 303(23): 2368-2376	[Cykert, Samuel; Corbie-Smith, Giselle; Edwards, Lloyd J.; Bunton, Audrina Jones] Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Cykert, Samuel; Corbie-Smith, Giselle] Univ N Carolina, Sch Med, Div Gen Internal Med & Clin Epidemiol, Chapel Hill, NC USA; [Dilworth-Anderson, Peggye] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Dilworth-Anderson, Peggye] Univ N Carolina, UNC Inst Aging, Chapel Hill, NC USA; [Edwards, Lloyd J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cykert, Samuel] Greensboro Area Hlth Educ Ctr, Moses Cone Hlth Syst, Internal Med Program, Greensboro, NC USA; [Monroe, Michael H.] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA; [Walker, Paul] E Carolina Univ, Leo Jenkins Canc Ctr, Brody Sch Med, Greenville, NC USA; [McGuire, Franklin R.] Univ S Carolina, Sch Med, Div Pulm & Crit Care Med, Columbia, SC 29208 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Carolinas Medical Center; University of North Carolina; East Carolina University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Cykert, S (corresponding author), Moses Cone Hosp, Internal Med Teaching Program, 1200 N Elm St, Greensboro, NC 27401 USA.	samuel_cykert@med.unc.edu	Edwards, Lloyd/N-2759-2019	Edwards, Lloyd/0000-0002-7788-4575; Cykert, Samuel/0000-0003-2037-6809; Corbie, Giselle/0000-0003-0737-6775	American Cancer Society [RSGPB-05-217-01-CPPB]; NATIONAL CANCER INSTITUTE [R01CA150980] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the American Cancer Society via grant RSGPB-05-217-01-CPPB.	Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Baile WF, 2005, CURR OPIN ONCOL, V17, P331, DOI 10.1097/01.cco.0000167738.49325.2c; Battafarano RJ, 2002, J THORAC CARDIOV SUR, V123, P280, DOI 10.1067/mtc.2002.119338; Bickell NA, 2008, JNCI-J NATL CANCER I, V100, P1717, DOI 10.1093/jnci/djn387; Clever SL, 2006, MED CARE, V44, P398, DOI 10.1097/01.mlr.0000208117.15531.da; Cykert S, 2003, MED DECIS MAKING, V23, P167, DOI 10.1177/0272989X03251244; Dewan NA, 1997, CHEST, V112, P416, DOI 10.1378/chest.112.2.416; Diggle PJ, 2002, ANAL LONGITUDINAL DA; EDWARDS FH, 1987, CHEST, V92, P888, DOI 10.1378/chest.92.5.888; Esnaola NF, 2008, ANN THORAC SURG, V86, P220, DOI 10.1016/j.athoracsur.2008.02.072; Farjah F, 2009, ARCH SURG-CHICAGO, V144, P14, DOI 10.1001/archsurg.2008.519; Gordon HS, 2006, CANCER-AM CANCER SOC, V107, P1313, DOI 10.1002/cncr.22122; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald HP, 1998, AM J PUBLIC HEALTH, V88, P1681, DOI 10.2105/AJPH.88.11.1681; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; King WD, 2004, J GEN INTERN MED, V19, P1146, DOI 10.1111/j.1525-1497.2004.30443.x; Kraetschmer N, 2004, HEALTH EXPECT, V7, P317, DOI 10.1111/j.1369-7625.2004.00296.x; Lathan CS, 2006, J CLIN ONCOL, V24, P413, DOI 10.1200/JCO.2005.02.1758; LIN AY, 1992, JAMA-J AM MED ASSOC, V267, P1661, DOI 10.1001/jama.267.12.1661; McCann J, 2005, CHEST, V128, P3440, DOI 10.1378/chest.128.5.3440; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mulligan CR, 2006, CANCER EPIDEM BIOMAR, V15, P25, DOI 10.1158/1055-9965.EPI-05-0537; National Cancer Institute, SEER CANC STAT REV 1; Osborne RH, 1999, PSYCHOL MED, V29, P1335, DOI 10.1017/S0033291799001142; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Salkeld G, 2004, HEALTH EXPECT, V7, P104, DOI 10.1111/j.1369-7625.2004.00257.x; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Strand TE, 2007, THORAX, V62, P991, DOI 10.1136/thx.2007.079145; Torke AM, 2004, ARCH INTERN MED, V164, P525, DOI 10.1001/archinte.164.5.525; VRDOLJAK E, 1994, CHEST, V106, P1797, DOI 10.1378/chest.106.6.1797; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams SW, 2008, J PALLIAT MED, V11, P1221, DOI 10.1089/jpm.2008.0057; Wilson FL, 2008, COMPR CHILD ADOLES N, V31, P7, DOI 10.1080/01460860701877142; Yin HS, 2008, ARCH PEDIAT ADOL MED, V162, P814, DOI 10.1001/archpedi.162.9.814; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	39	181	181	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2368	2376		10.1001/jama.2010.793	http://dx.doi.org/10.1001/jama.2010.793			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	610TE	20551407	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000278759200026
J	Kitajiri, S; Sakamoto, T; Belyantseva, IA; Goodyear, RJ; Stepanyan, R; Fujiwara, I; Bird, JE; Riazuddin, S; Riazuddin, S; Ahmed, ZM; Hinshaw, JE; Sellers, J; Bartles, JR; Hammer, JA; Richardson, GP; Griffith, AJ; Frolenkov, GI; Friedman, TB				Kitajiri, Shin-ichiro; Sakamoto, Takeshi; Belyantseva, Inna A.; Goodyear, Richard J.; Stepanyan, Ruben; Fujiwara, Ikuko; Bird, Jonathan E.; Riazuddin, Saima; Riazuddin, Sheikh; Ahmed, Zubair M.; Hinshaw, Jenny E.; Sellers, James; Bartles, James R.; Hammer, John A., III; Richardson, Guy P.; Griffith, Andrew J.; Frolenkov, Gregory I.; Friedman, Thomas B.			Actin-Bundling Protein TRIOBP Forms Resilient Rootlets of Hair Cell Stereocilia Essential for Hearing	CELL			English	Article							F-ACTIN; BINDING-PROTEIN; CUTICULAR PLATE; BIRD COCHLEA; MYOSIN-XVA; FILAMENTS; INNER; ELONGATION; MOUSE; ESPIN	Inner ear hair cells detect sound through deflection of mechanosensory stereocilia. Each stereocilium is supported by a paracrystalline array of parallel actin filaments that are packed more densely at the base, forming a rootlet extending into the cell body. The function of rootlets and the molecules responsible for their formation are unknown. We found that TRIOBP, a cytoskeleton-associated protein mutated in human hereditary deafness DFNB28, is localized to rootlets. In vitro, purified TRIOBP isoform 4 protein organizes actin filaments into uniquely dense bundles reminiscent of rootlets but distinct from bundles formed by espin, an actin crosslinker in stereocilia. We generated mutant Triobp mice (Triobp(Delta ex8/Delta ex8)) that are profoundly deaf. Stereocilia of Triobp(Delta ex8/Delta ex8) mice develop normally but fail to form rootlets and are easier to deflect and damage. Thus, F-actin bundling by TRIOBP provides durability and rigidity for normal mechanosensitivity of stereocilia and may contribute to resilient cytoskeletal structures elsewhere.	[Kitajiri, Shin-ichiro; Belyantseva, Inna A.; Bird, Jonathan E.; Riazuddin, Saima; Ahmed, Zubair M.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Mol Biol & Genet Sect, NIH, Rockville, MD 20850 USA; [Sakamoto, Takeshi; Sellers, James] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Fujiwara, Ikuko; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Goodyear, Richard J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Stepanyan, Ruben; Frolenkov, Gregory I.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 54700, Pakistan; [Hinshaw, Jenny E.] NIDDKD, Struct Cell Biol Sect, NIH, Bethesda, MD 20892 USA; [Bartles, James R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Sussex; University of Kentucky; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Northwestern University; Feinberg School of Medicine	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Bird, Jonathan/0000-0001-5531-8794; Frolenkov, Gregory/0000-0002-9810-5024; Bartles, James/0000-0002-7056-3875	NIDCD/NIH [R01DC008861, R01DC009434, R01 DC004314]; Wellcome Trust [071394/Z/03/Z]; HEC; MoST, Islamabad; NIDDK; NHLBI; NIDCD [Z01 DK060100, Z01 HL004232-08, Z01 DC 000064, Z01 DC000048]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006120, ZIAHL004232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039, ZIADC000048, ZIADC000060] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission); HEC; MoST, Islamabad; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank M. Ikeya for advice and vectors, M. Streuli for mononclonal antiserum to TRIOBP-1/5, P. Belyantsev for drawings, and N. Gavara, M. Barzik, R. Chadwick, J. Schultz, and D. Drayna for discussions. This work was supported by NIDCD/NIH R01DC008861 and R01DC009434 to G.I.F., R01 DC004314 to J.R.B., the Wellcome Trust grant 071394/Z/03/Z to G.P.R., the HEC and MoST, Islamabad to S.R., intramural programs of NIDDK, NHLBI, and NIDCD Z01 DK060100 to J.E.H., Z01 DK060100 to J.A.H., Z01 HL004232-08 to J.S., Z01 DC 000064 to A.J.G., and Z01 DC000048 to T.B.	Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chen B, 1999, MOL BIOL CELL, V10, P4327, DOI 10.1091/mbc.10.12.4327; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; Frolenkov GI, 1997, BIOPHYS J, V73, P1665, DOI 10.1016/S0006-3495(97)78198-0; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; ITOH M, 1982, HEARING RES, V6, P277, DOI 10.1016/0378-5955(82)90060-0; Karavitaki KD, 2006, Auditory Mechanisms: Processes and Models, P286, DOI 10.1142/9789812773456_0048; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Matsudaira P T, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 2, P845; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Purdy KR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058105; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Seipel K, 2001, J CELL SCI, V114, P389; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; TILNEY LG, 1986, DEV BIOL, V116, P119, DOI 10.1016/0012-1606(86)90048-5; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	37	137	141	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					786	798		10.1016/j.cell.2010.03.049	http://dx.doi.org/10.1016/j.cell.2010.03.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510926	Bronze, Green Accepted			2022-12-24	WOS:000278132900014
J	Gourine, AV; Kasymov, V; Marina, N; Tang, FG; Figueiredo, MF; Lane, S; Teschemacher, AG; Spyer, KM; Deisseroth, K; Kasparov, S				Gourine, Alexander V.; Kasymov, Vitaliy; Marina, Nephtali; Tang, Feige; Figueiredo, Melina F.; Lane, Samantha; Teschemacher, Anja G.; Spyer, K. Michael; Deisseroth, Karl; Kasparov, Sergey			Astrocytes Control Breathing Through pH-Dependent Release of ATP	SCIENCE			English	Article							IN-VIVO; RETROTRAPEZOID NUCLEUS; SYNAPTIC-TRANSMISSION; NEURONS; POTENTIATION; RATS	Astrocytes provide structural and metabolic support for neuronal networks, but direct evidence demonstrating their active role in complex behaviors is limited. Central respiratory chemosensitivity is an essential mechanism that, via regulation of breathing, maintains constant levels of blood and brain pH and partial pressure of CO(2). We found that astrocytes of the brainstem chemoreceptor areas are highly chemosensitive. They responded to physiological decreases in pH with vigorous elevations in intracellular Ca(2+) and release of adenosine triphosphate (ATP). ATP propagated astrocytic Ca(2+) excitation, activated chemoreceptor neurons, and induced adaptive increases in breathing. Mimicking pH-evoked Ca(2+) responses by means of optogenetic stimulation of astrocytes expressing channelrhodopsin-2 activated chemoreceptor neurons via an ATP-dependent mechanism and triggered robust respiratory responses in vivo. This demonstrates a potentially crucial role for brain glial cells in mediating a fundamental physiological reflex.	[Gourine, Alexander V.; Kasymov, Vitaliy; Marina, Nephtali; Spyer, K. Michael] UCL, London WC1E 6BT, England; [Tang, Feige; Figueiredo, Melina F.; Lane, Samantha; Teschemacher, Anja G.; Kasparov, Sergey] Univ Bristol, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of London; University College London; University of Bristol; Stanford University	Gourine, AV (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	a.gourine@ucl.ac.uk; sergey.kasparov@bristol.ac.uk	Kasparov, Sergey/C-4932-2014; Kasparov, Sergey/AAH-5286-2019	Kasparov, Sergey/0000-0002-1824-1764; Kasparov, Sergey/0000-0002-1824-1764	British Heart Foundation [PG/09/064/27886] Funding Source: Medline; Wellcome Trust [079040] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; FUKUDA Y, 1978, PFLUG ARCH EUR J PHY, V376, P229, DOI 10.1007/BF00584955; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hwang DY, 2001, HUM GENE THER, V12, P1731, DOI 10.1089/104303401750476230; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Ritucci NA, 2005, AM J PHYSIOL-REG I, V289, pR851, DOI 10.1152/ajpregu.00132.2005; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	26	599	614	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					571	575		10.1126/science.1190721	http://dx.doi.org/10.1126/science.1190721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20647426	Green Accepted			2022-12-24	WOS:000280483500039
J	Zhang, CL; Frias, MA; Mele, A; Ruggiu, M; Eom, T; Marney, CB; Wang, HD; Licatalosi, DD; Fak, JJ; Darnell, RB				Zhang, Chaolin; Frias, Maria A.; Mele, Aldo; Ruggiu, Matteo; Eom, Taesun; Marney, Christina B.; Wang, Huidong; Licatalosi, Donny D.; Fak, John J.; Darnell, Robert B.			Integrative Modeling Defines the Nova Splicing-Regulatory Network and Its Combinatorial Controls	SCIENCE			English	Article							PROTEIN INTERACTIONS; INSIGHTS; INCLUSION; SWITCH; MOTIF	The control of RNA alternative splicing is critical for generating biological diversity. Despite emerging genome-wide technologies to study RNA complexity, reliable and comprehensive RNA-regulatory networks have not been defined. Here, we used Bayesian networks to probabilistically model diverse data sets and predict the target networks of specific regulators. We applied this strategy to identify similar to 700 alternative splicing events directly regulated by the neuron-specific factor Nova in the mouse brain, integrating RNA-binding data, splicing microarray data, Nova-binding motifs, and evolutionary signatures. The resulting integrative network revealed combinatorial regulation by Nova and the neuronal splicing factor Fox, interplay between phosphorylation and splicing, and potential links to neurologic disease. Thus, we have developed a general approach to understanding mammalian RNA regulation at the systems level.	[Zhang, Chaolin; Frias, Maria A.; Mele, Aldo; Ruggiu, Matteo; Eom, Taesun; Marney, Christina B.; Wang, Huidong; Licatalosi, Donny D.; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Zhang, CL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	czhang@rockefeller.edu; darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Marney, Christina Beate/AAK-2494-2021	Darnell, Robert B/0000-0002-5134-8088; Marney, Christina Beate/0000-0001-5475-9811; Frias, Maria A/0000-0001-7753-6290; Ruggiu, Matteo/0000-0002-6404-1210	NIH [NS34389]; Rockefeller University Hospital CTSA [UL1 RR024143]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM095713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034389, R01NS034389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Hospital CTSA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. R. Krainer for Fox1/2 expression constructs, S. Dewell for Illumina sequencing, and all Darnell lab members for helpful discussions. This work was supported by grants from the NIH to R. B. D. (NS34389) and the Rockefeller University Hospital CTSA (UL1 RR024143). R. B. D. is an Investigator of the Howard Hughes Medical Institute. The HITS-CLIP and microarray data have been deposited to the National Center for Biotechnology Information Sequence Read Archive (SRA019982) and Gene Expression Omnibus (GSE22115) databases, respectively.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P5943, DOI 10.1093/nar/gkp625; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	27	206	211	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					439	443		10.1126/science.1191150	http://dx.doi.org/10.1126/science.1191150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558669	Green Accepted			2022-12-24	WOS:000280196500037
J	Cuello, LG; Jogini, V; Cortes, DM; Pan, AC; Gagnon, DG; Dalmas, O; Cordero-Morales, JF; Chakrapani, S; Roux, B; Perozo, E				Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Pan, Albert C.; Gagnon, Dominique G.; Dalmas, Olivier; Cordero-Morales, Julio F.; Chakrapani, Sudha; Roux, Benoit; Perozo, Eduardo			Structural basis for the coupling between activation and inactivation gates in K+ channels	NATURE			English	Article							MOLECULAR ARCHITECTURE; EXTERNAL K+; POTASSIUM; ION; DYNAMICS; KCSA; PORE; MECHANISMS; MUTATIONS; STATE	The coupled interplay between activation and inactivation gating is a functional hallmark of K+ channels(1,2). This coupling has been experimentally demonstrated through ion interaction effects(3,4) and cysteine accessibility(1), and is associated with a well defined boundary of energetically coupled residues(2). The structure of the K+ channel KcsA in its fully open conformation, in addition to four other partial channel openings, richly illustrates the structural basis of activation-inactivation gating(5). Here, we identify the mechanistic principles by which movements on the inner bundle gate trigger conformational changes at the selectivity filter, leading to the non-conductive C-type inactivated state. Analysis of a series of KcsA open structures suggests that, as a consequence of the hinge-bending and rotation of the TM2 helix, the aromatic ring of Phe 103 tilts towards residues Thr 74 and Thr 75 in the pore-helix and towards Ile 100 in the neighbouring subunit. This allows the network of hydrogen bonds among residues Trp 67, Glu 71 and Asp 80 to destabilize the selectivity filter(6,7), allowing entry to its non-conductive conformation. Mutations at position 103 have a size-dependent effect on gating kinetics: small side-chain substitutions F103A and F103C severely impair inactivation kinetics, whereas larger side chains such as F103W have more subtle effects. This suggests that the allosteric coupling between the inner helical bundle and the selectivity filter might rely on straightforward mechanical deformation propagated through a network of steric contacts. Average interactions calculated from molecular dynamics simulations show favourable open-state interaction-energies between Phe 103 and the surrounding residues. We probed similar interactions in the Shaker K+ channel where inactivation was impaired in the mutant I470A. We propose that side-chain rearrangements at position 103 mechanically couple activation and inactivation in KcsA and a variety of other K+ channels.	[Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Pan, Albert C.; Gagnon, Dominique G.; Dalmas, Olivier; Cordero-Morales, Julio F.; Chakrapani, Sudha; Roux, Benoit; Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Roux, Benoit; Perozo, Eduardo] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	eperozo@uchcicago.edu	Pan, Albert/G-1475-2013	chakrapani, sudha/0000-0003-0722-2338; Cordero Morales, Julio/0000-0002-6505-5403; Pan, Albert/0000-0001-5050-5603	NIH [R01-GM57846]; Palmer family [R01-GM62342]; NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057846, R01GM062342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Palmer family; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Bezanilla, H Mchaourab and R. Nakamoto for discussions and comments on the manuscript. We also thank K. Locher for comments on the manuscript. R. Mackinnon provided the Fab-expressing hybridoma cells. We thank the members of the Perozo laboratory for comments on the manuscript. We thank K. R. Rajashankar, R. Sanishvili and the staff at the NE-CAT 24ID and GM-CA 23ID beamlines at the Advanced Photon Source, Argonne National Laboratory for assistance during data collection. This work was supported in part by NIH grant R01-GM57846 and a gift from the Palmer family to E.P., by grant R01-GM62342 to B.R. and by an NRSA postdoctoral fellowship to A.C.P.	Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chapman M, 2006, PFLUG ARCH EUR J PHY, V451, P776, DOI 10.1007/s00424-005-1515-2; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Klement G, 2008, BIOPHYS J, V94, P3014, DOI 10.1529/biophysj.107.119842; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Olcese R, 2001, J GEN PHYSIOL, V117, P149, DOI 10.1085/jgp.117.2.149; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Rotem D, 2010, J GEN PHYSIOL, V135, P29, DOI 10.1085/jgp.200910305; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Schulte U, 2001, J PHYSIOL-LONDON, V534, P49, DOI 10.1111/j.1469-7793.2001.t01-1-00049.x; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	44	223	224	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					272	U154		10.1038/nature09136	http://dx.doi.org/10.1038/nature09136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613845	Green Accepted			2022-12-24	WOS:000279580800044
J	Kim, K; Doi, A; Wen, B; Ng, K; Zhao, R; Cahan, P; Kim, J; Aryee, MJ; Ji, H; Ehrlich, LIR; Yabuuchi, A; Takeuchi, A; Cunniff, KC; Hongguang, H; Mckinney-Freeman, S; Naveiras, O; Yoon, TJ; Irizarry, RA; Jung, N; Seita, J; Hanna, J; Murakami, P; Jaenisch, R; Weissleder, R; Orkin, SH; Weissman, IL; Feinberg, AP; Daley, GQ				Kim, K.; Doi, A.; Wen, B.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Aryee, M. J.; Ji, H.; Ehrlich, L. I. R.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Yoon, T. J.; Irizarry, R. A.; Jung, N.; Seita, J.; Hanna, J.; Murakami, P.; Jaenisch, R.; Weissleder, R.; Orkin, S. H.; Weissman, I. L.; Feinberg, A. P.; Daley, G. Q.			Epigenetic memory in induced pluripotent stem cells	NATURE			English	Article							MAMMALIAN-CELLS; DNA METHYLATION; IPS CELLS; DIFFERENTIATION; TISSUE; GENERATION; MICE; ACTIVATION; MICROARRAY; SYSTEM	Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an 'epigenetic memory' of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer more readily establishes the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.	[Doi, A.; Wen, B.; Ji, H.; Irizarry, R. A.; Jung, N.; Murakami, P.; Feinberg, A. P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Doi, A.; Wen, B.; Ji, H.; Irizarry, R. A.; Jung, N.; Murakami, P.; Feinberg, A. P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Orkin, S. H.; Daley, G. Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, J.; Orkin, S. H.] Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Aryee, M. J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Ehrlich, L. I. R.; Seita, J.; Weissman, I. L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Yoon, T. J.; Weissleder, R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA; [Hanna, J.; Jaenisch, R.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA.	afeinberg@jhu.edu; george.daley@childrens.harvard.edu	Wen, Bo/P-5332-2019; Kim, Jonghwan/AAR-2815-2021; Hanna, Jacob/K-1339-2012; Feinberg, Andrew/AAY-7666-2020; Seita, Jun/AAM-1478-2020; Aryee, Martin/AAC-8113-2020; jia, xu/A-8386-2016; McKinney-Freeman, Shannon/N-8161-2018	Wen, Bo/0000-0003-0394-7366; Hanna, Jacob/0000-0003-2042-9974; Seita, Jun/0000-0002-3008-3615; McKinney-Freeman, Shannon/0000-0001-8061-2557; Kim, Jonghwan/0000-0002-9919-9843; Feinberg, Andrew/0000-0002-8364-1991; Cahan, Patrick/0000-0003-3652-2540; Naveiras, Olaia/0000-0003-3434-0022; Ji, Hong/0000-0002-9558-0620; Ehrlich, Lauren/0000-0002-1697-1755; /0000-0003-0828-4143	NIH [RO1-DK70055, RO1-DK59279, K99HL093212-01, R37CA054358, P50HG003233, R01AI047457, R01AI047458, CA86065, HL099999]; American Recovery and Reinvestment Act [RC2-HL102815]; LLS [3567-07]; Cooley's Anemia Foundation; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [T1-00001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815, U01HL099999, K99HL093212] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047457, R01AI047458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; LLS; Cooley's Anemia Foundation; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	G.Q.D is an investigator of the Howard Hughes Medical Institute and was supported by NIH grants RO1-DK70055 and RO1-DK59279, and special funds received under the American Recovery and Reinvestment Act (RC2-HL102815). K. K. was supported by NIH (K99HL093212-01), LLS (3567-07) and Cooley's Anemia Foundation. A.P.F was funded by NIH grants R37CA054358 and P50HG003233. I.L.W. was funded by NIH grants R01AI047457, R01AI047458, CA86065 and HL099999, and the Thomas and Stacey Siebel Foundation. L.I.R.E. was supported by a Special Fellow Career Development award from the Leukemia and Lymphoma Society. J.S. is supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001). We acknowledge K. Hochedlinger for sharing his manuscript before publication.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Bourne S, 2004, TISSUE ENG, V10, P796, DOI 10.1089/1076327041348293; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HOOD RCWS, 1948, STAIN TECHNOL, V23, P209, DOI 10.3109/10520294809106251; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirov G, 2003, GENOMICS, V82, P433, DOI 10.1016/S0888-7543(03)00167-8; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nadin BM, 2003, BLOOD, V102, P2436, DOI 10.1182/blood-2003-01-0118; NOMIZU T, 1994, ANAL CHEM, V66, P3000, DOI 10.1021/ac00091a004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; WDZIEKONSKI B, 2007, CURR PROTOC CELL BIO, V23; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	54	1562	1624	1	500	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					285	U60		10.1038/nature09342	http://dx.doi.org/10.1038/nature09342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20644535	Green Submitted, Green Accepted			2022-12-24	WOS:000281824900030
J	Singhal, N; Graumann, J; Wu, GM; Arauzo-Bravo, MJ; Han, DW; Greber, B; Gentile, L; Mann, M; Scholer, HR				Singhal, Nishant; Graumann, Johannes; Wu, Guangming; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Gentile, Luca; Mann, Matthias; Schoeler, Hans R.			Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; SWI/SNF COMPLEX; GENE-EXPRESSION; SELF-RENEWAL; AMINO-ACIDS; FIBROBLASTS; INDUCTION; REQUIRES; EXTRACT	Reprogramming of somatic cells achieved by combination of the four transcription factors Oct4, Sox2, Klf4, and c-Myc has very low efficiency. To increase the reprogramming efficiency and better understand the process, we sought to identify factors that mediate reprogramming with higher efficiency. We established an assay to screen nuclear fractions from extracts of pluripotent mouse cells based on Oct4 reactivation. Using proteomics, we identified components of the ATP-dependent BAF chromatin-remodeling complex, which significantly increases reprogramming efficiency when used together with the four factors. The reprogrammed cells could transmit to the germline and exhibited pluripotency. Reprogramming remained highly efficient when c-Myc was not present but BAF components were overexpressed. BAF complex components mediate this effect by facilitating enhanced Oct4 binding to target promoters during reprogramming. Thus, somatic cell reprogramming using chromatin-remodeling molecules represents an efficient method of generating reprogrammed cells.	[Singhal, Nishant; Wu, Guangming; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Gentile, Luca; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Graumann, Johannes; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Max Planck Society; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Gentile, Luca/E-4908-2019; Gentile, Luca/L-4473-2014; Graumann, Johannes/C-5241-2008; , HS/AAB-4434-2019; Han, Dong Wook/D-6041-2011; Marcos, Arauzo-Bravo/A-1706-2011; Mann, Matthias/A-3454-2013	Gentile, Luca/0000-0002-7393-7502; Graumann, Johannes/0000-0002-3015-5850; , HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Mann, Matthias/0000-0003-1292-4799; Greber, Boris/0000-0002-9404-7293; Wu, Guangming/0000-0003-1923-7609; Singhal, Nishant/0000-0002-7988-5125	Max Planck Society; Deutsche Forschungsgemeinschaft DFG [SPP 1356, SCHO 340/5-1]; Federal Ministry of Education and Research BMBF [01GN0934]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	editing the manuscript. The project was partly funded by the Max Planck Society for the advancement of Sciences, by the Deutsche Forschungsgemeinschaft DFG within the Priority Programme SPP 1356 "Pluripotency and Cellular Reprogramming" (grant SCHO 340/5-1), and by the Federal Ministry of Education and Research BMBF "Cell-based regenerative medicine-Pluripotent cells for heart therapies" (grant 01GN0934).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Miyamoto K, 2007, MOL REPROD DEV, V74, P1268, DOI 10.1002/mrd.20691; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neri T, 2007, CLONING STEM CELLS, V9, P394, DOI 10.1089/clo.2006.0011; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	45	284	303	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					943	955		10.1016/j.cell.2010.04.037	http://dx.doi.org/10.1016/j.cell.2010.04.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550931	Bronze			2022-12-24	WOS:000278618800010
J	Lee, C; Goldberg, J				Lee, Changwook; Goldberg, Jonathan			Structure of Coatomer Cage Proteins and the Relationship among COPI, COPII, and Clathrin Vesicle Coats	CELL			English	Article							ADP-RIBOSYLATION FACTOR; MOLECULAR ARCHITECTURE; ENDOPLASMIC-RETICULUM; ALPHA-COP; IN-VITRO; COMPLEX; CARGO; MEMBRANE; SUBUNITS; EXCHANGE	COPI-coated vesicles form at the Golgi apparatus from two cytosolic components, ARF G protein and coatomer, a heptameric complex that can polymerize into a cage to deform the membrane into a bud. Although coatomer shares a common evolutionary origin with COPII and clathrin vesicle coat proteins, the architectural relationship among the three cages is unclear. Strikingly, the alpha beta'-COP core of coatomer crystallizes as a triskelion in which three copies of a beta'-COP beta-propeller domain converge through their axial ends. We infer that the trimer constitutes the vertex of the COPI cage. Our model proposes that the COPI cage is intermediate in design between COPII and clathrin: COPI shares with clathrin an arrangement of three curved alpha-solenoid legs radiating from a common center, and COPI shares with COPII highly similar vertex interactions involving the axial ends of beta-propeller domains.	[Lee, Changwook; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Lee, Changwook; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	jonathan@ximpact4.ski.mskcc.org	Lee, Changwook/D-6010-2011		Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank staff at beamline X25 of the NSLS and beamline 24ID of the APS for use of and assistance with synchrotron facilities. We thank Felix Wieland and Marianna Breitman for providing full-length cDNA and baculoviruses for expression of COPI subunits. This work was supported by a grant from the Howard Hughes Medical Institute.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lowe M, 1995, J BIOL CHEM, V270, P31364, DOI 10.1074/jbc.270.52.31364; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Nickel W, 1998, J CELL SCI, V111, P3081; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	41	137	141	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					123	132		10.1016/j.cell.2010.05.030	http://dx.doi.org/10.1016/j.cell.2010.05.030			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20579721	Green Accepted, Bronze			2022-12-24	WOS:000279637300018
J	Woodward, JJ; Iavarone, AT; Portnoy, DA				Woodward, Joshua J.; Iavarone, Anthony T.; Portnoy, Daniel A.			c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response	SCIENCE			English	Article							CHECKPOINT PROTEIN; ESSENTIAL GENES; RECOGNITION; FLAGELLIN; TRANSPORTERS; INFECTION; BACTERIA; REQUIRES	Intracellular bacterial pathogens, such as Listeria monocytogenes, are detected in the cytosol of host immune cells. Induction of this host response is often dependent on microbial secretion systems and, in L. monocytogenes, is dependent on multidrug efflux pumps (MDRs). Using L. monocytogenes mutants that overexpressed MDRs, we identified cyclic diadenosine monophosphate (c-di-AMP) as a secreted molecule able to trigger the cytosolic host response. Overexpression of the di-adenylate cyclase, dacA (lmo2120), resulted in elevated levels of the host response during infection. c-di-AMP thus represents a putative bacterial secondary signaling molecule that triggers a cytosolic pathway of innate immunity and is predicted to be present in a wide variety of bacteria and archea.	[Woodward, Joshua J.; Portnoy, Daniel A.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; [Portnoy, Daniel A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Portnoy, DA (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	portnoy@berkeley.edu			NIH [P01 AI063302, T32 CA 009179]; NATIONAL CANCER INSTITUTE [T32CA009179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank K. Monroe and R. Vance for MAVS<SUP>-/-</SUP> BMDMs and Portnoy laboratory members J. D. Sauer and C. Rae for BMDMs. This work was supported by NIH grant P01 AI063302 (D. A. P.) and NIH training grant T32 CA 009179 (J. J. W.). D. A. Portnoy has a consulting relationship with and a financial interest in Aduro BioTech, which stands to benefit from commercialization of the results of this research. A patent covering the use of Listeria monocytogenes strains that express enhanced or diminished levels of c-di-AMP for use as vaccine vectors has been applied for.	Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Crimmins GT, 2008, P NATL ACAD SCI USA, V105, P10191, DOI 10.1073/pnas.0804170105; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Neyfakh AA, 1997, TRENDS MICROBIOL, V5, P309, DOI 10.1016/S0966-842X(97)01064-0; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Song JH, 2005, MOL CELLS, V19, P365; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Yang S, 2006, P NATL ACAD SCI USA, V103, P2386, DOI 10.1073/pnas.0502890102	26	546	584	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1703	1705		10.1126/science.1189801	http://dx.doi.org/10.1126/science.1189801			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20508090	Green Accepted			2022-12-24	WOS:000279107400046
J	Dasenbrook, EC; Checkley, W; Merlo, CA; Konstan, MW; Lechtzin, N; Boyle, MP				Dasenbrook, Elliott C.; Checkley, William; Merlo, Christian A.; Konstan, Michael W.; Lechtzin, Noah; Boyle, Michael P.			Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; PULMONARY-FUNCTION; CHOICE	Context The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the respiratory tract of individuals with cystic fibrosis (CF) has increased dramatically; however, its impact on outcomes in CF is unclear. Because the time between infection with bacteria in CF and death can be decades, observational studies with long periods of follow-up are well suited to address the current gap in knowledge. Objective To determine whether isolation of MRSA from the respiratory tract of CF patients is associated with worse survival compared with patients who never have a culture positive for MRSA. Design, Setting, and Participants Cohort study of 19 833 CF patients aged 6 to 45 years seen at centers accredited by the Cystic Fibrosis Foundation in the United States. Patients entered between January 1996 and December 2006 and were followed up through December 2008. Cox regression models with time-varying covariates were used to compare survival between CF patients with and without respiratory tract MRSA. Main Outcome Measure Time from age at entry until age at death from any cause. Results In 137 819 patient-years of observation (median, 7.3 years/patient), 2537 CF patients died and 5759 patients had MRSA detected. The mortality rate was 18.3 deaths (95% confidence interval [CI], 17.5-19.1) per 1000 patient-years in patients without MRSA and 27.7 deaths (95% CI, 25.3-30.4) per 1000 patient-years in those with MRSA. Among those with MRSA, the attributable risk percentage of death associated with MRSA was 34.0% (95% CI, 26.7%-40.4%). The unadjusted hazard ratio associated with MRSA was 1.47 (95% CI, 1.32-1.62). After adjustment for time-varying covariates associated with severity of illness, MRSA remained associated with a higher risk of death (1.27; 95% CI, 1.11-1.45). Conclusion Detection of MRSA in the respiratory tract of CF patients was associated with worse survival. JAMA. 2010; 303(23): 2386-2392	[Dasenbrook, Elliott C.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.] Case Western Reserve Univ, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Konstan, Michael W.] Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediat Pulmonol & Allergy Immunol, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Konstan, Michael W.] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Checkley, William; Merlo, Christian A.; Lechtzin, Noah; Boyle, Michael P.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Checkley, William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dasenbrook, EC (corresponding author), Univ Hosp Case Med Ctr, 11100 Euclid Ave,Mailstop WRN 5067, Cleveland, OH 44106 USA.	ecd28@case.edu		Checkley, William/0000-0003-1106-8812; Konstan, Michael/0000-0002-0557-7277; Boyle, Michael/0000-0002-9740-1630; Dasenbrook, Elliott/0000-0001-9811-8004	Cystic Fibrosis Foundation [DASENB08D0]; Johns Hopkins University; National Heart, Lung, and Blood Institute [K99HL096955]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Johns Hopkins University(Johns Hopkins University); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant DASENB08D0 from the Cystic Fibrosis Foundation and a Research Development Program grant to Case Western Reserve University from the Cystic Fibrosis Foundation. Dr Checkley is supported by a Clinician Scientist Award from Johns Hopkins University and a Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute.	Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; Collett D., 1994, MODELING SURVIVAL DA; *CYST FIBR FDN PAT, 2009, 2008 ANN DAT REP; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Elizur A, 2007, CHEST, V131, P1718, DOI 10.1378/chest.06-2756; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Moran A., 1999, Diabetes Research and Clinical Practice, V45, P61, DOI 10.1016/S0168-8227(99)00058-3; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sawicki GS, 2008, PEDIATR PULM, V43, P1117, DOI 10.1002/ppul.20914; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Therneau TM, 2000, MODELING SURVIVAL DA; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; VANDENBRANDEN SL, 2007, PEDIAT PULMONOL S30, V42, pS365; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S	21	251	253	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2386	2392		10.1001/jama.2010.791	http://dx.doi.org/10.1001/jama.2010.791			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551409	Bronze			2022-12-24	WOS:000278759200028
J	Aragao, LEOC; Shimabukuro, YE				Aragao, Luiz E. O. C.; Shimabukuro, Yosio E.			The Incidence of Fire in Amazonian Forests with Implications for REDD	SCIENCE			English	Article							CLIMATE-CHANGE; DEFORESTATION; EMISSIONS; REGROWTH; BIOMASS; DIEBACK; CARBON	Reducing emissions from deforestation and degradation (REDD) may curb carbon emissions, but the consequences for fire hazard are poorly understood. By analyzing satellite-derived deforestation and fire data from the Brazilian Amazon, we show that fire occurrence has increased in 59% of the area that has experienced reduced deforestation rates. Differences in fire frequencies across two land-use gradients reveal that fire-free land-management can substantially reduce fire incidence by as much as 69%. If sustainable fire-free land-management of deforested areas is not adopted in the REDD mechanism, then the carbon savings achieved by avoiding deforestation may be partially negated by increased emissions from fires.	[Aragao, Luiz E. O. C.] Univ Exeter, Sch Geog, Landscape & Ecosyst Dynam Grp, Exeter EX4 4RJ, Devon, England; [Shimabukuro, Yosio E.] Natl Inst Space Res, Remote Sensing Div, BR-12227010 Sao Paulo, Brazil	University of Exeter; Instituto Nacional de Pesquisas Espaciais (INPE)	Aragao, LEOC (corresponding author), Univ Exeter, Sch Geog, Landscape & Ecosyst Dynam Grp, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.	l.aragao@exeter.ac.uk	Shimabukuro, Yosio E/F-2956-2012; aragao, luiz eoc/G-8387-2012	Shimabukuro, Yosio E/0000-0002-1469-8433; aragao, luiz eoc/0000-0002-4134-6708	U.K. Natural Environment Research Council [NE/F015356/2]; NERC [NE/F015356/2] Funding Source: UKRI; Natural Environment Research Council [NE/F015356/2] Funding Source: researchfish	U.K. Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the U.K. Natural Environment Research Council for providing funds to L.E.O.C.A. (NE/F015356/2). We acknowledge the valuable discussions with L. Anderson, T. Quine, and P. Cox during elaboration of this manuscript and thank A. Lima for providing the MODIS fire data set for the supporting analysis. We thank the Brazilian Institute for Space Research for making available their deforestation and fire data sets and the European Commission's Joint Research Centre for making available their land cover map.	Alves DS, 2002, INT J REMOTE SENS, V23, P2903, DOI 10.1080/01431160110096791; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Carvalho GO, 2002, ENVIRONMENT, V44, P34, DOI 10.1080/00139150209605606; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Denich M, 2005, AGR ECOSYST ENVIRON, V110, P43, DOI 10.1016/j.agee.2005.05.005; Eva H, 2000, J BIOGEOGR, V27, P765, DOI 10.1046/j.1365-2699.2000.00441.x; Eva HD, 2004, GLOBAL CHANGE BIOL, V10, P731, DOI 10.1111/j.1529-8817.2003.00774.x; Ewers RM, 2008, ENVIRON CONSERV, V35, P303, DOI 10.1017/S0376892908005122; Fearnside PM, 2007, FOREST ECOL MANAG, V242, P678, DOI 10.1016/j.foreco.2007.02.002; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; *INPE, PRODES PROGR DEF ASS; *INPE, 2006, QUEIM PROJ; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671	29	200	205	8	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1275	1278		10.1126/science.1186925	http://dx.doi.org/10.1126/science.1186925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522775				2022-12-24	WOS:000278318600034
J	Jackson, LP; Kelly, BT; McCoy, AJ; Gaffry, T; James, LC; Collins, BM; Honing, S; Evans, PR; Owen, DJ				Jackson, Lauren P.; Kelly, Bernard T.; McCoy, Airlie J.; Gaffry, Thomas; James, Leo C.; Collins, Brett M.; Hoening, Stefan; Evans, Philip R.; Owen, David J.			A Large-Scale Conformational Change Couples Membrane Recruitment to Cargo Binding in the AP2 Clathrin Adaptor Complex	CELL			English	Article							COATED VESICLES; STRUCTURAL EXPLANATION; SORTING SIGNALS; MEDIATED ENDOCYTOSIS; MOLECULAR-GRAPHICS; PHASE INFORMATION; APPENDAGE DOMAIN; ALPHA-ADAPTIN; PROTEINS; RECOGNITION	The AP2 adaptor complex (alpha, beta 2, sigma 2, and mu 2 sub-units) crosslinks the endocytic clathrin scaffold to PtdIns4,5P(2)-containing membranes and transmembrane protein cargo. In the "locked" cytosolic form, AP2's binding sites for the two endocytic motifs, Yxx Phi on the C-terminal domain of mu 2 (C-mu 2) and [ED]xxxL[LI] on sigma 2, are blocked by parts of beta 2. Using protein crystallography, we show that AP2 undergoes a large conformational change in which C-mu 2 relocates to an orthogonal face of the complex, simultaneously unblocking both cargo-binding sites; the previously unstructured mu 2 linker becomes helical and binds back onto the complex. This structural rearrangement results in AP2's four PtdIns4,5P(2)- and two endocytic motif-binding sites becoming coplanar, facilitating their simultaneous interaction with PtdIns4,5P(2)/cargo-containing membranes. Using a range of biophysical techniques, we show that the endocytic cargo binding of AP2 is driven by its interaction with PtdIns4,5P(2)-containing membranes.	[James, Leo C.; Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Jackson, Lauren P.; Kelly, Bernard T.; McCoy, Airlie J.; Owen, David J.] Univ Cambridge, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	MRC Laboratory Molecular Biology; University of Cambridge; University of Cologne; University of Cologne; University of Queensland	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	pre@mrc-lmb.cam.ac.uk; djo30@cam.ac.uk	Collins, Brett/J-1563-2014	Collins, Brett/0000-0002-6070-3774; Jackson, Lauren/0000-0002-3705-6126	Wellcome Trust; German Science Foundation [SFB 635, TP3, SFB 670 TP7]; Center for Molecular Medicine Cologne [TP C3]; National Health and Medical Research Council (NHMRC), Australia; MRC [MC_U105181010, MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105181010, MC_U105178845] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); German Science Foundation(German Research Foundation (DFG)); Center for Molecular Medicine Cologne; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the staff of ID29 at the ESRF, especially Elspeth Gordon, and beamline staff at Diamond Lightsource, especially Katherine McAuley and Dave Hall. We also thank Maria Jose Sanchez Barrena for assistance in data collection, Meredith Roberts-Thompson for assistance with fluorescence anisotropy measurements, and Margaret Robinson for access to the transmembrane protein database. We thank Lesley McKeane for creating part of Figure 3. D.J.O., L.P.J., and B. T. K. are supported by a Wellcome Trust Senior Fellowship to D.J.O.; T. G. and S. H. are supported by the German Science Foundation (SFB 635, TP3, SFB 670 TP7) and the Center for Molecular Medicine Cologne (TP C3); and B. M. C. is supported by a Career Development Award from the National Health and Medical Research Council (NHMRC), Australia.	Abrahams JP, 1997, ACTA CRYSTALLOGR D, V53, P371, DOI 10.1107/S0907444996015272; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Austin C, 2000, J BIOL CHEM, V275, P21862, DOI 10.1074/jbc.M908875199; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; KEEN JH, 1981, J BIOL CHEM, V256, P2538; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; KRISSINEL E, 2005, DETECTION PROTEIN AS; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x	55	232	239	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1220	U213		10.1016/j.cell.2010.05.006	http://dx.doi.org/10.1016/j.cell.2010.05.006			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603002	Green Published, hybrid			2022-12-24	WOS:000279148100018
J	Langston, RF; Ainge, JA; Couey, JJ; Canto, CB; Bjerknes, TL; Witter, MP; Moser, EI; Moser, MB				Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Development of the Spatial Representation System in the Rat	SCIENCE			English	Article							ENTORHINAL CORTEX; PLACE CELLS; GRID CELLS; PATH-INTEGRATION; MAP; MODEL; HIPPOCAMPUS; DIRECTION	In the adult brain, space and orientation are represented by an elaborate hippocampal-parahippocampal circuit consisting of head-direction cells, place cells, and grid cells. We report that a rudimentary map of space is already present when 21/2-week-old rat pups explore an open environment outside the nest for the first time. Head-direction cells in the pre- and parasubiculum have adultlike properties from the beginning. Place and grid cells are also present but evolve more gradually. Grid cells show the slowest development. The gradual refinement of the spatial representation is accompanied by an increase in network synchrony among entorhinal stellate cells. The presence of adultlike directional signals at the onset of navigation raises the possibility that such signals are instrumental in setting up networks for place and grid representation.	[Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, Med Tech Res Ctr, N-7489 Trondheim, Norway; [Ainge, James A.] Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of St Andrews	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Ainge, James A/D-5831-2012; Couey, Jonathan/GXG-6340-2022	Ainge, James A/0000-0002-0007-1533; Langston, Rosamund/0000-0002-4668-3105; Couey, Jonathan/0000-0003-2658-692X; Bjerknes, Tale Litlere/0000-0001-7518-5132	European Commission; Kavli Foundation; Research Council of Norway	European Commission(European CommissionEuropean Commission Joint Research Centre); Kavli Foundation; Research Council of Norway(Research Council of Norway)	We thank R. Skjerpeng for programming; C. N. Boccara for sharing adult pre- and parasubiculum data; and A. M. Amundsgard, K. Haugen, K. Jenssen, H. Waade, and T. Asmul for technical assistance. Supported by Fondation Bettencourt-Schueller, Seventh Framework Programme of the European Commission (SPACEBRAIN), Kavli Foundation, and a Centre of Excellence grant from the Research Council of Norway.	BOCCARA CN, 2008, SOC NEUROSCI ABSTR, V34; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Kant I., 1781, KRITIK REINEN VERNUN; Martin PD, 2002, HIPPOCAMPUS, V12, P465, DOI 10.1002/hipo.10021; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420	20	389	395	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1576	1580		10.1126/science.1188210	http://dx.doi.org/10.1126/science.1188210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558721				2022-12-24	WOS:000278859200052
J	Mangan, SA; Schnitzer, SA; Herre, EA; Mack, KML; Valencia, MC; Sanchez, EI; Bever, JD				Mangan, Scott A.; Schnitzer, Stefan A.; Herre, Edward A.; Mack, Keenan M. L.; Valencia, Mariana C.; Sanchez, Evelyn I.; Bever, James D.			Negative plant-soil feedback predicts tree-species relative abundance in a tropical forest	NATURE			English	Article							LOCAL NEIGHBORHOOD; DENSITY-DEPENDENCE; SEEDLING MORTALITY; MAINTAIN DIVERSITY; SPATIAL-PATTERNS; PATHOGENS; COMMUNITY; GROWTH; RECRUITMENT; COEXISTENCE	The accumulation of species-specific enemies around adults is hypothesized to maintain plant diversity by limiting the recruitment of conspecific seedlings relative to heterospecific seedlings(1-6). Although previous studies in forested ecosystems have documented patterns consistent with the process of negative feedback(7-16), these studies are unable to address which classes of enemies (for example, pathogens, invertebrates, mammals) exhibit species-specific effects strong enough to generate negative feedback(17), and whether negative feedback at the level of the individual tree is sufficient to influence community-wide forest composition. Here we use fully reciprocal shade-house and field experiments to test whether the performance of conspecific tree seedlings (relative to heterospecific seedlings) is reduced when grown in the presence of enemies associated with adult trees. Both experiments provide strong evidence for negative plant-soil feedback mediated by soil biota. In contrast, above-ground enemies (mammals, foliar herbivores and foliar pathogens) contributed little to negative feedback observed in the field. In both experiments, we found that tree species that showed stronger negative feedback were less common as adults in the forest community, indicating that susceptibility to soil biota may determine species relative abundance in these tropical forests. Finally, our simulation models confirm that the strength of local negative feedback that we measured is sufficient to produce the observed community-wide patterns in tree-species relative abundance. Our findings indicate that plant-soil feedback is an important mechanism that can maintain species diversity and explain patterns of tree-species relative abundance in tropical forests.	[Mangan, Scott A.; Schnitzer, Stefan A.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Mangan, Scott A.; Schnitzer, Stefan A.; Herre, Edward A.; Sanchez, Evelyn I.] Smithsonian Trop Res Inst, MRC 0580 06, Dpo, AA 34002 USA; [Mack, Keenan M. L.; Bever, James D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Valencia, Mariana C.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mangan, SA (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	smangan37@gmail.com		Schnitzer, Stefan/0000-0002-2715-9455	Smithsonian Tropical Research Institute (STRI); University of Wisconsin-Milwaukee (UWM) Research Growth Initiative; UWM Research Foundation; National Science Foundation; STRI Soil Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092660] Funding Source: NIH RePORTER	Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of Wisconsin-Milwaukee (UWM) Research Growth Initiative; UWM Research Foundation; National Science Foundation(National Science Foundation (NSF)); STRI Soil Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Adler, M. Kaspari, E. Leigh, T. Lambert, I. Rubinoff, E. Tanner, M. Tobin, B. Turner, S. Van Bael and N. Wurzburger for providing discussions and comments on the manuscript. R. Kolodziej, K. Meyer, K. McElligott and T. Shirshac provided greenhouse and field assistance. Logistical support was provided by the Smithsonian Tropical Research Institute. The Center of Tropical Forest Science provided BCI tree abundance data published online at https://ctfs.arnarb.harvard.edu/webatlas/datasets/bci/abundance. This study was supported by a Smithsonian Tropical Research Institute (STRI) postdoctoral fellowship to S. A. M., a University of Wisconsin-Milwaukee (UWM) Research Growth Initiative grant to S. A. S., a fellowship from the UWM Research Foundation, and a grant from the National Science Foundation to J.D.B. We thank I. Rubinoff for his support of the STRI Soil Initiative.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Carson WP., 2008, TROPICAL FOREST COMM, P210; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; COMITA LS, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1190772; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; HUBBELI SP, 2001, UNIFIED NEUTRAL THEO; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; McCarthy-Neumann S, 2010, J ECOL, V98, P396, DOI 10.1111/j.1365-2745.2009.01619.x; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	30	703	725	20	664	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					752	U10		10.1038/nature09273	http://dx.doi.org/10.1038/nature09273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20581819	Green Submitted			2022-12-24	WOS:000280562500038
J	Siegel, JB; Zanghellini, A; Lovick, HM; Kiss, G; Lambert, AR; Clair, JLS; Gallaher, JL; Hilvert, D; Gelb, MH; Stoddard, BL; Houk, KN; Michael, FE; Baker, D				Siegel, Justin B.; Zanghellini, Alexandre; Lovick, Helena M.; Kiss, Gert; Lambert, Abigail R.; Clair, Jennifer L. St.; Gallaher, Jasmine L.; Hilvert, Donald; Gelb, Michael H.; Stoddard, Barry L.; Houk, Kendall N.; Michael, Forrest E.; Baker, David			Computational Design of an Enzyme Catalyst for a Stereoselective Bimolecular Diels-Alder Reaction	SCIENCE			English	Article							MACROPHOMATE SYNTHASE; CYCLODEXTRINS; ANTIBODIES; ORIGINS	The Diels-Alder reaction is a cornerstone in organic synthesis, forming two carbon-carbon bonds and up to four new stereogenic centers in one step. No naturally occurring enzymes have been shown to catalyze bimolecular Diels-Alder reactions. We describe the de novo computational design and experimental characterization of enzymes catalyzing a bimolecular Diels-Alder reaction with high stereoselectivity and substrate specificity. X-ray crystallography confirms that the structure matches the design for the most active of the enzymes, and binding site substitutions reprogram the substrate specificity. Designed stereoselective catalysts for carbon-carbon bond-forming reactions should be broadly useful in synthetic chemistry.	[Siegel, Justin B.; Zanghellini, Alexandre; Clair, Jennifer L. St.; Gallaher, Jasmine L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Siegel, Justin B.; Zanghellini, Alexandre; Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Lovick, Helena M.; Gelb, Michael H.; Michael, Forrest E.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Kiss, Gert; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lambert, Abigail R.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; gelb, michael/0000-0001-7000-5219; Michael, Forrest/0000-0001-8071-4676	Defense Advanced Research Projects Agency (DARPA); Howard Hughes Medical Institute (HHMI); NIH; Lawrence Livermore National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075962, T32GM008268] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Defense Advanced Research Projects Agency (DARPA), the Howard Hughes Medical Institute (HHMI), a Molecular Biophysics traineeship from the NIH for J.B.S., and the Lawrence Livermore National Laboratory Lawrence Scholars program for G. K. We thank M. Toscano (ETH) and C. Rosewall (University of Washington) for chemical synthesis and B. Siegel and Y.-h. Lam for helpful comments on the manuscript. The x-ray crystallographic coordinates have been deposited in the Protein Data Bank with accession ID 3I1C. The University of Washington has submitted a patent application on the protein sequence coding for the engineered enzymes reported here as well as some of the design methodology.	[Anonymous], PYMOL MOL GRAPH SYST; BLAKE JF, 1994, J ORG CHEM, V59, P803, DOI 10.1021/jo00083a021; Boger D., 1999, MODERN ORGANIC SYNTH, P213; Breslow R, 1998, CHEM REV, V98, P1997, DOI 10.1021/cr970011j; Cannizzaro CE, 2003, J AM CHEM SOC, V125, P2489, DOI 10.1021/ja020879d; GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kim SP, 2002, J ORG CHEM, V67, P4250, DOI 10.1021/jo011180d; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; YLIKAUHALUOMA JT, 1995, J AM CHEM SOC, V117, P7041, DOI 10.1021/ja00132a001; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	15	609	642	10	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					309	313		10.1126/science.1190239	http://dx.doi.org/10.1126/science.1190239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	625VW	20647463	Green Accepted			2022-12-24	WOS:000279925900037
J	Kasanetz, F; Deroche-Gamonet, V; Berson, N; Balado, E; Lafourcade, M; Manzoni, O; Piazza, PV				Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo			Transition to Addiction Is Associated with a Persistent Impairment in Synaptic Plasticity	SCIENCE			English	Article							LONG-TERM DEPRESSION; DRUG-SEEKING; COCAINE ADDICTION; NEURAL MECHANISMS; NUCLEUS-ACCUMBENS; BEHAVIOR; LTD; VTA	Chronic exposure to drugs of abuse induces countless modifications in brain physiology. However, the neurobiological adaptations specifically associated with the transition to addiction are unknown. Cocaine self-administration rapidly suppresses long-term depression (LTD), an important form of synaptic plasticity in the nucleus accumbens. Using a rat model of addiction, we found that animals that progressively develop the behavioral hallmarks of addiction have permanently impaired LTD, whereas LTD is progressively recovered in nonaddicted rats maintaining a controlled drug intake. By making drug seeking consistently resistant to modulation by environmental contingencies and consequently more and more inflexible, a persistently impaired LTD could mediate the transition to addiction.	[Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo] INSERM, U862, NeuroCtr Magendie, F-33077 Bordeaux, France; [Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo] Univ Bordeaux, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Manzoni, O (corresponding author), INSERM, U862, NeuroCtr Magendie, 147 Rue Leo Saignat, F-33077 Bordeaux, France.	olivier.manzoni@inserm.fr; pier-vincenzo.piazza@inserm.fr	Lafourcade, Mathieu/GQZ-7267-2022; Deroche-Gamonet, Véronique/E-5728-2010; Manzoni, Olivier/M-7899-2016	Manzoni, Olivier/0000-0002-5579-6208; Lafourcade, Mathieu/0000-0001-6117-1194; Kasanetz, Fernando/0000-0003-4585-2314; Deroche-Gamonet, Veronique/0000-0002-9704-6624	ANR [2005]; EU-STREPPheCOMP; MILDT/INCa/Inserm [2008]	ANR(French National Research Agency (ANR)); EU-STREPPheCOMP; MILDT/INCa/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Institut National du Cancer (INCA) France)	Supported by ANR (2005), EU-STREPPheCOMP (FP6), MILDT/INCa/Inserm (2008) grants to P. V. P., O.M., and V. D.-G. The authors report no conflict of interest.	Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, NAT NEUROSCI, V8, P1440, DOI 10.1038/nn1105-1440; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; Panlilio LV, 2007, ADDICTION, V102, P1863, DOI 10.1111/j.1360-0443.2007.02011.x; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	30	270	274	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1709	1712		10.1126/science.1187801	http://dx.doi.org/10.1126/science.1187801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576893				2022-12-24	WOS:000279107400048
J	Lee, JH; Yu, WH; Kumar, A; Lee, S; Mohan, PS; Peterhoff, CM; Wolfe, DM; Martinez-Vicente, M; Massey, AC; Sovak, G; Uchiyama, Y; Westaway, D; Cuervo, AM; Nixon, RA				Lee, Ju-Hyun; Yu, W. Haung; Kumar, Asok; Lee, Sooyeon; Mohan, Panaiyur S.; Peterhoff, Corrinne M.; Wolfe, Devin M.; Martinez-Vicente, Marta; Massey, Ashish C.; Sovak, Guy; Uchiyama, Yasuo; Westaway, David; Cuervo, Ana Maria; Nixon, Ralph A.			Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations	CELL			English	Article							POSTTRANSLATIONAL N-GLYCOSYLATION; INTRACELLULAR PROTEIN-DEGRADATION; CATHEPSIN-D; MOUSE MODELS; ACIDIC ORGANELLES; DISEASE; ATPASE; ACIDIFICATION; NEURONS; CELLS	Macroautophagy is a lysosomal degradative pathway essential for neuron survival. Here, we show that macroautophagy requires the Alzheimer's disease (AD)-related protein presenilin-1 (PS1). In PS1 null blastocysts, neurons from mice hypomorphic for PS1 or conditionally depleted of PS1, substrate proteolysis and autophagosome clearance during macroautophagy are prevented as a result of a selective impairment of autolysosome acidification and cathepsin activation. These deficits are caused by failed PS1-dependent targeting of the v-ATPase V0a1 subunit to lysosomes. N-glycosylation of the V0a1 subunit, essential for its efficient ER-to-lysosome delivery, requires the selective binding of PS1 holoprotein to the unglycosylated subunit and the Sec61alpha/oligosaccharyltransferase complex. PS1 mutations causing early-onset AD produce a similar lysosomal/autophagy phenotype in fibroblasts from AD patients. PS1 is therefore essential for v-ATPase targeting to lysosomes, lysosome acidification, and proteolysis during autophagy. Defective lysosomal proteolysis represents a basis for pathogenic protein accumulations and neuronal cell death in AD and suggests previously unidentified therapeutic targets.	[Lee, Ju-Hyun; Yu, W. Haung; Kumar, Asok; Lee, Sooyeon; Mohan, Panaiyur S.; Peterhoff, Corrinne M.; Wolfe, Devin M.; Nixon, Ralph A.] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Lee, Ju-Hyun; Yu, W. Haung; Mohan, Panaiyur S.; Nixon, Ralph A.] NYU, Langone Med Ctr, Dept Psychiat, New York, NY 10016 USA; [Kumar, Asok] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Lee, Sooyeon] NYU, Langone Med Ctr, Dept Neurosci, New York, NY 10016 USA; [Nixon, Ralph A.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Martinez-Vicente, Marta; Massey, Ashish C.; Sovak, Guy; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Res, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan; [Westaway, David] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Yeshiva University; Albert Einstein College of Medicine; Juntendo University; University of Alberta	Nixon, RA (corresponding author), Nathan S Kline Inst, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	nixon@nki.rfmh.org	Martinez-Vicente, Marta/K-4312-2014	Martinez-Vicente, Marta/0000-0001-7053-2625; Lee, Ju-hyun/0000-0002-0280-8375; Cuervo, Ana Maria/0000-0002-0771-700X; Yu, Wai Haung/0000-0001-7186-6731	National Institutes of Health [P01AG017617]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are very grateful to Alan Bernstein (Global HIV Vaccine Enterprise, Seattle) for blastocysts, Tamotsu Yoshimori (Osaka University) for the tandem-tagged LC3 construct, Samuel E. Gandy (Mount Sinai Medical Center) for PS1 antibody, Satoshi Sato (Kyoto University) for the rabbit pAb against 116 kDa subunit of the v-ATPase, Jean Gruenberg (Universite de Geneve) for anti-LBPA antibody, and Richard Cowburn (Karolinska Institute), Ralph Martins (Cornell University), Sandro Sorbi (Universita degli studi di Firenze) for PS1-FAD human fibroblasts, and Sangram S. Sisodia (University of Chicago) for PS cKO mice. We also thank Gert Kreibich (New York University Langone Medical Center) and members of the Nixon laboratory for valuable discussions and Nicole Piorkowski for assistance with manuscript preparation. This work was supported by National Institutes of Health grant number P01AG017617 (R.A.N) and the Alzheimer's Association (R.A.N).	ANDERSON RGW, 1984, P NATL ACAD SCI-BIOL, V81, P4838, DOI 10.1073/pnas.81.15.4838; AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Diwu ZJ, 1999, CHEM BIOL, V6, P411, DOI 10.1016/S1074-5521(99)80059-3; DOTTAVIOMARTIN D, 1978, ANAL BIOCHEM, V87, P562, DOI 10.1016/0003-2697(78)90706-6; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; GILLESPIE J, 1991, FEBS LETT, V282, P69, DOI 10.1016/0014-5793(91)80446-A; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim TW, 1997, CURR OPIN NEUROBIOL, V7, P683, DOI 10.1016/S0959-4388(97)80089-X; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; NAKANISHI H, 1994, EXP NEUROL, V126, P119, DOI 10.1006/exnr.1994.1048; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; U.S. Office of Science and Technology Policy, 1985, Fed Regist, V50, P20864; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	53	806	827	6	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1146	U91		10.1016/j.cell.2010.05.008	http://dx.doi.org/10.1016/j.cell.2010.05.008			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20541250	Bronze, Green Accepted			2022-12-24	WOS:000279148100012
J	Wu, XL; Yang, ZY; Li, YX; Hogerkorp, CM; Schief, WR; Seaman, MS; Zhou, TQ; Schmidt, SD; Wu, L; Xu, L; Longo, NS; McKee, K; O'Dell, S; Louder, MK; Wycuff, DL; Feng, Y; Nason, M; Doria-Rose, N; Connors, M; Kwong, PD; Roederer, M; Wyatt, RT; Nabel, GJ; Mascola, JR				Wu, Xueling; Yang, Zhi-Yong; Li, Yuxing; Hogerkorp, Carl-Magnus; Schief, William R.; Seaman, Michael S.; Zhou, Tongqing; Schmidt, Stephen D.; Wu, Lan; Xu, Ling; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Louder, Mark K.; Wycuff, Diane L.; Feng, Yu; Nason, Martha; Doria-Rose, Nicole; Connors, Mark; Kwong, Peter D.; Roederer, Mario; Wyatt, Richard T.; Nabel, Gary J.; Mascola, John R.			Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1	SCIENCE			English	Article							TYPE-1 INFECTION; HIGH-AFFINITY; VIRUS; GP120; BREADTH; GLYCOPROTEIN; INDIVIDUALS; PANEL; IMMUNOGENICITY; SPECIFICITIES	Cross-reactive neutralizing antibodies (NAbs) are found in the sera of many HIV-1-infected individuals, but the virologic basis of their neutralization remains poorly understood. We used knowledge of HIV-1 envelope structure to develop antigenically resurfaced glycoproteins specific for the structurally conserved site of initial CD4 receptor binding. These probes were used to identify sera with NAbs to the CD4-binding site (CD4bs) and to isolate individual B cells from such an HIV-1-infected donor. By expressing immunoglobulin genes from individual cells, we identified three monoclonal antibodies, including a pair of somatic variants that neutralized over 90% of circulating HIV-1 isolates. Exceptionally broad HIV-1 neutralization can be achieved with individual antibodies targeted to the functionally conserved CD4bs of glycoprotein 120, an important insight for future HIV-1 vaccine design.	[Wu, Xueling; Yang, Zhi-Yong; Li, Yuxing; Hogerkorp, Carl-Magnus; Zhou, Tongqing; Schmidt, Stephen D.; Wu, Lan; Xu, Ling; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Louder, Mark K.; Wycuff, Diane L.; Feng, Yu; Kwong, Peter D.; Roederer, Mario; Wyatt, Richard T.; Nabel, Gary J.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Doria-Rose, Nicole; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov; jmascola@nih.gov	Schmidt, Stephen/AAC-6967-2019; Schief, William/ABF-3645-2020; Feng, Yu/A-3396-2012; Zhou, Tongqing/A-6880-2010; Mascola, John/AAI-7193-2021; Roederer, Mario/G-1887-2011; Schmidt, Stephen/B-5398-2012	Schief, William/0000-0002-1120-0150; Zhou, Tongqing/0000-0002-3935-4637; 	Vaccine Research Center; Division of Clinical Research; Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH; Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005002, ZIAAI005067, ZIAAI005089, ZIAAI005095, ZIAAI005022, ZIAAI001090, ZIAAI005010] Funding Source: NIH RePORTER	Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Clinical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, the Division of Clinical Research and the Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH. M.S.S. was supported in part by the Bill and Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery, Comprehensive Antibody-Vaccine Immune Monitoring Consortium, grant number 38619. W.R.S. was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery through a grant to Seattle Biomedical Research Institute and by the International AIDS Vaccine Initiative. Nucleotide sequences of VRC01, VRC02, and VRC03 variable regions are available under GenBank accession numbers GU980702 to GU980707. Patent applications have been filed by the NIH on mAbs VRC01, VRC02, and VRC03 (listed investigators are X.W., Z.Y.Y., Y.L., C.M.H, W.R.S., T.Z., M.C., P.D.K., M.R., R.T.W., G.J.N., and J.R.M.) and on the RSC3 probe (listed investigators are Z.Y.Y., W.R.S., T.Z., P.D.K. and G.J.N.). We thank M. Nussenzweig and J. Scheid (Laboratory of Molecular Immunology, Howard Hughes Medical Institute, Rockefeller University, New York, NY) for sharing expertise and reagents for IgG cloning and expression; B. Haynes (Duke University Medical Center, Durham, NC) for sharing reagents and PCR methods; S. Perfetto, R. Nguyen, and D. Ambrozak for assistance with cell sorting; E. Lybarger for neutralization assays; J. Stuckey and B. Hartman for assistance with figures; A. Tislerics for manuscript preparation; D. Follman for statistical advice; C. Carrico for discussions on resurfacing; Y.-E.A. Ban and L. Kong for glycan modeling; P. Chattopadhyay and J. Yu for fluorescent antibody production and qualification; C. Williamson (University of Capetown, Capetown, South Africa), M. Thomson (Instituto de Salud Carlos III, Madrid, Spain), J. Overbaugh (Fred Hutchinson Cancer Research Center, Seattle, WA), and S. Tovanabutra and E. Sanders-Buell (Henry M. Jackson Foundation and the U. S. Military HIV Research Program, Rockville, MD) for contributing HIV-1 Env plasmids for pseudovirus production.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Montefiori DC, 2007, CURR OPIN HIV AIDS, V2, P169, DOI 10.1097/COH.0b013e3280ef691e; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	33	1278	1397	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					856	861		10.1126/science.1187659	http://dx.doi.org/10.1126/science.1187659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20616233	Green Accepted			2022-12-24	WOS:000280809900055
J	Cai, JM; Ruffieux, P; Jaafar, R; Bieri, M; Braun, T; Blankenburg, S; Muoth, M; Seitsonen, AP; Saleh, M; Feng, XL; Mullen, K; Fasel, R				Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Muoth, Matthias; Seitsonen, Ari P.; Saleh, Moussa; Feng, Xinliang; Muellen, Klaus; Fasel, Roman			Atomically precise bottom-up fabrication of graphene nanoribbons	NATURE			English	Article							CARBON; FORM	Graphene nanoribbons-narrow and straight-edged stripes of graphene, or single-layer graphite-are predicted to exhibit electronic properties that make them attractive for the fabrication of nanoscale electronic devices(1-3). In particular, although the twodimensional parent material graphene(4,5) exhibits semimetallic behaviour, quantum confinement and edge effects(2,6) should render all graphene nanoribbons with widths smaller than 10 nm semiconducting. But exploring the potential of graphene nanoribbons is hampered by their limited availability: although they have been made using chemical(7-9), sonochemical(10) and lithographic(11,12) methods as well as through the unzipping of carbon nanotubes(13-16), the reliable production of graphene nanoribbons smaller than 10 nm with chemical precision remains a significant challenge. Here we report a simple method for the production of atomically precise graphene nanoribbons of different topologies and widths, which uses surface-assisted coupling(17,18) of molecular precursors into linear polyphenylenes and their subsequent cyclodehydrogenation(19,20). The topology, width and edge periphery of the graphene nanoribbon products are defined by the structure of the precursor monomers, which can be designed to give access to a wide range of different graphene nanoribbons. We expect that our bottom-up approach to the atomically precise fabrication of graphene nanoribbons will finally enable detailed experimental investigations of the properties of this exciting class of materials. It should even provide a route to graphene nanoribbon structures with engineered chemical and electronic properties, including the theoretically predicted intraribbon quantum dots(21), superlattice structures(22) and magnetic devices based on specific graphene nanoribbon edge states(3).	[Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-3602 Thun, Switzerland; [Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-8600 Dubendorf, Switzerland; [Muoth, Matthias] ETH, Dept Mech & Proc Engn Micro & Nanosyst, CH-8092 Zurich, Switzerland; [Seitsonen, Ari P.] Univ Zurich, Inst Phys Chem, CH-8057 Zurich, Switzerland; [Seitsonen, Ari P.] CNRS, IMPMC, F-75252 Paris, France; [Seitsonen, Ari P.] Univ Paris 06, F-75252 Paris, France; [Saleh, Moussa; Feng, Xinliang; Muellen, Klaus] Max Planck Inst Polymer Res, D-55124 Mainz, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of Bern	Fasel, R (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-3602 Thun, Switzerland.	muellen@mpip-mainz.mpg.de; roman.fasel@empa.ch	Fasel, Roman/B-5396-2011; Fasel, Roman/M-9992-2019; Ruffieux, Pascal/E-8227-2010; Seitsonen, Ari P/B-1552-2009; cai, jinming/G-7604-2015	Fasel, Roman/0000-0002-1553-6487; Fasel, Roman/0000-0002-1553-6487; Ruffieux, Pascal/0000-0001-5729-5354; Seitsonen, Ari P/0000-0003-4331-0650; cai, jinming/0000-0003-0869-1515; Feng, Xinliang/0000-0003-3885-2703; Bieri, Marco/0000-0002-9831-2146	Swiss National Science Foundation; NCCR Nanoscale Science; Max Planck Society; German Science Foundation (Korean-German IRTG); DFG [SPP 1355, DFG MU 334/32-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Nanoscale Science(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation (Korean-German IRTG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation and the NCCR Nanoscale Science. R.F. and P.R. thank O. Groning and P. Groning for stimulating discussions and continued support. A. P. S. acknowledges discussions with F. Mauri and M. Lazzeri. The Mainz group acknowledges financial support from the Max Planck Society through the program ENERCHEM, the German Science Foundation (Korean-German IRTG), the DFG Priority Program SPP 1355 and DFG MU 334/32-1.	Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033; BRIGGS D, 1992, HIGH RESOLUTION XPS; Caldwell JD, 2010, ACS NANO, V4, P1108, DOI 10.1021/nn901585p; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Canas-Ventura ME, 2007, ANGEW CHEM INT EDIT, V46, P1814, DOI 10.1002/anie.200604083; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Classen T, 2005, ANGEW CHEM INT EDIT, V44, P6142, DOI 10.1002/anie.200502007; Datta SS, 2008, NANO LETT, V8, P1912, DOI 10.1021/nl080583r; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gourdon A, 2008, ANGEW CHEM INT EDIT, V47, P6950, DOI 10.1002/anie.200802229; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Huang L, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/34/344203; Jiao LY, 2010, NAT NANOTECHNOL, V5, P321, DOI [10.1038/NNANO.2010.54, 10.1038/nnano.2010.54]; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z; Lee Y, 2010, NANO LETT, V10, P490, DOI 10.1021/nl903272n; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Otero G, 2008, NATURE, V454, P865, DOI 10.1038/nature07193; Rim KT, 2007, ANGEW CHEM INT EDIT, V46, P7891, DOI 10.1002/anie.200701117; Sevincli H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245402; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Vandescuren M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195401; Wakabayashi K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125428; Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801; Yang XY, 2008, J AM CHEM SOC, V130, P4216, DOI 10.1021/ja710234t	30	2600	2673	56	2187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					470	473		10.1038/nature09211	http://dx.doi.org/10.1038/nature09211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	628SJ	20651687				2022-12-24	WOS:000280141200031
J	Seymour, JR; Simo, R; Ahmed, T; Stocker, R				Seymour, Justin R.; Simo, Rafel; Ahmed, Tanvir; Stocker, Roman			Chemoattraction to Dimethylsulfoniopropionate Throughout the Marine Microbial Food Web	SCIENCE			English	Article							CHEMICAL DEFENSE; DIMETHYL SULFIDE; OXYRRHIS-MARINA; DMSP; CHEMOTAXIS; SULFUR; BEHAVIOR; PLANKTON; ECOLOGY; FLUX	Phytoplankton-produced dimethylsulfoniopropionate (DMSP) provides underwater and atmospheric foraging cues for several species of marine invertebrates, fish, birds, and mammals. However, its role in the chemical ecology of marine planktonic microbes is largely unknown, and there is evidence for contradictory functions. By using microfluidics and image analysis of swimming behavior, we observed attraction toward microscale pulses of DMSP and related compounds among several motile strains of phytoplankton, heterotrophic bacteria, and bacterivore and herbivore microzooplankton. Because microbial DMSP cycling is the main natural source of cloud-forming sulfur aerosols, our results highlight how adaptations to microscale chemical seascapes shape planktonic food webs, while potentially influencing climate at the global scale.	[Seymour, Justin R.; Ahmed, Tanvir; Stocker, Roman] MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Seymour, Justin R.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seymour, Justin R.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Simo, Rafel] CSIC, ICM, Barcelona 08003, Catalonia, Spain	Massachusetts Institute of Technology (MIT); Flinders University South Australia; University of Technology Sydney; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Seymour, JR (corresponding author), MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	Justin.Seymour@uts.edu.au	Stocker, Roman/T-9456-2017; Ahmed, Tanvir/AAL-3026-2020; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; Simo, Rafel/0000-0003-3276-7663; Seymour, Justin/0000-0002-3745-6541	Australian Research Council [DP0772186]; Martin Fellowship for Sustainability; Spanish Ministry of Science and Innovation; La Cambra de Barcelona; Hayashi Fund; NSF;  [OCE-0744641-CAREER]	Australian Research Council(Australian Research Council); Martin Fellowship for Sustainability; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); La Cambra de Barcelona; Hayashi Fund; NSF(National Science Foundation (NSF)); 	This research was funded by Australian Research Council grant DP0772186 to J.R.S., a Martin Fellowship for Sustainability to T. A., the Spanish Ministry of Science and Innovation project SUMMER to R. Si., funding from La Cambra de Barcelona to R. Si. and R. S., and support from the Hayashi Fund, a Doherty Professorship and NSF grant OCE-0744641-CAREER to R. S. We thank P. Jimenez and A. Calbet for growing and providing O. marina, W. M. Durham for preparing M. pusilla, Marcos for preparing N. designis, and R. Belas for providing Silicibacter. We thank S. Strom and J. G. Mitchell for comments on an earlier version of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; DeBose JL, 2008, SCIENCE, V319, P1356, DOI 10.1126/science.1151109; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; FUSE H, 1995, BIOSCI BIOTECH BIOCH, V59, P1773, DOI 10.1271/bbb.59.1773; Hartz AJ, 2008, J EUKARYOT MICROBIOL, V55, P18, DOI 10.1111/j.1550-7408.2007.00297.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 2006, LIMNOL OCEANOGR-METH, V4, P80, DOI 10.4319/lom.2006.4.80; LEDYARD KM, 1993, ARCH MICROBIOL, V160, P312, DOI 10.1007/BF00292083; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; Miller TR, 2004, APPL ENVIRON MICROB, V70, P4692, DOI 10.1128/AEM.70.8.4692-4701.2004; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Salo V, 2009, ENVIRON MICROBIOL, V11, P3063, DOI 10.1111/j.1462-2920.2009.02011.x; Seymour JR, 2008, LIMNOL OCEANOGR-METH, V6, P477, DOI 10.4319/lom.2008.6.477; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Simo R, 2009, AQUAT MICROB ECOL, V57, P43, DOI 10.3354/ame01325; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Strom S, 2003, LIMNOL OCEANOGR, V48, P230, DOI 10.4319/lo.2003.48.1.0230; Van Alstyne KL, 2001, MAR ECOL PROG SER, V213, P53, DOI 10.3354/meps213053; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; Wolfe GV, 2000, BIOL BULL-US, V198, P225, DOI 10.2307/1542526; ZimmerFaust RK, 1996, LIMNOL OCEANOGR, V41, P1330, DOI 10.4319/lo.1996.41.6.1330	30	245	249	5	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					342	345		10.1126/science.1188418	http://dx.doi.org/10.1126/science.1188418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647471				2022-12-24	WOS:000279925900048
J	Gomez, JM; Verdu, M; Perfectti, F				Gomez, Jose M.; Verdu, Miguel; Perfectti, Francisco			Ecological interactions are evolutionarily conserved across the entire tree of life	NATURE			English	Article							PHYLOGENETIC SIGNAL; PATTERNS	Ecological interactions are crucial to understanding both the ecology and the evolution of organisms(1,2). Because the phenotypic traits regulating species interactions are largely a legacy of their ancestors, it is widely assumed that ecological interactions are phylogenetically conserved, with closely related species interacting with similar partners(2). However, the existing empirical evidence is inadequate to appropriately evaluate the hypothesis of phylogenetic conservatism in ecological interactions, because it is both ecologically and taxonomically biased. In fact, most studies on the evolution of ecological interactions have focused on specialized organisms, such as some parasites or insect herbivores(3-7), belonging to a limited subset of the overall tree of life. Here we study the evolution of host use in a large and diverse group of interactions comprising both specialist and generalist acellular, unicellular and multicellular organisms. We show that, as previously found for specialized interactions, generalized interactions can be evolutionarily conserved. Significant phylogenetic conservatism of interaction patterns was equally likely to occur in symbiotic and non-symbiotic interactions, as well as in mutualistic and antagonistic interactions. Host-use differentiation among species was higher in phylogenetically conserved clades, irrespective of their generalization degree and taxonomic position within the tree of life. Our findings strongly suggest a shared pattern in the organization of biological systems through evolutionary time, mediated by marked conservatism of ecological interactions among taxa.	[Gomez, Jose M.] Univ Granada, Dept Ecol, E-18071 Granada, Spain; [Verdu, Miguel] Univ Valencia Generalitat Valenciana, CSIC, Ctr Invest Desertificac, E-46470 Valencia, Spain; [Perfectti, Francisco] Univ Granada, Dept Genet, E-18071 Granada, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); University of Granada	Gomez, JM (corresponding author), Univ Granada, Dept Ecol, E-18071 Granada, Spain.	jmgreyes@ugr.es	Perfectti, Francisco/C-5087-2008; Gómez, José M/K-8061-2017; Verdu, Miguel/C-4461-2008	Perfectti, Francisco/0000-0002-5551-213X; Gómez, José M/0000-0002-2487-4664; Verdu, Miguel/0000-0002-9778-7692	Spanish Ministry of Science; Junta de Andalucia	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	We thank J. Bascompte, J. Bosch, A. Gonzalez-Megias, P. Jordano, M. Lineham, M. Mendez, I. Reche, E. W. Schupp and S. Strauss for comments on a previous draft, R. Guimera for kindly providing NETCARTO software, and B. Krasnov, C. Mitter, L. Navarro, J. Ollerton and J. M. Pleguezuelos for providing access to their data set. This work was funded by the Spanish Ministry of Science (J. M. G., M. V. and F. P.) and by the Junta de Andalucia (J. M. G. and F. P.)	Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; CHASE JM, 2003, ECOLOGICAL NICHES LI, P19; DARWIN C, 1859, ORIGIN SPECIES, P78; De Nooy W., 2005, EXPLORATORY SOCIAL N; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Holmes E., 2009, EVOLUTION EMERGENCE; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Maddison, 2019, MESQUITE MODULAR SYS; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; OKSANEN J, 2008, MULTIVARIATE ANAL EC; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Price P.W., 2003, MACROEVOLUTIONARY TH; Price PW, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P174; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Sasal P, 1998, ECOGRAPHY, V21, P639, DOI 10.1111/j.1600-0587.1998.tb00557.x; Thompson J. N., 2005, INTERSPEC INTERACT; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	29	157	157	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					918	U6		10.1038/nature09113	http://dx.doi.org/10.1038/nature09113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20520609	Green Submitted			2022-12-24	WOS:000278804500036
J	Fischer, N; Konevega, AL; Wintermeyer, W; Rodnina, MV; Stark, H				Fischer, Niels; Konevega, Andrey L.; Wintermeyer, Wolfgang; Rodnina, Marina V.; Stark, Holger			Ribosome dynamics and tRNA movement by time-resolved electron cryomicroscopy	NATURE			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI RIBOSOMES; MESSENGER-RNA; L1 STALK; INTERMEDIATE STATES; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; SINGLE RIBOSOMES; GTP HYDROLYSIS; HYBRID STATES	The translocation step of protein synthesis entails large-scale rearrangements of the ribosome-transfer RNA (tRNA) complex. Here we have followed tRNA movement through the ribosome during translocation by time-resolved single-particle electron cryomicroscopy (cryo-EM). Unbiased computational sorting of cryo-EM images yielded 50 distinct three-dimensional reconstructions, showing the tRNAs in classical, hybrid and various novel intermediate states that provide trajectories and kinetic information about tRNA movement through the ribosome. The structures indicate how tRNA movement is coupled with global and local conformational changes of the ribosome, in particular of the head and body of the small ribosomal subunit, and show that dynamic interactions between tRNAs and ribosomal residues confine the path of the tRNAs through the ribosome. The temperature dependence of ribosome dynamics reveals a surprisingly flat energy landscape of conformational variations at physiological temperature. The ribosome functions as a Brownian machine that couples spontaneous conformational changes driven by thermal energy to directed movement.	[Fischer, Niels; Stark, Holger] Max Planck Inst Biophys Chem, Elect Cryomicroscopy Grp 3D, D-37077 Gottingen, Germany; [Konevega, Andrey L.; Wintermeyer, Wolfgang; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Konevega, Andrey L.] Petersburg Nucl Phys Inst, Gatchina 188300, Russia	Max Planck Society; Max Planck Society; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Elect Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany.	hstark1@gwdg.de	Fischer, Niels/ABA-5342-2021; Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008	Fischer, Niels/0000-0002-4609-4052; Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150; Holger, Stark/0000-0002-6161-1118; Wintermeyer, Wolfgang/0000-0001-5119-8481	Federal Ministry of Education and Research (BMBF), Germany; European Union; state of Lower-Saxony; Volkswagen Foundation, Hannover, Germany; Boehringer-Ingelheim fellowship; Deutsche Forschungsgemeinschaft	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); state of Lower-Saxony(European Commission); Volkswagen Foundation, Hannover, Germany(Volkswagen); Boehringer-Ingelheim fellowship(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C. Blau for technical help in preparing Fig. 4. Research in the laboratory of H.S. was supported by grants from the Federal Ministry of Education and Research (BMBF), Germany, the Sixth Framework Programme of the European Union via the Integrated Project 3DRepertoire, by the state of Lower-Saxony and the Volkswagen Foundation, Hannover, Germany. N.F. was supported by a Boehringer-Ingelheim fellowship. M.V.R. and W.W. were supported by grants from the Deutsche Forschungsgemeinschaft.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; BHAT TN, 1984, J APPL CRYSTALLOGR, V17, P244, DOI 10.1107/S0021889884011456; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CORDOVA NJ, 1992, P NATL ACAD SCI USA, V89, P339, DOI 10.1073/pnas.89.1.339; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kim HD, 2007, BIOPHYS J, V93, P3575, DOI 10.1529/biophysj.107.109884; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Lancaster LE, 2008, MOL MICROBIOL, V69, P390, DOI 10.1111/j.1365-2958.2008.06283.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; PAULSEN H, 1986, BIOCHEMISTRY-US, V25, P2749, DOI 10.1021/bi00358a002; ROBERTSON JM, 1986, J MOL BIOL, V192, P351, DOI 10.1016/0022-2836(86)90370-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI 10.1016/j.jsb,2005.04.004; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	44	295	297	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					329	333		10.1038/nature09206	http://dx.doi.org/10.1038/nature09206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631791				2022-12-24	WOS:000279867100040
J	Goodall, J; Pintea, L				Goodall, Jane; Pintea, Lilian			Securing a future for chimpanzees	NATURE			English	Editorial Material									[Goodall, Jane; Pintea, Lilian] Jane Goodall Inst, Arlington, VA 22203 USA		Goodall, J (corresponding author), Jane Goodall Inst, 4245 N Fairfax Dr,Suite 600, Arlington, VA 22203 USA.	lpintea@janegoodall.org							0	2	2	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					180	181		10.1038/466180a	http://dx.doi.org/10.1038/466180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621LR	20613821				2022-12-24	WOS:000279580800016
J	Li, L; Leid, M; Rothenberg, EV				Li, Long; Leid, Mark; Rothenberg, Ellen V.			An Early T Cell Lineage Commitment Checkpoint Dependent on the Transcription Factor Bcl11b	SCIENCE			English	Article							ALPHA-BETA; DENDRITIC CELLS; EXPRESSION; DIFFERENTIATION; SURVIVAL; PATHWAY; GENE; DECISION; GATA-3; NOTCH1	The identities of the regulators that mediate commitment of hematopoietic precursors to the T lymphocyte lineage have been unknown. The last stage of T lineage commitment in vivo involves mechanisms to suppress natural killer cell potential, to suppress myeloid and dendritic cell potential, and to silence the stem cell or progenitor cell regulatory functions that initially provide T cell receptor-independent self-renewal capability. The zinc finger transcription factor Bcl11b is T cell-specific in expression among hematopoietic cell types and is first expressed in precursors immediately before T lineage commitment. We found that Bcl11b is necessary for T lineage commitment in mice and is specifically required both to repress natural killer cell-associated genes and to down-regulate a battery of stem cell or progenitor cell genes at the pivotal stage of commitment.	[Li, Long; Rothenberg, Ellen V.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Leid, Mark] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	California Institute of Technology; Oregon State University	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X; Li, Long/0000-0002-4727-9307	California Institute; NIH [R33 HL089123, RC2 CA148278, R01 GM60852]; Caltech-City of Hope Biomedical Initiative; Louis Garfinkle Memorial Laboratory; Al Sherman Foundation; FOGARTY INTERNATIONAL CENTER [F06TW002367] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [RC2CA148278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	California Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech-City of Hope Biomedical Initiative; Louis Garfinkle Memorial Laboratory; Al Sherman Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Liu, H. Kawamoto, P. Li, T. Ikawa, D. Scripture-Adams, and members of the Rothenberg lab for sharing unpublished results and helpful discussion; D. Metzger and J.-M. Bornert for help with generation of the floxed Bcl11b mice; H.-Y. Kueh for guidance in data analysis; T. Taghon and F. Costantini for vectors and mice; D. Perez and R. Diamond for flow cytometry support; and R. Butler and S. Washburn for animal care and breeding supervision. Supported by a California Institute for Regenerative Medicine fellowship (L. L.), NIH grants R33 HL089123 and RC2 CA148278 (E. V. R.), NIH grant R01 GM60852 (M. L.), the Caltech-City of Hope Biomedical Initiative, the Louis Garfinkle Memorial Laboratory Fund, the Al Sherman Foundation, and the A. B. Ruddock Professorship.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Kamimura K, 2007, BIOCHEM BIOPH RES CO, V355, P538, DOI 10.1016/j.bbrc.2007.02.003; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Welner RS, 2007, BLOOD, V109, P4825, DOI 10.1182/blood-2006-08-043810; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	32	264	268	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					89	93		10.1126/science.1188989	http://dx.doi.org/10.1126/science.1188989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595614	Green Accepted			2022-12-24	WOS:000279402700039
J	Vijaykrishna, D; Poon, LLM; Zhu, HC; Ma, SK; Li, OTW; Cheung, CL; Smith, GJD; Peiris, JSM; Guan, Y				Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.			Reassortment of Pandemic H1N1/2009 Influenza A Virus in Swine	SCIENCE			English	Article									[Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Vijaykrishna, D.; Zhu, H. C.; Smith, G. J. D.; Guan, Y.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou 515031, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Shantou University	Peiris, JSM (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	malik@hkucc.hku.hk; yguan@hkucc.hku.hk	Dhanasekaran, Vijaykrishna/D-1011-2010; Zhu, Huachen/A-8252-2017; Poon, Leo Lit Man/C-4382-2009; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Poon, Leo/AAP-6887-2020; Cheung, Yiu Man/T-2708-2019	Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Zhu, Huachen/0000-0003-2711-0501; Poon, Leo Lit Man/0000-0002-9101-7953; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Smith, Gavin JD/0000-0001-5031-468X; Guan, Yi/0000-0001-6057-9243	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN266200700005C]; University Grants Committee of the Hong Kong SAR Government [AoE/M-12/06]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Committee of the Hong Kong SAR Government	This work was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN266200700005C and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/06) of the Hong Kong SAR Government. We acknowledge the Food and Environmental Hygiene Department of Hong Kong for facilitating this study. Authors declare no conflict of interest. Sequence data generated from this study were deposited in GenBank with accession nos. CY061626 to CY061881.	Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; WHO website, PAND H1N1 2009 UPD 8	7	304	325	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1529	1529		10.1126/science.1189132	http://dx.doi.org/10.1126/science.1189132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558710	Green Accepted			2022-12-24	WOS:000278859200038
J	Sun, YJ; Wu, GK; Liu, BH; Li, P; Zhou, M; Xiao, Z; Tao, HW; Zhang, LI				Sun, Yujiao J.; Wu, Guangying K.; Liu, Bao-hua; Li, Pingyang; Zhou, Mu; Xiao, Zhongju; Tao, Huizhong W.; Zhang, Li I.			Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development	NATURE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELDS; NEURONS; CIRCUITS; RAT; REPRESENTATION; SELECTIVITY; INPUTS; MAPS	Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development(1-4). Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency-intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation-inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.	[Sun, Yujiao J.; Wu, Guangying K.; Liu, Bao-hua; Li, Pingyang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Xiao, Zhongju] So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China	University of Southern California; University of Southern California; University of Southern California; Southern Medical University - China	Zhang, LI (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	htao@usc.edu; liizhang@usc.edu	Tao, Huizhong W/HDM-9767-2022; Zhou, Mu/K-8137-2016; Sun, Yujiao/E-5668-2015; Wu, Guangying/E-8117-2010	Zhou, Mu/0000-0001-5326-4884; Wu, Guangying/0000-0002-7243-5412; Sun, Yujiao Jennifer/0000-0003-2437-2936	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC008983, R21DC008588]; Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation; US National Institutes of Health [EY018718, EY019049]; Karl Kirchgessner Foundation; National Natural Science Foundation of China [30730039, 30970982, 30670665]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019049, R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008588, R03DC006814, R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karl Kirchgessner Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.R. Chan for suggestions. This work was supported by grants to L.I.Z. from the US National Institutes of Health/National Institute on Deafness and Other Communication Disorders (R01DC008983, R21DC008588), the Searle Scholar Program, the Klingenstein Foundation and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). H. W. T. is supported by the US National Institutes of Health (EY018718 and EY019049) and the Karl Kirchgessner Foundation. Z.X. is supported by the National Natural Science Foundation of China (grant numbers 30730039, 30970982 and 30670665).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chapman B, 1996, J NEUROSCI, V16, P6443; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; GEALDOR M, 1993, HEARING RES, V69, P236, DOI 10.1016/0378-5955(93)90113-F; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	30	134	135	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					927	U8		10.1038/nature09079	http://dx.doi.org/10.1038/nature09079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559386	Green Accepted			2022-12-24	WOS:000278804500038
J	Zucker, I; Beery, AK				Zucker, Irving; Beery, Annaliese K.			Males still dominate animal studies	NATURE			English	Editorial Material									[Zucker, Irving] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Beery, Annaliese K.] Univ Calif San Francisco, Ctr Hlth & Community, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Zucker, I (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	irvzuck@berkeley.edu		Beery, Annaliese/0000-0002-1249-9182				BEERY AK, NEUROSCI BI IN PRESS; Gold SM, 2009, J NEUROL SCI, V286, P99, DOI 10.1016/j.jns.2009.05.028; Hughes RN, 2007, BEHAV PHARMACOL, V18, P583, DOI 10.1097/FBP.0b013e3282eff0e8; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Veliskova J, 2007, NEUROSCIENTIST, V13, P77, DOI 10.1177/1073858406295827; Wang CH, 1923, COMP PSYCHOL MONOGR, V6, P1	6	278	280	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					690	690		10.1038/465690a	http://dx.doi.org/10.1038/465690a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535186	Bronze			2022-12-24	WOS:000278551800020
J	Zhou, TQ; Georgiev, I; Wu, XL; Yang, ZY; Dai, KF; Finzi, A; Kwon, YD; Scheid, JF; Shi, W; Xu, L; Yang, YP; Zhu, JA; Nussenzweig, MC; Sodroski, J; Shapiro, L; Nabel, GJ; Mascola, JR; Kwong, PD				Zhou, Tongqing; Georgiev, Ivelin; Wu, Xueling; Yang, Zhi-Yong; Dai, Kaifan; Finzi, Andres; Kwon, Young Do; Scheid, Johannes F.; Shi, Wei; Xu, Ling; Yang, Yongping; Zhu, Jiang; Nussenzweig, Michel C.; Sodroski, Joseph; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.			Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01	SCIENCE			English	Article							GP120 ENVELOPE GLYCOPROTEIN; RECEPTOR; SITE; EPITOPE; SURFACE; INDIVIDUALS; ATTACHMENT; MATURATION; HYPOTHESIS; VACCINES	During HIV-1 infection, antibodies are generated against the region of the viral gp120 envelope glycoprotein that binds CD4, the primary receptor for HIV-1. Among these antibodies, VRC01 achieves broad neutralization of diverse viral strains. We determined the crystal structure of VRC01 in complex with a human immunodeficiency virus HIV-1 gp120 core. VRC01 partially mimics CD4 interaction with gp120. A shift from the CD4-defined orientation, however, focuses VRC01 onto the vulnerable site of initial CD4 attachment, allowing it to overcome the glycan and conformational masking that diminishes the neutralization potency of most CD4-binding-site antibodies. To achieve this recognition, VRC01 contacts gp120 mainly through immunoglobulin V-gene regions substantially altered from their genomic precursors. Partial receptor mimicry and extensive affinity maturation thus facilitate neutralization of HIV-1 by natural human antibodies.	[Zhou, Tongqing; Georgiev, Ivelin; Wu, Xueling; Yang, Zhi-Yong; Dai, Kaifan; Kwon, Young Do; Shi, Wei; Xu, Ling; Yang, Yongping; Zhu, Jiang; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Finzi, Andres; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Do Kwon, Young/A-6957-2010; Shapiro, Lawrence/AAE-7172-2019; Zhou, Tongqing/A-6880-2010; Mascola, John/AAI-7193-2021; Nussenzweig, Michel/AAE-7292-2019	Do Kwon, Young/0000-0002-1188-7458; Zhou, Tongqing/0000-0002-3935-4637; Finzi, Andres/0000-0002-4992-5288	NIH; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022, ZIAAI005095, P30AI060354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T.Z., I.G., Z.Y., J.S., L.S., G.J.N., J.R.M., and P.D.K. designed the research; T.Z., I.G., X.W., Z.Y., K.D.A.F., W.S., L.X., Y.Y., and J.Z. performed the research; X.W., Y.K., J.F.S., M.C.N., and J.R.M. contributed new reagents or reference data; T.Z., I.G., X.W., J.S., L.S., G.J.N., J.R.M., and P.D.K. analyzed the data; and T.Z., I.G., J.S., L.S., G.J.N., J.R.M., and P.D.K. wrote the paper, on which all authors commented. We thank I.A. Wilson and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript; the staff of sector 22 for assistance with data collection; and J. Stuckey for assistance with figures. Support for this work was provided by the Intramural Research Program of NIH and by grants from NIH and from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Coordinates and structure factors for the VRC01-gp120 complex have been deposited with the PDB under accession code 3NGB.	Anderson JP, 2000, J VIROL, V74, P10752, DOI 10.1128/JVI.74.22.10752-10765.2000; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rits-Volloch S, 2006, EMBO J, V25, P5026, DOI 10.1038/sj.emboj.7601358; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	38	857	922	0	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					811	817		10.1126/science.1192819	http://dx.doi.org/10.1126/science.1192819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20616231	Green Published, Green Accepted			2022-12-24	WOS:000280809900043
J	Kravitz, AV; Freeze, BS; Parker, PRL; Kay, K; Thwin, MT; Deisseroth, K; Kreitzer, AC				Kravitz, Alexxai V.; Freeze, Benjamin S.; Parker, Philip R. L.; Kay, Kenneth; Thwin, Myo T.; Deisseroth, Karl; Kreitzer, Anatol C.			Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry	NATURE			English	Article							SUBTHALAMIC NUCLEUS; MOVEMENT-DISORDERS; IN-VIVO; NEURONS; INTERNEURONS; LESIONS; MODELS; MICE	Neural circuits of the basal ganglia are critical for motor planning and action selection(1-3). Two parallel basal ganglia pathways have been described(4), and have been proposed to exert opposing influences on motor function(5-7). According to this classical model, activation of the 'direct' pathway facilitates movement and activation of the 'indirect' pathway inhibits movement. However, more recent anatomical and functional evidence has called into question the validity of this hypothesis(8-10). Because this model has never been empirically tested, the specific function of these circuits in behaving animals remains unknown. Here we report direct activation of basal ganglia circuitry in vivo, using optogenetic control(11-14) of direct-and indirect-pathway medium spiny projection neurons (MSNs), achieved through Cre-dependent viral expression of channelrhodopsin-2 in the striatum of bacterial artificial chromosome transgenic mice expressing Cre recombinase under control of regulatory elements for the dopamine D1 or D2 receptor. Bilateral excitation of indirect-pathway MSNs elicited a parkinsonian state, distinguished by increased freezing, bradykinesia and decreased locomotor initiations. In contrast, activation of direct-pathway MSNs reduced freezing and increased locomotion. In a mouse model of Parkinson's disease, direct-pathway activation completely rescued deficits in freezing, bradykinesia and locomotor initiation. Taken together, our findings establish a critical role for basal ganglia circuitry in the bidirectional regulation of motor behaviour and indicate that modulation of direct-pathway circuitry may represent an effective therapeutic strategy for ameliorating parkinsonian motor deficits.	[Kravitz, Alexxai V.; Freeze, Benjamin S.; Parker, Philip R. L.; Kay, Kenneth; Thwin, Myo T.; Kreitzer, Anatol C.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Parker, Philip R. L.; Kreitzer, Anatol C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Freeze, Benjamin S.; Kreitzer, Anatol C.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Freeze, Benjamin S.; Kay, Kenneth; Kreitzer, Anatol C.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Kreitzer, AC (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	akreitzer@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218; Parker, Philip R. L./0000-0002-6224-9747	W.M. Keck Foundation; Pew Biomedical Scholars Program; McKnight Foundation; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); Pew Biomedical Scholars Program; McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Marzullo and NeuroNexus Technologies for their assistance with the custom probe design, the Nikon Imaging Center at UCSF for assistance with image acquisition, R. Javier and A. Gittis for assistance with slice electrophysiology experiments, and L. Shoenfeld for assistance with genotyping and histology. A. C. K and co-workers are funded by the W.M. Keck Foundation, the Pew Biomedical Scholars Program, the McKnight Foundation and the NIH.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Gatev P, 2006, MOVEMENT DISORD, V21, P1566, DOI 10.1002/mds.21033; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	27	1156	1200	4	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					622	U7		10.1038/nature09159	http://dx.doi.org/10.1038/nature09159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20613723	Bronze, Green Accepted			2022-12-24	WOS:000280412100053
J	Tay, S; Hughey, JJ; Lee, TK; Lipniacki, T; Quake, SR; Covert, MW				Tay, Savas; Hughey, Jacob J.; Lee, Timothy K.; Lipniacki, Tomasz; Quake, Stephen R.; Covert, Markus W.			Single-cell NF-kappa B dynamics reveal digital activation and analogue information processing	NATURE			English	Article							VARIABILITY; STABILITY; RESPONSES	Cells operate in dynamic environments using extraordinary communication capabilities that emerge from the interactions of genetic circuitry. The mammalian immune response is a striking example of the coordination of different cell types(1). Cell-to-cell communication is primarily mediated by signalling molecules that form spatiotemporal concentration gradients, requiring cells to respond to a wide range of signal intensities(2). Here we use high-throughput microfluidic cell culture(3) and fluorescence microscopy, quantitative gene expression analysis and mathematical modelling to investigate how single mammalian cells respond to different concentrations of the signalling molecule tumour-necrosis factor (TNF)-alpha, and relay information to the gene expression programs by means of the transcription factor nuclear factor (NF)-kappa B. We measured NF-kappa B activity in thousands of live cells under TNF-alpha doses covering four orders of magnitude. We find, in contrast to population-level studies with bulk assays(2), that the activation is heterogeneous and is a digital process at the single-cell level with fewer cells responding at lower doses. Cells also encode a subtle set of analogue parameters to modulate the outcome; these parameters include NF-kappa B peak intensity, response time and number of oscillations. We developed a stochastic mathematical model that reproduces both the digital and analogue dynamics as well as most gene expression profiles at all measured conditions, constituting a broadly applicable model for TNF-alpha-induced NF-kappa B signalling in various types of cells. These results highlight the value of high-throughput quantitative measurements with single-cell resolution in understanding how biological systems operate.	[Tay, Savas; Hughey, Jacob J.; Lee, Timothy K.; Quake, Stephen R.; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tay, Savas; Quake, Stephen R.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Lipniacki, Tomasz] Inst Fundamental Technol Res, PL-02106 Warsaw, Poland	Stanford University; Howard Hughes Medical Institute; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Covert, MW (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	tlipnia@ippt.gov.pl; quake@stanford.edu; mcovert@stanford.edu	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Hughey, Jacob/0000-0002-1558-6089; Covert, Markus/0000-0002-5993-8912	NIH; NCI [K99CA125994]; Foundation for Polish Science [TEAM 2009-3/6]; NSF/NIH [R01-GM086885]; Stanford Graduate Fellowship; Stanford Bio-X Graduate Fellowship; NATIONAL CANCER INSTITUTE [R00CA125994, K99CA125994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Stanford Bio-X Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Leyrat and R. Gomez-Sjoberg for development of the automated cell culture system, assistance with the software, and for contributions to experimental design and preliminary data. This research was supported in part by an NIH Director's Pioneer Award (to S.R.Q.), an NCI Pathway to Independence Award (K99CA125994) (to M.W.C.), the Foundation for Polish Science (TEAM 2009-3/6) and NSF/NIH grant no. R01-GM086885 (to T.L.), a Stanford Graduate Fellowship (to T.K.L.), and a Stanford Bio-X Graduate Fellowship (to J.J.H.).	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; CHEN YM, 2004, J PHARMACOL EXP THER, V103; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; WILSON JW, 1999, APOPTOSIS GENES	28	576	585	5	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					267	U149		10.1038/nature09145	http://dx.doi.org/10.1038/nature09145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20581820	Green Accepted			2022-12-24	WOS:000279580800043
J	May, RM				May, Robert M.			Tropical Arthropod Species, More or Less?	SCIENCE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	May, RM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	robert.may@zoo.ox.ac.uk						ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; *UK HL SCI TECHN S, 2007, 5 UK HOUS LORDS SCI	5	74	80	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					41	42		10.1126/science.1191058	http://dx.doi.org/10.1126/science.1191058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595603				2022-12-24	WOS:000279402700022
J	Iskow, RC; McCabe, MT; Mills, RE; Torene, S; Pittard, WS; Neuwald, AF; Van Meir, EG; Vertino, PM; Devine, SE				Iskow, Rebecca C.; McCabe, Michael T.; Mills, Ryan E.; Torene, Spencer; Pittard, W. Stephen; Neuwald, Andrew F.; Van Meir, Erwin G.; Vertino, Paula M.; Devine, Scott E.			Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons	CELL			English	Article							TRANSPOSABLE ELEMENTS; L1 RETROTRANSPOSITION; STRUCTURAL VARIATION; INSERTION; SEQUENCE; HYPOMETHYLATION; FREQUENCY; TUMORS; GENE	Two abundant classes of mobile elements, namely Alu and L1 elements, continue to generate new retrotransposon insertions in human genomes. Estimates suggest that these elements have generated millions of new germline insertions in individual human genomes worldwide. Unfortunately, current technologies are not capable of detecting most of these young insertions, and the true extent of germline mutagenesis by endogenous human retrotransposons has been difficult to examine. Here, we describe technologies for detecting these young retrotransposon insertions and demonstrate that such insertions indeed are abundant in human populations. We also found that new somatic L1 insertions occur at high frequencies in human lung cancer genomes. Genome-wide analysis suggests that altered DNA methylation may be responsible for the high levels of L1 mobilization observed in these tumors. Our data indicate that transposon-mediated mutagenesis is extensive in human genomes and is likely to have a major impact on human biology and diseases.	[Iskow, Rebecca C.; Vertino, Paula M.; Devine, Scott E.] Emory Univ, Genet & Mol Biol Grad Program, Atlanta, GA 30322 USA; [Iskow, Rebecca C.; Mills, Ryan E.; Torene, Spencer; Devine, Scott E.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [McCabe, Michael T.; Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [McCabe, Michael T.; Van Meir, Erwin G.; Vertino, Paula M.; Devine, Scott E.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Neuwald, Andrew F.; Devine, Scott E.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 20201 USA; [Neuwald, Andrew F.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 20201 USA; [Devine, Scott E.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 20201 USA; [Devine, Scott E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 20201 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Devine, SE (corresponding author), Emory Univ, Genet & Mol Biol Grad Program, Atlanta, GA 30322 USA.	sdevine@som.umaryland.edu	Mills, Ryan/F-4225-2010	Mills, Ryan/0000-0003-3425-6998; Van Meir, Erwin G./0000-0003-2444-7707	American Cancer Society [PF-07-130-01-MGO]; SUN Microsystems; National Institute for General Medical Sciences, National Insitutes of Health (NIH) [R01GM078541]; National Cancer Institute, NIH [R01CA086335, R01CA116804, 1R01CA132065, 5P01CA116676]; National Human Genome Research Institute, NIH [F32HG004207, R01HG002898]; NATIONAL CANCER INSTITUTE [R01CA132065, P01CA116676, R01CA086335, R01CA116804] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004207, R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490, R01GM078541] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); SUN Microsystems; National Institute for General Medical Sciences, National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kristie Jones and Luke Tallon for help with 454 Titanium sequencing. We also thank Shari Corin, Julienne Mullaney, Michael Zwick, Ichiro Matsumura, and Xiaodong Cheng for helpful advice and Mark Mazaitis for help with artwork. This work was funded by grants from the American Cancer Society (PF-07-130-01-MGO to M. T. M.), SUN Microsystems (to W. S. P. and S. E. D.), the National Institute for General Medical Sciences, National Insitutes of Health (NIH) (R01GM078541 to A.F.N.), the National Cancer Institute, NIH (R01CA086335 and R01CA116804 to E. G. V. M.; 1R01CA132065 and 5P01CA116676 to P. M. V.), and the National Human Genome Research Institute, NIH (F32HG004207 to R. E. M. and R01HG002898 to S. E. D.).	Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; BATZER MA, 2002, NAT REV GENET, V35, P501; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bestor TH, 1998, NOVART FDN SYMP, V214, P228; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; Liu J, 1997, GENE CHROMOSOME CANC, V18, P232, DOI 10.1002/(SICI)1098-2264(199703)18:3<232::AID-GCC10>3.0.CO;2-K; MIKI Y, 1992, CANCER RES, V52, P643; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; PEARSON M, 1985, ANNU REV MED, V36, P471; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; TAYLOR J, 2007, CURRENT PROTOCOLS BI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	44	398	423	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1253	U268		10.1016/j.cell.2010.05.020	http://dx.doi.org/10.1016/j.cell.2010.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603005	Green Accepted, Bronze			2022-12-24	WOS:000279148100021
J	Yu, L; McPhee, CK; Zheng, LX; Mardones, GA; Rong, YG; Peng, JY; Mi, N; Zhao, Y; Liu, ZH; Wan, FY; Hailey, DW; Oorschot, V; Klumperman, J; Baehrecke, EH; Lenardo, MJ				Yu, Li; McPhee, Christina K.; Zheng, Lixin; Mardones, Gonzalo A.; Rong, Yueguang; Peng, Junya; Mi, Na; Zhao, Ying; Liu, Zhihua; Wan, Fengyi; Hailey, Dale W.; Oorschot, Viola; Klumperman, Judith; Baehrecke, Eric H.; Lenardo, Michael J.			Termination of autophagy and reformation of lysosomes regulated by mTOR	NATURE			English	Article							CELL-DEATH; MATURATION; SURVIVAL; PROGRAM; TOR	Autophagy is an evolutionarily conserved process by which cytoplasmic proteins and organelles are catabolized(1,2). During starvation, the protein TOR (target of rapamycin), a nutrient-responsive kinase, is inhibited, and this induces autophagy. In autophagy, double-membrane autophagosomes envelop and sequester intracellular components and then fuse with lysosomes to form autolysosomes, which degrade their contents to regenerate nutrients. Current models of autophagy terminate with the degradation of the autophagosome cargo in autolysosomes(3-5), but the regulation of autophagy in response to nutrients and the subsequent fate of the autolysosome are poorly understood. Here we show that mTOR signalling in rat kidney cells is inhibited during initiation of autophagy, but reactivated by prolonged starvation. Reactivation of mTOR is autophagy-dependent and requires the degradation of autolysosomal products. Increased mTOR activity attenuates autophagy and generates proto-lysosomal tubules and vesicles that extrude from autolysosomes and ultimately mature into functional lysosomes, thereby restoring the full complement of lysosomes in the cell-a process we identify in multiple animal species. Thus, an evolutionarily conserved cycle in autophagy governs nutrient sensing and lysosome homeostasis during starvation.	[Yu, Li; Zheng, Lixin; Liu, Zhihua; Wan, Fengyi; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Yu, Li; Rong, Yueguang; Peng, Junya; Mi, Na] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Li; Rong, Yueguang; Peng, Junya; Mi, Na] State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [McPhee, Christina K.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Mardones, Gonzalo A.; Hailey, Dale W.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Mardones, Gonzalo A.] Univ Austral Chile, Dept Physiol, Valdivia 5099200, Chile; [Zhao, Ying] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Oorschot, Viola; Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tsinghua University; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad Austral de Chile; Peking University; Utrecht University; Utrecht University Medical Center	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov		Kary, Christina/0000-0002-2586-4185; RONG, YUEGUANG/0000-0001-6661-9664; Mi, Na/0000-0003-3090-197X	Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services; NIH [GM079431]; 973 program [2010CB833704]; NSF [20091300700]; Tsinghua University [20091081391]; Netherlands Organisation for Scientific Research (NWO) [918.56.611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 program(National Basic Research Program of China); NSF(National Science Foundation (NSF)); Tsinghua University; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of Allergy and Infectious Diseases (NIAID) imaging core facility and Olympus China for technical support; O. Schwartz, J. Kabat, L. Koo, M. Czapiga (Bio-imaging facility (BIF), NIAID, NIH) and Q. Dong (Olympus China) for assistance with confocal microscopy and imaging processing; K. Nagashima and M. J. de la Cruz (NCI) for TEM analyses: J. Lippincott-Schwartz, H Bernstein, and J. Bonifacino for helpful discussions; D. Yamamoto, G. Davis and H. Kramer for constructs and fly strains; and M. v. Peski and R. Scriwanek for assistance with the preparation of the EM figures. This research was supported by the Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services and NIH Grant GM079431 to E. B., 973 program 2010CB833704, NSF grant 20091300700, and Tsinghua University grant 20091081391 to Y.L. J. K. is the recipient of VICI grant 918.56.611 of the Netherlands Organisation for Scientific Research (NWO).	Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yu L, 2004, CELL CYCLE, V3, P1124; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902	17	1037	1095	7	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					942	U11		10.1038/nature09076	http://dx.doi.org/10.1038/nature09076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20526321	Green Accepted			2022-12-24	WOS:000278804500041
J	Chow, JC; Ciaudo, C; Fazzari, MJ; Mise, N; Servant, N; Glass, JL; Attreed, M; Avner, P; Wutz, A; Barillot, E; Greally, JM; Voinnet, O; Heard, E				Chow, Jennifer C.; Ciaudo, Constance; Fazzari, Melissa J.; Mise, Nathan; Servant, Nicolas; Glass, Jacob L.; Attreed, Matthew; Avner, Philip; Wutz, Anton; Barillot, Emmanuel; Greally, John M.; Voinnet, Olivier; Heard, Edith			LINE-1 Activity in Facultative Heterochromatin Formation during X Chromosome Inactivation	CELL			English	Article							LYON REPEAT HYPOTHESIS; SMALL INTERFERING RNAS; XIST RNA; RETROTRANSPOSON SUBFAMILY; L1 RETROTRANSPOSITION; DOSAGE COMPENSATION; GENE-EXPRESSION; MOUSE; ELEMENTS; CELLS	During X chromosome inactivation (XCI), Xist RNA coats and silences one of the two X chromosomes in female cells. Little is known about how XCI spreads across the chromosome, although LINE-1 elements have been proposed to play a role. Here we show that LINEs participate in creating a silent nuclear compartment into which genes become recruited. A subset of young LINE-1 elements, however, is expressed during XCI, rather than being silenced. We demonstrate that such LINE expression requires the specific heterochromatic state induced by Xist. These LINEs often lie within escape-prone regions of the X chromosome, but close to genes that are subject to XCI, and are associated with putative endo-siRNAs. LINEs may thus facilitate XCI at different levels, with silent LINEs participating in assembly of a heterochromatic nuclear compartment induced by Xist, and active LINEs participating in local propagation of XCI into regions that would otherwise be prone to escape.	[Chow, Jennifer C.; Ciaudo, Constance; Servant, Nicolas; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Chow, Jennifer C.; Ciaudo, Constance; Heard, Edith] Univ Strasbourg, CNRS UMR3215, F-67084 Strasbourg, France; [Chow, Jennifer C.; Ciaudo, Constance; Heard, Edith] Univ Strasbourg, INSERM U934, F-67084 Strasbourg, France; [Ciaudo, Constance; Voinnet, Olivier] Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, F-67084 Strasbourg, France; [Fazzari, Melissa J.; Glass, Jacob L.; Attreed, Matthew; Greally, John M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Fazzari, Melissa J.; Glass, Jacob L.; Attreed, Matthew; Greally, John M.] Albert Einstein Coll Med, Ctr Epigenom, Bronx, NY 10461 USA; [Mise, Nathan; Avner, Philip] Inst Pasteur, URA1968, F-75015 Paris, France; [Mise, Nathan] Jichi Med Univ, Dept Pharmacol, Mibu, Tochigi 3290431, Japan; [Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Servant, Nicolas; Barillot, Emmanuel] INSERM U900, F-77300 Fontainebleau, France; [Wutz, Anton] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QN, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Jichi Medical University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cambridge	Heard, E (corresponding author), Inst Curie, F-75248 Paris, France.	edith.heard@curie.fr	Ciaudo, Constance/A-2014-2012; 名丹, 三瀬/AAD-1036-2021; Heard, Edith/D-7197-2017; Greally, John/AAF-9540-2019	Ciaudo, Constance/0000-0002-0857-4506; Heard, Edith/0000-0001-8052-7117; Greally, John/0000-0001-6069-7960; BARILLOT, Emmanuel/0000-0003-2724-2002; Voinnet, Olivier/0000-0001-6982-9544; Servant, Nicolas/0000-0003-1678-7410; Fazzari, Melissa/0000-0002-5674-3589	ANR; FRM; European Union [LSHG-CT-2005-018883]; Canceropole IdF; ERC [ERC-210890]; Prix Liliane Bettencourt for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; Medical Research Council [G0800784B, G0300723B, G0800784] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole IdF(Region Ile-de-France); ERC(European Research Council (ERC)European Commission); Prix Liliane Bettencourt for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the Heard laboratory and Vincent Colot for critical reading of the manuscript; John Goodier and Deborah Bourc'his for advice and mouse LINE-1 plasmid constructs; and Valerie Cognat (IBMP) for expert bioinformatics analyses. This work was supported by grants from the ANR ("RNA ES"; to both E. H. and O.V.); FRM (Equipe FRM to E. H. and FRM fellowship to J.C.); HEROIC, an Integrated Project funded by the European Union under the 6th Framework Programme (LSHG-CT-2005-018883); and Canceropole IdF (GET project) to E. H; O.V.'s laboratory was further supported by an ERC Young Investigator Award (Grant ERC-210890 "Frontiers of RNAi") and Prix Liliane Bettencourt for Life Sciences.	Abrusan G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000172; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Horman SR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/32713; Huntley D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-501; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Popova BC, 2006, P NATL ACAD SCI USA, V103, P7706, DOI 10.1073/pnas.0602021103; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008	55	227	239	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					956	969		10.1016/j.cell.2010.04.042	http://dx.doi.org/10.1016/j.cell.2010.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550932	Bronze			2022-12-24	WOS:000278618800011
J	Deal, RB; Henikoff, JG; Henikoff, S				Deal, Roger B.; Henikoff, Jorja G.; Henikoff, Steven			Genome-Wide Kinetics of Nucleosome Turnover Determined by Metabolic Labeling of Histones	SCIENCE			English	Article							H3.3 REPLACEMENT; REPLICATION; PROMOTERS; CHROMATIN; MARKS; EXCHANGE; GENES; SITES; CELLS; YEAST	Nucleosome disruption and replacement are crucial activities that maintain epigenomes, but these highly dynamic processes have been difficult to study. Here, we describe a direct method for measuring nucleosome turnover dynamics genome-wide. We found that nucleosome turnover is most rapid over active gene bodies, epigenetic regulatory elements, and replication origins in Drosophila cells. Nucleosomes turn over faster at sites for trithorax-group than polycomb-group protein binding, suggesting that nucleosome turnover differences underlie their opposing activities and challenging models for epigenetic inheritance that rely on stability of histone marks. Our results establish a general strategy for studying nucleosome dynamics and uncover nucleosome turnover differences across the genome that are likely to have functional importance for epigenome maintenance, gene regulation, and control of DNA replication.	[Deal, Roger B.; Henikoff, Jorja G.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685	NIH [1R21DA025758, 1F32GM083449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Furuyama for suggesting this approach, members of our lab for helpful discussions, and the Hutchinson Center Genomics Shared Resource for microarray processing. This work was supported by NIH grant 1R21DA025758 to S. H. and NIH Postdoctoral Fellowship 1F32GM083449 to R. B. D. All data sets can be found in GEO: GSE19788.	Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; YAMASU K, 1990, J BIOCHEM-TOKYO, V107, P15, DOI 10.1093/oxfordjournals.jbchem.a122999	23	340	348	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1161	1164		10.1126/science.1186777	http://dx.doi.org/10.1126/science.1186777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508129	Green Accepted			2022-12-24	WOS:000278104700045
J	Gilbert, PM; Havenstrite, KL; Magnusson, KEG; Sacco, A; Leonardi, NA; Kraft, P; Nguyen, NK; Thrun, S; Lutolf, MP; Blau, HM				Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Thrun, S.; Lutolf, M. P.; Blau, H. M.			Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture	SCIENCE			English	Article							SATELLITE CELLS; REGENERATION; EXPANSION; FATES	Stem cells that naturally reside in adult tissues, such as muscle stem cells (MuSCs), exhibit robust regenerative capacity in vivo that is rapidly lost in culture. Using a bioengineered substrate to recapitulate key biophysical and biochemical niche features in conjunction with a highly automated single-cell tracking algorithm, we show that substrate elasticity is a potent regulator of MuSC fate in culture. Unlike MuSCs on rigid plastic dishes (similar to 10(6) kilopascals), MuSCs cultured on soft hydrogel substrates that mimic the elasticity of muscle (12 kilopascals) self-renew in vitro and contribute extensively to muscle regeneration when subsequently transplanted into mice and assayed histologically and quantitatively by noninvasive bioluminescence imaging. Our studies provide novel evidence that by recapitulating physiological tissue rigidity, propagation of adult muscle stem cells is possible, enabling future cell-based therapies for muscle-wasting diseases.	[Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Blau, H. M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Baxter Lab Stem Cell Biol,Dept Microbiol & Immuno, Stanford, CA 94305 USA; [Havenstrite, K. L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Magnusson, K. E. G.] Royal Inst Technol KTH, Signal Proc Lab, Sch Elect Engn, SE-10044 Stockholm, Sweden; [Leonardi, N. A.; Lutolf, M. P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Leonardi, N. A.; Lutolf, M. P.] Ecole Polytech Fed Lausanne, Lab Stem Cell Bioengn, CH-1015 Lausanne, Switzerland; [Thrun, S.] Stanford Univ, Dept Comp Sci, Stanford Artificial Intelligence Lab, Stanford, CA 94305 USA	Stanford University; Stanford University; Royal Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University	Blau, HM (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Baxter Lab Stem Cell Biol,Dept Microbiol & Immuno, Stanford, CA 94305 USA.	hblau@stanford.edu	Lutolf, Matthias P/E-5914-2010	Gilbert, Penney/0000-0001-5509-9616	PHS [CA09151]; CIRM [TG2-01159, RT1-01001]; Leukemia and Lymphoma Society; European Young Investigator Award; NSF; NIH [2 T32 HD007249, HL096113, AG009521, AG020961, U01 HL100397]; Muscular Dystrophy Association (MDA) [4063, 4320]; EPFL; Swiss Study Foundation; John och Karin Engbloms Stipendiefond; Bio X Undergraduate Research Award; Howard Hughes Medical Institute [52005886]; JDRF [34-2008-623]; LLS [TR6025-09]; Stanford Bio-X Award [IIP3-34]; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CIRM(California Institute for Regenerative Medicine); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Young Investigator Award; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); EPFL; Swiss Study Foundation; John och Karin Engbloms Stipendiefond; Bio X Undergraduate Research Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JDRF(Juvenile Diabetes Research Foundation); LLS; Stanford Bio-X Award; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Koleckar, R. Tran, IBM Almaden, the Stanford Center for Innovation in In-Vivo Imaging, and the Stanford Shared FACS Facility core facilities for technical support; J. Sly, R. D. Miller, S. Kobal, S. Gobaa, R. Doyonnas, and A. Barron for valuable discussions; and F. Rossi and M. Kyba for providing alpha-7 integrin antibody and Pax7-ZsGreen mice, respectively. This work was financially supported by PHS CA09151 and CIRM TG2-01159 (P.M.G.); Leukemia and Lymphoma Society Fellow and European Young Investigator Award (M.P.L.); NSF and NIH Training Grant 2 T32 HD007249 (K.H.); Muscular Dystrophy Association (MDA) grant 4063 (A.S.); EPFL Excellence Scholarship and the Swiss Study Foundation (N.A.L.); John och Karin Engbloms Stipendiefond (K.E.G.M.); Bio X Undergraduate Research Award and Howard Hughes Medical Institute grant 52005886 (N.K.N.); and NIH grants HL096113, AG009521, AG020961, U01 HL100397, JDRF 34-2008-623, MDA grant 4320, LLS grant TR6025-09, CIRM grant RT1-01001, Stanford Bio-X Award IIP3-34, and the Baxter Foundation (H.M.B.).	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Callister W.D., 2000, FUNDAMENTALS MAT SCI, V5th; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Heslop L, 2000, J CELL SCI, V113, P2299; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Partridge T A, 1997, Methods Mol Biol, V75, P131; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	26	1117	1145	19	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1078	1081		10.1126/science.1191035	http://dx.doi.org/10.1126/science.1191035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20647425	Green Accepted			2022-12-24	WOS:000281253500041
J	Pinto, D; Pagnamenta, AT; Klei, L; Anney, R; Merico, D; Regan, R; Conroy, J; Magalhaes, TR; Correia, C; Abrahams, BS; Almeida, J; Bacchelli, E; Bader, GD; Bailey, AJ; Baird, G; Battaglia, A; Berney, T; Bolshakova, N; Bolte, S; Bolton, PF; Bourgeron, T; Brennan, S; Brian, J; Bryson, SE; Carson, AR; Casallo, G; Casey, J; Chung, BHY; Cochrane, L; Corsello, C; Crawford, EL; Crossett, A; Cytrynbaum, C; Dawson, G; de Jonge, M; Delorme, R; Drmic, I; Duketis, E; Duque, F; Estes, A; Farrar, P; Fernandez, BA; Folstein, SE; Fombonne, E; Freitag, CM; Gilbert, J; Gillberg, C; Glessner, JT; Goldberg, J; Green, A; Green, J; Guter, SJ; Hakonarson, H; Heron, EA; Hill, M; Holt, R; Howe, JL; Hughes, G; Hus, V; Igliozzi, R; Kim, C; Klauck, SM; Kolevzon, A; Korvatska, O; Kustanovich, V; Lajonchere, CM; Lamb, JA; Laskawiec, M; Leboyer, M; Le Couteur, A; Leventhal, BL; Lionel, AC; Liu, XQ; Lord, C; Lotspeich, L; Lund, SC; Maestrini, E; Mahoney, W; Mantoulan, C; Marshall, CR; McConachie, H; McDougle, CJ; McGrath, J; McMahon, WM; Merikangas, A; Migita, O; Minshew, NJ; Mirza, GK; Munson, J; Nelson, SF; Noakes, C; Noor, A; Nygren, G; Oliveira, G; Papanikolaou, K; Parr, JR; Parrini, B; Paton, T; Pickles, A; Pilorge, M; Piven, J; Ponting, CP; Posey, DJ; Poustka, A; Poustka, F; Prasad, A; Ragoussis, J; Renshaw, K; Rickaby, J; Roberts, W; Roeder, K; Roge, B; Rutter, ML; Bierut, LJ; Rice, JP; Salt, J; Sansom, K; Sato, D; Segurado, R; Sequeira, AF; Senman, L; Shah, N; Sheffield, VC; Soorya, L; Sousa, I; Stein, O; Sykes, N; Stoppioni, V; Strawbridge, C; Tancredi, R; Tansey, K; Thiruvahindrapduram, B; Thompson, AP; Thomson, S; Tryfon, A; Tsiantis, J; Van Engeland, H; Vincent, JB; Volkmar, F; Wallace, S; Wang, K; Wang, ZZ; Wassink, TH; Webber, C; Weksberg, R; Wing, K; Wittemeyer, K; Wood, S; Wu, J; Yaspan, BL; Zurawiecki, D; Zwaigenbaum, L; Buxbaum, JD; Cantor, RM; Cook, EH; Coon, H; Cuccaro, ML; Devlin, B; Ennis, S; Gallagher, L; Geschwind, DH; Gill, M; Haines, JL; Hallmayer, J; Miller, J; Monaco, AP; Nurnberger, JI; Paterson, AD; Pericak-Vance, MA; Schellenberg, GD; Szatmari, P; Vicente, AM; Vieland, VJ; Wijsman, EM; Scherer, SW; Sutcliffe, JS; Betancur, C				Pinto, Dalila; Pagnamenta, Alistair T.; Klei, Lambertus; Anney, Richard; Merico, Daniele; Regan, Regina; Conroy, Judith; Magalhaes, Tiago R.; Correia, Catarina; Abrahams, Brett S.; Almeida, Joana; Bacchelli, Elena; Bader, Gary D.; Bailey, Anthony J.; Baird, Gillian; Battaglia, Agatino; Berney, Tom; Bolshakova, Nadia; Boelte, Sven; Bolton, Patrick F.; Bourgeron, Thomas; Brennan, Sean; Brian, Jessica; Bryson, Susan E.; Carson, Andrew R.; Casallo, Guillermo; Casey, Jillian; Chung, Brian H. Y.; Cochrane, Lynne; Corsello, Christina; Crawford, Emily L.; Crossett, Andrew; Cytrynbaum, Cheryl; Dawson, Geraldine; de Jonge, Maretha; Delorme, Richard; Drmic, Irene; Duketis, Eftichia; Duque, Frederico; Estes, Annette; Farrar, Penny; Fernandez, Bridget A.; Folstein, Susan E.; Fombonne, Eric; Freitag, Christine M.; Gilbert, John; Gillberg, Christopher; Glessner, Joseph T.; Goldberg, Jeremy; Green, Andrew; Green, Jonathan; Guter, Stephen J.; Hakonarson, Hakon; Heron, Elizabeth A.; Hill, Matthew; Holt, Richard; Howe, Jennifer L.; Hughes, Gillian; Hus, Vanessa; Igliozzi, Roberta; Kim, Cecilia; Klauck, Sabine M.; Kolevzon, Alexander; Korvatska, Olena; Kustanovich, Vlad; Lajonchere, Clara M.; Lamb, Janine A.; Laskawiec, Magdalena; Leboyer, Marion; Le Couteur, Ann; Leventhal, Bennett L.; Lionel, Anath C.; Liu, Xiao-Qing; Lord, Catherine; Lotspeich, Linda; Lund, Sabata C.; Maestrini, Elena; Mahoney, William; Mantoulan, Carine; Marshall, Christian R.; McConachie, Helen; McDougle, Christopher J.; McGrath, Jane; McMahon, William M.; Merikangas, Alison; Migita, Ohsuke; Minshew, Nancy J.; Mirza, Ghazala K.; Munson, Jeff; Nelson, Stanley F.; Noakes, Carolyn; Noor, Abdul; Nygren, Gudrun; Oliveira, Guiomar; Papanikolaou, Katerina; Parr, Jeremy R.; Parrini, Barbara; Paton, Tara; Pickles, Andrew; Pilorge, Marion; Piven, Joseph; Ponting, Chris P.; Posey, David J.; Poustka, Annemarie; Poustka, Fritz; Prasad, Aparna; Ragoussis, Jiannis; Renshaw, Katy; Rickaby, Jessica; Roberts, Wendy; Roeder, Kathryn; Roge, Bernadette; Rutter, Michael L.; Bierut, Laura J.; Rice, John P.; Salt, Jeff; Sansom, Katherine; Sato, Daisuke; Segurado, Ricardo; Sequeira, Ana F.; Senman, Lili; Shah, Naisha; Sheffield, Val C.; Soorya, Latha; Sousa, Ines; Stein, Olaf; Sykes, Nuala; Stoppioni, Vera; Strawbridge, Christina; Tancredi, Raffaella; Tansey, Katherine; Thiruvahindrapduram, Bhooma; Thompson, Ann P.; Thomson, Susanne; Tryfon, Ana; Tsiantis, John; Van Engeland, Herman; Vincent, John B.; Volkmar, Fred; Wallace, Simon; Wang, Kai; Wang, Zhouzhi; Wassink, Thomas H.; Webber, Caleb; Weksberg, Rosanna; Wing, Kirsty; Wittemeyer, Kerstin; Wood, Shawn; Wu, Jing; Yaspan, Brian L.; Zurawiecki, Danielle; Zwaigenbaum, Lonnie; Buxbaum, Joseph D.; Cantor, Rita M.; Cook, Edwin H.; Coon, Hilary; Cuccaro, Michael L.; Devlin, Bernie; Ennis, Sean; Gallagher, Louise; Geschwind, Daniel H.; Gill, Michael; Haines, Jonathan L.; Hallmayer, Joachim; Miller, Judith; Monaco, Anthony P.; Nurnberger, John I., Jr.; Paterson, Andrew D.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Szatmari, Peter; Vicente, Astrid M.; Vieland, Veronica J.; Wijsman, Ellen M.; Scherer, Stephen W.; Sutcliffe, James S.; Betancur, Catalina			Functional impact of global rare copy number variation in autism spectrum disorders	NATURE			English	Article							HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; GENETIC DISORDER; ASSOCIATION; MUTATIONS; LINKAGE; LOCI; ANCESTRY; REVEALS; COMPLEX	The autism spectrum disorders (ASDs) are a group of conditions characterized by impairments in reciprocal social interaction and communication, and the presence of restricted and repetitive behaviours(1). Individuals with an ASD vary greatly in cognitive development, which can range from above average to intellectual disability(2). Although ASDs are known to be highly heritable (similar to 90%)(3), the underlying genetic determinants are still largely unknown. Here we analysed the genome-wide characteristics of rare (<1% frequency) copy number variation in ASD using dense genotyping arrays. When comparing 996 ASD individuals of European ancestry to 1,287 matched controls, cases were found to carry a higher global burden of rare, genic copy number variants (CNVs) (1.19 fold, P=0.012), especially so for loci previously implicated in either ASD and/or intellectual disability (1.69 fold, P=3.4 x 10(-4)). Among the CNVs there were numerous de novo and inherited events, sometimes in combination in a given family, implicating many novel ASD genes such as SHANK2, SYNGAP1, DLGAP2 and the X-linked DDX53-PTCHD1 locus. We also discovered an enrichment of CNVs disrupting functional gene sets involved in cellular proliferation, projection and motility, and GTPase/Ras signalling. Our results reveal many new genetic and functional targets in ASD that may lead to final connected pathways.	[Pinto, Dalila; Carson, Andrew R.; Casallo, Guillermo; Chung, Brian H. Y.; Cytrynbaum, Cheryl; Howe, Jennifer L.; Lionel, Anath C.; Liu, Xiao-Qing; Marshall, Christian R.; Migita, Ohsuke; Paton, Tara; Prasad, Aparna; Rickaby, Jessica; Sansom, Katherine; Sato, Daisuke; Thiruvahindrapduram, Bhooma; Wang, Zhouzhi; Weksberg, Rosanna; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Pinto, Dalila; Carson, Andrew R.; Casallo, Guillermo; Chung, Brian H. Y.; Cytrynbaum, Cheryl; Howe, Jennifer L.; Lionel, Anath C.; Liu, Xiao-Qing; Marshall, Christian R.; Migita, Ohsuke; Paton, Tara; Prasad, Aparna; Rickaby, Jessica; Sansom, Katherine; Sato, Daisuke; Thiruvahindrapduram, Bhooma; Wang, Zhouzhi; Weksberg, Rosanna; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Pagnamenta, Alistair T.; Farrar, Penny; Holt, Richard; Mirza, Ghazala K.; Ragoussis, Jiannis; Sousa, Ines; Sykes, Nuala; Wing, Kirsty; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Klei, Lambertus; Wood, Shawn; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Anney, Richard; Bolshakova, Nadia; Brennan, Sean; Cochrane, Lynne; Heron, Elizabeth A.; Hill, Matthew; Hughes, Gillian; McGrath, Jane; Merikangas, Alison; Segurado, Ricardo; Tansey, Katherine; Gallagher, Louise; Gill, Michael] Trinity Coll Dublin, Sch Med, Dept Psychiat, Autism Genet Grp, Dublin 8, Ireland; [Merico, Daniele; Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Regan, Regina; Conroy, Judith; Casey, Jillian; Green, Andrew; Shah, Naisha; Ennis, Sean] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] Inst Nacl Saude Dr Ricardo Jorge, P-1649016 Lisbon, Portugal; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] Gulbenkian Inst Sci, P-2780156 Oeiras, Portugal; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res & Treatment, Semel Inst, Los Angeles, CA 90095 USA; [Almeida, Joana; Duque, Frederico; Oliveira, Guiomar] Hosp Pediat Coimbra, P-3000076 Coimbra, Portugal; [Bacchelli, Elena; Maestrini, Elena] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Bailey, Anthony J.; Laskawiec, Magdalena; Renshaw, Katy; Wallace, Simon] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Baird, Gillian] Guys Hosp, Newcomen Ctr, London SE1 9RT, England; [Battaglia, Agatino; Igliozzi, Roberta; Parrini, Barbara; Tancredi, Raffaella] Stella Maris Inst Child & Adolescent Neuropsychia, I-56128 Pisa, Italy; [Berney, Tom; Le Couteur, Ann; McConachie, Helen] Univ Newcastle, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Boelte, Sven; Duketis, Eftichia; Freitag, Christine M.; Poustka, Fritz] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat, D-60528 Frankfurt, Germany; [Bolton, Patrick F.] Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Bourgeron, Thomas] Univ Paris 07, CNRS, URA 2182, Inst Pasteur, F-75015 Paris, France; [Brian, Jessica; Drmic, Irene; Noakes, Carolyn; Roberts, Wendy; Senman, Lili] Univ Toronto, Hosp Sick Children & Bloorview Kids Rehab, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Bryson, Susan E.] Dalhousie Univ, Dept Pediat & Psychol, Halifax, NS B3K 6R8, Canada; [Corsello, Christina; Hus, Vanessa; Lord, Catherine] Univ Michigan, Autism & Communicat Disorders Ctr, Ann Arbor, MI 48109 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Crossett, Andrew; Roeder, Kathryn; Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Dawson, Geraldine] Autism Speaks, New York, NY 10016 USA; [Dawson, Geraldine] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [de Jonge, Maretha; Van Engeland, Herman] Univ Med Ctr, Dept Child Psychiat, NL-3508 GA Utrecht, Netherlands; [Delorme, Richard] Hop Robert Debre, AP HP, Fdn FondaMental, INSERM,U955, F-75019 Paris, France; [Estes, Annette] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada; [Folstein, Susan E.; Gilbert, John; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33101 USA; [Fombonne, Eric] McGill Univ, Div Psychiat, Montreal, PQ H3A 1A1, Canada; [Gillberg, Christopher; Nygren, Gudrun] Univ Gothenburg, Dept Child & Adolescent Psychiat, S-41345 Gothenburg, Sweden; [Glessner, Joseph T.; Hakonarson, Hakon; Kim, Cecilia; Wang, Kai] Childrens Hosp Philadelphia, Ctr Appl Genom, Div Human Genet, Philadelphia, PA 19104 USA; [Goldberg, Jeremy; Strawbridge, Christina; Thompson, Ann P.; Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; [Green, Jonathan] Booth Hall Childrens Hosp, Acad Dept Child Psychiat, Manchester M9 7AA, Lancs, England; [Guter, Stephen J.; Salt, Jeff; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Klauck, Sabine M.; Poustka, Annemarie] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Kolevzon, Alexander; Soorya, Latha; Tryfon, Ana; Zurawiecki, Danielle; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Korvatska, Olena] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Kustanovich, Vlad; Lajonchere, Clara M.] Autism Speaks, Autism Genet Resource Exchange, Los Angeles, CA 90036 USA; [Lamb, Janine A.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [Leboyer, Marion] Univ Paris 12, AP HP, Grp Hosp Henri Mondor Albert Chenevier, INSERM,U995,Dept Psychiat,Fdn FondaMental, F-94000 Creteil, France; [Leventhal, Bennett L.] Nathan S Kline Inst Psychiat Res NKI, Orangeburg, NY 10962 USA; [Leventhal, Bennett L.] NYU, Dept Child & Adolescent Psychiat, New York, NY 10016 USA; [Leventhal, Bennett L.] NYU, Ctr Child Study, New York, NY 10016 USA; [Lotspeich, Linda; Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat & Child Dev, Palo Alto, CA 94304 USA; [Mahoney, William] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Mantoulan, Carine; Roge, Bernadette; Wittemeyer, Kerstin] Univ Toulouse Le Mirail, Ctr Eudes & Rech Psychopathol, F-31200 Toulouse, France; [McDougle, Christopher J.; Posey, David J.; Nurnberger, John I., Jr.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McMahon, William M.; Coon, Hilary; Miller, Judith] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84108 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Munson, Jeff] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Nelson, Stanley F.; Cantor, Rita M.] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Noor, Abdul; Vincent, John B.] Univ Toronto, Ctr Addict & Mental Hlth, Clarke Inst, Toronto, ON M5G 1X8, Canada; [Noor, Abdul; Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Papanikolaou, Katerina; Tsiantis, John] Univ Athens, Sch Med, Agia Sophia Childrens Hosp, Univ Dept Child Psychiat, GR-11527 Athens, Greece; [Berney, Tom; Le Couteur, Ann; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Berney, Tom; Le Couteur, Ann; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pickles, Andrew] Univ Manchester, Sch Epidemiol & Hlth Sci, Dept Med, Manchester M13 9PT, Lancs, England; [Pilorge, Marion; Betancur, Catalina] INSERM, U952, F-75005 Paris, France; [Pilorge, Marion; Betancur, Catalina] CNRS, UMR 7224, F-75005 Paris, France; [Pilorge, Marion; Betancur, Catalina] UPMC, F-75005 Paris, France; [Piven, Joseph] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Ponting, Chris P.; Webber, Caleb] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Rutter, Michael L.] Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Bierut, Laura J.; Rice, John P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Stein, Olaf; Vieland, Veronica J.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Stein, Olaf; Vieland, Veronica J.] Ohio State Univ, Columbus, OH 43205 USA; [Stoppioni, Vera] Osped Santa Croce, I-61032 Fano, Italy; [Volkmar, Fred] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Wassink, Thomas H.] Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2J3, Canada; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; [Schellenberg, Gerard D.] Univ Penn, Philadelphia, PA 19104 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Trinity College Dublin; University of Toronto; University College Dublin; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Bologna; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; IRCCS Fondazione Stella Maris; Newcastle University - UK; Goethe University Frankfurt; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; Hospital for Sick Children (SickKids); Dalhousie University; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Vanderbilt University; Carnegie Mellon University; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Washington; University of Washington Seattle; Memorial University Newfoundland; Memorial University Newfoundland; University of Miami; McGill University; University of Gothenburg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McMaster University; Royal Manchester Children's Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Helmholtz Association; German Cancer Research Center (DKFZ); Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Nathan Kline Institute for Psychiatric Research; New York University; New York University; Stanford University; McMaster University; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Newcastle University - UK; Newcastle University - UK; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; University of London; King's College London; Washington University (WUSTL); University of Iowa; Howard Hughes Medical Institute; University of Iowa; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Yale University; University of Alberta; Vanderbilt University; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada.	stephen.scherer@sickkids.ca	Battaglia, Agatino/AAG-1406-2020; Ponting, Chris/AAV-2621-2021; Rutter, Michael/C-8570-2013; Papanikolaou, Katerina/AAB-4771-2020; Igliozzi, Roberta/AAA-4568-2021; Koo, Jawoo/F-9397-2010; Oliveira, Guiomar/AAF-3911-2021; Scherer, Stephen W./B-3785-2013; Bader, Gary/C-1176-2009; Volkmar, Fred/AEB-0666-2022; Paterson, Andrew/AAQ-7511-2020; Prasad, Aparna/N-4253-2015; De Jonge, Maretha V/F-4942-2013; Pinto, Dalila/C-4218-2016; Ragoussis, Ioannis/AAD-9790-2022; Monaco, Anthony P/A-4495-2010; Betancur, Catalina/K-3791-2017; Vicente, Astrid/F-8692-2014; Buxbaum, Joseph D/G-6001-2010; Haines, Jonathan/C-3374-2012; Maestrini, Elena/K-7508-2012; Nelson, Stanley F/D-4771-2009; Tancredi, Raffaella/C-3868-2018; Tansey, Katherine E/B-1033-2013; Fombonne, Eric/M-4893-2018; Leboyer, Marion/AAW-3648-2021; Paterson, Andrew D/A-4088-2011; Oliveira, Guiomar/I-7255-2013; Bal, Vanessa Hus/AAN-2381-2020; Sutcliffe, James S/C-1348-2012; Green, Andrew/AAJ-7592-2020; Bölte, Sven/AAH-8675-2019; Pickles, Andrew/A-9625-2011; Hill, Matthew/E-7730-2010; Bailey, Anthony/J-2860-2014; Bierut, Laura Jean/W-6806-2019; Heron, Elizabeth Ann/HCI-9636-2022; Mahoney, William/GQB-0802-2022; Duque, Frederico/H-3692-2014; Noor, Abdul/J-2345-2016; bacchelli, elena/R-3675-2016; Segurado, Ricardo/K-6116-2014	Battaglia, Agatino/0000-0002-7128-7606; Igliozzi, Roberta/0000-0002-1245-972X; Koo, Jawoo/0000-0003-3424-9229; Oliveira, Guiomar/0000-0002-7049-1277; Scherer, Stephen W./0000-0002-8326-1999; Bader, Gary/0000-0003-0185-8861; Paterson, Andrew/0000-0002-9169-118X; Prasad, Aparna/0000-0002-6786-2313; Pinto, Dalila/0000-0002-8769-0846; Monaco, Anthony P/0000-0001-7480-3197; Betancur, Catalina/0000-0002-3327-4804; Vicente, Astrid/0000-0001-7134-8037; Haines, Jonathan/0000-0002-4351-4728; Maestrini, Elena/0000-0001-5924-3179; Nelson, Stanley F/0000-0002-2082-3114; Tancredi, Raffaella/0000-0003-3517-4919; Tansey, Katherine E/0000-0002-9663-3376; Fombonne, Eric/0000-0002-8605-3538; Leboyer, Marion/0000-0001-5473-3697; Paterson, Andrew D/0000-0002-9169-118X; Bal, Vanessa Hus/0000-0003-0750-823X; Sutcliffe, James S/0000-0001-5200-6007; Bölte, Sven/0000-0002-4579-4970; Pickles, Andrew/0000-0003-1283-0346; Hill, Matthew/0000-0001-6776-8709; Bailey, Anthony/0000-0003-4257-972X; Bierut, Laura Jean/0000-0002-9952-4810; Heron, Elizabeth Ann/0000-0003-2219-4005; Duque, Frederico/0000-0001-5684-1472; bacchelli, elena/0000-0001-8800-9568; Sequeira, Ana Filipa/0000-0001-8445-6221; Dawson, Geraldine/0000-0003-1410-2764; Liu, Xiao-Qing/0000-0002-4034-5156; Merico, Daniele/0000-0002-3728-4401; Rutter, Michael Llewellyn/0000-0003-1577-7405; Gill, Michael/0000-0003-0206-5337; McGrath, Jane/0000-0002-4894-4823; R Magalhaes, Tiago/0000-0002-5528-2119; Roeder, Kathryn/0000-0002-8869-6254; Estes, Annette/0000-0003-2687-4155; Ragoussis, Ioannis/0000-0002-8515-0934; Guter, Stephen/0000-0002-4476-2045; Sheffield, Val/0000-0002-6282-0835; Bolshakova, Nadia/0000-0003-2173-6562; Ennis, Sean/0000-0002-4330-1386; Simpson, Nuala/0000-0003-3390-9993; Buxbaum, Joseph/0000-0001-8898-8313; Lund, Sabata/0000-0002-6092-5131; Lamb, Janine/0000-0002-7248-0539; Glessner, Joseph/0000-0001-5131-2811; Freitag, Christine Margarete/0000-0001-9676-4782; Gallagher, Louise/0000-0001-9462-2836; Girao Meireles de Sousa, Ines/0000-0001-6983-8870; Nurnberger, John/0000-0002-7674-1767; Wassink, Thomas/0000-0002-0952-8333; Green, Andrew/0000-0002-1077-7417; Wijsman, Ellen/0000-0002-2725-6669; Anney, Richard/0000-0002-6083-407X; Green, Jonathan/0000-0002-0143-181X; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; Segurado, Ricardo/0000-0002-3547-6733; Delorme, Richard/0000-0002-5614-3663; McNeil, Kirsty/0000-0003-0437-3608; Merikangas, Alison/0000-0003-2253-839X; Webber, Caleb/0000-0001-8063-7674; Correia, Catarina/0000-0001-5481-2010; Ponting, Chris/0000-0003-0202-7816; Yaspan, Brian/0000-0002-3787-2510; Bourgeron, Thomas/0000-0001-8164-9220	Autism Genome Project Consortium (AGP): Autism Speaks (USA); Health Research Board (HRB; Ireland); Medical Research Council (MRC; UK); Genome Canada/Ontario Genomics Institute; Hilibrand Foundation (USA); US National Institutes of Health (NIH) [HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261]; Canadian Institute for Advanced Research (CIFAR); Canadian Institutes for Health Research (CIHR); Assistance Publique-Hopitaux de Paris (France); Autistica; Canada Foundation for Innovation/Ontario Innovation Trust; Deutsche Forschungsgemeinschaft (Germany) [Po 255/17-4]; EC; Fundacao Calouste Gulbenkian (Portugal); Fondation de France; Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France); Fundacao para a Ciencia e Tecnologia (Portugal); Hospital for Sick Children Foundation; University of Toronto (Canada); INSERM (France); Institut Pasteur (France); Italian Ministry of Health [181]; John P Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK) [075491/Z/04]; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Netherlands Organization for Scientific Research [825.06.031]; GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto; Hospital for Sick Children (Canada); MRC [G0601030, MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446, G0601030, G9817803B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748, P50HD055751, U19HD035469, P50HD055782, P01HD035465] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, R01MH081754, U54MH066673, U10MH066766, R01MH080647, T32MH065215, R01MH052708, R01MH061009, R01MH055284, R01MH057881, R10MH055284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049261, P01NS026630, R01NS042165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423, R01DA019963] Funding Source: NIH RePORTER	Autism Genome Project Consortium (AGP): Autism Speaks (USA); Health Research Board (HRB; Ireland); Medical Research Council (MRC; UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genome Canada/Ontario Genomics Institute(Genome Canada); Hilibrand Foundation (USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Assistance Publique-Hopitaux de Paris (France); Autistica(Autistica); Canada Foundation for Innovation/Ontario Innovation Trust(Canada Foundation for Innovation); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Fundacao Calouste Gulbenkian (Portugal); Fondation de France(Fondation de France); Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Hospital for Sick Children Foundation; University of Toronto (Canada)(University of Toronto); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur (France); Italian Ministry of Health(Ministry of Health, Italy); John P Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada)(Ministry of Research and Innovation, Ontario); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK)(Wellcome Trust); Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children (Canada); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge the families participating in the study and the main funders of the Autism Genome Project Consortium (AGP): Autism Speaks (USA), the Health Research Board (HRB; Ireland), The Medical Research Council (MRC; UK), Genome Canada/Ontario Genomics Institute, and the Hilibrand Foundation (USA). Additional support for individual groups was provided by the US National Institutes of Health (NIH grants HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261), the Canadian Institute for Advanced Research (CIFAR), the Canadian Institutes for Health Research (CIHR), Assistance Publique-Hopitaux de Paris (France), Autistica, Canada Foundation for Innovation/Ontario Innovation Trust, Deutsche Forschungsgemeinschaft (grant Po 255/17-4) (Germany), EC Sixth FP AUTISM MOLGEN, Fundacao Calouste Gulbenkian (Portugal), Fondation de France, Fondation FondaMental (France), Fondation Orange (France), Fondation pour la Recherche Medicale (France), Fundacao para a Ciencia e Tecnologia (Portugal), the Hospital for Sick Children Foundation and University of Toronto (Canada), INSERM (France), Institut Pasteur (France), the Italian Ministry of Health (convention 181 of 19.10.2001), the John P Hussman Foundation (USA), McLaughlin Centre (Canada), Ontario Ministry of Research and Innovation (Canada), the Seaver Foundation (USA), the Swedish Science Council, The Centre for Applied Genomics (Canada), the Utah Autism Foundation (USA) and the Wellcome Trust core award 075491/Z/04 (UK). D. P. is supported by fellowships from the Royal Netherlands Academy of Arts and Sciences (TMF/DA/5801) and the Netherlands Organization for Scientific Research (Rubicon 825.06.031). S.W.S. holds the GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children (Canada).	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meechan DW, 2009, P NATL ACAD SCI USA, V106, P16434, DOI 10.1073/pnas.0905696106; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490	30	1419	1514	4	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					368	372		10.1038/nature09146	http://dx.doi.org/10.1038/nature09146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20531469	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-24	WOS:000279867100049
J	Hicks, WM; Kim, M; Haber, JE				Hicks, Wade M.; Kim, Minlee; Haber, James E.			Increased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion	SCIENCE			English	Article							STRAND-BREAK-REPAIR; DNA-POLYMERASE-EPSILON; SACCHAROMYCES-CEREVISIAE; HETERODUPLEX DNA; CANCER; RECOMBINATION; DELTA; MODEL; YEAST; REPLICATION	To examine the fidelity of DNA synthesis during double-strand break (DSB) repair in Saccharomyces cerevisiae we studied gene conversion in which both strands of DNA are newly synthesized. The mutation rate increases up to 1400 times over spontaneous events, with a significantly different mutation signature. Especially prominent are microhomology-mediated template switches. Recombination-induced mutations are largely independent of mismatch repair, by DNA polymerases Pol zeta, Pol eta, and Pol32, but result from errors made by Pol delta and Pol epsilon. These observations suggest that increased DSB frequencies in oncogene-activated mammalian cells may also increase the probability of acquiring mutations required for transition to a cancerous state.	[Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	NIH [GM007122, GM20056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R37GM020056, T32GM007122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Kl-URA3 (GenBank: Y00454) was a gift from O. Zill and J. Rine. pol30-K127,164R was a gift from H. Ulrich. NIH Genetics Training Grant GM007122 supported W.M.H. NIH grant GM20056 to J.E.H. supported the research.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BUDD ME, 1995, MOL CELL BIOL, V15, P2173; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Greenblatt MS, 1996, CANCER RES, V56, P2130; HABER JE, 1993, P NATL ACAD SCI USA, V90, P3363, DOI 10.1073/pnas.90.8.3363; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Halas A, 1999, ACTA BIOCHIM POL, V46, P863; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Holbeck SL, 1997, GENETICS, V147, P1017; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Rattray AJ, 2002, GENETICS, V162, P1063; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; STRATHERN JN, 1995, GENETICS, V140, P965; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	29	189	190	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					82	85		10.1126/science.1191125	http://dx.doi.org/10.1126/science.1191125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595613	Green Accepted			2022-12-24	WOS:000279402700037
J	Moran, U; Phillips, R; Milo, R				Moran, Uri; Phillips, Rob; Milo, Ron			SnapShot: Key Numbers in Biology	CELL			English	Editorial Material									[Moran, Uri; Milo, Ron] Weizmann Inst Sci, Rehovot, Israel; [Phillips, Rob] CALTECH, Pasadena, CA USA	Weizmann Institute of Science; California Institute of Technology	Moran, U (corresponding author), Weizmann Inst Sci, Rehovot, Israel.		Milo, Hilla/C-8767-2016	Milo, Ron/0000-0003-1641-2299					0	121	122	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1262	1262	1262.e1	10.1016/j.cell.2010.06.019	http://dx.doi.org/10.1016/j.cell.2010.06.019			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603006	Bronze			2022-12-24	WOS:000279148100022
J	Grubb, MS; Burrone, J				Grubb, Matthew S.; Burrone, Juan			Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability	NATURE			English	Article							ACTION-POTENTIAL INITIATION; CA1 PYRAMIDAL NEURONS; CA2+ CHANNELS; HOMEOSTASIS; GENERATION; HIPPOCAMPAL; PROPAGATION; NA(V)1.6; SITE	In neurons, the axon initial segment (AIS) is a specialized region near the start of the axon that is the site of action potential initiation(1-6). The precise location of the AIS varies across and within different neuronal types(7,8), and has been linked to cells' information-processing capabilities(8); however, the factors determining AIS position in individual neurons remain unknown. Here we show that changes in electrical activity can alter the location of the AIS. In dissociated hippocampal cultures, chronic depolarization with high extracellular potassium moves multiple components of the AIS, including voltage-gated sodium channels, up to 17 mu m away from the soma of excitatory neurons. This movement reverses when neurons are returned to non-depolarized conditions, and depends on the activation of T- and/or L-type voltage-gated calcium channels. The AIS also moved distally when we combined long-term LED (light-emitting diode) photostimulation with sparse neuronal expression of the light-activated cation channel channelrhodopsin-2; here, burst patterning of activity was successful where regular stimulation at the same frequency failed. Furthermore, changes in AIS position correlate with alterations in current thresholds for action potential spiking. Our results show that neurons can regulate the position of an entire subcellular structure according to their ongoing levels and patterns of electrical activity. This novel form of activity-dependent plasticity may fine-tune neuronal excitability during development.	[Grubb, Matthew S.; Burrone, Juan] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Grubb, MS (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Campus, London SE1 1UL, England.	matthew.grubb@kcl.ac.uk; juan.burrone@kcl.ac.uk	Grubb, Matthew S/B-4939-2008	Grubb, Matthew S/0000-0002-2673-274X; Burrone, Juan/0000-0003-1233-668X	Wellcome Trust; Lister Institute; MRC [G0901899] Funding Source: UKRI; Medical Research Council [G0901899, G0901899B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Lister Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Komada for the anti-bIV-spectrin antibody, K. Deisseroth for the ChR2 construct, N. Ben Fredj for assistance with cell culture, S. Poopalasundaramfor help with molecular biology, P. Degenaar and N. Grossman for assistance with LED photostimulation, and I. Thompson and K. Bender for comments on the manuscript. This work was supported by the Wellcome Trust and a Lister Institute Research Prize to J.B.	AKRITAS MG, 1990, J AM STAT ASSOC, V85, P73, DOI 10.2307/2289527; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Cendes F, 2005, CURR OPIN NEUROL, V18, P173, DOI 10.1097/01.wco.0000162860.49842.90; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kress GJ, 2010, HIPPOCAMPUS, V20, P558, DOI 10.1002/hipo.20667; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PALMER MN, 2010, J PHYSL, V588, P1709; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	32	405	406	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1070	U131		10.1038/nature09160	http://dx.doi.org/10.1038/nature09160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543823	Green Accepted			2022-12-24	WOS:000279056900051
J	Jacob, Y; Stroud, H; LeBlanc, C; Feng, SH; Zhuo, LT; Caro, E; Hassel, C; Gutierrez, C; Michaels, SD; Jacobsen, SE				Jacob, Yannick; Stroud, Hume; LeBlanc, Chantal; Feng, Suhua; Zhuo, Luting; Caro, Elena; Hassel, Christiane; Gutierrez, Crisanto; Michaels, Scott D.; Jacobsen, Steven E.			Regulation of heterochromatic DNA replication by histone H3 lysine 27 methyltransferases	NATURE			English	Article							ARABIDOPSIS-THALIANA; GENE REPRESSION; METHYLATION; SET; PROTEIN; REREPLICATION; MAINTENANCE; GENOME; PCNA; FORK	Multiple pathways prevent DNA replication from occurring more than once per cell cycle(1). These pathways block re-replication by strictly controlling the activity of pre-replication complexes, which assemble at specific sites in the genome called origins. Here we show that mutations in the homologous histone 3 lysine 27 (H3K27) monomethyltransferases, ARABIDOPSIS TRITHORAX-RELATED PROTEIN5 (ATXR5) and ATXR6, lead to re-replication of specific genomic locations. Most of these locations correspond to transposons and other repetitive and silent elements of the Arabidopsis genome. These sites also correspond to high levels of H3K27 monomethylation, and mutation of the catalytic SET domain is sufficient to cause the re-replication defect. Mutation of ATXR5 and ATXR6 also causes upregulation of transposon expression and has pleiotropic effects on plant development. These results uncover a novel pathway that prevents over-replication of heterochromatin in Arabidopsis.	[Jacob, Yannick; LeBlanc, Chantal; Zhuo, Luting; Hassel, Christiane; Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Stroud, Hume; Caro, Elena; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Gutierrez, Crisanto] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Michaels, SD (corresponding author), Indiana Univ, Dept Biol, 915 E 3rd St, Bloomington, IN 47405 USA.	michaels@indiana.edu; jacobsen@ucla.edu	Caro, Elena/G-6352-2012; Gutierrez, Crisanto/ABH-8782-2020; Michaels, Scott/D-5458-2009; Caro, Elena/A-8097-2011; Caro, Elena/D-2611-2014	Caro, Elena/0000-0002-1034-1621; Michaels, Scott/0000-0001-5248-3487; Gutierrez, Crisanto/0000-0001-8905-8222	Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); National Institutes of Health [GM075060]; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; Spanish Ministry of Science and Innovation [BFU2009-9783, CSD2007-57B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075060] Funding Source: NIH RePORTER	Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Lambert and D. Galbraith for assistance with flow cytometry; Y. Bernatavichute for assistance with ChIP experiments; and M. Pellegrini and S. Cokus for advice on data analyses. Y.J. was supported by a fellowship from Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT). S. F. is a Howard Hughes Medical Institute Fellow of the Life Science Research Foundation. Research in the Michaels' laboratory was supported by grants from the National Institutes of Health (GM075060), the Indiana METACyt Initiative of Indiana University, and the Lilly Endowment, Inc. C. G. was supported by grants from the Spanish Ministry of Science and Innovation (BFU2009-9783 and CSD2007-57B). S.E.J. is an investigator of the Howard Hughes Medical Institute.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Caro Elena, 2008, SEB Exp Biol Ser, V59, P167; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; Gomez M, 2008, CELL CYCLE, V7, P1313, DOI 10.4161/cc.7.10.5881; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zhang L, 2009, NEURAL REGEN RES, V4, P10	29	126	132	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					987	U117		10.1038/nature09290	http://dx.doi.org/10.1038/nature09290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20631708	Green Accepted			2022-12-24	WOS:000281030300037
J	Genovese, G; Friedman, DJ; Ross, MD; Lecordier, L; Uzureau, P; Freedman, BI; Bowden, DW; Langefeld, CD; Oleksyk, TK; Knob, ALU; Bernhardy, AJ; Hicks, PJ; Nelson, GW; Vanhollebeke, B; Winkler, CA; Kopp, JB; Pays, E; Pollak, MR				Genovese, Giulio; Friedman, David J.; Ross, Michael D.; Lecordier, Laurence; Uzureau, Pierrick; Freedman, Barry I.; Bowden, Donald W.; Langefeld, Carl D.; Oleksyk, Taras K.; Knob, Andrea L. Uscinski; Bernhardy, Andrea J.; Hicks, Pamela J.; Nelson, George W.; Vanhollebeke, Benoit; Winkler, Cheryl A.; Kopp, Jeffrey B.; Pays, Etienne; Pollak, Martin R.			Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans	SCIENCE			English	Article							STAGE RENAL-DISEASE; 9 GENE MYH9; POSITIVE SELECTION; NATURAL-SELECTION; HUMAN SERUM; POLYMORPHISMS; RHODESIENSE; GENOME	African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease-associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.	[Genovese, Giulio; Friedman, David J.; Bernhardy, Andrea J.; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Genovese, Giulio; Friedman, David J.; Bernhardy, Andrea J.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Genovese, Giulio] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Friedman, David J.] Beth Israel Deaconess Med Ctr, Dept Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ross, Michael D.; Knob, Andrea L. Uscinski] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02215 USA; [Lecordier, Laurence; Uzureau, Pierrick; Vanhollebeke, Benoit; Pays, Etienne] Univ Libre Bruxelles, Inst Biol & Med Mol, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Freedman, Barry I.] Wake Forest Univ, Sch Med, Nephrol Sect, Dept Internal Med, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Ctr Diabet Res, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Langefeld, Carl D.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Ctr Publ Hlth Genom, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00681 USA; [Nelson, George W.; Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Winkler, Cheryl A.] NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21702 USA; [Pollak, Martin R.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Dartmouth College; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Universite Libre de Bruxelles; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; University of Puerto Rico; University of Puerto Rico Mayaguez; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pollak, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.	epays@ulb.ac.be; mpollak@bidmc.harvard.edu	Rinaldi2, Carlos/D-4479-2011; Taras, Oleksyk/J-8805-2013; Kopp, Jeffrey B/O-2681-2015	Taras, Oleksyk/0000-0002-8148-3918; Kopp, Jeffrey B/0000-0001-9052-186X; Friedman, David/0000-0002-0301-9298; Vanhollebeke, Benoit/0000-0002-0353-365X; Genovese, Giulio/0000-0003-3066-5575	Walloon Region; Fonds National de la Recherche Scientifique; Belgian Science Policy; NIH [R01 DK54931, K08-DK076868, R01 DK066358, R01 DK053591, R01 HL56266, R01 DK 070941, R01 DK 084149]; National Institute of Diabetes, Digestive, and Kidney Disease [Z01 DK043308]; NCI, Center for Cancer Research [ZIA BC 010022]; NephCure Foundation; NCI, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010022, ZIABC010297] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070941, ZIADK043308, R01DK084149, R01DK054931, K08DK076868, R01DK066358, R01DK053591, Z01DK043308] Funding Source: NIH RePORTER	Walloon Region; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive, and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NephCure Foundation; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Broad Institute Medical and Population Genetics Program for helpful advice and review of the manuscript. We thank the study participants for their participation and J. Robinson for the help provided accessing the 1000 Genomes project data. We thank X. C. Zhou [National Cancer Institute (NCI)] and E. Binns-Roemer (NCI), P. Poelvoorde [Universite Libre de Bruxelles (ULB)], P. Tebabi (ULB) and A. Pays (ULB) for excellent technical assistance. We thank the investigators in the BWH and NIH FSGS genetic studies: W. Briggs, R. Dart, S. Korbet, M. Mokrzycki, P. Kimmel, T. Ahuja, J. Berns, E. Simon, M. Smith, H. Trachtman, M. Michel, J. R. Schelling, G. Appel, and A. Katz. The work at the University of Brussels was supported by the "CIBLES" program of the Walloon Region, the Fonds National de la Recherche Scientifique, and the Interuniversity Attraction Poles program of the Belgian Science Policy. This work was also supported by grants from the NIH (R01 DK54931 to M.R.P; K08-DK076868 to D.J.F.; R01 DK066358 and R01 DK053591 to D. W. B.; and R01 HL56266, R01 DK 070941, and R01 DK 084149 to B.I.F.), the National Institute of Diabetes, Digestive, and Kidney Disease Intramural research program (Z01 DK043308 to J.B.K.), the Intramural Research Program of NCI, Center for Cancer Research (Project ZIA BC 010022; C.A.W. and G.W.N.), and the NephCure Foundation (to M.R.P). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The publisher or recipient acknowledges right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article. This project has been funded in part with federal funds from the NCI, NIH, under contract HHSN261200800001E. All participants gave informed consent for genetic studies, and research was conducted under protocols approved by the appropriate institutional review boards. J.B.K., G.W.N., C.A.W., and the NCI have a patent application pending for chromosome 22 polymorphisms and haplotypes for genetic screening and clinical applications. M.R.P., G.G., the Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center have been added as coinventors to an amendment to this application naming the specific ApoL1 SNPs described in this manuscript. E.P., L.L., P.U., and ULB have applied for a patent related to the use of plasma from ESKD patients to treat human sleeping sickness by plasma transfer.	Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; BYRNE C, 1994, AM J KIDNEY DIS, V23, P16, DOI 10.1016/S0272-6386(12)80806-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Gibson W, 2002, TRENDS PARASITOL, V18, P486, DOI 10.1016/S1471-4922(02)02390-5; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Satko SG, 2005, KIDNEY INT, V67, pS46, DOI 10.1111/j.1523-1755.2005.09411.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	23	1299	1340	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					841	845		10.1126/science.1193032	http://dx.doi.org/10.1126/science.1193032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20647424	Green Accepted			2022-12-24	WOS:000280809900051
J	Yan, JS; Aldrich, RW				Yan, Jiusheng; Aldrich, Richard W.			LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium	NATURE			English	Article							LEUCINE-RICH REPEAT; POTASSIUM CHANNELS; BETA-SUBUNITS; CLONING; SENSOR; CELLS; EXPRESSION; HKCNMB3; FAMILY; CANCER	Large-conductance, voltage-and calcium-activated potassium (BK, or K(Ca)1.1) channels are ubiquitously expressed in electrically excitable and non-excitable cells(1,2), either as alpha-subunit (BK alpha) tetramers or together with tissue specific auxiliary beta-subunits (beta 1-beta 4)(3-5). Activation of BK channels typically requires coincident membrane depolarization and elevation in free cytosolic Ca2+ concentration ([Ca2+](i))(6,7), which are not physiological conditions for most non-excitable cells. Here we present evidence that in non-excitable LNCaP prostate cancer cells, BK channels can be activated at negative voltages without rises in [Ca2+](i) through their complex with an auxiliary protein, leucine-rich repeat (LRR)-containing protein 26 (LRRC26). LRRC26 modulates the gating of a BK channel by enhancing the allosteric coupling between voltage-sensor activation and the channel's closed-open transition. This finding reveals a novel auxiliary protein of a voltage- gated ion channel that gives an unprecedentedly large negative shift (similar to-140 mV) in voltage dependence and provides a molecular basis for activation of BK channels at physiological voltages and calcium levels in non-excitable cells.	[Yan, Jiusheng; Aldrich, Richard W.] Univ Texas Austin, Ctr Learning & Memory, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Aldrich, RW (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Neurobiol Sect, Austin, TX 78712 USA.	raldrich@mail.utexas.edu			American Heart Association	American Heart Association(American Heart Association)	We are grateful to I. Pastan and X. F. Liu for the generous gift of LRRC26 antibody and plasmids. We thank J. Trimmer for discussion and W. Li, L. Scott, J. Greeson, X. Chen and H. Liu for reading the manuscript. We thank A. Hall, H. Cha and U. Bagaria for research assistance. Mass spectrometry was performed at the UC Davis Proteomics Facility. J. Y. acknowledges postdoctoral fellowship support from the American Heart Association.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Egland KA, 2006, P NATL ACAD SCI USA, V103, P5929, DOI 10.1073/pnas.0601296103; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Gessner G, 2005, J MEMBRANE BIOL, V208, P229, DOI 10.1007/s00232-005-0830-z; Horrigan FT, 2008, J GEN PHYSIOL, V131, P13, DOI 10.1085/jgp.200709877; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOLB HA, 1990, REV PHYSIOL BIOCH P, V115, P51; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507	28	164	168	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					513	U15		10.1038/nature09162	http://dx.doi.org/10.1038/nature09162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20613726				2022-12-24	WOS:000280141200041
J	Sozzani, R; Cui, H; Moreno-Risueno, MA; Busch, W; Van Norman, JM; Vernoux, T; Brady, SM; Dewitte, W; Murray, JAH; Benfey, PN				Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Dewitte, W.; Murray, J. A. H.; Benfey, P. N.			Spatiotemporal regulation of cell-cycle genes by SHORTROOT links patterning and growth	NATURE			English	Article							ARABIDOPSIS ROOT; EXPRESSION; SCARECROW; PROGRESSION; ENDODERMIS; MECHANISM; MOVEMENT; DIVISION; PATHWAY; SHR	The development of multicellular organisms relies on the coordinated control of cell divisions leading to proper patterning and growth(1-3). The molecular mechanisms underlying pattern formation, particularly the regulation of formative cell divisions, remain poorly understood. In Arabidopsis, formative divisions generating the root ground tissue are controlled by SHORTROOT (SHR) and SCARECROW (SCR)(4-6). Here we show, using cell-type-specific transcriptional effects of SHR and SCR combined with data from chromatin immunoprecipitation-based microarray experiments, that SHR regulates the spatiotemporal activation of specific genes involved in cell division. Coincident with the onset of a specific formative division, SHR and SCR directly activate a D-type cyclin; furthermore, altering the expression of this cyclin resulted in formative division defects. Our results indicate that proper pattern formation is achieved through transcriptional regulation of specific cell-cycle genes in a cell-type-and developmental-stage-specific context. Taken together, we provide evidence for a direct link between developmental regulators, specific components of the cell-cycle machinery and organ patterning.	[Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Benfey, P. N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Benfey, P. N.] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA; [Dewitte, W.; Murray, J. A. H.] Cardiff Sch Biosci, Cardiff CF10 3AX, Wales	Duke University; Duke University; Cardiff University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Brady, Siobhan/AAY-1729-2021; Murray, James AH/D-3399-2009; MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016; Cui, Hongchang/ABD-3278-2021; Busch, Wolfgang/B-8593-2008; Dewitte, Walter/B-4560-2011; Vernoux, Teva/J-1695-2019	Murray, James AH/0000-0002-2282-3839; MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450; Cui, Hongchang/0000-0002-9870-748X; Busch, Wolfgang/0000-0003-2042-7290; Vernoux, Teva/0000-0002-8257-4088; Dewitte, Walter/0000-0002-0606-1686; Brady, Siobhan/0000-0001-9424-8055; Sozzani, Rosangela/0000-0003-3316-2367	Ministerio de Ciencia y Innovacion (Spain); Biotechnology and Biological Sciences Research Council [BB/E022383]; European Research Area in Plant Genomics network on Plant Stem Cells [BB/E024858]; NIH [RO1-GM043778, P50-GM081883]; NSF [AT2010 0618304]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778, P50GM081883] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E022383/1, BB/E024858/1, BB/E022383/2] Funding Source: researchfish; BBSRC [BB/E022383/1, BB/E022383/2, BB/E024858/1] Funding Source: UKRI	Ministerio de Ciencia y Innovacion (Spain); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Area in Plant Genomics network on Plant Stem Cells; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Orlando and R. Twigg for generating the list of probes for the ChIP-array; J. Nieuwland, S. Maughan and C. Collins for construction of the CYCD6; 1 reporter line and assistance in isolation of the cycd6; 1 mutant; L. Sanz, F. Patell and S. Scofield for isolation of the cycd2; 1 and cycd5; 1 mutants; J. Dinneny, M. Noor and members of the Benfey laboratory for their comments on the manuscript. Funding to M.A.M.-R. is provided by the Ministerio de Ciencia y Innovacion (Spain). W. D. and J.A.H.M. were funded by a Biotechnology and Biological Sciences Research Council grant (BB/E022383) and the European Research Area in Plant Genomics network on Plant Stem Cells (BB/E024858). This work was funded by grants to P.N.B. from the NIH (RO1-GM043778 and P50-GM081883) and from the NSF (AT2010 0618304).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; FOE VE, 1989, DEVELOPMENT, V107, P1; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Herranz H, 2008, CELL CYCLE, V7, P3335, DOI 10.4161/cc.7.21.6996; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Paquette AJ, 2005, PLANT PHYSIOL, V138, P636, DOI 10.1104/pp.104.058362; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	38	281	290	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					128	U149		10.1038/nature09143	http://dx.doi.org/10.1038/nature09143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596025	Green Accepted			2022-12-24	WOS:000279343800048
J	Donnell, D; Baeten, JM; Kiarie, J; Thomas, KK; Stevens, W; Cohen, CR; McIntyre, J; Lingappa, JR; Celum, C				Donnell, Deborah; Baeten, Jared M.; Kiarie, James; Thomas, Katherine K.; Stevens, Wendy; Cohen, Craig R.; McIntyre, James; Lingappa, Jairam R.; Celum, Connie		Partners Prevention HSV HIV Transm	Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis	LANCET			English	Article							CD4 CELL COUNT; VIRAL LOAD; SEXUAL-BEHAVIOR; INFECTION; DISEASE; RISK; RNA	Background High plasma HIV-1 RNA concentrations are associated with increased risk of HIV-1 transmission. Initiation of antiretroviral therapy (ART) reduces plasma HIV-1 concentrations. We aimed to assess the effect of ART use by patients infected with HIV-1 on risk of transmission to their uninfected partners. Methods Participants in our prospective cohort analysis were from a randomised placebo-controlled trial that enrolled heterosexual African adults who were seropositive for both HIV-1 and herpes simplex virus type 2, and their HIV-1 seronegative partners. At enrolment, HIV-1 infected participants had CD4 counts of 250 cells per mu L or greater and did not meet national guidelines for ART initiation; during 24 months of follow-up, CD4 counts were measured every 6 months and ART was initiated in accordance with national guidelines. Uninfected partners were tested for HIV-1 every 3 months. The primary outcome was genetically-linked HIV-1 transmission within the study partnership. We assessed rates of HIV-1 transmission by ART status of infected participants. Findings 3381 couples were eligible for analysis. 349 (10%) participants with HIV-1 initiated ART during the study, at a median CD4 cell count of 198 (IQR 161-265) cells per mu L. Only one of 103 genetically-linked HIV-1 transmissions was from an infected participant who had started ART, corresponding to transmission rates of 0.37 (95% CI 0.09-2.04) per 100 person-years in those who had initiated treatment and 2.24 (1.84-2.72) per 100 person-years in those who had not-a 92% reduction (adjusted incidence rate ratio 0.08,95% CI 0.00-0.57, p=0.004). In participants not on ART, the highest HIV-1 transmission rate (8.79 per 100 person-years) was from those with CD4 cell counts lower than 200 cells per pL. In couples in whom the untreated HIV-1 infected partner had a CD4 cell count greater than 200 cells per pL, 66 (70%) of 94 transmissions occurred when plasma HIV-1 concentrations exceeded 50 000 copies per mL. Interpretation Low CD4 cell counts and high plasma HIV-1 concentrations might guide use of ART to achieve an HIV-1 prevention benefit. Provision of ART to HIV-1 infected patients could be an effective strategy to achieve population-level reductions in HIV-1 transmission.	[Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Donnell, Deborah; Baeten, Jared M.; Kiarie, James; Thomas, Katherine K.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Natl Hlth Lab Serv, Johannesburg, South Africa; [McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; National Health Laboratory Service; University of Witwatersrand; University of California System; University of California San Francisco	Donnell, D (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1100 Fairview Ave N, Seattle, WA 98109 USA.	deborah@fhcrc.org	Lingappa, Jairam/N-7760-2017; McIntyre, James/V-7115-2019	Were, Edwin/0000-0002-4783-0795; Thomas, Katherine K/0000-0002-7024-468X; Donnell, Deborah/0000-0002-0587-7480; Kapiga, Saidi/0000-0003-1753-4060; kiarie, james/0000-0003-4180-7858	Bill & Melinda Gates Foundation; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757, R01AI083034, U01AI038858] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding Bill & Melinda Gates Foundation; US National Institutes of Health.	[Anonymous], [No title captured]; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Eisele TP, 2009, AIDS BEHAV, V13, P1097, DOI 10.1007/s10461-008-9473-2; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Luchters S, 2008, AIDS PATIENT CARE ST, V22, P587, DOI 10.1089/apc.2007.0247; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Mofenson LM, 1999, JAMA-J AM MED ASSOC, V282, P577, DOI 10.1001/jama.282.6.577; Munderi P, 2010, CURR OPIN HIV AIDS, V5, P6, DOI 10.1097/COH.0b013e32833384d3; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Stevens WS, 2010, J INFECT DIS, V201, pS16, DOI 10.1086/650392; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wood E, 2007, LANCET, V370, P8, DOI 10.1016/S0140-6736(07)61025-3; World Health Organization, 2009, RAP ADV ANT THER HIV	28	688	716	3	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2092	2098		10.1016/S0140-6736(10)60705-2	http://dx.doi.org/10.1016/S0140-6736(10)60705-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20537376	Green Accepted			2022-12-24	WOS:000279069300021
J	Shanbhag, NM; Rafalska-Metcalf, IU; Balane-Bolivar, C; Janicki, SM; Greenberg, RA				Shanbhag, Niraj M.; Rafalska-Metcalf, Ilona U.; Balane-Bolivar, Carlo; Janicki, Susan M.; Greenberg, Roger A.			ATM-Dependent Chromatin Changes Silence Transcription In cis to DNA Double-Strand Breaks	CELL			English	Article							RNA-POLYMERASE-II; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; DAMAGE RESPONSE; REPAIR; UBIQUITINATION; PHOSPHORYLATION; IDENTIFICATION; UBIQUITYLATION; CHECKPOINT	DNA double-strand breaks (DSBs) initiate extensive local and global alterations in chromatin structure, many of which depend on the ATM kinase. Histone H2A ubiquitylation (uH2A) on chromatin surrounding DSBs is one example, thought to be important for recruitment of repair proteins. uH2A is also implicated in transcriptional repression; an intriguing yet untested hypothesis is that this function is conserved in the context of DSBs. Using a novel reporter that allows for visualization of repair protein recruitment and local transcription in single cells, we describe an ATM-dependent transcriptional silencing program in cis to DSBs. ATM prevents RNA polymerase II elongation-dependent chromatin decondensation at regions distal to DSBs. Silencing is partially dependent on E3 ubiquitin ligases RNF8 and RNF168, whereas reversal of silencing relies on the uH2A deubiquitylating enzyme USP16. These findings give insight into the role of posttranslational modifications in mediating crosstalk between diverse processes occurring on chromatin.	[Shanbhag, Niraj M.; Balane-Bolivar, Carlo; Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA; [Rafalska-Metcalf, Ilona U.; Janicki, Susan M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; ACS; Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; Penn Genome Frontiers Institute;  [1-T32-CA-115299-01A2]; NATIONAL CANCER INSTITUTE [R01CA138835, T32CA115299, K08CA106597] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; Penn Genome Frontiers Institute; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Genentech for providing linkage-specific antibodies; E. Brown, B. Johnson, G. Blobel, M. Lampson, and members of the Greenberg lab for critical discussion. R.A.G. gratefully acknowledges funding from the following: 1R01CA138835-01 from the NCI, an ACS Research Scholar Grant, K08 awards 1K08CA106597-01 and 3K08CA106597-04S1 from the NCI, the Sidney Kimmel Foundation Scholar Award, and funds from the Abramson Family Cancer Research Institute and from the Penn Genome Frontiers Institute. N.M.S. was supported by training grant 1-T32-CA-115299-01A2.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WAUGH DS, 1993, P NATL ACAD SCI USA, V90, P9596, DOI 10.1073/pnas.90.20.9596; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	46	500	510	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					970	981		10.1016/j.cell.2010.04.038	http://dx.doi.org/10.1016/j.cell.2010.04.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550933	Green Accepted, Bronze			2022-12-24	WOS:000278618800012
J	Peters, J; Dieppa-Perea, LM; Melendez, LM; Quirk, GJ				Peters, Jamie; Dieppa-Perea, Laura M.; Melendez, Loyda M.; Quirk, Gregory J.			Induction of Fear Extinction with Hippocampal-Infralimbic BDNF	SCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; MEMORY; CONSOLIDATION; AMYGDALA; NEURONS; MECHANISMS; EXPRESSION	The extinction of conditioned fear memories requires plasticity in the infralimbic medial prefrontal cortex (IL mPFC), but little is known about the molecular mechanisms involved. Brain-derived neurotrophic factor (BDNF) is a key mediator of synaptic plasticity in multiple brain areas. In rats subjected to auditory fear conditioning, BDNF infused into the IL mPFC reduced conditioned fear for up to 48 hours, even in the absence of extinction training, which suggests that BDNF substituted for extinction. Similar to extinction, BDNF-induced reduction in fear required N-methyl-D-aspartate receptors and did not erase the original fear memory. Rats failing to learn extinction showed reduced BDNF in hippocampal inputs to the IL mPFC, and augmenting BDNF in this pathway prevented extinction failure. Hence, boosting BDNF activity in hippocampal-infralimbic circuits may ameliorate disorders of learned fear.	[Peters, Jamie; Dieppa-Perea, Laura M.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA; [Peters, Jamie; Dieppa-Perea, Laura M.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Melendez, Loyda M.] Univ Puerto Rico, Sch Med, Dept Microbiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA.	gjquirk@yahoo.com	Peters, Jamie/B-4288-2013		NIH [MH058883, MH081975, NS043011, MH083516, MH085383, RR003051]; University of Puerto Rico; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058883, R01MH083516, R01MH081975, R37MH058883, F32MH085383, R29MH058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS043011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank V. Garcia, D. Merced, N. Padilla, C. Rodriguez, J. Rodriguez-Romaguera, D. Sierra-Mercado, and A. Torrado for technical assistance and D. Pare and J. F. McGinty for helpful comments. Supported by NIH grants MH058883, MH081975, NS043011, MH083516, MH085383, and RR003051 and by the University of Puerto Rico.	Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; FALLS WA, 1992, J NEUROSCI, V12, P854; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Sotres-Bayon F, 2009, CEREB CORTEX, V19, P474, DOI 10.1093/cercor/bhn099	27	345	359	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1288	1290		10.1126/science.1186909	http://dx.doi.org/10.1126/science.1186909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522777	Green Accepted			2022-12-24	WOS:000278318600038
J	Hsu, NY; Ilnytska, O; Belov, G; Santiana, M; Chen, YH; Takvorian, PM; Pau, C; van der Schaar, H; Kaushik-Basu, N; Balla, T; Cameron, CE; Ehrenfeld, E; van Kuppeveld, FJM; Altan-Bonnet, N				Hsu, Nai-Yun; Ilnytska, Olha; Belov, Georgiy; Santiana, Marianita; Chen, Ying-Han; Takvorian, Peter M.; Pau, Cyrilla; van der Schaar, Hilde; Kaushik-Basu, Neerja; Balla, Tamas; Cameron, Craig E.; Ehrenfeld, Ellie; van Kuppeveld, Frank J. M.; Altan-Bonnet, Nihal			Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication	CELL			English	Article							HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM; EXCHANGE FACTOR; COP-I; PROTEIN; TRANSPORT; DYNAMICS; BETA; ARF; TRAFFICKING	Many RNA viruses remodel intracellular membranes to generate specialized sites for RNA replication. How membranes are remodeled and what properties make them conducive for replication are unknown. Here we show how RNA viruses can manipulate multiple components of the cellular secretory pathway to generate organelles specialized for replication that are distinct in protein and lipid composition from the host cell. Specific viral proteins modulate effector recruitment by Arf1 GTPase and its guanine nucleotide exchange factor GBF1, promoting preferential recruitment of phosphatidylinositol-4-kinase IIIb (PI4KIIIb) to membranes over coat proteins, yielding uncoated phosphatidylinositol-4-phosphate (PI4P) lipid-enriched organelles. The PI4P-rich lipid micro-environment is essential for both enteroviral and flaviviral RNA replication; PI4KIIIb inhibition interferes with this process; and enteroviral RNA polymerases specifically bind PI4P. These findings reveal how RNA viruses can selectively exploit specific elements of the host to form specialized organelles where cellular phosphoinositide lipids are key to regulating viral RNA replication.	[Hsu, Nai-Yun; Ilnytska, Olha; Santiana, Marianita; Chen, Ying-Han; Takvorian, Peter M.; Pau, Cyrilla; Altan-Bonnet, Nihal] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Belov, Georgiy; Ehrenfeld, Ellie] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [van der Schaar, Hilde; van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Kaushik-Basu, Neerja] Univ Med & Dent Newark, Dept Biochem & Mol Biol, Newark, NJ 07101 USA; [Balla, Tamas] NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16803 USA	Rutgers State University Newark; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Radboud University Nijmegen; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Altan-Bonnet, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	nabonnet@andromeda.rutgers.edu	Belov, George/B-4625-2008	Belov, George/0000-0002-0892-1731; Ilnytska, Olga/0000-0003-0807-9158; Balla, Tamas/0000-0002-9077-3335; van Kuppeveld, Frank/0000-0001-5800-749X	NIH (NIAID) [AI053531]; NIH(NICHD); Netherlands Organisation for Scientific Research [NWO-VIDI-917.46.306, NWO-ECHO-700.57.001]; NIDDK, NIH [DK06687]; National Science Foundation [MCB0822058]; Busch Foundation [649117]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000816, R01AI053531] Funding Source: NIH RePORTER	NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Busch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lippincott-Schwartz, S. M. Simon, K. Hirschberg, T. Ward, R. Hegde, R. Collins, J. Arnold, and G. Altan-Bonnet for insightful discussions. E.E. and G.B. were supported by the Intramural Research Program of the NIH (NIAID); T.B. was supported by the Intramural Research Program of the NIH(NICHD); C.E.C. was supported by grant AI053531 (NIAID, NIH); F.J.M.v.K. was supported by Netherlands Organisation for Scientific Research (NWO-VIDI-917.46.306, NWO-ECHO-700.57.001); N.K.B. was supported by grant DK06687 (NIDDK, NIH); and N.A.-B. was supported with grant MCB0822058 from the National Science Foundation and grant 649117 from the Busch Foundation.	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; BARTON DJ, 1993, J VIROL, V67, P822, DOI 10.1128/JVI.67.2.822-831.1993; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Fogg MH, 2003, J VIROL, V77, P11408, DOI 10.1128/JVI.77.21.11408-11416.2003; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ishiyama N, 2002, CHEM PHYS LIPIDS, V114, P103, DOI 10.1016/S0009-3084(02)00002-6; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Magliano D, 1998, VIROLOGY, V240, P57, DOI 10.1006/viro.1997.8906; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; RICHARDS OC, 1990, CURR TOP MICROBIOL, V161, P89; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Towner JS, 1996, J BIOL CHEM, V271, P26810, DOI 10.1074/jbc.271.43.26810; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142	51	492	503	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					799	811		10.1016/j.cell.2010.03.050	http://dx.doi.org/10.1016/j.cell.2010.03.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510927	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000278132900015
J	Cantin, NE; Cohen, AL; Karnauskas, KB; Tarrant, AM; McCorkle, DC				Cantin, Neal E.; Cohen, Anne L.; Karnauskas, Kristopher B.; Tarrant, Ann M.; McCorkle, Daniel C.			Ocean Warming Slows Coral Growth in the Central Red Sea	SCIENCE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; TEMPERATURE; CALCIFICATION; MECHANISM; PHOTOSYNTHESIS; PORITES; RATES	Sea surface temperature (SST) across much of the tropics has increased by 0.4 degrees to 1 degrees C since the mid-1970s. A parallel increase in the frequency and extent of coral bleaching and mortality has fueled concern that climate change poses a major threat to the survival of coral reef ecosystems worldwide. Here we show that steadily rising SSTs, not ocean acidification, are already driving dramatic changes in the growth of an important reef-building coral in the central Red Sea. Three-dimensional computed tomography analyses of the massive coral Diploastrea heliopora reveal that skeletal growth of apparently healthy colonies has declined by 30% since 1998. The same corals responded to a short-lived warm event in 1941/1942, but recovered within 3 years as the ocean cooled. Combining our data with climate model simulations by the Intergovernmental Panel on Climate Change, we predict that should the current warming trend continue, this coral could cease growing altogether by 2070.	[Cantin, Neal E.; Cohen, Anne L.; Karnauskas, Kristopher B.; Tarrant, Ann M.; McCorkle, Daniel C.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Cantin, NE (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.		Tarrant, Ann/AAU-8263-2021	Tarrant, Ann/0000-0002-1909-7899	KAUST [USA 00002/KSA 00011]	KAUST(King Abdullah University of Science & Technology)	The authors thank G. P. Lohmann, C. Saenger, M. X. Weber, and A. Venti for their assistance with fieldwork. A. Al Suwailem; Y. Kattan; H. Al Jahdali; W. Moazen; Nageeb from King Abdullah University of Science and Technology (KAUST); and E. Mason, R. Maravilla, and the staff at Dream Divers provided logistical support in Saudi Arabia. D. Ketten and J. Arruda provided invaluable technical support and advice for the CAT scanning of our coral cores. Comments from D. Oppo and two anonymous reviewers helped to improve the original manuscript. This research was funded by award no. USA 00002/KSA 00011 from KAUST to A.L.C. and D.C.M.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Clement AC, 2010, NAT GEOSCI, V3, P8, DOI 10.1038/ngeo728; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Devantier L, 2000, STATUS CORAL REEFS S; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Furla P, 2000, J EXP BIOL, V203, P3445; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; Hart DE, 2007, CORAL REEFS, V26, P53, DOI 10.1007/s00338-006-0168-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1	28	316	325	36	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					322	325		10.1126/science.1190182	http://dx.doi.org/10.1126/science.1190182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647466				2022-12-24	WOS:000279925900041
J	Cao, L; Liu, XL; Lin, EJD; Wang, CS; Choi, EY; Riban, V; Lin, B; During, MJ				Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; Lin, Benjamin; During, Matthew J.			Environmental and Genetic Activation of a Brain-Adipocyte BDNF/Leptin Axis Causes Cancer Remission and Inhibition	CELL			English	Article							NEUROTROPHIC FACTOR; STRESS; LEPTIN; EXERCISE; OBESITY; BDNF; HYPOTHALAMUS; ADAPTATION; PLASTICITY; ENRICHMENT	Cancer is influenced by its microenvironment, yet broader, environmental effects also play a role but remain poorly defined. We report here that mice living in an enriched housing environment show reduced tumor growth and increased remission. We found this effect in melanoma and colon cancer models, and that it was not caused by physical activity alone. Serum from animals held in an enriched environment (EE) inhibited cancer proliferation in vitro and was markedly lower in leptin. Hypothalamic brain-derived neurotrophic factor (BDNF) was selectively upregulated by EE, and its genetic overexpression reduced tumor burden, whereas BDNF knockdown blocked the effect of EE. Mechanistically, we show that hypothalamic BDNF downregulated leptin production in adipocytes via sympathoneural beta-adrenergic signaling. These results suggest that genetic or environmental activation of this BDNF/leptin axis may have therapeutic significance for cancer.	[Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Dept Neurosci & Neurol Surg, Columbus, OH 43210 USA; [Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cao, Lei; Lin, Benjamin; During, Matthew J.] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [During, Matthew J.] Univ Auckland, Ctr Brain Res, Dept Mol Med & Pathol, Fac Med & Hlth Sci, Auckland 1023, New Zealand	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cornell University; University of Auckland	Cao, L (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	cao.76@osu.edu; during.1@osu.edu	During, Matthew/AAC-1388-2020; During, Matthew/E-3003-2011; Cao, Lei/E-2841-2011; Cao, Lei/H-3185-2019	During, Matthew/0000-0002-3797-5026; Cao, Lei/0000-0003-0322-4985	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. F. Lee of Weill Medical College of Cornell University for providing the BDNF<SUP>+/-</SUP> mice and Professors C. Croce, J. Groden, and M. Caligiuri for helpful comments and discussion on the manuscript. We appreciate the technical assistance of Michael Cahill and Adam Martin. This work was supported in part by the National Institutes of Health.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Evans BA, 1999, FEBS LETT, V444, P149, DOI 10.1016/S0014-5793(99)00049-6; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Hahn S, 2006, EUR J ENDOCRINOL, V154, P287, DOI 10.1530/eje.1.02078; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Jenkins PJ, 2004, EUR J ENDOCRINOL, V151, pS17, DOI 10.1530/eje.0.151S017; Jonsdottir IH, 2000, INT J SPORTS MED, V21, pS20; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16301, DOI 10.1073/pnas.0607789103; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McDougall SJ, 2005, AUTON NEUROSCI-BASIC, V123, P1, DOI 10.1016/j.autneu.2005.09.005; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mehl KA, 2005, J APPL PHYSIOL, V98, P2219, DOI 10.1152/japplphysiol.00975.2004; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MILSUM JH, 1985, BEHAV SCI, V30, P179, DOI 10.1002/bs.3830300402; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nagatomi R, 2006, EXERC IMMUNOL REV, V12, P54; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Rage F, 2002, NEUROSCIENCE, V112, P309, DOI 10.1016/S0306-4522(02)00072-6; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Selye H., 1974, STRESS DISTRESS; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki K, 2005, EUR J APPL PHYSIOL, V94, P514, DOI 10.1007/s00421-005-1378-4; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Wisse BE, 2003, NAT NEUROSCI, V6, P655, DOI 10.1038/nn0703-655; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	49	232	240	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					52	64		10.1016/j.cell.2010.05.029	http://dx.doi.org/10.1016/j.cell.2010.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603014	Green Accepted, Bronze			2022-12-24	WOS:000279637300012
J	Surolia, I; Pirnie, SP; Chellappa, V; Taylor, KN; Cariappa, A; Moya, J; Liu, H; Bell, DW; Driscoll, DR; Diederichs, S; Haider, K; Netravali, I; Le, S; Elia, R; Dow, E; Lee, A; Freudenberg, J; De Jager, PL; Chretien, Y; Varki, A; MacDonald, ME; Gillis, T; Behrens, TW; Bloch, D; Collier, D; Korzenik, J; Podolsky, DK; Hafler, D; Murali, M; Sands, B; Stone, JH; Gregersen, PK; Pillai, S				Surolia, Ira; Pirnie, Stephan P.; Chellappa, Vasant; Taylor, Kendra N.; Cariappa, Annaiah; Moya, Jesse; Liu, Haoyuan; Bell, Daphne W.; Driscoll, David R.; Diederichs, Sven; Haider, Khaleda; Netravali, Ilka; Le, Sheila; Elia, Roberto; Dow, Ethan; Lee, Annette; Freudenberg, Jan; De Jager, Philip L.; Chretien, Yves; Varki, Ajit; MacDonald, Marcy E.; Gillis, Tammy; Behrens, Timothy W.; Bloch, Donald; Collier, Deborah; Korzenik, Joshua; Podolsky, Daniel K.; Hafler, David; Murali, Mandakolathur; Sands, Bruce; Stone, John H.; Gregersen, Peter K.; Pillai, Shiv			Functionally defective germline variants of sialic acid acetylesterase in autoimmunity	NATURE			English	Article							MUTATIONS; DISEASE; MARKER	Sialic acid acetylesterase (SIAE) is an enzyme that negatively regulates B lymphocyte antigen receptor signalling and is required for the maintenance of immunological tolerance in mice(1,2). Heterozygous loss-of-function germline rare variants and a homozygous defective polymorphic variant of SIAE were identified in 24/923 subjects of European origin with relatively common autoimmune disorders and in 2/648 controls of European origin. All heterozygous loss-of-function SIAE mutations tested were capable of functioning in a dominant negative manner. Ahomozygous secretion-defective polymorphic variant of SIAE was catalytically active, lacked the ability to function in a dominant negative manner, and was seen in eight autoimmune subjects but in no control subjects. The odds ratio for inheriting defective SIAE alleles was 8.6 in all autoimmune subjects, 8.3 in subjects with rheumatoid arthritis, and 7.9 in subjects with type I diabetes. Functionally defective SIAE rare and polymorphic variants represent a strong genetic link to susceptibility in relatively common human autoimmune disorders.	[Surolia, Ira; Pirnie, Stephan P.; Chellappa, Vasant; Taylor, Kendra N.; Cariappa, Annaiah; Moya, Jesse; Liu, Haoyuan; Bell, Daphne W.; Driscoll, David R.; Diederichs, Sven; Haider, Khaleda; Netravali, Ilka; Le, Sheila; Elia, Roberto; Dow, Ethan; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Lee, Annette; Freudenberg, Jan; Gregersen, Peter K.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [De Jager, Philip L.; Hafler, David] Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [De Jager, Philip L.; Hafler, David] MIT, Cambridge, MA 02142 USA; [Chretien, Yves] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [MacDonald, Marcy E.; Gillis, Tammy] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Bloch, Donald; Collier, Deborah; Stone, John H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Rheumatol, Boston, MA 02114 USA; [Korzenik, Joshua; Podolsky, Daniel K.; Sands, Bruce] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Murali, Mandakolathur] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Clin Immunol Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwell Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Roche Holding; Genentech; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	pillai@helix.mgh.harvard.edu	Sands, Bruce/R-7887-2019; Diederichs, Sven/J-6237-2012	Sands, Bruce/0000-0001-5762-5042; Diederichs, Sven/0000-0001-7901-4752; Bloch, Donald/0000-0002-6828-4754	Alliance for Lupus Research; Center for the Study of Inflammatory Bowel Disease at MGH; NIH [AI 064930, AI 076505, AR 058481, NS 32765]; NIH for NARAC [AR 044422, AR 022263]; MADGC [AI 068759]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338] Funding Source: NIH RePORTER	Alliance for Lupus Research; Center for the Study of Inflammatory Bowel Disease at MGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH for NARAC; MADGC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Cohen for coordinating the recall of inflammatory bowel disease patients, and K. Pedrick and E. Chung for their contributions. These studies were supported by grants from the Alliance for Lupus Research, the Center for the Study of Inflammatory Bowel Disease at MGH, and the NIH (AI 064930, AI 076505, and AR 058481) to S. P. and a grant to M.E.M. (NS 32765). P.K.G. acknowledges NIH support for NARAC (AR 044422 and AR 022263) and MADGC (AI 068759). The NIDDK is acknowledged for making samples available from the EDIC collection of its DNA repository. D. W. B. acknowledges the Intramural program of the National Human Genome Research Institute at NIH.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bell DW, 1999, CANCER RES, V59, P3883; Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Jessani N, 2005, ANGEW CHEM INT EDIT, V44, P2400, DOI 10.1002/anie.200463098; Krishna M, 1997, J EXP MED, V185, P1997, DOI 10.1084/jem.185.11.1997; Kwak EL, 2006, CLIN CANCER RES, V12, P4283, DOI 10.1158/1078-0432.CCR-06-0189; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pillai S, 2009, TRENDS IMMUNOL, V30, P488, DOI 10.1016/j.it.2009.07.006; SHUKLA AK, 1982, H-S Z PHYSIOL CHEM, V363, P255, DOI 10.1515/bchm2.1982.363.1.255; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	16	129	134	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					243	U118		10.1038/nature09115	http://dx.doi.org/10.1038/nature09115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20555325	Green Accepted			2022-12-24	WOS:000279580800038
J	Christen, M; Kulasekara, HD; Christen, B; Kulasekara, BR; Hoffman, LR; Miller, SI				Christen, Matthias; Kulasekara, Hemantha D.; Christen, Beat; Kulasekara, Bridget R.; Hoffman, Lucas R.; Miller, Samuel I.			Asymmetrical Distribution of the Second Messenger c-di-GMP upon Bacterial Cell Division	SCIENCE			English	Article							CAULOBACTER-CRESCENTUS; ALLOSTERIC CONTROL; STRUCTURAL BASIS; PROTEINS	The bacterial second messenger cyclic diguanosine monophosphate (c-di-GMP) regulates cellular motility and the synthesis of organelles and molecules that promote adhesion to a variety of biological and nonbiological surfaces. These properties likely require tight spatial and temporal regulation of c-di-GMP concentration. We have developed genetically encoded fluorescence resonance energy transfer (FRET)-based biosensors to monitor c-di-GMP concentrations within single bacterial cells by microscopy. Fluctuations of c-di-GMP were visualized in diverse Gram-negative bacterial species and observed to be cell cycle dependent. Asymmetrical distribution of c-di-GMP in the progeny correlated with the time of cell division and polarization for Caulobacter crescentus and Pseudomonas aeruginosa. Thus, asymmetrical distribution of c-di-GMP was observed as part of cell division, which may indicate an important regulatory step in extracellular organelle biosynthesis or function.	[Christen, Matthias; Kulasekara, Hemantha D.; Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Christen, Beat] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kulasekara, Bridget R.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Hoffman, Lucas R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	millersi@uw.edu	Christen, Beat/AAC-2974-2021; Hoffman, Lucas/AAX-1853-2021	Christen, Matthias/0000-0001-7724-4562; Christen, Beat/0000-0002-9528-3685	National Institute of Allergy and Infectious Diseases, NIH [1R21NS067579-01, U54AI057141, KO8AI066251]; NSF; Swiss National Foundation [PA00P3-124140, PBBSA-120489, PA00P3-126243]; Novartis Foundation; Cystic Fibrosis Foundation [HOFFMA04L0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL105543, R01HL098084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, K08AI066251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067579] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF(National Science Foundation (NSF)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Jones from Rutgers University, Piscataway, NJ, for c-di-GMP and T. Ohashi from Duke University, Durham, NC, for the pET15b::mCYPet_12AA_mYPet plasmids. This research was supported by the National Institute of Allergy and Infectious Diseases, NIH (1R21NS067579-01 and U54AI057141 to S.I.M; KO8AI066251 to L.R.H and 1R21NS067579-01 to H. D. K), NSF (Graduate Research Fellowship to B.R.K), Swiss National Foundation (PA00P3-124140 and PBBSA-120489 to M.C. and PA00P3-126243 to B.C), Novartis Foundation to M.C., and Cystic Fibrosis Foundation (HOFFMA04L0 to L.R.H).	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2	16	194	197	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1295	1297		10.1126/science.1188658	http://dx.doi.org/10.1126/science.1188658			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522779	Green Accepted			2022-12-24	WOS:000278318600040
J	Dowling, RJO; Topisirovic, I; Alain, T; Bidinosti, M; Fonseca, BD; Petroulakis, E; Wang, XS; Larsson, O; Selvaraj, A; Liu, Y; Kozma, SC; Thomas, G; Sonenberg, N				Dowling, Ryan J. O.; Topisirovic, Ivan; Alain, Tommy; Bidinosti, Michael; Fonseca, Bruno D.; Petroulakis, Emmanuel; Wang, Xiaoshan; Larsson, Ola; Selvaraj, Anand; Liu, Yi; Kozma, Sara C.; Thomas, George; Sonenberg, Nahum			mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs	SCIENCE			English	Article							INSULIN-RESISTANCE; CANCER-THERAPY; MTOR; INHIBITOR; PHOSPHORYLATION; DOWNSTREAM; DROSOPHILA; REGULATOR; PROTEINS; KINASE	The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size. Hence, mTORC1 is implicated in a large number of human diseases-including diabetes, obesity, heart disease, and cancer-that are characterized by aberrant cell growth and proliferation. Although eukaryotic translation initiation factor 4E-binding proteins (4E-BPs) are critical mediators of mTORC1 function, their precise contribution to mTORC1 signaling and the mechanisms by which they mediate mTORC1 function have remained unclear. We inhibited the mTORC1 pathway in cells lacking 4E-BPs and analyzed the effects on cell size, cell proliferation, and cell cycle progression. Although the 4E-BPs had no effect on cell size, they inhibited cell proliferation by selectively inhibiting the translation of messenger RNAs that encode proliferation-promoting proteins and proteins involved in cell cycle progression. Thus, control of cell size and cell cycle progression appear to be independent in mammalian cells, whereas in lower eukaryotes, 4E-BPs influence both cell growth and proliferation.	[Dowling, Ryan J. O.; Topisirovic, Ivan; Alain, Tommy; Bidinosti, Michael; Fonseca, Bruno D.; Petroulakis, Emmanuel; Wang, Xiaoshan; Larsson, Ola; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Dowling, Ryan J. O.; Topisirovic, Ivan; Alain, Tommy; Bidinosti, Michael; Fonseca, Bruno D.; Petroulakis, Emmanuel; Wang, Xiaoshan; Larsson, Ola; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Selvaraj, Anand; Kozma, Sara C.; Thomas, George] Univ Cincinnati, Dept Canc & Cell Biol, Metab Dis Inst, Cincinnati, OH 45237 USA; [Liu, Yi] Intellikine, La Jolla, CA 92037 USA	McGill University; McGill University; University System of Ohio; University of Cincinnati	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca	Larsson, Ola/F-8151-2013; Topisirovic, Ivan/A-9426-2008; Thomas, George/K-9235-2014; Dowling, Ryan/Q-8912-2018	Topisirovic, Ivan/0000-0002-5510-9762; Thomas, George/0000-0003-3518-8149; Larsson, Ola/0000-0003-1412-1308; Dowling, Ryan/0000-0002-5381-8805	Canadian Cancer Society; Howard Hughes Medical Institute; Terry Fox Foundation; NIH Mouse Models for Human Cancer Consortium [U01 CA84292-06]; Leukemia and Lymphoma Society; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Natural Sciences and Engineering Research Council of Canada; Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB; NIH [R01 DK73802, P50 NS057531]; John and Gladys Strauss Chair in Cancer Research; NATIONAL CANCER INSTITUTE [U01CA084292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073802, R01DK078019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS057531] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Terry Fox Foundation; NIH Mouse Models for Human Cancer Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB(United States Department of DefenseUS Air Force Research Laboratory); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Gladys Strauss Chair in Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Rapamycin was from LC laboratories and Calbiochem, PP242 was from Intellikine, and Torin1 was from N. Gray D. Sabatini. Experimental procedures are described in the supplementary material. We thank M. Pende for S6K1CA construct; M. Holcik and N. Colburn for antibody to PDCD4; K. Shokat, C. Rommel, L. W. Ler, S. Fumagalli, and M. Livingstone for advice; C. Lister and P. Kirk for assistance; and M. Daston for editing. Supported by a grant from the Canadian Cancer Society and a Howard Hughes Medical Institute international research scholarship (N. S.); a Terry Fox Foundation research studentship (R.J.O.D.); NIH Mouse Models for Human Cancer Consortium grant U01 CA84292-06 (N. S., G. T., and S. C. K.); a Leukemia and Lymphoma Society special fellowship (I. T.); Canadian Institutes of Health Research and Alberta Heritage Foundation for Medical Research postdoctoral fellowships (T. A.); a Natural Sciences and Engineering Research Council of Canada predoctoral fellowship (M. B.); a CIHR consortium training fellowship award (B. D. F.); the Research Participation Program at the Air Force Research Laboratory, Human Effectiveness Directorate, Bioscience and Protection, Wright-Patterson AFB, administered by the Oak Ridge Institute for Science and Education (A. S.); NIH grants R01 DK73802 and P50 NS057531 (G. T. and S. C. K.); and the John and Gladys Strauss Chair in Cancer Research (G. T.). G. T. is a paid consultant for Novartis Oncology. There are MTAs or patents restricting use of materials listed, described as: PP242 and Torin1.	Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kim YY, 2009, CANCER RES, V69, P8455, DOI 10.1158/0008-5472.CAN-09-1923; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	26	509	528	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1172	1176		10.1126/science.1187532	http://dx.doi.org/10.1126/science.1187532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508131	Green Accepted, Green Published			2022-12-24	WOS:000278104700048
J	Okiyoneda, T; Barriere, H; Bagdany, M; Rabeh, WM; Du, K; Hohfeld, J; Young, JC; Lukacs, GL				Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Hoehfeld, Joerg; Young, Jason C.; Lukacs, Gergely L.			Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; E3 UBIQUITIN LIGASE; RETICULUM-ASSOCIATED DEGRADATION; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; CHIP; HSC70; CELLS; CFTR-DELTA-F508	Therapeutic efforts to restore biosynthetic processing of the cystic fibrosis transmembrane conductance regulator lacking the F508 residue (Delta F508CFTR) are hampered by ubiquitin-dependent lysosomal degradation of nonnative, rescued Delta F508CFTR from the plasma membrane. Here, functional small interfering RNA screens revealed the contribution of chaperones, cochaperones, and ubiquitin-conjugating and -ligating enzymes to the elimination of unfolded CFTR from the cell surface, as part of a peripheral protein quality-control system. Ubiquitination of nonnative CFTR was required for efficient internalization and lysosomal degradation. This peripheral protein quality-control mechanism probably participates in the preservation of cellular homeostasis by degrading damaged plasma membrane proteins that have escaped from the endoplasmic reticulum quality control or are generated by environmental stresses in situ.	[Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Young, Jason C.; Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ H3G 1Y6, Canada; [Hoehfeld, Joerg] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Young, Jason C.] McGill Univ, Dept Chem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of Bonn; McGill University	Lukacs, GL (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	gergely.lukacs@mcgill.ca	Rabeh, Wael/AAO-4647-2020	Rabeh, Wael/0000-0001-6071-8581; Okiyoneda, Tsukasa/0000-0002-5175-2224; Lukacs, Gergely/0000-0003-0900-0675	Canadian Cystic Fibrosis Foundation; Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Deutsche Forschungsgemeinschaft; Canadian Institute of Health Resources; NIH; Cystic Fibrosis Foundation Therapeutics; Canadian Foundation for Innovation	Canadian Cystic Fibrosis Foundation; Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institute of Health Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank J. Tavares and C. M. Mulvihill for CHIP purification and generating CFTR-His10 cells, respectively; H. Stenmark for Hrs antibody; and H. Lewis, C. Lima, and K. Iwai for NBD1-3S, SUMO, Ulp1, and UbcH5 plasmids, respectively. Lamp1, Lamp2, and CD63 antibodies were developed by J. August and J. Hildreth (University of Iowa). T.O. and W.M.R. were supported by a Canadian Cystic Fibrosis Foundation and a Groupe de Recherche Axe sur la Structure des Proteines (GRASP) postdoctoral fellowship, respectively. This work was supported by grants to J. H. from Deutsche Forschungsgemeinschaft, J.C.Y. and G.L.L. from the Canadian Institute of Health Resources, NIH, Cystic Fibrosis Foundation Therapeutics, the Canadian Cystic Fibrosis Foundation, and the Canadian Foundation for Innovation. J.C.Y. and G.L.L. are holders of Canada Research Chairs.	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	38	322	323	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					805	810		10.1126/science.1191542	http://dx.doi.org/10.1126/science.1191542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20595578	Green Accepted			2022-12-24	WOS:000280809900042
J	Frankel, N; Davis, GK; Vargas, D; Wang, S; Payre, F; Stern, DL				Frankel, Nicolas; Davis, Gregory K.; Vargas, Diego; Wang, Shu; Payre, Francois; Stern, David L.			Phenotypic robustness conferred by apparently redundant transcriptional enhancers	NATURE			English	Article							REGULATORY ELEMENTS; WINGLESS; ACTIVATION; EXPRESSION; MUTATIONS; EVOLUTION; EPIDERMIS; HEDGEHOG; DORSAL; ROLES	Genes include cis-regulatory regions that contain transcriptional enhancers. Recent reports have shown that developmental genes often possess multiple discrete enhancer modules that drive transcription in similar spatio-temporal patterns(1-4): primary enhancers located near the basal promoter and secondary, or 'shadow', enhancers located at more remote positions. It has been proposed that the seemingly redundant activity of primary and secondary enhancers contributes to phenotypic robustness(1,5). We tested this hypothesis by generating a deficiency that removes two newly discovered enhancers of shavenbaby (svb, a transcript of the ovo locus), a gene encoding a transcription factor that directs development of Drosophila larval trichomes(6). At optimal temperatures for embryonic development, this deficiency causes minor defects in trichome patterning. In embryos that develop at both low and high extreme temperatures, however, absence of these secondary enhancers leads to extensive loss of trichomes. These temperature-dependent defects can be rescued by a transgene carrying a secondary enhancer driving transcription of the svb cDNA. Finally, removal of one copy of wingless, a gene required for normal trichome patterning(7), causes a similar loss of trichomes only in flies lacking the secondary enhancers. These results support the hypothesis that secondary enhancers contribute to phenotypic robustness in the face of environmental and genetic variability.	[Frankel, Nicolas; Vargas, Diego; Wang, Shu; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Frankel, Nicolas; Vargas, Diego; Wang, Shu; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Davis, Gregory K.] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Payre, Francois] Univ Toulouse, F-31062 Toulouse, France; [Payre, Francois] CNRS, UMR5547, Ctr Dev Biol, F-31062 Toulouse, France	Howard Hughes Medical Institute; Princeton University; Princeton University; Bryn Mawr College; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stern, DL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	dstern@princeton.edu		PAYRE, Francois/0000-0002-8144-6711; Stern, David/0000-0002-1847-6483	Pew Charitable Trusts; Agence Nationale de la Recherche; NIH [GM063622-06A1]; NSF [IOS-0640339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER	Pew Charitable Trusts; Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Chien and D. Erezyilmaz for assistance with early experiments, L. Kruglyak, S. Levin and S. Tavazoie for helpful comments on the manuscript, and E. Wieschaus for providing the wg mutant flies. This work was supported by The Pew Charitable Trusts Latin American Fellows Program in the Biomedical Sciences Fellowship to N.F., Agence Nationale de la Recherche (Blanc 2008, Netoshape) to F.P., and NIH (GM063622-06A1) and NSF (IOS-0640339) grants to D.L.S.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bokor P, 1996, DEVELOPMENT, V122, P1083; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Crane-Robinson C, 2009, METHODS MOL BIOL, V543, P625, DOI 10.1007/978-1-60327-015-1_37; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; NIJHOUT HF, 2003, DEV INSTABILITY CAUS, pCH1; Overton PM, 2007, DEVELOPMENT, V134, P2807, DOI 10.1242/dev.02878; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Perry MW, 2009, COLD SH Q B, V74, P275, DOI 10.1101/sqb.2009.74.021; POWSNER LOUIS, 1935, PHYSIOL ZOOL, V8, P474; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	26	332	337	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					490	U8		10.1038/nature09158	http://dx.doi.org/10.1038/nature09158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20512118	Green Submitted, Green Accepted			2022-12-24	WOS:000280141200036
J	Song, H; Hu, JX; Chen, W; Elliott, G; Andre, P; Gao, B; Yang, YZ				Song, Hai; Hu, Jianxin; Chen, Wen; Elliott, Gene; Andre, Philipp; Gao, Bo; Yang, Yingzi			Planar cell polarity breaks bilateral symmetry by controlling ciliary positioning	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; GENE-EXPRESSION; SITUS-INVERSUS; LEFTWARD FLOW; PATHWAYS; MOUSE; ESTABLISHMENT; POLARIZATION; REGULATOR	Defining the three body axes is a central event of vertebrate morphogenesis. Establishment of left-right (L-R) asymmetry in development follows the determination of dorsal-ventral and anterior-posterior (A-P) body axes 1,2, although the molecular mechanism underlying precise L-R symmetry breaking in reference to the other two axes is still poorly understood. Here, by removing both Vangl1 and Vangl2, the two mouse homologues of a Drosophila core planar cell polarity (PCP) gene Van Gogh (Vang), we reveal a previously unrecognized function of PCP in the initial breaking of lateral symmetry. The leftward nodal flow across the posterior notochord (PNC) has been identified as the earliest event in the de novo formation of L-R asymmetry(3,4). We show that PCP is essential in interpreting the A-P patterning information and linking it to L-R asymmetry. In the absence of Vangl1 and Vangl2, cilia are positioned randomly around the centre of the PNC cells and nodal flow is turbulent, which results in disrupted L-R asymmetry. PCP in mouse, unlike what has been implicated in other vertebrate species, is not required for ciliogenesis, cilium motility, Sonic hedgehog (Shh) signalling or apical docking of basal bodies in ciliated tracheal epithelial cells. Our data suggest that PCP acts earlier than the unidirectional nodal flow during bilateral symmetry breaking in vertebrates and provide insight into the functional mechanism of PCP in organizing the vertebrate tissues in development.	[Song, Hai; Hu, Jianxin; Chen, Wen; Andre, Philipp; Gao, Bo; Yang, Yingzi] NHGRI, Dev Genet Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Yang, YZ (corresponding author), NHGRI, Dev Genet Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Gao, Bo/0000-0002-8684-5199	National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187, ZIAHG200342, ZICHG200349] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Yang laboratory for stimulating discussion; M. Kuehn, A. Kumar and J. Regard for critical reading of the manuscript; J. Fekecs and D. Leja for preparing the graphics; D. Wu for teaching us to dissect the mouse cochlea; and M. Kelley for the anti-Vangl2 antibodies. This study is supported by the intramural research programme of National Human Genome Research Institute.	Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; BROWN NA, 1990, DEVELOPMENT, V109, P1; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; POOLE CA, 1985, CELL MOTIL CYTOSKEL, V5, P175, DOI 10.1002/cm.970050302; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wilhelmi H, 1921, ARCH ENTWICKLUNG ORG, V48, P517, DOI 10.1007/BF02554577; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	32	211	213	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					378	U130		10.1038/nature09129	http://dx.doi.org/10.1038/nature09129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20562861	Green Accepted			2022-12-24	WOS:000279867100051
J	Beck, CR; Collier, P; Macfarlane, C; Malig, M; Kidd, JM; Eichler, EE; Badge, RM; Moran, JV				Beck, Christine R.; Collier, Pamela; Macfarlane, Catriona; Malig, Maika; Kidd, Jeffrey M.; Eichler, Evan E.; Badge, Richard M.; Moran, John V.			LINE-1 Retrotransposition Activity in Human Genomes	CELL			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; MULTIPLE SEQUENCE ALIGNMENT; HUMAN L1 RETROTRANSPOSITION; CULTURED HUMAN-CELLS; STRUCTURAL VARIATION; TRANSCRIPTION INITIATION; MAMMALIAN-CELLS; ELEMENTS; ENDONUCLEASE; DIVERSITY	Highly active (i.e., "hot") long interspersed element-1 (LINE-1 or L1) sequences comprise the bulk of retrotransposition activity in the human genome; however, the abundance of hot L1s in the human population remains largely unexplored. Here, we used a fosmid-based, paired-end DNA sequencing strategy to identify 68 full-length L1s that are differentially present among individuals but are absent from the human genome reference sequence. The majority of these L1s were highly active in a cultured cell retrotransposition assay. Genotyping 26 elements revealed that two L1s are only found in Africa and that two more are absent from the H952 subset of the Human Genome Diversity Panel. Therefore, these results suggest that hot L1s are more abundant in the human population than previously appreciated, and that ongoing L1 retrotransposition continues to be a major source of interindividual genetic variation.	[Beck, Christine R.; Moran, John V.] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Howard Hughes Med Inst, Sch Med, Ann Arbor, MI 48109 USA; [Collier, Pamela; Macfarlane, Catriona; Badge, Richard M.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Malig, Maika; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Leicester; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Beck, CR (corresponding author), Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA.	cregina@umich.edu; moranj@umich.edu		Kidd, Jeffrey/0000-0002-9631-1465; Badge, Richard/0000-0003-3201-336X; macfarlane, catriona/0000-0002-4733-5356	NIH [T32GM7544, T32000040, GM066695, GM060518]; National Science Foundation; Wellcome Trust [075163/Z/04/Z]; University of Michigan Cancer Center [5P30CA46592];  [HG004120]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082970, T32GM007544, R01GM066695, R01GM060518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Michigan Cancer Center(University of Michigan System); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Sir Alec Jeffreys FRS for access to CEPH and Zimbabwean DNA samples and Professor Mark Jobling for access to HGDP DNA samples. We thank Dr. Elizabeth Marchani for advice on maximum likelihood age estimates and Dr. Jose Luis Garcia-Perez for plasmid JJ105/L1.3. We thank Dr. Garcia-Perez and members of the Moran lab for helpful comments. C. R. B. was supported in part by NIH training grants T32GM7544 and T32000040. J.M.K. was supported by a National Science Foundation Graduate Research Fellowship. Work in the laboratory of E. E. E. was supported by grant HG004120. P. C. and C. M. were supported by a Wellcome Trust Project Grant (075163/Z/04/Z) to R. M. B. and Professor Sir Alec Jeffreys FRS. J.V.M. is supported by NIH grants GM066695 and GM060518. The University of Michigan Cancer Center Support Grant (5P30CA46592) helped defray sequencing costs incurred in this study. J.V.M. and E. E. E. are Investigators of the Howard Hughes Medical Institute. E. E. E. is a member of the SAB for Pacific Biosciences.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boeke JD, 2003, GENOME RES, V13, P1975, DOI 10.1101/gr.1392003; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Cann HM, 2002, SCIENCE, V296, P261; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Donahue William F, 2007, Curr Protoc Hum Genet, VChapter 5, DOI 10.1002/0471142905.hg0520s54; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P46; Frikke-Schmidt R, 2010, ATHEROSCLEROSIS, V208, P305, DOI 10.1016/j.atherosclerosis.2009.06.005; Garcia-Perez JL, 2007, GENOME RES, V17, P602, DOI 10.1101/gr.5870107; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; GRIMALDI G, 1983, NUCLEIC ACIDS RES, V11, P321, DOI 10.1093/nar/11.2.321; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavie L, 2004, GENOME RES, V14, P2253, DOI 10.1101/gr.2745804; Lutz SM, 2003, AM J HUM GENET, V73, P1431, DOI 10.1086/379744; Marchani EE, 2009, GENOMICS, V94, P78, DOI 10.1016/j.ygeno.2009.04.002; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Seleme MDC, 2006, P NATL ACAD SCI USA, V103, P6611, DOI 10.1073/pnas.0601324103; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Tarraga J, 2007, NUCLEIC ACIDS RES, V35, pW38, DOI 10.1093/nar/gkm224; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	77	382	389	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1159	U110		10.1016/j.cell.2010.05.021	http://dx.doi.org/10.1016/j.cell.2010.05.021			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602998	Green Accepted, Bronze			2022-12-24	WOS:000279148100013
J	Benazeraf, B; Francois, P; Baker, RE; Denans, N; Little, CD; Pourquie, O				Benazeraf, Bertrand; Francois, Paul; Baker, Ruth E.; Denans, Nicolas; Little, Charles D.; Pourquie, Olivier			A random cell motility gradient downstream of FGF controls elongation of an amniote embryo	NATURE			English	Article							CHICK-EMBRYO; MOVEMENT; SOMITOGENESIS; GASTRULATION; BOUNDARY; DYNAMICS; MATRIX	Vertebrate embryos are characterized by an elongated anteroposterior (AP) body axis, which forms by progressive cell deposition from a posterior growth zone in the embryo. Here, we used tissue ablation in the chicken embryo to demonstrate that the caudal presomitic mesoderm (PSM) has a key role in axis elongation. Using time-lapse microscopy, we analysed the movements of fluorescently labelled cells in the PSM during embryo elongation, which revealed a clear posterior-to-anterior gradient of cell motility and directionality in the PSM. We tracked the movement of the PSM extracellular matrix in parallel with the labelled cells and subtracted the extracellular matrix movement from the global motion of cells. After subtraction, cell motility remained graded but lacked directionality, indicating that the posterior cell movements associated with axis elongation in the PSM are not intrinsic but reflect tissue deformation. The gradient of cell motion along the PSM parallels the fibroblast growth factor (FGF)/mitogenactivated protein kinase (MAPK) gradient(1), which has been implicated in the control of cell motility in this tissue(2). Both FGF signalling gain-and loss-of-function experiments lead to disruption of the motility gradient and a slowing down of axis elongation. Furthermore, embryos treated with cell movement inhibitors (blebbistatin or RhoK inhibitor), but not cell cycle inhibitors, show a slower axis elongation rate. We propose that the gradient of random cell motility downstream of FGF signalling in the PSM controls posterior elongation in the amniote embryo. Our data indicate that tissue elongation is an emergent property that arises from the collective regulation of graded, random cell motion rather than by the regulation of directionality of individual cellular movements.	[Benazeraf, Bertrand; Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Benazeraf, Bertrand; Denans, Nicolas; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Benazeraf, Bertrand; Denans, Nicolas; Pourquie, Olivier] Univ Strasbourg, CNRS, INSERM, IGBMC,UMR 7104,U964, F-67400 Illkirch Graffenstaden, France; [Francois, Paul] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Baker, Ruth E.] Univ Oxford, Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Little, Charles D.; Pourquie, Olivier] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Howard Hughes Medical Institute; Stowers Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rockefeller University; University of Oxford; University of Kansas; University of Kansas Medical Center	Pourquie, O (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	pourquie@igbmc.fr	Francois, Paul/G-5673-2010; Pourquié, Olivier/CAJ-5443-2022; Benazeraf, Bertrand/X-9968-2019	Francois, Paul/0000-0002-2223-839X; Pourquié, Olivier/0000-0001-5189-1227; Baker, Ruth/0000-0002-6304-9333; denans, nicolas/0000-0002-1875-0841	Howard Hughes Medical Institute; Stowers Institute for Medical Research; NIH [R02 HD043158]; Chaire d'excellence; NSF [DMR-0129848]; Lavoisier Fellowship; RCUK Fellowship in Mathematical Biology; Microsoft European Postdoctoral Research Fellowship; Mathers Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076692] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stowers Institute for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chaire d'excellence(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); Lavoisier Fellowship; RCUK Fellowship in Mathematical Biology; Microsoft European Postdoctoral Research Fellowship(Microsoft); Mathers Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Li, D. Roellig and members of the Pourquie laboratory for critical reading of the manuscript. The authors acknowledge E. Siggia for support, B. Rongish, M. Filla, C. Cui, A. Peterson, K. Perko, R. Alexander, R. Fender, J. D. Fauny, T. Cheuvront, and members of the IGBMC imaging center for assistance with imaging-related techniques. We thank L. Kennedy and T. Iimura for help with the experiments, and the members of the Cytometry Facility at the Stowers Institute for Medical Research for assistance. We thank S. Leblanc, H. Li, N. Wicker and P. Moncuquet for help with statistical analysis. The authors thank S. Esteban for artwork and J. Chatfield for editorial assistance. This research was supported by the Howard Hughes Medical Institute, the Stowers Institute for Medical Research, NIH grant R02 HD043158 and a Chaire d'excellence to O.P.; P.F. is supported by NSF grant DMR-0129848 (attributed to E. Siggia) and Lavoisier Fellowship. R. E. B. is supported by an RCUK Fellowship in Mathematical Biology and a Microsoft European Postdoctoral Research Fellowship. C. D. L. is supported by the Mathers Charitable Foundation.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Araki I, 1999, DEVELOPMENT, V126, P5127; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; BELLAIRS R, 1963, J EMBRYOL EXP MORPH, V11, P697; Berg, 2018, RANDOM WALKS BIOL; Cai AQ, 2006, B MATH BIOL, V68, P25, DOI 10.1007/s11538-005-9028-x; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; Czirok A, 2006, CURR TOP DEV BIOL, V73, P237, DOI 10.1016/S0070-2153(05)73008-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kulesa PM, 2002, SCIENCE, V298, P991, DOI 10.1126/science.1075544; Lawson A, 2001, ANAT RECORD, V262, P238, DOI 10.1002/1097-0185(20010301)262:3<238::AID-AR1041>3.0.CO;2-8; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Rupp PA, 2003, BIOTECHNIQUES, V34, P274, DOI 10.2144/03342st01; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SPRATT NT, 1955, J EXP ZOOL, V128, P121, DOI 10.1002/jez.1401280106; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247	30	197	199	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					248	252		10.1038/nature09151	http://dx.doi.org/10.1038/nature09151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613841	Green Accepted			2022-12-24	WOS:000279580800039
J	Hollander, JA; Im, HI; Amelio, AL; Kocerha, J; Bali, P; Lu, Q; Willoughby, D; Wahlestedt, C; Conkright, MD; Kenny, PJ				Hollander, Jonathan A.; Im, Heh-In; Amelio, Antonio L.; Kocerha, Jannet; Bali, Purva; Lu, Qun; Willoughby, David; Wahlestedt, Claes; Conkright, Michael D.; Kenny, Paul J.			Striatal microRNA controls cocaine intake through CREB signalling	NATURE			English	Article							ADDICTION-LIKE BEHAVIOR; GENE-EXPRESSION; DORSAL STRIATUM; DRUG-ADDICTION; RAF INHIBITOR; ACTIVATION; SEEKING; BRAIN; NEUROPLASTICITY; PLASTICITY	Cocaine addiction is characterized by a gradual loss of control over drug use, but the molecular mechanisms regulating vulnerability to this process remain unclear. Here we report that microRNA-212 (miR-212) is upregulated in the dorsal striatum of rats with a history of extended access to cocaine. Striatal miR-212 decreases responsiveness to the motivational properties of cocaine by markedly amplifying the stimulatory effects of the drug on cAMP response element binding protein (CREB) signalling. This action occurs through miR-212-enhanced Raf1 activity, resulting in adenylyl cyclase sensitization and increased expression of the essential CREB co-activator TORC (transducer of regulated CREB; also known as CRTC). Our findings indicate that striatal miR-212 signalling has a key role in determining vulnerability to cocaine addiction, reveal new molecular regulators that control the complex actions of cocaine in brain reward circuitries and provide an entirely new direction for the development of anti-addiction therapeutics based on the modulation of noncoding RNAs.	[Hollander, Jonathan A.; Im, Heh-In; Bali, Purva; Lu, Qun; Kenny, Paul J.] Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA; [Amelio, Antonio L.; Conkright, Michael D.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kocerha, Jannet; Wahlestedt, Claes] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Kocerha, Jannet; Wahlestedt, Claes] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Willoughby, David] Ocean Ridge Biosci, Palm Beach Gardens, FL 33410 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kenny, PJ (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu		Amelio, Antonio L./0000-0002-6295-2694	National Institute on Drug Abuse (NIDA); NATIONAL CANCER INSTITUTE [F32CA134121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983, F32DA024932] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse (NIDA) to P.J.K. and C.W., and NIDA post-doctoral awards to J.A.H. and H.-I.I. We thank M. Fallahi-Sichani for help with miRNA expression analysis and T. Balla for the Raf1 expression constructs. We also thank C. Fowler and P. Griffin for comments on the manuscript, and NIDA for supplying the cocaine used in these studies. This is manuscript 19873 from Scripps Florida.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Caine S. B., 1993, BEHAV NEUROSCIENCE P, V2, P117; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ding QM, 2004, MOL PHARMACOL, V66, P921, DOI 10.1124/mol.66.4.921; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Ito R, 2002, J NEUROSCI, V22, P6247; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Paterson NE, 2003, NEUROREPORT, V14, P2229, DOI 10.1097/00001756-200312020-00019; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Varga EV, 2002, EUR J PHARMACOL, V451, P101, DOI 10.1016/S0014-2999(02)02220-3; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	59	294	327	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					197	U66		10.1038/nature09202	http://dx.doi.org/10.1038/nature09202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613834	Green Accepted			2022-12-24	WOS:000279580800028
J	Marso, SP; Amin, AP; House, JA; Kennedy, KF; Spertus, JA; Rao, SV; Cohen, DJ; Messenger, JC; Rumsfeld, JS				Marso, Steven P.; Amin, Amit P.; House, John A.; Kennedy, Kevin F.; Spertus, John A.; Rao, Sunil V.; Cohen, David J.; Messenger, John C.; Rumsfeld, John S.		Natl Cardiovasc Data Registry	Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITION; EARLY INVASIVE MANAGEMENT; PROPENSITY SCORE; CARDIAC-CATHETERIZATION; ECONOMIC-EVALUATION; AMERICAN-COLLEGE; BIVALIRUDIN; PREDICTORS; IMPACT; HEPARIN	Context Bleeding complications with percutaneous coronary intervention (PCI) are associated with adverse patient outcomes. The association between the use of bleeding avoidance strategies and post-PCI bleeding as a function of a patient's preprocedural risk of bleeding is unknown. Objective To describe the use of 2 bleeding avoidance strategies, vascular closure devices and bivalirudin, and associated post-PCI bleeding rates in a nationally representative PCI population. Design, Setting, and Patients Analysis of data from 1 522 935 patients undergoing PCI procedures performed at 955 US hospitals participating in the National Cardiovascular Data Registry (NCDR) CathPCI Registry from January 1, 2004, through September 30, 2008. Main Outcome Measure Periprocedural bleeding. Results Bleeding occurred in 30 654 patients (2%). Manual compression, vascular closure devices, bivalirudin, or vascular closure devices plus bivalirudin were used in 35%, 24%, 23%, and 18% of patients, respectively. Bleeding events were reported in 2.8% of patients who received manual compression, compared with 2.1%, 1.6%, and 0.9% of patients receiving vascular closure devices, bivalirudin, and both strategies, respectively (P<.001). Bleeding rates differed by preprocedural risk assessed with the NCDR bleeding risk model (low risk, 0.72%; intermediate risk, 1.73%; high risk, 4.69%). In high-risk patients, use of both strategies was associated with lower bleeding rates (manual compression, 6.1%; vascular closure devices, 4.6%; bivalirudin, 3.8%; vascular closure devices plus bivalirudin, 2.3%; P<.001). This association persisted following adjustment using a propensity-matched and site-controlled model. Use of both strategies was used least often in high-risk patients (14.4% vs 21.0% in low-risk patients, P<.001). Conclusions In a large national PCI registry, vascular closure devices and bivalirudin were associated with significantly lower bleeding rates, particularly among patients at greatest risk for bleeding. However, these strategies were less often used among higher-risk patients. JAMA. 2010; 303(21): 2156-2164	[Marso, Steven P.; Amin, Amit P.; House, John A.; Kennedy, Kevin F.; Spertus, John A.; Cohen, David J.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Rao, Sunil V.] Duke Clin Res Inst, Durham, NC USA; [Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Denver, CO 80202 USA; [Messenger, John C.; Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Duke University; University of Colorado System; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Marso, SP (corresponding author), Univ Missouri, St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	smarso@saint-lukes.org	Spertus, John/ABD-3075-2021		American Diabetes Association; Amylin Pharmaceuticals; Boston Scientific; Medicines Company; Volcano Corporation; Terumo Corporation; National Institutes of Health; American College of Cardiology Foundation; American Heart Association; Amgen; Lilly; Bristol-Myers Squibb/Sanofi-Aventis; EvaHeart; Cordis Corporation; Atherotech; Roche Diagnostics; Momenta Pharmaceuticals; Portola Pharmaceuticals; Schering-Plough; Eli Lilly; Daichi Sankyo; Pfizer; Medtronic; Sanofi-Aventis; Society for Cardiac Angiography and Interventions	American Diabetes Association(American Diabetes Association); Amylin Pharmaceuticals(Bristol-Myers Squibb); Boston Scientific(Boston Scientific); Medicines Company; Volcano Corporation; Terumo Corporation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Cardiology Foundation(General Electric); American Heart Association(American Heart Association); Amgen(Amgen); Lilly(Eli Lilly); Bristol-Myers Squibb/Sanofi-Aventis(Sanofi-AventisBristol-Myers Squibb); EvaHeart; Cordis Corporation; Atherotech; Roche Diagnostics; Momenta Pharmaceuticals; Portola Pharmaceuticals; Schering-Plough(Merck & CompanySchering Plough Corporation); Eli Lilly(Eli Lilly); Daichi Sankyo; Pfizer(Pfizer); Medtronic(Medtronic); Sanofi-Aventis(Sanofi-Aventis); Society for Cardiac Angiography and Interventions	Dr Marso reported receiving research support from the American Diabetes Association, Amylin Pharmaceuticals, Boston Scientific, The Medicines Company, Volcano Corporation, and Terumo Corporation and serving as a consultant for Abbott Vascular, NovoNordisk, Volcano Corporation, and The Medicines Company. Mr House reported receiving consulting fees from Volcano Corporation. Dr Spertus reported receiving research funding from the National Institutes of Health, American College of Cardiology Foundation, American Heart Association, Amgen, Lilly, Bristol-Myers Squibb/Sanofi-Aventis, EvaHeart, and Cordis Corporation; receiving in-kind research support from Atherotech and Roche Diagnostics; serving as a consultant for United Healthcare, St Jude Medical, and Amgen; serving as a copyright holder of the Seattle Angina Questionnaire, the Kansas City Cardiomyopathy Questionnaire, and the Peripheral Artery Questionnaire; having equity ownership in Health Outcomes Sciences; and holding a patent on the PRISM technology, which executes multivariable models at the point of clinical care. Dr Rao reported receiving research support from Momenta Pharmaceuticals, Portola Pharmaceuticals, and Cordis Corporation and serving as a consultant for Bristol-Myers Squibb, Sanofi-Aventis, The Medicines Company, AstraZeneca, and Terumo Corporation. Dr Cohen reported receiving research support from The Medicines Company, Schering-Plough, Eli Lilly, and Daichi Sankyo; serving as a consultant for Schering-Plough and Eli Lilly; and receiving speaking honoraria from The Medicines Company, Eli Lilly, and St Jude Medical. Dr Messenger reported receiving research support from Pfizer, Medtronic, and Sanofi-Aventis. Dr Rumsfeld reported receiving salary support for the position of chief science officer for the NCDR. No other authors reported financial disclosures.; The views expressed in this article represent those of the authors and do not necessarily represent the American College of Cardiology Foundation or the Society for Cardiac Angiography and Interventions, which cosponsor the National Cardiovascular Data Registry.	*AG HEALTHC RES QU, DAT REL TOOLS HEALTH; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; [Anonymous], 2008, CATHPCI REG COMP GUI; ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Aronow HD, 2001, AM HEART J, V142, P799, DOI 10.1067/mhj.2001.119371; Arora N, 2007, AM HEART J, V153, P606, DOI 10.1016/j.ahj.2006.12.014; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1202, DOI 10.1002/pds.1673; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Chatellier G, 1996, BRIT MED J, V312, P426; Cohen DJ, 2004, J AM COLL CARDIOL, V44, P1792, DOI 10.1016/j.jacc.2004.05.085; *CTR MED MED SERV, DET MED AC CAR EP AC; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026; Grantham JA, 2009, JACC-CARDIOVASC INTE, V2, P479, DOI 10.1016/j.jcin.2009.02.008; Halon DA, 2004, J AM COLL CARDIOL, V43, P346, DOI 10.1016/j.jacc.2003.08.044; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Kirtane AJ, 2006, J AM COLL CARDIOL, V47, P2374, DOI 10.1016/j.jacc.2005.09.080; Koreny M, 2004, JAMA-J AM MED ASSOC, V291, P350, DOI 10.1001/jama.291.3.350; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lincoff AM, 2004, AM J CARDIOL, V93, P1092, DOI 10.1016/j.amjcard.2004.01.033; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; McAlister FA, 2007, ARCH INTERN MED, V167, P1019, DOI 10.1001/archinte.167.10.1019; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; National Priorities Partnership, 2008, NAT PRIOR GOALS AL O; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Pilote L, 1996, NEW ENGL J MED, V335, P1198, DOI 10.1056/NEJM199610173351606; Pinto DS, 2008, J AM COLL CARDIOL, V52, P1758, DOI 10.1016/j.jacc.2008.08.021; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sanborn TA, 2010, CIRC-CARDIOVASC INTE, V3, P57, DOI 10.1161/CIRCINTERVENTIONS.109.896704; Segev A, 2005, AM HEART J, V150, P690, DOI 10.1016/j.ahj.2004.11.012; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; SPERTUS JA, 1995, ARCH INTERN MED, V155, P2309, DOI 10.1001/archinte.155.21.2309; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Tavris Dale R, 2005, J Invasive Cardiol, V17, P644; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yan AT, 2009, ARCH INTERN MED, V169, P372, DOI 10.1001/archinternmed.2008.563	49	232	236	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2156	2164		10.1001/jama.2010.708	http://dx.doi.org/10.1001/jama.2010.708			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516416	Bronze			2022-12-24	WOS:000278182100024
J	Nakakuki, T; Birtwistle, MR; Saeki, Y; Yumoto, N; Ide, K; Nagashima, T; Brusch, L; Ogunnaike, BA; Okada-Hatakeyama, M; Kholodenko, BN				Nakakuki, Takashi; Birtwistle, Marc R.; Saeki, Yuko; Yumoto, Noriko; Ide, Kaori; Nagashima, Takeshi; Brusch, Lutz; Ogunnaike, Babatunde A.; Okada-Hatakeyama, Mariko; Kholodenko, Boris N.			Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics	CELL			English	Article							IMMEDIATE-EARLY GENE; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; SERUM RESPONSE FACTOR; ERK PHOSPHORYLATION; TRANSCRIPTION; TRANSDUCTION; PHOSPHATASE; SEQUENCE; HORMONE	Activation of ErbB receptors by epidermal growth factor (EGF) or heregulin (HRG) determines distinct cell-fate decisions, although signals propagate through shared pathways. Using mathematical modeling and experimental approaches, we unravel how HRG and EGF generate distinct, all-or-none responses of the phosphorylated transcription factor c-Fos. In the cytosol, EGF induces transient and HRG induces sustained ERK activation. In the nucleus, however, ERK activity and c-fos mRNA expression are transient for both ligands. Knockdown of dual-specificity phosphatases extends HRG-stimulated nuclear ERK activation, but not c-fos mRNA expression, implying the existence of a HRG-induced repressor of c-fos transcription. Further experiments confirmed that this repressor is mainly induced by HRG, but not EGF, and requires new protein synthesis. We show how a spatially distributed, signaling-transcription cascade robustly discriminates between transient and sustained ERK activities at the c-Fos system level. The proposed control mechanisms are general and operate in different cell types, stimulated by various ligands.	[Nakakuki, Takashi; Saeki, Yuko; Yumoto, Noriko; Ide, Kaori; Nagashima, Takeshi; Okada-Hatakeyama, Mariko] RIKEN Adv Sci Inst, Adv Computat Sci Dept, Computat Syst Biol Res Grp, Kanagawa 2300045, Japan; [Birtwistle, Marc R.; Kholodenko, Boris N.] Univ Coll Dublin, Dublin 4, Ireland; [Birtwistle, Marc R.; Ogunnaike, Babatunde A.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA; [Birtwistle, Marc R.; Kholodenko, Boris N.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Saeki, Yuko; Yumoto, Noriko; Nagashima, Takeshi; Okada-Hatakeyama, Mariko] RIKEN Res Ctr Allergy & Immunol, Lab Cellular Syst Modeling, Yokohama, Kanagawa 2300045, Japan; [Brusch, Lutz] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany	RIKEN; University College Dublin; University of Delaware; Jefferson University; RIKEN; Technische Universitat Dresden	Okada-Hatakeyama, M (corresponding author), RIKEN Adv Sci Inst, Adv Computat Sci Dept, Computat Syst Biol Res Grp, 1-7-22 Tsurumi Ku, Kanagawa 2300045, Japan.	marikoh@rcai.riken.jp; boris.kholodenko@ucd.ie	Ogunnaike, Babatunde/A-4894-2008; Admin, SBI/HGB-2738-2022	Ogunnaike, Babatunde/0000-0002-8246-070X; Kholodenko, Boris/0000-0002-9483-4975; Birtwistle, Marc/0000-0002-0341-0705; Birtwistle, Marc/0000-0003-0415-6523	Science Foundation Ireland [06/CE/B1129]; National Institutes of Health [GM059570]; Marie Curie International Incoming Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059570] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Incoming Fellowship(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rony Seger and Walter Kolch for helpful discussions. Parameter estimation was performed with the RIKEN Super Combined Cluster system. This work was supported in part by Science Foundation Ireland under grant number 06/CE/B1129, National Institutes of Health grant GM059570, and a Marie Curie International Incoming Fellowship (for M.R.B.).	Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; CHARLES CH, 1992, ONCOGENE, V7, P187; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; KIMURA S, 2003, INT C SYST MAN CYB; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Ogunnaike B., 1994, PROCESS DYNAMICS MOD, V1; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SARIBAN E, 1988, MOL CELL BIOL, V8, P340, DOI 10.1128/MCB.8.1.340; Sauro HM, 2004, PROG BIOPHYS MOL BIO, V86, P5, DOI 10.1016/j.pbiomolbio.2004.03.002; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SUPERTIFURGA G, 1991, P NATL ACAD SCI USA, V88, P5114, DOI 10.1073/pnas.88.12.5114; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	41	162	164	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					884	896		10.1016/j.cell.2010.03.054	http://dx.doi.org/10.1016/j.cell.2010.03.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20493519	Bronze, Green Accepted			2022-12-24	WOS:000278132900022
J	Marcheva, B; Ramsey, KM; Buhr, ED; Kobayashi, Y; Su, H; Ko, CH; Ivanova, G; Omura, C; Mo, S; Vitaterna, MH; Lopez, JP; Philipson, LH; Bradfield, CA; Crosby, SD; JeBailey, L; Wang, XZ; Takahashi, JS; Bass, J				Marcheva, Biliana; Ramsey, Kathryn Moynihan; Buhr, Ethan D.; Kobayashi, Yumiko; Su, Hong; Ko, Caroline H.; Ivanova, Ganka; Omura, Chiaki; Mo, Shelley; Vitaterna, Martha H.; Lopez, James P.; Philipson, Louis H.; Bradfield, Christopher A.; Crosby, Seth D.; JeBailey, Lellean; Wang, Xiaozhong; Takahashi, Joseph S.; Bass, Joseph			Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; INSULIN-SECRETION; MOUSE; LIVER; MICE; TRANSCRIPTION; CHOLESTEROL; BIOLOGY	The molecular clock maintains energy constancy by producing circadian oscillations of rate-limiting enzymes involved in tissue metabolism across the day and night(1-3). During periods of feeding, pancreatic islets secrete insulin to maintain glucose homeostasis, and although rhythmic control of insulin release is recognized to be dysregulated in humans with diabetes(4), it is not known how the circadian clock may affect this process. Here we show that pancreatic islets possess self-sustained circadian gene and protein oscillations of the transcription factors CLOCK and BMAL1. The phase of oscillation of islet genes involved in growth, glucose metabolism and insulin signalling is delayed in circadian mutant mice, and both Clock(5,6) and Bmal1(7) (also called Arntl) mutants show impaired glucose tolerance, reduced insulin secretion and defects in size and proliferation of pancreatic islets that worsen with age. Clock disruption leads to transcriptome-wide alterations in the expression of islet genes involved in growth, survival and synaptic vesicle assembly. Notably, conditional ablation of the pancreatic clock causes diabetes mellitus due to defective beta-cell function at the very latest stage of stimulus-secretion coupling. These results demonstrate a role for the beta-cell clock in coordinating insulin secretion with the sleep-wake cycle, and reveal that ablation of the pancreatic clock can trigger the onset of diabetes mellitus.	[Marcheva, Biliana; Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Ivanova, Ganka; Omura, Chiaki; Bass, Joseph] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Marcheva, Biliana; Ramsey, Kathryn Moynihan; Buhr, Ethan D.; Kobayashi, Yumiko; Ko, Caroline H.; Ivanova, Ganka; Omura, Chiaki; Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Su, Hong; Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Mo, Shelley] Northwestern Univ, Weinberg Coll Arts & Sci, Evanston, IL 60208 USA; [Vitaterna, Martha H.; Bass, Joseph] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Lopez, James P.; Philipson, Louis H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53706 USA; [Crosby, Seth D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [JeBailey, Lellean] GeneGo Inc, St Joseph, MI 49085 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Northwestern University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bass, J (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Marcheva, Biliana/0000-0001-8697-2625	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [R37-ES-005703]; Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation; National Institute of Mental Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Turek, R. Allada and G. Bell for discussions and comments on the manuscript. We thank A. Kohsaka, E. Chen, J. Doering and C. Radosevich for their technical support, as well as the Biological Imaging Facility at Northwestern University and the Islet Biology Core of the University of Chicago DRTC. We thank D. Melton for the PdxCre mice. Work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases to K. M. R. and L. H. P.; the National Institutes of Health, Chicago Biomedical Consortium Searle Funds, and Juvenile Diabetes Research Foundation to J. B.; grant R37-ES-005703 from the National Institutes of Health to C. A. B.; and the National Institute of Mental Health to J.S.T.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gu GQ, 2002, DEVELOPMENT, V129, P2447; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	30	975	1028	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					627	631		10.1038/nature09253	http://dx.doi.org/10.1038/nature09253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20562852	Green Accepted			2022-12-24	WOS:000280412100054
J	Jin, X; Costa, RM				Jin, Xin; Costa, Rui M.			Start/stop signals emerge in nigrostriatal circuits during sequence learning	NATURE			English	Article							DOPAMINE NEURONS ENCODE; HUNTINGTONS-DISEASE; BASAL GANGLIA; STRIATUM; REPRESENTATION; PATTERN; TIME; POPULATIONS; INITIATION; MOVEMENTS	Learning new action sequences subserves a plethora of different abilities such as escaping a predator, playing the piano, or producing fluent speech. Proper initiation and termination of each action sequence is critical for the organization of behaviour, and is compromised in nigrostriatal disorders like Parkinson's and Huntington's diseases. Using a self-paced operant task in which mice learn to perform a particular sequence of actions to obtain an outcome, we found neural activity in nigrostriatal circuits specifically signalling the initiation or the termination of each action sequence. This start/stop activity emerged during sequence learning, was specific for particular actions, and did not reflect interval timing, movement speed or action value. Furthermore, genetically altering the function of striatal circuits disrupted the development of start/stop activity and selectively impaired sequence learning. These results have important implications for understanding the functional organization of actions and the sequence initiation and termination impairments observed in basal ganglia disorders.	[Jin, Xin; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, P-2780156 Oeiras, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Costa, RM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	ruicosta@fchampalimaud.org		Costa, Rui M./0000-0003-0495-8374	NIAAA Division of Intramural Clinical and Biological Research; Institute Gulbenkian de Ciencia; European Research Council [243393]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	NIAAA Division of Intramural Clinical and Biological Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Institute Gulbenkian de Ciencia; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Li for the RGS9-Cre mice, C. Gerfen for the TH-Cre mice, K. Nakazawa for the NMDAR1-loxP mice, F. Tecuapetla and S. Lima for help in the optogenetics experiment, G. Luo for genotyping, and D. Lovinger, G. Cui, C. French, C. Gremel and E. Dias-Ferreira for comments on the manuscript. This research was supported by the NIAAA Division of Intramural Clinical and Biological Research, the Champalimaud Neuroscience Programme at Institute Gulbenkian de Ciencia and European Research Council Grant 243393 to R.M.C.	AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Aldridge JW, 1998, J NEUROSCI, V18, P2777; Bailey KR, 2006, J NEUROSCI, V26, P1016, DOI 10.1523/JNEUROSCI.3883-05.2006; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; CASTIELLO U, 1993, NEUROPSYCHOLOGIA, V31, P395, DOI 10.1016/0028-3932(93)90162-S; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gallistel C. R., 1980, ORG ACTION NEW SYNTH; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Hikosaka O, 1998, NEUROBIOL LEARN MEM, V70, P137, DOI 10.1006/nlme.1998.3844; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; Lashley K.S., 1951, PROBLEM SERIAL ORDER, V21; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meyer-Luehmann M, 2002, EUR J NEUROSCI, V16, P1599, DOI 10.1046/j.1460-9568.2002.02210.x; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; PHILLIPS JG, 1995, NEUROPSYCHOLOGIA, V33, P365, DOI 10.1016/0028-3932(94)00114-5; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stefanova ED, 2000, MOVEMENT DISORD, V15, P1095, DOI 10.1002/1531-8257(200011)15:6<1095::AID-MDS1006>3.0.CO;2-R; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	40	363	364	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					457	462		10.1038/nature09263	http://dx.doi.org/10.1038/nature09263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651684	Green Accepted			2022-12-24	WOS:000280141200028
J	Pieper, AA; Xie, SH; Capota, E; Estill, SJ; Zhong, JN; Long, JM; Becker, GL; Huntington, P; Goldman, SE; Shen, CH; Capota, M; Britt, JK; Kotti, T; Ure, K; Brat, DJ; Williams, NS; MacMillan, KS; Naidoo, J; Melito, L; Hsieh, J; De Brabander, J; Ready, JM; McKnight, SL				Pieper, Andrew A.; Xie, Shanhai; Capota, Emanuela; Estill, Sandi Jo; Zhong, Jeannie; Long, Jeffrey M.; Becker, Ginger L.; Huntington, Paula; Goldman, Shauna E.; Shen, Ching-Han; Capota, Maria; Britt, Jeremiah K.; Kotti, Tiina; Ure, Kerstin; Brat, Daniel J.; Williams, Noelle S.; MacMillan, Karen S.; Naidoo, Jacinth; Melito, Lisa; Hsieh, Jenny; De Brabander, Jef; Ready, Joseph M.; McKnight, Steven L.			Discovery of a Proneurogenic, Neuroprotective Chemical	CELL			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; TRANSCRIPTION FACTOR; DENTATE GYRUS; CYTOCHROME-C; CELL-DEATH; NEURONS; BRAIN; NPAS3; MICE	An in vivo screen was performed in search of chemicals capable of enhancing neuron formation in the hippocampus of adult mice. Eight of 1000 small molecules tested enhanced neuron formation in the subgranular zone of the dentate gyrus. Among these was an aminopropyl carbazole, designated P7C3, endowed with favorable pharmacological properties. In vivo studies gave evidence that P7C3 exerts its proneurogenic activity by protecting newborn neurons from apoptosis. Mice missing the gene encoding neuronal PAS domain protein 3 (NPAS3) are devoid of hippocampal neurogenesis and display malformation and electrophysiological dysfunction of the dentate gyrus. Prolonged administration of P7C3 to npas3(-/-) mice corrected these deficits by normalizing levels of apoptosis of newborn hippocampal neurons. Prolonged administration of P7C3 to aged rats also enhanced neurogenesis in the dentate gyrus, impeded neuron death, and preserved cognitive capacity as a function of terminal aging.	[Pieper, Andrew A.; Xie, Shanhai; Estill, Sandi Jo; Long, Jeffrey M.; Shen, Ching-Han; Kotti, Tiina; Williams, Noelle S.; MacMillan, Karen S.; Naidoo, Jacinth; Melito, Lisa; De Brabander, Jef; Ready, Joseph M.; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pieper, Andrew A.; Capota, Emanuela; Zhong, Jeannie; Becker, Ginger L.; Huntington, Paula; Goldman, Shauna E.; Capota, Maria; Britt, Jeremiah K.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30332 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Pieper, AA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	andrew.pieper@utsouthwestern.edu; steven.mcknight@utsouthwestern.edu	Britt, Jeremiah/L-9441-2015; Pieper, Andrew A/R-5552-2016	Britt, Jeremiah/0000-0003-4010-662X; Goldman, Shauna/0000-0001-5729-890X; Pieper, Andrew/0000-0001-6299-6577	Hartwell Foundation; Staglin Family fund; University of Texas Southwestern Medical Center High Risk/High Impact research fund; National Alliance for Research on Schizophrenia and Depression; Morton H. Meyerson Family Tzedakah Fund; National Institute of Mental Health [NIMH] [RO1, 1RO1MH087986]; National Institutes of Health (NIH); National Institute of General Medical Sciences [5DP1OD000276]; NIH Method to Extend Research [NIMH RO1MH59388]; National Cancer Institute Program [5PO1CA95471]; Simons Foundation Autism Research; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388, R01MH087986, R37MH059388] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000276] Funding Source: NIH RePORTER	Hartwell Foundation; Staglin Family fund; University of Texas Southwestern Medical Center High Risk/High Impact research fund; National Alliance for Research on Schizophrenia and Depression(NARSAD); Morton H. Meyerson Family Tzedakah Fund; National Institute of Mental Health [NIMH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Method to Extend Research; National Cancer Institute Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simons Foundation Autism Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Wang lab for extensive help in establishing the live-cell imaging assay used to measure mitochondrial membrane permeability; Xiaodong Wang and Sol Snyder for invaluable scientific input; Patrick Harran for helping select the 1000 chemicals chosen for in vivo screening; David Russell and members of the Russell lab for extensive help in electrophysiological recording assays; Christopher Cowan and members of the Cowan laboratory for assistance with primary neuronal cultures; Farah Veerjee, Saira Hussein, Latisha McDaniel, Ruth Starwalt, and Leeju Wu for technical assistance; and Huda Zoghbi, Sol Snyder, Joe Goldstein, Ueli Schibler, Al Gilman, Mike Brown, Richard Axel, and Martin Raff for critical review of the manuscript. We thank Angela Diehl for help with the graphical abstract artwork. This work was supported by grants from The Hartwell Foundation, Staglin Family fund, University of Texas Southwestern Medical Center High Risk/High Impact research fund, National Alliance for Research on Schizophrenia and Depression, and Morton H. Meyerson Family Tzedakah Fund awarded to A.A.P.; a Transformative RO1 grant (National Institute of Mental Health [NIMH] 1RO1MH087986) awarded to A.A.P. and S.L.M.; and a National Institutes of Health (NIH) Pioneer grant (National Institute of General Medical Sciences 5DP1OD000276), an NIH Method to Extend Research in Time grant (NIMH RO1MH59388), a National Cancer Institute Program Project Grant (5PO1CA95471), a Simons Foundation Autism Research Initiative grant from the Simons Foundation, and funds from an anonymous donor provided to S.L.M.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bachurin S, 2001, ANN NY ACAD SCI, V939, P425; Bachurin SO, 2003, ANN NY ACAD SCI, V993, P334, DOI 10.1111/j.1749-6632.2003.tb07541.x; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bombrun A, 2003, J MED CHEM, V46, P4365, DOI 10.1021/jm034107j; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burns A, 2008, LANCET, V372, P179, DOI 10.1016/S0140-6736(08)61046-6; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Driscoll I, 2006, NEUROSCIENCE, V139, P1173, DOI 10.1016/j.neuroscience.2006.01.040; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200; McKnight SL, 2010, US Patent, Patent No. [2010/020681, 2010020681]; Miller G, 2010, SCIENCE, V327, P1309, DOI 10.1126/science.327.5971.1309; O'Brien JT, 2008, LANCET NEUROL, V7, P768, DOI 10.1016/S1474-4422(08)70177-7; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pickard BS, 2006, ANN MED, V38, P439, DOI 10.1080/07853890600946500; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; STANFIELD BB, 1988, CEREB CORTEX, V7, P91; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; YANG J, 1997, SCIENCE, V275, P1132	34	266	282	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					39	51		10.1016/j.cell.2010.06.018	http://dx.doi.org/10.1016/j.cell.2010.06.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603013	Green Accepted, Bronze			2022-12-24	WOS:000279637300011
J	Cooper-DeHoff, RM; Gong, Y; Handberg, EM; Bavry, AA; Denardo, SJ; Bakris, GL; Pepine, CJ				Cooper-DeHoff, Rhonda M.; Gong, Yan; Handberg, Eileen M.; Bavry, Anthony A.; Denardo, Scott J.; Bakris, George L.; Pepine, Carl J.			Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VERAPAMIL SR-TRANDOLAPRIL; METAANALYSIS; ASSOCIATION; MANAGEMENT; MORTALITY; INVEST	Context Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD). Objective To determine the association of systolic BP control achieved and adverse cardiovascular outcomes in a cohort of patients with diabetes and CAD. Design, Setting, and Patients Observational subgroup analysis of 6400 of the 22 576 participants in the International Verapamil SR-Trandolapril Study (INVEST). For this analysis, participants were at least 50 years old and had diabetes and CAD. Participants were recruited between September 1997 and December 2000 from 862 sites in 14 countries and were followed up through March 2003 with an extended follow-up through August 2008 through the National Death Index for US participants. Intervention Patients received first-line treatment of either a calcium antagonist or beta-blocker followed by angiotensin-converting enzyme inhibitor, a diuretic, or both to achieve systolic BP of less than 130 and diastolic BP of less than 85 mm Hg. Patients were categorized as having tight control if they could maintain their systolic BP at less than 130 mm Hg; usual control if it ranged from 130 mm Hg to less than 140 mm Hg; and uncontrolled if it was 140 mm Hg or higher. Main Outcome Measures Adverse cardiovascular outcomes, including the primary outcomes which was the first occurrence of all-cause death, nonfatal myocardial infarction, or nonfatal stroke. Results During 16 893 patient-years of follow-up, 286 patients (12.7%) who maintained tight control, 249 (12.6%) who had usual control, and 431 (19.8%) who had uncontrolled systolic BP experienced a primary outcome event. Patients in the usual-control group had a cardiovascular event rate of 12.6% vs a 19.8% event rate for those in the uncontrolled group (adjusted hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.25-1.71; P<.001). However, little difference existed between those with usual control and those with tight control. Their respective event rates were 12.6% vs 12.7% (adjusted HR, 1.11; 95% CI, 0.93-1.32; P=.24). The all-cause mortality rate was 11.0% in the tight-control group vs 10.2% in the usual-control group (adjusted HR, 1.20; 95% CI, 0.99-1.45; P=.06); however, when extended follow-up was included, risk of all-cause mortality was 22.8% in the tight control vs 21.8% in the usual control group (adjusted HR, 1.15; 95% CI, 1.01-1.32; P=.04). Conclusion Tight control of systolic BP among patients with diabetes and CAD was not associated with improved cardiovascular outcomes compared with usual control.	[Cooper-DeHoff, Rhonda M.; Gong, Yan] Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, Gainesville, FL 32610 USA; [Cooper-DeHoff, Rhonda M.; Handberg, Eileen M.; Bavry, Anthony A.; Denardo, Scott J.; Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA; [Bakris, George L.] Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit,Sec Endocrinol Diabet & Metab, Chicago, IL 60637 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Chicago	Cooper-DeHoff, RM (corresponding author), Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, 1600 SW Archer Rd,POB 100486, Gainesville, FL 32610 USA.	dehoff@cop.ufl.edu		Patt, Mitchell/0000-0001-9696-4477; Handberg, Eileen/0000-0002-7805-9577	Abbott Laboratories; National Heart, Lung, and Blood Institute (NHLBI); Fujisawa; Pfizer; GlaxoSmithKline; Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA); Juvenile Diabetes Research Foundation; Forest Laboratories; CVRx; Merck; Novartis; Boehringer-Ingelheim; Takeda; Walgreens; Bristol Meyer Squibb/Sanofi; Gilead; Forest Labs; Fibrogen; Spherix; Johnson Johnson; Daiichi Sankyo; Bioheart Inc; AstraZeneca; AtCor Medical Inc; Daiichi Sankyo Inc; Eli Lilly; Pfizer Inc; Sanofi-Aventis; Schering-Plough; University of Florida; National Institutes of Health [K23HL086558, UOIGM074492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL086558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fujisawa; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA)(Sanofi-AventisMerck & CompanySchering Plough CorporationAstraZeneca); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Forest Laboratories; CVRx; Merck(Merck & Company); Novartis(Novartis); Boehringer-Ingelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd); Walgreens; Bristol Meyer Squibb/Sanofi; Gilead(Gilead Sciences); Forest Labs; Fibrogen; Spherix; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bioheart Inc; AstraZeneca(AstraZeneca); AtCor Medical Inc; Daiichi Sankyo Inc(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Pfizer Inc(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); University of Florida(University of Florida); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Cooper-DeHoff reported receiving research funding from Abbott Laboratories during the conduct of INVEST. Dr Handberg reported receiving grant support from National Heart, Lung, and Blood Institute (NHLBI), Abbott Laboratories, Fujisawa, Pfizer, GlaxoSmithKline, and educational grants from the Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA. Dr Bakris reported receiving grant and research support from the Juvenile Diabetes Research Foundation, GlaxoSmithKline, Forest Laboratories, and CVRx; reported also serving as a consultant for GlaxoSmithKline, Merck, Novartis, Boehringer-Ingelheim, Takeda, Abbott Laboratories, Walgreens, Bristol Meyer Squibb/Sanofi, Gilead, Forest Labs and CVRx, Fibrogen, Spherix, Johnson & Johnson, Daiichi Sankyo, and Mitsubishi. Dr Pepine reported receiving research grants from the NHLBI, Abbott Laboratories, Baxter, Pfizer, GlaxoSmithKline, and Bioheart Inc; serving as consultant for Abbott Laboratories, Forest Laboratories, Novartis/Cleveland Clinic, NicOx, Angloblast, Sanofi-Aventis, NHLBI, NIH, Medtelligence, and SLACK Inc; receiving unrestricted educational grants from AstraZeneca, AtCor Medical Inc, Daiichi Sankyo Inc, Eli Lilly, Pfizer Inc, Sanofi-Aventis, and Schering-Plough. Drs Gong, Bavry, and Denardo reported that they have no financial disclosures.; INVEST was funded by a grant from Abbott Laboratories and the University of Florida Opportunity Fund. The present research is supported in part by grants K23HL086558 and UOIGM074492 from the National Institutes of Health (Dr Cooper-DeHoff).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; *AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS85, DOI DOI 10.2337/DIACARE.25.2007.S85; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P199; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 1984, ARCH INTERN MED, V144, P1045; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Boutitie F, 2002, ANN INTERN MED, V136, P438, DOI 10.7326/0003-4819-136-6-200203190-00007; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Denardo SJ, 2009, HYPERTENSION, V53, P624, DOI 10.1161/HYPERTENSIONAHA.108.111542; Estacio RO, 2000, DIABETES CARE, V23, pB54; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Kalaitzidis R, 2009, J CLIN HYPERTENS, V11, P345, DOI 10.1111/j.1751-7176.2009.00143.x; Khosla N, 2009, MED CLIN N AM, V93, P697, DOI 10.1016/j.mcna.2009.02.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Pepine CJ, 1998, J AM COLL CARDIOL, V32, P1228, DOI 10.1016/S0735-1097(98)00423-9; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4	27	476	504	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					61	68		10.1001/jama.2010.884	http://dx.doi.org/10.1001/jama.2010.884			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606150	Bronze, Green Accepted			2022-12-24	WOS:000279519600022
J	Guang, SH; Bochner, AF; Burkhart, KB; Burton, N; Pavelec, DM; Kennedy, S				Guang, Shouhong; Bochner, Aaron F.; Burkhart, Kirk B.; Burton, Nick; Pavelec, Derek M.; Kennedy, Scott			Small regulatory RNAs inhibit RNA polymerase II during the elongation phase of transcription	NATURE			English	Article							PRE-MESSENGER-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INTERFERENCE; MEDIATED PATHWAYS; REVEALS; NUCLEUS; TARGET; LIN-15	Eukaryotic cells express a wide variety of endogenous small regulatory RNAs that regulate heterochromatin formation, developmental timing, defence against parasitic nucleic acids and genome rearrangement. Many small regulatory RNAs are thought to function in nuclei(1,2). For instance, in plants and fungi, short interfering RNA (siRNAs) associate with nascent transcripts and direct chromatin and/or DNA modifications(1,2). To understand further the biological roles of small regulatory RNAs, we conducted a genetic screen to identify factors required for RNA interference (RNAi) in Caenorhabditis elegans nuclei(3). Here we show that the gene nuclear RNAi defective-2 (nrde-2) encodes an evolutionarily conserved protein that is required for siRNA-mediated silencing in nuclei. NRDE-2 associates with the Argonaute protein NRDE-3 within nuclei and is recruited by NRDE-3/siRNA complexes to nascent transcripts that have been targeted by RNAi. We find that nuclear-localized siRNAs direct an NRDE-2-dependent silencing of pre-messenger RNAs (pre-mRNAs) 3' to sites of RNAi, an NRDE-2-dependent accumulation of RNA polymerase (RNAP) II at genomic loci targeted by RNAi, and NRDE-2-dependent decreases in RNAP II occupancy and RNAP II transcriptional activity 39 to sites of RNAi. These results define NRDE-2 as a component of the nuclear RNAi machinery and demonstrate that metazoan siRNAs can silence nuclear-localized RNAs co-transcriptionally. In addition, these results establish a novel mode of RNAP II regulation: siRNA-directed recruitment of NRDE factors that inhibit RNAP II during the elongation phase of transcription.	[Guang, Shouhong; Bochner, Aaron F.; Burkhart, Kirk B.; Burton, Nick; Kennedy, Scott] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Pavelec, Derek M.; Kennedy, Scott] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, S (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	sgkennedy@wisc.edu		Kennedy, Scott/0000-0002-7974-8155; Burton, Nicholas/0000-0002-5495-3988	Pew and Shaw scholars programmes; National Institutes of Health; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076619, R01GM088289] Funding Source: NIH RePORTER	Pew and Shaw scholars programmes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Anderson, members of the Anderson laboratory, D. Wassarman and D. Brow for comments, and the Caenorhabditis Genetics Center for strains. This work was supported by grants from the Pew and Shaw scholars programmes, the National Institutes of Health and the American Heart Association.	Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bosher JM, 1999, GENETICS, V153, P1245; CLARK SG, 1994, GENETICS, V137, P987; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; ROGALSKI TM, 1990, GENETICS, V126, P889; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	20	207	218	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1097	U165		10.1038/nature09095	http://dx.doi.org/10.1038/nature09095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543824	Green Accepted			2022-12-24	WOS:000279056900057
J	Yeh, RW; Sidney, S; Chandra, M; Sorel, M; Selby, JV; Go, AS				Yeh, Robert W.; Sidney, Stephen; Chandra, Malini; Sorel, Michael; Selby, Joseph V.; Go, Alan S.			Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; UNITED-STATES; CHOLESTEROL LEVELS; TEMPORAL TRENDS; MEDICAL-CARE; US; MORTALITY; PREVENTION; RISK	Background: Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction. Methods: We identified patients 30 years of age or older in a large, diverse, community-based population who were hospitalized for incident myocardial infarction between 1999 and 2008. Age- and sex-adjusted incidence rates were calculated for myocardial infarction overall and separately for ST-segment elevation and non-ST-segment elevation myocardial infarction. Patient characteristics, outpatient medications, and cardiac biomarker levels during hospitalization were identified from health plan databases, and 30-day mortality was ascertained from administrative databases, state death data, and Social Security Administration files. Results: We identified 46,086 hospitalizations for myocardial infarctions during 18,691,131 person-years of follow-up from 1999 to 2008. The age- and sex-adjusted incidence of myocardial infarction increased from 274 cases per 100,000 person-years in 1999 to 287 cases per 100,000 person-years in 2000, and it decreased each year thereafter, to 208 cases per 100,000 person-years in 2008, representing a 24% relative decrease over the study period. The age- and sex-adjusted incidence of ST-segment elevation myocardial infarction decreased throughout the study period (from 133 cases per 100,000 person-years in 1999 to 50 cases per 100,000 person-years in 2008, P<0.001 for linear trend). Thirty-day mortality was significantly lower in 2008 than in 1999 (adjusted odds ratio, 0.76; 95% confidence interval, 0.65 to 0.89). Conclusions: Within a large community-based population, the incidence of myocardial infarction decreased significantly after 2000, and the incidence of ST-segment elevation myocardial infarction decreased markedly after 1999. Reductions in short-term case fatality rates for myocardial infarction appear to be driven, in part, by a decrease in the incidence of ST-segment elevation myocardial infarction and a lower rate of death after non-ST-segment elevation myocardial infarction. N Engl J Med 2010;362:2155-65.	[Sidney, Stephen; Chandra, Malini; Sorel, Michael; Selby, Joseph V.; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Yeh, Robert W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Cardiol Div, Boston, MA USA; [Sidney, Stephen; Selby, Joseph V.; Go, Alan S.] Permanente Med Grp Inc, Oakland, CA USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Kaiser Permanente; Harvard University; Harvard Medical School; Massachusetts General Hospital; Permanente Medical Groups; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Fl, Oakland, CA 94612 USA.	alan.s.go@kp.org	Go, Alan S./AAE-7745-2019; s, s/HIK-1178-2022; s, s/HHD-0404-2022; Yeh, Robert/AAJ-3463-2020; s, s/GYR-2278-2022		Permanente Medical Group; Schering-Plough Future Leaders in Cardiovascular Medical Research	Permanente Medical Group; Schering-Plough Future Leaders in Cardiovascular Medical Research	Supported by research funding from the Permanente Medical Group and by a Schering-Plough Future Leaders in Cardiovascular Medical Research grant.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; ANDERSON JL, 2008, J AM COLL CARDIOL, V51, P974; [Anonymous], 1981, JAMA-J AM MED ASSOC, V246, P2073; [Anonymous], 2008, KAIS PERM 2008 HEDIS; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; ANTMAN EM, 2008, CIRCULATION, V117, pE162; Arciero TJ, 2004, AM J MED, V117, P228, DOI 10.1016/j.amjmed.2004.04.008; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldberg RJ, 2004, AM J CARDIOL, V94, P1373, DOI 10.1016/j.amjcard.2004.07.142; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364; PEDERSEN TR, 1994, LANCET, V344, P1383; Pottenger BC, 2008, ANN EMERG MED, V52, P677, DOI 10.1016/j.annemergmed.2008.06.004; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Steinberg BA, 2008, AM HEART J, V156, P719, DOI 10.1016/j.ahj.2008.05.020; Sytkowski PA, 1996, AM J EPIDEMIOL, V143, P338, DOI 10.1093/oxfordjournals.aje.a008748; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 2000, NEW ENGL J MED, V342, P1376; [No title captured]; 2003, JAMA, V289, P176	55	1183	1236	0	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2155	2165		10.1056/NEJMoa0908610	http://dx.doi.org/10.1056/NEJMoa0908610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558366				2022-12-24	WOS:000278551500004
J	Muller, MP; Peters, H; Blumer, J; Blankenfeldt, W; Goody, RS; Itzen, A				Mueller, Matthias P.; Peters, Heide; Bluemer, Julia; Blankenfeldt, Wulf; Goody, Roger S.; Itzen, Aymelt			The Legionella Effector Protein DrrA AMPylates the Membrane Traffic Regulator Rab1b	SCIENCE			English	Article							GLUTAMINE-SYNTHETASE; STRUCTURAL BASIS; GTP HYDROLYSIS; ACTIVATION; GTPASES	In the course of Legionnaires' disease, the bacterium Legionella pneumophila affects the intracellular vesicular trafficking of infected eukaryotic cells by recruiting the small guanosine triphosphatase (GTPase) Rab1 to the cytosolic face of the Legionella-containing vacuole. In order to accomplish this, the Legionella protein DrrA contains a specific guanine nucleotide exchange activity for Rab1 activation that exchanges guanosine triphosphate (GTP) for guanosine diphosphate on Rab1. We found that the amino-terminal domain of DrrA possesses adenosine monophosphorylation (AMPylation) activity toward the switch II region of Rab1b, leading to posttranslational covalent modification of tyrosine 77. AMPylation of switch II by DrrA restricts the access of GTPase activating proteins, thereby rendering Rab1b constitutively active.	[Mueller, Matthias P.; Peters, Heide; Bluemer, Julia; Blankenfeldt, Wulf; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, NRW, Germany	Max Planck Society	Blankenfeldt, W (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, NRW, Germany.	wulf.blankenfeldt@mpi-dortmund.mpg.de; roger.goody@mpi-dortmund.mpg.de; aymelt.itzen@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010; Itzen, Aymelt/F-5157-2014; Goody, Roger S/J-8845-2014	Blankenfeldt, Wulf/0000-0001-9886-9668; Itzen, Aymelt/0000-0002-4249-5617; Goody, Roger S/0000-0002-0772-0444; Behrmann, Heide/0000-0002-1769-7049; Muller, Matthias/0000-0002-1529-8933	German research foundation [SFB 642]; International Max Planck Research School in Chemical Biology (Dortmund)	German research foundation(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology (Dortmund)	We thank P. Janning for guidance in tandem mass spectrometry, N. Bleimling for invaluable technical assistance, M. Sulc for help in flow cytometry, the staff of Beamline X10SA at the Paul Scherrer Institute (Villingen, Switzerland), the x-ray communities at the Max Planck Institute (MPI) Dortmund and the MPI Heidelberg (Germany), and M. Machner and A. Barnekow for LidA and MICAL-3 plasmids, respectively. R.S.G. thanks the German research foundation (SFB 642). M.P.M. is grateful to the International Max Planck Research School in Chemical Biology (Dortmund) for financial support. Coordinates of DrrA<INF>9-218</INF> and Rab1b-AMP have been deposited in the Protein Data Bank (Brookhaven National Laboratory) with accession numbers 3NKU and 3NKV, respectively.	Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; DATE T, 1991, BIOCHEMISTRY-US, V30, P5286, DOI 10.1021/bi00235a023; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu YB, 2010, J MOL BIOL, V396, P773, DOI 10.1016/j.jmb.2009.12.011; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	252	260	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					946	949		10.1126/science.1192276	http://dx.doi.org/10.1126/science.1192276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20651120				2022-12-24	WOS:000281084800035
J	Montaner, JSG; Lima, VD; Barrios, R; Yip, B; Wood, E; Kerr, T; Shannon, K; Harrigan, PR; Hogg, RS; Daly, P; Kendall, P				Montaner, Julio S. G.; Lima, Viviane D.; Barrios, Rolando; Yip, Benita; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard; Hogg, Robert S.; Daly, Patricia; Kendall, Peny			Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study	LANCET			English	Article							SEXUAL TRANSMISSION; PREVENTION; RNA; ACCESS; CURB; AIDS; GROWTH; POLICY	Background Results of cohort studies and mathematical models have suggested that increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV transmission. We aimed to estimate the association between plasma HIV-1 viral load, HAART coverage, and number of new cases of HIV in the population of a Canadian province. Methods We undertook a population-based study of HAART coverage and HIV transmission in British Columbia, Canada. Data for number of HIV tests done and new HIV diagnoses were obtained from the British Columbia Centre for Disease Control. Data for viral load, CD4 cell count, and HAART use were extracted from the British Columbia Centre for Excellence in HIV/AIDS population-based registries. We modelled trends of new HIV-positive tests and number of individuals on HAART using generalised additive models. Poisson log-linear regression models were used to estimate the association between new HIV diagnoses and viral load, year, and number of individuals on HAART. Findings Between 1996 and 2009, the number of individuals actively receiving HAART increased from 837 to 5413 (547% increase; p=0.002), and the number of new HIV diagnoses fell from 702 to 338 per year (52% decrease; p=0.001). The overall correlation between number of individuals on HAART and number of individuals newly testing positive for HIV per year was 0.89 (p<0.0001). For every 100 additional individuals on HAART, the number of new HIV cases decreased by a factor of 0.97 (95% CI 0.96-0.98), and per 1 log,o decrease in viral load, the number of new HIV cases decreased by a factor of 0.86 (0.75-0.98). Interpretation We have shown a strong population-level association between increasing HAART coverage, decreased viral load, and decreased number of new HIV diagnoses per year. Our results support the proposed secondary benefit of HAART used within existing medical guidelines to reduce HIV transmission.	[Montaner, Julio S. G.; Lima, Viviane D.; Barrios, Rolando; Yip, Benita; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard; Hogg, Robert S.] Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.; Lima, Viviane D.; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard] Univ British Columbia, Div Aids, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio S. G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Daly, Patricia] Vancouver Coastal Hlth Author, Vancouver, BC, Canada; [Kendall, Peny] Govt British Columbia, Minist Healthy Living & Sport, Off Prov Hlth Officer, Victoria, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego; Simon Fraser University; Vancouver Coastal Health Research Institute	Montaner, JSG (corresponding author), Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, 1081 Burrard St,Room 667, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012; Kendall, Carl/F-9002-2012	Hogg, Robert S/0000-0003-3463-5488; Kendall, Carl/0000-0002-0794-4333	Merck; Gilead and ViiV Healthcare; GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology; GlaxoSmithKline; Abbott; Viiv; Pfizer; Ministry of Health Services; Ministry of Healthy Living and Sport, Province of British Columbia through Canadian Institutes of Health Research (CIHR); National Institute on Drug Abuse at the US National Institutes of Health [1DP1DA026182-01]; CIHR [MOP-79297, RAA-79918]; Michael Smith Foundation for Health Research; US National Institutes of Health [R01DA021525]; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182, R01DA021525] Funding Source: NIH RePORTER	Merck(Merck & Company); Gilead and ViiV Healthcare; GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR)GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Viiv; Pfizer(Pfizer); Ministry of Health Services; Ministry of Healthy Living and Sport, Province of British Columbia through Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JSGM has received funding from Merck, Gilead and ViiV Healthcare to support research into Treatment as Prevention, consultancy fees from Merck, and speakers' fees from Clinical Care Options. PRH holds the GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology. RSH has received a research grant from Merck and a conference travel grant from GlaxoSmithKline. PRH has received honoraria from Viiv, Virco, Quest, and Merck, travel grants to attend conferences from Viiv and Quest, research grants from Abbott, Viiv, Pfizer, and Merck, and speakers' fees from Viiv. VDL, TK, EW, KS, RB, PD, PK, and BY declare that they have no conflicts of interest.; JSGM is supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No 1DP1DA026182-01) from the National Institute on Drug Abuse, at the US National Institutes of Health. TK is supported by CIHR and the Michael Smith Foundation for Health Research. VDL is supported through Fellowship Awards by CIHR and Michael Smith Foundation for Health Research. The study was further supported by the US National Institutes of Health (R01DA021525) and CIHR (MOP-79297, RAA-79918). Merck, Gilead and ViiV Healthcare support research into Treatment as Prevention. We thank Kelly Hsu for her assistance with preparation of the report, and Tom Patterson and Steffanie Strathdee for their helpful comments and advice.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; *BC CTR DIS CONTR, 2008, ANN SUMM REP DIS; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Breslow NE, 1987, IARC SCI PUBL, V82, P82; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Kerr T, 2009, J ADOLESCENT HEALTH, V45, P300, DOI 10.1016/j.jadohealth.2009.03.007; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lloyd-Smith E, 2009, ANN EPIDEMIOL, V19, P404, DOI 10.1016/j.annepidem.2009.03.007; Lorello G, 2009, HIV MED, V10, P548, DOI 10.1111/j.1468-1293.2009.00725.x; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; SHANNON K, 2009, BMJ-BRIT MED J, V11, pB2939; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; SIDIBE M, 2010, COMMUNICATION; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; *US CDCP, QUEST ANSW 15 INCR H; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	41	589	604	3	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					532	539		10.1016/S0140-6736(10)60936-1	http://dx.doi.org/10.1016/S0140-6736(10)60936-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20638713	Green Accepted			2022-12-24	WOS:000281266800032
J	Wu, H; Coskun, V; Tao, JF; Xie, W; Ge, WH; Yoshikawa, K; Li, E; Zhang, Y; Sun, YE				Wu, Hao; Coskun, Volkan; Tao, Jifang; Xie, Wei; Ge, Weihong; Yoshikawa, Kazuaki; Li, En; Zhang, Yi; Sun, Yi Eve			Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes	SCIENCE			English	Article							DE-NOVO METHYLATION; METHYLTRANSFERASES DNMT3A; NERVOUS-SYSTEM; HUMAN GENOME; HISTONE H3; HYPERMETHYLATION; EXPRESSION; DOMAIN; CELLS	DNA methylation at proximal promoters facilitates lineage restriction by silencing cell type-specific genes. However, euchromatic DNA methylation frequently occurs in regions outside promoters. The functions of such nonproximal promoter DNA methylation are unclear. Here we show that the de novo DNA methyltransferase Dnmt3a is expressed in postnatal neural stem cells (NSCs) and is required for neurogenesis. Genome-wide analysis of postnatal NSCs indicates that Dnmt3a occupies and methylates intergenic regions and gene bodies flanking proximal promoters of a large cohort of transcriptionally permissive genes, many of which encode regulators of neurogenesis. Surprisingly, Dnmt3a-dependent nonproximal promoter methylation promotes expression of these neurogenic genes by functionally antagonizing Polycomb repression. Thus, nonpromoter DNA methylation by Dnmt3a may be used for maintaining active chromatin states of genes critical for development.	[Wu, Hao; Ge, Weihong; Sun, Yi Eve] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Coskun, Volkan; Tao, Jifang; Sun, Yi Eve] Univ Calif Los Angeles, Semel Inst Neurosci, Intellectual Dev & Disabil Res Ctr, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Xie, Wei] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 5650871, Japan; [Li, En] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Osaka University; Novartis; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Wu, H (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	haowu7@gmail.com; ysun@mednet.ucla.edu	Wu, Hao/G-4145-2013; feng, jian/G-9313-2011; Xie, Wei/J-1380-2017	Wu, Hao/0000-0002-1256-6891; Xie, Wei/0000-0003-2126-3849; Zhang, Yi/0000-0002-2789-0811; Wu, Hao/0000-0003-4395-6929	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Carey (UCLA) for technical assistance on in vitro chromatin recruitment assays and J. Rubenstein (University of California San Francisco) for providing the pCAG-Dlx2 expression plasmid. This work was supported by NIH RO1 grants to Y.E.S. All microarray data are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE22476.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rush Margaret, 2009, Epigenetics, V4, P404; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	26	441	454	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					444	448		10.1126/science.1190485	http://dx.doi.org/10.1126/science.1190485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651149	Green Published, Green Accepted			2022-12-24	WOS:000280196500038
J	Bento, G; Ogawa, A; Sommer, RJ				Bento, Gilberto; Ogawa, Akira; Sommer, Ralf J.			Co-option of the hormone-signalling module dafachronic acid-DAF-12 in nematode evolution	NATURE			English	Article							PHENOTYPIC PLASTICITY; NUCLEAR RECEPTOR; DAUER FORMATION; DAF-12; IDENTIFICATION; ORIGINS	Morphological novelties are lineage-specific traits that serve new functions(1,2). Developmental polyphenisms have been proposed to be facilitators of phenotypic evolution, but little is known about the interplay between the associated genetic and environmental factors(3-11). Here, we study two alternative morphologies in the mouth of the nematode Pristionchus pacificus and the formation of teeth-like structures that are associated with bacteriovorous feeding and predatory behaviour on fungi and other worms(12-16). These teeth-like denticles represent an evolutionary novelty, which is restricted to some members of the nematode family Diplogastridae but is absent from Caenorhabditis elegans and related nematodes(14). We show that the mouth dimorphism is a polyphenism that is controlled by starvation and the co-option of an endocrine switch mechanism. Mutations in the nuclear hormone receptor DAF-12 and application of its ligand, the sterol hormone dafachronic acid, strongly influence this switch mechanism. The dafachronic acid-DAF-12 module has been shown to control the formation of arrested dauer larvae in both C. elegans and P. pacificus, as well as related life-history decisions in distantly related nematodes(17-20). The comparison of dauer formation and mouth morphology switch reveals that different thresholds of dafachronic acid signalling provide specificity. This study shows how hormonal signalling acts by coupling environmental change and genetic regulation and identifies dafachronic acid as a key hormone in nematode evolution.	[Bento, Gilberto; Ogawa, Akira; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Bento, Gilberto/AAY-8654-2020	Bento, Gilberto/0000-0002-8455-6625				Antebi A, 2000, GENE DEV, V14, P1512; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hirschmann H., 1951, Zoologische Jahrbuecher (Systematik), V80, P132; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mayr E., 1960, EVOLUTION DARWIN; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; NIJHOUT HF, 1994, INSECT PHEROMONES; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Pigliucci M., 2001, SYN ECO EVO; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Quinn GP, 2003, EXPT DESIGN DATA ANA; Saenko SV, 2008, PHILOS T R SOC B, V363, P1549, DOI 10.1098/rstb.2007.2245; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; West-Eberhard Mary Jane, 2003, pi	31	144	144	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					494	U9		10.1038/nature09164	http://dx.doi.org/10.1038/nature09164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20592728				2022-12-24	WOS:000280141200037
J	Comita, LS; Muller-Landau, HC; Aguilar, S; Hubbell, SP				Comita, Liza S.; Muller-Landau, Helene C.; Aguilar, Salomon; Hubbell, Stephen P.			Asymmetric Density Dependence Shapes Species Abundances in a Tropical Tree Community	SCIENCE			English	Article							LOCAL NEIGHBORHOOD; NEOTROPICAL FOREST; SHADE TOLERANCE; DIVERSITY; SURVIVAL; COEXISTENCE; RECRUITMENT; PATHOGENS; SEEDLINGS; GROWTH	The factors determining species commonness and rarity are poorly understood, particularly in highly diverse communities. Theory predicts that interactions with neighbors of the same (conspecific) and other (heterospecific) species can influence a species' relative abundance, but empirical tests are lacking. By using a hierarchical model of survival for more than 30,000 seedlings of 180 tropical tree species on Barro Colorado Island, Panama, we tested whether species' sensitivity to neighboring individuals relates to their relative abundance in the community. We found wide variation among species in the effect of conspecific, but not heterospecific, neighbors on survival, and we found a significant relationship between the strength of conspecific neighbor effects and species abundance. Specifically, rare species suffered more from the presence of conspecific neighbors than common species did, suggesting that conspecific density dependence shapes species abundances in diverse communities.	[Comita, Liza S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Comita, Liza S.; Muller-Landau, Helene C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Muller-Landau, Helene C.; Aguilar, Salomon; Hubbell, Stephen P.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA	National Center for Ecological Analysis & Synthesis; University of Minnesota System; University of Minnesota Twin Cities; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles	Comita, LS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	comita@nceas.ucsb.edu		Comita, Liza/0000-0002-9169-1331; Muller-Landau, Helene C./0000-0002-3526-9021	Packard Fellowship for Science and Engineering; NSF [DEB-0075102, 0425651, 0710211, 0823728]; Andrew W. Mellon Foundation; HSBC	Packard Fellowship for Science and Engineering; NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation; HSBC	We thank the dozens of field assistants who conducted the seedling and tree censuses; R. Perez for assistance with species identifications; S. Lao for help with data management; and S. Banerjee, S. M. Lee, M. Schofield, and A. Gelman for statistical advice. The study was financially supported by a Packard Fellowship for Science and Engineering (to H.C.M.), NSF (grants DEB-0075102, 0425651, 0710211, and 0823728 to S. P. H.), the Andrew W. Mellon Foundation, and the HSBC Climate Partnership, with logistical support from the Center of Tropical Forest Science, Smithsonian Tropical Research Institute, and University of Georgia.	Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Gaston K.J., 1994, RARITY, P1; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kunin W.E., 1997, J ANIM ECOL, DOI DOI 10.2307/6011; MANGAN SA, 2010, NATURE; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, SCIENCE, V314, P770, DOI 10.1126/science.1134920; Novotny V, 2007, SCIENCE, V315, DOI 10.1126/science.1139702; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	32	468	490	21	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					330	332		10.1126/science.1190772	http://dx.doi.org/10.1126/science.1190772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576853				2022-12-24	WOS:000279925900044
J	Grashoff, C; Hoffman, BD; Brenner, MD; Zhou, RB; Parsons, M; Yang, MT; McLean, MA; Sligar, SG; Chen, CS; Ha, T; Schwartz, MA				Grashoff, Carsten; Hoffman, Brenton D.; Brenner, Michael D.; Zhou, Ruobo; Parsons, Maddy; Yang, Michael T.; McLean, Mark A.; Sligar, Stephen G.; Chen, Christopher S.; Ha, Taekjip; Schwartz, Martin A.			Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics	NATURE			English	Article							CELL-MATRIX ADHESIONS; FORCE; ACTIN; TALIN; MECHANOSENSORS; COMPLEX; SWITCH	Mechanical forces are central to developmental, physiological and pathological processes(1). However, limited understanding of force transmission within sub-cellular structures is a major obstacle to unravelling molecular mechanisms. Here we describe the development of a calibrated biosensor that measures forces across specific proteins in cells with piconewton (pN) sensitivity, as demonstrated by single molecule fluorescence force spectroscopy(2). The method is applied to vinculin, a protein that connects integrins to actin filaments and whose recruitment to focal adhesions (FAs) is force-dependent(3). We show that tension across vinculin in stable FAs is similar to 2.5 pN and that vinculin recruitment to FAs and force transmission across vinculin are regulated separately. Highest tension across vinculin is associated with adhesion assembly and enlargement. Conversely, vinculin is under low force in disassembling or sliding FAs at the trailing edge of migrating cells. Furthermore, vinculin is required for stabilizing adhesions under force. Together, these data reveal that FA stabilization under force requires both vinculin recruitment and force transmission, and that, surprisingly, these processes can be controlled independently.	[Grashoff, Carsten; Hoffman, Brenton D.; Schwartz, Martin A.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Grashoff, Carsten; Hoffman, Brenton D.; Schwartz, Martin A.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Brenner, Michael D.; Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Brenner, Michael D.; Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Brenner, Michael D.; Ha, Taekjip] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Yang, Michael T.; Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [McLean, Mark A.; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Schwartz, Martin A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of London; King's College London; University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	tjha@illinois.edu; maschwartz@virginia.edu	Parsons, Maddy/B-2203-2013; Chen, Christopher S./ABD-8499-2021; Ha, Taekjip/B-9506-2009	Parsons, Maddy/0000-0002-2021-8379; Chen, Christopher S./0000-0003-2445-8449; Ha, Taekjip/0000-0003-2195-6258; Zhou, Ruobo/0000-0001-8628-0282; schwartz, martin/0000-0002-2071-1243; McLean, Mark/0000-0001-9125-293X	USPHS [U54 GM64346, 5T32-HL007284, R21 RR025341]; Deutsche Forschungsgemeinschaft (DFG) [GR3399/1-1]; AHA; US National Science Foundation Physics Frontier Center [0822613]; Royal Society; National Science Foundation [DGE-0221664]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM033775] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); AHA(American Heart Association); US National Science Foundation Physics Frontier Center; Royal Society(Royal Society of London); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Horwitz, M. Vicente-Manzanares, D. Schafer, L.K. Tamm and K.A. DeMali for reagents and M. Gardel for critical reading of the manuscript. This work was supported by USPHS grant U54 GM64346 to M.A.S., C.G. was supported by a Research Fellowship from the Deutsche Forschungsgemeinschaft (DFG, GR3399/1-1). B.D.H. was supported by USPHS training grant 5T32-HL007284 and an AHA Postdoctoral Fellowship. M.D.B., R.Z. and T.H. were supported by the US National Science Foundation Physics Frontier Center grant 0822613 and by USPHS grant R21 RR025341. T.H. is an investigator with the Howard Hughes Medical Institute. M.P. was supported by a Royal Society University Research Fellowship (UK). M.T.Y. was supported by an IGERT fellowship from the National Science Foundation (DGE-0221664).	Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Meng F, 2008, FEBS J, V275, P3072, DOI 10.1111/j.1742-4658.2008.06461.x; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Xu WM, 1998, DEVELOPMENT, V125, P327; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	30	985	1002	10	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					263	U143		10.1038/nature09198	http://dx.doi.org/10.1038/nature09198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613844	Green Accepted			2022-12-24	WOS:000279580800042
J	Yi, X; Liang, Y; Huerta-Sanchez, E; Jin, X; Cuo, ZXP; Pool, JE; Xu, X; Jiang, H; Vinckenbosch, N; Korneliussen, TS; Zheng, HC; Liu, T; He, WM; Li, K; Luo, RB; Nie, XF; Wu, HL; Zhao, MR; Cao, HZ; Zou, J; Shan, Y; Li, SZ; Yang, Q; Asan; Ni, PX; Tian, G; Xu, JM; Liu, XA; Jiang, T; Wu, RH; Zhou, GY; Tang, MF; Qin, JJ; Wang, T; Feng, SJ; Li, GH; Huasang; Luosang, JB; Wang, W; Chen, F; Wang, YD; Zheng, XG; Li, Z; Bianba, ZM; Yang, G; Wang, XP; Tang, SH; Gao, GY; Chen, Y; Luo, Z; Gusang, L; Cao, Z; Zhang, QH; Ouyang, WH; Ren, XL; Liang, HQ; Zheng, HS; Huang, YB; Li, JX; Bolund, L; Kristiansen, K; Li, YR; Zhang, Y; Zhang, XQ; Li, RQ; Li, SG; Yang, HM; Nielsen, R; Wang, J; Wang, JA				Yi, Xin; Liang, Yu; Huerta-Sanchez, Emilia; Jin, Xin; Cuo, Zha Xi Ping; Pool, John E.; Xu, Xun; Jiang, Hui; Vinckenbosch, Nicolas; Korneliussen, Thorfinn Sand; Zheng, Hancheng; Liu, Tao; He, Weiming; Li, Kui; Luo, Ruibang; Nie, Xifang; Wu, Honglong; Zhao, Meiru; Cao, Hongzhi; Zou, Jing; Shan, Ying; Li, Shuzheng; Yang, Qi; Asan; Ni, Peixiang; Tian, Geng; Xu, Junming; Liu, Xiao; Jiang, Tao; Wu, Renhua; Zhou, Guangyu; Tang, Meifang; Qin, Junjie; Wang, Tong; Feng, Shuijian; Li, Guohong; Huasang; Luosang, Jiangbai; Wang, Wei; Chen, Fang; Wang, Yading; Zheng, Xiaoguang; Li, Zhuo; Bianba, Zhuoma; Yang, Ge; Wang, Xinping; Tang, Shuhui; Gao, Guoyi; Chen, Yong; Luo, Zhen; Gusang, Lamu; Cao, Zheng; Zhang, Qinghui; Ouyang, Weihan; Ren, Xiaoli; Liang, Huiqing; Zheng, Huisong; Huang, Yebo; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Li, Yingrui; Zhang, Yong; Zhang, Xiuqing; Li, Ruiqiang; Li, Songgang; Yang, Huanming; Nielsen, Rasmus; Wang, Jun; Wang, Jian			Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude	SCIENCE			English	Article							HEMOGLOBIN LEVELS; POINT MUTATIONS; GENE; TIBETAN; ASSOCIATION; HIF-1-ALPHA; SELECTION; LHASA; LOCI	Residents of the Tibetan Plateau show heritable adaptations to extreme altitude. We sequenced 50 exomes of ethnic Tibetans, encompassing coding sequences of 92% of human genes, with an average coverage of 18x per individual. Genes showing population-specific allele frequency changes, which represent strong candidates for altitude adaptation, were identified. The strongest signal of natural selection came from endothelial Per-Arnt-Sim (PAS) domain protein 1 (EPAS1), a transcription factor involved in response to hypoxia. One single-nucleotide polymorphism (SNP) at EPAS1 shows a 78% frequency difference between Tibetan and Han samples, representing the fastest allele frequency change observed at any human gene to date. This SNP's association with erythrocyte abundance supports the role of EPAS1 in adaptation to hypoxia. Thus, a population genomic survey has revealed a functionally important locus in genetic adaptation to high altitude.	[Yi, Xin; Liang, Yu; Jin, Xin; Xu, Xun; Jiang, Hui; Zheng, Hancheng; Liu, Tao; He, Weiming; Luo, Ruibang; Nie, Xifang; Wu, Honglong; Zhao, Meiru; Cao, Hongzhi; Zou, Jing; Shan, Ying; Li, Shuzheng; Yang, Qi; Asan; Ni, Peixiang; Tian, Geng; Xu, Junming; Liu, Xiao; Jiang, Tao; Wu, Renhua; Zhou, Guangyu; Tang, Meifang; Qin, Junjie; Wang, Tong; Feng, Shuijian; Li, Guohong; Huasang; Luosang, Jiangbai; Wang, Wei; Chen, Fang; Wang, Yading; Zheng, Xiaoguang; Li, Zhuo; Cao, Zheng; Zhang, Qinghui; Ouyang, Weihan; Ren, Xiaoli; Liang, Huiqing; Zheng, Huisong; Huang, Yebo; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Li, Yingrui; Zhang, Yong; Zhang, Xiuqing; Li, Ruiqiang; Li, Songgang; Yang, Huanming; Nielsen, Rasmus; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Yi, Xin; Liang, Yu; Cuo, Zha Xi Ping; Li, Kui; Tian, Geng; Zheng, Xiaoguang] Chinese Acad Sci, Grad Univ, Beijing 100062, Peoples R China; [Huerta-Sanchez, Emilia; Pool, John E.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94820 USA; [Huerta-Sanchez, Emilia; Pool, John E.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94820 USA; [Jin, Xin; Zheng, Hancheng; Luo, Ruibang; Shan, Ying] S China Univ Technol, Innovat Program Undergrad Students, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Cuo, Zha Xi Ping; Li, Kui; Chen, Yong; Luo, Zhen; Gusang, Lamu] Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Pool, John E.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Korneliussen, Thorfinn Sand; Kristiansen, Karsten; Li, Ruiqiang; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [He, Weiming] S China Univ Technol, Sch Sci, Innovat Program Undergrad Students, Guangzhou 510641, Guangdong, Peoples R China; [Wu, Honglong; Cao, Hongzhi; Jiang, Tao] Shenzhen Univ, Genome Res Inst, Sch Med, Shenzhen 518060, Peoples R China; [Bianba, Zhuoma; Yang, Ge] Peoples Hosp Lhasa, Lhasa 850000, Peoples R China; [Wang, Xinping; Tang, Shuhui] Mil Gen Hosp Tibet, Lhasa 850007, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities, Autonomous Jinghong 666100, Yunnan, Peoples R China	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Berkeley; University of California System; University of California Berkeley; South China University of Technology; University of California System; University of California Davis; University of Copenhagen; South China University of Technology; Shenzhen University	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org; wangjian@genomics.org.cn	Nielsen, Rasmus/D-4405-2009; Korneliussen, Thorfinn Sand/F-6421-2014; Liu, Xiao/P-2732-2015; Jin, Xin/ABF-1329-2020; Xu, Xun/AAI-6763-2020; Kristiansen, Karsten/J-5148-2014; wang, jian/GVS-0711-2022; Korneliussen, Thorfinn Sand/ABB-7656-2021; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Nielsen, Rasmus/0000-0003-0513-6591; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Liu, Xiao/0000-0002-8073-0534; Jin, Xin/0000-0001-7554-4975; Xu, Xun/0000-0002-5338-5173; Kristiansen, Karsten/0000-0002-6024-0917; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Wang, Jun/0000-0002-8540-8931; Shan, Ying/0000-0003-3253-3197; Luo, Ruibang/0000-0001-9711-6533; Wang, Jun/0000-0002-2113-5874; Pool, John/0000-0003-2968-9545	National Natural Science Foundation of China [30890032, 30725008]; Ministry of Science and Technology of China [2006AA02A302, 2009AA022707, 2006CB504103]; Shenzhen Municipal Government of China [JC200903190772A, CXB200903110066A, ZYC200903240077A, ZYC200903240076A, ZYC200903240080A]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; Lundbeck Foundation; Swiss National Science Foundation [PBLAP3-124318]; U.S. NIH [R01MHG084695, R01HG003229]; U.S. NSF [DBI-0906065]; Chinese Academy of Sciences [KSCX2-YW-R-76]; Tibet Autonomous Region [2007-2-18]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084695] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. NSF(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences); Tibet Autonomous Region; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the National Natural Science Foundation of China (grants 30890032 and 30725008), the Ministry of Science and Technology of China (863 program, grants 2006AA02A302 and 2009AA022707; 973 program, grant 2006CB504103), the Shenzhen Municipal Government of China (grants JC200903190772A, CXB200903110066A, ZYC200903240077A, ZYC200903240076A, and ZYC200903240080A), the Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), the Danish Strategic Research Council grant (2106-07-0021), the Lundbeck Foundation, the Swiss National Science Foundation (PBLAP3-124318), the U.S. NIH R01MHG084695 and R01HG003229), the U.S. NSF (DBI-0906065), the Chinese Academy of Sciences (KSCX2-YW-R-76), and the Science and Technology Plan of the Tibet Autonomous Region (no. 2007-2-18). We are also indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this teamwork and to X. Wang (South China University of Technology). The data have NCBI Short Read Archive accession no. SRA012603.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bigham Abigail W., 2009, Human Genomics, V4, P79; Choudhury K, 2007, AM J HUM GENET, V80, P664, DOI 10.1086/513475; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; KANNO H, 1992, BLOOD, V79, P1347, DOI 10.1182/blood.V79.5.1347.bloodjournal7951347; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; NIERMEYER S, 1995, NEW ENGL J MED, V333, P1248, DOI 10.1056/NEJM199511093331903; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Rottgardt I, 2010, ANTHROPOL SCI, V118, P41, DOI 10.1537/ase.090402; Shriver Mark D, 2004, Hum Genomics, V1, P274; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Zhang XL, 2005, BLOOD, V106, P75, DOI 10.1182/blood-2004-08-3033; Zhuang JG, 1996, RESP PHYSIOL, V103, P75, DOI 10.1016/0034-5687(95)00041-0	25	979	1059	12	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					75	78		10.1126/science.1190371	http://dx.doi.org/10.1126/science.1190371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595611	Green Accepted			2022-12-24	WOS:000279402700035
J	Shank, EA; Cecconi, C; Dill, JW; Marqusee, S; Bustamante, C				Shank, Elizabeth A.; Cecconi, Ciro; Dill, Jesse W.; Marqusee, Susan; Bustamante, Carlos			The folding cooperativity of a protein is controlled by its chain topology	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; T4 LYSOZYME; SINGLE-MOLECULE; FLUCTUATION THEOREM; CONFORMATIONS; STABILITY; FRAGMENT; DNA	The three-dimensional structures of proteins often show a modular architecture comprised of discrete structural regions or domains. Cooperative communication between these regions is important for catalysis, regulation and efficient folding; lack of coupling has been implicated in the formation of fibrils and other misfolding pathologies(1). How different structural regions of a protein communicate and contribute to a protein's overall energetics and folding, however, is still poorly understood. Here we use a single-molecule optical tweezers approach to induce the selective unfolding of particular regions of T4 lysozyme and monitor the effect on other regions not directly acted on by force. We investigate how the topological organization of a protein (the order of structural elements along the sequence) affects the coupling and folding cooperativity between its domains. To probe the status of the regions not directly subjected to force, we determine the free energy changes during mechanical unfolding using Crooks' fluctuation theorem. We pull on topological variants (circular permutants) and find that the topological organization of the polypeptide chain critically determines the folding cooperativity between domains and thus what parts of the folding/unfolding landscape are explored. We speculate that proteins may have evolved to select certain topologies that increase coupling between regions to avoid areas of the landscape that lead to kinetic trapping and misfolding.	[Shank, Elizabeth A.; Cecconi, Ciro; Marqusee, Susan; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shank, Elizabeth A.; Cecconi, Ciro; Dill, Jesse W.; Marqusee, Susan; Bustamante, Carlos] Univ Calif Berkeley, Inst Quantitat Biosci, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Dill, Jesse W.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Marqusee, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	Marqusee@berkeley.edu; Carlos@alice.berkeley.edu	Cecconi, Ciro/K-5028-2016; Shank, Elizabeth A./AAV-9050-2021	Cecconi, Ciro/0000-0002-6101-2609; Shank, Elizabeth A./0000-0002-4804-1966; Bustamante, Carlos/0000-0002-2970-0073	NIH [GM 32543, GM 50945]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050945, R01GM032543, R29GM050945, R37GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank G. Crooks for assistance in use of Crooks fluctuation analysis, R. Dahlquist and B. Matthews for help in initiating this study, and the entire Bustamante and Marqusee labs for advice and technical help. We would particularly like to thank E. Kwon for her assistance in reagent preparation and data collection. This work was supported in part by NIH grants GM 32543 (C.B.), GM 50945 (S.M.) and a grant from the NSF (S.M.).	ANDERSON DE, 1993, NMR PROTEINS, pCH9; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Bornschlog T, 2008, LANGMUIR, V24, P1338, DOI 10.1021/la7023567; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Cellitti J, 2007, PROTEIN SCI, V16, P842, DOI 10.1110/ps.062628607; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collin D, 2005, NATURE, V437, P231, DOI 10.1038/nature04061; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; ELWELL M, 1975, BIOCHIM BIOPHYS ACTA, V386, P309, DOI 10.1016/0005-2795(75)90273-1; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; Ng Sean P., 2007, V350, P139; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Yang GL, 2000, P NATL ACAD SCI USA, V97, P139, DOI 10.1073/pnas.97.1.139; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	28	172	174	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					637	U134		10.1038/nature09021	http://dx.doi.org/10.1038/nature09021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20495548	Green Accepted			2022-12-24	WOS:000278249000046
J	Bueno, H; Ross, JS; Wang, Y; Chen, J; Vidan, MT; Normand, SLT; Curtis, JP; Drye, EE; Lichtman, JH; Keenan, PS; Kosiborod, M; Krumholz, HM				Bueno, Hector; Ross, Joseph S.; Wang, Yun; Chen, Jersey; Vidan, Maria T.; Normand, Sharon-Lise T.; Curtis, Jeptha P.; Drye, Elizabeth E.; Lichtman, Judith H.; Keenan, Patricia S.; Kosiborod, Mikhail; Krumholz, Harlan M.			Trends in Length of Stay and Short-term Outcomes Among Medicare Patients Hospitalized for Heart Failure, 1993-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							READMISSION RATES; TEMPORAL TRENDS; MORTALITY; SURVIVAL; CARE; PERFORMANCE	Context Whether decreases in the length of stay during the past decade for patients with heart failure (HF) may be associated with changes in outcomes is unknown. Objective To describe the temporal changes in length of stay, discharge disposition, and short-term outcomes among older patients hospitalized for HF. Design, Setting, and Participants An observational study of 6 955 461 Medicare fee-for-service hospitalizations for HF between 1993 and 2006, with a 30-day follow-up. Main Outcome Measures Length of hospital stay, in-patient and 30-day mortality, and 30-day readmission rates. Results Between 1993 and 2006, mean length of stay decreased from 8.81 days (95% confidence interval [CI], 8.79-8.83 days) to 6.33 days (95% CI, 6.32-6.34 days). In-hospital mortality decreased from 8.5% (95% CI, 8.4%-8.6%) in 1993 to 4.3% (95% CI, 4.2%-4.4%) in 2006, whereas 30-day mortality decreased from 12.8% (95% CI, 12.8%-12.9%) to 10.7% (95% CI, 10.7%-10.8%). Discharges to home or under home care service decreased from 74.0% to 66.9% and discharges to skilled nursing facilities increased from 13.0% to 19.9%. Thirty-day readmission rates increased from 17.2% (95% CI, 17.1%-17.3%) to 20.1% (95% CI, 20.0%-20.2%; all P<.001). Consistent with the unadjusted analyses, the 2005-2006 risk-adjusted 30-day mortality risk ratio was 0.92 (95% CI, 0.91-0.93) compared with 1993-1994, and the 30-day readmission risk ratio was 1.11 (95% CI, 1.10-1.11). Conclusion For patients admitted with HF during the past 14 years, reductions in length of stay and in-hospital mortality, less marked reductions in 30-day mortality, and changes in discharge disposition accompanied by increases in 30-day readmission rates were observed. JAMA. 2010; 303(21): 2141-2147	[Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Vidan, Maria T.] Hosp Gen Univ Gregorio Maranon, Serv Geriatr Med, Madrid, Spain; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, HSR&D Res Enhancement Award Program, Bronx, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Wang, Yun; Chen, Jersey; Curtis, Jeptha P.; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sch Publ Hlth, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Lichtman, Judith H.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Chron Dis Epidemiol, New Haven, CT 06510 USA; [Keenan, Patricia S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kosiborod, Mikhail] Univ Missouri, St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO USA; [Kosiborod, Mikhail] Univ Missouri, Dept Med, Kansas City, MO USA	General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sch Publ Hlth, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Bueno, Hector/I-3910-2015; Kosiborod, Mikhail/HDO-1541-2022	Bueno, Hector/0000-0003-0277-7596; Kosiborod, Mikhail/0000-0002-3750-9789; Normand, Sharon-Lise/0000-0001-7027-4769; Ross, Joseph/0000-0002-9218-3320	Centers for Medicare & Medicaid Services, US Department of Health and Human Services [HHSM-500-2005-CO001C]; Centers for Disease Control and Prevention [K01 DP000085-05]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III, Spain [BA08/90010, BA08/90012]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research; American Heart Association; Almirall; Bayer; Bristol-Myers Squibb; Sanofi-Aventis; Astra-Zeneca; Pfizer; Centers for Medicare & Medicaid Services; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [K01DP000085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services, US Department of Health and Human Services; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; American Heart Association(American Heart Association); Almirall(Almirall); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Astra-Zeneca(AstraZeneca); Pfizer(Pfizer); Centers for Medicare & Medicaid Services; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The analyses upon which this publication is based were performed under contract HHSM-500-2005-CO001C, entitled "Utilization and Quality Control Quality Improvement Organization for the State (commonwealth) of Colorado," which was funded by the Centers for Medicare & Medicaid Services, an agency of the US Department of Health and Human Services. This work was also funded by grant K01 DP000085-05 from the Centers for Disease Control and Prevention. Drs Bueno and Vidan were supported in part by grants BA08/90010 and BA08/90012, respectively, from the Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III, Spain, while at the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, where they participated in the development of this study. Dr Ross is supported by grant K08 AG032886 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. Dr Kosiborod is supported by the American Heart Association Career Development Award in Implementation Research.; Dr Bueno reported having received consulting fees from Almirall, Bayer, Bristol-Myers Squibb, and Sanofi-Aventis, and research grants from Astra-Zeneca, Bristol-Myers Squibb, and Pfizer. Drs Wang, Chen, Normand, Curtis, Drye, Keenan, and Krumholz reported that they develop and maintain performance measures under contract with the Centers for Medicare & Medicaid Services. Dr Kosiborod reported serving on the advisory board of Sanofi-Aventis and receiving speaking honoraria from the Vascular Biology Working Group and DiaVed Inc. Dr Krumholz reported chairing a scientific advisory board for United Healthcare. Drs Ross, Vidan, and Lichtman did not report any disclosures.	*AM HOSP ASS, TRENDW CHARTB 2008 T; Baker DW, 2004, ARCH INTERN MED, V164, P538, DOI 10.1001/archinte.164.5.538; Baker DW, 2003, AM HEART J, V146, P258, DOI 10.1016/S0002-8703(02)94784-8; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Feldman DE, 2001, CAN MED ASSOC J, V165, P1033; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]; Haldeman GA, 1999, AM HEART J, V137, P352, DOI 10.1053/hj.1999.v137.95495; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P3611, DOI 10.1001/jama.260.24.3611; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kosiborod M, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.11.019; Krumholz HM, 2008, CIRCULATION, V118, P1885, DOI 10.1161/CIRCULATIONAHA.108.190500; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lee DS, 2004, AM J MED, V116, P581, DOI 10.1016/j.amjmed.2003.11.025; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; McDermontt MM, 1997, AM HEART J, V134, P901, DOI 10.1016/S0002-8703(97)80013-0; *MEDPAC, REP C REF DEL SYST; Polanczyk CA, 2000, ARCH INTERN MED, V160, P325, DOI 10.1001/archinte.160.3.325; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Setoguchi S, 2008, INT J CARDIOL, V125, P172, DOI 10.1016/j.ijcard.2007.10.009; Shimada SL, 2009, MED CARE, V47, P517, DOI 10.1097/MLR.0b013e318195f86e; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0	27	463	475	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2010	303	21					2141	2147		10.1001/jama.2010.748	http://dx.doi.org/10.1001/jama.2010.748			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603BE	20516414	Green Accepted, Bronze			2022-12-24	WOS:000278182100022
J	Pace, P; Mosedale, G; Hodskinson, MR; Rosado, IV; Sivasubramaniam, M; Patel, KJ				Pace, Paul; Mosedale, Georgina; Hodskinson, Michael R.; Rosado, Ivan V.; Sivasubramaniam, Meera; Patel, Ketan J.			Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway	SCIENCE			English	Article							STRAND BREAK REPAIR; PROTEIN; GENE; PROMOTES; RECOMBINATION; FIDELITY; REVEALS	A conserved DNA repair response is defective in the human genetic illness Fanconi anemia (FA). Mutation of some FA genes impairs homologous recombination and error-prone DNA repair, rendering FA cells sensitive to DNA cross-linking agents. We found a genetic interaction between the FA gene FANCC and the nonhomologous end joining (NHEJ) factor Ku70. Disruption of both FANCC and Ku70 suppresses sensitivity to cross-linking agents, diminishes chromosome breaks, and reverses defective homologous recombination. Ku70 binds directly to free DNA ends, committing them to NHEJ repair. We show that purified FANCD2, a downstream effector of the FA pathway, might antagonize Ku70 activity by modifying such DNA substrates. These results reveal a function for the FA pathway in processing DNA ends, thereby diverting double-strand break repair away from abortive NHEJ and toward homologous recombination.	[Pace, Paul; Hodskinson, Michael R.; Rosado, Ivan V.; Sivasubramaniam, Meera; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Mosedale, Georgina] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	MRC Laboratory Molecular Biology; University of Oxford	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	kjp@mrc-lmb.cam.ac.uk	Rosado, Ivan/AAZ-9068-2020; Pace, Paul E/A-3104-2012	Rosado, Ivan/0000-0001-7409-7341; Pace, Paul E/0000-0003-1855-5760	Children's Leukaemia Trust; Leukaemia and Lymphoma Research Fund; FEBS; MRC [MC_U105178811] Funding Source: UKRI; Medical Research Council [MC_U105178811] Funding Source: researchfish	Children's Leukaemia Trust; Leukaemia and Lymphoma Research Fund; FEBS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Takata for the anti-Ku70 antibody and the Ku70 cDNA expression vector; H. Koyama and S. Takeda for Delta Lig4, Delta Ku70, and Delta DNA-PKcs DT40 cell lines; H. Joenje and J. DeWinter for human FANCC cell lines; and W. Niedzwiedz and J. Sale for help with IgM sequence analysis. Supported by the Children's Leukaemia Trust (G. M.), the Leukaemia and Lymphoma Research Fund (M. R. H.), and a FEBS fellowship (I.V.R.).	Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Escarceller M, 1997, SOMAT CELL MOLEC GEN, V23, P401, DOI 10.1007/BF02673750; Escarceller M, 1998, J MOL BIOL, V279, P375, DOI 10.1006/jmbi.1998.1784; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Houghtaling S, 2005, HUM MOL GENET, V14, P3027, DOI 10.1093/hmg/ddi334; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Mazloum N, 2009, MOL CELL, V36, P620, DOI 10.1016/j.molcel.2009.09.033; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhang ZM, 2001, J BIOL CHEM, V276, P38231	18	191	197	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					219	223		10.1126/science.1192277	http://dx.doi.org/10.1126/science.1192277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20538911				2022-12-24	WOS:000279635200050
J	Cazalla, D; Yario, T; Steitz, J				Cazalla, Demian; Yario, Therese; Steitz, Joan			Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNA	SCIENCE			English	Article							SMALL NUCLEAR RNAS; TRANSFORMED T-CELLS; GENES; EXPRESSION; DEGRADATION; MIR-27A	T cells transformed by Herpesvirus saimiri express seven viral U-rich noncoding RNAs of unknown function called HSURs. We noted that conserved sequences in HSURs 1 and 2 constitute potential binding sites for three host-cell microRNAs (miRNAs). Coimmunoprecipitation experiments confirmed that HSURs 1 and 2 interact with the predicted miRNAs in virally transformed T cells. The abundance of one of these miRNAs, miR-27, is dramatically lowered in transformed cells, with consequent effects on the expression of miR-27 target genes. Transient knockdown and ectopic expression of HSUR 1 demonstrate that it directs degradation of mature miR-27 in a sequence-specific and binding-dependent manner. This viral strategy illustrates use of a ncRNA to manipulate host-cell gene expression via the miRNA pathway.	[Cazalla, Demian; Yario, Therese; Steitz, Joan] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, J (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Cazalla, Demian/0000-0002-9076-3655	NIH [CA16038]; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Giraldez for initial bioinformatic searches, R. C. Desrosiers for plasmids and cell lines, R. Jobava for technical assistance, K. Tycowski and K. Riley for critical commentary, and A. Miccinello for editorial assistance. This work was supported by grant CA16038 from the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. J.S. is an investigator at the Howard Hughes Medical Institute.	Albrecht JC, 2000, J VIROL, V74, P1033, DOI 10.1128/JVI.74.2.1033-1037.2000; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; BIESINGER B, 1990, VIROLOGY, V176, P505, DOI 10.1016/0042-6822(90)90020-R; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034; Cook HL, 2004, MOL CELL BIOL, V24, P4522, DOI 10.1128/MCB.24.10.4522-4533.2004; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ensser A, 1999, J VIROL, V73, P10551, DOI 10.1128/JVI.73.12.10551-10555.1999; Ensser A, 2005, ADV CANCER RES, V93, P91, DOI 10.1016/S0065-230X(05)93003-0; Fan XHC, 1997, GENE DEV, V11, P2557, DOI 10.1101/gad.11.19.2557; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE SI, 1988, CELL, V54, P599, DOI 10.1016/S0092-8674(88)80004-7; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; MURTHY SCS, 1989, J VIROL, V63, P3307, DOI 10.1128/JVI.63.8.3307-3314.1989; MYER VE, 1992, P NATL ACAD SCI USA, V89, P1296, DOI 10.1073/pnas.89.4.1296; WASSARMAN DA, 1989, NUCLEIC ACIDS RES, V17, P1258, DOI 10.1093/nar/17.3.1258	24	348	367	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1563	1566		10.1126/science.1187197	http://dx.doi.org/10.1126/science.1187197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558719	Green Accepted			2022-12-24	WOS:000278859200048
J	Baldridge, MT; King, KY; Boles, NC; Weksberg, DC; Goodell, MA				Baldridge, Megan T.; King, Katherine Y.; Boles, Nathan C.; Weksberg, David C.; Goodell, Margaret A.			Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection	NATURE			English	Article							PROGENITOR CELLS; IDENTIFICATION; HOMEOSTASIS; DEFICIENT; ALPHA	Lymphocytes and neutrophils are rapidly depleted by systemic infection(1). Progenitor cells of the haematopoietic system, such as common myeloid progenitors and common lymphoid progenitors, increase the production of immune cells to restore and maintain homeostasis during chronic infection, but the contribution of haematopoietic stem cells (HSCs) to this process is largely unknown(2). Here we show, using an in vivo mouse model of Mycobacterium avium infection, that an increased proportion of long-term repopulating HSCs proliferate during M. avium infection, and that this response requires interferon-gamma (IFN-gamma) but not interferon-alpha (IFN-alpha) signalling. Thus, the haematopoietic response to chronic bacterial infection involves the activation not only of intermediate blood progenitors but of long-term repopulating HSCs as well. IFN-gamma is sufficient to promote long-term repopulating HSC proliferation in vivo; furthermore, HSCs from IFN-gamma-deficient mice have a lower proliferative rate, indicating that baseline IFN-gamma tone regulates HSC activity. These findings implicate IFN-gamma both as a regulator of HSCs during homeostasis and under conditions of infectious stress. Our studies contribute to a deeper understanding of haematological responses in patients with chronic infections such as HIV/AIDS or tuberculosis(3-5).	[Baldridge, Megan T.; Weksberg, David C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [King, Katherine Y.; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Boles, Nathan C.; Goodell, Margaret A.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	goodell@bcm.edu	King, Katherine/AAI-2436-2021; Baldridge, Megan/T-7274-2019	Baldridge, Megan/0000-0002-7030-6131; Goodell, Margaret A./0000-0003-1111-2932; King, Katherine/0000-0002-5093-6005	NIDDK institute of the National Institutes of Health (NIH); Texas Children's Hospital Auxiliary; Simmons Foundation; NHLBI institute of the NIH; NCI institute of the NIH; NIBIB institute of the NIH; NATIONAL CANCER INSTITUTE [P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007, R01HL096360, T32HL092332, K08HL098898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK082107, R01DK058192] Funding Source: NIH RePORTER	NIDDK institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Children's Hospital Auxiliary; Simmons Foundation; NHLBI institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Feng and A. Sher for providing Mycobacterium avium. We also thank D. Levy and C. Schindler for providing us with Stat1 and Ifnar1 knockout mice. We are grateful to G. Challen for providing information about Ifngr1, to Y. Zheng and S. Wu for technical assistance, and to J. Gilbert for critical reading of the manuscript. M. T. B. is supported by the NIDDK institute of the National Institutes of Health (NIH), and K. Y. K. was supported by the Adeline B. Landa Fellowship of the Texas Children's Hospital Auxiliary and the Simmons Foundation Collaborative Research Fund. This work was supported by the NIDDK, NHLBI, NCI and NIBIB institutes of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ezoe S, 2004, CELL CYCLE, V3, P314; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Florido M, 2005, INFECT IMMUN, V73, P3577, DOI 10.1128/IAI.73.6.3577-3586.2005; Hawkins CA, 2006, INTERN MED J, V36, P385, DOI 10.1111/j.1445-5994.2006.01076.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klautau Giselle Burlamaqui, 2005, Braz J Infect Dis, V9, P464, DOI 10.1590/S1413-86702005000600004; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saunders BM, 2002, IMMUNOL CELL BIOL, V80, P544, DOI 10.1046/j.1440-1711.2002.01121.x; Shahbazian LM, 2004, CRIT CARE MED, V32, P1740, DOI 10.1097/01.CCM.0000132900.84627.90; Singh K J, 2001, J Assoc Physicians India, V49, P790; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Sundell I Birgitta, 2006, J Stem Cells, V1, P283; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027	32	579	585	5	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					793	U9		10.1038/nature09135	http://dx.doi.org/10.1038/nature09135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535209	Green Accepted			2022-12-24	WOS:000278551800048
J	Barrett, MA; Brown, JL; Morikawa, MK; Labat, JN; Yoder, AD				Barrett, Meredith A.; Brown, Jason L.; Morikawa, Megan K.; Labat, Jean-Noel; Yoder, Anne D.			CITES Designation for Endangered Rosewood in Madagascar	SCIENCE			English	Editorial Material							FOREST; FRAGMENTATION; CONSERVATION; DIVERSITY		[Barrett, Meredith A.] Duke Univ, Univ Program Ecol, Durham, NC 27708 USA; [Brown, Jason L.; Yoder, Anne D.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Morikawa, Megan K.] Duke Univ, Trinity Coll Arts & Sci, Durham, NC 27708 USA; [Labat, Jean-Noel] Museum Natl Hist Nat, UMR 7205, Dept Systemat & Evolut, F-75005 Paris, France; [Yoder, Anne D.] Duke Univ, Duke Lemur Ctr, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Duke University	Barrett, MA (corresponding author), Duke Univ, Univ Program Ecol, Durham, NC 27708 USA.	meredith.barrett@duke.edu						Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Blundell AG, 2007, ECOL APPL, V17, P323, DOI 10.1890/06-0127; Bohannon J, 2010, SCIENCE, V328, P23, DOI 10.1126/science.328.5974.23; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Cochrane MA, 1998, CONSERV BIOL, V12, P948, DOI 10.1046/j.1523-1739.1998.012005948.x; Favreau B, 2007, MOL ECOL NOTES, V7, P774, DOI 10.1111/j.1471-8286.2007.01692.x; Gillespie TR, 2008, AM J PRIMATOL, V70, P222, DOI 10.1002/ajp.20475; Gillies ACM, 1999, HEREDITY, V83, P722, DOI 10.1038/sj.hdy.6886260; Global Witness and The Environmental Investigation Agency, 2009, INV ILL FELL TRANSP; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; IUCN, 2014, IUCN RED LIST THREAT; Keong CH, 2007, INT FOREST REV, V9, P805, DOI 10.1505/ifor.9.3.805; Labat J-N., 2003, NATURAL HIST MADAGAS, P346; Laurance WF, 2008, SCIENCE, V319, P1184, DOI 10.1126/science.319.5867.1184b; Louppe D., 2008, PLANT RESOURCES TROP, V7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEVILLE K, 2010, EARTH NEGOT B, V21, P1; Patel E. R., 2007, MADAG CONSERV DEV, V2, P11, DOI DOI 10.4314/MCD.V2I1.44124; Rapport DJ, 1999, BIOSCIENCE, V49, P193, DOI 10.2307/1313509; Rasolomampianina R, 2005, MOL ECOL, V14, P4135, DOI 10.1111/j.1365-294X.2005.02730.x; Schuurman D., 2009, Madagascar Conservation and Development, V4, P98; SCHUURMAN D, 2009, TRAFFIC B, V22, P49; WILME L, PRECIOUS TREES PAY O; *WWF, 2009, COMM; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	26	47	47	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1109	1110		10.1126/science.1187740	http://dx.doi.org/10.1126/science.1187740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20508116				2022-12-24	WOS:000278104700026
J	Baker, MG; Thornley, CN; Mills, C; Roberts, S; Perera, S; Peters, J; Kelso, A; Barr, I; Wilson, N				Baker, Michael G.; Thornley, Craig N.; Mills, Clair; Roberts, Sally; Perera, Shanika; Peters, Julia; Kelso, Anne; Barr, Ian; Wilson, Nick			Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							A H1N1 VIRUS; OUTBREAK; INFECTIONS	Objectives To assess the risk of transmission of pandemic A/H1N1 2009 influenza (pandemic A/H1N1) from an infected high school group to other passengers on an airline flight and the effectiveness of screening and follow-up of exposed passengers. Design Retrospective cohort investigation using a questionnaire administered to passengers and laboratory investigation of those with symptoms. Setting Auckland, New Zealand, with national and international follow-up of passengers. Participants Passengers seated in the rear section of a Boeing 747-400 long haul flight that arrived on 25 April 2009, including a group of 24 students and teachers and 97 (out of 102) other passengers in the same section of the plane who agreed to be interviewed. Main outcome measures Laboratory confirmed pandemic A/H1N1 infection in susceptible passengers within 3. 2 days of arrival; sensitivity and specificity of influenza symptoms for confirmed infection; and completeness and timeliness of contact tracing. Results Nine members of the school group were laboratory confirmed cases of pandemic A/H1N1 infection and had symptoms during the flight. Two other passengers developed confirmed pandemic A/H1N1 infection, 12 and 48 hours after the flight. They reported no other potential sources of infection. Their seating was within two rows of infected passengers, implying a risk of infection of about 3.5% for the 57 passengers in those rows. All but one of the confirmed pandemic A/H1N1 infected travellers reported cough, but more complex definitions of influenza cases had relatively low sensitivity. Rigorous follow-up by public health workers located 93% of passengers, but only 52% were contacted within 72 hours of arrival. Conclusions A low but measurable risk of transmission of pandemic A/H1N1 exists during modern commercial air travel. This risk is concentrated close to infected passengers with symptoms. Follow-up and screening of exposed passengers is slow and difficult once they have left the airport.	[Baker, Michael G.; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand; [Thornley, Craig N.; Perera, Shanika; Peters, Julia] Auckland Dist Hlth Board, Auckland Reg Publ Hlth Serv, Auckland 1150, New Zealand; [Mills, Clair] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Roberts, Sally] Auckland Dist Hlth Board, Dept Microbiol, Auckland, New Zealand; [Kelso, Anne; Barr, Ian] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3051, Australia	University of Otago; Auckland District Health Board; University of Auckland; Auckland District Health Board; World Health Organization	Baker, MG (corresponding author), Univ Otago, Dept Publ Hlth, Box 7343, Wellington 6242, New Zealand.	michael.baker@otago.ac.nz		Barr, Ian/0000-0002-7351-418X; Kelso, Anne/0000-0002-3166-3267; Thornley, Craig/0000-0001-9280-6260	Centers for Disease Control and Prevention (USA) [1 U01 CI000445-01]; Australian Government Department of Health and Ageing; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000445] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (USA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This investigation was largely funded by the internal resources of the investigators' employing organisations as part of the public health response to the A/H1N1 pandemic. MGB was partly supported by a grant from the Centers for Disease Control and Prevention (USA) for research on pandemic influenza (1 U01 CI000445-01). The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funding sources had no involvement with the decision to write this paper and submit it for publication.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; BAKER MG, 2009, EUROSURVEILLANCE, V14, pR2; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; KLONTZ KC, 1989, AM J EPIDEMIOL, V129, P341, DOI 10.1093/oxfordjournals.aje.a115137; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Malone JD, 2009, TRAVEL MED INFECT DI, V7, P181, DOI 10.1016/j.tmaid.2009.02.006; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Marsden AG, 2003, MED J AUSTRALIA, V179, P172, DOI 10.5694/j.1326-5377.2003.tb05483.x; McLeod M, 2008, NEW ZEAL MED J, V121, P62; Ministry of Health, 2006, NZ INFL PAND ACT PLA; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wagner BG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-81; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x	22	71	73	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2010	340								c2424	10.1136/bmj.c2424	http://dx.doi.org/10.1136/bmj.c2424			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LX	20495017	hybrid, Green Published			2022-12-24	WOS:000278062100002
J	Strathdee, SA; Hallett, TB; Bobrova, N; Rhodes, T; Booth, R; Abdool, R; Hankins, CA				Strathdee, Steffanie A.; Hallett, Timothy B.; Bobrova, Natalia; Rhodes, Tim; Booth, Robert; Abdool, Reychad; Hankins, Catherine A.			HIV in people who use drugs 1 HIV and risk environment for injecting drug users: the past, present, and future	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HARM REDUCTION PROGRAMS; HEPATITIS-C; SYRINGE EXCHANGE; SOCIAL EPIDEMIOLOGY; GENDER-DIFFERENCES; HIV/AIDS EPIDEMIC; SAN-FRANCISCO; VACCINE TRIAL; PUBLIC-HEALTH	We systematically reviewed reports about determinants of HIV infection in injecting drug users from 2000 to 2009, classifying findings by type of environmental influence. We then modelled changes in risk environments in regions with severe HIV epidemics associated with injecting drug use. Of 94 studies identified, 25 intentionally examined risk environments. Modelling of HIV epidemics showed substantial heterogeneity in the number of HIV infections that are attributed to injecting drug use and unprotected sex. We estimate that, during 2010-15, HIV prevalence could be reduced by 41% in Odessa (Ukraine), 43% in Karachi (Pakistan), and 30% in Nairobi (Kenya) through a 60% reduction of the unmet need of programmes for opioid substitution, needle exchange, and antiretroviral therapy. Mitigation of patient transition to injecting drugs from non-injecting forms could avert a 98% increase in HIV infections in Karachi; whereas elimination of laws prohibiting opioid substitution with concomitant scale-up could prevent 14% of HIV infections in Nairobi. Optimisation of effectiveness and coverage of interventions is crucial for regions with rapidly growing epidemics. Delineation of environmental risk factors provides a crucial insight into HIV prevention. Evidence-informed, rights-based, combination interventions protecting IDUs' access to HIV prevention and treatment could substantially curtail HIV epidemics.	[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England; [Bobrova, Natalia] UCL, London WC1E 6BT, England; [Rhodes, Tim] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England; [Booth, Robert] Univ Colorado Denver, Denver, CO USA; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Geneva, Switzerland	University of California System; University of California San Diego; Imperial College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Cuscó, Xavier Garcia/S-7576-2019; Hallett, Timothy/A-2390-2011; Strathdee, Steffanie A/B-9042-2009; Rhodes, Tim/DNJ-9679-2022	Cuscó, Xavier Garcia/0000-0001-7199-6931; Rhodes, Tim/0000-0003-2400-9838; Hallett, Timothy/0000-0002-9681-0424; Hankins, Catherine/0000-0002-1642-8592; Strathdee, Steffanie/0000-0002-7724-691X	US National Institute on Drug Abuse [DA027772-S1]; US Office of AIDS Research; The Wellcome Trust (UK); US NIH [RO1DA17620]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027772, R01DA017620] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US Office of AIDS Research; The Wellcome Trust (UK)(Wellcome Trust); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This report was funded by the US National Institute on Drug Abuse grant DA027772-S1, the US Office of AIDS Research, and The Wellcome Trust (UK). RB was supported by a US NIH grant (RO1DA17620). We thank Christy Anderson, Richard Armenta, Annick Borquez, Philippe Bourgois, David Celentano, Jessica Cubeta, Penny Coppernoll-Blach, Anna Dovbah, Faran Emmanuel, Samuel R Friedman, Micah Gell-Redman, Eleanor Gouws, Mauro Guarinieri, Peter Hartsock, Brian Houle, Francisco I Bastos, Natalia Kitsenko, Robert Malow, Bradley Mathers, Lisovska Oksana, Jane Marie Ongo'lo, Samiran Panda, Natalia Rehtina, Diana Rossi, Richard Rothenberg, Tatyana Saliuk, Oleg Semeryk, Ani Shakarishvili, Alexandra Thomas, Emily To, Lucas Wiessing, Daniel Wolfe, and Carl Latkin.	Agha A, 2006, J Pak Med Assoc, V56, pS55; Altaf Arshad, 2007, Harm Reduct J, V4, P7, DOI 10.1186/1477-7517-4-7; [Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2000, ACH BAL NAT OP CONTR; Azim T, 2008, SUBST USE MISUSE, V43, P2124, DOI 10.1080/10826080802344583; BALAKIREVA O, 2005, BEHAV MONITORING YOU; BALAKIREVA O, 2006, SITUATIONAL ANAL HIV; BALAKIREVA O, 2007, BEHAV MONITORING INJ; BALAKIREVA O, 2005, BEHAV MONITORING INJ; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; Barrio G, 2007, EPIDEMIOL INFECT, V135, P592, DOI 10.1017/S0950268806007266; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Beyrer C, 2009, AIDS RES HUM RETROV, V25, P853, DOI 10.1089/aid.2008.0206; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Boileau C, 2005, JAIDS-J ACQ IMM DEF, V39, P489, DOI 10.1097/01.qai.0000153424.56379.61; Bokhari A, 2007, INT J STD AIDS, V18, P486, DOI 10.1258/095646207781147201; Booth RE, 2004, JAIDS-J ACQ IMM DEF, V35, P82, DOI 10.1097/00126334-200401010-00012; BOOTH RE, 2010, 16 C INT AIDS SOC VI; Booth RE, 2006, AIDS, V20, P2217, DOI 10.1097/QAD.0b013e328010e019; Booth RE, 2009, ADDICTION, V104, P1864, DOI 10.1111/j.1360-0443.2009.02660.x; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Burris S, 2006, AIDS, V20, P117, DOI 10.1097/01.aids.0000194806.81917.19; BURRIS S, 2009, BLUEPRINT REFORMING; March JC, 2007, ENFERM INFEC MICR CL, V25, P91, DOI 10.1157/13098569; Chitwood DD, 2003, J PSYCHOACTIVE DRUGS, V35, P445, DOI 10.1080/02791072.2003.10400491; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; de la Fuente L, 2006, J EPIDEMIOL COMMUN H, V60, P537, DOI 10.1136/jech.2005.037333; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Des Jarlais DC, 2007, AIDS, V21, P231, DOI 10.1097/QAD.0b013e3280114a15; Dewing S, 2006, DRUG-EDUC PREV POLIC, V13, P121, DOI 10.1080/09687630500480228; Diaz T, 2001, J WOMEN HEALTH GEN-B, V10, P371, DOI 10.1089/152460901750269698; Doherty MC, 2000, AIDS, V14, P717, DOI 10.1097/00002030-200004140-00011; *EHRN, 2009, YOUNG PEOPL INJ DRUG; Emmanuel F, 2008, INT J DRUG POLICY, V19, pS59, DOI 10.1016/j.drugpo.2007.12.012; Emmanuel F, 2009, JAIDS-J ACQ IMM DEF, V51, P85, DOI 10.1097/QAI.0b013e31819906f3; Estebanez P, 2001, EUR J EPIDEMIOL, V17, P573, DOI 10.1023/A:1014563303831; Estebanez PE, 2000, INT J EPIDEMIOL, V29, P734, DOI 10.1093/ije/29.4.734; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; GELMON L, 2009, UNAIDS KENYA HIV PRE; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hacker MA, 2005, SUBST USE MISUSE, V40, P99, DOI 10.1081/JA-200030511; Hankins C, 2002, J ACQ IMMUN DEF SYND, V30, P514, DOI 10.1097/00126334-200208150-00007; HARDING R, 2007, PAIN RELIEVING DRUGS; Hien NT, 2001, J SUBST ABUSE, V13, P45, DOI 10.1016/S0899-3289(01)00059-1; Hu DJ, 2002, J ACQ IMMUN DEF SYND, V30, P240, DOI [10.1097/00042560-200206010-00013, 10.1097/01.QAI.0000014770.35851.44]; ISRAILOV B, 2008, EPIDEMIOL INFECT DIS, V4, P8; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jarlais DCD, 2009, AM J PUBLIC HEALTH, V99, pS445, DOI 10.2105/AJPH.2008.159327; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; KHEIRANDISH P, 2009, J ACQ IMMUN DEF SYND, V53, P273; Khuwaja A. K., 2007, SMJ Singapore Medical Journal, V48, P509; KOSHKINA EA, 2005, NARCOLOGIJA, V5, P16; Kral AH, 2003, AM J EPIDEMIOL, V157, P915, DOI 10.1093/aje/kwg070; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Latkin CA, 2003, SOC SCI MED, V56, P465, DOI 10.1016/S0277-9536(02)00047-3; Liu W, 2006, ADDICTION, V101, P1493, DOI 10.1111/j.1360-0443.2006.01557.x; Lopez-Zetina J, 2001, ADDICTION, V96, P589, DOI 10.1080/09652140020031638; Maas B, 2007, HEALTH PLACE, V13, P432, DOI 10.1016/j.healthplace.2006.05.005; Maslow CB, 2002, AM J PUBLIC HEALTH, V92, P382, DOI 10.2105/AJPH.92.3.382; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mayhew S, 2009, SEX TRANSM INFECT, V85, P31, DOI 10.1136/sti.2008.033670; Mehrabadi A, 2008, WOMEN HEALTH, V48, P235, DOI 10.1080/03630240802463186; Mesquita F, 2001, J ACQ IMMUN DEF SYND, V28, P298, DOI 10.1097/00042560-200111010-00016; Miller CL, 2006, SUBST USE MISUSE, V41, P199, DOI 10.1080/10826080500391795; *MIN HLTH UKR, 2008, NAT REP MON PROGR UN; National AIDS Control Program, 2008, HIV 2 GEN SURV PAK N; Neaigus A, 2008, J URBAN HEALTH, V85, P309, DOI 10.1007/s11524-008-9271-1; Niccolai LM, 2010, AIDS BEHAV, V14, P932, DOI 10.1007/s10461-008-9469-y; O'Connell JM, 2005, JAIDS-J ACQ IMM DEF, V40, P83, DOI 10.1097/01.qai.0000157006.28535.mL; ODEKOGUNDE M, 2003, P 14 INT C RED DRUG; Oelrichs RB, 2000, J VIROL, V74, P1149, DOI 10.1128/JVI.74.3.1149-1157.2000; Ouellet LJ, 2000, J ACQ IMMUN DEF SYND, V25, P443, DOI 10.1097/00126334-200012150-00010; *PAIN POL STUD GRO, 2007, INT NARC CONTR BOARD; Panda S, 2005, JAIDS-J ACQ IMM DEF, V39, P9, DOI 10.1097/01.qai.0000160713.94203.9b; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Parviz S, 2006, INT J INFECT DIS, V10, P364, DOI 10.1016/j.ijid.2005.07.010; Platt L, 2008, JAIDS-J ACQ IMM DEF, V47, P623, DOI 10.1097/QAI.0b013e318165dbf7; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; POHORILA NB, 2008, ANAL REPORT BASED 20; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Reyes JC, 2005, J URBAN HEALTH, V82, P446, DOI 10.1093/jurban/jti073; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 2006, ADDICTION, V101, P252, DOI 10.1111/j.1360-0443.2006.01317.x; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2002, AIDS, V16, pF25, DOI 10.1097/00002030-200209060-00002; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Rothenberg R, 2001, J URBAN HEALTH, V78, P419, DOI 10.1093/jurban/78.3.419; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Salmon AM, 2009, AUST NZ J PUBL HEAL, V33, P280, DOI 10.1111/j.1753-6405.2009.00389.x; Sanchez JL, 2006, DRUG ALCOHOL DEPEN, V82, pS15, DOI 10.1016/S0376-8716(06)80003-7; Santibanez SS, 2006, J URBAN HEALTH, V83, P86, DOI 10.1007/s11524-005-9009-2; Shafer KP, 2002, JAIDS-J ACQ IMM DEF, V31, P422, DOI 10.1097/00126334-200212010-00009; Spittal PM, 2007, INT J CIRCUMPOL HEAL, V66, P226, DOI 10.3402/ijch.v66i3.18259; Spittal PM, 2003, AIDS CARE, V15, P187, DOI 10.1080/0954012031000068335; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Stachowiak JA, 2006, DRUG ALCOHOL DEPEN, V82, pS7, DOI 10.1016/S0376-8716(06)80002-5; Stark K, 2006, EPIDEMIOL INFECT, V134, P814, DOI 10.1017/S0950268805005613; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Suntharasamai P, 2009, ADDICTION, V104, P235, DOI 10.1111/j.1360-0443.2008.02436.x; Tariq Zafar, 2002, International Journal of Drug Policy, V13, P121, DOI 10.1016/S0955-3959(02)00011-7; Tran TMT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-248; Tuan NA, 2007, B WORLD HEALTH ORGAN, V85, P35, DOI 10.2471/BLT.05.026153; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; *UN DRUG CONTR PRO, 2002, PROGR DRUG AB REP PA; *UNODC, 2004, STUD LINK DRUG AB IN; *UNODC, 2009, NAIR OUTR SERV TRUST; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vertefeuille J, 2002, J DRUG ISSUES, V32, P1125, DOI 10.1177/002204260203200408; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Vorobjov S, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-3; Welp EAE, 2002, AIDS, V16, P1279, DOI 10.1097/00002030-200206140-00011; *WHO REG OFF EUR, 2006, SEX TRANSM INF HIV A; *WHO UNAIDS UNICEF, 2009, SCAL PRIOR HIV AIDS; Williams ML, 2009, AIDS EDUC PREV, V21, P474, DOI 10.1521/aeap.2009.21.5.474; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2007, AM J MED, V120, P172, DOI 10.1016/j.amjmed.2006.02.030; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649; *WORLD BANK, 2006, INT HIV AIDS ALL UKR; World Health Organization, 2009, RAP ADV ANT THER HIV; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zamani S, 2005, AIDS, V19, P709, DOI 10.1097/01.aids.0000166094.24069.72; Zamani S, 2006, JAIDS-J ACQ IMM DEF, V42, P342, DOI 10.1097/01.qai.0000219785.81163.67; Zhang L, 2008, TROP MED INT HEALTH, V13, P814, DOI 10.1111/j.1365-3156.2008.02071.x; Zhang YZ, 2007, INT J INFECT DIS, V11, P318, DOI 10.1016/j.ijid.2006.09.001; Zhang Y, 2007, J INFECTION, V54, P285, DOI 10.1016/j.jinf.2006.06.001; 2009, PREVENTION HIV AIDS	140	391	394	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					268	284		10.1016/S0140-6736(10)60743-X	http://dx.doi.org/10.1016/S0140-6736(10)60743-X			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650523	Green Accepted			2022-12-24	WOS:000280457200037
J	Greer, EL; Maures, TJ; Hauswirth, AG; Green, EM; Leeman, DS; Maro, GS; Han, S; Banko, MR; Gozani, O; Brunet, A				Greer, Eric L.; Maures, Travis J.; Hauswirth, Anna G.; Green, Erin M.; Leeman, Dena S.; Maro, Geraldine S.; Han, Shuo; Banko, Max R.; Gozani, Or; Brunet, Anne			Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans	NATURE			English	Article							SYSTEMATIC RNAI SCREEN; SET-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; HISTONE H3; GENE-EXPRESSION; LONGEVITY; METHYLATION; METHYLTRANSFERASE; METABOLISM; COMPONENTS	The plasticity of ageing suggests that longevity may be controlled epigenetically by specific alterations in chromatin state. The link between chromatin and ageing has mostly focused on histone deacetylation by the Sir2 family(1,2), but less is known about the role of other histone modifications in longevity. Histone methylation has a crucial role in development and in maintaining stem cell pluripotency in mammals(3). Regulators of histone methylation have been associated with ageing in worms(4-7) and flies(8), but characterization of their role and mechanism of action has been limited. Here we identify the ASH-2 trithorax complex(9), which trimethylates histone H3 at lysine 4 (H3K4), as a regulator of lifespan in Caenorhabditis elegans in a directed RNA interference (RNAi) screen in fertile worms. Deficiencies in members of the ASH-2 complex-ASH-2 itself, WDR-5 and the H3K4 methyltransferase SET-2-extend worm lifespan. Conversely, the H3K4 demethylase RBR-2 is required for normal lifespan, consistent with the idea that an excess of H3K4 trimethylation-a mark associated with active chromatin is detrimental for longevity. Lifespan extension induced by ASH-2 complex deficiency requires the presence of an intact adult germline and the continuous production of mature eggs. ASH-2 and RBR-2 act in the germline, at least in part, to regulate lifespan and to control a set of genes involved in lifespan determination. These results indicate that the longevity of the soma is regulated by an H3K4 methyltransferase/demethylase complex acting in the C. elegans germline.	[Greer, Eric L.; Maures, Travis J.; Hauswirth, Anna G.; Leeman, Dena S.; Han, Shuo; Banko, Max R.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Greer, Eric L.; Leeman, Dena S.; Gozani, Or; Brunet, Anne] Stanford Univ, Canc Biol Grad Program, Stanford, CA 94305 USA; [Green, Erin M.; Maro, Geraldine S.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Maro, Geraldine S.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Gozani, Or P/I-6157-2013; Green, Erin/J-6098-2019	Greer, Eric/0000-0002-7501-7371; Green, Erin/0000-0003-3923-6726; Gozani, Or/0000-0002-1365-4463; han, shuo/0000-0003-1181-351X	NIH [R01-AG31198, T32-CA009302, ARRA-AG31198, T32-HG000044, F31-AG032837]; NSF; Stanford graduate fellowship; Human Frontier Science Program post-doctoral fellowship; Searle Scholar award; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032837, R56AG031198, R01AG031198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford graduate fellowship(Stanford University); Human Frontier Science Program post-doctoral fellowship(Human Frontier Science Program); Searle Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Fire, K. Helin, S. Kim, K. Shen, T. Stiernagle and the Caenorhabditis Genetics Center, M. W. Tan and A. Villeneuve for gifts of strains, reagents and antibodies. We thank S. Kim, G. Seydoux, C. Slightam and K. Shen for advice on worm transgenesis, and S. Kim, A. Morgan and Y. Kobayashi for help with microarray analysis. We thank A. Fire, S. Kim, G. Seydoux, M. W. Tan and J. Wysocka for discussions. We thank members of the Brunet laboratory, M. Kaeberlein, J. Lieberman, J. Sage and J. Wysocka for critical reading of the manuscript. This work was supported by NIH grant R01-AG31198 to A. B.; E. L. G. was supported by NIH training grant T32-CA009302, an NSF graduate fellowship and by NIH ARRA-AG31198. T. J. M. was supported by NIH grant T32-HG000044. D. S. L. and E. M. G. were supported by NIH training grant T32-CA009302. S. H. was supported by a Stanford graduate fellowship. G. S. M. was supported by a Human Frontier Science Program post-doctoral fellowship. M. R. B. was supported by NIH fellowship F31-AG032837. O.G. was supported by a Searle Scholar award.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Kelly WG, 1997, GENETICS, V146, P227; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; MERRITT C, 2010, WORMBOOK, DOI DOI 10.1895/W0RMBOOK.1.148.1; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Praitis V, 2001, GENETICS, V157, P1217; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu L, 2001, GENETICS, V159, P1019	42	335	392	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					383	U137		10.1038/nature09195	http://dx.doi.org/10.1038/nature09195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20555324	Green Accepted			2022-12-24	WOS:000279867100052
J	Huang, CRL; Schneider, AM; Lu, YQ; Niranjan, T; Shen, PL; Robinson, MA; Steranka, JP; Valle, D; Civin, CI; Wang, T; Wheelan, SJ; Ji, HK; Boeke, JD; Burns, KH				Huang, Cheng Ran Lisa; Schneider, Anna M.; Lu, Yunqi; Niranjan, Tejasvi; Shen, Peilin; Robinson, Matoya A.; Steranka, Jared P.; Valle, David; Civin, Curt I.; Wang, Tao; Wheelan, Sarah J.; Ji, Hongkai; Boeke, Jef D.; Burns, Kathleen H.			Mobile Interspersed Repeats Are Major Structural Variants in the Human Genome	CELL			English	Article							RETROTRANSPOSON INSERTION; L1 RETROTRANSPOSITION; LINE-1; GENE; SEQUENCE; ELEMENTS; DATABASE; FAMILY; IMPACT	Characterizing structural variants in the human genome is of great importance, but a genome wide analysis to detect interspersed repeats has not been done. Thus, the degree to which mobile DNAs contribute to genetic diversity, heritable disease, and oncogenesis remains speculative. We perform transposon insertion profiling by microarray (TIP-chip) to map human L1(Ta) retrotransposons (LINE-1 s) genome-wide. This identified numerous novel human L1(Ta) insertional polymorphisms with highly variant allelic frequencies. We also explored TIP-chip's usefulness to identify candidate alleles associated with different phenotypes in clinical cohorts. Our data suggest that the occurrence of new insertions is twice as high as previously estimated, and that these repeats are under-recognized as sources of human genomic and phenotypic diversity. We have just begun to probe the universe of human L1(Ta) polymorphisms, and as TIP-chip is applied to other insertions such as Alu SINEs, it will expand the catalog of genomic variants even further.	[Huang, Cheng Ran Lisa; Lu, Yunqi; Niranjan, Tejasvi; Steranka, Jared P.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21287 USA; [Huang, Cheng Ran Lisa; Lu, Yunqi; Niranjan, Tejasvi; Robinson, Matoya A.; Steranka, Jared P.; Valle, David; Wang, Tao; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21287 USA; [Schneider, Anna M.; Shen, Peilin; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Civin, Curt I.; Wheelan, Sarah J.; Boeke, Jef D.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Wheelan, Sarah J.; Ji, Hongkai] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21287 USA.	jboeke@jhmi.edu	Burns, Kathleen/A-3360-2011; Niranjan, Tejasvi/ABD-2892-2020	Boeke, Jef/0000-0001-5322-4946; Niranjan, Tejasvi/0000-0002-6458-2017; Burns, Kathleen/0000-0003-1620-3761	NIH [P01-CA16319, RC1 HG005359, K08-CA134746]; Brain Science Institute at Johns Hopkins University School of Medicine; Goldhirsh Foundation; Burroughs Wellcome Foundation; NATIONAL CANCER INSTITUTE [K08CA134746, P01CA016519] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins University School of Medicine; Goldhirsh Foundation; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported in part by NIH grant P01-CA16319, RC1 HG005359 and grants from the Brain Science Institute at Johns Hopkins University School of Medicine and the Goldhirsh Foundation (J.D.B.), and NIH grant K08-CA134746 and a Career Award for Medical Scientists from the Burroughs Wellcome Foundation (K. H. B.). We thank Jon Alder, Joe Costello, Lisa Scheifele, Daniel Yuan, Syntyche Walker, Ed Davis, Kate O'Donnell, Lixin Dai, Wengfeng An, and Christina Schrum for helpful discussions and Audrey Hendley, Naera El-Sharkawy, Lisa Scheifele, and Daniel Yuan for technical assistance. We thank Robert B. Weiss and Kevin M. Flanigan for X-linked dilated cardiomyopathy and Becker muscular dystrophy patient samples; Cindy Skinner, Cassandra Obie, and Abby Adamczyk for assistance in providing X-linked intellectual disability genomic DNA samples; and Pei-Lung Chen, Darci Ferrer, Sarah E. Ritter, and Gary Cutting for familial and twin genomic DNA. Finally, we thank Bang Wong at ClearScience and Cheng Lai Victor Huang for assistance with artwork.	Arnold C, 1991, PCR Methods Appl, V1, P39; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Credille KM, 2009, BRIT J DERMATOL, V161, P265, DOI 10.1111/j.1365-2133.2009.09161.x; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gasior SL, 2007, GENE, V390, P190, DOI 10.1016/j.gene.2006.08.024; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Konkel MK, 2007, GENE, V390, P28, DOI 10.1016/j.gene.2006.07.040; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Martini SR, 2000, DEVELOPMENT, V127, P2663; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morisada N, 2010, PEDIATR NEPHROL, V25, P1343, DOI 10.1007/s00467-010-1445-x; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smit A.F.A, 1996, REPEATMASKER OPEN 3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Ustyugova SV, 2006, GENETICA, V128, P261, DOI 10.1007/s10709-005-5967-2; Van de Water N, 1998, THROMB HAEMOSTASIS, V79, P938; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wheelan SJ, 2006, P NATL ACAD SCI USA, V103, P17632, DOI 10.1073/pnas.0605450103; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Witherspoon DJ, 2006, HUM HERED, V62, P30, DOI 10.1159/000095851; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yajima I, 1999, HUM MOL GENET, V8, P1431, DOI 10.1093/hmg/8.8.1431	54	190	194	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1171	U129		10.1016/j.cell.2010.05.026	http://dx.doi.org/10.1016/j.cell.2010.05.026			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602999	Bronze, Green Accepted			2022-12-24	WOS:000279148100014
J	Guiducci, C; Gong, M; Xu, ZH; Gill, M; Chaussabel, D; Meeker, T; Chan, JH; Wright, T; Punaro, M; Bolland, S; Soumelis, V; Banchereau, J; Coffman, RL; Pascual, V; Barrat, FJ				Guiducci, Cristiana; Gong, Mei; Xu, Zhaohui; Gill, Michelle; Chaussabel, Damien; Meeker, Thea; Chan, Jean H.; Wright, Tracey; Punaro, Marilynn; Bolland, Silvia; Soumelis, Vassili; Banchereau, Jacques; Coffman, Robert L.; Pascual, Virginia; Barrat, Franck J.			TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS; AUTOIMMUNE-DISEASES; I INTERFERON; ERYTHEMATOSUS; RECEPTOR; BLOOD; GENE; MICE; CORTICOSTEROIDS	Glucocorticoids are widely used to treat patients with autoimmune diseases such as systemic lupus erythematosus (SLE)(1,2). However, regimens used to treat many such conditions cannot maintain disease control in the majority of SLE patients and more aggressive approaches such as high-dose methylprednisolone pulse therapy are used to provide transient reductions in disease activity(3,4). The primary anti-inflammatory mechanism of glucocorticoids is thought to be NF-kappa B inhibition(5). Recognition of self nucleic acids by toll-like receptors TLR7 and TLR9 on B cells and plasmacytoid dendritic cells (PDCs) is an important step in the pathogenesis of SLE(6), promoting anti-nuclear antibodies and the production of type I interferon (IFN), both correlated with the severity of disease(1,7). Following their activation by self-nucleic acid-associated immune complexes, PDCs migrate to the tissues(8,9). We demonstrate, in vitro and in vivo, that stimulation of PDCs through TLR7 and 9 can account for the reduced activity of glucocorticoids to inhibit the IFN pathway in SLE patients and in two lupus-prone mouse strains. The triggering of PDCs through TLR7 and 9 by nucleic acid-containing immune complexes or by synthetic ligands activates the NF-kappa B pathway essential for PDC survival. Glucocorticoids do not affect NF-kappa B activation in PDCs, preventing glucocorticoid induction of PDC death and the consequent reduction of systemic IFN-alpha levels. These findings unveil a new role for self nucleic acid recognition by TLRs and indicate that inhibitors of TLR7 and 9 signalling could prove to be effective corticosteroid-sparing drugs.	[Guiducci, Cristiana; Gong, Mei; Meeker, Thea; Chan, Jean H.; Coffman, Robert L.; Barrat, Franck J.] Dynavax Technol Corp, Berkeley, CA 94710 USA; [Xu, Zhaohui; Gill, Michelle; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Wright, Tracey; Punaro, Marilynn; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Wright, Tracey; Punaro, Marilynn] Univ Texas Dallas, SW Med Ctr, Dallas, TX 75235 USA; [Wright, Tracey; Punaro, Marilynn] Childrens Med Ctr, Dallas, TX 75235 USA; [Bolland, Silvia] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Soumelis, Vassili] Inst Curie, Dept Immunol, F-75005 Paris, France	Baylor Scott & White Health; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Barrat, FJ (corresponding author), Dynavax Technol Corp, 2929 7th St,Suite 100, Berkeley, CA 94710 USA.	fbarrat@dynavax.com	Chaussabel, Damien/AAX-1909-2020; Pascual, Virginia/ABD-3099-2020	Chaussabel, Damien/0000-0002-6131-7242; Xu, Zhaohui/0000-0003-0645-1737	NIH [P50-ARO54083-01CORT, U19-AI082715-01]; Alliance for Lupus Research; Mary Kirkland Foundation; SBIR [2R44AI066483-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI066483, ZIAAI000912, U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Mary Kirkland Foundation; SBIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank A. O'Garra, G. Trinchieri, J.-L. Casanova and our colleagues at Dynavax Technologies for their critical reading of the manuscript. We thank S. Noonan and H. Lopez (Murigenics) for invaluable assistance with animal work. This work was supported by NIH grants P50-ARO54083-01CORT, U19-AI082715-01, The Alliance for Lupus Research, The Mary Kirkland Foundation (to V. P.) and SBIR grant 2R44AI066483-02 (to R. L. C.).	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boor P, 2006, AM J TRANSPLANT, V6, P2332, DOI 10.1111/j.1600-6143.2006.01476.x; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Franchin G, 2006, AUTOIMMUN REV, V5, P111, DOI 10.1016/j.autrev.2005.08.003; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Montague J W, 1995, Curr Top Microbiol Immunol, V200, P51; Parker BJ, 2007, LUPUS, V16, P387, DOI 10.1177/0961203307079502; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Shodell M, 2003, LUPUS, V12, P222, DOI 10.1191/0961203303lu362xx; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Tucci M, 2008, ARTHRITIS RHEUM-US, V58, P251, DOI 10.1002/art.23186; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96	30	262	278	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					937	U10		10.1038/nature09102	http://dx.doi.org/10.1038/nature09102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559388	Green Accepted			2022-12-24	WOS:000278804500040
J	Cock, JM; Sterck, L; Rouze, P; Scornet, D; Allen, AE; Amoutzias, G; Anthouard, V; Artiguenave, F; Aury, JM; Badger, JH; Beszteri, B; Billiau, K; Bonnet, E; Bothwell, JH; Bowler, C; Boyen, C; Brownlee, C; Carrano, CJ; Charrier, B; Cho, GY; Coelho, SM; Collen, J; Corre, E; Da Silva, C; Delage, L; Delaroque, N; Dittami, SM; Doulbeau, S; Elias, M; Farnham, G; Gachon, CMM; Gschloessl, B; Heesch, S; Jabbari, K; Jubin, C; Kawai, H; Kimura, K; Kloareg, B; Kupper, FC; Lang, D; Le Bail, A; Leblanc, C; Lerouge, P; Lohr, M; Lopez, PJ; Martens, C; Maumus, F; Michel, G; Miranda-Saavedra, D; Morales, J; Moreau, H; Motomura, T; Nagasato, C; Napoli, CA; Nelson, DR; Nyvall-Collen, P; Peters, AF; Pommier, C; Potin, P; Poulain, J; Quesneville, H; Read, B; Rensing, SA; Ritter, A; Rousvoal, S; Samanta, M; Samson, G; Schroeder, DC; Segurens, B; Strittmatter, M; Tonon, T; Tregear, JW; Valentin, K; von Dassow, P; Yamagishi, T; Van de Peer, Y; Wincker, P				Cock, J. Mark; Sterck, Lieven; Rouze, Pierre; Scornet, Delphine; Allen, Andrew E.; Amoutzias, Grigoris; Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Badger, Jonathan H.; Beszteri, Bank; Billiau, Kenny; Bonnet, Eric; Bothwell, John H.; Bowler, Chris; Boyen, Catherine; Brownlee, Colin; Carrano, Carl J.; Charrier, Benedicte; Cho, Ga Youn; Coelho, Susana M.; Collen, Jonas; Corre, Erwan; Da Silva, Corinne; Delage, Ludovic; Delaroque, Nicolas; Dittami, Simon M.; Doulbeau, Sylvie; Elias, Marek; Farnham, Garry; Gachon, Claire M. M.; Gschloessl, Bernhard; Heesch, Svenja; Jabbari, Kamel; Jubin, Claire; Kawai, Hiroshi; Kimura, Kei; Kloareg, Bernard; Kuepper, Frithjof C.; Lang, Daniel; Le Bail, Aude; Leblanc, Catherine; Lerouge, Patrice; Lohr, Martin; Lopez, Pascal J.; Martens, Cindy; Maumus, Florian; Michel, Gurvan; Miranda-Saavedra, Diego; Morales, Julia; Moreau, Herve; Motomura, Taizo; Nagasato, Chikako; Napoli, Carolyn A.; Nelson, David R.; Nyvall-Collen, Pi; Peters, Akira F.; Pommier, Cyril; Potin, Philippe; Poulain, Julie; Quesneville, Hadi; Read, Betsy; Rensing, Stefan A.; Ritter, Andres; Rousvoal, Sylvie; Samanta, Manoj; Samson, Gaelle; Schroeder, Declan C.; Segurens, Beatrice; Strittmatter, Martina; Tonon, Thierry; Tregear, James W.; Valentin, Klaus; von Dassow, Peter; Yamagishi, Takahiro; Van de Peer, Yves; Wincker, Patrick			The Ectocarpus genome and the independent evolution of multicellularity in brown algae	NATURE			English	Article							RECEPTOR-LIKE KINASES; LAMINARIA-DIGITATA; GENE FAMILY; PHAEOPHYCEAE; SILICULOSUS; PROPAGATION; EUKARYOTES; PATTERNS; BLADES; PLANTS	Brown algae (Phaeophyceae) are complex photosynthetic organisms with a very different evolutionary history to green plants, to which they are only distantly related(1). These seaweeds are the dominant species in rocky coastal ecosystems and they exhibit many interesting adaptations to these, often harsh, environments. Brown algae are also one of only a small number of eukaryotic lineages that have evolved complex multicellularity (Fig. 1). We report the 214 million base pair (Mbp) genome sequence of the filamentous seaweed Ectocarpus siliculosus (Dillwyn) Lyngbye, a model organism for brown algae(2-5), closely related to the kelps(6,7) (Fig. 1). Genome features such as the presence of an extended set of light-harvesting and pigment biosynthesis genes and new metabolic processes such as halide metabolism help explain the ability of this organism to cope with the highly variable tidal environment. The evolution of multicellularity in this lineage is correlated with the presence of a rich array of signal transduction genes. Of particular interest is the presence of a family of receptor kinases, as the independent evolution of related molecules has been linked with the emergence of multicellularity in both the animal and green plant lineages. The Ectocarpus genome sequence represents an important step towards developing this organism as a model species, providing the possibility to combine genomic and genetic(2) approaches to explore these and other(4,5) aspects of brown algal biology further.	[Cock, J. Mark; Scornet, Delphine; Boyen, Catherine; Charrier, Benedicte; Cho, Ga Youn; Coelho, Susana M.; Collen, Jonas; Delage, Ludovic; Dittami, Simon M.; Gschloessl, Bernhard; Heesch, Svenja; Kloareg, Bernard; Le Bail, Aude; Leblanc, Catherine; Michel, Gurvan; Nyvall-Collen, Pi; Peters, Akira F.; Potin, Philippe; Ritter, Andres; Rousvoal, Sylvie; Tonon, Thierry] Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, France; [Cock, J. Mark; Scornet, Delphine; Boyen, Catherine; Charrier, Benedicte; Cho, Ga Youn; Coelho, Susana M.; Collen, Jonas; Delage, Ludovic; Dittami, Simon M.; Gschloessl, Bernhard; Heesch, Svenja; Kloareg, Bernard; Le Bail, Aude; Leblanc, Catherine; Michel, Gurvan; Nyvall-Collen, Pi; Peters, Akira F.; Potin, Philippe; Ritter, Andres; Rousvoal, Sylvie; Tonon, Thierry] CNRS, UMR 7139, Lab Int Associe Dispersal & Adaptat Marine Specie, Stn Biol Roscoff, F-29682 Roscoff, France; [Sterck, Lieven; Rouze, Pierre; Amoutzias, Grigoris; Billiau, Kenny; Bonnet, Eric; Martens, Cindy; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Sterck, Lieven; Rouze, Pierre; Amoutzias, Grigoris; Billiau, Kenny; Bonnet, Eric; Martens, Cindy; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Anthouard, Veronique; Artiguenave, Francois; Aury, Jean-Marc; Da Silva, Corinne; Jabbari, Kamel; Jubin, Claire; Poulain, Julie; Samson, Gaelle; Segurens, Beatrice; Wincker, Patrick] CEA, DSV, Inst Genom, F-91057 Evry, France; [Beszteri, Bank; Valentin, Klaus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Bothwell, John H.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Bothwell, John H.] Queens Univ, Marine Lab, Portaferry BT22 1PF, Co Down, North Ireland; [Bothwell, John H.; Brownlee, Colin; Farnham, Garry; Schroeder, Declan C.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Bowler, Chris; Jabbari, Kamel; Lopez, Pascal J.; Maumus, Florian] Ecole Normale Super, CNRS, UMR8197, Inst Biol, F-75005 Paris, France; [Bowler, Chris] Stn Zool, I-80121 Naples, Italy; [Carrano, Carl J.] San Diego State Univ, San Diego, CA 92182 USA; [Corre, Erwan] Comp & Genom Resource Ctr, FR 2424, Stn Biol Roscoff, F-29682 Roscoff, France; [Delaroque, Nicolas] Fraunhofer Inst Cell Therapy & Immunol IZI, D-04103 Leipzig, Germany; [Doulbeau, Sylvie; Tregear, James W.] IRD, CIRAD Palm Dev Biol Grp, UMR DIAPC 1097, F-34394 Montpellier, France; [Elias, Marek] Charles Univ Prague, Fac Sci, Dept Bot, Prague 1280 12, Czech Republic; [Elias, Marek] Charles Univ Prague, Dept Parasitol, Prague 1280 12, Czech Republic; [Gachon, Claire M. M.; Kuepper, Frithjof C.; Strittmatter, Martina] Scottish Assoc Marine Sci, Dept Microbial & Mol Biol, Scottish Marine Inst, Oban PA37 1QA, Argyll, Scotland; [Kawai, Hiroshi; Yamagishi, Takahiro] Kobe Univ, Res Ctr Inland Seas, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kimura, Kei; Motomura, Taizo; Nagasato, Chikako] Hokkaido Univ, Field Sci Ctr No Biosphere, Muroran Marine Stn, Muroran, Hokkaido 0510003, Japan; [Lang, Daniel; Rensing, Stefan A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Lerouge, Patrice] Univ Rouen, IFRMP 23, Lab Glyco MEV EA 4358, F-76821 Mont St Aignan, France; [Lohr, Martin] Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; [Miranda-Saavedra, Diego] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England; [Morales, Julia] Univ Paris 06, UMR Mer & Sante 7150, Equipe Traduct Cycle Cellulaire & Dev, Stn Biol Roscoff, F-29680 Roscoff, France; [Morales, Julia] CNRS, UMR Mer & Sante 7150, Stn Biol Roscoff, F-29680 Roscoff, France; [Moreau, Herve] Lab Arago, F-66651 Banyuls Sur Mer, France; [Napoli, Carolyn A.] Univ Arizona, Inst Bio5, Tucson, AZ 85719 USA; [Napoli, Carolyn A.] Univ Arizona, Dept Plant Sci, Tucson, AZ 85719 USA; [Nelson, David R.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Pommier, Cyril; Quesneville, Hadi] INRA, Unite Rech Genom Info UR INRA 1164, Ctr Rech Versailles, F-78026 Versailles, France; [Read, Betsy] Cal State Univ, San Marcos, CA 92096 USA; [Ritter, Andres] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [von Dassow, Peter] CNRS, UMR 7144, Stn Biol Roscoff, F-29682 Roscoff, France; [Samanta, Manoj] Systemix Inst, Redmond, WA 98053 USA	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; J. Craig Venter Institute; CEA; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Queens University Belfast; Marine Biological Association United Kingdom; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); California State University System; San Diego State University; UDICE-French Research Universities; Sorbonne Universite; Fraunhofer Gesellschaft; CIRAD; Institut de Recherche pour le Developpement (IRD); Charles University Prague; Charles University Prague; UHI Millennium Institute; Kobe University; Hokkaido University; University of Freiburg; Universite de Rouen Normandie; Johannes Gutenberg University of Mainz; University of Cambridge; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; University of Arizona; University of Tennessee System; University of Tennessee Health Science Center; INRAE; UDICE-French Research Universities; Universite Paris Saclay; California State University System; California State University Monterey Bay; California State University San Marcos; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Cock, JM (corresponding author), Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, Pl Georges Teissier,BP74, F-29682 Roscoff, France.	cock@sb-roscoff.fr	Lohr, Martin/A-1214-2009; Yamagishi, Toshio/E-2384-2013; corre, erwan/O-4669-2019; Beszteri, Bank M/D-1961-2010; amoutzias, Grigoris/O-4565-2019; Van de Peer, Yves/D-4388-2009; Tonon, Thierry/A-3214-2009; Bowler, Chris/AAC-6256-2019; Van de Peer, Yves/AAE-7666-2019; Miranda-Saavedra, Diego/C-2707-2012; Lang, Daniel/C-7238-2008; Gachon, Claire/C-2787-2009; Valentin, Klaus/G-5862-2014; Dittami, Simon/E-8354-2011; Tregear, James/E-6954-2011; Allen, Andrew E/C-4896-2012; Schroeder, Declan C./O-9131-2019; Quesneville, Hadi/AAG-1048-2020; Coelho, Susana/ABH-8166-2020; Sterck, Lieven/A-9439-2016; Elias, Marek/D-6851-2014; Maumus, Florian/O-5426-2016; Nagasato, Chikako/A-3392-2012; MICHEL, Gurvan/B-3490-2008; Lopez, Pascal Jean/A-7427-2011; Aury, Jean-Marc/N-1621-2019; Lopez, Pascal Jean/P-5813-2019; von Dassow, Peter/A-5399-2012; Lang, Daniel/M-5597-2019	Lohr, Martin/0000-0002-4335-9887; Yamagishi, Toshio/0000-0002-8890-1115; corre, erwan/0000-0001-6354-2278; Beszteri, Bank M/0000-0002-6852-1588; amoutzias, Grigoris/0000-0001-5961-964X; Van de Peer, Yves/0000-0003-4327-3730; Tonon, Thierry/0000-0002-1454-6018; Van de Peer, Yves/0000-0003-4327-3730; Lang, Daniel/0000-0002-2166-0716; Valentin, Klaus/0000-0001-7401-9423; Dittami, Simon/0000-0001-7987-7523; Allen, Andrew E/0000-0001-5911-6081; Schroeder, Declan C./0000-0001-5991-2838; Quesneville, Hadi/0000-0003-3001-4908; Sterck, Lieven/0000-0001-7116-4000; Elias, Marek/0000-0003-0066-6542; Maumus, Florian/0000-0001-7325-0527; Aury, Jean-Marc/0000-0003-1718-3010; Lopez, Pascal Jean/0000-0002-9914-4252; Lang, Daniel/0000-0002-2166-0716; Bonnet, Eric/0000-0002-8468-2867; Strittmatter, Martina/0000-0002-1258-9751; Nelson, David/0000-0003-0583-5421; Bothwell, John/0000-0003-2964-5980; Gachon, Claire/0000-0002-3702-7472; Morales, Julia/0000-0003-1632-5419; Bowler, Chris/0000-0003-3835-6187; Peters, Akira/0000-0001-5332-199X; MICHEL, Gurvan/0000-0002-3009-6205; Heesch, Svenja/0000-0002-4531-0921; POTIN, Philippe/0000-0001-7358-6282; Poulain, Julie/0000-0002-8744-3116; von Dassow, Peter/0000-0002-1858-1953; Kuepper, Frithjof/0000-0003-1273-7109; Pommier, Cyril/0000-0002-9040-8733; Cock, J. Mark/0000-0002-2650-0383; Ritter, Andres/0000-0001-7011-6824; Charrier, Benedicte/0000-0001-5721-1640; DA SILVA, Corinne/0000-0002-7618-7831	French GIS 'Institut de la Genomique Marine'; Centre National de Recherche Scientifique; European Union; GIS Europole Mer; Inter-University Network for Fundamental Research [P6/25]; 'Conseil General' of the Finistere department; University Pierre and Marie Curie; NERC [NE/F012578/1, NE/D521522/1, mba010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [REI20579, P18266] Funding Source: researchfish; Natural Environment Research Council [mba010003, NE/D521522/1, NE/F012578/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22370024] Funding Source: KAKEN	French GIS 'Institut de la Genomique Marine'; Centre National de Recherche Scientifique; European Union(European Commission); GIS Europole Mer; Inter-University Network for Fundamental Research; 'Conseil General' of the Finistere department; University Pierre and Marie Curie; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Dieter G. Muller for his help and advice. The project was supported by the French GIS 'Institut de la Genomique Marine', the Centre National de Recherche Scientifique, the European Union network of excellence Marine Genomics Europe, the GIS Europole Mer, the Inter-University Network for Fundamental Research (P6/25, BioMaGNet), the 'Conseil General' of the Finistere department and the University Pierre and Marie Curie.	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x; Cock JM, 2002, CURR OPIN CELL BIOL, V14, P230, DOI 10.1016/S0955-0674(02)00305-8; Coelho SM, 2002, PLANT CELL, V14, P2369, DOI 10.1105/tpc.003285; Coelho SM, 2007, GENE, V406, P152, DOI 10.1016/j.gene.2007.07.025; Colin C, 2003, J BIOL CHEM, V278, P23545, DOI 10.1074/jbc.M300247200; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dixon NM, 2000, PHYCOLOGIA, V39, P258, DOI 10.2216/i0031-8884-39-3-258.1; Goddard H, 2000, P NATL ACAD SCI USA, V97, P1932, DOI 10.1073/pnas.020516397; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Kawai H, 2007, J PHYCOL, V43, P186, DOI 10.1111/j.1529-8817.2006.00308.x; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Muller DG, 2000, BOT MAR, V43, P157, DOI 10.1515/BOT.2000.016; Nakayama Y, 2007, P NATL ACAD SCI USA, V104, P5883, DOI 10.1073/pnas.0609996104; Peters AF, 2004, J PHYCOL, V40, P1079, DOI 10.1111/j.1529-8817.2004.04058.x; Peters AF, 2008, DEVELOPMENT, V135, P1503, DOI 10.1242/dev.016303; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Phillips N, 2008, J PHYCOL, V44, P394, DOI 10.1111/j.1529-8817.2008.00473.x; Rozema J, 2002, J PHOTOCH PHOTOBIO B, V66, P2, DOI 10.1016/S1011-1344(01)00269-X; RUSSELL G, 1983, MAR ECOL PROG SER, V13, P303, DOI 10.3354/meps013303; RUSSELL G, 1983, MAR ECOL PROG SER, V11, P181, DOI 10.3354/meps011181; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	29	598	640	6	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					617	621		10.1038/nature09016	http://dx.doi.org/10.1038/nature09016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520714	Green Published, hybrid			2022-12-24	WOS:000278249000042
J	Sycuro, LK; Pincus, Z; Gutierrez, KD; Biboy, J; Stern, CA; Vollmer, W; Salama, NR				Sycuro, Laura K.; Pincus, Zachary; Gutierrez, Kimberley D.; Biboy, Jacob; Stern, Chelsea A.; Vollmer, Waldemar; Salama, Nina R.			Peptidoglycan Crosslinking Relaxation Promotes Helicobacter pylori's Helical Shape and Stomach Colonization	CELL			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; CELL-SHAPE; CAMPYLOBACTER-PYLORIDIS; BACTERIAL CYTOSKELETON; SPIROPLASMA-CITRI; GENE; MUREIN; WALL; ULTRASTRUCTURE	The mechanisms by which bacterial cells generate helical cell shape and its functional role are poorly understood. Helical shape of the human pathogen Helicobacter pylori may facilitate penetration of the thick gastric mucus where it replicates. We identified four genes required for helical shape: three LytM peptidoglycan endopeptidase homologs (csd1-3) and a ccmA homolog. Surrounding the cytoplasmic membrane of most bacteria, the peptidoglycan (murein) sacculus is a meshwork of glycan strands joined by peptide crosslinks. Intact cells and isolated sacculi from mutants lacking any single csd gene or ccmA formed curved rods and showed increased peptidoglycan crosslinking. Quantitative morphological analyses of multiple-gene deletion mutants revealed each protein uniquely contributes to a shape-generating pathway. This pathway is required for robust colonization of the stomach in spite of normal directional motility. Our findings suggest that the coordinated action of multiple proteins relaxes peptidoglycan crosslinking, enabling helical cell curvature and twist.	[Gutierrez, Kimberley D.; Stern, Chelsea A.; Salama, Nina R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Sycuro, Laura K.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Sycuro, Laura K.; Stern, Chelsea A.; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Pincus, Zachary] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Yale University; Newcastle University - UK	Salama, NR (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	nsalama@fhcrc.org	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Pincus, Zachary/0000-0001-9785-5977; Sycuro, Laura/0000-0002-2011-6305	NIH [AI054423, AI082026]; National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/F001231/1]; European Commission; BBSRC [BB/F001231/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054423, R21AI082026] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI054423 and AI082026 (N.R.S.), a National Science Foundation Graduate Research Fellowship (LK.S.), and grants from the Biotechnology and Biological Sciences Research Council (grant No. BB/F001231/1) and the European Commission (EUR-INTAFAR project) (W.V.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of these funding agencies. We thank J. Fero, C. Tung, G. Cromie, S. Talarico, B. Stoddard, and D. Vollmer for technical assistance and consultation, P. Born for peptidoglycan analysis, R. Burmeister for graphic design, E. Gaynor and S. Miller for strains, and B. Schneider and staff (FHCRC Electron Microscopy Shared Resource), as well as V. Thompson and T. Davies (Newcastle University Electron Microscopy Research Service), for assistance with TEM.	Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Andersen LP, 2009, FEMS IMMUNOL MED MIC, V56, P112, DOI 10.1111/j.1574-695X.2009.00556.x; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Benaissa M, 1996, INFECT IMMUN, V64, P2331, DOI 10.1128/IAI.64.6.2331-2335.1996; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DeLoney CR, 1999, ANTIMICROB AGENTS CH, V43, P2702, DOI 10.1128/AAC.43.11.2702; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; GOODWIN CS, 1985, J MED MICROBIOL, V19, P257, DOI 10.1099/00222615-19-2-257; Hay NA, 1999, J BACTERIOL, V181, P2008, DOI 10.1128/JB.181.7.2008-2016.1999; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Humbert O, 2008, NUCLEIC ACIDS RES, V36, P6893, DOI 10.1093/nar/gkn718; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KOVACH ME, 1994, GENE, V148, P91, DOI 10.1016/0378-1119(94)90239-9; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ragurnani S, 2008, PROTEINS, V72, P1096, DOI 10.1002/prot.22095; Rasband W, 2009, IMAGEJ; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Smeets LC, 2000, J BACTERIOL, V182, P3948, DOI 10.1128/JB.182.14.3948-3954.2000; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Trachtenberg S, 2004, J MOL MICROB BIOTECH, V7, P78, DOI 10.1159/000077872; Trachtenberg S, 2008, J MOL BIOL, V378, P778, DOI 10.1016/j.jmb.2008.02.020; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Varma A, 2004, J BACTERIOL, V186, P6768, DOI 10.1128/JB.186.20.6768-6774.2004; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; Wolgemuth CW, 2006, J MOL MICROB BIOTECH, V11, P221, DOI 10.1159/000094056; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	47	183	186	3	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					822	833		10.1016/j.cell.2010.03.046	http://dx.doi.org/10.1016/j.cell.2010.03.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510929	Bronze, Green Accepted			2022-12-24	WOS:000278132900017
J	Kollman, JM; Polka, JK; Zelter, A; Davis, TN; Agard, DA				Kollman, Justin M.; Polka, Jessica K.; Zelter, Alex; Davis, Trisha N.; Agard, David A.			Microtubule nucleating gamma-TuSC assembles structures with 13-fold microtubule-like symmetry	NATURE			English	Article							TUBULIN RING COMPLEX; ALPHA-BETA-TUBULIN; SPINDLE POLE BODY; ELECTRON-MICROSCOPY; CENTROSOME; TEMPLATE; RECONSTITUTION; LATTICE	Microtubules are nucleated in vivo by gamma-tubulin complexes. The 300-kDa gamma-tubulin small complex (gamma-TuSC), consisting of two molecules of gamma-tubulin and one copy each of the accessory proteins Spc97 and Spc98, is the conserved, essential core of the microtubule nucleating machinery(1,2). In metazoa multiple gamma-TuSCs assemble with other proteins into gamma-tubulin ring complexes (gamma-TuRCs). The structure of gamma-TuRC indicated that it functions as a microtubule template(2-5). Because each gamma-TuSC contains two molecules of gamma-tubulin, it was assumed that the gamma-TuRC-specific proteins are required to organize gamma-TuSCs to match 13-fold microtubule symmetry. Here we show that Saccharomyces cerevisiae gamma-TuSC forms rings even in the absence of other gamma-TuRC components. The yeast adaptor protein Spc110 stabilizes the rings into extended filaments and is required for oligomer formation under physiological buffer conditions. The 8-angstrom cryo-electron microscopic reconstruction of the filament reveals 13 gamma-tubulins per turn, matching microtubule symmetry, with plus ends exposed for interaction with microtubules, implying that one turn of the filament constitutes a microtubule template. The domain structures of Spc97 and Spc98 suggest functions for conserved sequence motifs, with implications for the gamma-TuRC-specific proteins. The gamma-TuSC filaments nucleate microtubules at a low level, and the structure provides a strong hypothesis for how nucleation is regulated, converting this less active form to a potent nucleator.	[Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Keck Adv Microscopy Ctr, San Francisco, CA 94158 USA; [Zelter, Alex; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu	Davis, Trisha/F-8584-2010; Kollman, Justin/F-3012-2012	Davis, Trisha/0000-0003-4797-3152	National Institutes of Health (NIH) through the National Center for Research Resources'; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078790, R01GM031627, R01GM040506] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Braunfeld and A. Avila-Sakar for microscopy assistance; Y. Cheng, E. Muller, M. Moritz and K. Huang for helpful discussions; and B. Carragher, C. Potter and J. Quispe for the use of their electron microscopy facilities and technical assistance with data collection. Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health (NIH) through the National Center for Research Resources' P41 program. This work was supported by the NIH (D. A. A. and T.N.D.) and the Howard Hughes Medical Institute (D. A. A.). J. M. K. was a NIH Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellow.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; BYERS B, 1978, J CELL SCI, V30, P331; Choy RM, 2009, J STRUCT BIOL, V168, P571, DOI 10.1016/j.jsb.2009.08.012; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Erickson HP, 2000, NAT CELL BIOL, V2, pE93, DOI 10.1038/35014084; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quispe J, 2007, MICROSC MICROANAL, V13, P365, DOI 10.1017/S1431927607070791; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	30	174	174	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					879	U114		10.1038/nature09207	http://dx.doi.org/10.1038/nature09207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20631709	Green Accepted			2022-12-24	WOS:000280766100039
J	Li, Z; Jo, J; Jia, JM; Lo, SC; Whitcomb, DJ; Jiao, S; Cho, K; Sheng, M				Li, Zheng; Jo, Jihoon; Jia, Jie-Min; Lo, Shih-Ching; Whitcomb, Daniel J.; Jiao, Song; Cho, Kwangwook; Sheng, Morgan			Caspase-3 Activation via Mitochondria Is Required for Long-Term Depression and AMPA Receptor Internalization	CELL			English	Article							SYNAPTIC PLASTICITY; CELL-DEATH; INDUCED APOPTOSIS; STRUCTURAL BASIS; CLEAVAGE; LTD; INHIBITION; FAMILY; XIAP; HIPPOCAMPUS	NMDA receptor-dependent synaptic modifications, such as long-term potentiation (LTP) and long-term depression (LTD), are essential for brain development and function. LTD occurs mainly by the removal of AMPA receptors from the postsynaptic membrane, but the underlying molecular mechanisms remain unclear. Here, we show that activation of caspase-3 via mitochondria is required for LTD and AMPA receptor internalization in hippocampal neurons. LTD and AMPA receptor internalization are blocked by peptide inhibitors of caspase-3 and -9. In hippocampal slices from caspase-3 knockout mice, LTD is abolished whereas LTP remains normal. LTD is also prevented by overexpression of the anti-apoptotic proteins XIAP or Bcl-xL, and by a mutant Akt1 protein that is resistant to caspase-3 proteolysis. NMDA receptor stimulation that induces LTD transiently activates caspase-3 in dendrites, without causing cell death. These data indicate an unexpected causal link between the molecular mechanisms of apoptosis and LTD.	[Li, Zheng; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Jo, Jihoon; Whitcomb, Daniel J.; Cho, Kwangwook] Univ Bristol, Fac Med & Dent, Henry Wellcome LINE & MRC Ctr Synapt Plast, Bristol BS1 3NY, Avon, England; [Li, Zheng; Jia, Jie-Min; Jiao, Song] NIMH, Unit Synapse Dev & Plast, Gene Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Lo, Shih-Ching; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Massachusetts Institute of Technology (MIT); Northwell Health; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Roche Holding; Genentech	Li, Z (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lizheng2@mail.nih.gov; Kei.Cho@bristol.ac.uk	Jiao, Song/L-2803-2015; Jia, Jie-Min/O-1150-2013; Li, Zheng/I-8016-2014	Jiao, Song/0000-0003-0496-6454; Jia, Jie-Min/0000-0001-8446-3819; Li, Zheng/0000-0002-2978-2531; Lo, Shih-Ching/0000-0002-5187-0730; Whitcomb, Daniel/0000-0003-2703-1643; Cho, Kwangwook/0000-0001-6724-7073	NIH [F32-NS046126]; NIMH; BBSRC; Alzheimer's Research Trust UK; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002882, ZIAMH002881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046126] Funding Source: NIH RePORTER; BBSRC [BB/G003963/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer's Research Trust UK; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Colin S. Duckett and Azad Bonni for plasmid constructs. M. S. was Investigator of the Howard Hughes Medical Institute. Z. L. was a recipient of NIH fellowship (F32-NS046126) and is supported by NIMH Division of Intramural Research Programs. This work is supported by BBSRC (K.C.) Alzheimer's Research Trust UK (K.C.), and the Intramural Program of the NIH, NIMH (Z.L., J.J. and S.J.). M.S. and S.-C.L. are employees of Genentech Inc, a member of the Roche Group.	Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Barry MF, 1996, HIPPOCAMPUS, V6, P3; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chan SL, 1999, J NEUROSCI RES, V57, P315, DOI 10.1002/(SICI)1097-4547(19990801)57:3<315::AID-JNR3>3.3.CO;2-R; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; CHRISTIE BR, 1995, J NEUROPHYSIOL, V74, P1244, DOI 10.1152/jn.1995.74.3.1244; DENNY JB, 1990, BRAIN RES, V534, P317, DOI 10.1016/0006-8993(90)90148-5; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lu CB, 2002, NEUROMOL MED, V1, P69; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pivovarova NB, 2002, J NEUROSCI, V22, P10653; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rokudai S, 2000, J CELL PHYSIOL, V182, P290, DOI 10.1002/(SICI)1097-4652(200002)182:2<290::AID-JCP18>3.0.CO;2-8; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scanziani M, 1996, J PHYSIOLOGY-PARIS, V90, P165, DOI 10.1016/S0928-4257(97)81416-7; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Ye B, 2002, NEUROSCIENCE, V114, P217, DOI 10.1016/S0306-4522(02)00142-2; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan JY, 2006, MOL CELL, V23, P1, DOI 10.1016/j.molcel.2006.06.008; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	56	399	420	3	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					859	871		10.1016/j.cell.2010.03.053	http://dx.doi.org/10.1016/j.cell.2010.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510932	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000278132900020
J	Gao, J; Wang, WY; Mao, YW; Graff, J; Guan, JS; Pan, L; Mak, G; Kim, D; Su, SC; Tsai, LH				Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Graeff, Johannes; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei			A novel pathway regulates memory and plasticity via SIRT1 and miR-134	NATURE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; NEURONAL-ACTIVITY; CIRCADIAN CONTROL; RECOGNITION; HIPPOCAMPUS; EXPRESSION; NEURODEGENERATION; INHIBITION	The NAD-dependent deacetylase Sir2 was initially identified as a mediator of replicative lifespan in budding yeast and was subsequently shown to modulate longevity in worms and flies(1,2). Its mammalian homologue, SIRT1, seems to have evolved complex systemic roles in cardiac function, DNA repair and genomic stability. Recent studies suggest a functional relevance of SIRT1 in normal brain physiology and neurological disorders. However, it is unknown if SIRT1 has a role in higher-order brain functions. We report that SIRT1 modulates synaptic plasticity and memory formation via a microRNA-mediated mechanism. Activation of SIRT1 enhances, whereas its loss-of-function impairs, synaptic plasticity. Surprisingly, these effects were mediated via post-transcriptional regulation of cAMP response binding protein (CREB) expression by a brain-specific microRNA, miR-134. SIRT1 normally functions to limit expression of miR-134 via a repressor complex containing the transcription factor YY1, and unchecked miR-134 expression following SIRT1 deficiency results in the downregulated expression of CREB and brain-derived neurotrophic factor (BDNF), thereby impairing synaptic plasticity. These findings demonstrate a new role for SIRT1 in cognition and a previously unknown microRNA-based mechanism by which SIRT1 regulates these processes. Furthermore, these results describe a separate branch of SIRT1 signalling, in which SIRT1 has a direct role in regulating normal brain function in a manner that is disparate from its cell survival functions, demonstrating its value as a potential therapeutic target for the treatment of central nervous system disorders.	[Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Graeff, Johannes; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gao, Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Graeff, Johannes; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Nanjing University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Pan, Ling/K-9333-2013; wang, wenyuan/F-7218-2011	Pan, Ling/0000-0001-9947-9071; Guan, Ji-Song/0000-0001-5219-0289; Mao, Yingwei/0000-0001-7339-1565; Graff, Johannes/0000-0002-3219-3578; Gao, Jun/0000-0002-5925-537X	NIH [PO1 AG027916]; Simons Foundation; Swiss National Science Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [P01AG027916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Jaenisch and M. Rios for providing BDNF knockout frozen brains, L. Guarente and D. Cohen for providing SIRT1 Delta and SIRT1 knockout mice, Y. Shi for providing the plasmids expressing YY1 and YY1 shRNA, A. Mungenast for manuscript editing, K. Singh and M. Dobbin for critical reading of the manuscript, M. Dobbin for help with Supplementary Fig. 5, X. Ge for help with model illustration, and N. Joseph for help with mouse colony maintenance. This work is partially supported by an NIH grant, PO1 AG027916, to L.-H.T.; W.-Y.W. is supported by a Postdoctoral Fellowship from the Simons Foundation; J.Gr. is supported by a Prospective Researchers Fellowship from the Swiss National Science Foundation; J.Gao is supported by the Howard Hughes Medical Institute. L.-H.T. is an investigator of the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200	30	713	754	6	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1105	U120		10.1038/nature09271	http://dx.doi.org/10.1038/nature09271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20622856	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000281203600040
J	Kerr, E; Arulraj, N; Scott, M; McDowall, M; van Dijke, M; Keir, S; Sandercock, P; Dennis, M				Kerr, Enda; Arulraj, Nolan; Scott, Maggie; McDowall, Mike; van Dijke, Margrethe; Keir, Sarah; Sandercock, Peter; Dennis, Martin			Quality Improvement Report A telephone hotline for transient ischaemic attack and stroke: prospective audit of a model to improve rapid access to specialist stroke care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK	Problem Patients with transient ischaemic attack or stroke benefit from early diagnosis, specialist assessment, and treatment with thrombolysis, and from stroke unit care and secondary prevention. The challenge with such patients is to minimise delays and ensure that treatment is appropriate, and to provide this care with the available resources. Design An ongoing prospective audit of a transient ischaemic attack and stroke clinic (1 January 2005 to 30 September 2009), as part of the Scottish Stroke Care Audit, and a three month targeted audit of immediate telephone access to a specialist stroke consultant (1 February 2009 to 30 April 2009). Setting Stroke and transient ischaemic attack services in Lothian, a region of Scotland with a population of 810 000. Key measures for improvement Delays to assessment at a rapid access transient ischaemic attack and stroke clinic; delays to appropriate treatment. Strategy for change In February 2007 we introduced a 24 hours a day, seven days a week hotline to a consultant, who provided immediate advice on diagnosis, investigation, and emergency treatment for patients with transient ischaemic attack or stroke, and suggested the most appropriate care pathway, which might include an early appointment in a transient ischaemic attack and stroke clinic. Effects of change The introduction of the hotline was associated with an immediate and sustained reduction in delays to assessment (from 13 to three days) and treatment. The proportion of participants taking statins at the time of visiting the clinic increased from 40% before the introduction of the hotline to 60% after the hotline was in place. Also, the hotline contributed to a reduction in the delay from last event to carotid surgery, from 58 days to 21.5 days. A total of 376 calls were received during the three month audit. Of the 273 (88%) referrers who responded to our questionnaire, 257 (94%) were very satisfied with the advice given over the hotline. Lessons learnt Although associated with some disruption to the activities of the consultants, a 24 hours a day, seven days a week telephone hotline to a consultant is a feasible and effective means of reducing delays to specialist assessment and treatment of patients with transient ischaemic attack or stroke.	[Scott, Maggie; Dennis, Martin] Western Gen Hosp, Dept Clin Neurosci, Transient Ischaem Attack Clin, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Transient Ischaem Attack Clin, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk		dennis, martin/0000-0003-1148-8972; Sandercock, Peter/0000-0001-8484-0135				Department of Health, 2007, NAT STROK STRAT; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Henderson GR, 2008, QUAL SAF HEALTH CARE, V17, P301, DOI 10.1136/qshc.2006.020784; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; *NAT AUD OFF, 2005, 452 HC NAT AUD OFF; National Institute for Health and Clinical Excellence, 2008, DIAGN IN MAN AC STRO; *NHS QUAL IMPR SCO, 2004, CLIN STAND STROK SER; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Royal College of Physicians of England and Wales, 2007, NAT SENT STROK AUD 2; *SCOTT STROK CAR A, 2009, 2009 NAT REP STROK S; *STROK FDN NZ INC, 2008, NZ GUID ASS MAN PAT	14	9	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2010	341								c3265	10.1136/bmj.c3265	http://dx.doi.org/10.1136/bmj.c3265			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NY	20601699				2022-12-24	WOS:000279586800001
J	Uemura, T; Lee, SJ; Yasumura, M; Takeuchi, T; Yoshida, T; Ra, M; Taguchi, R; Sakimura, K; Mishina, M				Uemura, Takeshi; Lee, Sung-Jin; Yasumura, Misato; Takeuchi, Tomonori; Yoshida, Tomoyuki; Ra, Moonjin; Taguchi, Ryo; Sakimura, Kenji; Mishina, Masayoshi			Trans-Synaptic Interaction of GluR delta 2 and Neurexin through Cbln1 Mediates Synapse Formation in the Cerebellum	CELL			English	Article							LONG-TERM DEPRESSION; GLUTAMATE-RECEPTOR DELTA-2; PURKINJE-CELLS; ALPHA-NEUREXINS; BETA-NEUREXINS; MUTANT MICE; 2 SUBUNIT; NEUROLIGINS; EXPRESSION; PARALLEL	Elucidation of molecular mechanisms that regulate synapse formation is required for the understanding of neural wiring, higher brain functions, and mental disorders. Despite the wealth of in vitro information, fundamental questions about how glutamatergic synapses are formed in the mammalian brain remain unanswered. Glutamate receptor (GluR) delta 2 is essential for cerebellar synapse formation in vivo. Here, we show that the N-terminal domain (NTD) of GluR delta 2 interacts with presynaptic neurexins (NRXNs) through cerebellin 1 precursor protein (Cbln1). The synaptogenic activity of GluR delta 2 is abolished in cerebellar primary cultures from Cbln1 knockout mice and is restored by recombinant Cbln1. Knockdown of NRXNs in cerebellar granule cells also hinders the synaptogenic activity of GluR delta 2. Both the NTD of GluR delta 2 and the extracellular domain of NRXN1 beta suppressed the synaptogenic activity of Cbln1 in cerebellar primary cultures and in vivo. These results suggest that GluR delta 2 mediates cerebellar synapse formation by interacting with presynaptic NRXNs through Cbln1.	[Uemura, Takeshi; Lee, Sung-Jin; Yasumura, Misato; Takeuchi, Tomonori; Yoshida, Tomoyuki; Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Niigata University	Mishina, M (corresponding author), Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan.	mishina@m.u-tokyo.ac.jp	ra, moonjin/AAK-3816-2021; Takeuchi, Tomonori/P-5988-2016	Takeuchi, Tomonori/0000-0002-9981-4260; Yoshida, Tomoyuki/0000-0002-8476-3798; Yasumura, Misato/0000-0003-1965-4867	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22700392] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank M. Watanabe for antibodies against Cbln1, GluR alpha 1, GluR alpha 2, GluR alpha 2, VGluT1 and calbindin, J. Miyazaki for CAG-cre transgenic mice and pCAGCS, M. Kataoka for pEGFP-VAMP2, and Y. Miwa for pEB6-CAGMCS. We are grateful to H. Sagara, T. Miyazaki, and Y. Mikami for helpful advice on electron microscopy, T. Shimizu and S. Tokuoka for use of Biacore 3000 biosensor, T. Fuse for advice on cerebellar culture, A. Maeda for technical assistance, K. Osaki and R. Natsume for help in knockout mouse generation, and Y. Nakajima for help in preparation of the manuscript.	ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Kurihara H, 1997, J NEUROSCI, V17, P9613; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Mishina M, 2003, INT CONGR SER, V1250, P473, DOI 10.1016/S0531-5131(03)00186-9; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SLEMMON JR, 1984, P NATL ACAD SCI-BIOL, V81, P6866, DOI 10.1073/pnas.81.21.6866; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Takeuchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002297; Tsujita M, 1999, J NEUROSCI, V19, P10318; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	46	333	337	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1068	1079		10.1016/j.cell.2010.04.035	http://dx.doi.org/10.1016/j.cell.2010.04.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20537373	Green Submitted, Bronze			2022-12-24	WOS:000278618800020
J	Ahn, YY; Bagrow, JP; Lehmann, S				Ahn, Yong-Yeol; Bagrow, James P.; Lehmann, Sune			Link communities reveal multiscale complexity in networks	NATURE			English	Article							HIERARCHICAL ORGANIZATION	Networks have become a key approach to understanding systems of interacting objects, unifying the study of diverse phenomena including biological organisms and human society(1-3). One crucial step when studying the structure and dynamics of networks is to identify communities(4,5): groups of related nodes that correspond to functional subunits such as protein complexes(6,7) or social spheres(8-10). Communities in networks often overlap(9,10) such that nodes simultaneously belong to several groups. Meanwhile, many networks are known to possess hierarchical organization, where communities are recursively grouped into a hierarchical structure(11-13). However, the fact that many real networks have communities with pervasive overlap, where each and every node belongs to more than one group, has the consequence that a global hierarchy of nodes cannot capture the relationships between overlapping groups. Here we reinvent communities as groups of links rather than nodes and show that this unorthodox approach successfully reconciles the antagonistic organizing principles of overlapping communities and hierarchy. In contrast to the existing literature, which has entirely focused on grouping nodes, link communities naturally incorporate overlap while revealing hierarchical organization. We find relevant link communities in many networks, including major biological networks such as protein-protein interaction(6,7,14) and metabolic networks(11,15,16), and show that a large social network(10,17,18) contains hierarchically organized community structures spanning inner-city to regional scales while maintaining pervasive overlap. Our results imply that link communities are fundamental building blocks that reveal overlap and hierarchical organization in networks to be two aspects of the same phenomenon.	[Lehmann, Sune] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Ahn, Yong-Yeol; Bagrow, James P.] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Ahn, Yong-Yeol; Bagrow, James P.] Harvard Univ, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Lehmann, Sune] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA	Harvard University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Northeastern University	Lehmann, S (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	sune.lehmann@gmail.com	Ahn, Yong-Yeol/C-6334-2011; Bagrow, James/E-1701-2016	Ahn, Yong-Yeol/0000-0002-4352-4301; Bagrow, James/0000-0002-4614-0792; Lehmann, Sune/0000-0001-6099-2345	James S. McDonnell Foundation; NSF-DDDAS [CNS-0540348]; NSF-ITR [DMR-0426737]; US ONR [N00014-07-C]; NIH [U01 A1070499-01, 111620-2]; DTRA [BRBAA07-J-2-0035]; US ARL [W911NF-09-2-0053]; NKTH NAP [KCKHA005]; Danish Natural Science Research Council;  [NSF-IIS-0513650]	James S. McDonnell Foundation; NSF-DDDAS(National Science Foundation (NSF)); NSF-ITR(National Science Foundation (NSF)); US ONR(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); US ARL; NKTH NAP; Danish Natural Science Research Council(Danish Natural Science Research Council); 	The authors thank A.-L. Barabasi, S. Ahnert, J. Park, D.-S. Lee, P.-J. Kim, N. Blumm, D. Wang, M. A. Yildirim and H. Yu. The authors acknowledge the Center for Complex Network Research, supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; the NSF-DDDAS (CNS-0540348), NSF-ITR (DMR-0426737) and NSF-IIS-0513650 programmes; US ONR Award N00014-07-C; the NIH (U01 A1070499-01/Sub #:111620-2); the DTRA (BRBAA07-J-2-0035); the NS-CTA sponsored by US ARL (W911NF-09-2-0053); and NKTH NAP (KCKHA005). S. L. acknowledges support from the Danish Natural Science Research Council.	Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; EVANS TS, 2009, EDGE PARTITIONS OVER; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	30	1168	1310	14	304	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					761	U11		10.1038/nature09182	http://dx.doi.org/10.1038/nature09182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20562860	Green Submitted			2022-12-24	WOS:000280562500040
J	Hajkova, P; Jeffries, SJ; Lee, C; Miller, N; Jackson, SP; Surani, MA				Hajkova, Petra; Jeffries, Sean J.; Lee, Caroline; Miller, Nigel; Jackson, Stephen P.; Surani, M. Azim			Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway	SCIENCE			English	Article							DNA METHYLATION; MAMMALIAN-CELLS; PATERNAL GENOME; DEMETHYLATION; CHROMATIN; 5-HYDROXYMETHYLCYTOSINE; POLY(ADP-RIBOSYL)ATION; EMBRYOGENESIS; ARABIDOPSIS; DEMETER	Genome-wide active DNA demethylation in primordial germ cells (PGCs), which reprograms the epigenome for totipotency, is linked to changes in nuclear architecture, loss of histone modifications, and widespread histone replacement. Here, we show that DNA demethylation in the mouse PGCs is mechanistically linked to the appearance of single-stranded DNA (ssDNA) breaks and the activation of the base excision repair (BER) pathway, as is the case in the zygote where the paternal pronucleus undergoes active DNA demethylation shortly after fertilization. Whereas BER might be triggered by deamination of a methylcytosine (5mC), cumulative evidence indicates other mechanisms in germ cells. We demonstrate that DNA repair through BER represents a core component of genome-wide DNA demethylation in vivo and provides a mechanistic link to the extensive chromatin remodeling in developing PGCs.	[Hajkova, Petra; Jeffries, Sean J.; Lee, Caroline; Jackson, Stephen P.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; [Miller, Nigel] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Hajkova, Petra] MRC, Ctr Clin Sci, London W12 0NN, England; [Jeffries, Sean J.] Templeman Automat, Somerville, MA 02143 USA; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; University of Cambridge	Hajkova, P (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	petra.hajkova@csc.mrc.ac.uk; a.surani@gurdon.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Surani, Azim/0000-0002-8640-4318; Hajkova, Petra/0000-0003-4145-1468	Wellcome Trust; Cancer Research UK [11224] Funding Source: researchfish; Medical Research Council [G0800784B, MC_U120092689, G0800784] Funding Source: researchfish; MRC [MC_U120092689, G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Galanty, S. Polo, and members of the Surani lab for stimulating discussions. S.J.J. was a NIH-Cambridge Health Science Scholar. This work was funded by grants from the Wellcome Trust to M.A.S.	Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; HOWLETT SK, 1986, ROUX ARCH DEV BIOL, V195, P499, DOI 10.1007/BF00375890; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; RODMAN TC, 1981, J CELL BIOL, V90, P351, DOI 10.1083/jcb.90.2.351; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Svetlova M, 1999, FEBS LETT, V463, P49, DOI 10.1016/S0014-5793(99)01592-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299	29	347	358	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					78	82		10.1126/science.1187945	http://dx.doi.org/10.1126/science.1187945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595612	Green Accepted			2022-12-24	WOS:000279402700036
J	Poliseno, L; Salmena, L; Zhang, JW; Carver, B; Haveman, WJ; Pandolfi, PP				Poliseno, Laura; Salmena, Leonardo; Zhang, Jiangwen; Carver, Brett; Haveman, William J.; Pandolfi, Pier Paolo			A coding-independent function of gene and pseudogene mRNAs regulates tumour biology	NATURE			English	Article							HUMAN GENOME; MICRORNAS; EXPRESSION; CANCER; TRANSFORMATION; AUTOIMMUNITY; RECOGNITION; SIGNATURE; REVEALS; TARGETS	The canonical role of messenger RNA (mRNA) is to deliver protein-coding information to sites of protein synthesis. However, given that microRNAs bind to RNAs, we hypothesized that RNAs could possess a regulatory role that relies on their ability to compete for microRNA binding, independently of their protein-coding function. As a model for the protein-coding-independent role of RNAs, we describe the functional relationship between the mRNAs produced by the PTEN tumour suppressor gene and its pseudogene PTENP1 and the critical consequences of this interaction. We find that PTENP1 is biologically active as it can regulate cellular levels of PTEN and exert a growth-suppressive role. We also show that the PTENP1 locus is selectively lost in human cancer. We extended our analysis to other cancer-related genes that possess pseudogenes, such as oncogenic KRAS. We also demonstrate that the transcripts of protein-coding genes such as PTEN are biologically active. These findings attribute a novel biological role to expressed pseudogenes, as they can regulate coding gene expression, and reveal a non-coding function for mRNAs.	[Poliseno, Laura; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Poliseno, Laura; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Surg, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Chan, Edward K. L./B-5671-2009; Califano, Andrea/F-7239-2012; Zhang, Jiangwen/A-7654-2013; Poliseno, Laura/B-5711-2012	Chan, Edward K. L./0000-0003-3938-9503; Zhang, Jiangwen/0000-0002-2911-8446; Salmena, Leonardo/0000-0003-4023-658X; Poliseno, Laura/0000-0001-6557-955X	Istituto Toscano Tumori; American Italian Cancer Foundation; Human Frontier Science Program; Canadian Institutes of Health Research; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328, R01CA102142] Funding Source: NIH RePORTER	Istituto Toscano Tumori; American Italian Cancer Foundation; Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Pandolfi laboratory members for critical discussions, in particular A. Carracedo for critical input; S. Feng for technical assistance. We thank B. Vogelstein for DICER<SUP>-/-</SUP> cells; T. Yuan for assistance with FACS analysis; A. Tuccoli for assistance with miRNA RT-PCR; I. Osman for support and suggestions. L. P. was supported by fellowships from the Istituto Toscano Tumori and the American Italian Cancer Foundation. L.S. was supported by fellowships from the Human Frontier Science Program and the Canadian Institutes of Health Research. This work was supported by NIH grant R01 CA-82328-09 to P.P.P.	ALIMONTI A, 2010, NATURE GENET; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRISTOW J, 1993, J BIOL CHEM, V268, P12919; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Fujii GH, 1999, ONCOGENE, V18, P1765, DOI 10.1038/sj.onc.1202492; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; JIANG SL, 1995, J IMMUNOL, V154, P825; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee JJ, 2009, J FORAMIN RES, V39, P4, DOI 10.2113/gsjfr.39.1.4; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Plantaz D, 1997, AM J PATHOL, V150, P81; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; van der Wal JE, 2003, J CLIN PATHOL, V56, P26, DOI 10.1136/jcp.56.1.26; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zimonjic DB, 1999, HEPATOLOGY, V29, P1208, DOI 10.1002/hep.510290410	52	1765	1891	5	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1033	U90		10.1038/nature09144	http://dx.doi.org/10.1038/nature09144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577206	Green Accepted			2022-12-24	WOS:000279056900043
J	Frank, F; Sonenberg, N; Nagar, B				Frank, Filipp; Sonenberg, Nahum; Nagar, Bhushan			Structural basis for 5 '-nucleotide base-specific recognition of guide RNA by human AGO2	NATURE			English	Article							MESSENGER-RNA; CRYSTAL-STRUCTURE; ARGONAUTE; MICRORNAS; COMPLEXES; STRAND	MicroRNAs (miRNAs) mediate post-transcriptional gene regulation through association with Argonaute proteins (AGOs)(1). Crystal structures of archaeal and bacterial homologues of AGOs have shown that the MID(middle) domain mediates the interaction with the phosphorylated 5' end of the miRNA guide strand and this interaction is thought to be independent of the identity of the 5' nucleotide in these systems(2,3). However, analysis of the known sequences of eukaryotic miRNAs and co-immunoprecipitation experiments indicate that there is a clear bias for U or A at the 5' position(4-7). Here we report the crystal structure of a MID domain from a eukaryotic AGO protein, human AGO2. The structure, in complex with nucleoside monophosphates (AMP, CMP, GMP, and UMP) mimicking the 5' end of miRNAs, shows that there are specific contacts made between the base of UMP or AMP and a rigid loop in the MID domain. Notably, the structure of the loop discriminates against CMP and GMP and dissociation constants calculated from NMR titration experiments confirm these results, showing that AMP (0.26 mM) and UMP (0.12 mM) bind with up to 30-fold higher affinity than either CMP (3.6 mM) or GMP (3.3 mM). This study provides structural evidence for nucleotide-specific interactions in the MID domain of eukaryotic AGO proteins and explains the observed preference for U or A at the 5' end of miRNAs.	[Frank, Filipp; Sonenberg, Nahum; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Frank, Filipp; Sonenberg, Nahum] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 0B1, Canada; [Frank, Filipp; Nagar, Bhushan] Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Nagar, B (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca		Frank, Filipp/0000-0001-8680-2757	Canada Research Chair; Human Frontiers Science Program [CDA 0018/2006-C/1]; Canadian Institutes of Health Research (CIHR) [MOP-82929]; Boehringer Ingelheim Fonds	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Human Frontiers Science Program(Human Frontier Science Program); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank O. Larsson for help with bioinformatic analysis; J.-F. Trempe, G. Kozlov, S. Azeroual and D. Rodionov for help with X-ray and NMR data collection at the QANUC NMR facility; and K. Gehring and A. Berghuis for sharing resources and critical reading of the manuscript. We also thank M. Fabian, T. Sundermeier and T. Duchaine for comments on the manuscript; W. Filipowicz for discussions; R. Szittner, K. Illes and G. Virgili for technical assistance. B. N. is supported by a Canada Research Chair, a Career Development Award from the Human Frontiers Science Program (CDA 0018/2006-C/1) and an operating grant from the Canadian Institutes of Health Research (CIHR grant MOP-82929). N. S. is funded by a CIHR grant. F. F. is supported by a Boehringer Ingelheim Fonds PhD Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Felice KM, 2009, BIOCHEM J, V422, P329, DOI 10.1042/BJ20090534; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938	30	402	429	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					818	822		10.1038/nature09039	http://dx.doi.org/10.1038/nature09039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20505670	Green Published			2022-12-24	WOS:000278551800053
J	Ou, CY; Poon, VY; Maeder, CI; Watanabe, S; Lehrman, EK; Fu, AKY; Park, M; Fu, WY; Jorgensen, EM; Ip, NY; Shen, K				Ou, Chan-Yen; Poon, Vivian Y.; Maeder, Celine I.; Watanabe, Shigeki; Lehrman, Emily K.; Fu, Amy K. Y.; Park, Mikyoung; Fu, Wing-Yu; Jorgensen, Erik M.; Ip, Nancy Y.; Shen, Kang			Two Cyclin-Dependent Kinase Pathways Are Essential for Polarized Trafficking of Presynaptic Components	CELL			English	Article							AXONAL-TRANSPORT; CDK5; NEURONS; PROTEIN; EXPRESSION; PHOSPHORYLATION; DISRUPTION; MECHANISMS; REGULATOR; PCTAIRE-1	Polarized trafficking of synaptic proteins to axons and dendrites is crucial to neuronal function. Through forward genetic analysis in C. elegans, we identified a cyclin (CYY-1) and a cyclin-dependent Pctaire kinase (PCT-1) necessary for targeting presynaptic components to the axon. Another cyclin-dependent kinase, CDK-5, and its activator p35, act in parallel to and partially redundantly with the CYY-1/PCT-1 pathway. Synaptic vesicles and active zone proteins mostly mislocalize to dendrites in animals defective for both PCT-1 and CDK-5 pathways. Unlike the kinesin-3 motor, unc-104/Kif1a mutant, cyy-1 cdk-5 double mutants have no reduction in anterogradely moving synaptic vesicle precursors (SVPs) as observed by dynamic imaging. Instead, the number of retrogradely moving SVPs is dramatically increased. Furthermore, this mislocalization defect is suppressed by disrupting the retrograde motor, the cytoplasmic dynein complex. Thus, PCT-1 and CDK-5 pathways direct polarized trafficking of presynaptic components by inhibiting dynein-mediated retrograde transport and setting the balance between anterograde and retrograde motors.	[Ou, Chan-Yen; Maeder, Celine I.; Lehrman, Emily K.; Park, Mikyoung; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Poon, Vivian Y.] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA; [Watanabe, Shigeki; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA; [Fu, Amy K. Y.; Fu, Wing-Yu; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Biotechnol Res Inst, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Fu, Amy K. Y.; Fu, Wing-Yu; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu		OU, CHAN-YEN/0000-0002-6627-5088; Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Watanabe, Shigeki/0000-0001-7580-8141	Human Frontier Science Foundation; W.M. Keck Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392, R01NS034307] Funding Source: NIH RePORTER	Human Frontier Science Foundation(Human Frontier Science Program); W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Human Frontier Science Foundation, the W.M. Keck Foundation, and the Howard Hughes Medical Institute. We thank the International C. elegans Gene Knockout Consortium, the National Bioresource Project-Japan, and the Nonet lab for strains. We also thank Y. Wu, M. Margeta, C. Gao, and Y. Fu for technical assistance, and C. Bargmann, L. H. Tsai, and members of the Shen lab for thoughtful comments on the manuscript.	BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Cai Q, 2007, J NEUROSCI, V27, P7284, DOI 10.1523/JNEUROSCI.0731-07.2007; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Graeser R, 2002, J CELL SCI, V115, P3479; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Herskovits AZ, 2006, NEUROBIOL DIS, V23, P398, DOI 10.1016/j.nbd.2006.04.004; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; KIESS M, 1995, ONCOGENE, V10, P159; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Le Boffant F, 1998, EUR J BIOCHEM, V257, P112, DOI 10.1046/j.1432-1327.1998.2570112.x; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Ma S, 2002, J CELL SCI, V115, P1453; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; MIYAJIMA M, 1995, NEUROREPORT, V6, P1130, DOI 10.1097/00001756-199505300-00014; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Ratner N, 1998, J NEUROSCI, V18, P7717; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Smith D, 2003, NEUROSIGNALS, V12, P239, DOI 10.1159/000074626; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; UCHIDA T, 1994, FEBS LETT, V355, P35, DOI 10.1016/0014-5793(94)01163-X; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1986, PHILOS T R SOC LON B, V314, P340; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yamochi T, 2001, BIOCHEM BIOPH RES CO, V286, P1045, DOI 10.1006/bbrc.2001.5493; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yip YP, 2007, J COMP NEUROL, V503, P297, DOI 10.1002/cne.21377; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	49	113	126	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 28	2010	141	5					846	858		10.1016/j.cell.2010.04.011	http://dx.doi.org/10.1016/j.cell.2010.04.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20510931	Bronze, Green Accepted			2022-12-24	WOS:000278132900019
J	May, M; Boulle, A; Phiri, S; Messou, E; Myer, L; Wood, R; Keiser, O; Sterne, JAC; Dabis, F; Egger, M				May, Margaret; Boulle, Andrew; Phiri, Sam; Messou, Eugene; Myer, Landon; Wood, Robin; Keiser, Olivia; Sterne, Jonathan A. C.; Dabis, Francois; Egger, Matthias		IeDEA So Africa W Africa	Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes	LANCET			English	Article							HIV-1-INFECTED PATIENTS; POSITIVE PATIENTS; SURVIVAL; ANEMIA; MORTALITY; ADULTS; SETTINGS; GENDER; MODEL; ERA	Background Prognostic models have been developed for patients infected with HIV-1 who start combination antiretroviral therapy (ART) in high-income countries, but not for patients in sub-Saharan Africa. We developed two prognostic models to estimate the probability of death in patients starting ART in sub-Saharan Africa. Methods We analysed data for adult patients who started ART in four scale-up programmes in Cote d'Ivoire, South Africa, and Malawi from 2004 to 2007. Patients lost to follow-up in the first year were excluded. We used Weibull survival models to construct two prognostic models: one with CD4 cell count, clinical stage, bodyweight, age, and sex (CD4 count model); and one that replaced CD4 cell count with total lymphocyte count and severity of anaemia (total lymphocyte and haemoglobin model), because CD4 cell count is not routinely measured in many African ART programmes. Death from all causes in the first year of ART was the primary outcome. Findings 912 (8.2%) of 11 153 patients died in the first year of ART. 822 patients were lost to follow-up and not included in the main analysis; 10331 patients were analysed. Mortality was strongly associated with high baseline CD4 cell count (>= 200 cells per mu L vs <25; adjusted hazard ratio 0.21, 95% CI 0.17-0.27), WHO clinical stage (stages III-IV vs I-II; 3.45, 2.43-4.90), bodyweight (60 kg vs <45 kg; 0.23, 0.18-0.30), and anaemia status (none vs severe: 0.27, 0.20-0.36). Other independent risk factors for mortality were low total lymphocyte count, advanced age, and male sex. Probability of death at 1 year ranged from 0.9% (95% CI 0.6-1.4) to 52.5% (43.8-61.7) with the CD4 model, and from 0.9% (0.5-1.4) to 59.6% (48.2-71.4) with the total lymphocyte and haemoglobin model. Both models accurately predict early mortality in patients starting ART in sub-Saharan Africa compared with observed data. Interpretation Prognostic models should be used to counsel patients, plan health services, and predict outcomes for patients with HIV-1 infection in sub-Saharan Africa.	[Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [May, Margaret; Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Boulle, Andrew; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Myer, Landon] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Myer, Landon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Phiri, Sam] Lighthouse Trust Kamuzu Cent Hosp, Lilongwe, Malawi; [Messou, Eugene] CEPREF Clin, Abidjan, Cote Ivoire; [Messou, Eugene] Programme PAC CI, Abidjan, Cote Ivoire; [Wood, Robin] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Dabis, Francois] Univ Victor Segalen, ISPED, INSERM, U897, Bordeaux, France	University of Bern; University of Bristol; University of Cape Town; Columbia University; Columbia University; University of Cape Town; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Egger, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch	May, Margaret T/E-8099-2013; Boulle, Andrew/C-1413-2008; DABIS, FRANCOIS/S-9298-2019; Sterne, Jonathan/Z-3106-2019; Wood, Robin/G-8509-2011	May, Margaret T/0000-0002-9733-1003; Boulle, Andrew/0000-0002-7713-8062; DABIS, FRANCOIS/0000-0002-1614-8857; Sterne, Jonathan/0000-0001-8496-6053; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132	National Institute of Allergy And Infectious Diseases (NIAID) [1U01AI069924, 5U01AI069919]; National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); United Kingdom Medical Research Council [G0700820]; French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales [ANRS 12101, ANRS 12138]; Swiss National Science Foundation [32473B-122116]; Office of AIDS Research of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, U01AI069919] Funding Source: NIH RePORTER; Medical Research Council [G0700820, G0100221] Funding Source: researchfish; MRC [G0700820, G0100221] Funding Source: UKRI	National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales(ANRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Office of AIDS Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all patients, doctors, and study nurses associated with the four cohort studies. The International epidemiologic Databases to Evaluate AIDS (IeDEA) is supported by the National Institute of Allergy And Infectious Diseases (NIAID) (grant 1U01AI069924 to the Southern African Region and 5U01AI069919 to the West African Region), the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). MM and JACS were supported by the United Kingdom Medical Research Council (grant G0700820), FD was supported by the French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (grants ANRS 12101 and 12138) and ME was supported by the Swiss National Science Foundation (grant 32473B-122116) and the Office of AIDS Research of the National Institutes of Health.	Beadles WI, 2009, TROP DOCT, V39, P78, DOI 10.1258/td.2008.080213; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Harris RJ, 2008, ANTIVIR THER, V13, P959; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Lau B, 2005, JAIDS-J ACQ IMM DEF, V39, P620; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mwamburi DM, 2005, CLIN INFECT DIS, V40, P167, DOI 10.1086/426591; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, 2004, SCAL ANT THER RES LT	34	179	179	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					449	457		10.1016/S0140-6736(10)60666-6	http://dx.doi.org/10.1016/S0140-6736(10)60666-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20638120	Green Accepted			2022-12-24	WOS:000281012900030
J	Perkins, EA; Moran, JA				Perkins, Elizabeth A.; Moran, Julie A.			Aging Adults With Intellectual Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE ACCESS; DISPARITIES		[Perkins, Elizabeth A.] Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Florida Ctr Inclus Communities UCEDD, Tampa, FL 33612 USA; [Moran, Julie A.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA	State University System of Florida; University of South Florida; Harvard University; Beth Israel Deaconess Medical Center	Perkins, EA (corresponding author), Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Florida Ctr Inclus Communities UCEDD, 13301 Bruce B Downs Blvd,MHC 2113A, Tampa, FL 33612 USA.	eperkins@mail.usf.edu			PHS HHS [K01-HP00007-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bittles AH, 2002, J GERONTOL A-BIOL, V57, pM470, DOI 10.1093/gerona/57.7.M470; Haveman M, 2010, J POLICY PRACT INTEL, V7, P59, DOI 10.1111/j.1741-1130.2010.00248.x; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Janicki MP, 2008, DISABIL HEALTH J, V1, P116, DOI 10.1016/j.dhjo.2008.02.004; Janicki MP, 1999, DISABIL REHABIL, V21, P284; Krahn GL, 2006, MENT RETARD DEV D R, V12, P70, DOI 10.1002/mrdd.20098; Krahn GL, 2007, MENT RETARD DEV D R, V13, P160, DOI 10.1002/mrdd.20149; U.S Department of Health and Human Services, 2005, SURG GEN CALL ACT IM; *US BUR CENS, TABL 2A PROJ POP US; US Public Health Service, 2002, CLOS GAP NAT BLUEPR	10	64	66	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					91	92		10.1001/jama.2010.906	http://dx.doi.org/10.1001/jama.2010.906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620SJ	20606156				2022-12-24	WOS:000279519600028
J	Behrends, C; Sowa, ME; Gygi, SP; Harper, JW				Behrends, Christian; Sowa, Mathew E.; Gygi, Steven P.; Harper, J. Wade			Network organization of the human autophagy system	NATURE			English	Article							PROTEIN; UBIQUITIN; ACCUMULATION; COMPLEXES; RUBICON; ATG14L; LC3	Autophagy, the process by which proteins and organelles are sequestered in autophagosomal vesicles and delivered to the lysosome/vacuole for degradation, provides a primary route for turnover of stable and defective cellular proteins. Defects in this system are linked with numerous human diseases. Although conserved protein kinase, lipid kinase and ubiquitin-like protein conjugation subnetworks controlling autophagosome formation and cargo recruitment have been defined, our understanding of the global organization of this system is limited. Here we report a proteomic analysis of the autophagy interaction network in human cells under conditions of ongoing (basal) autophagy, revealing a network of 751 interactions among 409 candidate interacting proteins with extensive connectivity among subnetworks. Many new autophagy interaction network components have roles in vesicle trafficking, protein or lipid phosphorylation and protein ubiquitination, and affect autophagosome number or flux when depleted by RNA interference. The six ATG8 orthologues in humans (MAP1LC3/GABARAP proteins) interact with a cohort of 67 proteins, with extensive binding partner overlap between family members, and frequent involvement of a conserved surface on ATG8 proteins known to interact with LC3-interacting regions in partner proteins. These studies provide a global view of the mammalian autophagy interaction landscape and a resource for mechanistic analysis of this critical protein homeostasis pathway.	[Behrends, Christian; Sowa, Mathew E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Behrends, Christian/AAX-4201-2021	Behrends, Christian/0000-0002-9184-7607; Harper, Jeffrey/0000-0002-6944-7236	Millennium Pharmaceuticals; National Institutes of Health; Paul F. Glenn Foundation on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137, R01GM070565, R01GM095567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Dikic for discussions and for sharing unpublished data, D. Bowman and J. Ringeling for assistance with Acapela software, N. Perrimon, S. Mohr and M. Ocana for access to the Opera microscope, and N. Gray for Torin1. This work was supported by grants to J. W. H. from Millennium Pharmaceuticals, the National Institutes of Health, and the Paul F. Glenn Foundation on Aging. C. B. is a Humboldt Postdoctoral Fellow.	Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; KARNITZ LM, 2007, SCI STKE, pPE22; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lippai M, 2008, AUTOPHAGY, V4, P476, DOI 10.4161/auto.5719; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	38	1120	1171	10	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					68	U84		10.1038/nature09204	http://dx.doi.org/10.1038/nature09204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20562859	Green Accepted			2022-12-24	WOS:000279343800036
J	Seppala, S; Slusky, JS; Lloris-Garcera, P; Rapp, M; von Heijne, G				Seppala, Susanna; Slusky, Joanna S.; Lloris-Garcera, Pilar; Rapp, Mikaela; von Heijne, Gunnar			Control of Membrane Protein Topology by a Single C-Terminal Residue	SCIENCE			English	Article							POSITIVELY CHARGED RESIDUES; MULTIDRUG TRANSPORTER EMRE; EVOLUTION; MODEL	The mechanism by which multispanning helix-bundle membrane proteins are inserted into their target membrane remains unclear. In both prokaryotic and eukaryotic cells, membrane proteins are inserted cotranslationally into the lipid bilayer. Positively charged residues flanking the transmembrane helices are important topological determinants, but it is not known whether they act strictly locally, affecting only the nearest transmembrane helices, or can act globally, affecting the topology of the entire protein. Here we found that the topology of an Escherichia coli inner membrane protein with four or five transmembrane helices could be controlled by a single positively charged residue placed in different locations throughout the protein, including the very C terminus. This observation points to an unanticipated plasticity in membrane protein insertion mechanisms.	[Seppala, Susanna; Slusky, Joanna S.; Lloris-Garcera, Pilar; Rapp, Mikaela; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Solna, Sweden	Stockholm University; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Rapp, Mikaela/0000-0002-4401-9518; Seppala, Susanna/0000-0002-2983-3669; Slusky, Joanna/0000-0003-0842-6340	European Research Council [ERC-2008-AdG 232648]; Swedish Cancer Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; International Human Frontier Science Program Organization; European Communities [TranSys PITN-2008-215524]	European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); International Human Frontier Science Program Organization(Human Frontier Science Program); European Communities(European Commission)	We thank Ann-Louise Johansson for technical assistance. This work was supported by grants to G. v. H. from the European Research Council (ERC-2008-AdG 232648), the Swedish Cancer Foundation, the Swedish Research Council, and the Swedish Foundation for Strategic Research, to J.S.S. from the International Human Frontier Science Program Organization, and to P. L. G. from the European Communities (TranSys PITN-2008-215524).	Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Monne M, 1999, EUR J BIOCHEM, V263, P264, DOI 10.1046/j.1432-1327.1999.00498.x; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200	18	111	114	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1698	1700		10.1126/science.1188950	http://dx.doi.org/10.1126/science.1188950			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20508091				2022-12-24	WOS:000279107400044
J	Osi, A; Butler, RJ; Weishampel, DB				Osi, Attila; Butler, Richard J.; Weishampel, David B.			A Late Cretaceous ceratopsian dinosaur from Europe with Asian affinities	NATURE			English	Article							NEOCERATOPSIAN DINOSAUR; EARLY EVOLUTION; REMAINS; HUNGARY; CHINA	Ceratopsians (horned dinosaurs) represent a highly diverse and abundant radiation of non-avian dinosaurs(1-5) known primarily from the Cretaceous period (65-145 million years ago). This radiation has been considered to be geographically limited to Asia and western North America(1-3), with only controversial remains reported from other continents. Here we describe new ceratopsian cranial material from the Late Cretaceous of Iharkut, Hungary(6), from a coronosaurian ceratopsian, Ajkaceratops kozmai. Ajkaceratops is most similar to 'bagaceratopsids' such as Bagaceratops and Magnirostris, previously known only from Late Cretaceous east Asia(3,5,7,8). The new material unambiguously demonstrates that ceratopsians occupied Late Cretaceous Europe and, when considered with the recent discovery of possible leptoceratopsid teeth from Sweden(9), indicates that the clade may have reached Europe on at least two independent occasions. European Late Cretaceous dinosaur faunas have been characterized as consisting of a mix of endemic 'relictual' taxa and 'Gondwanan' taxa, with typical Asian and North American groups largely absent(10,11). Ajkaceratops demonstrates that this prevailing biogeographical hypothesis is overly simplified and requires reassessment. Iharkut was part of the western Tethyan archipelago, a tectonically complex series of island chains between Africa and Europe(12), and the occurrence of a coronosaurian ceratopsian in this locality may represent an early Late Cretaceous 'island-hopping' dispersal across the Tethys Ocean.	[Osi, Attila] Hungarian Acad Sci, Res Grp Paleontol, Hungarian Nat Hist Museum, H-1083 Budapest, Hungary; [Butler, Richard J.] Bayer Staatssammlung Palaontol & Geol, D-80333 Munich, Germany; [Weishampel, David B.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD 21205 USA	Hungarian Academy of Sciences; Johns Hopkins University	Osi, A (corresponding author), Hungarian Acad Sci, Res Grp Paleontol, Hungarian Nat Hist Museum, Ludovika Ter 2, H-1083 Budapest, Hungary.	hungaros@freemail.hu	Ősi, Attila/K-2414-2018; Butler, Richard J./A-5239-2011	Ősi, Attila/0000-0003-2967-997X; Butler, Richard J./0000-0003-2136-7541	Hungarian Scientific Research Fund (OTKA) [PD 73021]; Hantken Foundation; Humboldt Postdoctoral Fellowship	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hantken Foundation; Humboldt Postdoctoral Fellowship	We thank L. Kocsis, P. Barrett, D. Norman, P. Dodson, J. Kirkland, P. Makovicky, S. Sampson, P. Godefroit, Z. Csiki, J. Palfy and R. Sissons for discussion, R. Blakey for the use of the palaeogeographical reconstruction, P. Gulyas for preparation, J. Kirkland for unpublished data and U. Gohlich for logistical support. Research was supported by the Hungarian Scientific Research Fund (OTKA PD 73021) and the Hantken Foundation (A.O.), and a Humboldt Postdoctoral Fellowship (R.J.B.). This is MTA-MTM Paleo contribution 109.	BENTON MJ, PALAEOGEOGR IN PRESS; Bonaparte Jose F., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P73; Csontos L, 2004, PALAEOGEOGR PALAEOCL, V210, P1, DOI 10.1016/j.palaeo.2004.02.033; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Godefroit P, 2007, BULL INST R SC N B-S, V77, P83; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P627; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Kirkland James I., 2007, P90; KIRKLAND JI, NEW PERSPEC IN PRESS; Knauer J, 1992, PALYNOSTRATIGRAPHIC, P463; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; Lindgren J, 2007, PALAEONTOLOGY, V50, P929, DOI 10.1111/j.1475-4983.2007.00690.x; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; Osi A, 2005, J VERTEBR PALEONTOL, V25, P370, DOI 10.1671/0272-4634(2005)025[0370:HTANAD]2.0.CO;2; Osi A, 2004, GEOBIOS-LYON, V37, P749, DOI 10.1016/j.geobios.2003.06.005; Pereda-Suberbiola X, 2009, CR PALEVOL, V8, P559, DOI 10.1016/j.crpv.2009.05.002; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Rich Thomas H., 2003, Records of the Queen Victoria Museum, V113, P1; Sampson Scott D., 2001, Journal of Vertebrate Paleontology, V21, p96A; Sereno Paul C., 2000, P480; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wolfe Douglas G., 2007, P159; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; You Hailu, 2004, P478; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P299; You HL, 2003, ACTA PALAEONTOL POL, V48, P261	30	44	46	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					466	468		10.1038/nature09019	http://dx.doi.org/10.1038/nature09019			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505726				2022-12-24	WOS:000278043700032
J	Ito, S; D'Alessio, AC; Taranova, OV; Hong, K; Sowers, LC; Zhang, Y				Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Sowers, Lawrence C.; Zhang, Yi			Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification	NATURE			English	Article							ZYGOTIC PATERNAL GENOME; EMBRYONIC STEM-CELLS; DNA METHYLATION; DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; PLURIPOTENCY; PATTERNS; GENE	DNA methylation is one of the best-characterized epigenetic modifications(1-4). Although the enzymes that catalyse DNA methylation have been characterized, enzymes responsible for demethylation have been elusive(5). A recent study indicates that the human TET1 protein could catalyse the conversion of 5-methylcytosine (5mC) of DNA to 5-hydroxymethylcytosine (5hmC), raising the possibility that DNA demethylation may be a Tet1-mediated process(6). Here we extend this study by demonstrating that all three mouse Tet proteins (Tet1, Tet2 and Tet3) can also catalyse a similar reaction. Tet1 has an important role in mouse embryonic stem (ES) cell maintenance through maintaining the expression of Nanog in ES cells. Downregulation of Nanog via Tet1 knockdown correlates with methylation of the Nanog promoter, supporting a role for Tet1 in regulating DNA methylation status. Furthermore, knockdown of Tet1 in pre-implantation embryos results in a bias towards trophectoderm differentiation. Thus, our studies not only uncover the enzymatic activity of the Tet proteins, but also demonstrate a role for Tet1 in ES cell maintenance and inner cell mass cell specification.	[Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sowers, Lawrence C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Loma Linda University	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	jia, xu/A-8386-2016	Hong, Kwonho/0000-0001-7479-4091; Zhang, Yi/0000-0002-2789-0811	NIH [GM68804, CA084487]; NATIONAL CANCER INSTITUTE [R01CA084487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Okano for the J1 and DNMT triple knockout ES cells; J. He and A. Nguyen for help in FACS sorting; and S. Wu for critical reading of the manuscript. This work was supported by NIH grants GM68804 (to Y.Z.) and CA084487 (to L.C.S.). S.I. is a research fellow of the Japan Society for the Promotion of Science. O.T. is a postdoctoral fellow of Juvenile Diabetes Research Foundation International. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x	19	1813	1927	1	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1129	U151		10.1038/nature09303	http://dx.doi.org/10.1038/nature09303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20639862	Green Submitted, Green Accepted			2022-12-24	WOS:000281203600045
J	Choi, JH; Banks, AS; Estall, JL; Kajimura, S; Bostrom, P; Laznik, D; Ruas, JL; Chalmers, MJ; Kamenecka, TM; Bluher, M; Griffin, PR; Spiegelman, BM				Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Chalmers, Michael J.; Kamenecka, Theodore M.; Blueher, Matthias; Griffin, Patrick R.; Spiegelman, Bruce M.			Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR gamma by Cdk5	NATURE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; LIGAND-BINDING; ADIPOSE-TISSUE; OLIGONUCLEOTIDE ARRAYS; EXPRESSION; ADIPOGENESIS; HORMONE; THIAZOLIDINEDIONES; STIMULATION	Obesity induced in mice by high-fat feeding activates the protein kinase Cdk5 (cyclin-dependent kinase 5) in adipose tissues. This results in phosphorylation of the nuclear receptor PPAR gamma (peroxisome proliferator-activated receptor c), a dominant regulator of adipogenesis and fat cell gene expression, at serine 273. This modification of PPAR gamma does not alter its adipogenic capacity, but leads to dysregulation of a large number of genes whose expression is altered in obesity, including a reduction in the expression of the insulin-sensitizing adipokine, adiponectin. The phosphorylation of PPAR gamma by Cdk5 is blocked by anti-diabetic PPAR gamma ligands, such as rosiglitazone and MRL24. This inhibition works both in vivo and in vitro, and is completely independent of classical receptor transcriptional agonism. Similarly, inhibition of PPAR gamma phosphorylation in obese patients by rosiglitazone is very tightly associated with the anti-diabetic effects of this drug. All these findings strongly suggest that Cdk5-mediated phosphorylation of PPAR gamma may be involved in the pathogenesis of insulin-resistance, and present an opportunity for development of an improved generation of anti-diabetic drugs through PPAR gamma.	[Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Metab & Chron Dis, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Chalmers, Michael J.; Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; Leipzig University	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019; Banks, Alexander/B-4832-2012; Ruas, Jorge/AAE-6094-2019; Choi, Jang Hyun/B-3055-2012	Kajimura, Shingo/0000-0003-0672-5910; Banks, Alexander/0000-0003-1787-6925; Ruas, Jorge/0000-0002-1110-2606; Chalmers, Michael/0000-0002-2139-6089; Estall, Jennifer/0000-0002-9838-1440	NIH [DK31405, DK087853]; Deutsche Forschungsgemeinschaft (DFG); N National Institute of Mental Health [U54-MH084512]; NIH National Institute of General Medical Sciences [R01-GM084041]; Clinical Research group [KFO 152, BL 833/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, R01DK031405, R00DK087853, K99DK087853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); N National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clinical Research group; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Mootha for help with the analysis of microarray data and for critical comments. We thank M. Kirschner for a critical reading of the manuscript and for comments. We are grateful to R. Gupta and P. Cohen for critical comments on the manuscript. J.H.C., A.S.B., J.L.E., P.B., D.L., J.L.R. and B.M.S are supported by NIH DK31405. S.K. is supported by NIH grant DK087853. M.B. is supported by a grant from Deutsche Forschungsgemeinschaft (DFG) and the Clinical Research group 'Atherobesity' KFO 152 (project BL 833/1-1). P.R.G., M.J.C. and T.M.K. are supported in part by the by the Intramural Research Program of the N National Institute of Mental Health (P.R.G., M.J.C., T.M.K., U54-MH084512; H. Rosen Principal Investigator) and by the NIH National Institute of General Medical Sciences (P.R.G. and M.J.C., R01-GM084041).	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Musa FRM, 2000, J ANDROL, V21, P392; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ostberg T, 2004, J BIOL CHEM, V279, P41124, DOI 10.1074/jbc.M401552200; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Salim C, 2009, GLIA, V57, P535, DOI 10.1002/glia.20782; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	46	631	660	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					451	U1		10.1038/nature09291	http://dx.doi.org/10.1038/nature09291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651683	Green Accepted			2022-12-24	WOS:000280141200027
J	Zhang, J; Wagh, P; Guay, D; Sanchez-Pulido, L; Padhi, BK; Korzh, V; Andrade-Navarro, MA; Akimenko, MA				Zhang, Jing; Wagh, Purva; Guay, Danielle; Sanchez-Pulido, Luis; Padhi, Bhaja K.; Korzh, Vladimir; Andrade-Navarro, Miguel A.; Akimenko, Marie-Andree			Loss of fish actinotrichia proteins and the fin-to-limb transition	NATURE			English	Article							APICAL ECTODERMAL RIDGE; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SONIC-HEDGEHOG; PECTORAL FIN; CAUDAL FIN; ZEBRAFISH; GLI3; MORPHOGENESIS; REGENERATION	The early development of teleost paired fins is strikingly similar to that of tetrapod limb buds and is controlled by similar mechanisms(1,2). One early morphological divergence between pectoral fins and limbs is in the fate of the apical ectodermal ridge (AER), the distal epidermis that rims the bud. Whereas the AER of tetrapods regresses after specification of the skeletal progenitors(3), the AER of teleost fishes forms a fold that elongates(4,5). Formation of the fin fold is accompanied by the synthesis of two rows of rigid, unmineralized fibrils called actinotrichia, which keep the fold straight(6,7) and guide the migration of mesenchymal cells within the fold(5,8). The actinotrichia are made of elastoidin, the components of which, apart from collagen, are unknown. Here we show that two zebrafish proteins, which we name actinodin 1 and 2 (And1 and And2), are essential structural components of elastoidin. The presence of actinodin sequences in several teleost fishes and in the elephant shark (Callorhinchus milii, which occupies a basal phylogenetic position), but not in tetrapods, suggests that these genes have been lost during tetrapod species evolution. Double gene knockdown of and1 and and2 in zebrafish embryos results in the absence of actinotrichia and impaired fin folds. Gene expression profiles in embryos lacking and1 and and2 function are consistent with pectoral fin truncation and may offer a potential explanation for the polydactyly observed in early tetrapod fossils. We propose that the loss of both actinodins and actinotrichia during evolution may have led to the loss of lepidotrichia and may have contributed to the fin-to-limb transition.	[Zhang, Jing; Wagh, Purva; Guay, Danielle; Akimenko, Marie-Andree] Univ Ottawa, Dept Biol, CAREG, Ottawa, ON K1N 6N5, Canada; [Sanchez-Pulido, Luis] Univ Oxford, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Padhi, Bhaja K.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Korzh, Vladimir] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	University of Ottawa; University of Oxford; Health Canada; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Akimenko, MA (corresponding author), Univ Ottawa, Dept Biol, CAREG, Ottawa, ON K1N 6N5, Canada.	makimen@uottawa.ca	Korzh, Vladimir P/H-1596-2011; Andrade, Miguel A/B-6565-2008	Korzh, Vladimir P/0000-0002-6580-7986; Andrade, Miguel A/0000-0001-6650-1711; Sanchez Pulido, Luis/0000-0002-2300-8502; Padhi, Bhaja Krushna/0000-0002-8705-9173	European Modular Biology Organization [ALT 325-2008]; Natural Science Engineering and Research Council of Canada; Canadian Institutes of Health Research; Canada Research Chairs; Helmholtz Alliance on Systems Biology; Agency for Science, Technology and Research of Singapore; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: researchfish	European Modular Biology Organization; Natural Science Engineering and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Helmholtz Alliance on Systems Biology; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank I. Duran for technical advice, A. Maurya for assistance in the early stages of this work and M. Ekker, F. Avaron and M. Debiais for discussions and critical reading of the manuscript. L.S.-P. is supported by a European Modular Biology Organization Long-Term Fellowship (ALT 325-2008). This work was supported by grants to M.-A.A. from the Natural Science Engineering and Research Council of Canada and the Canadian Institutes of Health Research. M.A.A.-N. received funding from the Canada Research Chairs programme and from the Helmholtz Alliance on Systems Biology. V.K. received funding from the Agency for Science, Technology and Research of Singapore.	Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; BOUVET J, 1974, ARCH ANAT MICROSC MO, V63, P79; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; DAMODARAN M, 1956, BIOCHEM J, V62, P621, DOI 10.1042/bj0620621; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; GARRAULT H, 1936, ARCH ANAT MICROSC, V130, P105; GERAUDIE J, 1977, J MORPHOL, V151, P353, DOI 10.1002/jmor.1051510304; GERAUDIE J, 1985, BIOL INVERTEBRATE LO, V451, P455; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; KIMURA S, 1966, J BIOCHEM-TOKYO, V60, P615, DOI 10.1093/oxfordjournals.jbchem.a128487; KIMURA S, 1986, COMP BIOCHEM PHYS B, V84, P305, DOI 10.1016/0305-0491(86)90081-7; KRUKENBERG CF, 1885, MITT ZOOL STAT NEAPE, V6, P286; Lang C, 1999, J CELL SCI, V112, P749; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2007, DEV GROWTH DIFFER, V49, P421, DOI 10.1111/j.1440-169x.2007.00942.x; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Pizette S, 1999, DEVELOPMENT, V126, P883; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; WOOD A, 1984, J CELL SCI, V66, P205; WOOD A, 1982, ANAT REC, V204, P349, DOI 10.1002/ar.1092040408; Zakany J, 2007, DEV BIOL, V306, P883, DOI 10.1016/j.ydbio.2007.03.517; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008	35	92	95	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					234	U106		10.1038/nature09137	http://dx.doi.org/10.1038/nature09137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20574421				2022-12-24	WOS:000279580800036
J	Humphries, NE; Queiroz, N; Dyer, JRM; Pade, NG; Musyl, MK; Schaefer, KM; Fuller, DW; Brunnschweiler, JM; Doyle, TK; Houghton, JDR; Hays, GC; Jones, CS; Noble, LR; Wearmouth, VJ; Southall, EJ; Sims, DW				Humphries, Nicolas E.; Queiroz, Nuno; Dyer, Jennifer R. M.; Pade, Nicolas G.; Musyl, Michael K.; Schaefer, Kurt M.; Fuller, Daniel W.; Brunnschweiler, Juerg M.; Doyle, Thomas K.; Houghton, Jonathan D. R.; Hays, Graeme C.; Jones, Catherine S.; Noble, Leslie R.; Wearmouth, Victoria J.; Southall, Emily J.; Sims, David W.			Environmental context explains Levy and Brownian movement patterns of marine predators	NATURE			English	Article							FLIGHT SEARCH PATTERNS; POWER-LAW DISTRIBUTIONS; WANDERING ALBATROSSES; STRATEGIES; BEHAVIOR; PACIFIC; SUCCESS; SPEED; OCEAN; PREY	An optimal search theory, the so-called Levy-flight foraging hypothesis(1), predicts that predators should adopt search strategies known as Levy flights where prey is sparse and distributed unpredictably, but that Brownian movement is sufficiently efficient for locating abundant prey(2-4). Empirical studies have generated controversy because the accuracy of statistical methods that have been used to identify Levy behaviour has recently been questioned(5,6). Consequently, whether foragers exhibit Levy flights in the wild remains unclear. Crucially, moreover, it has not been tested whether observed movement patterns across natural landscapes having different expected resource distributions conform to the theory's central predictions. Here we use maximum-likelihood methods to test for Levy patterns in relation to environmental gradients in the largest animal movement data set assembled for this purpose. Strong support was found for Levy search patterns across 14 species of open-ocean predatory fish (sharks, tuna, billfish and ocean sunfish), with some individuals switching between Levy and Brownian movement as they traversed different habitat types. We tested the spatial occurrence of these two principal patterns and found Levy behaviour to be associated with less productive waters (sparser prey) and Brownian movements to be associated with productive shelf or convergence-front habitats (abundant prey). These results are consistent with the Levy-flight foraging hypothesis(1,7), supporting the contention(8,9) that organism search strategies naturally evolved in such a way that they exploit optimal Levy patterns.	[Humphries, Nicolas E.; Queiroz, Nuno; Dyer, Jennifer R. M.; Pade, Nicolas G.; Wearmouth, Victoria J.; Southall, Emily J.; Sims, David W.] Marine Biol Assoc UK, The Lab, Plymouth PL1 2PB, Devon, England; [Humphries, Nicolas E.; Sims, David W.] Univ Plymouth, Sch Marine Sci & Engn, Inst Marine, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Queiroz, Nuno] Univ Porto, CIBIO, P-4485668 Vairao, Portugal; [Queiroz, Nuno; Pade, Nicolas G.; Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland; [Musyl, Michael K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Kewalo Res Facil, NOAA Fisheries, Honolulu, HI 96814 USA; [Schaefer, Kurt M.; Fuller, Daniel W.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Brunnschweiler, Juerg M.] ETH, CH-8092 Zurich, Switzerland; [Doyle, Thomas K.] Univ Coll Cork, Glucksman Marine Facil, ERI, Coastal & Marine Resources Ctr, Cork, Ireland; [Houghton, Jonathan D. R.] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Hays, Graeme C.] Swansea Univ, Inst Environm Sustainabil, Dept Pure & Appl Ecol, Swansea SA2 8PP, W Glam, Wales	Marine Biological Association United Kingdom; University of Plymouth; Universidade do Porto; University of Aberdeen; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; Swiss Federal Institutes of Technology Domain; ETH Zurich; University College Cork; Queens University Belfast; Swansea University	Sims, DW (corresponding author), Marine Biol Assoc UK, The Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Brunnschweiler, Juerg/A-2110-2008; SOUTHALL, EMILY J/AGP-5395-2022; Queiroz, Nuno/G-3850-2010; Humphries, Nick/AAE-7170-2019	Brunnschweiler, Juerg/0000-0002-9901-3279; SOUTHALL, EMILY J/0000-0001-7246-278X; Queiroz, Nuno/0000-0002-3860-7356; Humphries, Nick/0000-0003-3741-1594; Sims, David/0000-0002-0916-7363; Pade, Nicolas/0000-0003-2733-9752; Noble, leslie/0000-0003-3076-0759; Hays, Graeme/0000-0002-3314-8189; Doyle, Thomas/0000-0003-1616-5590	UK Natural Environment Research Council (NERC); Save Our Seas Foundation; Leverhulme Trust; UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia [SFRH/BD/21354/2005]; UK Royal Society; Fisheries Society of the British Isles; Udaras na Gaeltachta; Taighde Mara Teo; Marine Institute (Ireland); Irish Research Council for Science Engineering and Technology; Shark Foundation Switzerland; University of Aberdeen; PADI Project; Japan Fisheries Agency; US Tuna Foundation; Tagging of Pacific Pelagics programme in the Census of Marine Life; National Oceanic and Atmospheric Administration (US Department of Commerce) [NA37RJ0199, NA67RJ0154]; University of Hawaii [NA37RJ0199, NA67RJ0154]; Royal Society; Marine Biological Association of the UK; UK NERC; Natural Environment Research Council [mba010004] Funding Source: researchfish; NERC [mba010004] Funding Source: UKRI	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Save Our Seas Foundation; Leverhulme Trust(Leverhulme Trust); UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia(Department for Environment, Food & Rural Affairs (DEFRA)Portuguese Foundation for Science and Technology); UK Royal Society(Royal Society of London); Fisheries Society of the British Isles; Udaras na Gaeltachta; Taighde Mara Teo; Marine Institute (Ireland); Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Shark Foundation Switzerland; University of Aberdeen; PADI Project; Japan Fisheries Agency; US Tuna Foundation; Tagging of Pacific Pelagics programme in the Census of Marine Life; National Oceanic and Atmospheric Administration (US Department of Commerce)(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii; Royal Society(Royal Society of London); Marine Biological Association of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was facilitated through the European Tracking of Predators in the Atlantic programme in the European Census of Marine Life. Funding was provided by the UK Natural Environment Research Council (NERC) Oceans 2025 Strategic Research Programme (Theme 6 Science for Sustainable Marine Resources), the Save Our Seas Foundation, the Leverhulme Trust, the UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia grant SFRH/BD/21354/2005, the UK Royal Society, the Fisheries Society of the British Isles, the Udaras na Gaeltachta, the Taighde Mara Teo, the Marine Institute (Ireland), the Irish Research Council for Science Engineering and Technology, the Shark Foundation Switzerland, a University of Aberdeen Scholarship and PADI Project Aware. The tuna research of K. M. S. and D. W. F. was made possible through financial contributions by the Japan Fisheries Agency, the US Tuna Foundation and the Tagging of Pacific Pelagics programme in the Census of Marine Life. M. K. M. was funded by Cooperative Agreements NA37RJ0199 and NA67RJ0154 between the National Oceanic and Atmospheric Administration (US Department of Commerce) and the Pelagic Fisheries Research Program (University of Hawaii). The authors or their agencies do not necessarily approve, recommend or endorse any proprietary hardware or software mentioned in this publication. The views expressed herein are those of the authors and do not necessarily reflect the views of their agencies. For field assistance, D. W. S. thanks P. Harris and D. Uren; T. K. D. thanks V. Roantree, M. Norman, M. Lilley and P. F. O'Suilleabhain; J. M. B. thanks G. Adkison, J.-P. Botha, H. Baensch and A. Cumming. D. W. S. and N. E. H. thank A. Clauset and J. Pitchford for help with maximum-likelihood estimation and log-likelihoods, and E. P. White for manuscript comments. This research complied with all animal welfare laws of the countries or sovereign territories in which it was conducted. C. S. J. was supported by a Royal Society of Edinburgh Sabbatical Fellowship, G. C. H. by a Ray Lankester Investigatorship from the Marine Biological Association of the UK (MBA) and D. W. S. by a UK NERC-funded MBA Senior Research Fellowship.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434002; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Buchanan M, 2008, NATURE, V453, P714, DOI 10.1038/453714a; CLARKE MR, 1974, J MAR BIOL ASSOC UK, V54, P949, DOI 10.1017/S0025315400057672; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CORNELIUS JM, 1991, ECOLOGY, V72, P2057, DOI 10.2307/1941559; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Kashtan N, 2007, P NATL ACAD SCI USA, V104, P13711, DOI 10.1073/pnas.0611630104; Moteki M, 2001, FISHERIES SCI, V67, P1063, DOI 10.1046/j.1444-2906.2001.00362.x; POWELL TM, 1975, SCIENCE, V189, P1088, DOI 10.1126/science.189.4208.1088; Shlesinger M. F., 1986, On Growth and Form - Fractal and Non-Fractal Patterns in Physics. Proceedings of the NATO Advanced Study Institute, P279; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Travis J, 2007, SCIENCE, V318, P742, DOI 10.1126/science.318.5851.742; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	29	602	609	11	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1066	1069		10.1038/nature09116	http://dx.doi.org/10.1038/nature09116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20531470	Green Accepted			2022-12-24	WOS:000279056900050
J	Kuba, H; Oichi, Y; Ohmori, H				Kuba, Hiroshi; Oichi, Yuki; Ohmori, Harunori			Presynaptic activity regulates Na+ channel distribution at the axon initial segment	NATURE			English	Article							STEM AUDITORY NUCLEI; ACTION-POTENTIAL INITIATION; AFFERENT INFLUENCES; PYRAMIDAL NEURONS; INTRINSIC EXCITABILITY; N-MAGNOCELLULARIS; COCHLEA REMOVAL; SODIUM-CHANNELS; CHICKEN; SYSTEM	Deprivation of afferent inputs in neural circuits leads to diverse plastic changes in both pre- and postsynaptic elements that restore neural activity(1). The axon initial segment (AIS) is the site at which neural signals arise(2,3), and should be the most efficient site to regulate neural activity. However, none of the plasticity currently known involves the AIS. We report here that deprivation of auditory input in an avian brainstem auditory neuron leads to an increase in AIS length, thus augmenting the excitability of the neuron. The length of the AIS, defined by the distribution of voltage-gated Na+ channels and the AIS anchoring protein, increased by 1.7 times in seven days after auditory input deprivation. This was accompanied by an increase in the whole-cell Na+ current, membrane excitability and spontaneous firing. Our work demonstrates homeostatic regulation of the AIS, which may contribute to the maintenance of the auditory pathway after hearing loss. Furthermore, plasticity at the spike initiation site suggests a powerful pathway for refining neuronal computation in the face of strong sensory deprivation.	[Kuba, Hiroshi; Oichi, Yuki] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Ohmori, Harunori] Kyoto Univ, Grad Sch Med, Dept Physiol, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Kuba, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan.	kuba@nbiol.med.kyoto-u.ac.jp	Kuba, Hiroshi/I-7519-2014	Ohmori, Harunori/0000-0002-4319-4947	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank G. Alcaraz for providing ankyrin-G antibody. We also thank L. O. Trussell for advice and for editing the manuscript; M. N. Rasband, T. M. Ishii and R. Yamada for reading the manuscript; and K. Bender for discussions. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to H.K. and H.O.	Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BORN DE, 1991, BRAIN RES, V557, P37, DOI 10.1016/0006-8993(91)90113-A; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kuba H, 2009, J PHYSIOL-LONDON, V587, P87, DOI 10.1113/jphysiol.2008.162651; KUBKE MF, 1998, HEARING RES, V147, P1; Lu Y, 2004, J COMP NEUROL, V470, P93, DOI 10.1002/cne.11037; Lu Y, 2007, J NEUROPHYSIOL, V97, P635, DOI 10.1152/jn.00915.2006; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SHERMAN SJ, 1984, P NATL ACAD SCI-BIOL, V81, P262, DOI 10.1073/pnas.81.1.262; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; TUCCI DL, 1985, J COMP NEUROL, V238, P371, DOI 10.1002/cne.902380402; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009	30	287	288	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1075	U136		10.1038/nature09087	http://dx.doi.org/10.1038/nature09087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543825				2022-12-24	WOS:000279056900052
J	Stulberg, JJ; Delaney, CP; Neuhauser, DV; Aron, DC; Fu, PF; Koroukian, SM				Stulberg, Jonah J.; Delaney, Conor P.; Neuhauser, Duncan V.; Aron, David C.; Fu, Pingfu; Koroukian, Siran M.			Adherence to Surgical Care Improvement Project Measures and the Association With Postoperative Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE-MEASURES; COLORECTAL SURGERY; CLINICAL-OUTCOMES; HOSPITAL QUALITY; MORTALITY-RATES; SITE INFECTION; CO-MORBIDITY; COMPLICATIONS; PREVENTION; ICD-9-CM	Context The Surgical Care Improvement Project (SCIP) aims to reduce surgical infectious complication rates through measurement and reporting of 6 infection-prevention process-of-care measures. However, an association between SCIP performance and clinical outcomes has not been demonstrated. Objective To examine the relationship between SCIP infection-prevention process-of-care measures and postoperative infection rates. Design, Setting, Participants A retrospective cohort study, using Premier Inc's Perspective Database for discharges between July 1, 2006 and March 31, 2008, of 405 720 patients (69% white and 11% black; 46% Medicare patients; and 68% elective surgical cases) from 398 hospitals in the United States for whom SCIP performance was recorded and submitted for public report on the Hospital Compare Web site. Three original infection-prevention measures (S-INF-Core) and all 6 infection-prevention measures (S-INF) were aggregated into 2 separate all-or-none composite scores. Hierarchical logistical models were used to assess process-of-care relationships at the patient level while accounting for hospital characteristics. Main Outcome Measure The ability of reported adherence to SCIP infection-prevention process-of-care measures (using the 2 composite scores of S-INF and S-INF-Core) to predict postoperative infections. Results There were 3996 documented postoperative infections. The S-INF composite process-of-care measure predicted a decrease in postoperative infection rates from 14.2 to 6.8 per 1000 discharges (adjusted odds ratio, 0.85; 95% confidence interval, 0.76-0.95). The S-INF-Core composite process-of-care measure predicted a decrease in postoperative infection rates from 11.5 to 5.3 per 1000 discharges (adjusted odds ratio, 0.86; 95% confidence interval, 0.74-1.01), which was not a statistically significantly lower probability of infection. None of the individual SCIP measures were significantly associated with a lower probability of infection. Conclusions Among hospitals in the Premier Inc Perspective Database reporting SCIP performance, adherence measured through a global all-or-none composite infection-prevention score was associated with a lower probability of developing a postoperative infection. However, adherence reported on individual SCIP measures, which is the only form in which performance is publicly reported, was not associated with a significantly lower probability of infection. JAMA. 2010; 303(24): 2479-2485 www.jama.com	[Stulberg, Jonah J.; Neuhauser, Duncan V.; Aron, David C.; Fu, Pingfu; Koroukian, Siran M.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stulberg, Jonah J.; Delaney, Conor P.] Univ Hosp, Case Med Ctr, Dept Surg, Div Colorectal Surg, Cleveland, OH 44106 USA; [Aron, David C.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, VA HSR&D Ctr Qual Improvement Res, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Stulberg, JJ (corresponding author), Univ Hosp, Case Med Ctr, Dept Surg, Div Colorectal Surg, 11100 Euclid Ave,LKS 7,MS 5047, Cleveland, OH 44106 USA.	Jonah.Stulberg@case.edu	Stulberg, Jonah/J-8713-2019; Fu, Pingfu/O-5415-2019; Stulberg, Jonah/I-7434-2012; Koroukian, Siran/S-9127-2019	Stulberg, Jonah/0000-0001-9971-8693; Fu, Pingfu/0000-0002-2334-5218; Koroukian, Siran/0000-0002-8106-9581	Agency for Healthcare Research and Quality [T32 HS00059]; National Cancer Institute [K07 CA96705]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000059] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA096705] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: Dr Stulberg was supported, in part, by grant T32 HS00059 from the Agency for Healthcare Research and Quality. Dr Koroukian was supported by career development award K07 CA96705 from the National Cancer Institute at the time this study was conducted.	Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Birkmeyer JD, 2009, ANNU REV MED, V60, P405, DOI 10.1146/annurev.med.60.062107.101214; Bratzler DW, 2006, AM SURGEON, V72, P1010; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; Centers for Medicare & Medicaid Services; Joint Commission, SPEC MAN NAT HOSP IN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung ES, 2008, AM J MED QUAL, V23, P168, DOI 10.1177/1062860608315337; Clancy Carolyn M, 2008, AORN J, V87, P621, DOI 10.1016/j.aorn.2008.02.007; Delaney CP, 2008, ANN SURG, V247, P819, DOI 10.1097/SLA.0b013e31816d950e; Delaney CP, 2001, BRIT J SURG, V88, P1533, DOI 10.1046/j.0007-1323.2001.01905.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dimick JB, 2003, SURGERY, V134, P534, DOI 10.1016/S0039-6060(03)00273-3; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; ELBADAWI K, 2009, ANN M AM SOC COL REC; Fonarow Gregg C, 2007, Congest Heart Fail, V13, P342, DOI 10.1111/j.1527-5299.2007.07233.x; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; *JOINT COMM, 2008 CERT QUAL REP U; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Leibson CL, 2008, MED CARE, V46, P127, DOI 10.1097/MLR.0b013e3181589b92; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; MCGLYNN EA, 2003, MED CARE S, V41, P1; Nguyen N, 2008, AM SURGEON, V74, P1012; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Olsen MA, 2008, J AM COLL SURGEONS, V207, P326, DOI 10.1016/j.jamcollsurg.2008.04.021; PASTOR C, 2009, ANN M AM SOC COL REC; Premier inc, PREM PERSP DAT; *QMIS, QUAL NET; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; STRAUBE B, 2005, HLTH AFF MILLWOOD; *US DEP HHS, HOSP COMP QUAL TOOL; US Department of Health and Human Services, 2003, OCR PRIV BRIEF SUMM; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	394	397	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2479	2485		10.1001/jama.2010.841	http://dx.doi.org/10.1001/jama.2010.841			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571014	Bronze			2022-12-24	WOS:000279010900025
J	Ameres, SL; Horwich, MD; Hung, JH; Xu, J; Ghildiyal, M; Weng, ZP; Zamore, PD				Ameres, Stefan L.; Horwich, Michael D.; Hung, Jui-Hung; Xu, Jia; Ghildiyal, Megha; Weng, Zhiping; Zamore, Phillip D.			Target RNA-Directed Trimming and Tailing of Small Silencing RNAs	SCIENCE			English	Article							PIWI-INTERACTING RNAS; DISTINCT MECHANISMS; ENDOGENOUS SIRNAS; STRUCTURAL BASIS; MESSENGER-RNA; RECOGNITION; ARGONAUTE2; MICRORNAS; 2'-O-METHYLATION; URIDYLATION	In Drosophila, microRNAs (miRNAs) typically guide Argonaute1 to repress messenger RNA (mRNA), whereas small interfering RNAs (siRNAs) guide Argonaute2 to destroy viral and transposon RNA. Unlike siRNAs, miRNAs rarely form extensive numbers of base pairs to the mRNAs they regulate. We find that extensive complementarity between a target RNA and an Argonaute1-bound miRNA triggers miRNA tailing and 3'-to-5' trimming. In flies, Argonaute2-bound small RNAs-but not those bound to Argonaute1-bear a 2'-O-methyl group at their 3' ends. This modification blocks target-directed small RNA remodeling: In flies lacking Hen1, the enzyme that adds the 2'-O-methyl group, Argonaute2-associated siRNAs are tailed and trimmed. Target complementarity also affects small RNA stability in human cells. These results provide an explanation for the partial complementarity between animal miRNAs and their targets.	[Ameres, Stefan L.; Horwich, Michael D.; Ghildiyal, Megha; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Ameres, Stefan L.; Horwich, Michael D.; Ghildiyal, Megha; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Hung, Jui-Hung; Xu, Jia] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Ameres, Stefan/G-3775-2010; Ameres, Stefan Ludwig/B-4046-2012; Hung, Jui-Hung/G-2673-2012; Zamore, Phillip D/A-8941-2013; Ghildiyal, Megha/F-7980-2014; Xu, Jia/F-7750-2012	Ameres, Stefan Ludwig/0000-0002-8248-3098; Hung, Jui-Hung/0000-0003-2208-9213; Xu, Jia/0000-0003-3921-018X; Zamore, Phillip/0000-0002-4505-9618	National Institute on Aging NRSA [F30AG030283]; EMBO [ALTF 522-2008]; Austrian Science Fund (FWF) [J2832-B09]; NIH [GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R37GM062862, R01GM062862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030283] Funding Source: NIH RePORTER	National Institute on Aging NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EMBO(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Ma and A. Boucher for help with fly husbandry, G. Farley for technical assistance, E. Pfister for cloning of miR-16 and miR-21 reporter constructs, and members of the Zamore lab for advice, suggestions, and critical comments on the manuscript. Sequence data are available through the NCBI Short Read Archive (www.ncbi.nlm.nih.gov/sites/sra) as GSM278704 (ago2414), SRA010045 (hen1<SUP>f00810</SUP> National Institute on Aging NRSA grant F30AG030283 (M. D. H.), and HeLa cell data), and GSE18806 (Oregon R). Supported by EMBO long-term fellowship ALTF 522-2008, Austrian Science Fund (FWF) Erwin Schrodinger-Auslandsstipendium J2832-B09 (S. L. A.), and NIH grants GM62862 and GM65236 (P.D.Z.). P.D.Z. is a member of the scientific advisory board of Regulus Therapeutics.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; PELISSON A, 1951, J VIROL, V81, P2007; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	42	393	421	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1534	1539		10.1126/science.1187058	http://dx.doi.org/10.1126/science.1187058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558712	Green Accepted			2022-12-24	WOS:000278859200040
J	Tian, Y; Li, ZP; Hu, WQ; Ren, HY; Tian, E; Zhao, Y; Lu, Q; Huang, XX; Yang, PG; Li, X; Wang, XC; Kovacs, AL; Yu, L; Zhang, H				Tian, Ye; Li, Zhipeng; Hu, Wanqiu; Ren, Haiyan; Tian, E.; Zhao, Yu; Lu, Qun; Huang, Xinxin; Yang, Peiguo; Li, Xin; Wang, Xiaochen; Kovacs, Attila L.; Yu, Li; Zhang, Hong			C. elegans Screen Identifies Autophagy Genes Specific to Multicellular Organisms	CELL			English	Article							PANCREATITIS; VACUOLES	The molecular understanding of autophagy has originated almost exclusively from yeast genetic studies. Little is known about essential autophagy components specific to higher eukaryotes. Here we perform genetic screens in C. elegans and identify four metazoan-specific autophagy genes, named epg-2, -3, -4, and -5. Genetic analysis reveals that epg-2, -3, -4, and -5 define discrete genetic steps of the autophagy pathway. epg-2 encodes a coiled-coil protein that functions in specific autophagic cargo recognition. Mammalian homologs of EPG-3/VMP1, EPG-4/EI24, and EPG-5/mEPG5 are essential for starvation-induced autophagy. VMP1 regulates autophagosome formation by controlling the duration of omegasomes. EI24 and mEPG5 are required for formation of degradative autolysosomes. This study establishes C. elegans as a multicellular genetic model to delineate the autophagy pathway and provides mechanistic insights into the metazoan-specific autophagic process.	[Hu, Wanqiu; Yu, Li] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Ye; Li, Zhipeng; Ren, Haiyan; Tian, E.; Zhao, Yu; Lu, Qun; Huang, Xinxin; Yang, Peiguo; Li, Xin; Wang, Xiaochen; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Tian, Ye] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Kovacs, Attila L.] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, H-1117 Budapest, Hungary	Tsinghua University; National Institute of Biological Sciences, Beijing; Beijing Normal University; Eotvos Lorand University	Yu, L (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.	liyulab@mail.tsinghua.edu.cn; zhanghong@nibs.ac.cn	Lu, Qun/O-2978-2018; ren, haiyan/A-8907-2015	Tian, Ye/0000-0002-7675-9270; ren, haiyan/0000-0001-9995-3255; Huang, Xinxin/0000-0002-4298-4859; YANG, PEIGUO/0000-0002-2334-5664; Li, Zhipeng/0000-0001-8806-9667; Zhang, Hong/0000-0002-3342-5377	National High Technology Projects 863 [2008AA022306]; Hungarian Scientific Research Funds [OTKA K75843]	National High Technology Projects 863(National High Technology Research and Development Program of China); Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank Dr Xiaodong Wang for comments on the manuscript; Edvard Burghardt, Mariann Sarody, Fan Wu, Tao Sun, and Hui Zhang for technical assistance; Dr. Shohei Mitani for epg-5(tm3425); Dr. Gang Zhi and the NIBS antibody facility for preparing antibodies; and Dr. Isabel Hanson for editing services. This work was supported by the National High Technology Projects 863 (2008AA022306) (H.Z.) and Hungarian Scientific Research Funds OTKA K75843 (A.L.K.).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Dusetti NJ, 2002, BIOCHEM BIOPH RES CO, V290, P641, DOI 10.1006/bbrc.2001.6244; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kovacs AL, 2010, FEBS LETT, V584, P1335, DOI 10.1016/j.febslet.2010.02.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sigmond T, 2008, METHOD ENZYMOL, V451, P467, DOI 10.1016/S0076-6879(08)03228-X; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; YU L, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09076; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	24	302	320	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1042	1055		10.1016/j.cell.2010.04.034	http://dx.doi.org/10.1016/j.cell.2010.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550938	Bronze			2022-12-24	WOS:000278618800018
J	Beer, C; Reichstein, M; Tomelleri, E; Ciais, P; Jung, M; Carvalhais, N; Rodenbeck, C; Arain, MA; Baldocchi, D; Bonan, GB; Bondeau, A; Cescatti, A; Lasslop, G; Lindroth, A; Lomas, M; Luyssaert, S; Margolis, H; Oleson, KW; Roupsard, O; Veenendaal, E; Viovy, N; Williams, C; Woodward, FI; Papale, D				Beer, Christian; Reichstein, Markus; Tomelleri, Enrico; Ciais, Philippe; Jung, Martin; Carvalhais, Nuno; Roedenbeck, Christian; Arain, M. Altaf; Baldocchi, Dennis; Bonan, Gordon B.; Bondeau, Alberte; Cescatti, Alessandro; Lasslop, Gitta; Lindroth, Anders; Lomas, Mark; Luyssaert, Sebastiaan; Margolis, Hank; Oleson, Keith W.; Roupsard, Olivier; Veenendaal, Elmar; Viovy, Nicolas; Williams, Christopher; Woodward, F. Ian; Papale, Dario			Terrestrial Gross Carbon Dioxide Uptake: Global Distribution and Covariation with Climate	SCIENCE			English	Article							VEGETATION; BIOSPHERE; CO2; RADIATION; PRODUCTS; FRACTION; SULFIDE; NETWORK; IMPACT; MODEL	Terrestrial gross primary production (GPP) is the largest global CO2 flux driving several ecosystem functions. We provide an observation-based estimate of this flux at 123 +/- 8 petagrams of carbon per year (Pg C year(-1)) using eddy covariance flux data and various diagnostic models. Tropical forests and savannahs account for 60%. GPP over 40% of the vegetated land is associated with precipitation. State-of-the-art process-oriented biosphere models used for climate predictions exhibit a large between-model variation of GPP's latitudinal patterns and show higher spatial correlations between GPP and precipitation, suggesting the existence of missing processes or feedback mechanisms which attenuate the vegetation response to climate. Our estimates of spatially distributed GPP and its covariation with climate can help improve coupled climate-carbon cycle process models.	[Beer, Christian; Reichstein, Markus; Tomelleri, Enrico; Jung, Martin; Carvalhais, Nuno; Lasslop, Gitta] Max Planck Inst Biogeochem, Biogeochem Model Data Integrat Grp, D-07745 Jena, Germany; [Ciais, Philippe; Viovy, Nicolas] CEA CNRS UVSQ, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, Caparica, Portugal; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON, Canada; [Baldocchi, Dennis] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Baldocchi, Dennis] Univ Calif Berkeley, Berkeley Atmospher Sci Ctr, Berkeley, CA 94720 USA; [Bonan, Gordon B.; Oleson, Keith W.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA; [Bondeau, Alberte] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany; [Cescatti, Alessandro] Commiss European Communities, DG Joint Res Ctr, Inst Environm & Sustainabil, Climate Change Unit, Ispra, Italy; [Lindroth, Anders] Lund Univ, Dept Earth & Ecosyst Sci, S-22100 Lund, Sweden; [Lomas, Mark] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Luyssaert, Sebastiaan] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Margolis, Hank] Univ Laval, Ctr Etud Foret, Fac Foresterie Geogr & Geomat, Quebec City, PQ, Canada; [Roupsard, Olivier] Cirad Persyst, UPR80, Fonct & Pilotage Ecosyst Plantat, Montpellier, France; [Roupsard, Olivier] CATIE, Turrialba, Costa Rica; [Veenendaal, Elmar] Wageningen Univ, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [Williams, Christopher] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Papale, Dario] Univ Tuscia, Dept Forest Enviromm & Resources, Viterbo, Italy	Max Planck Society; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Nova de Lisboa; McMaster University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Center Atmospheric Research (NCAR) - USA; Potsdam Institut fur Klimafolgenforschung; European Commission Joint Research Centre; EC JRC ISPRA Site; Lund University; University of Sheffield; University of Antwerp; Laval University; CIRAD; Wageningen University & Research; Clark University; Tuscia University	Beer, C (corresponding author), Max Planck Inst Biogeochem, Biogeochem Model Data Integrat Grp, D-07745 Jena, Germany.	christian.beer@bgc-jena.mpg.de	Woodward, Frank Ian/P-4530-2019; Roupsard, Olivier/C-1219-2008; Baldocchi, Dennis/A-1625-2009; Viovy, Nicolas/S-2631-2018; Veenendaal, Elmar M/B-4628-2009; Papale, Dario/W-7302-2019; Beer, Christian/D-2296-2013; Luyssaert, Sebastiaan/F-6684-2011; Arain, M. Altaf/ABA-9750-2020; Woodward, Ian F/B-7762-2008; Lindroth, Anders/N-4697-2014; Tomelleri, Enrico/N-6147-2014; Ciais, Philippe/A-6840-2011; Reichstein, Markus/A-7494-2011; Tomelleri, Enrico/AAJ-3219-2020; Cescatti, Alessandro/ABE-6319-2020; Bondeau, Alberte/E-9909-2012; Oleson, Keith/A-9328-2008	Roupsard, Olivier/0000-0002-1319-142X; Baldocchi, Dennis/0000-0003-3496-4919; Viovy, Nicolas/0000-0002-9197-6417; Papale, Dario/0000-0001-5170-8648; Beer, Christian/0000-0002-5377-3344; Luyssaert, Sebastiaan/0000-0003-1121-1869; Arain, M. Altaf/0000-0002-1433-5173; Lindroth, Anders/0000-0002-7669-784X; Tomelleri, Enrico/0000-0001-6546-6459; Ciais, Philippe/0000-0001-8560-4943; Reichstein, Markus/0000-0001-5736-1112; Bondeau, Alberte/0000-0002-8729-5061; Oleson, Keith/0000-0002-0057-9900; Lasslop, Gitta/0000-0001-9939-1459; Williams, Christopher A./0000-0002-5047-0639; Carvalhais, Nuno/0000-0003-0465-1436	Department of Energy, Biological and Environmental Research [DE-FG02-04ER63917, DE-FG02-04ER63911]; AfriFlux; AsiaFlux; CarboAfrica; CarboEuropeIP; CarboItaly; CarboMont; ChinaFlux; Fluxnet-Canada; CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; GreenGrass; KoFlux; LBA; NECC; OzFlux; TCOS-Siberia; USCCC; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study; MaxPlanck Institute for Biogeochemistry; National Science Foundation; University of Tuscia; Universite Laval; NERC [earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [0910766] Funding Source: National Science Foundation	Department of Energy, Biological and Environmental Research(United States Department of Energy (DOE)); AfriFlux; AsiaFlux; CarboAfrica; CarboEuropeIP(European Commission); CarboItaly; CarboMont; ChinaFlux; Fluxnet-Canada; CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); GreenGrass; KoFlux; LBA; NECC; OzFlux; TCOS-Siberia; USCCC; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study; MaxPlanck Institute for Biogeochemistry; National Science Foundation(National Science Foundation (NSF)); University of Tuscia; Universite Laval; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: AmeriFlux [U.S. Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (DEFG02-04ER63917 and DE-FG02-04ER63911)], AfriFlux, AsiaFlux, CarboAfrica, CarboEuropeIP, CarboItaly, CarboMont, ChinaFlux, Fluxnet-Canada (supported by CFCAS, NSERC, BIOCAP, Environment Canada, and NRCan), GreenGrass, KoFlux, LBA, NECC, OzFlux, TCOS-Siberia, and USCCC. We acknowledge the support to the eddy covariance data harmonization provided by CarboEuropeIP, FAO-GTOS-TCO, Integrated Land Ecosystem-Atmosphere Processes Study, MaxPlanck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and U.S. Department of Energy and the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, and University of Virginia. Remotely sensed land cover, fAPAR, and LAI were available through the Joint Research Centre of the European Commission, the National Aeronautics and Space Administration, and the projects GLC2000 and CYCLOPES. Climate data came from the European Centre for Medium-Range Weather Forecasts, the Climate Research Unit of the University of East Anglia, and the GEWEX project GPCP. We thank Mahendra K. Karki at GMAO/NASA for extracting the MOD17 required surface meteorological variables from the GMAO reanalysis dataset and Maosheng Zhao at NTSG of University of Montana for calculating the respective daytime VPD. We further acknowledge support by the European Commission FP7 projects COMBINE and CARBO-Extreme and a grant from the Max-Planck Society establishing the MPRG Biogeochemical Model-Data Integration. C.B., D.P., M.R., P.C., D.B., and S.L. conceived the study. C.B., C.R., D.P., E.T., M.J., M.R., and N.C. contributed diagnostic modeling results. C.B., A.B., G.B.B., M.L., F.I.W., and N.V. contributed process model results. C.B., E.T., and M.R. performed the analysis. C.B. and M.R. wrote the manuscript. All other coauthors contributed with data or substantial input to the manuscript.	Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baret F, 2007, REMOTE SENS ENVIRON, V110, P275, DOI 10.1016/j.rse.2007.02.018; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Campbell JE, 2008, SCIENCE, V322, P1085, DOI 10.1126/science.1164015; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Fekete BM, 2004, J CLIMATE, V17, P294, DOI 10.1175/1520-0442(2004)017<0294:UIPATI>2.0.CO;2; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerten D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024247; Gobron N, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006511; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Papale D, 2003, GLOBAL CHANGE BIOL, V9, P525, DOI 10.1046/j.1365-2486.2003.00609.x; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Sandoval-Soto L, 2005, BIOGEOSCIENCES, V2, P125, DOI 10.5194/bg-2-125-2005; Saugier B., 2001, TERRESTRIAL GLOBAL P, P401; Schulze E. D., 1970, Flora, Jena, V159, P177; Simmons A, 2007, ECMWF NEWSLETTER; Suntharalingam P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034332; Whittaker RH, 1975, PRIMARY PRODUCTIVITY, P305, DOI DOI 10.1007/978-3-642-80913-2_15; Wingate L, 2009, P NATL ACAD SCI USA, V106, P22411, DOI 10.1073/pnas.0905210106; Zhao M, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2004JG000004	37	1613	1713	80	1269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					834	838		10.1126/science.1184984	http://dx.doi.org/10.1126/science.1184984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20603496	Green Published			2022-12-24	WOS:000280809900049
J	Ittner, LM; Ke, YD; Delerue, F; Bi, MA; Gladbach, A; van Eersel, J; Wolfing, H; Chieng, BC; Christie, MJ; Napier, IA; Eckert, A; Staufenbiel, M; Hardeman, E; Gotz, J				Ittner, Lars M.; Ke, Yazi D.; Delerue, Fabien; Bi, Mian; Gladbach, Amadeus; van Eersel, Janet; Woelfing, Heidrun; Chieng, Billy C.; Christie, MacDonald J.; Napier, Ian A.; Eckert, Anne; Staufenbiel, Matthias; Hardeman, Edna; Goetz, Juergen			Dendritic Function of Tau Mediates Amyloid-beta Toxicity in Alzheimer's Disease Mouse Models	CELL			English	Article							PAIRED HELICAL FILAMENT; APP23 TRANSGENIC MICE; TYROSINE PHOSPHORYLATION; COGNITIVE IMPAIRMENTS; PROTEIN; FYN; DEFICITS; KINASE; SUBUNIT; NEURODEGENERATION	Alzheimer's disease (AD) is characterized by amyloid-beta (A beta) and tau deposition in brain. It has emerged that A beta toxicity is tau dependent, although mechanistically this link remains unclear. Here, we show that tau, known as axonal protein, has a dendritic function in postsynaptic targeting of the Src kinase Fyn, a substrate of which is the NMDA receptor (NR). Missorting of tau in transgenic mice expressing truncated tau (Delta tau) and absence of tau in tau(-/-) mice both disrupt postsynaptic targeting of Fyn. This uncouples NR-mediated excitotoxicity and hence mitigates A beta toxicity. Delta tau expression and tau deficiency prevent memory deficits and improve survival in A beta-forming APP23 mice, a model of AD. These deficits are also fully rescued with a peptide that uncouples the Fyn-mediated interaction of NR and PSD-95 in vivo. Our findings suggest that this dendritic role of tau confers A beta toxicity at the postsynapse with direct implications for patho-genesis and treatment of AD.	[Ittner, Lars M.; Ke, Yazi D.; Delerue, Fabien; Bi, Mian; Gladbach, Amadeus; van Eersel, Janet; Woelfing, Heidrun; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2050, Australia; [Chieng, Billy C.; Christie, MacDonald J.; Napier, Ian A.] Univ Sydney, Brain & Mind Res Inst, Neuropharmacol Lab, Sydney, NSW 2050, Australia; [Eckert, Anne] Univ Basel, Psychiat Univ Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland; [Staufenbiel, Matthias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Hardeman, Edna] Univ New S Wales, Neuromuscular & Regenerat Med Unit, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; University of Basel; Novartis; University of New South Wales Sydney	Ittner, LM (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2050, Australia.	littner@med.usyd.edu.au; jgoetz@med.usyd.edu.au	Ke, Yazi/ABC-3052-2020; Götz, Jürgen/C-2448-2014; Hardeman, Edna C/F-8872-2012; Christie, MacDonald J/F-4724-2013; van Eersel, Janet/AAZ-4197-2020	Ke, Yazi/0000-0002-1423-0451; Götz, Jürgen/0000-0001-8501-7896; Christie, MacDonald J/0000-0002-0622-609X; van Eersel, Janet/0000-0002-1354-6171; Bi, Mian/0000-0002-4383-3606; Eckert, Anne/0000-0002-9341-3669; Hardeman, Edna/0000-0003-1649-7712; Ittner, Lars/0000-0001-6738-3825; Delerue, Fabien/0000-0001-7944-2108; Chieng, Billy/0000-0003-0222-8001	University of Sydney; National Health and Medical Research Council; Australian Research Council; Deutsche Forschungsgemeinschaft	University of Sydney(University of Sydney); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Yves-Alain Barde for providing tau<SUP>-/-</SUP> mice and him as well as Hanns Mohler and Nikolas Haass for helpful comments. This research was supported by grants from the University of Sydney, National Health and Medical Research Council, Australian Research Council, and Deutsche Forschungsgemeinschaft. J.G. is a Medical Foundation Fellow.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ashe KH, 2007, NEW ENGL J MED, V357, P933, DOI 10.1056/NEJMcibr073552; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CROWTHER T, 1989, ANN MED, V21, P127, DOI 10.3109/07853898909149199; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kojima N, 1998, LEARN MEMORY, V5, P429; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Lee G, 1998, J CELL SCI, V111, P3167; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roskam S, 2010, NEUROSCI BIOBEHAV R, V34, P487, DOI 10.1016/j.neubiorev.2009.10.006; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	54	1266	1322	3	248	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					387	397		10.1016/j.cell.2010.06.036	http://dx.doi.org/10.1016/j.cell.2010.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20655099	Bronze			2022-12-24	WOS:000280609100016
J	Wyatt, MA; Wang, WL; Roux, CM; Beasley, FC; Heinrichs, DE; Dunman, PM; Magarvey, NA				Wyatt, Morgan A.; Wang, Wenliang; Roux, Christelle M.; Beasley, Federico C.; Heinrichs, David E.; Dunman, Paul M.; Magarvey, Nathan A.			Staphylococcus aureus Nonribosomal Peptide Secondary Metabolites Regulate Virulence	SCIENCE			English	Article							NATURAL-PRODUCT; CLUMPING FACTOR; PATHOGENESIS; ANTIBIOTICS; EXPRESSION; BINDING; PROTEIN; GENES	Staphylococcus aureus is a major human pathogen that is resistant to numerous antibiotics in clinical use. We found two nonribosomal peptide secondary metabolites-the aureusimines, made by S. aureus-that are not antibiotics, but function as regulators of virulence factor expression and are necessary for productive infections. In vivo mouse models of bacteremia showed that strains of S. aureus unable to produce aureusimines were attenuated and/or cleared from major organs, including the spleen, liver, and heart. Targeting aureusimine synthesis may offer novel leads for anti-infective drugs.	[Wyatt, Morgan A.; Wang, Wenliang; Magarvey, Nathan A.] McMaster Univ, Dept Biochem & Biomed Sci, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Roux, Christelle M.; Dunman, Paul M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Beasley, Federico C.; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Beasley, Federico C.; Heinrichs, David E.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada	McMaster University; University of Nebraska System; University of Nebraska Medical Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Magarvey, NA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Dept Chem & Chem Biol, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	magarv@mcmaster.ca	Heinrichs, David/ABD-5702-2021	Heinrichs, David/0000-0002-7217-2456	McMaster University; Canadian Institutes of Health Research [MOP-38002]; NIH [RA107380, GSE21373]	McMaster University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by generous gifts from McMaster University (N.A.M.), Canadian Institutes of Health Research (MOP-38002 to D. E. H.), and NIH (RA107380 to P.M.D.). For animal infections, all protocols were reviewed and approved by the University of Western Ontario's Animal Use Subcommittee, a subcommittee of the University Council on Animal Care. Gene microarray data have been deposited in National Center for Biotechnology Information, NIH (accession no. GSE21373). N.A.M. declares no competing financial interests but does declare patent applications related to this work (U.S. patent applications, no. 61/183,152 and no. 61/306,239).	ALVAREZ ME, 1995, J ANTIBIOT, V48, P1165, DOI 10.7164/antibiotics.48.1165; Autret N, 2003, INFECT IMMUN, V71, P4463, DOI 10.1128/IAI.71.8.4463-4471.2003; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Becker JE, 2004, GENE, V325, P35, DOI 10.1016/j.gene.2003.09.034; Byford MF, 1997, CHEM REV, V97, P2631, DOI 10.1021/cr960018l; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fujii T, 2008, J BACTERIOL, V190, P7655, DOI 10.1128/JB.01489-07; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Heying R, 2007, THROMB HAEMOSTASIS, V97, P617, DOI 10.1160/TH06-11-0640; Kopp F, 2006, J AM CHEM SOC, V128, P16478, DOI 10.1021/ja0667458; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	28	89	90	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					294	296		10.1126/science.1188888	http://dx.doi.org/10.1126/science.1188888			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	625VW	20522739				2022-12-24	WOS:000279925900032
J	Houtkooper, RH; Williams, RW; Auwerx, J				Houtkooper, Riekelt H.; Williams, Robert W.; Auwerx, Johan			Metabolic Networks of Longevity	CELL			English	Article							EXTENDS LIFE-SPAN; MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; C-ELEGANS; RESVERATROL; SIRT1; MICE; RESTRICTION; DIET		[Houtkooper, Riekelt H.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Williams, Robert W.] Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tennessee System; University of Tennessee Health Science Center	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	johan.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Williams, Robert W./0000-0001-8924-4447; Auwerx, Johan/0000-0002-5065-5393	Netherlands Organization for Scientific Research; NIAAA; NIDA; NIMH; Ecole Polytechnique Federale de Lausanne; NIH [DK59820]; EU [ERC-2008-AdG-23118]; Swiss National Science Foundation (SNF) [31003A-124713]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ecole Polytechnique Federale de Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Ed Baetge, Ann Kato, Carles Canto, Penelope Andreux, and Evan G. Williams for helpful suggestions. R.H.H. is supported by a Rubicon fellowship of the Netherlands Organization for Scientific Research. GeneNetwork is supported by grants from the NIAAA, NIDA, and NIMH. The authors are supported by the Ecole Polytechnique Federale de Lausanne, NIH (DK59820), the EU Ideas program (Sirtuins; ERC-2008-AdG-23118), and the Swiss National Science Foundation (SNF 31003A-124713).	Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; CANTO C, 2010, J CELL METAB, V11, P213; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; GELMAN R, 1988, GENETICS, V118, P693; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Libert S, 2007, CELL, V131, P1231, DOI 10.1016/j.cell.2007.12.002; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	39	146	153	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					9	14		10.1016/j.cell.2010.06.029	http://dx.doi.org/10.1016/j.cell.2010.06.029			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603007	Bronze, Green Accepted			2022-12-24	WOS:000279637300005
J	Willeit, P; Willeit, J; Mayr, A; Weger, S; Oberhollenzer, F; Brandstatter, A; Kronenberg, F; Kiechl, S				Willeit, Peter; Willeit, Johann; Mayr, Agnes; Weger, Siegfried; Oberhollenzer, Friedrich; Brandstaetter, Anita; Kronenberg, Florian; Kiechl, Stefan			Telomere Length and Risk of Incident Cancer and Cancer Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN FIBROBLASTS; DYSFUNCTION; INSTABILITY; EXPRESSION; CARCINOMA; DISEASE; MEN	Context Telomeres are essential to preserve the integrity of the genome. Critically short telomeres lead to replicative cell senescence and chromosomal instability and may thereby increase cancer risk. Objective To determine the association between baseline telomere length and incident cancer and cancer mortality. Design, Setting, and Participants Leukocyte telomere length was measured by quantitative polymerase chain reaction in 787 participants free of cancer at baseline in 1995 from the prospective, population-based Bruneck Study in Italy. Main Outcome Measures Incident cancer and cancer mortality over a follow-up period of 10 years (1995-2005 with a follow-up rate of 100%). Results A total of 92 of 787 participants (11.7%) developed cancer (incidence rate, 13.3 per 1000 person-years). Short telomere length at baseline was associated with incident cancer independently of standard cancer risk factors (multivariable hazard ratio [HR] per 1-SD decrease in loge-transformed telomere length, 1.60; 95% confidence interval [CI], 1.30-1.98; P<.001). Compared with participants in the longest telomere length group, the multivariable HR for incident cancer was 2.15 (95% CI, 1.12-4.14) in the middle length group and 3.11 (95% CI, 1.65-5.84) in the shortest length group (P<.001). Incidence rates were 5.1 (95% CI, 2.9-8.7) per 1000 person-years in the longest telomere length group, 14.2 (95% CI, 10.0-20.1) per 1000 person-years in the middle length group, and 22.5 (95% CI, 16.9-29.9) per 1000 person-years in the shortest length group. The association equally applied to men and women and emerged as robust under a variety of circumstances. Furthermore, short telomere length was associated with cancer mortality (multivariable HR per 1-SD decrease in loge-transformed telomere length, 2.13; 95% CI, 1.58-2.86; P<.001) and individual cancer subtypes with a high fatality rate. Conclusion In this study population, there was a statistically significant inverse relationship between telomere length and both cancer incidence and mortality. JAMA. 2010;304(1):69-75 www.jama.com	[Willeit, Peter; Willeit, Johann; Kiechl, Stefan] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Human Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Weger, Siegfried; Oberhollenzer, Friedrich] Bruneck Hosp, Dept Internal Med, Brunico, Italy	Medical University of Innsbruck; Medical University of Innsbruck; University of Cambridge	Kiechl, S (corresponding author), Innsbruck Med Univ, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	stefan.kiechl@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Willeit, Peter/HCI-7091-2022	Kronenberg, Florian/0000-0003-2229-1120; Willeit, Peter/0000-0002-1866-7159; , Agnes Mayr/0000-0001-9363-873X; Kloss-Brandstatter, Anita/0000-0002-0873-6704	Dr Johannes and Hertha Tuba Foundation; Competence Centers for Excellent Technologies Center; ONCOTYROL; Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University; Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit, Province of Bolzano, Italy	Dr Johannes and Hertha Tuba Foundation; Competence Centers for Excellent Technologies Center; ONCOTYROL; Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University; Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit, Province of Bolzano, Italy	Dr P. Willeit was supported by a scholarship from the Dr Johannes and Hertha Tuba Foundation. Dr Kronenberg was supported by a grant from the Competence Centers for Excellent Technologies Center, ONCOTYROL, and the Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University. The study was supported by the Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck, and the Assessorat fuer Gesundheit, Province of Bolzano, Italy.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; DAVIDSON HR, 1988, J MED GENET, V25, P843, DOI 10.1136/jmg.25.12.843; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kiechl S, 2007, CIRCULATION, V116, P385, DOI 10.1161/CIRCULATIONAHA.106.686774; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Lee IM, 2010, CLIN CHEM LAB MED, V48, P259, DOI 10.1515/CCLM.2010.049; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Weng NP, 1997, IMMUNOL REV, V160, P43, DOI 10.1111/j.1600-065X.1997.tb01026.x; Wenning GK, 2005, LANCET NEUROL, V4, P815, DOI 10.1016/S1474-4422(05)70226-X; Wood C, 2005, CELL RES, V15, P947, DOI 10.1038/sj.cr.7290372; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360	34	358	375	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					69	75		10.1001/jama.2010.897	http://dx.doi.org/10.1001/jama.2010.897			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606151	Bronze			2022-12-24	WOS:000279519600023
J	Hang, CT; Yang, J; Han, P; Cheng, HL; Shang, C; Ashley, E; Zhou, B; Chang, CP				Hang, Calvin T.; Yang, Jin; Han, Pei; Cheng, Hsiu-Ling; Shang, Ching; Ashley, Euan; Zhou, Bin; Chang, Ching-Pin			Chromatin regulation by Brg1 underlies heart muscle development and disease	NATURE			English	Article							MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; DILATED CARDIOMYOPATHY; ISOFORM EXPRESSION; CARDIAC GROWTH; POLY(ADP-RIBOSE); HYPERTROPHY; INHIBITION; VENTRICLE	Cardiac hypertrophy and failure are characterized by transcriptional reprogramming of gene expression. Adult cardiomyocytes in mice primarily express alpha-myosin heavy chain (alpha-MHC, also known as Myh6), whereas embryonic cardiomyocytes express beta-MHC (also known as Myh7). Cardiac stress triggers adult hearts to undergo hypertrophy and a shift from alpha-MHC to fetal beta-MHC expression. Here we show that Brg1, a chromatin-remodelling protein, has a critical role in regulating cardiac growth, differentiation and gene expression. In embryos, Brg1 promotes myocyte proliferation by maintaining Bmp10 and suppressing p57(kip2) expression. It preserves fetal cardiac differentiation by interacting with histone deacetylase (HDAC) and poly (ADP ribose) polymerase (PARP) to repress alpha-MHC and activate beta-MHC. In adults, Brg1 (also known as Smarca4) is turned off in cardiomyocytes. It is reactivated by cardiac stresses and forms a complex with its embryonic partners, HDAC and PARP, to induce a pathological alpha-MHC to beta-MHC shift. Preventing Brg1 re-expression decreases hypertrophy and reverses this MHC switch. BRG1 is activated in certain patients with hypertrophic cardiomyopathy, its level correlating with disease severity and MHC changes. Our studies show that Brg1 maintains cardiomyocytes in an embryonic state, and demonstrate an epigenetic mechanism by which three classes of chromatin-modifying factors-Brg1, HDAC and PARP-cooperate to control developmental and pathological gene expression.	[Hang, Calvin T.; Yang, Jin; Han, Pei; Cheng, Hsiu-Ling; Shang, Ching; Ashley, Euan; Chang, Ching-Pin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chang, CP (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	chingpin@stanford.edu	Yang, Jin/C-5468-2013; Pei, Han/E-8237-2012		NIH; American Heart Association (AHA); Children's Heart Foundation; March of Dimes Foundation; Office of the University of California; California Institute of Regenerative Medicine; Kaiser Foundation; Baxter Foundation; Oak Foundation; Stanford Cardiovascular Institute; Kirschstein-NRSA Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Children's Heart Foundation; March of Dimes Foundation(March of Dimes); Office of the University of California; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Kaiser Foundation; Baxter Foundation; Oak Foundation; Stanford Cardiovascular Institute; Kirschstein-NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Black for providing Mef2c-cre mice; G. R. Crabtree, D. Bernstein, M. Rabinovitch, R. Robbins, V. Christoffels, W. Shou, J. Wysocka and K. Zhao for materials and discussions; B. Wu, A. Sun, J. Lehrer-Graiwer, W. Li, C. Y. Lin and C. J. Lin for technical assistance; M. Zhao, M. Zeini and K. Stankunas for technical advice to H.-L. C., P. H. and C. T. H. C.-P. C. was supported by funds from the NIH, American Heart Association (AHA), Children's Heart Foundation, March of Dimes Foundation, Office of the University of California, California Institute of Regenerative Medicine, Kaiser Foundation, Baxter Foundation, Oak Foundation, Stanford Cardiovascular Institute and W. Younger. C. T. H. was supported by predoctoral training fellowships from the NIH and AHA; H.-L. C. by a visiting scholar fellowship; C. S. by Kirschstein-NRSA Postdoctoral Fellowship; B.Z. by NIH and AHA grants.	Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Braunwald E., 1997, HEART DIS TXB CARDIO, V5th; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chang CP, 2003, GENESIS, V36, P7, DOI 10.1002/gene.10186; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; James J, 2005, CIRCULATION, V111, P2339, DOI 10.1161/01.CIR.0000164233.09448.B1; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORROW AG, 1961, ANN SURG, V154, P181, DOI 10.1097/00000658-196108000-00003; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Pandya K, 2008, P NATL ACAD SCI USA, V105, P13063, DOI 10.1073/pnas.0805120105; Pillai JB, 2006, AM J PHYSIOL-HEART C, V291, pH1545, DOI 10.1152/ajpheart.01124.2005; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573	39	329	347	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					62	U74		10.1038/nature09130	http://dx.doi.org/10.1038/nature09130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596014	Green Accepted			2022-12-24	WOS:000279343800035
J	Petukhova, L; Duvic, M; Hordinsky, M; Norris, D; Price, V; Shimomura, Y; Kim, H; Singh, P; Lee, A; Chen, WV; Meyer, KC; Paus, R; Jahoda, CAB; Amos, CI; Gregersen, PK; Christiano, AM				Petukhova, Lynn; Duvic, Madeleine; Hordinsky, Maria; Norris, David; Price, Vera; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Lee, Annette; Chen, Wei V.; Meyer, Katja C.; Paus, Ralf; Jahoda, Colin A. B.; Amos, Christopher I.; Gregersen, Peter K.; Christiano, Angela M.			Genome-wide association study in alopecia areata implicates both innate and adaptive immunity	NATURE			English	Article							AUTOIMMUNE-DISEASE; HAIR FOLLICLE; NKG2D LIGAND; RISK LOCUS; EXPRESSION; CANCER; GENES; CELLS; PEROXIREDOXIN-5; SUSCEPTIBILITY	Alopecia areata (AA) is among the most highly prevalent human autoimmune diseases, leading to disfiguring hair loss due to the collapse of immune privilege of the hair follicle and subsequent autoimmune attack(1,2). The genetic basis of AA is largely unknown. We undertook a genome-wide association study (GWAS) in a sample of 1,054 cases and 3,278 controls and identified 139 single nucleotide polymorphisms that are significantly associated with AA (P <= 5 x 10(-7)). Here we show an association with genomic regions containing several genes controlling the activation and proliferation of regulatory T cells (T-reg cells), cytotoxic T lymphocyte-associated antigen 4 (CTLA4), interleukin (IL)-2/IL-21, IL-2 receptor A (IL-2RA; CD25) and Eos (also known as Ikaros family zinc finger 4; IKZF4), as well as the human leukocyte antigen (HLA) region. We also find association evidence for regions containing genes expressed in the hair follicle itself (PRDX5 and STX17). A region of strong association resides within the ULBP (cytomegalovirus UL16-binding protein) gene cluster on chromosome 6q25.1, encoding activating ligands of the natural killer cell receptor NKG2D that have not previously been implicated in an autoimmune disease. By probing the role of ULBP3 in disease pathogenesis, we also show that its expression in lesional scalp from patients with AA is markedly upregulated in the hair follicle dermal sheath during active disease. This study provides evidence for the involvement of both innate and acquired immunity in the pathogenesis of AA. We have defined the genetic underpinnings of AA, placing it within the context of shared pathways among autoimmune diseases, and implicating a novel disease mechanism, the upregulation of ULBP ligands, in triggering autoimmunity.	[Petukhova, Lynn; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Duvic, Madeleine] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Hordinsky, Maria] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; [Norris, David] Univ Colorado, Dept Dermatol, Denver, CO 80010 USA; [Price, Vera] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Lee, Annette; Gregersen, Peter K.] N Shore LIJHS, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Chen, Wei V.; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Meyer, Katja C.; Paus, Ralf] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England; [Jahoda, Colin A. B.] Univ Durham, Dept Biol Sci, Durham DH1 3LE, England; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Denver; University of California System; University of California San Francisco; Northwell Health; University of Texas System; UTMD Anderson Cancer Center; University of Lubeck; University of Manchester; Durham University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	amc65@columbia.edu	; Paus, Ralf/B-5279-2015	Jahoda, Colin/0000-0002-1762-1220; Paus, Ralf/0000-0002-3492-9358	National Alopecia Areata Foundation (NAAF); DFG Cluster of Excellence, Inflammation at Interfaces; National Institutes of Health [R01AR44422, R01CA133996, P30CA016772, R01AR52579, R01AR56016]; NATIONAL CANCER INSTITUTE [R01CA133996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, R01AR056016, R01AR052579] Funding Source: NIH RePORTER	National Alopecia Areata Foundation (NAAF); DFG Cluster of Excellence, Inflammation at Interfaces(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the many patients and their family members who participated in the National Alopecia Areata Registry from which the patient cohort was derived; S. Schwartz, D. A. Greenberg, S. E. Hodge, R. Ottman, K. Kiryluk, J. Lee, J. D. Terwilliger and R. Plenge for discussions about statistical methodology; A. Bowcock, M. Girardi, R. Clark, J. Trowsdale, R. Clynes, S. Ghosh and R. Bernstein for critical insights and perspectives on genetics, hair and immunobiology; C. Higgins, M. Kurban, M. Kiuru, H. Lam and M. Zhang for expert assistance in the laboratory; A. Martinez-Mir, M. Peacocke, A. Zlotogorski, M. Grossman, P. Schneiderman, D. Gordon and J. Ott for their critical input in the early phases of this study. We are grateful to the National Alopecia Areata Foundation (NAAF) for support of funding the initial studies, and to V. Kalabokes and her staff at NAAF for their efforts on our behalf. The patient cohort was collected and maintained by the National Alopecia Areata Registry (N01AR62279) (to M. D.). This work was supported in part by the DFG Cluster of Excellence, Inflammation at Interfaces (to R. P.) and by the National Institutes of Health grants R01AR44422 (to C. I. A. and P. K. G.), R01CA133996 and P30CA016772 (to C. I. A.) and R01AR52579 and R01AR56016 (to A. M. C.).	Akar A, 2002, J DERMATOL SCI, V29, P85, DOI 10.1016/S0923-1811(02)00015-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Caillat-Zucman S, 2006, HUM IMMUNOL, V67, P204, DOI 10.1016/j.humimm.2006.02.013; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Duvic M, 2003, J INVEST DERM SYMP P, V8, P219, DOI 10.1046/j.1087-0024.2003.00814.x; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Gerard AC, 2005, THYROID, V15, P205, DOI 10.1089/thy.2005.15.205; Gilhar A, 1999, J INVEST DERM SYMP P, V4, P207, DOI 10.1038/sj.jidsp.5640212; Gilhar A, 2003, CLIN IMMUNOL, V106, P181, DOI 10.1016/S1521-6616(02)00042-6; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Holley JE, 2007, MULT SCLER, V13, P955, DOI 10.1177/1352458507078064; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; Ito Taisuke, 2008, V10, P27, DOI 10.1159/000131412; Jackow C, 1998, J AM ACAD DERMATOL, V38, P418, DOI 10.1016/S0190-9622(98)70499-2; JELINEK JE, 1972, B NEW YORK ACAD MED, V48, P1003; Karasawa R, 2005, MICROBIOL IMMUNOL, V49, P57, DOI 10.1111/j.1348-0421.2005.tb03640.x; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonagh AJG, 2002, CLIN EXP DERMATOL, V27, P409, DOI 10.1046/j.1365-2230.2002.01077.x; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Monteleone G, 2009, TRENDS PHARMACOL SCI, V30, P441, DOI 10.1016/j.tips.2009.05.006; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; VANDERSTEEN P, 1992, ACTA DERM-VENEREOL, V72, P373; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	39	472	491	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					113	U129		10.1038/nature09114	http://dx.doi.org/10.1038/nature09114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596022	Green Accepted			2022-12-24	WOS:000279343800045
J	Iannacone, M; Moseman, EA; Tonti, E; Bosurgi, L; Junt, T; Henrickson, SE; Whelan, SP; Guidotti, LG; von Andrian, UH				Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Junt, Tobias; Henrickson, Sarah E.; Whelan, Sean P.; Guidotti, Luca G.; von Andrian, Ulrich H.			Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus	NATURE			English	Article							LIPOSOME-MEDIATED DEPLETION; VESICULAR STOMATITIS-VIRUS; IN-VIVO DEPLETION; CD8(+) T-CELLS; LYMPH-NODES; B-CELLS; DENDRITIC CELLS; MICE; ACTIVATION; ANTIGEN	Lymph nodes (LNs) capture microorganisms that breach the body's external barriers and enter draining lymphatics, limiting the systemic spread of pathogens(1). Recent work has shown that CD11b(+)CD169(+) macrophages, which populate the subcapsular sinus (SCS) of LNs, are critical for the clearance of viruses from the lymph and for initiating antiviral humoral immune responses(2-4). Here we show, using vesicular stomatitis virus (VSV), a relative of rabies virus transmitted by insect bites, that SCS macrophages perform a third vital function: they prevent lymph-borne neurotropic viruses from infecting the central nervous system (CNS). On local depletion of LN macrophages, about 60% of mice developed ascending paralysis and died 7-10 days after subcutaneous infection with a small dose of VSV, whereas macrophage-sufficient animals remained asymptomatic and cleared the virus. VSV gained access to the nervous system through peripheral nerves in macrophage-depleted LNs. In contrast, within macrophage-sufficient LNs VSV replicated preferentially in SCS macrophages but not in adjacent nerves. Removal of SCS macrophages did not compromise adaptive immune responses against VSV, but decreased type I interferon (IFN-I) production within infected LNs. VSV-infected macrophages recruited IFN-I-producing plasmacytoid dendritic cells to the SCS and in addition were a major source of IFN-I themselves. Experiments in bone marrow chimaeric mice revealed that IFN-I must act on both haematopoietic and stromal compartments, including the intranodal nerves, to prevent lethal infection with VSV. These results identify SCS macrophages as crucial gatekeepers to the CNS that prevent fatal viral invasion of the nervous system on peripheral infection.	[Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Iannacone, Matteo; Guidotti, Luca G.] Ist Sci San Raffaele, Dept Immunol Infect Dis & Transplantat, I-20132 Milan, Italy; [Junt, Tobias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Novartis; Harvard University; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	Matteo_Iannacone@hms.harvard.edu; uva@hms.harvard.edu	Junt, Tobias/AAE-4389-2021; von Andrian, Ulrich H/A-5775-2008; Iannacone, Matteo/I-8507-2018; Guidotti, Luca G. G/I-8542-2018	Iannacone, Matteo/0000-0002-9370-2671; Guidotti, Luca G. G/0000-0002-0205-2678; Henrickson, Sarah/0000-0001-5569-4132; Bosurgi, Lidia/0000-0002-8775-4950; Tonti, Elena/0000-0001-5002-7613; Whelan, Sean/0000-0003-1564-8590	National Institutes of Health (NIH) [AI069259, AI072252, AI078897, AR42689]; Giovanni Armenise-Harvard Foundation; NIH; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, P01AI078897, R01AI072252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise-Harvard Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Cheng and M. Flynn for technical support; J. Alton for secretarial assistance; D. Cureton for help and advice with VSV preparations; H. Leung for help with image quantification; R. M. Zinkernagel and H. Hengartner for providing tg7 mice; R. Bronson for help with reading neuropathology; S. Cohen for advice on nerve staining; N. van Rooijen for clodronate liposomes; and the members of the von Andrian laboratory for discussion. This work was supported by National Institutes of Health (NIH) grants AI069259, AI072252, AI078897 and AR42689 (to U.H.v.A.), the Giovanni Armenise-Harvard Foundation (to M.I.) and a NIH T32 Training Grant in Hematology (to E.A.M.).	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1363; Maloy KJ, 1999, J IMMUNOL, V162, P2867; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Shao CX, 2007, MICROSURG, V27, P487, DOI 10.1002/micr.20392; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388	26	236	237	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1079	U143		10.1038/nature09118	http://dx.doi.org/10.1038/nature09118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577213	Green Accepted			2022-12-24	WOS:000279056900053
J	Schindler, DE; Hilborn, R; Chasco, B; Boatright, CP; Quinn, TP; Rogers, LA; Webster, MS				Schindler, Daniel E.; Hilborn, Ray; Chasco, Brandon; Boatright, Christopher P.; Quinn, Thomas P.; Rogers, Lauren A.; Webster, Michael S.			Population diversity and the portfolio effect in an exploited species	NATURE			English	Article							PACIFIC SALMON; FRESH-WATER; BIODIVERSITY; FISHERIES; BIOCOMPLEXITY; MANAGEMENT; NUTRIENTS; DYNAMICS	One of the most pervasive themes in ecology is that biological diversity stabilizes ecosystem processes and the services they provide to society(1-4), a concept that has become a common argument for biodiversity conservation(5). Species-rich communities are thought to produce more temporally stable ecosystem services because of the complementary or independent dynamics among species that perform similar ecosystem functions(6). Such variance dampening within communities is referred to as a portfolio effect(7) and is analogous to the effects of asset diversity on the stability of financial portfolios(8). In ecology, these arguments have focused on the effects of species diversity on ecosystem stability but have not considered the importance of biologically relevant diversity within individual species(9). Current rates of population extirpation are probably at least three orders of magnitude higher than species extinction rates(10), so there is a pressing need to clarify how population and life history diversity affect the performance of individual species in providing important ecosystem services. Here we use five decades of data from Oncorhynchus nerka (sockeye salmon) in Bristol Bay, Alaska, to provide the first quantification of portfolio effects that derive from population and life history diversity in an important and heavily exploited species. Variability in annual Bristol Bay salmon returns is 2.2 times lower than it would be if the system consisted of a single homogenous population rather than the several hundred discrete populations it currently consists of. Furthermore, if it were a single homogeneous population, such increased variability would lead to ten times more frequent fisheries closures. Portfolio effects are also evident in watershed food webs, where they stabilize and extend predator access to salmon resources. Our results demonstrate the critical importance of maintaining population diversity for stabilizing ecosystem services and securing the economies and livelihoods that depend on them. The reliability of ecosystem services will erode faster than indicated by species loss alone.	[Schindler, Daniel E.; Hilborn, Ray; Chasco, Brandon; Boatright, Christopher P.; Quinn, Thomas P.; Rogers, Lauren A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Webster, Michael S.] Gordon & Betty Moore Fdn, Palo Alto, CA 94304 USA	University of Washington; University of Washington Seattle	Schindler, DE (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	deschind@u.washington.edu	Hilborn, Ray W/D-6332-2013; Ebersole, Joseph L/A-8371-2009	Rogers, Lauren/0000-0003-3305-6441	Gordon and Betty Moore Foundation; US National Science Foundation; University of Washington; Alaska salmon processing industry; H. Mason Keeler Professorship	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF)); University of Washington(University of Washington); Alaska salmon processing industry; H. Mason Keeler Professorship	We thank the Gordon and Betty Moore Foundation, the US National Science Foundation, the University of Washington, the Alaska salmon processing industry and the H. Mason Keeler Professorship for support for this work. N. Baron, L. Neeley and S. Sethi provided feedback and comments on the manuscript, and P. Lisi and G. Holtgrieve helped prepare the figures.	Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Elton C., 1958; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Helfield JM, 2006, ECOSYSTEMS, V9, P167, DOI 10.1007/s10021-004-0063-5; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Hutchinson WF, 2008, BIOL LETTERS, V4, P693, DOI 10.1098/rsbl.2008.0443; Lindley S.T., 2009, WHAT CAUSED SACRAMEN; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Olsen EM, 2008, EVOL APPL, V1, P524, DOI 10.1111/j.1752-4571.2008.00024.x; Payne LX, 2006, OIKOS, V115, P69; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Schindler DE, 2008, FISHERIES, V33, P502, DOI 10.1577/1548-8446-33.10.502; Schindler DE, 2005, ECOLOGY, V86, P3225, DOI 10.1890/04-1730; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; WEST FW, 2006, FISHERY DATA SERIES, V647	31	973	996	20	656	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					609	612		10.1038/nature09060	http://dx.doi.org/10.1038/nature09060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20520713				2022-12-24	WOS:000278249000040
J	Breitkreutz, A; Choi, H; Sharom, JR; Boucher, L; Neduva, V; Larsen, B; Lin, ZY; Breitkreutz, BJ; Stark, C; Liu, GM; Ahn, J; Dewar-Darch, D; Reguly, T; Tang, XJ; Almeida, R; Qin, ZS; Pawson, T; Gingras, AC; Nesvizhskii, AI; Tyers, M				Breitkreutz, Ashton; Choi, Hyungwon; Sharom, Jeffrey R.; Boucher, Lorrie; Neduva, Victor; Larsen, Brett; Lin, Zhen-Yuan; Breitkreutz, Bobby-Joe; Stark, Chris; Liu, Guomin; Ahn, Jessica; Dewar-Darch, Danielle; Reguly, Teresa; Tang, Xiaojing; Almeida, Ricardo; Qin, Zhaohui Steve; Pawson, Tony; Gingras, Anne-Claude; Nesvizhskii, Alexey I.; Tyers, Mike			A Global Protein Kinase and Phosphatase Interaction Network in Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PHOSPHORYLATION; TRANSDUCTION; PROTEOMICS; FEEDBACK; MITOSIS; SIGNAL	The interactions of protein kinases and phosphatases with their regulatory subunits and substrates underpin cellular regulation. We identified a kinase and phosphatase interaction (KPI) network of 1844 interactions in budding yeast by mass spectrometric analysis of protein complexes. The KPI network contained many dense local regions of interactions that suggested new functions. Notably, the cell cycle phosphatase Cdc14 associated with multiple kinases that revealed roles for Cdc14 in mitogen-activated protein kinase signaling, the DNA damage response, and metabolism, whereas interactions of the target of rapamycin complex 1 (TORC1) uncovered new effector kinases in nitrogen and carbon metabolism. An extensive backbone of kinase-kinase interactions cross-connects the proteome and may serve to coordinate diverse cellular responses.	[Breitkreutz, Ashton; Sharom, Jeffrey R.; Boucher, Lorrie; Larsen, Brett; Lin, Zhen-Yuan; Breitkreutz, Bobby-Joe; Stark, Chris; Liu, Guomin; Ahn, Jessica; Dewar-Darch, Danielle; Reguly, Teresa; Tang, Xiaojing; Pawson, Tony; Gingras, Anne-Claude; Tyers, Mike] Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Choi, Hyungwon; Nesvizhskii, Alexey I.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Sharom, Jeffrey R.; Pawson, Tony; Gingras, Anne-Claude; Tyers, Mike] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Neduva, Victor; Almeida, Ricardo; Tyers, Mike] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Neduva, Victor; Almeida, Ricardo; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Qin, Zhaohui Steve] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey I.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Michigan System; University of Michigan; University of Toronto; University of Edinburgh; University of Edinburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gingras, AC (corresponding author), Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; nesvi@med.umich.edu; tyers@lunenfeld.ca	Pawson, Tony J/E-4578-2013; Tyers, Michael/ABE-3194-2021; Gingras, Anne-Claude/ABA-8341-2020; Qin, Zhaohui S/E-8196-2011; Nesvizhskii, Alexey/A-5410-2012; Choi, Hyungwon/S-8824-2019; Qin, Zhaohui/Q-3133-2019; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Qin, Zhaohui S/0000-0002-1583-146X; Nesvizhskii, Alexey/0000-0002-2806-7819; Choi, Hyungwon/0000-0002-6687-3088; Qin, Zhaohui/0000-0002-1583-146X; Gingras, Anne-Claude/0000-0002-6090-4437	Canadian Institutes of Health Research [MOP-84314, MOP-57793, MOP-12246]; Ontario Research Fund [-044]; National Institutes of Health; National Center for Research Resources [R01RR024031]; National Cancer Institute of Canada; Canada Research Chairs in Functional Genomics and Bioinformatics; Functional Proteomics; Lea Reichmann Chair in Cancer Proteomics; Royal Society;  [CA-126239]; NATIONAL CANCER INSTITUTE [R01CA126239] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR024031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010929] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chairs in Functional Genomics and Bioinformatics(Canada Research Chairs); Functional Proteomics; Lea Reichmann Chair in Cancer Proteomics; Royal Society(Royal Society of London); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Raught, A. Amon, L. Harrington, J. Bader, M. Costanzo, B. Andrews, C. Boone, R. Aebersold, B. Bodenmiller, I. Sadowski, and F. Sicheri for discussions; J. P. Zhang and D. Fermin for technical support; and M. Snyder, Y. Ohsumi, S. Piatti, S. Hahn, H. Reizman, S. Biggins, T. Petes, M. P. Longhese, and D. Mao for reagents. Supported by grants from the Canadian Institutes of Health Research to A. C. G. (MOP-84314), T. P. (MOP-57793), and M. T. (MOP-12246); the Ontario Research Fund to T. P. and A. C. G. (REO#-044); the National Institutes of Health to M. T. (R01RR024031 from the National Center for Research Resources) and A.I.N. (CA-126239); a Terry Fox Foundation Research Studentship from the National Cancer Institute of Canada to J. R. S.; Federation of European Biochemical Societies and Marie Curie Fellowships to V.N.; Canada Research Chairs in Functional Genomics and Bioinformatics (to M. T.) and in Functional Proteomics (to A. C. G.); the Lea Reichmann Chair in Cancer Proteomics to A. C. G.; and a Scottish Universities Life Sciences Alliance Research Professorship and a Royal Society Wolfson Research Merit Award to M.	Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Magasanik B, 2005, P NATL ACAD SCI USA, V102, P16537, DOI 10.1073/pnas.0507116102; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Reiser V, 2006, MOL BIOL CELL, V17, P3136, DOI 10.1091/mbc.E05-12-1102; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	22	494	512	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1043	1046		10.1126/science.1176495	http://dx.doi.org/10.1126/science.1176495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489023	Green Accepted			2022-12-24	WOS:000277877100045
J	Garcia-Pino, A; Balasubramanian, S; Wyns, L; Gazit, E; De Greve, H; Magnuson, RD; Charlier, D; van Nuland, NAJ; Loris, R				Garcia-Pino, Abel; Balasubramanian, Sreeram; Wyns, Lode; Gazit, Ehud; De Greve, Henri; Magnuson, Roy D.; Charlier, Daniel; van Nuland, Nico A. J.; Loris, Remy			Allostery and Intrinsic Disorder Mediate Transcription Regulation by Conditional Cooperativity	CELL			English	Article							PLASMID ADDICTION SYSTEM; SCATTERING DATA-ANALYSIS; X-RAY-SCATTERING; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; YEFM ANTITOXIN; TOXIN; PHD; PROTEIN; REPRESSOR	Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co- or derepressor depending on the ratio between Phd and Doc, a phenomenon known as conditional cooperativity. The mechanism underlying this observed behavior is not understood. Here we show that monomeric Doc engages two Phd dimers on two unrelated binding sites. The binding of Doc to the intrinsically disordered C-terminal domain of Phd structures its N-terminal DNA-binding domain, illustrating allosteric coupling between highly disordered and highly unstable domains. This allosteric effect also couples Doc neutralization to the conditional regulation of transcription. In this way, higher levels of Doc tighten repression up to a point where the accumulation of toxin triggers the production of Phd to counteract its action. Our experiments provide the basis for understanding the mechanism of conditional cooperative regulation of transcription typical of toxin-antitoxin modules. This model may be applicable for the regulation of other biological systems.	[Garcia-Pino, Abel; Wyns, Lode; De Greve, Henri; Charlier, Daniel; van Nuland, Nico A. J.; Loris, Remy] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Garcia-Pino, Abel; Wyns, Lode; De Greve, Henri; van Nuland, Nico A. J.; Loris, Remy] Free Univ Brussels VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Balasubramanian, Sreeram; Magnuson, Roy D.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Gazit, Ehud] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Alabama System; University of Alabama Huntsville; Tel Aviv University	Garcia-Pino, A (corresponding author), Vrije Univ Brussel, Pl Laan 2, B-1050 Brussels, Belgium.	agarciap@vub.ac.be; reloris@vub.ac.be	Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/C-3715-2011; Loris, Remy/GPG-0894-2022; Gazit, Ehud/M-8026-2019	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Charlier, Daniel/0000-0002-6844-376X; Garcia-Pino, Abel/0000-0002-0634-0300; Loris, Remy/0000-0002-8862-3338	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; NIH NIGMS [2R15GM067668-03, 2R15GM067668-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM067668] Funding Source: NIH RePORTER	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge financial support from the Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), the Onderzoeksraad of the Vrije Universiteit Brussel, and NIH NIGMS grants 2R15GM067668-03 and 2R15GM067668-04. The authors acknowledge the use of beamtime at the EMBL beamlines at the DESY (Hamburg, Germany) synchrotron and at the ESRF (Grenoble, France) and SOLEIL (Gif-sur-Yvette, France) synchrotrons. The authors thank Dr. P. Pernot (ESRF) for assistance with the collection of SAXS data and K. Wahni and S. Haesarts for technical support with protein purification.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Afonine P., 2005, CCP4 NEWSL, V42, P1; Albright RA, 1998, P NATL ACAD SCI USA, V95, P3431, DOI 10.1073/pnas.95.7.3431; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Porod G., 1982, GEN THEORY SMALL ANG; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Zhao XY, 2005, J BACTERIOL, V187, P1901, DOI 10.1128/JB.187.6.1901-1912.2005	38	187	191	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					101	111		10.1016/j.cell.2010.05.039	http://dx.doi.org/10.1016/j.cell.2010.05.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603017	Bronze			2022-12-24	WOS:000279637300016
J	Ricklefs, RE; Outlaw, DC				Ricklefs, Robert E.; Outlaw, Diana C.			A Molecular Clock for Malaria Parasites	SCIENCE			English	Article							AVIAN MALARIA; CO-SPECIATION; EVOLUTION; PLASMODIUM; PREVALENCE; PHYLOGENY; PATTERNS; ORIGIN; GENERA	The evolutionary origins of new lineages of pathogens are fundamental to understanding emerging diseases. Phylogenetic reconstruction based on DNA sequences has revealed the sister taxa of human pathogens, but the timing of host-switching events, including the human malaria pathogen Plasmodium falciparum, remains controversial. Here, we establish a rate for cytochrome b evolution in avian malaria parasites relative to its rate in birds. We found that the parasite cytochrome b gene evolves about 60% as rapidly as that of host cytochrome b, corresponding to similar to 1.2% sequence divergence per million years. This calibration puts the origin of P. falciparum at 2.5 million years ago (Ma), the initial radiation of mammalian Plasmodium at 12.8 Ma, and the contemporary global diversity of the Haemosporida across terrestrial vertebrates at 16.2 Ma.	[Ricklefs, Robert E.; Outlaw, Diana C.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	ricklefs@umsl.edu			NSF [DEB 0542390]; University of Missouri; Alexander von Humboldt Foundation	NSF(National Science Foundation (NSF)); University of Missouri; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank S. S. Renner and two anonymous reviewers for constructive comments on the manuscript. The study was supported by NSF DEB 0542390 to R.E.R., who also acknowledges the generous support of the Curators of the University of Missouri and the Alexander von Humboldt Foundation.	Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2004, P ROY SOC B-BIOL SCI, V271, P493, DOI 10.1098/rspb.2003.2621; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Latta SC, 2010, J AVIAN BIOL, V41, P25, DOI 10.1111/j.1600-048X.2009.04685.x; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Nerlich AG, 2008, EMERG INFECT DIS, V14, P1317, DOI 10.3201/eid1408.080235; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Outlaw DC, 2010, MOL BIOL EVOL, V27, P537, DOI 10.1093/molbev/msp283; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Page Roderic D. M., 1996, P255; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Sallares R, 2004, MED HIST, V48, P311, DOI 10.1017/S0025727300007651; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Garamszegi LZ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-110	31	105	105	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					226	229		10.1126/science.1188954	http://dx.doi.org/10.1126/science.1188954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616281				2022-12-24	WOS:000279635200052
J	Behar, DM; Yunusbayev, B; Metspalu, M; Metspalu, E; Rosset, S; Parik, J; Rootsi, S; Chaubey, G; Kutuev, I; Yudkovsky, G; Khusnutdinova, EK; Balanovsky, O; Semino, O; Pereira, L; Comas, D; Gurwitz, D; Bonne-Tamir, B; Parfitt, T; Hammer, MF; Skorecki, K; Villems, R				Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Rosset, Saharon; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Yudkovsky, Guennady; Khusnutdinova, Elza K.; Balanovsky, Oleg; Semino, Ornella; Pereira, Luisa; Comas, David; Gurwitz, David; Bonne-Tamir, Batsheva; Parfitt, Tudor; Hammer, Michael F.; Skorecki, Karl; Villems, Richard			The genome-wide structure of the Jewish people	NATURE			English	Article							POPULATION STRATIFICATION; EUROPEAN AMERICANS; MIDDLE-EASTERN; ANCESTRY; INDIVIDUALS; ASSOCIATION; GENOTYPE; PATTERNS	Contemporary Jews comprise an aggregate of ethno-religious communities whose worldwide members identify with each other through various shared religious, historical and cultural traditions(1,2). Historical evidence suggests common origins in the Middle East, followed by migrations leading to the establishment of communities of Jews in Europe, Africa and Asia, in what is termed the Jewish Diaspora(3-5). This complex demographic history imposes special challenges in attempting to address the genetic structure of the Jewish people(6). Although many genetic studies have shed light on Jewish origins and on diseases prevalent among Jewish communities, including studies focusing on uniparentally and biparentally inherited markers(7-16), genome-wide patterns of variation across the vast geographic span of Jewish Diaspora communities and their respective neighbours have yet to be addressed. Here we use high-density bead arrays to genotype individuals from 14 Jewish Diaspora communities and compare these patterns of genome-wide diversity with those from 69 Old World non-Jewish populations, of which 25 have not previously been reported. These samples were carefully chosen to provide comprehensive comparisons between Jewish and non-Jewish populations in the Diaspora, as well as with non-Jewish populations from the Middle East and north Africa. Principal component and structure-like analyses identify previously unrecognized genetic substructure within the Middle East. Most Jewish samples form a remarkably tight subcluster that overlies Druze and Cypriot samples but not samples from other Levantine populations or paired Diaspora host populations. In contrast, Ethiopian Jews (Beta Israel) and Indian Jews (Bene Israel and Cochini) cluster with neighbouring autochthonous populations in Ethiopia and western India, respectively, despite a clear paternal link between the Bene Israel and the Levant. These results cast light on the variegated genetic architecture of the Middle East, and trace the origins of most Jewish Diaspora communities to the Levant.	[Behar, Doron M.; Yudkovsky, Guennady; Skorecki, Karl] Mol Med Lab, IL-31096 Haifa, Israel; [Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Villems, Richard] Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia; [Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Yunusbayev, Bayazit; Kutuev, Ildus; Khusnutdinova, Elza K.] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Rosset, Saharon] Tel Aviv Univ, Sch Math Sci, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel; [Yudkovsky, Guennady; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, IL-31096 Haifa, Israel; [Balanovsky, Oleg] Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; [Semino, Ornella] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Pereira, Luisa] IPATIMUP, P-4200465 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal; [Comas, David] CEXS UPF PRBB, Inst Evolutionary Biol, CSIC, Barcelona 08003, Spain; [Comas, David] CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; [Gurwitz, David; Bonne-Tamir, Batsheva] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Parfitt, Tudor] Univ London Sch Oriental & African Studies, Fac Languages & Cultures, Dept Languages & Cultures Near & Middle E, London WC1H 0XG, England; [Hammer, Michael F.] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA	Rambam Health Care Campus; Estonian Biocentre; University of Tartu; University of Tartu; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Tel Aviv University; Technion Israel Institute of Technology; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; University of Pavia; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Tel Aviv University; Sackler Faculty of Medicine; University of London; University of London School Oriental & African Studies (SOAS); University of Arizona	Behar, DM (corresponding author), Mol Med Lab, Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	behardm@usernet.com; skorecki@tx.technion.ac.il; rvillems@ebc.ee	Metspalu, Mait/G-8671-2015; Chaubey, Gyaneshwer/H-2753-2012; Comas, David/D-5382-2014; Chaubey, Gyaneshwer/AAC-6409-2019; Pereira, Luisa/H-3050-2011; Yunusbaev, Bayazit/T-5444-2019; Gurwitz, David/E-7642-2013; Khusnutdinova, Elza Kamilevna/A-4810-2013; Balanovsky, Oleg/G-1549-2014	Metspalu, Mait/0000-0003-3099-9161; Chaubey, Gyaneshwer/0000-0003-2899-3852; Comas, David/0000-0002-5075-0956; Chaubey, Gyaneshwer/0000-0003-2899-3852; Pereira, Luisa/0000-0002-4271-1527; Gurwitz, David/0000-0002-9363-1869; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Yunusbayev, Bayazit/0000-0002-6035-8763; SEMINO, Ornella/0000-0002-9675-9403	European Commission [205419]; European Union through a Centre of Excellence in Genomics; Swedish Collegium for Advanced Studies; Estonian Science Foundation [7858, 7445]; Arthur and Rosalinde Gilbert Foundation; American Technion Society; European Union for Marie Curie International Reintegration [CT-2007-208019]; Israeli Science Foundation [1227/09]; Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education; Fundacao para a Ciencia ea Tecnologia; Portuguese Foundation for Science and Technology	European Commission(European CommissionEuropean Commission Joint Research Centre); European Union through a Centre of Excellence in Genomics; Swedish Collegium for Advanced Studies; Estonian Science Foundation; Arthur and Rosalinde Gilbert Foundation; American Technion Society; European Union for Marie Curie International Reintegration; Israeli Science Foundation(Israel Science Foundation); Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education; Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We thank the individuals who provided DNA samples for this study, including the National Laboratory for the Genetics of Israeli Populations; Mari Nelis, Georgi Hudjashov and Viljo Soo for conducting the autosomal genotyping; Lauri Anton for computational help. R. V. and D. M. B. thank the European Commission, Directorate-General for Research for FP7 Ecogene grant 205419. R. V. thanks the European Union, Regional Development Fund through a Centre of Excellence in Genomics grant and the Swedish Collegium for Advanced Studies for support during the initial stage of this study. E. M. and Si. R. thank the Estonian Science Foundation for grants 7858 and 7445, respectively. K. S. thanks the Arthur and Rosalinde Gilbert Foundation fund of the American Technion Society. Sa. R. thanks the European Union for Marie Curie International Reintegration grant CT-2007-208019, and the Israeli Science Foundation for grant 1227/09. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partly supported by Fundacao para a Ciencia ea Tecnologia, the Portuguese Foundation for Science and Technology.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, V4; De Lange N, 1984, ATLAS JEWISH WORLD; Gao XY, 2009, HUM HERED, V68, P182, DOI 10.1159/000224638; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hourani Albert, 1991, HIST ARAB PEOPLES; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kopelman NM, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-80; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mahler Raphael, 1971, HIST MODERN JEWRY; Need AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r7; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olshen AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-14; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sergio DellaPergola, 1997, PAPERS JEWISH DEMOGR, P11; Stillman, 1979, JEWS ARAB LANDS HIST; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Weiss KM, 2009, GENOME RES, V19, P703, DOI 10.1101/gr.076539.108	30	270	275	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					238	U112		10.1038/nature09103	http://dx.doi.org/10.1038/nature09103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20531471				2022-12-24	WOS:000279580800037
J	Devireddy, LR; Hart, DO; Goetz, DH; Green, MR				Devireddy, Laxminarayana R.; Hart, Daniel O.; Goetz, David H.; Green, Michael R.			A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production	CELL			English	Article							RNA-BINDING PROTEIN; MITOCHONDRIAL IRON; ESCHERICHIA-COLI; LABILE IRON; DEHYDROGENASE; LIPOCALIN; APOPTOSIS; ACONITASE; MITOFERRIN; INDUCTION	Intracellular iron homeostasis is critical for survival and proliferation. Lipocalin 24p3 is an iron-trafficking protein that binds iron through association with a bacterial siderophore, such as enterobactin, or a postulated mammalian siderophore. Here, we show that the iron-binding moiety of the 24p3-associated mammalian siderophore is 2,5-dihydroxybenzoic acid (2,5-DHBA), which is similar to 2,3-DHBA, the iron-binding component of enterobactin. We find that the murine enzyme responsible for 2,5-DHBA synthesis, BDH2, is the homolog of bacterial EntA, which catalyzes 2,3-DHBA production during enterobactin biosynthesis. RNA interference-mediated knockdown of BDH2 results in siderophore depletion. Mammalian cells lacking the siderophore accumulate abnormally high amounts of cytoplasmic iron, resulting in elevated levels of reactive oxygen species, whereas the mitochondria are iron deficient. Siderophore-depleted mammalian cells and zebrafish embryos fail to synthesize heme, an iron-dependent mitochondrial process. Our results reveal features of intracellular iron homeostasis that are conserved from bacteria through humans.	[Devireddy, Laxminarayana R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Devireddy, Laxminarayana R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Hart, Daniel O.; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Program Gene Funct & Express, Sch Med, Worcester, MA 01605 USA; [Hart, Daniel O.; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Goetz, David H.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco	Devireddy, LR (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	laxminarayana.devireddy@case.edu; michael.green@umassmed.edu			National Institutes of Health (NIH) [R01 DK081395-01, R01 CA115817-04]; Case Western Reserve University; March of Dimes and American Society of Hematology; NATIONAL CANCER INSTITUTE [R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081395] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; March of Dimes and American Society of Hematology(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Andrew Gulick, Michael Mueller, Udo Oppermann, Kostas Panto-poulos, Barry Paw, Arthur Skoultchi, David Plas, Sonia Levi, Jerry Kaplan, Maurice Burg, and David Turner for providing reagents; Andy Dancis, Heidi O'Neill, Yavuz Oktay, Stacy Dalheimer, Jon Donze, David Yao, Wei-Dong Chen, Marvin Neiman, Kiran Velpula, and Jun Liu for assistance with various experimental procedures; Jim and Barbara Evans from the University of Massachusetts Medical School Proteomics and Mass Spectrometry Facility for GC-MS analysis; and Sara Evans for editorial assistance. This work is supported by National Institutes of Health (NIH) grant R01 DK081395-01 and Case Western Reserve University start-up funds to L.R.D. and NIH grant R01 CA115817-04 to M.R.G. L.R.D. is also a recipient of career developmental awards from March of Dimes and American Society of Hematology. M.R.G. is an Investigator of the Howard Hughes Medical Institute.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Blat D, 2008, J MED CHEM, V51, P126, DOI 10.1021/jm070800l; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; FERNANDEZPOL JA, 1978, CELL, V14, P489, DOI 10.1016/0092-8674(78)90235-0; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Lukinova N, 2009, INVEST OPHTH VIS SCI, V50, P1440, DOI 10.1167/iovs.08-2545; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Powell CS, 2003, AM J PHYSIOL-LUNG C, V285, pL189, DOI 10.1152/ajplung.00253.2002; Rauen U, 2007, CHEMBIOCHEM, V8, P341, DOI 10.1002/cbic.200600311; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sundlov JA, 2006, ACTA CRYSTALLOGR D, V62, P734, DOI 10.1107/S0907444906015824; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	37	213	223	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1006	1017		10.1016/j.cell.2010.04.040	http://dx.doi.org/10.1016/j.cell.2010.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550936	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000278618800015
J	Bloom, JD; Gong, LI; Baltimore, D				Bloom, Jesse D.; Gong, Lizhi Ian; Baltimore, David			Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance	SCIENCE			English	Article							NEURAMINIDASE INHIBITORS; A VIRUS; ANTIBIOTIC-RESISTANCE; PROTEIN; TRANSMISSION; REPLICATION; STABILITY; SEGMENTS; MUTANTS	The His(274)-> Tyr(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidase but had long been thought to compromise viral fitness. However, beginning in 2007-2008, viruses containing H274Y rapidly became predominant among human seasonal H1N1 isolates. We show that H274Y decreases the amount of neuraminidase that reaches the cell surface and that this defect can be counteracted by secondary mutations that also restore viral fitness. Two such mutations occurred in seasonal H1N1 shortly before the widespread appearance of H274Y. The evolution of oseltamivir resistance was therefore enabled by "permissive" mutations that allowed the virus to tolerate subsequent occurrences of H274Y. An understanding of this process may provide a basis for predicting the evolution of oseltamivir resistance in other influenza strains.	[Bloom, Jesse D.; Gong, Lizhi Ian; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Bloom, Jesse D/C-6837-2013; Bloom, Jesse D/K-3695-2019	Bloom, Jesse D/0000-0003-1267-3408; 	Cancer Research Institute; California Institute of Technology; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER	Cancer Research Institute; California Institute of Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.D.B. was supported by a Beckman Institute Postdoctoral Fellowship and the Irvington Institute Fellowship Program of the Cancer Research Institute. L.I.G. was supported by a Summer Undergraduate Research Fellowship from the California Institute of Technology. Oseltamivir carboxylate was kindly provided by Roche.	Abed Y, 2004, ANTIVIR THER, V9, P577; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kramarz P, 2009, EUROSURVEILLANCE, V14; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Po ALW, 2009, EMERG INFECT DIS, V15, P1686, DOI 10.3201/eid1510.090844; Poteete AR, 1997, PROTEIN SCI, V6, P2418; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; 2010, WKLY EPIDEMIOL REC, V85, P37	32	473	494	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1272	1275		10.1126/science.1187816	http://dx.doi.org/10.1126/science.1187816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522774	Green Accepted			2022-12-24	WOS:000278318600033
J	Liu, W; Tanasa, B; Tyurina, OV; Zhou, TY; Gassmann, R; Liu, WT; Ohgi, KA; Benner, C; Garcia-Bassets, I; Aggarwal, AK; Desai, A; Dorrestein, PC; Glass, CK; Rosenfeld, MG				Liu, Wen; Tanasa, Bogdan; Tyurina, Oksana V.; Zhou, Tian Yuan; Gassmann, Reto; Liu, Wei Ting; Ohgi, Kenneth A.; Benner, Chris; Garcia-Bassets, Ivan; Aggarwal, Aneel K.; Desai, Arshad; Dorrestein, Pieter C.; Glass, Christopher K.; Rosenfeld, Michael G.			PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression	NATURE			English	Article							S-PHASE; CHROMOSOME STRUCTURE; MENTAL-RETARDATION; HEAT REPEATS; METHYLATION; IDENTIFICATION; STABILITY; BINDING; PROTEIN; GENOME	While reversible histone modifications are linked to an ever-expanding range of biological functions(1-5), the demethylases for histone H4 lysine 20 and their potential regulatory roles remain unknown. Here we report that the PHD and Jumonji C (JmjC) domain-containing protein, PHF8, while using multiple substrates, including H3K9me1/2 and H3K27me2, also functions as an H4K20me1 demethylase. PHF8 is recruited to promoters by its PHD domain based on interaction with H3K4me2/3 and controls G1-S transition in conjunction with E2F1, HCF-1 (also known as HCFC1) and SET1A (also known as SETD1A), at least in part, by removing the repressive H4K20me1 mark from a subset of E2F1-regulated gene promoters. Phosphorylation-dependent PHF8 dismissal from chromatin in prophase is apparently required for the accumulation of H4K20me1 during early mitosis, which might represent a component of the condensin II loading process. Accordingly, the HEAT repeat clusters in two non-structuralmaintenance of chromosomes (SMC) condensin II subunits, N-CAPD3 and N-CAPG2 (also known as NCAPD3 and NCAPG2, respectively), are capable of recognizing H4K20me1, and ChIP-Seq analysis demonstrates a significant overlap of condensin II and H4K20me1 sites in mitotic HeLa cells. Thus, the identification and characterization of an H4K20me1 demethylase, PHF8, has revealed an intimate link between this enzyme and two distinct events in cell cycle progression.	[Liu, Wen; Tanasa, Bogdan; Tyurina, Oksana V.; Zhou, Tian Yuan; Ohgi, Kenneth A.; Garcia-Bassets, Ivan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Liu, Wen] Univ Calif San Diego, Grad Program Biol, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Gassmann, Reto; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Liu, Wei Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Glass, Christopher/AAI-3933-2021; Dorrestein, Pieter/D-5012-2012; Garcia-Bassets, Ivan/F-5075-2010; Gassmann, Reto/M-6488-2013	Glass, Christopher/0000-0003-4344-3592; Gassmann, Reto/0000-0002-0360-2977; Garcia-Bassets, Ivan/0000-0002-6941-9585; Benner, Christopher/0000-0002-4618-0719; Liu, Wen/0000-0003-3434-4162	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097134-09, R01 CA097134] Funding Source: Medline; NHLBI NIH HHS [R01 HL065445] Funding Source: Medline; NIDDK NIH HHS [R01 DK018477-35, R01 DK039949, R01 DK039949-18, R37 DK039949, R01 DK018477] Funding Source: Medline; NINDS NIH HHS [R01 NS034934-21, R01 NS034934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Haering CH, 2009, CHROMOSOME RES, V17, P127, DOI 10.1007/s10577-008-9008-8; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schwender H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-144; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wolf F, 2007, CELL CYCLE, V6, P1408; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	289	300	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					508	U14		10.1038/nature09272	http://dx.doi.org/10.1038/nature09272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20622854	Green Accepted, Green Published			2022-12-24	WOS:000280141200040
J	Hapfelmeier, S; Lawson, MAE; Slack, E; Kirundi, JK; Stoel, M; Heikenwalder, M; Cahenzli, J; Velykoredko, Y; Balmer, ML; Endt, K; Geuking, MB; Curtiss, R; McCoy, KD; Macpherson, AJ				Hapfelmeier, Siegfried; Lawson, Melissa A. E.; Slack, Emma; Kirundi, Jorum K.; Stoel, Maaike; Heikenwalder, Mathias; Cahenzli, Julia; Velykoredko, Yuliya; Balmer, Maria L.; Endt, Kathrin; Geuking, Markus B.; Curtiss, Roy, III; McCoy, Kathy D.; Macpherson, Andrew J.			Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses	SCIENCE			English	Article							PLASMA-CELLS; COMMENSAL BACTERIA; T-CELLS; MEMORY; MAINTENANCE; GUT	The lower intestine of adult mammals is densely colonized with nonpathogenic (commensal) microbes. Gut bacteria induce protective immune responses, which ensure host-microbial mutualism. The continuous presence of commensal intestinal bacteria has made it difficult to study mucosal immune dynamics. Here, we report a reversible germ-free colonization system in mice that is independent of diet or antibiotic manipulation. A slow (more than 14 days) onset of a long-lived (half-life over 16 weeks), highly specific anticommensal immunoglobulin A (IgA) response in germ-free mice was observed. Ongoing commensal exposure in colonized mice rapidly abrogated this response. Sequential doses lacked a classical prime-boost effect seen in systemic vaccination, but specific IgA induction occurred as a stepwise response to current bacterial exposure, such that the antibody repertoire matched the existing commensal content.	[Hapfelmeier, Siegfried; Slack, Emma; Kirundi, Jorum K.; Balmer, Maria L.; Macpherson, Andrew J.] Univ Bern, Univ Klin Viszerale Chirurg & Med UVCM, DKF Maurice Muller Labs, MEM, CH-3013 Bern, Switzerland; [Hapfelmeier, Siegfried; Lawson, Melissa A. E.; Slack, Emma; Kirundi, Jorum K.; Stoel, Maaike; Cahenzli, Julia; Velykoredko, Yuliya; Geuking, Markus B.; McCoy, Kathy D.; Macpherson, Andrew J.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Endt, Kathrin] Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA	University of Bern; University Hospital of Bern; McMaster University; University of Zurich; University Zurich Hospital; Arizona State University; Arizona State University-Tempe	Hapfelmeier, S (corresponding author), Univ Bern, Univ Klin Viszerale Chirurg & Med UVCM, DKF Maurice Muller Labs, MEM, CH-3013 Bern, Switzerland.	hapfelmeier@gmail.com; andrew.macpherson@insel.ch	McCoy, Kathy/ABD-5814-2021; Hapfelmeier, Siegfried/B-6005-2011; Lawson, Melissa/K-5848-2014; Balmer, Maria L/A-8546-2013; Heikenwalder, Mathias/AAA-2269-2020; Slack, Emma/AAD-5837-2019; Slack, Emma/B-1612-2016; Balmer, Maria Luisa/AAB-8993-2021	Hapfelmeier, Siegfried/0000-0002-6913-7932; Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Balmer, Maria Luisa/0000-0003-0356-6352; Lawson, Melissa/0000-0001-9882-8663; Kirundi, Jorum/0000-0001-9617-0634	Swiss National Science Foundation [310030_124732]; Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Genome Canada; Farncombe Foundation; Canadian Association of Gastroenterology; Canada Research Chairs program; Oncosuisse Foundation [OCS 02113-08-2007]; German Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Genome Canada(Genome Canada); Farncombe Foundation; Canadian Association of Gastroenterology; Canada Research Chairs program(Canada Research Chairs); Oncosuisse Foundation; German Science Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Zhang, H. Roberts, J. Notarangelo, S. Armstrong, S. Competente, M. Provenza, J. Bodewes, and R. McArthur for their technical support and B. Stecher, W.-D. Hardt, A. J. Muller, N. A. Bos, C. Mueller, R. M. Zinkernagel, A. G. Rolink, A. Lanzavecchia, and C. Reis e Sousa for their helpful comments and editing the manuscript. Grant support: Swiss National Science Foundation (310030_124732), Canadian Institutes of Health Research, Crohn's and Colitis Foundation of Canada, Genome Canada, Farncombe Foundation, Canadian Association of Gastroenterology. This research was also supported with funding from the Canada Research Chairs program to K. D. M. and A. J. M. M. H. is a fellow of the Prof. Dr. Max Cloetta foundation and was supported by grants of the Oncosuisse Foundation (OCS 02113-08-2007). S. H. was supported in part by a German Science Foundation fellowship, and the clean mouse facility Bern was supported by the Genaxen Foundation. The authors have no conflicts of interests to declare.	BENTLEY AT, 1988, J BACTERIOL, V170, P1063, DOI 10.1128/jb.170.3.1063-1068.1988; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; FECSIK AI, 1964, J EXP MED, V120, P1041, DOI 10.1084/jem.120.6.1041; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MATTIOLI CA, 1973, J EXP MED, V138, P452, DOI 10.1084/jem.138.2.452; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Tough DF, 2003, TRENDS IMMUNOL, V24, P404, DOI 10.1016/S1471-4906(03)00169-8; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	16	485	526	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1705	1709		10.1126/science.1188454	http://dx.doi.org/10.1126/science.1188454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576892	Green Accepted			2022-12-24	WOS:000279107400047
J	Martello, G; Rosato, A; Ferrari, F; Manfrin, A; Cordenonsi, M; Dupont, S; Enzo, E; Guzzardo, V; Rondina, M; Spruce, T; Parenti, AR; Daidone, MG; Bicciato, S; Piccolo, S				Martello, Graziano; Rosato, Antonio; Ferrari, Francesco; Manfrin, Andrea; Cordenonsi, Michelangelo; Dupont, Sirio; Enzo, Elena; Guzzardo, Vincenza; Rondina, Maria; Spruce, Thomas; Parenti, Anna R.; Daidone, Maria Grazia; Bicciato, Silvio; Piccolo, Stefano			A MicroRNA Targeting Dicer for Metastasis Control	CELL			English	Article							EXPRESSION; DEFINITION; SIGNATURE; INVASION; SUBTYPES; GENES; FILES; ZEB1; RNAS	Although specific microRNAs (miRNAs) can be upregulated in cancer, global miRNA downregulation is a common trait of human malignancies. The mechanisms of this phenomenon and the advantages it affords remain poorly understood. Here we identify a microRNA family, miR-103/107, that attenuates miRNA biosynthesis by targeting Dicer, a key component of the miRNA processing machinery. In human breast cancer, high levels of miR-103/107 are associated with metastasis and poor outcome. Functionally, miR-103/107 confer migratory capacities in vitro and empower metastatic dissemination of otherwise nonaggressive cells in vivo. Inhibition of miR-103/107 opposes migration and metastasis of malignant cells. At the cellular level, a key event fostered by miR-103/107 is induction of epithelial-to-mesenchymal transition (EMT), attained by downregulating miR-200 levels. These findings suggest a new pathway by which Dicer inhibition drifts epithelial cancer toward a less-differentiated, mesenchymal fate to foster metastasis.	[Martello, Graziano; Manfrin, Andrea; Cordenonsi, Michelangelo; Dupont, Sirio; Enzo, Elena; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35126 Padua, Italy; [Rosato, Antonio; Rondina, Maria] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Rosato, Antonio] Ist Oncol Veneto, I-35126 Padua, Italy; [Ferrari, Francesco; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy; [Guzzardo, Vincenza; Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Spruce, Thomas] Univ London Imperial Coll Sci Technol & Med, MRC, Mol Embryol Grp, Ctr Clin Sci, London W12 0NN, England; [Daidone, Maria Grazia] Natl Canc Inst, Dept Expt Oncol, I-20133 Milan, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Universita di Modena e Reggio Emilia; University of Padua; Imperial College London; Fondazione IRCCS Istituto Nazionale Tumori Milan	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35126 Padua, Italy.	piccolo@bio.unipd.it	Manfrin, Andrea/AAC-1066-2020; Rosato, Antonio/E-8626-2010; Spruce, Thomas/K-7520-2017; Cordenonsi, Michelangelo/K-7692-2016; Daidone, Maria Grazia/E-9232-2017; BICCIATO, Silvio/J-4466-2019; Ferrari, Francesco/H-5007-2012; Dupont, Sirio/AAP-8133-2021; Bicciato, Silvio/C-9825-2009; Martello, Graziano/AAM-3325-2021	Manfrin, Andrea/0000-0002-1519-6582; Rosato, Antonio/0000-0002-5263-8386; Spruce, Thomas/0000-0001-7389-9254; Cordenonsi, Michelangelo/0000-0002-8253-5724; Daidone, Maria Grazia/0000-0002-4786-1321; BICCIATO, Silvio/0000-0002-1944-7078; Ferrari, Francesco/0000-0002-9811-3753; Bicciato, Silvio/0000-0002-1944-7078; Dupont, Sirio/0000-0002-6869-1966; Enzo, Elena/0000-0001-9768-6368; PICCOLO, STEFANO/0000-0002-2037-0004; Martello, Graziano/0000-0001-5520-085X	Cariparo Foundation; Carimodena Foundation; AIRC; University of Padua; IIT (Italian Institute of Technology); Telethon; ISSN "Giovani Ricercatori"	Cariparo Foundation(Fondazione Cariparo); Carimodena Foundation; AIRC(Fondazione AIRC per la ricerca sul cancro); University of Padua; IIT (Italian Institute of Technology)(Istituto Italiano di Tecnologia - IIT); Telethon(Fondazione Telethon); ISSN "Giovani Ricercatori"	This work is supported by Cariparo Foundation Excellence-grant and Carimodena Foundation international grants to S. B., and AIRC, University of Padua Strategic-grant, Cariparo Foundation Excellence-grant, IIT (Italian Institute of Technology), and Telethon grants to S. P., and ISSN "Giovani Ricercatori" to G. M. We thank T. Rodriguez, O. Wessely, and D. Volpin for comments on the manuscript; the anonymous reviewers for thoughtful directions; and S. Bobisse and R. Venerando for help with cytofluorimeter. We are grateful to colleagues for gifts of reagents: L. Naldini (lentiviral vectors), T. Jacks (mouse shDicer plasmid), P. Provost (Dicer cDNA), W. Filipowicz (Dicer antibody), R. Agami (miR-Vec), F. Miller (4T1 cells), G. Hannon (Dicer null cells), and R. Weinberg (SUM149 cells).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bicciato S, 2009, NUCLEIC ACIDS RES, V37, P5057, DOI 10.1093/nar/gkp520; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	46	528	556	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1195	U176		10.1016/j.cell.2010.05.017	http://dx.doi.org/10.1016/j.cell.2010.05.017			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603000	Bronze			2022-12-24	WOS:000279148100016
J	Alvarez, SE; Harikumar, KB; Hait, NC; Allegood, J; Strub, GM; Kim, EY; Maceyka, M; Jiang, HL; Luo, C; Kordula, T; Milstien, S; Spiegel, S				Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Jiang, Hualiang; Luo, Cheng; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah			Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE; TNF-ALPHA; ACTIVATION; KINASE; RIP1; IKK; UBIQUITYLATION; BINDING; CELLS; P38	Tumour-necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key component in NF-kappa B signalling triggered by TNF-alpha(1,2). Genetic evidence indicates that TRAF2 is necessary for the polyubiquitination of receptor interacting protein 1 (RIP1)(3) that then serves as a platform for recruitment and stimulation of I kappa B kinase, leading to activation of the transcription factor NF-kappa B. Although TRAF2 is a RING domain ubiquitin ligase, direct evidence that TRAF2 catalyses the ubiquitination of RIP1 is lacking. TRAF2 binds to sphingosine kinase 1 (SphK1)(4), one of the isoenzymes that generates the pro-survival lipid mediator sphingosine-1-phosphate (S1P) inside cells. Here we show that SphK1 and the production of S1P is necessary for lysine-63-linked polyubiquitination of RIP1, phosphorylation of I kappa B kinase and I kappa B alpha, and I kappa B alpha degradation, leading to NF-kappa B activation. These responses were mediated by intracellular S1P independently of its cell surface G-protein-coupled receptors. S1P specifically binds to TRAF2 at the amino-terminal RING domain and stimulates its E3 ligase activity. S1P, but not dihydro-S1P, markedly increased recombinant TRAF2-catalysed lysine-63-linked, but not lysine-48-linked, polyubiquitination of RIP1 in vitro in the presence of the ubiquitin conjugating enzymes (E2) UbcH13 or UbcH5a. Our data show that TRAF2 is a novel intracellular target of S1P, and that S1P is the missing cofactor for TRAF2 E3 ubiquitin ligase activity, indicating a new paradigm for the regulation of lysine-63-linked polyubiquitination. These results also highlight the key role of SphK1 and its product S1P in TNF-alpha signalling and the canonical NF-kappa B activation pathway important in inflammatory, antiapoptotic and immune processes.	[Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, Richmond, VA 23298 USA; [Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Harikumar, Kuzhuvelil/AAC-2407-2020; Maceyka, Michael/B-9277-2008	Harikumar, Kuzhuvelil/0000-0002-1763-4179; 	National Institute of Health [R37GM043880, R01CA61774, R01AI50094, U19AI077435]; Ministry of Scientific and Technology of China [2009CB918502]; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050094, U19AI077435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Scientific and Technology of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. J. Chen, B. Darnay and M. Karin for HA-ubiquitin and TRAF constructs, and R. Proia for the Sphk1<SUP>-/-</SUP> mice. This work was supported by grants from the National Institute of Health (R37GM043880, R01CA61774, R01AI50094, U19AI077435 to S.S.) and in part by the Ministry of Scientific and Technology of China (2009CB918502 to C.L.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; VAN BJ, 1998, J CELL BIOL, V142, P229; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	30	548	583	8	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1084	U149		10.1038/nature09128	http://dx.doi.org/10.1038/nature09128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577214	Green Accepted			2022-12-24	WOS:000279056900054
J	Takeuchi, H; Inokuchi, K; Aoki, M; Suto, F; Tsuboi, A; Matsuda, I; Suzuki, M; Aiba, A; Serizawa, S; Yoshihara, Y; Fujisawa, H; Sakano, H				Takeuchi, Haruki; Inokuchi, Kasumi; Aoki, Mari; Suto, Fumikazu; Tsuboi, Akio; Matsuda, Ikuo; Suzuki, Misao; Aiba, Atsu; Serizawa, Shou; Yoshihara, Yoshihiro; Fujisawa, Hajime; Sakano, Hitoshi			Sequential Arrival and Graded Secretion of Sema3F by Olfactory Neuron Axons Specify Map Topography at the Bulb	CELL			English	Article							ODORANT RECEPTOR GENES; CELL-ADHESION MOLECULE; SENSORY NEURONS; ZONAL SEGREGATION; SEMAPHORIN 3F; MOUSE; EXPRESSION; GLOMERULI; SYSTEM; NEUROPILIN-2	In the mouse olfactory system, the anatomical locations of olfactory sensory neurons (OSNs) roughly correlate with their axonal projection sites along the dorsal-ventral (D-V) axis of the olfactory bulb (OB). Here we report that an axon guidance receptor, Neuropilin-2 (Nrp2), and its repulsive ligand, Sema-phorin-3F (Sema3F), are expressed by OSNs in a complementary manner that is important for establishing olfactory map topography. Sema3F is secreted by early-arriving axons of OSNs and is deposited at the anterodorsal OB to repel Nrp2-positive axons that arrive later. Sequential arrival of OSN axons as well as the graded and complementary expression of Nrp2 and Sema3F by OSNs help to form the topographic order along the D-V axis.	[Takeuchi, Haruki; Inokuchi, Kasumi; Aoki, Mari; Serizawa, Shou; Sakano, Hitoshi] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan; [Suto, Fumikazu] Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; [Suto, Fumikazu] Tohoku Univ, Div Dev Neurosci, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Tsuboi, Akio] Nara Med Univ, Lab Mol Biol Neural Syst, Nara 6348521, Japan; [Matsuda, Ikuo; Aiba, Atsu] Kobe Univ, Grad Sch Med, Div Mol Genet, Kobe, Hyogo 6500017, Japan; [Suzuki, Misao] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; [Fujisawa, Hajime] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Nara Medical University; Kobe University; Kumamoto University; RIKEN; Nagoya University	Sakano, H (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Tsuboi, Akio/R-6793-2019; Yoshihara, Yoshihiro/N-6481-2015	Tsuboi, Akio/0000-0002-4790-4512; Yoshihara, Yoshihiro/0000-0002-0319-7166; Aoki, Mari/0000-0002-2598-9850; Aiba, Atsu/0000-0002-8192-0778; Takeuchi, Haruki/0000-0003-4911-4060	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program, Biosignaling, at the University of Tokyo	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program, Biosignaling, at the University of Tokyo(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to M. Hori and S. Takashima for Nrp2 knockin mice, Y. Hiromi for anti-PlxnA3 antibodies, and members of our laboratory for their valuable comments. This work was supported by the Mitsubishi Foundation and by the Specially Promoted Research Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H.T. was a pre-doctoral fellow of the Japan Society for the Promotion of Science and is supported by the Global COE Program, Biosignaling, at the University of Tokyo. This paper is dedicated to the late Shou Serizawa, who was a brilliant young scientist with a lot of potential.	ASTIC L, 1987, BRAIN RES, V424, P144, DOI 10.1016/0006-8993(87)91204-2; Bailey MS, 1999, J COMP NEUROL, V415, P423; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen Y, 2006, CELL, V127, P881, DOI 10.1016/j.cell.2006.11.017; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Duggan CD, 2008, J NEUROSCI, V28, P5229, DOI 10.1523/JNEUROSCI.1134-08.2008; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Hirata T, 2006, DEVELOPMENT, V133, P1433, DOI 10.1242/dev.02329; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Prince JEA, 2009, J NEUROSCI, V29, P14211, DOI 10.1523/JNEUROSCI.3948-09.2009; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sahay A, 2003, J NEUROSCI, V23, P6671; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Treloar HB, 2003, J COMP NEUROL, V458, P389, DOI 10.1002/cne.10590; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	53	102	102	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1056	1067		10.1016/j.cell.2010.04.041	http://dx.doi.org/10.1016/j.cell.2010.04.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550939	Bronze			2022-12-24	WOS:000278618800019
J	Kim, AM; Tingen, CM; Woodruff, TK				Kim, Alison M.; Tingen, Candace M.; Woodruff, Teresa K.			Sex bias in trials and treatment must end	NATURE			English	Editorial Material							BLOOD INSTITUTE; CLINICAL-TRIALS; NATIONAL HEART; WOMEN; LUNG; GUIDELINES; ENROLLMENT; ADHERENCE; HEALTH		[Kim, Alison M.; Tingen, Candace M.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Woodruff, Teresa K.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Kim, AM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu	Kim, Alison/D-6969-2014	Kim, Alison/0000-0001-5845-1865; Woodruff, Teresa/0000-0002-1197-3399; Tingen, Candace/0000-0003-3503-019X				Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Bristol-Gould S, 2010, WOMENS HEALTH, V6, P183, DOI [10.2217/whe.10.10, 10.2217/WHE.10.10]; Day SC, 1996, AM J MED, V100, P375, DOI 10.1016/S0002-9343(97)89510-1; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Henrich JB, 2006, ACAD MED, V81, P476, DOI 10.1097/01.ACM.0000222268.60211.fc; Holden C, 2008, SCIENCE, V322, P219, DOI 10.1126/science.322.5899.219; Kim ESH, 2008, J AM COLL CARDIOL, V52, P672, DOI 10.1016/j.jacc.2008.05.025; Lewis V, 2010, INT J CARDIOL, V139, P204, DOI 10.1016/j.ijcard.2008.08.024; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mostertz W, 2010, JAMA-J AM MED ASSOC, V303, P535, DOI 10.1001/jama.2010.80; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	13	153	154	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					688	689		10.1038/465688a	http://dx.doi.org/10.1038/465688a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535184				2022-12-24	WOS:000278551800018
J	Smith, MR; Caron, JB				Smith, Martin R.; Caron, Jean-Bernard			Primitive soft-bodied cephalopods from the Cambrian	NATURE			English	Article							BURGESS SHALE; BRITISH-COLUMBIA; MOLLUSK; RADULA; ORIGIN; FOSSIL	The exquisite preservation of soft-bodied animals in Burgess Shale-type deposits provides important clues into the early evolution of body plans that emerged during the Cambrian explosion(1). Until now, such deposits have remained silent regarding the early evolution of extant molluscan lineages-in particular the cephalopods. Nautiloids, traditionally considered basal within the cephalopods, are generally depicted as evolving from a creeping Cambrian ancestor whose dorsal shell afforded protection and buoyancy(2). Although nautiloid-like shells occur from the Late Cambrian onwards, the fossil record provides little constraint on this model, or indeed on the early evolution of cephalopods. Here, we reinterpret the problematic Middle Cambrian animal Nectocaris pteryx(3,4) as a primitive (that is, stem-group), non-mineralized cephalopod, based on new material from the Burgess Shale. Together with Nectocaris, the problematic Lower Cambrian taxa Petalilium(5) and (probably) Vetustovermis(6,7) form a distinctive clade, Nectocarididae, characterized by an open axial cavity with paired gills, wide lateral fins, a single pair of long, prehensile tentacles, a pair of non-faceted eyes on short stalks, and a large, flexible anterior funnel. This clade extends the cephalopods' fossil record(2) by over 30 million years, and indicates that primitive cephalopods lacked a mineralized shell, were hyperbenthic, and were presumably carnivorous. The presence of a funnel suggests that jet propulsion evolved in cephalopods before the acquisition of a shell. The explosive diversification of mineralized cephalopods in the Ordovician may have an understated Cambrian 'fuse'.	[Smith, Martin R.; Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada; [Smith, Martin R.; Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	Caron, JB (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	jcaron@rom.on.ca	Smith, Martin Ross/B-8461-2012	Smith, Martin Ross/0000-0001-5660-1727; Caron, Jean-Bernard/0000-0002-1670-5502	Natural Sciences and Engineering Research Council of Canada; University of Toronto	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Toronto(University of Toronto)	We thank S. Conway Morris, D. Fuchs, A. Lindgren, A. Scheltema, C. Schander and M. Vecchione for critically reading earlier drafts; R. Gaines for comments on preservation; J.-Y. Chen, M.-Y. Zhu and J. Paterson for images of Petalilium and Vetustovermis; and Parks Canada for research and collection permits delivered to Royal Ontario Museum teams led by D. Collins. P. Fenton assisted with collections, and S. Lackie with scanning electron microscopy. This research was undertaken as part of a PhD thesis (M.R.S.) in the Department of Ecology and Evolutionary Biology, University of Toronto. Funding was provided by Natural Sciences and Engineering Research Council of Canada Discovery Grant through J.-B. C and University of Toronto fellowships to M. R. S. This is Royal Ontario Museum Burgess Shale Research Project 27.	BEEDHAM GE, 1968, J ZOOL, V154, P443; BRIGGS DEG, 1981, PHILOS T ROY SOC B, V291, P541, DOI 10.1098/rstb.1981.0007; Butterfield NJ, 2008, J PALEONTOL, V82, P543, DOI 10.1666/07-066.1; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Chen JY, 2005, P ROY SOC B-BIOL SCI, V272, P2003, DOI 10.1098/rspb.2005.3159; Conway Morris Simon, 1997, CRUCIBLE CREATION BU; Dzik J, 2010, MALACOLOGIA, V52, P97, DOI 10.4002/040.052.0107; Fedonkin MA, 2007, GEOL SOC SPEC PUBL, V286, P157, DOI 10.1144/SP286.12; FLOWER RH, 1961, J PALEONTOL, V35, P569; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gabbott SE, 2008, J GEOL SOC LONDON, V165, P307, DOI 10.1144/0016-76492007-023; Glaessner M.F., 1979, ALCHERINGA, V3, P21, DOI DOI 10.1080/03115517908565437; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; JOHNSON R G, 1969, Fieldiana Geology, V12, P119; LUO H., 1999, EARLY CAMBRIAN CHENG; Marin F, 1996, P NATL ACAD SCI USA, V93, P1554, DOI 10.1073/pnas.93.4.1554; Marinichev AN, 2007, RUSS J APPL CHEM+, V80, P209, DOI 10.1134/S1070427207020085; MORRIS S C, 1977, Palaeontologische Zeitschrift, V51, P271; MORRIS SC, 1976, NEUES JB GEOLOGIE PA, V12, P703; NIXON M, 1985, PALAEONTOLOGY NEONTO, P103; Shea EK, 2005, INVERTEBR BIOL, V124, P25, DOI 10.1111/j.1744-7410.2005.1241-04.x; SIMONETTA AM, 1988, B ZOOL, V55, P63; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; YOCHELSON EL, 1973, LETHAIA, V6, P275, DOI 10.1111/j.1502-3931.1973.tb01199.x	25	50	53	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					469	472		10.1038/nature09068	http://dx.doi.org/10.1038/nature09068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20505727	Green Published			2022-12-24	WOS:000278043700033
J	Cardenas, C; Miller, RA; Smith, I; Bui, T; Molgo, J; Muller, M; Vais, H; Cheung, KH; Yang, J; Parker, I; Thompson, CB; Birnbaum, MJ; Hallows, KR; Foskett, JK				Cardenas, Cesar; Miller, Russell A.; Smith, Ian; Bui, Thi; Molgo, Jordi; Mueller, Marioly; Vais, Horia; Cheung, King-Ho; Yang, Jun; Parker, Ian; Thompson, Craig B.; Birnbaum, Morris J.; Hallows, Kenneth R.; Foskett, J. Kevin			Essential Regulation of Cell Bioenergetics by Constitutive InsP(3) Receptor Ca2+ Transfer to Mitochondria	CELL			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; CALCIUM SIGNALS; ATP SYNTHESIS; AUTOPHAGY; CHANNEL; APOPTOSIS; MTOR	Mechanisms that regulate cellular metabolism are a fundamental requirement of all cells. Most eukaryotic cells rely on aerobic mitochondrial metabolism to generate ATP. Nevertheless, regulation of mitochondrial activity is incompletely understood. Here we identified an unexpected and essential role for constitutive InsP(3)R-mediated Ca2+ release in maintaining cellular bioenergetics. Macroautophagy provides eukaryotes with an adaptive response to nutrient deprivation that prolongs survival. Constitutive InsP(3)R Ca2+ signaling is required for macroautophagy suppression in cells in nutrient-replete media. In its absence, cells become metabolically compromised due to diminished mitochondrial Ca2+ uptake. Mitochondrial uptake of InsP(3)R-released Ca2+ is fundamentally required to provide optimal bioenergetics by providing sufficient reducing equivalents to support oxidative phosphorylation. Absence of this Ca2+ transfer results in enhanced phosphorylation of pyruvate dehydrogenase and activation of AMPK, which activates prosurvival macroautophagy. Thus, constitutive InsP(3)R Ca2+ release to mitochondria is an essential cellular process that is required for efficient mitochondrial respiration and maintenance of normal cell bioenergetics.	[Cardenas, Cesar; Mueller, Marioly; Vais, Horia; Cheung, King-Ho; Yang, Jun; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Miller, Russell A.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Bui, Thi; Thompson, Craig B.] Univ Penn, Abramson Canc Inst, Philadelphia, PA 19104 USA; [Bui, Thi; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Smith, Ian; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Dev,UPR 3294, F-91198 Gif Sur Yvette, France; [Hallows, Kenneth R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; smith, ian/E-7528-2011; Muller, Marioly/J-5420-2014; Hallows, Kenneth/A-8477-2013; Cardenas, Julio C/I-3221-2013; /B-3424-2011	Hallows, Kenneth/0000-0002-2964-2440; Birnbaum, Morris/0000-0001-9972-8680; /0000-0001-8683-1654; Foskett, J. Kevin/0000-0002-8854-0268	NIH [GM/DK56328, MH059937, DK075048, CA099179, CA092660, GM48071, GM065830]; American Heart Association;  [DK079572]; NATIONAL CANCER INSTITUTE [R01CA092660, R01CA099179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056328, R01DK075048, F32DK079572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048071, R01GM056328, R37GM048071, R01GM065830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Robert Balaban for helpful discussions. This work was supported by NIH grants GM/DK56328 and MH059937 (J.K.F.), DK075048 (K. R. H.), CA099179 and CA092660 (C. T.), GM48071 (I. P.), and GM065830 (J.K.F. and I. P.). We thank the University of Pennsylvania Institute for Diabetes, Obesity and Metabolism (P30-DK19535) for assistance. C. C. was supported by an award from the American Heart Association. R. A. M. was supported by DK079572.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BROWN GC, 1992, BIOCHEM J, V284, P1; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Demuro A, 2006, CELL CALCIUM, V40, P413, DOI 10.1016/j.ceca.2006.08.006; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kimball SR, 2006, MED SCI SPORT EXER, V38, P1958, DOI 10.1249/01.mss.0000233796.16411.13; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MAK DOD, 1994, J BIOL CHEM, V269, P29375; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656	48	722	741	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					270	283		10.1016/j.cell.2010.06.007	http://dx.doi.org/10.1016/j.cell.2010.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655468	Bronze, Green Accepted			2022-12-24	WOS:000280204300018
J	Zhao, Z; Andersen, SU; Ljung, K; Dolezal, K; Miotk, A; Schultheiss, SJ; Lohmann, JU				Zhao, Zhong; Andersen, Stig U.; Ljung, Karin; Dolezal, Karel; Miotk, Andrej; Schultheiss, Sebastian J.; Lohmann, Jan U.			Hormonal control of the shoot stem-cell niche	NATURE			English	Article							AUXIN RESPONSE FACTORS; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYTOKININ; MERISTEM; WUSCHEL; FATE; EMBRYOGENESIS; BIOSYNTHESIS	The classic phytohormones cytokinin and auxin play essential roles in the maintenance of stem-cell systems embedded in shoot and root meristems, and exhibit complex functional interactions(1-4). Here we show that the activity of both hormones directly converges on the promoters of two A-type ARABIDOPSIS RESPONSE REGULATOR (ARR) genes, ARR7 and ARR15, which are negative regulators of cytokinin signalling(5) and have important meristematic functions(3). Whereas ARR7 and ARR15 expression in the shoot apical meristem (SAM) is induced by cytokinin, auxin has a negative effect, which is, at least in part, mediated by the AUXIN RESPONSE FACTOR5/MONOPTEROS (MP) transcription factor(6). Our results provide a mechanistic framework for hormonal control of the apical stem-cell niche and demonstrate how root and shoot stem-cell systems differ in their response to phytohormones.	[Zhao, Zhong; Miotk, Andrej; Lohmann, Jan U.] Heidelberg Univ, Dept Stem Cell Biol, D-69120 Heidelberg, Germany; [Zhao, Zhong; Andersen, Stig U.; Miotk, Andrej; Schultheiss, Sebastian J.; Lohmann, Jan U.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Ljung, Karin; Dolezal, Karel] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Dolezal, Karel] Palacky Univ, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Dolezal, Karel] Acad Sci Czech Republ, Inst Expt Bot, Olomouc 78371, Czech Republic; [Schultheiss, Sebastian J.] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Swedish University of Agricultural Sciences; Umea University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Eberhard Karls University of Tubingen; Max Planck Society	Lohmann, JU (corresponding author), Heidelberg Univ, Dept Stem Cell Biol, D-69120 Heidelberg, Germany.	jlohmann@meristemania.org	Doležal, Karel/H-2436-2014; Lohmann, Jan/T-3776-2019; Ljung, Karin/AAE-8691-2019; Zhao, Zhong/N-1999-2013	Doležal, Karel/0000-0003-4938-0350; Lohmann, Jan/0000-0003-3667-187X; Ljung, Karin/0000-0003-2901-189X; Zhao, Zhong/0000-0001-8044-0409; Schultheiss, Sebastian J/0000-0001-8488-906X; Andersen, Stig U./0000-0002-1096-1468	Human Frontier Science Program; EMBO; Carlsberg Foundation; Czech Ministry of Education [MSM 6198959216]; Max Planck Society;  [SFB446]	Human Frontier Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Carlsberg Foundation(Carlsberg Foundation); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Max Planck Society(Max Planck Society); 	We thank G. Jurgens, K. Schneitz and D. Weigel for reading the manuscript, and I. Weisswange for imaging. This work was supported by a Human Frontier Science Program Career Development Award, an EMBO Young Investigator Award, the SFB446 (all to J.U.L.), a Carlsberg Foundation fellowship (to S. U. A.), a Czech Ministry of Education grant (MSM 6198959216) (to K. D.) and the Max Planck Society.	Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KIEBER JJ, 2002, ARABIDOPSIS BOOK; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Nordstrom A, 2004, ANAL CHEM, V76, P2869, DOI 10.1021/ac0499017; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Speed T., 2003, STAT ANAL GENE EXPRE; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	34	331	355	8	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1089	U154		10.1038/nature09126	http://dx.doi.org/10.1038/nature09126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577215				2022-12-24	WOS:000279056900055
J	Ferron, M; Wei, JW; Yoshizawa, T; Del Fattore, A; DePinho, RA; Teti, A; Ducy, P; Karsenty, G				Ferron, Mathieu; Wei, Jianwen; Yoshizawa, Tatsuya; Del Fattore, Andrea; DePinho, Ronald A.; Teti, Anna; Ducy, Patricia; Karsenty, Gerard			Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; OSTEOCLAST FORMATION; GLUCOSE-TOLERANCE; BETA-CELL; OSTEOCALCIN; RECEPTOR; MICE; EXPRESSION; KNOCKOUT; DELETION	The broad expression of the insulin receptor suggests that the spectrum of insulin function has not been fully described. A cell type expressing this receptor is the osteoblast, a bone-specific cell favoring glucose metabolism through a hormone, osteocalcin, that becomes active once uncarboxylated. We show here that insulin signaling in osteoblasts is necessary for whole-body glucose homeostasis because it increases osteocalcin activity. To achieve this function insulin signaling in osteoblasts takes advantage of the regulation of osteoclastic bone resorption exerted by osteoblasts. Indeed, since bone resorption occurs at a pH acidic enough to decarboxylate proteins, osteoclasts determine the carboxylation status and function of osteocalcin. Accordingly, increasing or decreasing insulin signaling in osteoblasts promotes or hampers glucose metabolism in a bone resorption-dependent manner in mice and humans. Hence, in a feed-forward loop, insulin signals in osteoblasts activate a hormone, osteocalcin, that promotes glucose metabolism.	[Ferron, Mathieu; Wei, Jianwen; Yoshizawa, Tatsuya; Karsenty, Gerard] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Ducy, Patricia] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Del Fattore, Andrea; Teti, Anna] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA	Columbia University; Columbia University; University of L'Aquila; Harvard University; Harvard Medical School	Karsenty, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Del Fattore, Andrea/H-4409-2015; Del Fattore, Andrea/AAP-2045-2020; Ferron, Mathieu/M-7794-2013	Del Fattore, Andrea/0000-0003-3848-412X; Del Fattore, Andrea/0000-0003-3848-412X; DePinho, Ronald/0000-0002-5625-577X; Teti, Anna Maria/0000-0002-5887-4419; Yoshizawa, Tatsuya/0000-0002-5728-1996	Fond de la recherche en sante du Quebec; National Institutes of Health; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078042] Funding Source: NIH RePORTER	Fond de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Kousteni, T. Zee, R. L. Levine, M. Tremblay, and J. Vacher for reagents; Dr. J. Lacombe for help with transplantations; Drs. K. Henriksen and J. Bollerslev for generously sharing patient serum samples; Dr. T. Lam at the W. M. Keck Foundation Biotechnology Resource Laboratory, Yale University, for FT-ICR mass spectral analyses; and Drs. J. K. Kim and F. Mauvais-Jarvis for critical reading of the manuscript. This work was supported by a fellowship from the Fond de la recherche en sante du Quebec (M. F.), grants from the National Institutes of Health (G. K.), and the Juvenile Diabetes Research Foundation (P. D.). G. K. is a founder and member of the scientific advisory board of Escoublac Inc. P. D. is a founder and consultant of Escoublac Inc.	Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chengalvala MV, 2001, BIOCHEMISTRY-US, V40, P814, DOI 10.1021/bi0019996; Cousin W, 2004, BIOCHEM BIOPH RES CO, V321, P259, DOI 10.1016/j.bbrc.2004.06.137; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; ENGELKE JA, 1991, BIOCHIM BIOPHYS ACTA, V1078, P31, DOI 10.1016/0167-4838(91)90088-H; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Kaji H, 2009, J BONE MINER METAB, V27, P76, DOI 10.1007/s00774-008-0005-y; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; KASUGA M, 1983, J BIOL CHEM, V258, P973; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Sadler JE, 2004, NATURE, V427, P493, DOI 10.1038/427493a; Schaller S, 2005, DRUG NEWS PERSPECT, V18, P489, DOI 10.1358/dnp.2005.18.8.944546; Scheen AJ, 2005, DRUG SAFETY, V28, P601, DOI 10.2165/00002018-200528070-00004; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Yamauchi M, 2010, CLIN NUTR, V29, P761, DOI 10.1016/j.clnu.2010.02.010; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366	37	783	839	4	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					296	308		10.1016/j.cell.2010.06.003	http://dx.doi.org/10.1016/j.cell.2010.06.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655470	Green Accepted, Bronze			2022-12-24	WOS:000280204300020
J	Gahlay, G; Gauthier, L; Baibakov, B; Epifano, O; Dean, J				Gahlay, Gagandeep; Gauthier, Lyn; Baibakov, Boris; Epifano, Olga; Dean, Jurrien			Gamete Recognition in Mice Depends on the Cleavage Status of an Egg's Zona Pellucida Protein	SCIENCE			English	Article							SPERM RECEPTOR ACTIVITY; MOUSE SPERM; FERTILIZATION; ZP3; BINDING; INACTIVATION; FERTILITY; GLYCANS; GENE	At fertilization, mouse sperm bind to the zona pellucida (which consists of glycoproteins ZP1, ZP2, and ZP3) that surrounds eggs. A ZP2 cleavage model of gamete recognition requires intact ZP2, and a glycan release model postulates that zona glycans are ligands for sperm. These two models were tested by replacing endogenous protein with ZP2 that cannot be cleaved (Zp2(Mut)) or with ZP3 lacking implicated O glycans (Zp3(Mut)). Sperm bound to two-cell Zp2(Mut) embryos despite fertilization and cortical granule exocytosis. Contrary to prediction, sperm fertilized Zp3(Mut) eggs. Sperm at the surface of the zona pellucida remained acrosome-intact for more than 2 hours and were displaced by additional sperm. These data indicate that sperm-egg recognition depends on the cleavage status of ZP2 and that binding at the surface of the zona is not sufficient to induce sperm acrosome exocytosis.	[Gahlay, Gagandeep; Gauthier, Lyn; Baibakov, Boris; Epifano, Olga; Dean, Jurrien] NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, J (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA.	jurrien@helix.nih.gov	Gahlay, Gagandeep/F-3975-2010; Gahlay, Gagandeep/AAO-7928-2020	Gahlay, Gagandeep/0000-0002-0058-2827; 	NIH, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of NIH, National Institute of Diabetes and Digestive and Kidney Diseases.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; EAST IJ, 1985, DEV BIOL, V109, P268, DOI 10.1016/0012-1606(85)90454-3; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Jungnickel MK, 2003, CELL, V114, P401, DOI 10.1016/S0092-8674(03)00648-2; LEYTON L, 1989, J CELL BIOL, V108, P2163, DOI 10.1083/jcb.108.6.2163; LOPEZ LC, 1985, J CELL BIOL, V101, P1501, DOI 10.1083/jcb.101.4.1501; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rankin T, 1999, DEVELOPMENT, V126, P3847; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; Rankin TL, 1998, DEVELOPMENT, V125, P2415; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Tulsiani DRP, 1997, BIOL REPROD, V57, P487, DOI 10.1095/biolreprod57.3.487; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291	18	123	131	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					216	219		10.1126/science.1188178	http://dx.doi.org/10.1126/science.1188178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616279	Green Accepted			2022-12-24	WOS:000279635200049
J	Jin, H; White, SR; Shida, T; Schulz, S; Aguiar, M; Gygi, SP; Bazan, JF; Nachury, MV				Jin, Hua; White, Susan Roehl; Shida, Toshinobu; Schulz, Stefan; Aguiar, Mike; Gygi, Steven P.; Bazan, J. Fernando; Nachury, Maxence V.			The Conserved Bardet-Biedl Syndrome Proteins Assemble a Coat that Traffics Membrane Proteins to Cilia	CELL			English	Article							COMPLEX; IDENTIFICATION; MUTATIONS; DEFECTS; BBSOME; CARGO; LOCALIZATION; TRANSPORT; VESICLES; INPP5E	The BBSome is a complex of Bardet-Biedl Syndrome (BBS) proteins that shares common structural elements with COPI, COPII, and clathrin coats. Here, we show that the BBSome constitutes a coat complex that sorts membrane proteins to primary cilia. The BBSome is the major effector of the Arf-like GTPase Arl6/BBS3, and the BBSome and GTP-bound Arl6 colocalize at ciliary punctae in an interdependent manner. Strikingly, Arl6(GTP)-mediated recruitment of the BBSome to synthetic liposomes produces distinct patches of polymerized coat apposed onto the lipid bilayer. Finally, the ciliary targeting signal of somatostatin receptor 3 needs to be directly recognized by the BBSome in order to mediate targeting of membrane proteins to cilia. Thus, we propose that trafficking of BBSome cargoes to cilia entails the coupling of BBSome coat polymerization to the recognition of sorting signals by the BBSome.	[Jin, Hua; White, Susan Roehl; Shida, Toshinobu; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, D-07743 Jena, Germany; [Aguiar, Mike; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bazan, J. Fernando] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Stanford University; Friedrich Schiller University of Jena; Harvard University; Harvard Medical School; Roche Holding; Genentech	Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	nachury@stanford.edu	Nachury, Maxence/H-3695-2019; Bazan, J. Fernando/B-4562-2010; Nachury, Maxence/A-8759-2008; Schulz, Stefan/A-6928-2017	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; Schulz, Stefan/0000-0002-5997-8885; Aguiar, Mike/0000-0001-8175-010X	American Heart Association [AHA-0930365N]; March of Dimes [5-FY09-112]; National Institutes of Health/National Institute of General Medical Sciences [R01GM089933]; Sloan Research Fellowship [BR-5014]; Klingenstein Fellowship; NIH/NIGMS [F32GM089218]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089218, R01GM089933] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Klingenstein Fellowship(Klingenstein Philanthropies); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Suzanne Pfeffer and Scott Seeley for comments on the manuscript; Randy Schekman, Sean Studer, Susan Hamamoto, Ken Matsuoka and Chris Fromme for advice on liposome preparation and processing for EM; John Perrino and Jon Mulholland for assistance with EM; members of Dick Tsien's laboratory for help with hippocampal neuron culture; Brian Kobilka and Juan Jose Fung for help with liposome preparation; Val Sheffield for the BBS1 antibody; Melanie Tallent for the SSTR3 knockout; Joachim Seemann for the CD8 alpha cDNA; and Applied Precision for OMX imaging. This work was supported in part by grants to M.V.N. from the American Heart Association (AHA-0930365N), the March of Dimes (5-FY09-112), National Institutes of Health/National Institute of General Medical Sciences (R01GM089933), a Sloan Research Fellowship (BR-5014) and a Klingenstein Fellowship and by an NIH/NIGMS fellowship to S.R.W (F32GM089218). J.F.B. is an employee of Genentech, Inc.	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	52	406	414	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1208	U198		10.1016/j.cell.2010.05.015	http://dx.doi.org/10.1016/j.cell.2010.05.015			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603001	Bronze, Green Accepted			2022-12-24	WOS:000279148100017
J	Dorrn, AL; Yuan, K; Barker, AJ; Schreiner, CE; Froemke, RC				Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.			Developmental sensory experience balances cortical excitation and inhibition	NATURE			English	Article							PRIMARY AUDITORY-CORTEX; VISUAL-CORTEX; SYNAPTIC DEPRESSION; RECEPTIVE-FIELDS; BARREL CORTEX; IN-VIVO; PLASTICITY; RAT; NEURONS; COMPETITION	Early in life, neural circuits are highly susceptible to outside influences. The organization of the primary auditory cortex (A1) in particular is governed by acoustic experience during the critical period, an epoch near the beginning of postnatal development throughout which cortical synapses and networks are especially plastic(1-8). This neonatal sensitivity to the pattern of sensory inputs is believed to be essential for constructing stable and adequately adapted representations of the auditory world and for the acquisition of language skills by children(5,9,10). One important principle of synaptic organization in mature brains is the balance between excitation and inhibition, which controls receptive field structure and spatiotemporal flow of neural activity(11-15), but it is unknown how and when this excitatory-inhibitory balance is initially established and calibrated. Here we use whole-cell recording to determine the processes underlying the development of synaptic receptive fields in rat A1. We find that, immediately after the onset of hearing, sensory-evoked excitatory and inhibitory responses are equally strong, although inhibition is less stimulus-selective and mismatched with excitation. However, during the third week of postnatal development, excitation and inhibition become highly correlated. Patterned sensory stimulation drives coordinated synaptic changes across receptive fields, rapidly improves excitatory-inhibitory coupling and prevents further exposure-induced modifications. Thus, the pace of cortical synaptic receptive field development is set by progressive, experience-dependent refinement of intracortical inhibition.	[Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; [Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, WM Keck Fdn Ctr Integrat Neurosci, Neurosci Grad Program,Dept Otolaryngol, San Francisco, CA 94143 USA; [Dorrn, Anja L.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; [Dorrn, Anja L.] NeuroCure Neurosci Res Ctr NWFZ, D-13125 Berlin, Germany; [Froemke, Robert C.] NYU, Sch Med, Mol Neurobiol Program, Helen & Martin Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Skirball Inst Biomol Med, Dept Otolaryngol, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University; New York University; New York University; New York University	Froemke, RC (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	robert.froemke@med.nyu.edu	Barker, Alison/AAH-1905-2021	Barker, Alison/0000-0001-9103-9258; Dorrn, Anja L./0000-0002-4215-3609; Schreiner, Christoph/0000-0002-4571-4328; Froemke, Robert/0000-0002-1230-6811	National Institute on Deafness and Other Communication Disorders [K99/R00]; Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco; Hearing Research Inc.; John C. and Edward Coleman Fund; Jane Coffin Childs Postdoctoral Research Fellowship; Sandler Translational Research Fellowship; National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260, K99DC009635] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco(University of California System); Hearing Research Inc.; John C. and Edward Coleman Fund; Jane Coffin Childs Postdoctoral Research Fellowship; Sandler Translational Research Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. A. Atencio, T. Babcock, E. Chang, E. de Villers-Sidani, M. R. DeWeese, G. Ehret, S. Gandhi, K. Imaizumi, M. M. Merzenich, C. Niell, A.-M. Oswald, and A. Y. Tan for comments, discussions and technical assistance. This work was supported by the National Institute on Deafness and Other Communication Disorders, the Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco, Hearing Research Inc. and the John C. and Edward Coleman Fund. R. C. F. is a recipient of a National Institute on Deafness and Other Communication Disorders K99/R00 Career Award, a Jane Coffin Childs Postdoctoral Research Fellowship and a Sandler Translational Research Fellowship. A.J.B. is a recipient of a National Science Foundation Graduate Research Fellowship.	Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenet T, 2007, P NATL ACAD SCI USA, V104, P7646, DOI 10.1073/pnas.0701944104; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; SPITZER NC, 1979, ANNU REV NEUROSCI, V2, P363, DOI 10.1146/annurev.ne.02.030179.002051; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tallal P, 2002, DEV PSYCHOPATHOL, V14, P559, DOI 10.1017/S0954579402003097; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	29	196	198	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					932	U9		10.1038/nature09119	http://dx.doi.org/10.1038/nature09119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559387	Green Accepted, Green Submitted			2022-12-24	WOS:000278804500039
